Citrus Sinensis ID: 044510
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 253 | 2.2.26 [Sep-21-2011] | |||||||
| Q7X8C5 | 748 | Wall-associated receptor | yes | no | 0.984 | 0.332 | 0.519 | 1e-74 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.833 | 0.266 | 0.584 | 1e-71 | |
| Q9S9M5 | 730 | Wall-associated receptor | no | no | 0.826 | 0.286 | 0.593 | 2e-71 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.818 | 0.283 | 0.598 | 9e-71 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.826 | 0.274 | 0.569 | 2e-70 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.826 | 0.278 | 0.559 | 3e-70 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.822 | 0.270 | 0.578 | 2e-69 | |
| Q9S9M1 | 731 | Wall-associated receptor | no | no | 0.845 | 0.292 | 0.564 | 7e-69 | |
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.996 | 0.35 | 0.486 | 7e-68 | |
| Q9LN59 | 788 | Putative wall-associated | no | no | 0.826 | 0.265 | 0.576 | 8e-68 |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 279 bits (714), Expect = 1e-74, Method: Compositional matrix adjust.
Identities = 135/260 (51%), Positives = 191/260 (73%), Gaps = 11/260 (4%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VP+LVYEF+PNG L + +HD+++++T+TWE+ L IA+E++GALSYLHS S PIYHRDIK
Sbjct: 484 VPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIK 543
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
+ NILLD++ RAK+SDFG SR VTIDQTHLTT+V GTFGY+D EYF+SS+FT+K DVYSF
Sbjct: 544 TTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSF 603
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GVV V LLTG+KP +EE++ LA +F+ A+KEN + D++D ++ E +++++VA
Sbjct: 604 GVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDECNMDQVMSVAN 663
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIRAS-------IGPQNCEGIDFVGGNF----ETGS 229
LA+RCLN G+KRP M+EV+ EL IR+S I + E + NF E G+
Sbjct: 664 LARRCLNRKGKKRPNMREVSIELEMIRSSHYDSGIHIEDDDEEDDQAMELNFNDTWEVGA 723
Query: 230 SSTGAILNAVAFSVDADPLL 249
++ ++ N + + DA+PL+
Sbjct: 724 TAPASMFNNASPTSDAEPLV 743
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 269 bits (688), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 124/212 (58%), Positives = 163/212 (76%), Gaps = 1/212 (0%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEE-FTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDI 59
VP+LVYEFIPNG L+ ++HD+ +E TW I LRIA++++GALSYLHS+ S PIYHRD+
Sbjct: 515 VPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDIAGALSYLHSSASSPIYHRDV 574
Query: 60 KSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYS 119
KS NI+LD+K+RAK+SDFG SR VT+D THLTT V GT GY+D EYF+SSQFT K DVYS
Sbjct: 575 KSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYS 634
Query: 120 FGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVA 179
FGVV V L+TG+K I ++E+++LA YF+ AMKEN LFD++DA++ ++ A
Sbjct: 635 FGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFDIIDARIRDGCMLSQVTATA 694
Query: 180 MLAKRCLNLNGRKRPTMKEVAFELGGIRASIG 211
+A++CLNL GRKRP+M+EV+ EL IR G
Sbjct: 695 KVARKCLNLKGRKRPSMREVSMELDSIRMPCG 726
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 269 bits (687), Expect = 2e-71, Method: Compositional matrix adjust.
Identities = 124/209 (59%), Positives = 169/209 (80%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VP+LVYE+IPNG L++ +HD+++++T+TWE+ LRIA+E++GAL+Y+HS S PI+HRDIK
Sbjct: 497 VPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIK 556
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
+ NILLD+K+RAK+SDFG SR VT+DQTHLTT V GTFGY+D EYF SSQ+T K DVYSF
Sbjct: 557 TTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSF 616
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GVV V L+TG+KP+ +EE + LA +FL AMKEN + D++D ++ E+K E+++ VA
Sbjct: 617 GVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRIKDESKLEQVMAVAK 676
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIRAS 209
LA++CLN G+ RP MKEV+ EL IR+S
Sbjct: 677 LARKCLNRKGKNRPNMKEVSNELERIRSS 705
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 266 bits (681), Expect = 9e-71, Method: Compositional matrix adjust.
Identities = 125/209 (59%), Positives = 162/209 (77%), Gaps = 2/209 (0%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VP+LVYE+IPNG L++ +HD+ +++ +TWE+ LRIAVE++GALSY+HS S PI+HRDIK
Sbjct: 496 VPILVYEYIPNGDLFKRLHDEYDDYMMTWEVRLRIAVEIAGALSYMHSAASFPIFHRDIK 555
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
+ NILLD+K+RAKISDFG SR V DQTHLTT V GTFGY+D EYF SSQ+T K DVYSF
Sbjct: 556 TTNILLDEKYRAKISDFGTSRSVATDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSF 615
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GVV V L+TG+KP+ +EE LA YFL AMKEN D++D ++ E+K +++ VA
Sbjct: 616 GVVLVELITGEKPMSRVRSEEGIGLATYFLEAMKENRAVDIIDIRIKDESK--QVMAVAK 673
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIRAS 209
LA+RCLN G KRP M+EV+ +L IR+S
Sbjct: 674 LARRCLNRKGNKRPNMREVSIKLERIRSS 702
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 265 bits (677), Expect = 2e-70, Method: Compositional matrix adjust.
Identities = 119/209 (56%), Positives = 161/209 (77%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VP+LVYEF+PNG L + + D+ +++ +TWE+ L IA+E++GALSYLHS S PIYHRDIK
Sbjct: 492 VPVLVYEFVPNGDLCKRLRDECDDYIMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIK 551
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
+ NILLD+K++ K+SDFG SR VTIDQTHLTT+V GTFGY+D EYF+SS+FT K DVYSF
Sbjct: 552 TTNILLDEKYQVKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTDKSDVYSF 611
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GVV V L+TG+ P +EE++ A +F+ A+KEN D++D ++ E ++++ VA
Sbjct: 612 GVVLVELITGKNPSSRVQSEENRGFAAHFVAAVKENRFLDIVDERIKDECNLDQVMAVAK 671
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIRAS 209
LAKRCLN G+KRP M+EV+ EL IR+S
Sbjct: 672 LAKRCLNRKGKKRPNMREVSVELERIRSS 700
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 264 bits (675), Expect = 3e-70, Method: Compositional matrix adjust.
Identities = 117/209 (55%), Positives = 164/209 (78%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VP+LVYE IPNG L++ +H ++++T+TW++ LRI+VE++GAL+YLHS S P+YHRD+K
Sbjct: 489 VPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVK 548
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
+ NILLD+K+RAK+SDFG SR + +DQTHLTT V GTFGYLD EYF++SQFT K DVYSF
Sbjct: 549 TTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSF 608
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GVV V L+TG+KP EE++ L +F AMK+N + D++D+++ + E+++ VA
Sbjct: 609 GVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCTLEQVLAVAK 668
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIRAS 209
LA+RCL+L G+KRP M+EV+ EL IR+S
Sbjct: 669 LARRCLSLKGKKRPNMREVSVELERIRSS 697
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 262 bits (670), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 121/209 (57%), Positives = 162/209 (77%), Gaps = 1/209 (0%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTIT-WEISLRIAVEVSGALSYLHSTTSIPIYHRDI 59
VP+LVYEFIPNG L+ ++HD ++++T+T WE+ LRIAV+++GALSYLHS S PIYHRDI
Sbjct: 501 VPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDIAGALSYLHSAASSPIYHRDI 560
Query: 60 KSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYS 119
KS NI+LD+K RAK+SDFG SR VT+D THLTT V GT GY+D EYF+SSQFT K DVYS
Sbjct: 561 KSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYS 620
Query: 120 FGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVA 179
FGVV L+TG+K + ++E ++LA YF AMKEN L D++DA++ K ++ A
Sbjct: 621 FGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLSDIIDARIRDGCKLNQVTAAA 680
Query: 180 MLAKRCLNLNGRKRPTMKEVAFELGGIRA 208
+A++CLN+ GRKRP+M++V+ EL IR+
Sbjct: 681 KIARKCLNMKGRKRPSMRQVSMELEKIRS 709
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M1|WAKLE_ARATH Wall-associated receptor kinase-like 5 OS=Arabidopsis thaliana GN=WAKL5 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 260 bits (664), Expect = 7e-69, Method: Compositional matrix adjust.
Identities = 122/216 (56%), Positives = 171/216 (79%), Gaps = 2/216 (0%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VP+LVYE+IPNG +++ +HD+++++ +TWE+ LRIA+E++GAL+Y+HS S PIYHRDIK
Sbjct: 500 VPILVYEYIPNGDMFKRLHDESDDYAMTWEVRLRIAIEIAGALTYMHSAASFPIYHRDIK 559
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
+ NILLD+K+ AK+SDFG SR VTIDQTHLTT V GTFGY+D EYF SSQ+T K DVYSF
Sbjct: 560 TTNILLDEKYGAKVSDFGTSRSVTIDQTHLTTMVAGTFGYMDPEYFLSSQYTDKSDVYSF 619
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GVV V L+TG+KP+ +EE + LA +FL AMKEN + D++D ++ +E+K ++++ VA
Sbjct: 620 GVVLVELITGEKPLSRIRSEEGRGLATHFLEAMKENRVIDIIDIRIKEESKLDQLMAVAK 679
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNCE 216
LA++CL+ G KRP M+E + EL IR+S P++ E
Sbjct: 680 LARKCLSRKGIKRPNMREASLELERIRSS--PEDLE 713
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. May be involved in plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 257 bits (656), Expect = 7e-68, Method: Compositional matrix adjust.
Identities = 127/261 (48%), Positives = 175/261 (67%), Gaps = 9/261 (3%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VP+LVYEFIPN L+ ++H+ +E+F ++WE+ L IA EV+ ALSYLHS SIPIYHRD+K
Sbjct: 458 VPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVADALSYLHSAVSIPIYHRDVK 517
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
S NILLD+K RAK+SDFG SR V ID THLTT VQGT GY+D EY +S+ FT K DVYSF
Sbjct: 518 STNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSDVYSF 577
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GV+ + LLTG+KP+ +E + L YFL AM+ + L ++LDA++ +E EE++ VA
Sbjct: 578 GVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEECDREEVLAVAK 637
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGI---------RASIGPQNCEGIDFVGGNFETGSSS 231
LA+RCL+LN RPTM++V EL + +A G ++ + + SS
Sbjct: 638 LARRCLSLNSEHRPTMRDVFIELDRMQSKRKGTQSQAQNGEEHAHIQIAMPESMSLSYSS 697
Query: 232 TGAILNAVAFSVDADPLLSNK 252
++ +FS+D PL+ +K
Sbjct: 698 PNIVVENSSFSLDTKPLMPHK 718
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 256 bits (655), Expect = 8e-68, Method: Compositional matrix adjust.
Identities = 121/210 (57%), Positives = 162/210 (77%), Gaps = 1/210 (0%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VP LVYEFIPNG L+++IH++++++T TW + LRIAV+++GALSYLHS S PIYHRDIK
Sbjct: 519 VPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLRIAVDIAGALSYLHSAASSPIYHRDIK 578
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
S NILLD+K+R K+SDFG SR VTID TH TT + GT GY+D EY+ SSQ+T K DVYSF
Sbjct: 579 STNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGTVGYVDPEYYGSSQYTDKSDVYSF 638
Query: 121 GVVFVGLLTGQKP-IRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVA 179
GVV V L+TG+KP I ++++E + LA +F AMKEN F+++DA++ K E+++ VA
Sbjct: 639 GVVLVELITGEKPVITVSNSQEIRGLADHFRVAMKENRFFEIMDARIRDGCKPEQVMAVA 698
Query: 180 MLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209
LA+RCLN G+KRP M++V +L I AS
Sbjct: 699 NLARRCLNSKGKKRPCMRKVFTDLEKILAS 728
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 253 | ||||||
| 359475622 | 867 | PREDICTED: wall-associated receptor kina | 0.956 | 0.279 | 0.644 | 1e-85 | |
| 255545824 | 727 | kinase, putative [Ricinus communis] gi|2 | 0.980 | 0.341 | 0.619 | 6e-85 | |
| 147852023 | 413 | hypothetical protein VITISV_028337 [Viti | 0.996 | 0.610 | 0.609 | 2e-84 | |
| 147765961 | 679 | hypothetical protein VITISV_007744 [Viti | 0.956 | 0.356 | 0.636 | 3e-84 | |
| 359475620 | 822 | PREDICTED: wall-associated receptor kina | 0.802 | 0.246 | 0.733 | 5e-84 | |
| 255545828 | 694 | kinase, putative [Ricinus communis] gi|2 | 0.833 | 0.304 | 0.701 | 7e-84 | |
| 255541802 | 743 | kinase, putative [Ricinus communis] gi|2 | 0.826 | 0.281 | 0.703 | 3e-83 | |
| 225455808 | 718 | PREDICTED: wall-associated receptor kina | 0.826 | 0.291 | 0.712 | 6e-83 | |
| 297734146 | 1029 | unnamed protein product [Vitis vinifera] | 0.826 | 0.203 | 0.712 | 2e-82 | |
| 224053054 | 722 | predicted protein [Populus trichocarpa] | 0.996 | 0.349 | 0.606 | 4e-82 |
| >gi|359475622|ref|XP_003631717.1| PREDICTED: wall-associated receptor kinase-like 10-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 322 bits (824), Expect = 1e-85, Method: Compositional matrix adjust.
Identities = 161/250 (64%), Positives = 195/250 (78%), Gaps = 8/250 (3%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VPLLVYEFIPNGTL +IH Q EEF ITWEI LRIA EV+GALSYLHS S+PIYHRDIK
Sbjct: 441 VPLLVYEFIPNGTLSEHIHGQNEEFPITWEIRLRIATEVAGALSYLHSAASVPIYHRDIK 500
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
S NILLDDK+RAK++DFG S++V IDQTHLTT+VQGTFGYLD EYF+SSQFT+K DVYSF
Sbjct: 501 STNILLDDKYRAKVADFGISKFVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSF 560
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
G+V + LLTG+KPI ST +EE KSLA YF+ +M E+ L D+LDAQV+KE+++EEI +A
Sbjct: 561 GIVLIELLTGKKPILSTASEEGKSLASYFILSMNEDRLSDLLDAQVVKESRKEEINAIAF 620
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIRASIG----PQNCEGIDF----VGGNFETGSSST 232
LA+RC+NLNG+KRPTM EVA EL IR G +N E I++ + G ++ S ST
Sbjct: 621 LARRCINLNGKKRPTMMEVAMELERIRKCQGDFGAQENSEEIEYNTIELIGPWDVTSIST 680
Query: 233 GAILNAVAFS 242
+ LN A S
Sbjct: 681 DSCLNTNASS 690
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545824|ref|XP_002513972.1| kinase, putative [Ricinus communis] gi|223547058|gb|EEF48555.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 319 bits (818), Expect = 6e-85, Method: Compositional matrix adjust.
Identities = 161/260 (61%), Positives = 201/260 (77%), Gaps = 12/260 (4%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VPLLVYEFIPNGTL++YI + +EF ITWE+ LRIA EV+GAL+YLHS S+PIYHRDIK
Sbjct: 463 VPLLVYEFIPNGTLFQYIQNPNKEFPITWEMRLRIATEVAGALAYLHSAASMPIYHRDIK 522
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
S+NILLD+K+RAK++DFG S+ + I+QTH+TT VQGTFGYLD EYF+SSQFT+K DVYSF
Sbjct: 523 SSNILLDEKYRAKVADFGTSKSIAIEQTHVTTLVQGTFGYLDPEYFQSSQFTEKSDVYSF 582
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GVV V LLTGQKPI S + E++SLA YFL M+EN LF++LDA+VLKE EEII +A
Sbjct: 583 GVVLVELLTGQKPISSLRSVEERSLATYFLMTMEENRLFEILDARVLKEGGREEIIAMAK 642
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIRASIG-----PQNCEGIDFVGGNF----ETGSSS 231
+A++CLNLNG+KRP MK VA EL GIR+S G Q+ E +D+V G++ + SSS
Sbjct: 643 MAEKCLNLNGKKRPKMKTVAIELEGIRSSQGVSSTIQQDYEEVDYVVGDYTASWDVASSS 702
Query: 232 TGAILNAVAFSV--DADPLL 249
TG+ LN+ D PLL
Sbjct: 703 TGS-LNSTTIRARFDVKPLL 721
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147852023|emb|CAN82287.1| hypothetical protein VITISV_028337 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 317 bits (813), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 159/261 (60%), Positives = 198/261 (75%), Gaps = 9/261 (3%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VPLLVYE+IPNGTL +IHDQ EEF ITW++ L+IA EV+GALSYLHS SIPIYHRDIK
Sbjct: 151 VPLLVYEYIPNGTLSEHIHDQNEEFPITWKMRLQIATEVAGALSYLHSAASIPIYHRDIK 210
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
S NILLDDK+RAK++DFG S+ V IDQTHLTT+VQGTFGYLD EYF+SSQFT+K DVYSF
Sbjct: 211 STNILLDDKYRAKVADFGTSKSVAIDQTHLTTKVQGTFGYLDPEYFQSSQFTEKSDVYSF 270
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
G+V + LLTG+KPI S + E KSLA YF+ +MKE+ L D+LDA+V+KE ++EEI +A
Sbjct: 271 GIVLIELLTGKKPILSIGSGEGKSLASYFIMSMKEDRLSDLLDARVVKEGRKEEINAIAF 330
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIRASIG----PQNCEGIDF----VGGNFETGSSST 232
LAKRC+NLNG+KRPTM EVA EL IR G +N + +++ + ++ S+ST
Sbjct: 331 LAKRCINLNGKKRPTMMEVAMELERIRKCEGDFNAQENSDEVEYDTIELTRPWDVASTST 390
Query: 233 GAILNAVAF-SVDADPLLSNK 252
G+ N A +D PLL K
Sbjct: 391 GSCFNTNASPPLDVQPLLFQK 411
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147765961|emb|CAN70207.1| hypothetical protein VITISV_007744 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 317 bits (812), Expect = 3e-84, Method: Compositional matrix adjust.
Identities = 159/250 (63%), Positives = 193/250 (77%), Gaps = 8/250 (3%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VPLLVYEFIPNGTL +IH Q EEF ITWE+ LRIA EV GALSYLHS SIPIYHRDIK
Sbjct: 426 VPLLVYEFIPNGTLSEHIHGQNEEFPITWEMRLRIATEVXGALSYLHSXASIPIYHRDIK 485
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
S NILLBDK+RAK++DFG S++V IDQTHLTT+VQGTFGYLD EYF+SSQFT+K DVYSF
Sbjct: 486 STNILLBDKYRAKVADFGISKFVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSF 545
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
G+V + LLTG+KPI S +EE KSLA YF+ +M E+ L D+LDAQV+KE+++EEI +A
Sbjct: 546 GIVLIELLTGKKPILSIASEEGKSLASYFILSMNEDRLSDLLDAQVVKESRKEEINAIAF 605
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIRASIG----PQNCEGIDF----VGGNFETGSSST 232
LA+RC+NLNG+KRPTM EVA EL IR G +N E I++ + G ++ S ST
Sbjct: 606 LARRCINLNGKKRPTMMEVAMELERIRKCQGDFRAQENFEEIEYNTTELIGPWDVTSIST 665
Query: 233 GAILNAVAFS 242
+ LN A S
Sbjct: 666 DSCLNTNASS 675
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475620|ref|XP_002266785.2| PREDICTED: wall-associated receptor kinase-like 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 316 bits (810), Expect = 5e-84, Method: Compositional matrix adjust.
Identities = 149/203 (73%), Positives = 174/203 (85%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VPLLVYEFIPNGTL +IHDQ EEF ITWE+ LRIA+EV+GALSYLHS SIPIYHRDIK
Sbjct: 597 VPLLVYEFIPNGTLSEHIHDQNEEFPITWEMRLRIAIEVAGALSYLHSAASIPIYHRDIK 656
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
S NILLDDK+RAK++DFG S+ V IDQTHLTT+VQGTFGYLD EYF+SSQFT+K DVYSF
Sbjct: 657 STNILLDDKYRAKVADFGTSKSVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSF 716
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
G+V + LLTG+KPI ST +EE KSLA YF+ +M E+ L D+LDAQV+KE K+EEI +A
Sbjct: 717 GIVLIELLTGKKPILSTASEEGKSLASYFILSMNEDRLSDLLDAQVVKEGKKEEINAIAF 776
Query: 181 LAKRCLNLNGRKRPTMKEVAFEL 203
LA+RC+NLNG+KRPTM EVA EL
Sbjct: 777 LARRCINLNGKKRPTMMEVAMEL 799
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545828|ref|XP_002513974.1| kinase, putative [Ricinus communis] gi|223547060|gb|EEF48557.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 316 bits (809), Expect = 7e-84, Method: Compositional matrix adjust.
Identities = 148/211 (70%), Positives = 180/211 (85%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VPLLVYEFIPNGTLY+YIH+ EEF +TWE+ LRIA EV+GAL+YLH+ S+PIYHRDIK
Sbjct: 468 VPLLVYEFIPNGTLYQYIHNPNEEFPVTWEMRLRIATEVAGALAYLHAAASMPIYHRDIK 527
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
S+NILLD+K+RAK++DFG S+ ++IDQTH+TTRVQGTFGYLD EYF+SSQFT+K DVYSF
Sbjct: 528 SSNILLDEKYRAKVADFGTSKSISIDQTHVTTRVQGTFGYLDPEYFQSSQFTEKSDVYSF 587
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GVV V LLTGQKPI S + E++SLA YFL M+E+ LF++LDA+VLKE EEII +A
Sbjct: 588 GVVLVELLTGQKPISSYRSVEERSLATYFLMTMEESRLFEILDARVLKEGGREEIIAMAK 647
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIRASIG 211
LA++CLNLNG+KRP MK VA EL GIR+S G
Sbjct: 648 LAEKCLNLNGKKRPKMKTVAIELEGIRSSQG 678
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255541802|ref|XP_002511965.1| kinase, putative [Ricinus communis] gi|223549145|gb|EEF50634.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 314 bits (804), Expect = 3e-83, Method: Compositional matrix adjust.
Identities = 147/209 (70%), Positives = 176/209 (84%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VPLLVYEFIPNGTLY+++HD +EEF ITWE+ LRIA+E ALSYLHS S+PIYHRDIK
Sbjct: 470 VPLLVYEFIPNGTLYQHLHDPSEEFPITWEMRLRIAIETGSALSYLHSAASVPIYHRDIK 529
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
S NILLDDK+RAK+SDFG S+ + +DQTH+TTRVQGTFGYLD EYF+SSQFT+K DVYSF
Sbjct: 530 STNILLDDKYRAKVSDFGTSKSIAVDQTHVTTRVQGTFGYLDPEYFQSSQFTEKSDVYSF 589
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GVV V LLTGQKPI S E++SLA YFL +M++N LF++LDA+VLKE +EEI+ VA
Sbjct: 590 GVVLVELLTGQKPISSARAVEERSLAMYFLLSMEQNRLFEILDARVLKEGGKEEILAVAK 649
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIRAS 209
LA+RCLNLNG+KRPTM+ V E+ IRAS
Sbjct: 650 LARRCLNLNGKKRPTMRTVVTEVERIRAS 678
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455808|ref|XP_002274809.1| PREDICTED: wall-associated receptor kinase-like 9-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 313 bits (801), Expect = 6e-83, Method: Compositional matrix adjust.
Identities = 149/209 (71%), Positives = 178/209 (85%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VPLLVYEFI NGTL++ IHDQ EF ++WE+ LRIA+EVSGALSYLHS SIPIYHRDIK
Sbjct: 455 VPLLVYEFISNGTLFQLIHDQNSEFPLSWEMRLRIALEVSGALSYLHSACSIPIYHRDIK 514
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
S NILLDDK++AK+SDFG SR ++IDQTHLTT VQGTFGYLD EYF+SSQFT+K DVYSF
Sbjct: 515 STNILLDDKYKAKVSDFGTSRSISIDQTHLTTIVQGTFGYLDPEYFQSSQFTEKSDVYSF 574
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GVV V LLTGQKPI ST + E+KSLA +F+ +++E+ LFD+LDA+V+KE ++E+I+T A
Sbjct: 575 GVVLVELLTGQKPISSTRSPEEKSLATHFILSLQESRLFDILDARVVKEGRKEDIMTFAK 634
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIRAS 209
LA RCLNLNGRKRPTMKEV E+ IR S
Sbjct: 635 LAGRCLNLNGRKRPTMKEVTTEIDNIRVS 663
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297734146|emb|CBI15393.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 311 bits (797), Expect = 2e-82, Method: Compositional matrix adjust.
Identities = 149/209 (71%), Positives = 178/209 (85%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VPLLVYEFI NGTL++ IHDQ EF ++WE+ LRIA+EVSGALSYLHS SIPIYHRDIK
Sbjct: 335 VPLLVYEFISNGTLFQLIHDQNSEFPLSWEMRLRIALEVSGALSYLHSACSIPIYHRDIK 394
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
S NILLDDK++AK+SDFG SR ++IDQTHLTT VQGTFGYLD EYF+SSQFT+K DVYSF
Sbjct: 395 STNILLDDKYKAKVSDFGTSRSISIDQTHLTTIVQGTFGYLDPEYFQSSQFTEKSDVYSF 454
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GVV V LLTGQKPI ST + E+KSLA +F+ +++E+ LFD+LDA+V+KE ++E+I+T A
Sbjct: 455 GVVLVELLTGQKPISSTRSPEEKSLATHFILSLQESRLFDILDARVVKEGRKEDIMTFAK 514
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIRAS 209
LA RCLNLNGRKRPTMKEV E+ IR S
Sbjct: 515 LAGRCLNLNGRKRPTMKEVTTEIDNIRVS 543
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053054|ref|XP_002297684.1| predicted protein [Populus trichocarpa] gi|222844942|gb|EEE82489.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 310 bits (794), Expect = 4e-82, Method: Compositional matrix adjust.
Identities = 160/264 (60%), Positives = 191/264 (72%), Gaps = 12/264 (4%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VPLLVYEFIPNG L+ YIHDQ EEF +WE+ LRIA EV+ ALSYLHS SIP+YHRDIK
Sbjct: 457 VPLLVYEFIPNGNLFEYIHDQKEEFEFSWEMRLRIATEVARALSYLHSAASIPVYHRDIK 516
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
S NI+LD+KFRAK+SDFG SR + IDQTHLTT VQGTFGYLD EYF+SSQFT K DVYSF
Sbjct: 517 STNIMLDEKFRAKVSDFGTSRSIAIDQTHLTTHVQGTFGYLDPEYFQSSQFTGKSDVYSF 576
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GVV LL+GQKPI +EE SLA +F+ ++EN +FD+LD +++ + +EEE+I VA
Sbjct: 577 GVVLAELLSGQKPISYERSEERGSLATHFILLVEENKIFDILDERLMGQDREEEVIAVAN 636
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIRASIG---PQNC----EGI-DFVGGNFETGSSST 232
LA+RCLNL GRKRPTM+EVA EL IR S G PQ C E I D V +E T
Sbjct: 637 LARRCLNLIGRKRPTMREVAIELEQIRLSKGALHPQQCSKELENIWDEVPNVWEIAGPPT 696
Query: 233 ----GAILNAVAFSVDADPLLSNK 252
G N A S+D PL+S++
Sbjct: 697 SVTIGDFRNGTAPSLDVQPLISHE 720
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 253 | ||||||
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.826 | 0.286 | 0.593 | 7.2e-68 | |
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.984 | 0.332 | 0.519 | 1.2e-67 | |
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.920 | 0.294 | 0.542 | 1.2e-65 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.845 | 0.284 | 0.550 | 1.1e-64 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.822 | 0.270 | 0.578 | 4.7e-64 | |
| TAIR|locus:2016377 | 788 | AT1G19390 [Arabidopsis thalian | 0.865 | 0.277 | 0.546 | 3.8e-62 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.996 | 0.35 | 0.498 | 1.6e-61 | |
| TAIR|locus:2030988 | 764 | AT1G17910 [Arabidopsis thalian | 0.802 | 0.265 | 0.558 | 3.9e-60 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.826 | 0.265 | 0.563 | 1.7e-59 | |
| TAIR|locus:2126271 | 793 | AT4G31110 [Arabidopsis thalian | 0.826 | 0.263 | 0.554 | 2.2e-59 |
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 689 (247.6 bits), Expect = 7.2e-68, P = 7.2e-68
Identities = 124/209 (59%), Positives = 169/209 (80%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VP+LVYE+IPNG L++ +HD+++++T+TWE+ LRIA+E++GAL+Y+HS S PI+HRDIK
Sbjct: 497 VPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIK 556
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
+ NILLD+K+RAK+SDFG SR VT+DQTHLTT V GTFGY+D EYF SSQ+T K DVYSF
Sbjct: 557 TTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSF 616
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GVV V L+TG+KP+ +EE + LA +FL AMKEN + D++D ++ E+K E+++ VA
Sbjct: 617 GVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRIKDESKLEQVMAVAK 676
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIRAS 209
LA++CLN G+ RP MKEV+ EL IR+S
Sbjct: 677 LARKCLNRKGKNRPNMKEVSNELERIRSS 705
|
|
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 687 (246.9 bits), Expect = 1.2e-67, P = 1.2e-67
Identities = 135/260 (51%), Positives = 191/260 (73%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VP+LVYEF+PNG L + +HD+++++T+TWE+ L IA+E++GALSYLHS S PIYHRDIK
Sbjct: 484 VPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIK 543
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
+ NILLD++ RAK+SDFG SR VTIDQTHLTT+V GTFGY+D EYF+SS+FT+K DVYSF
Sbjct: 544 TTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSF 603
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GVV V LLTG+KP +EE++ LA +F+ A+KEN + D++D ++ E +++++VA
Sbjct: 604 GVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDECNMDQVMSVAN 663
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIRAS-------IGPQNCEGIDFVGGNF----ETGS 229
LA+RCLN G+KRP M+EV+ EL IR+S I + E + NF E G+
Sbjct: 664 LARRCLNRKGKKRPNMREVSIELEMIRSSHYDSGIHIEDDDEEDDQAMELNFNDTWEVGA 723
Query: 230 SSTGAILNAVAFSVDADPLL 249
++ ++ N + + DA+PL+
Sbjct: 724 TAPASMFNNASPTSDAEPLV 743
|
|
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 668 (240.2 bits), Expect = 1.2e-65, P = 1.2e-65
Identities = 128/236 (54%), Positives = 171/236 (72%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEE-FTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDI 59
VP+LVYEFIPNG L+ ++HD+ +E TW I LRIA++++GALSYLHS+ S PIYHRD+
Sbjct: 515 VPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDIAGALSYLHSSASSPIYHRDV 574
Query: 60 KSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYS 119
KS NI+LD+K+RAK+SDFG SR VT+D THLTT V GT GY+D EYF+SSQFT K DVYS
Sbjct: 575 KSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYS 634
Query: 120 FGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVA 179
FGVV V L+TG+K I ++E+++LA YF+ AMKEN LFD++DA++ ++ A
Sbjct: 635 FGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFDIIDARIRDGCMLSQVTATA 694
Query: 180 MLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNCEGIDFVGGNFETGSSSTGAI 235
+A++CLNL GRKRP+M+EV+ EL IR G + + V N E + G +
Sbjct: 695 KVARKCLNLKGRKRPSMREVSMELDSIRMPCGDMQLQ--ECVSENEEGEEQNKGLV 748
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 659 (237.0 bits), Expect = 1.1e-64, P = 1.1e-64
Identities = 119/216 (55%), Positives = 168/216 (77%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VP+LVYE IPNG L++ +H ++++T+TW++ LRI+VE++GAL+YLHS S P+YHRD+K
Sbjct: 489 VPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVK 548
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
+ NILLD+K+RAK+SDFG SR + +DQTHLTT V GTFGYLD EYF++SQFT K DVYSF
Sbjct: 549 TTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSF 608
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GVV V L+TG+KP EE++ L +F AMK+N + D++D+++ + E+++ VA
Sbjct: 609 GVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCTLEQVLAVAK 668
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNCE 216
LA+RCL+L G+KRP M+EV+ EL IR+S P++ E
Sbjct: 669 LARRCLSLKGKKRPNMREVSVELERIRSS--PEDLE 702
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 653 (234.9 bits), Expect = 4.7e-64, P = 4.7e-64
Identities = 121/209 (57%), Positives = 162/209 (77%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTIT-WEISLRIAVEVSGALSYLHSTTSIPIYHRDI 59
VP+LVYEFIPNG L+ ++HD ++++T+T WE+ LRIAV+++GALSYLHS S PIYHRDI
Sbjct: 501 VPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDIAGALSYLHSAASSPIYHRDI 560
Query: 60 KSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYS 119
KS NI+LD+K RAK+SDFG SR VT+D THLTT V GT GY+D EYF+SSQFT K DVYS
Sbjct: 561 KSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYS 620
Query: 120 FGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVA 179
FGVV L+TG+K + ++E ++LA YF AMKEN L D++DA++ K ++ A
Sbjct: 621 FGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLSDIIDARIRDGCKLNQVTAAA 680
Query: 180 MLAKRCLNLNGRKRPTMKEVAFELGGIRA 208
+A++CLN+ GRKRP+M++V+ EL IR+
Sbjct: 681 KIARKCLNMKGRKRPSMRQVSMELEKIRS 709
|
|
| TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 635 (228.6 bits), Expect = 3.8e-62, P = 3.8e-62
Identities = 123/225 (54%), Positives = 169/225 (75%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VP LVYEFIPNG L+++IH++++++T TW + LRIAV+++GALSYLHS S PIYHRDIK
Sbjct: 519 VPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLRIAVDIAGALSYLHSAASSPIYHRDIK 578
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
S NILLD+K+R K+SDFG SR VTID TH TT + GT GY+D EY+ SSQ+T K DVYSF
Sbjct: 579 STNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGTVGYVDPEYYGSSQYTDKSDVYSF 638
Query: 121 GVVFVGLLTGQKPIRS-TDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVA 179
GVV V L+TG+KP+ + ++++E + LA +F AMKEN F+++DA++ K E+++ VA
Sbjct: 639 GVVLVELITGEKPVITVSNSQEIRGLADHFRVAMKENRFFEIMDARIRDGCKPEQVMAVA 698
Query: 180 MLAKRCLNLNGRKRPTMKEVAFELGGIRAS-----IGPQNCEGID 219
LA+RCLN G+KRP M++V +L I AS + +N +G D
Sbjct: 699 NLARRCLNSKGKKRPCMRKVFTDLEKILASQEDSLVNIENDDGAD 743
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 629 (226.5 bits), Expect = 1.6e-61, P = 1.6e-61
Identities = 130/261 (49%), Positives = 177/261 (67%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VP+LVYEFIPN L+ ++H+ +E+F ++WE+ L IA EV+ ALSYLHS SIPIYHRD+K
Sbjct: 458 VPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVADALSYLHSAVSIPIYHRDVK 517
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
S NILLD+K RAK+SDFG SR V ID THLTT VQGT GY+D EY +S+ FT K DVYSF
Sbjct: 518 STNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSDVYSF 577
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GV+ + LLTG+KP+ +E + L YFL AM+ + L ++LDA++ +E EE++ VA
Sbjct: 578 GVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEECDREEVLAVAK 637
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIRASI-GPQ----NCEG---IDF-VGGNFETGSSS 231
LA+RCL+LN RPTM++V EL +++ G Q N E I + + SS
Sbjct: 638 LARRCLSLNSEHRPTMRDVFIELDRMQSKRKGTQSQAQNGEEHAHIQIAMPESMSLSYSS 697
Query: 232 TGAILNAVAFSVDADPLLSNK 252
++ +FS+D PL+ +K
Sbjct: 698 PNIVVENSSFSLDTKPLMPHK 718
|
|
| TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 616 (221.9 bits), Expect = 3.9e-60, P = 3.9e-60
Identities = 114/204 (55%), Positives = 156/204 (76%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
VP+LVYEFIPNG L++++H++ +++T W + +RIAV++SGA SYLH+ PIYHRDIK
Sbjct: 522 VPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMRIAVDISGAFSYLHTAACSPIYHRDIK 581
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
S NILLD+K+RAK+SDFG SR V+ID TH TT + GT GY+D EY+ SS FT+K DVYSF
Sbjct: 582 STNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYGSSHFTEKSDVYSF 641
Query: 121 GVVFVGLLTGQKPIRS-TDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVA 179
GVV V L+TG+KP+ + ++T+E LA YF AM+EN LF+++DA++ + K E++I VA
Sbjct: 642 GVVLVELITGEKPVITLSETQEITGLADYFRLAMRENRLFEIIDARIRNDCKLEQVIAVA 701
Query: 180 MLAKRCLNLNGRKRPTMKEVAFEL 203
LA RCL G+ RP M+EV+ L
Sbjct: 702 NLALRCLKKTGKTRPDMREVSTAL 725
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 610 (219.8 bits), Expect = 1.7e-59, P = 1.7e-59
Identities = 119/211 (56%), Positives = 160/211 (75%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQ-TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDI 59
VP+LVYEFI NG L+++IH++ +++T+ W + LRIAV+++GALSYLHS S PIYHRDI
Sbjct: 512 VPILVYEFIINGNLFKHIHEEEADDYTMIWGMRLRIAVDIAGALSYLHSAASSPIYHRDI 571
Query: 60 KSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYS 119
KS NILLD+K+RAK++DFG SR VTIDQTH TT + GT GY+D EY+RSSQ+T+K DVYS
Sbjct: 572 KSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYRSSQYTEKSDVYS 631
Query: 120 FGVVFVGLLTGQKP-IRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITV 178
FGV+ L+TG KP I +T+E +LA +F AMKE L D++DA++ ++K E+++ V
Sbjct: 632 FGVILAELITGDKPVIMVQNTQEIIALAEHFRVAMKERRLSDIMDARIRDDSKPEQVMAV 691
Query: 179 AMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209
A LA +CL+ GR RP M+EV EL I S
Sbjct: 692 ANLAMKCLSSRGRNRPNMREVFTELERICTS 722
|
|
| TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 609 (219.4 bits), Expect = 2.2e-59, P = 2.2e-59
Identities = 117/211 (55%), Positives = 162/211 (76%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQ-TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDI 59
VP+LVYEFI NG L+++IH++ ++++T+ W + LRIAV+++GALSYLHS+ S PIYHRDI
Sbjct: 521 VPMLVYEFIINGNLFKHIHEEESDDYTMLWGMRLRIAVDIAGALSYLHSSASSPIYHRDI 580
Query: 60 KSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYS 119
KS NILLD+K+RAK++DFG SR VTIDQTH TT + GT GY+D EY++SSQ+T+K DVYS
Sbjct: 581 KSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYQSSQYTEKSDVYS 640
Query: 120 FGVVFVGLLTGQKP-IRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITV 178
FGV+ L+TG KP I +T+E +LA +F AMKE L D++DA++ + K E+++ V
Sbjct: 641 FGVILAELITGDKPVIMVQNTQEIVALAEHFRVAMKEKRLTDIIDARIRNDCKPEQVMAV 700
Query: 179 AMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209
A +A +CL+ G+KRP M+EV EL I S
Sbjct: 701 AKVAMKCLSSKGKKRPNMREVFTELERICTS 731
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 253 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-33 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-30 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-30 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-26 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-25 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-24 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-22 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-22 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-16 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-16 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-13 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-12 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-12 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-11 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-11 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-10 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-09 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-08 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-08 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-08 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-08 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-07 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-06 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-05 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-05 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-04 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-04 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-04 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 0.002 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 0.002 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 0.002 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.002 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-33
Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 18/199 (9%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
LV E+ G L+ Y+ ++ + + +IA+++ L YLHS I HRD+K
Sbjct: 73 LYLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIALQILRGLEYLHS---NGIIHRDLKP 126
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLE-YFRSSQFTKKGDVYSF 120
NILLD+ KI+DFG ++ + + LTT V GT Y+ E + + K DV+S
Sbjct: 127 ENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVDVWSL 185
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GV+ LLTG+ P + + L + + +EAK+
Sbjct: 186 GVILYELLTGKPPFSGENILDQLQL--IRRILGPPLEFDEPKWSSGSEEAKD-------- 235
Query: 181 LAKRCLNLNGRKRPTMKEV 199
L K+CLN + KRPT +E+
Sbjct: 236 LIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-30
Identities = 59/199 (29%), Positives = 87/199 (43%), Gaps = 27/199 (13%)
Query: 4 LVYEFIPNGTLYRYIHDQ---TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
LV E+ G L+ + + +E+ ++ AL YLHS I HRD+K
Sbjct: 74 LVMEYCEGGDLFDLLKKRGRLSEDEAR------FYLRQILSALEYLHS---KGIVHRDLK 124
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
NILLD+ K++DFG +R + LTT V GT Y+ E + K D++S
Sbjct: 125 PENILLDEDGHVKLADFGLARQLD-PGEKLTTFV-GTPEYMAPEVLLGKGYGKAVDIWSL 182
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GV+ LLTG+ P D L F + K F + + EAK+
Sbjct: 183 GVILYELLTGKPPF-----PGDDQLLELFKKIGKPKPPFPPPEWDISPEAKD-------- 229
Query: 181 LAKRCLNLNGRKRPTMKEV 199
L ++ L + KR T +E
Sbjct: 230 LIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-30
Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 56/198 (28%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV E+ G+L + + E ++ + LRI +++ L YLHS I HRD+K N
Sbjct: 68 LVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPEN 122
Query: 64 ILLD-DKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQ-FTKKGDVYSFG 121
ILLD D + K++DFG S+ +T D++ L T V GT Y+ E +++K D++S G
Sbjct: 123 ILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKSDIWSLG 181
Query: 122 VVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAML 181
V+ Y L +K+ L
Sbjct: 182 VIL-----------------------YELPELKD-------------------------L 193
Query: 182 AKRCLNLNGRKRPTMKEV 199
++ L + KRP+ KE+
Sbjct: 194 IRKMLQKDPEKRPSAKEI 211
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-26
Identities = 51/201 (25%), Positives = 84/201 (41%), Gaps = 25/201 (12%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
++V E++P G L Y+ ++ L A++++ + YL S HRD+ +
Sbjct: 76 LMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAA 131
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
N L+ + KISDFG SR + D + + ++ E + +FT K DV+SFG
Sbjct: 132 RNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFG 191
Query: 122 VVFVGLLT-GQKPIRSTDTEE--DKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITV 178
V+ + T G++P E + GY L NC E+
Sbjct: 192 VLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKP-PNC--------------PPEL--- 233
Query: 179 AMLAKRCLNLNGRKRPTMKEV 199
L +C + RPT E+
Sbjct: 234 YKLMLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 26/205 (12%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
+V E++ G L Y+ ++ L A++++ + YL S HRD+ +
Sbjct: 76 LYIVMEYMEGGDLLSYLRKNRP--KLSLSDLLSFALQIARGMEYLES---KNFIHRDLAA 130
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
N L+ + KISDFG SR + D + + ++ E + +FT K DV+SFG
Sbjct: 131 RNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFG 190
Query: 122 VVFVGLLT-GQKPIRSTDTEE--DKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITV 178
V+ + T G++P EE + GY L NC E+
Sbjct: 191 VLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQP-PNC--------------PPEL--- 232
Query: 179 AMLAKRCLNLNGRKRPTMKEVAFEL 203
L +C + RPT E+ L
Sbjct: 233 YDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 5e-25
Identities = 57/213 (26%), Positives = 84/213 (39%), Gaps = 33/213 (15%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEF------TITWEISLRIAVEVSGALSYLHSTTSIPIY 55
LV E++ G L Y+ F T++ + L A++++ + YL S
Sbjct: 71 LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFV 127
Query: 56 HRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF--GYLDLEYFRSSQFTK 113
HRD+ + N L+ + KISDFG SR V D + G ++ E + FT
Sbjct: 128 HRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT-GGKLPIRWMAPESLKDGIFTS 186
Query: 114 KGDVYSFGVVFVGLLT-GQKPIRSTDTEE--DKSLAGYFLRAMKENCLFDMLDAQVLKEA 170
K DV+SFGV+ + T G P EE + GY L E C ++
Sbjct: 187 KSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL-PKPEYCPDEL--------- 236
Query: 171 KEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203
L C L+ RPT E+ L
Sbjct: 237 --------YELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 4e-24
Identities = 52/203 (25%), Positives = 84/203 (41%), Gaps = 31/203 (15%)
Query: 3 LLVYEFIPNGTLYRYIHDQTE------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYH 56
+V E+ G L + I Q + E I + +++ + AL YLHS I H
Sbjct: 75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQI-LDWFVQLCL----ALKYLHSRK---ILH 126
Query: 57 RDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGD 116
RDIK NI L K+ DFG S+ ++ T V GT YL E ++ + K D
Sbjct: 127 RDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYYLSPELCQNKPYNYKSD 185
Query: 117 VYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEII 176
++S G V L T + P +L L+ +K + + +Q E +
Sbjct: 186 IWSLGCVLYELCTLKHPFEGE------NLLELALKILKGQ--YPPIPSQYSSELRN---- 233
Query: 177 TVAMLAKRCLNLNGRKRPTMKEV 199
L L + +RP++ ++
Sbjct: 234 ----LVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (240), Expect = 7e-24
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 31/208 (14%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
+V E++P G L ++ E+ T+ + +A++++ + YL S HRD+ +
Sbjct: 76 LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQ--MALQIAKGMEYLES---KNFVHRDLAA 130
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFG---YLDLEYFRSSQFTKKGDVY 118
N L+ + KISDFG SR + D + G ++ E + +FT K DV+
Sbjct: 131 RNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPESLKDGKFTSKSDVW 188
Query: 119 SFGVVFVGLLT-GQKPIRSTDTEEDKSL--AGYFLRAMKENCLFDMLDAQVLKEAKEEEI 175
SFGV+ + T G++P EE L GY L ENC +E+
Sbjct: 189 SFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRP-ENC--------------PDEL 233
Query: 176 ITVAMLAKRCLNLNGRKRPTMKEVAFEL 203
L +C + RPT E+ +L
Sbjct: 234 ---YELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 94.0 bits (232), Expect = 2e-22
Identities = 49/204 (24%), Positives = 78/204 (38%), Gaps = 16/204 (7%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV E++ G+L + + ++ +L I ++ AL YLH S I HRDIK N
Sbjct: 75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPEN 131
Query: 64 ILLD-DKFRAKISDFGASRYVTIDQTHLTTRVQ-----GTFGYLDLEYFRSSQF---TKK 114
ILLD D K+ DFG ++ + + + GT GY+ E +
Sbjct: 132 ILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSS 191
Query: 115 GDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEE 174
D++S G+ LLTG P S + L + + E
Sbjct: 192 SDIWSLGITLYELLTGLPPFEGEKNSSATSQ----TLKIILELPTPSLASPLSPSNPELI 247
Query: 175 IITVAMLAKRCLNLNGRKRPTMKE 198
+ L K+ L + + R +
Sbjct: 248 SKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 4e-22
Identities = 47/163 (28%), Positives = 77/163 (47%), Gaps = 22/163 (13%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYV-TIDQTHLTTRVQGTFGY 100
L+YLHS I HRDIK ANIL+D K++DFG ++ + I+ T V+GT +
Sbjct: 113 GLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 101 LDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160
+ E R ++ + D++S G + + TG+ P +E +A +
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW----SELGNPMAALYKIGSSGEP--P 223
Query: 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203
+ + +EAK+ ++CL + +KRPT A EL
Sbjct: 224 EIPEHLSEEAKD--------FLRKCLRRDPKKRPT----ADEL 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 4e-19
Identities = 53/195 (27%), Positives = 80/195 (41%), Gaps = 21/195 (10%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V EF G+L + + T + I+ + E+ L YLHS I HRDIK+AN
Sbjct: 74 IVMEFCSGGSLKDLLKSTNQTLTESQ-IAY-VCKELLKGLEYLHS---NGIIHRDIKAAN 128
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
ILL K+ DFG S + T + GT ++ E + K D++S G+
Sbjct: 129 ILLTSDGEVKLIDFGLS--AQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGIT 186
Query: 124 FVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAK 183
+ L G+ P E + F A L+ ++ L K
Sbjct: 187 AIELAEGKPPYS-----ELPPMKALFKIATN--------GPPGLRNPEKWSDEFKDFL-K 232
Query: 184 RCLNLNGRKRPTMKE 198
+CL N KRPT ++
Sbjct: 233 KCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-18
Identities = 53/191 (27%), Positives = 85/191 (44%), Gaps = 21/191 (10%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E+ NG L++ + Q + + R +++ L++LHS I HRDIKS N
Sbjct: 76 IVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLN 131
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
+ LD KI D G ++ ++ D T+ + GT YL E + +K DV++ GVV
Sbjct: 132 LFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVV 190
Query: 124 FVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAK 183
TG+ P D +L +R + + M Q +A L
Sbjct: 191 LYECCTGKHPF---DANNQGALILKIIRGVFPP-VSQMYSQQ------------LAQLID 234
Query: 184 RCLNLNGRKRP 194
+CL + R+RP
Sbjct: 235 QCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-17
Identities = 49/133 (36%), Positives = 66/133 (49%), Gaps = 10/133 (7%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKSA 62
LV + + G L RY Q +F+ E ++ E+ AL YLHS I HRDIK
Sbjct: 77 LVVDLLLGGDL-RYHLSQKVKFS---EEQVKFWICEIVLALEYLHSKG---IIHRDIKPD 129
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
NILLD++ I+DF + VT D LTT GT GY+ E ++ D +S GV
Sbjct: 130 NILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGV 187
Query: 123 VFVGLLTGQKPIR 135
L G++P R
Sbjct: 188 TAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 1e-16
Identities = 46/138 (33%), Positives = 72/138 (52%), Gaps = 7/138 (5%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV E+ P G L+ ++ +E + E + A E+ AL YLHS + I +RD+K N
Sbjct: 70 LVLEYAPGGELFSHLS---KEGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPEN 123
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
ILLD K++DFG ++ ++ + + T GT YL E + K D +S GV+
Sbjct: 124 ILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGKAVDWWSLGVL 182
Query: 124 FVGLLTGQKPIRSTDTEE 141
+LTG+ P + D +E
Sbjct: 183 LYEMLTGKPPFYAEDRKE 200
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 3e-16
Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 25/151 (16%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
V E+ PNG L +YI ++ + + A E+ AL YLHS I HRD+K N
Sbjct: 79 FVLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPEN 132
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQ-------------------GTFGYLDLE 104
ILLD KI+DFG ++ + + + + + GT Y+ E
Sbjct: 133 ILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPE 192
Query: 105 YFRSSQFTKKGDVYSFGVVFVGLLTGQKPIR 135
K D+++ G + +LTG+ P R
Sbjct: 193 LLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 3e-16
Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 32/202 (15%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISL-RIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+V E++ G+L + + + E L IA ++ L YLH+ I HRDIK +
Sbjct: 76 IVLEYMDGGSLAD-LLKKVGKIP---EPVLAYIARQILKGLDYLHTKRHI--IHRDIKPS 129
Query: 63 NILLDDKFRAKISDFGASRYV--TIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
N+L++ K KI+DFG S+ + T+DQ + T V GT Y+ E + ++ D++S
Sbjct: 130 NLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSPERIQGESYSYAADIWSL 186
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKE-EEIITVA 179
G+ + G+ P + F+++ A
Sbjct: 187 GLTLLECALGKFPFLPP----------------GQPSFFELMQAICDGPPPSLPAEEFSP 230
Query: 180 MLA---KRCLNLNGRKRPTMKE 198
CL + +KRP+ E
Sbjct: 231 EFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 6e-16
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
L+ E++P+G+L Y+ ++ I + L + ++ + YL S I HRD+ +
Sbjct: 83 LRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDYLGSQRYI---HRDLAA 137
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQG---TFGYLDLEYFRSSQFTKKGDVY 118
NIL++ + KISDFG ++ + D+ + + G F Y E R+S+F+ DV+
Sbjct: 138 RNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP-ECLRTSKFSSASDVW 196
Query: 119 SFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIIT- 177
SFGV L T P +S FLR M M+ ++L+ KE E +
Sbjct: 197 SFGVTLYELFTYGDP--------SQSPPAEFLR-MIGIAQGQMIVTRLLELLKEGERLPR 247
Query: 178 -------VAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207
V L K C + RP+ ++ + +R
Sbjct: 248 PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-16
Identities = 37/96 (38%), Positives = 57/96 (59%), Gaps = 8/96 (8%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTR-----VQGT 97
L+YLH+ I HRDIK ANIL+D+K KISDFG S+ + + T +QG+
Sbjct: 119 LNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 98 FGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKP 133
++ E + + +T+K D++S G + V +LTG+ P
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-15
Identities = 45/132 (34%), Positives = 68/132 (51%), Gaps = 11/132 (8%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E++ NG L Y+ ++ + E L + +V A+ YL S I HRD+ + N
Sbjct: 76 IVTEYMANGCLLNYLRERKGKLGT--EWLLDMCSDVCEAMEYLESNGFI---HRDLAARN 130
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGT---FGYLDLEYFRSSQFTKKGDVYSF 120
L+ + K+SDFG +RYV DQ T QGT + E F S+F+ K DV+SF
Sbjct: 131 CLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSF 187
Query: 121 GVVFVGLLTGQK 132
GV+ + + K
Sbjct: 188 GVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-14
Identities = 39/135 (28%), Positives = 61/135 (45%), Gaps = 9/135 (6%)
Query: 3 LLVYEFIPNGTLYRYIHD-QTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
++V E P G+L + F I+ AV+++ + YL S I HRD+ +
Sbjct: 71 MMVTELAPLGSLLDRLRKDALGHFLIS--TLCDYAVQIANGMRYLESKRFI---HRDLAA 125
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGT--FGYLDLEYFRSSQFTKKGDVYS 119
NILL + KI DFG R + ++ H F + E R+ F+ DV+
Sbjct: 126 RNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWM 185
Query: 120 FGVVFVGLLT-GQKP 133
FGV + T G++P
Sbjct: 186 FGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-14
Identities = 49/204 (24%), Positives = 90/204 (44%), Gaps = 41/204 (20%)
Query: 7 EFIPNGTL---YRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
E++ G+L + + + E + +IAV V L+YLH I HRD+K +N
Sbjct: 79 EYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEKHKI--IHRDVKPSN 131
Query: 64 ILLDDKFRAKISDFGASRYVT--IDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
IL++ + + K+ DFG S + + +T + GT Y+ E + + ++ K D++S G
Sbjct: 132 ILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQGNDYSVKSDIWSLG 186
Query: 122 VVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAML 181
+ + L TG+ P + D +F++L ++ E +
Sbjct: 187 LSLIELATGRFPYPPENDPPDG--------------IFELLQ-YIVNE--PPPRLPSGKF 229
Query: 182 AK-------RCLNLNGRKRPTMKE 198
+ CL + R+RP+ KE
Sbjct: 230 SPDFQDFVNLCLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-14
Identities = 41/151 (27%), Positives = 70/151 (46%), Gaps = 9/151 (5%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFT-ITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+V E+ P G L + I + ++ I + RI +++ L LH I HRD+KSA
Sbjct: 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSA 132
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
NILL KI D G S+ + + T++ GT Y+ E ++ ++ K D++S G
Sbjct: 133 NILLVANDLVKIGDLGISKVLK--KNMAKTQI-GTPHYMAPEVWKGRPYSYKSDIWSLGC 189
Query: 123 VFVGLLTGQKPIRSTDTEE--DKSLAGYFLR 151
+ + T P + ++ K G +
Sbjct: 190 LLYEMATFAPPFEARSMQDLRYKVQRGKYPP 220
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 5e-14
Identities = 41/120 (34%), Positives = 68/120 (56%), Gaps = 5/120 (4%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV+EF+ +G L Y+ Q +F+ E L + ++V ++YL S+ I HRD+ + N
Sbjct: 76 LVFEFMEHGCLSDYLRAQRGKFSQ--ETLLGMCLDVCEGMAYLESSNVI---HRDLAARN 130
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
L+ + K+SDFG +R+V DQ +T + + E F S+++ K DV+SFGV+
Sbjct: 131 CLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVL 190
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-14
Identities = 54/198 (27%), Positives = 87/198 (43%), Gaps = 23/198 (11%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
++V E+ P GTL YI + I L V++ AL ++H+ I HRD+K+
Sbjct: 75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTI-LHFFVQILLALHHVHTKL---ILHRDLKTQ 130
Query: 63 NILLDD-KFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
NILLD K KI DFG S+ ++ T V GT Y+ E + +K D+++ G
Sbjct: 131 NILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKPYNQKSDIWALG 188
Query: 122 VVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAML 181
V L + ++ E +L L+ M F + + + + L
Sbjct: 189 CVLYELASLKRAF------EAANLPALVLKIMSGT--FAPISDRYSPDLR--------QL 232
Query: 182 AKRCLNLNGRKRPTMKEV 199
LNL+ KRP + ++
Sbjct: 233 ILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-14
Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 9/122 (7%)
Query: 27 ITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYV--T 84
I EI +IAV V L+YL++ I HRDIK +NIL++ + + K+ DFG S + +
Sbjct: 100 IPVEILGKIAVAVVEGLTYLYNVHRI--MHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157
Query: 85 IDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKS 144
I T + GT Y+ E + ++T K DV+S G+ + L G+ P ++ ++D
Sbjct: 158 IADTFV-----GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ 212
Query: 145 LA 146
Sbjct: 213 DD 214
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 8e-14
Identities = 53/198 (26%), Positives = 82/198 (41%), Gaps = 20/198 (10%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFT-ITWEISLRIAVEVSGALSYLH--STTSIPIYHRDIK 60
+V E+ G L + I +E I E RI ++ AL H S + HRD+K
Sbjct: 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLK 137
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
ANI LD K+ DFG ++ + D + T V GT Y+ E + +K D++S
Sbjct: 138 PANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNHMSYDEKSDIWSL 196
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
G + L P + + + LA F + + E E+I
Sbjct: 197 GCLIYELCALSPPFTARNQLQ---LASKIKEGK-----FRRIPYRYSSELN--EVI---- 242
Query: 181 LAKRCLNLNGRKRPTMKE 198
K LN++ KRP+ +E
Sbjct: 243 --KSMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-13
Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 29/205 (14%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L+ + +P G L Y+ + + I + L V+++ +SYL + HRD+ + N
Sbjct: 85 LITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARN 139
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQG---TFGYLDLEYFRSSQFTKKGDVYSF 120
+L+ KI+DFG ++ + +D+ +G ++ LE +T K DV+S+
Sbjct: 140 VLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMALESILHRIYTHKSDVWSY 197
Query: 121 GVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLR-AMKENCLFDMLDAQVLKEAKEEEIITV 178
GV L+T G KP E L R C D V
Sbjct: 198 GVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTID-----------------V 240
Query: 179 AMLAKRCLNLNGRKRPTMKEVAFEL 203
M+ +C ++ RPT KE+ E
Sbjct: 241 YMVLVKCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-13
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 25/212 (11%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV + +P+G L Y+H+ + I ++ L V+++ + YL + HRD+ + N
Sbjct: 85 LVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARN 139
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTR-VQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
+L+ KI+DFG +R + D+ + ++ LE +FT + DV+S+GV
Sbjct: 140 VLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGV 199
Query: 123 VFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAML 181
L+T G KP T E + D+L+ I V M+
Sbjct: 200 TIWELMTFGGKPYDGIPTRE----------------IPDLLEKGERLPQPPICTIDVYMV 243
Query: 182 AKRCLNLNGRKRPTMKEVAFELGGIRASIGPQ 213
+C ++ RP KE+A E R + PQ
Sbjct: 244 MVKCWMIDADSRPKFKELAAEFS--RMARDPQ 273
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-13
Identities = 36/105 (34%), Positives = 50/105 (47%), Gaps = 9/105 (8%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFG-- 99
L+YLHS I HRDIK ANI LD K+ DFG + + + T + VQ G
Sbjct: 111 GLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167
Query: 100 -YLDLEYFRSSQFTKKG---DVYSFGVVFVGLLTGQKPIRSTDTE 140
Y+ E + G D++S G V + + TG++P D E
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-13
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 29/217 (13%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV E++P G+L Y+ E + L A ++ + YL S + HRD+ + N
Sbjct: 84 LVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQICKGMEYLGSKRYV---HRDLATRN 138
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQG---TFGYLDLEYFRSSQFTKKGDVYSF 120
IL++ + R KI DFG ++ + D+ + R G F Y E S+F+ DV+SF
Sbjct: 139 ILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP-ESLTESKFSVASDVWSF 197
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN-----CLFDMLDAQVLKE-----A 170
GVV L T +++ S F+R M + ++ +++ +LK A
Sbjct: 198 GVVLYELF--------TYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE--LLKNNGRLPA 247
Query: 171 KEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207
+ + K C N + +RP+ E+A ++ IR
Sbjct: 248 PPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 3e-13
Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 44/207 (21%)
Query: 4 LVYEFIPNGTL----YRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDI 59
+V E++ G+L + E +I+ + EV L YLHS I HRDI
Sbjct: 92 VVMEYMDGGSLTDIITQNFVRMNEP-----QIA-YVCREVLQGLEYLHSQNVI---HRDI 142
Query: 60 KSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYS 119
KS NILL K++DFG + +T +++ + V GT ++ E + + K D++S
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKDYGPKVDIWS 201
Query: 120 FGVVFVGLLTGQKPIRSTDTEEDKSLAGYF----LRAMK---ENCLFDMLDAQVL-KEAK 171
G++ + + G+ P Y LRA+ + + + + E K
Sbjct: 202 LGIMCIEMAEGEPP--------------YLREPPLRALFLITTKGIPPLKNPEKWSPEFK 247
Query: 172 EEEIITVAMLAKRCLNLNGRKRPTMKE 198
+ +CL + KRP+ +E
Sbjct: 248 D--------FLNKCLVKDPEKRPSAEE 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-13
Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 10/141 (7%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E++ NG L Y+ + + F + L + +V ++YL S I HRD+ + N
Sbjct: 76 IVTEYMSNGCLLNYLREHGKRFQPSQ--LLEMCKDVCEGMAYLESKQFI---HRDLAARN 130
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF--GYLDLEYFRSSQFTKKGDVYSFG 121
L+DD+ K+SDFG SRYV D+ T+ V F + E S+F+ K DV++FG
Sbjct: 131 CLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFG 188
Query: 122 VVFVGLLT-GQKPIRSTDTEE 141
V+ + + G+ P + E
Sbjct: 189 VLMWEVYSLGKMPYERFNNSE 209
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-13
Identities = 39/134 (29%), Positives = 68/134 (50%), Gaps = 6/134 (4%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V EF+ NG L Y+ + + + ++ L + +V + YL + I HRD+ + N
Sbjct: 76 IVTEFMENGCLLNYLRQRQGKLSK--DMLLSMCQDVCEGMEYLERNSFI---HRDLAARN 130
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
L+ K+SDFG +RYV D+ ++ + + E F S+++ K DV+SFGV+
Sbjct: 131 CLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVL 190
Query: 124 FVGLLT-GQKPIRS 136
+ T G+ P
Sbjct: 191 MWEVFTEGKMPFEK 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-13
Identities = 47/201 (23%), Positives = 84/201 (41%), Gaps = 21/201 (10%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
++ EF+ G L Y+ + + + + L +A ++S A+ YL I HRD+ + N
Sbjct: 79 IITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKNFI---HRDLAARN 134
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
L+ + K++DFG SR +T D + + E ++F+ K DV++FGV+
Sbjct: 135 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 194
Query: 124 FVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLA 182
+ T G P D + ++++L+ E E V L
Sbjct: 195 LWEIATYGMSPYPGIDLSQ----------------VYELLEKGYRMERPEGCPPKVYELM 238
Query: 183 KRCLNLNGRKRPTMKEVAFEL 203
+ C N RP+ E+
Sbjct: 239 RACWQWNPSDRPSFAEIHQAF 259
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-13
Identities = 43/142 (30%), Positives = 73/142 (51%), Gaps = 9/142 (6%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
PL+V ++ +G L +I +T T+ I ++V+ + YL S + HRD+ +
Sbjct: 72 PLVVLPYMKHGDLRNFIRSETHNPTVKDLIGF--GLQVAKGMEYLASKKFV---HRDLAA 126
Query: 62 ANILLDDKFRAKISDFGASRYV---TIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVY 118
N +LD+ F K++DFG +R + H T + ++ LE ++ +FT K DV+
Sbjct: 127 RNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVW 186
Query: 119 SFGVVFVGLLT-GQKPIRSTDT 139
SFGV+ L+T G P D+
Sbjct: 187 SFGVLLWELMTRGAPPYPDVDS 208
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 8e-13
Identities = 43/116 (37%), Positives = 63/116 (54%), Gaps = 6/116 (5%)
Query: 37 VEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR-YVTIDQTHLTTRVQ 95
++V A+ ++HS I HRDIKSANILL K+ DFG S+ Y +
Sbjct: 150 IQVLLAVHHVHSKHMI---HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206
Query: 96 GTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE--DKSLAGYF 149
GT Y+ E +R ++KK D++S GV+ LLT ++P + EE K+LAG +
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262
|
Length = 496 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-12
Identities = 45/130 (34%), Positives = 67/130 (51%), Gaps = 10/130 (7%)
Query: 7 EFIPNGTLYRYIHDQTEEF-TITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANIL 65
E++P G+ + DQ + + +T ++ + ++ +SYLHS I HRDIK ANIL
Sbjct: 86 EYMPGGS----VKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANIL 138
Query: 66 LDDKFRAKISDFGAS-RYVTIDQTHLTTR-VQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
D K+ DFGAS R TI + R V GT ++ E + +K DV+S G
Sbjct: 139 RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCT 198
Query: 124 FVGLLTGQKP 133
V +LT + P
Sbjct: 199 VVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-12
Identities = 36/111 (32%), Positives = 54/111 (48%), Gaps = 8/111 (7%)
Query: 34 RIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTR 93
++ V + AL YL + HRD+K +NILLD K+ DFG S + + TR
Sbjct: 118 KMTVAIVKALHYLKEKHGV--IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TR 173
Query: 94 VQGTFGYLDLEYF----RSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTE 140
G Y+ E + ++ + DV+S G+ V L TGQ P ++ TE
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE 224
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-12
Identities = 43/142 (30%), Positives = 57/142 (40%), Gaps = 23/142 (16%)
Query: 4 LVYEFIPNGTLYRYIH-----DQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRD 58
LV E++P G L + D+ EI L AL YLHS I HRD
Sbjct: 70 LVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVL--------ALEYLHS---NGIIHRD 118
Query: 59 IKSANILLDDKFRAKISDFGASRY-------VTIDQTHLTTRVQGTFGYLDLEYFRSSQF 111
+K NIL+D K++DFG S+ D R+ GT Y+ E
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 112 TKKGDVYSFGVVFVGLLTGQKP 133
+K D +S G + L G P
Sbjct: 179 SKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-12
Identities = 39/139 (28%), Positives = 73/139 (52%), Gaps = 14/139 (10%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+LV E G L +++ + +E T++ + L +VS + YL + HRD+ +
Sbjct: 70 MLVMEMASGGPLNKFLSGKKDEITVSNVVEL--MHQVSMGMKYLEGKNFV---HRDLAAR 124
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSS-----QFTKKGDV 117
N+LL ++ AKISDFG S+ + D ++ R + G L+++ +F+ + DV
Sbjct: 125 NVLLVNQHYAKISDFGLSKALGADDSYYKAR---SAGKWPLKWYAPECINFRKFSSRSDV 181
Query: 118 YSFGV-VFVGLLTGQKPIR 135
+S+G+ ++ GQKP +
Sbjct: 182 WSYGITMWEAFSYGQKPYK 200
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 2e-12
Identities = 46/180 (25%), Positives = 75/180 (41%), Gaps = 32/180 (17%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTH-LTTRVQGTFGY 100
L YLHS I HRDIK +NIL+++ K++DFG +R T + T RV
Sbjct: 112 GLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV------ 162
Query: 101 LDLEY------FRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDK-----SLAGYF 149
+ L Y ++++ + D++S G + L G KPI TE ++ L G
Sbjct: 163 ITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG-KPIFQGSTELEQLEKIFELCGSP 221
Query: 150 LRAMKENC----LFDMLDAQVLKEAKEEEII-----TVAM-LAKRCLNLNGRKRPTMKEV 199
F+ L + + + E A+ L + L L+ +KR + +
Sbjct: 222 TDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQA 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (159), Expect = 3e-12
Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 21/146 (14%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFT------ITWEISLRIAVEVSGALSYLHSTTSIPIYHR 57
LV+E+ L +Y+ + + I +++ LR L+Y HS I HR
Sbjct: 75 LVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQL-LR-------GLAYCHS---HRILHR 122
Query: 58 DIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLE-YFRSSQFTKKGD 116
D+K NIL++ K++DFG +R I T V T Y E S ++ D
Sbjct: 123 DLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHYSTAVD 181
Query: 117 VYSFGVVFVGLLTGQKPIRSTDTEED 142
++S G +F ++TG KP+ D+E D
Sbjct: 182 IWSVGCIFAEMITG-KPLFPGDSEID 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-12
Identities = 44/130 (33%), Positives = 67/130 (51%), Gaps = 10/130 (7%)
Query: 7 EFIPNGTLYRYIHDQTEEF-TITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANIL 65
E++P G+ I DQ + + +T ++ R ++ +SYLHS I HRDIK ANIL
Sbjct: 86 EYMPGGS----IKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANIL 138
Query: 66 LDDKFRAKISDFGASRYV-TIDQTHLTTR-VQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
D K+ DFGAS+ + TI + + V GT ++ E + +K DV+S
Sbjct: 139 RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACT 198
Query: 124 FVGLLTGQKP 133
V +LT + P
Sbjct: 199 VVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-12
Identities = 53/200 (26%), Positives = 84/200 (42%), Gaps = 25/200 (12%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+LV E P G L +Y+ + E I +A +V+ ++YL S + HRD+ +
Sbjct: 71 MLVMELAPLGPLLKYLKKRRE---IPVSDLKELAHQVAMGMAYLESKHFV---HRDLAAR 124
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF--GYLDLEYFRSSQFTKKGDVYSF 120
N+LL ++ +AKISDFG SR + + G + + E +F+ K DV+S+
Sbjct: 125 NVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSY 184
Query: 121 GVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVA 179
GV + G KP Y MK + ML++ EE +
Sbjct: 185 GVTLWEAFSYGAKP--------------Y--GEMKGAEVIAMLESGERLPRPEECPQEIY 228
Query: 180 MLAKRCLNLNGRKRPTMKEV 199
+ C RPT E+
Sbjct: 229 SIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-12
Identities = 44/131 (33%), Positives = 67/131 (51%), Gaps = 12/131 (9%)
Query: 7 EFIPNGTLYRYIHDQTEEF-TITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANIL 65
E++P G+ + DQ + + +T ++ + ++ + YLHS I HRDIK ANIL
Sbjct: 84 EYMPGGS----VKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANIL 136
Query: 66 LDDKFRAKISDFGAS-RYVTI--DQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
D K+ DFGAS R TI T + + V GT ++ E + +K DV+S G
Sbjct: 137 RDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPEVISGEGYGRKADVWSVGC 195
Query: 123 VFVGLLTGQKP 133
V +LT + P
Sbjct: 196 TVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-12
Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 26/207 (12%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E P G L Y+ Q ++++ + + ++S AL+YL S + HRDI + N
Sbjct: 83 IVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLESKRFV---HRDIAARN 137
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV- 122
+L+ K+ DFG SRY+ + + ++ + ++ E +FT DV+ FGV
Sbjct: 138 VLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 197
Query: 123 VFVGLLTGQKPIRSTDTEE--DKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
++ L+ G KP + + + G L M NC T+
Sbjct: 198 MWEILMLGVKPFQGVKNNDVIGRIENGERL-PMPPNC-----------------PPTLYS 239
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIR 207
L +C + KRP E+ +L I
Sbjct: 240 LMTKCWAYDPSKRPRFTELKAQLSDIL 266
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 5e-12
Identities = 52/181 (28%), Positives = 69/181 (38%), Gaps = 34/181 (18%)
Query: 4 LVYEFIPNGTL-----YRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRD 58
LV ++ G+L Y +E I + EV L YLHS I HRD
Sbjct: 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIA-----TVLKEVLKGLEYLHSNGQI---HRD 127
Query: 59 IKSANILLDDKFRAKISDFG--ASRYVTIDQTHLT-TRVQGTFGYLDLEYFRSSQ-FTKK 114
IK+ NILL + KI+DFG AS D+T GT ++ E + K
Sbjct: 128 IKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFK 187
Query: 115 GDVYSFGVVFVGLLTG-----------------QKPIRSTDTEEDKSLAGYFLRAMKENC 157
D++SFG+ + L TG Q S +T D R M C
Sbjct: 188 ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLC 247
Query: 158 L 158
L
Sbjct: 248 L 248
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 6e-12
Identities = 41/125 (32%), Positives = 61/125 (48%), Gaps = 12/125 (9%)
Query: 14 LYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAK 73
Y+Y+++ + I EI +IAV AL+YL + I HRD+K +NILLD K
Sbjct: 92 FYKYVYEVLKS-VIPEEILGKIAVATVKALNYL--KEELKIIHRDVKPSNILLDRNGNIK 148
Query: 74 ISDFGASRYV--TIDQTHLTTRVQGTFGYLDLEYFRSSQFTK---KGDVYSFGVVFVGLL 128
+ DFG S + +I + TR G Y+ E S + DV+S G+ +
Sbjct: 149 LCDFGISGQLVDSIAK----TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVA 204
Query: 129 TGQKP 133
TG+ P
Sbjct: 205 TGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-12
Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 29/197 (14%)
Query: 7 EFIPNGTLYRYIHDQT----EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
E+ GTLY I Q EE + W + ++ A+SY+H I HRDIK+
Sbjct: 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYL-----FQIVSAVSYIHK---AGILHRDIKTL 130
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
NI L K+ DFG S+ + + + T V GT Y+ E + ++ K D+++ G
Sbjct: 131 NIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYNFKSDIWALGC 189
Query: 123 VFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLA 182
V LLT ++ T + + ++ ++ + + + E L
Sbjct: 190 VLYELLTLKR------TFDATNPLNLVVKIVQ--GNYTPVVSVYSSELI--------SLV 233
Query: 183 KRCLNLNGRKRPTMKEV 199
L + KRPT EV
Sbjct: 234 HSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-11
Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
L+ E++P G+L Y+ + + L A ++ ++YLHS I HRD+ +
Sbjct: 84 QLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQHYI---HRDLAAR 136
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQG---TFGYLDLEYFRSSQFTKKGDVYS 119
N+LLD+ KI DFG ++ V + R G F Y +E + ++F+ DV+S
Sbjct: 137 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-VECLKENKFSYASDVWS 195
Query: 120 FGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVA 179
FGV LLT +S + ++ + G M L ++L+ + + V
Sbjct: 196 FGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVY 254
Query: 180 MLAKRCLNLNGRKRPTMK 197
+L K C + RPT +
Sbjct: 255 ILMKNCWETEAKFRPTFR 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 55/165 (33%), Positives = 82/165 (49%), Gaps = 20/165 (12%)
Query: 35 IAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRV 94
I E+ L YLHS I HRDIK+AN+LL ++ K++DFG + +T Q T V
Sbjct: 106 ILREILKGLDYLHSERKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162
Query: 95 QGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK 154
GT ++ E + S + K D++S G+ + L G+ P ++D + L FL +
Sbjct: 163 -GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP--NSDLHPMRVL---FL--IP 214
Query: 155 ENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
+N L+ Q K KE + CLN + R RPT KE+
Sbjct: 215 KNSP-PTLEGQYSKPFKE--------FVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-11
Identities = 42/131 (32%), Positives = 67/131 (51%), Gaps = 12/131 (9%)
Query: 7 EFIPNGTLYRYIHDQTEEF-TITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANIL 65
E +P G+ I DQ + + +T ++ + ++ +SYLHS I HRDIK ANIL
Sbjct: 86 EHMPGGS----IKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANIL 138
Query: 66 LDDKFRAKISDFGASR---YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
D K+ DFGAS+ + + T + + V GT ++ E + +K D++S G
Sbjct: 139 RDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSPEVISGEGYGRKADIWSVGC 197
Query: 123 VFVGLLTGQKP 133
V +LT + P
Sbjct: 198 TVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-11
Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 27/204 (13%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV + +P G L Y+ + + I + L V+++ +SYL + + HRD+ + N
Sbjct: 85 LVTQLMPYGCLLDYVRENKDR--IGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARN 139
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQG---TFGYLDLEYFRSSQFTKKGDVYSF 120
+L+ KI+DFG +R + ID+T G ++ LE +FT + DV+S+
Sbjct: 140 VLVKSPNHVKITDFGLARLLDIDETEY--HADGGKVPIKWMALESILHRRFTHQSDVWSY 197
Query: 121 GVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVA 179
GV L+T G KP E + D+L+ I V
Sbjct: 198 GVTVWELMTFGAKPYDGIPARE----------------IPDLLEKGERLPQPPICTIDVY 241
Query: 180 MLAKRCLNLNGRKRPTMKEVAFEL 203
M+ +C ++ RP +E+ E
Sbjct: 242 MIMVKCWMIDSECRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-11
Identities = 35/121 (28%), Positives = 59/121 (48%), Gaps = 8/121 (6%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+V E++ G+L Y+ + IT L A++V + YL HRD+ +
Sbjct: 76 YIVTEYMAKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAAR 131
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N+L+ + AK+SDFG ++ + Q V+ T E R +F+ K DV+SFG+
Sbjct: 132 NVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAP----EALREKKFSTKSDVWSFGI 187
Query: 123 V 123
+
Sbjct: 188 L 188
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 24/149 (16%)
Query: 2 PLLVYEFIPNGTLYRYI--HD---------QTEEFTITWEISLRIAVEVSGALSYLHSTT 50
P++V+E++ +G L +++ H + +T L+IAV+++ + YL S
Sbjct: 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH 142
Query: 51 SIPIYHRDIKSANILLDDKFRAKISDFGASRYV-TIDQTHLTTRVQGT----FGYLDLEY 105
+ HRD+ + N L+ KI DFG SR V T D RV G ++ E
Sbjct: 143 FV---HRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY----YRVGGHTMLPIRWMPPES 195
Query: 106 FRSSQFTKKGDVYSFGVVFVGLLT-GQKP 133
+FT + DV+SFGVV + T G++P
Sbjct: 196 IMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-11
Identities = 45/209 (21%), Positives = 90/209 (43%), Gaps = 28/209 (13%)
Query: 2 PLLVYEFIPNGTLYRYI-HDQTEE--FTITWEISLRIAVEVSGALSYLHSTTSIPIYHRD 58
P+++ F+ +G L+ ++ + + + + L+ V+++ + YL + I HRD
Sbjct: 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFI---HRD 138
Query: 59 IKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRV-QGTFGYLDLEYFRSSQFTKKGDV 117
+ + N +L + ++DFG S+ + + R+ + ++ +E +T K DV
Sbjct: 139 LAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDV 198
Query: 118 YSFGVVFVGLLT-GQKPIRSTDTEE--DKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEE 174
++FGV + T GQ P + E D G L+ E+CL ++ D
Sbjct: 199 WAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ-PEDCLDELYD----------- 246
Query: 175 IITVAMLAKRCLNLNGRKRPTMKEVAFEL 203
L C + + RPT ++ L
Sbjct: 247 ------LMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-11
Identities = 40/129 (31%), Positives = 66/129 (51%), Gaps = 9/129 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L+ EF+P+G+L Y+ + I + L+ AV++ + YL S + HRD+ + N
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNK--INLKQQLKYAVQICKGMDYLGSRQYV---HRDLAARN 139
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTT---RVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
+L++ + + KI DFG ++ + D+ + T F Y E S+F DV+SF
Sbjct: 140 VLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP-ECLIQSKFYIASDVWSF 198
Query: 121 GVVFVGLLT 129
GV LLT
Sbjct: 199 GVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-11
Identities = 49/172 (28%), Positives = 80/172 (46%), Gaps = 23/172 (13%)
Query: 29 WEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQT 88
W I +++ + AL YLH I HRD+ NI+L + + I+DFG ++ ++
Sbjct: 116 WNIFVQMVL----ALRYLHKEKRI--VHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PES 168
Query: 89 HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGY 148
LT+ V GT Y E ++ + +K DV++FG + + T Q P ST+ SLA
Sbjct: 169 KLTSVV-GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLATK 224
Query: 149 FLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVA 200
+ A+ E L E E +T + CL + RP + +V+
Sbjct: 225 IVEAVYEP----------LPEGMYSEDVT--DVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 4e-11
Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 9/133 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E++ G+L ++ E + + +A +++ ++YL S I HRD+ + N
Sbjct: 78 IVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRNYI---HRDLAARN 133
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF--GYLDLEYFRSSQFTKKGDVYSFG 121
IL+ + KI+DFG +R I+ T R F + E +FT K DV+SFG
Sbjct: 134 ILVGENLVCKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFG 191
Query: 122 VVFVGLLT-GQKP 133
++ ++T G+ P
Sbjct: 192 ILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-11
Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 42/173 (24%)
Query: 38 EVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGT 97
E+ L YLHS I HRDIK+AN+LL ++ K++DFG + +T Q T V GT
Sbjct: 109 EILKGLDYLHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GT 164
Query: 98 FGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDK-----------SLA 146
++ E + S + K D++S G+ + L G+ P ++D + +L
Sbjct: 165 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP--NSDMHPMRVLFLIPKNNPPTLT 222
Query: 147 GYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
G F + KE +DA CLN + RPT KE+
Sbjct: 223 GEFSKPFKE-----FIDA--------------------CLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 4e-11
Identities = 39/131 (29%), Positives = 58/131 (44%), Gaps = 11/131 (8%)
Query: 5 VYEFIPNGTLYRYI--HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+ E+ NG+L + I E + +V L+YLH I HRDIK+A
Sbjct: 77 ILEYAENGSLRQIIKKFGPFPE-----SLVAVYVYQVLQGLAYLHEQGVI---HRDIKAA 128
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
NIL K++DFG + + D + V GT ++ E S + D++S G
Sbjct: 129 NILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGC 187
Query: 123 VFVGLLTGQKP 133
+ LLTG P
Sbjct: 188 TVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-11
Identities = 35/120 (29%), Positives = 62/120 (51%), Gaps = 5/120 (4%)
Query: 34 RIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTR 93
+I++ V L+YL I HRD+K +NIL++ + K+ DFG S + ID +
Sbjct: 103 KISIAVLRGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANS 157
Query: 94 VQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAM 153
GT Y+ E + + +T + D++S G+ V + G+ PI D +E +++ G +
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEG 217
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-11
Identities = 44/173 (25%), Positives = 73/173 (42%), Gaps = 19/173 (10%)
Query: 31 ISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK-FRAKISDFGASRYVTIDQT- 88
+ + ++ LSYLH I HRD+K AN+L+D R +I+DFGA+ + T
Sbjct: 104 VIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160
Query: 89 --HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLA 146
++ GT ++ E R Q+ + DV+S G V + + T + P + +L
Sbjct: 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL- 219
Query: 147 GYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
+F + A E + + RCL L RP +E+
Sbjct: 220 -----------IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-11
Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 7 EFIPNGTL--YRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANI 64
EF+ G+L YR I + + RIAV V L+YL S + I HRD+K +N+
Sbjct: 79 EFMDGGSLDVYRKIPEH---------VLGRIAVAVVKGLTYLWS---LKILHRDVKPSNM 126
Query: 65 LLDDKFRAKISDFGASRYV--TIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
L++ + + K+ DFG S + +I +T++ GT Y+ E Q+ DV+S G+
Sbjct: 127 LVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQYGIHSDVWSLGI 181
Query: 123 VFVGLLTGQKP 133
F+ L G+ P
Sbjct: 182 SFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-11
Identities = 38/106 (35%), Positives = 54/106 (50%), Gaps = 4/106 (3%)
Query: 36 AVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQ 95
A E++ AL YLHS + I +RD+K NILLD + ++DFG + I+ + T+
Sbjct: 102 AAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFC 157
Query: 96 GTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE 141
GT YL E R + + D + G V +L G P S DT E
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-11
Identities = 46/138 (33%), Positives = 63/138 (45%), Gaps = 7/138 (5%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
V +F+ G L+ H Q E + + A E++ AL YLHS I I +RD+K N
Sbjct: 73 FVLDFVNGGELF--FHLQRER-SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPEN 126
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
ILLD + ++DFG + I Q+ TT GT YL E R + D + G V
Sbjct: 127 ILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAV 185
Query: 124 FVGLLTGQKPIRSTDTEE 141
+L G P D E
Sbjct: 186 LYEMLYGLPPFYCRDVAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-11
Identities = 46/141 (32%), Positives = 74/141 (52%), Gaps = 13/141 (9%)
Query: 4 LVYEFIPNGTLYRYIHDQ---TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
L+ +F+ G L+ + + TEE ++ +A E++ AL +LHS + I +RD+K
Sbjct: 75 LILDFLRGGDLFTRLSKEVMFTEE-----DVKFYLA-ELALALDHLHS---LGIIYRDLK 125
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
NILLD++ K++DFG S+ +ID GT Y+ E T+ D +SF
Sbjct: 126 PENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSF 184
Query: 121 GVVFVGLLTGQKPIRSTDTEE 141
GV+ +LTG P + D +E
Sbjct: 185 GVLMFEMLTGSLPFQGKDRKE 205
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-11
Identities = 43/141 (30%), Positives = 66/141 (46%), Gaps = 11/141 (7%)
Query: 3 LLVYEFIPNGTLYRYIHDQT--EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
V EF+ G L +I D+ + + T+ A E+ L +LHS I +RD+K
Sbjct: 72 FFVMEFLNGGDLMFHIQDKGRFDLYRATF-----YAAEIVCGLQFLHSKGII---YRDLK 123
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
N++LD KI+DFG + +T GT Y+ E + ++T D +SF
Sbjct: 124 LDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYTFSVDWWSF 182
Query: 121 GVVFVGLLTGQKPIRSTDTEE 141
GV+ +L GQ P D +E
Sbjct: 183 GVLLYEMLIGQSPFHGDDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-11
Identities = 45/132 (34%), Positives = 69/132 (52%), Gaps = 8/132 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L+ +++ G L+ +++ Q E FT + E+ + IA E+ AL +LH + I +RDIK N
Sbjct: 82 LILDYVNGGELFTHLY-QREHFTES-EVRVYIA-EIVLALDHLHQ---LGIIYRDIKLEN 135
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFR--SSQFTKKGDVYSFG 121
ILLD + ++DFG S+ ++ GT Y+ E R S K D +S G
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLG 195
Query: 122 VVFVGLLTGQKP 133
V+ LLTG P
Sbjct: 196 VLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-11
Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYV-TIDQTHLTTRVQGTFGYL 101
L+YLHS I HRD+K+ N+L+D KISDFG S+ I +QG+ ++
Sbjct: 121 LAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 102 DLEYFRSSQ--FTKKGDVYSFGVVFVGLLTGQKP 133
E S ++ K D++S G V + + G++P
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-11
Identities = 51/201 (25%), Positives = 83/201 (41%), Gaps = 31/201 (15%)
Query: 10 PNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK 69
P G + E T+T + + A +V+ + +L S I HRD+ + N+L+ +
Sbjct: 112 PPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCI---HRDLAARNVLVTED 168
Query: 70 FRAKISDFGASRYV-TIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLL 128
KI+DFG +R + ID TT + ++ E +T + DV+SFGV+ +
Sbjct: 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
Query: 129 T-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEE-----IITVAMLA 182
T G P EE LF + LKE E + L
Sbjct: 229 TLGGSPYPGIPVEE----------------LFKL-----LKEGYRMEKPQNCTQELYHLM 267
Query: 183 KRCLNLNGRKRPTMKEVAFEL 203
+ C + +RPT K++ +L
Sbjct: 268 RDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 37/134 (27%), Positives = 70/134 (52%), Gaps = 8/134 (5%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+++ E++ NG L +Y+ D EF+ S ++ + G + + + + HRD+ +
Sbjct: 82 MIITEYMENGALDKYLRDHDGEFS-----SYQLVGMLRGIAAGMKYLSDMNYVHRDLAAR 136
Query: 63 NILLDDKFRAKISDFGASRYVTID--QTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
NIL++ K+SDFG SR + D T+ T+ + + E +FT DV+SF
Sbjct: 137 NILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSF 196
Query: 121 GVVFVGLLT-GQKP 133
G+V +++ G++P
Sbjct: 197 GIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-10
Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 14/133 (10%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAV---EVSGALSYLHSTTSIPIYHRDIK 60
+V E++ G+L T+ T T +IA E AL +LHS I HRDIK
Sbjct: 93 VVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI---HRDIK 142
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
S NILL K++DFG +T +Q+ +T V GT ++ E + K D++S
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSL 201
Query: 121 GVVFVGLLTGQKP 133
G++ + ++ G+ P
Sbjct: 202 GIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-10
Identities = 34/134 (25%), Positives = 65/134 (48%), Gaps = 9/134 (6%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+V E + G+L Y+ + + +A +V+ ++YL + I HRD+ +
Sbjct: 77 YIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQNYI---HRDLAAR 132
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF--GYLDLEYFRSSQFTKKGDVYSF 120
N+L+ + K++DFG +R I + R F + E ++F+ K DV+SF
Sbjct: 133 NVLVGENNICKVADFGLAR--VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSF 190
Query: 121 GVVFVGLLT-GQKP 133
G++ ++T G+ P
Sbjct: 191 GILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 37/121 (30%), Positives = 64/121 (52%), Gaps = 5/121 (4%)
Query: 27 ITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTID 86
I EI ++++ V L+YL I HRD+K +NIL++ + K+ DFG S + ID
Sbjct: 100 IPEEILGKVSIAVLRGLAYLREKHQI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-ID 156
Query: 87 QTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLA 146
+ GT Y+ E + + ++ + D++S G+ V L G+ PI D +E +++
Sbjct: 157 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214
Query: 147 G 147
G
Sbjct: 215 G 215
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-10
Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 25/204 (12%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+LV E G L +++ +T + + +VS + YL T + HRD+ +
Sbjct: 71 MLVMELAELGPLNKFLQKNKH---VTEKNITELVHQVSMGMKYLEETNFV---HRDLAAR 124
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF--GYLDLEYFRSSQFTKKGDVYSF 120
N+LL + AKISDFG S+ + D+ + + G + + E +F+ K DV+SF
Sbjct: 125 NVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSF 184
Query: 121 GVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVA 179
GV+ + GQKP + MK N + M+++ E + +
Sbjct: 185 GVLMWEAFSYGQKP----------------YKGMKGNEVTQMIESGERMECPQRCPPEMY 228
Query: 180 MLAKRCLNLNGRKRPTMKEVAFEL 203
L K C +RP V L
Sbjct: 229 DLMKLCWTYGVDERPGFAVVELRL 252
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 44/215 (20%)
Query: 2 PLLVYEFIPNGTLYRYI--HDQTEEFT-----ITWEISLRIAVEVSGALSYLHSTTSIPI 54
L+V E + G L Y+ E T + +++A E++ ++YL + +
Sbjct: 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFV-- 141
Query: 55 YHRDIKSANILLDDKFRAKISDFGASR-------YVTIDQTHLTTRVQGTFGYLDLEYFR 107
HRD+ + N ++ + KI DFG +R Y + L R ++ E +
Sbjct: 142 -HRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR------WMAPESLK 194
Query: 108 SSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEE--DKSLAGYFLRAMKENCLFDMLDA 164
FT K DV+SFGVV + T ++P + EE + G L + ENC +L+
Sbjct: 195 DGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD-LPENCPDKLLE- 252
Query: 165 QVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
L + C N + RPT E+
Sbjct: 253 ----------------LMRMCWQYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-10
Identities = 38/138 (27%), Positives = 66/138 (47%), Gaps = 15/138 (10%)
Query: 4 LVYEFIPNGTLYRYIHDQ-----TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRD 58
+V E+ G L + I Q E+ + W + + + V+ ++H + HRD
Sbjct: 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ------HIHEKR---VLHRD 125
Query: 59 IKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVY 118
IKS NI L + K+ DFG++R +T + T V GT Y+ E + + + K D++
Sbjct: 126 IKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNNKSDIW 184
Query: 119 SFGVVFVGLLTGQKPIRS 136
S G + L T + P ++
Sbjct: 185 SLGCILYELCTLKHPFQA 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-10
Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 5/100 (5%)
Query: 36 AVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQ 95
A E+ L LH I +RD+K NILLDD +ISD G + +V QT + RV
Sbjct: 108 AAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV- 162
Query: 96 GTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIR 135
GT GY+ E ++ ++T D ++ G + ++ GQ P +
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-10
Identities = 36/130 (27%), Positives = 68/130 (52%), Gaps = 10/130 (7%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEE-FTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
++ E++ NG+L ++ +T E +T + +A +++ ++++ I HRD+++
Sbjct: 76 YIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI---HRDLRA 130
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF--GYLDLEYFRSSQFTKKGDVYS 119
ANIL+ + KI+DFG +R I+ T R F + E FT K DV+S
Sbjct: 131 ANILVSETLCCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 188
Query: 120 FGVVFVGLLT 129
FG++ ++T
Sbjct: 189 FGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-10
Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 4/99 (4%)
Query: 35 IAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRV 94
I E+ L YLHS I HRDIK+AN+LL + K++DFG + +T Q T V
Sbjct: 106 ILREILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 162
Query: 95 QGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKP 133
GT ++ E + S + K D++S G+ + L G+ P
Sbjct: 163 -GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-10
Identities = 43/141 (30%), Positives = 71/141 (50%), Gaps = 9/141 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E++ G+L ++ D E + + +A +V+ ++Y+ I HRD++SAN
Sbjct: 77 IVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIERMNYI---HRDLRSAN 132
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF--GYLDLEYFRSSQFTKKGDVYSFG 121
IL+ D KI+DFG +R I+ T R F + E +FT K DV+SFG
Sbjct: 133 ILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 190
Query: 122 VVFVGLLT-GQKPIRSTDTEE 141
++ L+T G+ P + E
Sbjct: 191 ILLTELVTKGRVPYPGMNNRE 211
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-10
Identities = 32/98 (32%), Positives = 41/98 (41%), Gaps = 8/98 (8%)
Query: 36 AVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQ 95
EV + LH I HRDIK N+L+D K++DFG SR ++ +
Sbjct: 103 IAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-----KFV 154
Query: 96 GTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKP 133
GT YL E K D +S G V L G P
Sbjct: 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-10
Identities = 45/146 (30%), Positives = 72/146 (49%), Gaps = 12/146 (8%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
++ E++P G L+ Y+ + + L A E+ AL YLHS I +RD+K N
Sbjct: 78 MLMEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPEN 131
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
ILLD + K++DFG ++ + D+T + GT YL E +S K D ++ G++
Sbjct: 132 ILLDKEGHIKLTDFGFAKKL-RDRTW---TLCGTPEYLAPEVIQSKGHNKAVDWWALGIL 187
Query: 124 FVGLLTGQKPIRSTDTEE--DKSLAG 147
+L G P + +K LAG
Sbjct: 188 IYEMLVGYPPFFDDNPFGIYEKILAG 213
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-10
Identities = 35/133 (26%), Positives = 70/133 (52%), Gaps = 9/133 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E++ G+L ++ + ++ ++ + +A +++ ++Y+ + HRD+++AN
Sbjct: 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVERMNYV---HRDLRAAN 132
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF--GYLDLEYFRSSQFTKKGDVYSFG 121
IL+ + K++DFG +R I+ T R F + E +FT K DV+SFG
Sbjct: 133 ILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 190
Query: 122 VVFVGLLT-GQKP 133
++ L T G+ P
Sbjct: 191 ILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 6e-10
Identities = 52/170 (30%), Positives = 80/170 (47%), Gaps = 31/170 (18%)
Query: 35 IAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRV 94
I EV L YLH I HRDIK+ANILL ++ K++DFG S +T + T V
Sbjct: 103 ILREVLLGLEYLHEEGKI---HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV 159
Query: 95 QGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF-LRAM 153
GT ++ E + S + +K D++S G+ + L G+ P L+ +R +
Sbjct: 160 -GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP-----------LSDLHPMRVL 207
Query: 154 ----KENCLFDMLDAQVL-KEAKEEEIITVAMLAKRCLNLNGRKRPTMKE 198
K N L+ K K+ V++ CLN + ++RP+ KE
Sbjct: 208 FLIPKNNP--PSLEGNKFSKPFKD----FVSL----CLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-10
Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 16/178 (8%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
++ E++ G+L ++ E + + + +++ ++Y+ I HRD+++AN
Sbjct: 78 IITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKNYI---HRDLRAAN 133
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF--GYLDLEYFRSSQFTKKGDVYSFG 121
+L+ + KI+DFG +R I+ T R F + E FT K DV+SFG
Sbjct: 134 VLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFG 191
Query: 122 VVFVGLLTGQK---PIRSTDTEEDKSLAGYFLRAMKENC---LFDMLDAQVLKEAKEE 173
++ ++T K P S GY + M ENC L+D++ KE EE
Sbjct: 192 ILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRM-ENCPDELYDIM-KTCWKEKAEE 247
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 6e-10
Identities = 35/137 (25%), Positives = 70/137 (51%), Gaps = 15/137 (10%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+++ E++ NG+L +++ + +FT + + ++ + YL + HRD+ +
Sbjct: 81 MIITEYMENGSLDKFLRENDGKFT--VGQLVGMLRGIASGMKYLSEMNYV---HRDLAAR 135
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTR-----VQGTFGYLDLEYFRSSQFTKKGDV 117
NIL++ K+SDFG SR + + TT+ ++ T E +FT DV
Sbjct: 136 NILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAP----EAIAYRKFTSASDV 191
Query: 118 YSFGVVFVGLLT-GQKP 133
+SFG+V +++ G++P
Sbjct: 192 WSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-10
Identities = 37/106 (34%), Positives = 50/106 (47%), Gaps = 4/106 (3%)
Query: 36 AVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQ 95
A E+ L +LHS I +RD+K NILLD KI+DFG + + T
Sbjct: 102 AAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFC 157
Query: 96 GTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE 141
GT Y+ E ++ D +SFGV+ +L GQ P D EE
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-10
Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 34/186 (18%)
Query: 26 TITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR---- 81
T+T + L+ A +V+ + YL I HRD+ + N+L+ + +KI+DFG SR
Sbjct: 115 TLTSQQLLQFASDVATGMQYLSEKQFI---HRDLAARNVLVGENLASKIADFGLSRGEEV 171
Query: 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTE 140
YV L R ++ +E S +T K DV+SFGV+ +++ G P
Sbjct: 172 YVKKTMGRLPVR------WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA 225
Query: 141 E--DKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKE 198
E +K GY + + NC D +V + L ++C +RP +
Sbjct: 226 ELYEKLPQGYRMEKPR-NC-----DDEVYE------------LMRQCWRDRPYERPPFAQ 267
Query: 199 VAFELG 204
++ +L
Sbjct: 268 ISVQLS 273
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 8e-10
Identities = 33/91 (36%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLD 102
L YLHS I HRDIK+ NILL+++ +AK++DFG S +T D V GT ++
Sbjct: 112 LEYLHSNKKI---HRDIKAGNILLNEEGQAKLADFGVSGQLT-DTMAKRNTVIGTPFWMA 167
Query: 103 LEYFRSSQFTKKGDVYSFGVVFVGLLTGQKP 133
E + + K D++S G+ + + G+ P
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-10
Identities = 35/137 (25%), Positives = 63/137 (45%), Gaps = 23/137 (16%)
Query: 4 LVYEFIPNGTLYRYI-----HDQTEEFTITWEIS--------LRIAVEVSGALSYLHSTT 50
+++E++ +G L+ ++ H + + L IA++++ + YL S
Sbjct: 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH 144
Query: 51 SIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGT----FGYLDLEYF 106
HRD+ + N L+ + KISDFG SR + + RVQ ++ E
Sbjct: 145 ---FVHRDLAARNCLVGEGLTVKISDFGLSRDI---YSADYYRVQSKSLLPVRWMPPEAI 198
Query: 107 RSSQFTKKGDVYSFGVV 123
+FT + D++SFGVV
Sbjct: 199 LYGKFTTESDIWSFGVV 215
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-10
Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 5/100 (5%)
Query: 35 IAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRV 94
I EV AL Y+H + + HRDIK+ANIL+ + K+ DFG + + + + +T V
Sbjct: 106 IIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV 162
Query: 95 QGTFGYLDLEYFRSSQ-FTKKGDVYSFGVVFVGLLTGQKP 133
GT ++ E + + K D++S G+ + TG P
Sbjct: 163 -GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-10
Identities = 41/124 (33%), Positives = 64/124 (51%), Gaps = 10/124 (8%)
Query: 14 LYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAK 73
Y+ ++D+ TI +I +IAV + AL YLHS S+ HRD+K +N+L++ + K
Sbjct: 89 FYKKVYDK--GLTIPEDILGKIAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNGQVK 144
Query: 74 ISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYF----RSSQFTKKGDVYSFGVVFVGLLT 129
+ DFG S Y+ +D T G Y+ E + K DV+S G+ + L T
Sbjct: 145 LCDFGISGYL-VDSVAKTIDA-GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELAT 202
Query: 130 GQKP 133
G+ P
Sbjct: 203 GRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-10
Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 48/228 (21%)
Query: 2 PLLVYEFIPNGTLYRYIH---------------------DQTEEFTITWEISLRIAVEVS 40
LL+ E+ G+L ++ D +E +T + A ++S
Sbjct: 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQIS 137
Query: 41 GALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF-- 98
+ YL + + HRD+ + N+L+ + + KISDFG SR V + +++ R +G
Sbjct: 138 RGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV-KRSKGRIPV 193
Query: 99 GYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSL--AGYFLRAMKE 155
++ +E +T + DV+SFGV+ ++T G P E +L GY + E
Sbjct: 194 KWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRME-RPE 252
Query: 156 NCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203
NC EE+ L C KRPT +++ EL
Sbjct: 253 NC--------------SEEMYN---LMLTCWKQEPDKRPTFADISKEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 36/105 (34%), Positives = 50/105 (47%), Gaps = 14/105 (13%)
Query: 34 RIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTR 93
+IA V LSYLHS I HRDIK +NILL K + K+ DFG S L
Sbjct: 109 KIAESVLKGLSYLHSRKII---HRDIKPSNILLTRKGQVKLCDFGVS-------GELVNS 158
Query: 94 VQGTFG----YLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPI 134
+ GTF Y+ E + ++ DV+S G+ + + + P
Sbjct: 159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 44/141 (31%), Positives = 67/141 (47%), Gaps = 9/141 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L+ ++I G L+ ++ Q E F E+ + E+ AL +LH + I +RDIK N
Sbjct: 82 LILDYINGGELFTHL-SQRERFK-EQEVQIYSG-EIVLALEHLHK---LGIIYRDIKLEN 135
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFR--SSQFTKKGDVYSFG 121
ILLD ++DFG S+ D+ GT Y+ + R K D +S G
Sbjct: 136 ILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMG 195
Query: 122 VVFVGLLTGQKPIRSTDTEED 142
V+ LLTG P + D E++
Sbjct: 196 VLMYELLTGASPF-TVDGEKN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-09
Identities = 33/114 (28%), Positives = 60/114 (52%), Gaps = 5/114 (4%)
Query: 34 RIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTR 93
++++ V L+YL I HRD+K +NIL++ + K+ DFG S + ID +
Sbjct: 107 KVSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANS 161
Query: 94 VQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAG 147
GT Y+ E + + ++ + D++S G+ V + G+ PI D +E + + G
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFG 215
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-09
Identities = 39/141 (27%), Positives = 60/141 (42%), Gaps = 15/141 (10%)
Query: 5 VYEFIPNGTLYRYIHDQ---TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
V E++ G L +I E + A E+ L +LH I +RD+K
Sbjct: 74 VMEYVNGGDLMFHIQRSGRFDEPRARFY------AAEIVLGLQFLHERG---IIYRDLKL 124
Query: 62 ANILLDDKFRAKISDFGASRY-VTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
N+LLD + KI+DFG + + T T+ GT Y+ E + D ++
Sbjct: 125 DNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQPYGPAVDWWAL 182
Query: 121 GVVFVGLLTGQKPIRSTDTEE 141
GV+ +L GQ P D +E
Sbjct: 183 GVLLYEMLAGQSPFEGDDEDE 203
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 39/139 (28%), Positives = 64/139 (46%), Gaps = 11/139 (7%)
Query: 5 VYEFIPNGTLYRYIHD--QTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
V E++ G L +I + +E + A E+ L +LH I +RD+K
Sbjct: 74 VMEYLNGGDLMFHIQSSGRFDEARARF-----YAAEIICGLQFLHKKGII---YRDLKLD 125
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N+LLD KI+DFG + ++ + GT Y+ E + ++ + D +SFGV
Sbjct: 126 NVLLDKDGHIKIADFGMCK-ENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGV 184
Query: 123 VFVGLLTGQKPIRSTDTEE 141
+ +L GQ P D +E
Sbjct: 185 LLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-09
Identities = 33/121 (27%), Positives = 63/121 (52%), Gaps = 8/121 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E++ G+L Y+ + + + L+ +++V A+ YL + + HRD+ + N
Sbjct: 77 IVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANNFV---HRDLAARN 132
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
+L+ + AK+SDFG ++ + Q V+ T E R +F+ K DV+SFG++
Sbjct: 133 VLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSFGIL 188
Query: 124 F 124
Sbjct: 189 L 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-09
Identities = 39/150 (26%), Positives = 75/150 (50%), Gaps = 8/150 (5%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
++ E + G+L ++ E + + +A +V+ ++YL SI HRD+ + N
Sbjct: 79 IITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQNSI---HRDLAARN 134
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
IL+ + K++DFG +R + + +L++ + + + E F+ K DV+SFG++
Sbjct: 135 ILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGIL 193
Query: 124 FVGLLT-GQKPIRSTDTEE--DKSLAGYFL 150
+ T GQ P + E D+ AGY +
Sbjct: 194 LYEMFTYGQVPYPGMNNHEVYDQITAGYRM 223
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-09
Identities = 43/141 (30%), Positives = 66/141 (46%), Gaps = 16/141 (11%)
Query: 4 LVYEFIPNGTLYRYIHDQ-----TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRD 58
+V E+ G L + I+ Q +E+ ++W V++S L ++H I HRD
Sbjct: 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLKHIHDRK---ILHRD 126
Query: 59 IKSANILLD-DKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDV 117
IKS NI L + AK+ DFG +R + D L GT YL E ++ + K D+
Sbjct: 127 IKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPEICQNRPYNNKTDI 185
Query: 118 YSFGVVFVGLLTGQKPIRSTD 138
+S G V L T + P +
Sbjct: 186 WSLGCVLYELCTLKHPFEGNN 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 41/140 (29%), Positives = 62/140 (44%), Gaps = 14/140 (10%)
Query: 5 VYEFIPNGTLYRYIHDQ--TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
V E+ G L +IH +E + + A V L YLH I +RD+K
Sbjct: 80 VMEYAAGGDLMMHIHTDVFSEPRAVFY------AACVVLGLQYLHENK---IVYRDLKLD 130
Query: 63 NILLDDKFRAKISDFGASRY-VTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
N+LLD + KI+DFG + + T+ GT +L E + +T+ D + G
Sbjct: 131 NLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVLTETSYTRAVDWWGLG 188
Query: 122 VVFVGLLTGQKPIRSTDTEE 141
V+ +L G+ P D EE
Sbjct: 189 VLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 15/146 (10%)
Query: 5 VYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANI 64
V+E++P TL + + + R+ ++V AL+ H+ I HRD+K NI
Sbjct: 57 VFEYVPGRTLREVLAADG---ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNI 110
Query: 65 LL---DDKFRAKISDFGASRYVT----IDQTHLT--TRVQGTFGYLDLEYFRSSQFTKKG 115
++ + AK+ DFG + D LT T V GT Y E R T
Sbjct: 111 MVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNS 170
Query: 116 DVYSFGVVFVGLLTGQKPIRSTDTEE 141
D+Y++G++F+ LTGQ+ ++ E
Sbjct: 171 DLYAWGLIFLECLTGQRVVQGASVAE 196
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-09
Identities = 37/138 (26%), Positives = 65/138 (47%), Gaps = 13/138 (9%)
Query: 7 EFIPNGTLYRYIHDQTEEFTITWEISL-RIAVEVSGALSYLHSTTSIPIYHRDIKSANIL 65
EF+P G++ + F E + ++ ++YLH+ + HRDIK N++
Sbjct: 82 EFVPGGSISSIL----NRFGPLPEPVFCKYTKQILDGVAYLHNNCVV---HRDIKGNNVM 134
Query: 66 LDDKFRAKISDFGASR---YVTIDQTH--LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
L K+ DFG +R +V + TH + + GT ++ E S + +K D++S
Sbjct: 135 LMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSI 194
Query: 121 GVVFVGLLTGQKPIRSTD 138
G + TG+ P+ S D
Sbjct: 195 GCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-09
Identities = 33/107 (30%), Positives = 53/107 (49%), Gaps = 6/107 (5%)
Query: 35 IAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRV 94
+ +++ L YLH I HRD+K +N+LL DK KI+DFG +R + +T +V
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169
Query: 95 QGTFGYLDLE-YFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTE 140
T Y E + +T D+++ G + LL KP+ +E
Sbjct: 170 V-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPLLPGKSE 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 3e-09
Identities = 50/181 (27%), Positives = 71/181 (39%), Gaps = 40/181 (22%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
L YLHS I HRD+K N+L+ K++DFG +R +T +V T Y
Sbjct: 114 GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYR 169
Query: 102 DLE-YFRSSQFTKKGDVYSFGVVF------VGLLTGQKPIR---------STDTEED--- 142
E F + + D++S G +F V L G I T TEE+
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229
Query: 143 -KSLAGYFLRAMKENCLFDMLDAQVLKE----AKEEEIITVAMLAKRCLNLNGRKRPTMK 197
SL Y F LK+ A ++ + L +R L LN KR T +
Sbjct: 230 VTSLPDY--------VEFKPFPPTPLKQIFPAASDDAL----DLLQRLLTLNPNKRITAR 277
Query: 198 E 198
+
Sbjct: 278 Q 278
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 3e-09
Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 62/196 (31%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
AL Y+HS I HRD+K +NILL+ R K++DFG +R ++ + +
Sbjct: 119 ALKYIHSGNVI---HRDLKPSNILLNSDCRVKLADFGLAR--SLSEL------EENPENP 167
Query: 102 DL-EY-----FR-------SSQFTKKGDVYSFGVVFVGLLTGQKPI---RST-------- 137
L +Y +R S+++TK D++S G + +L G KP+ ST
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPLFPGTSTLNQLEKII 226
Query: 138 -----DTEEDKSLAGYFLRAMKENCLFDMLD----------AQVLKEAKEEEIITVAMLA 182
+ ED + ++K MLD ++L +A ++ + L
Sbjct: 227 EVIGPPSAED-------IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDAL----DLL 275
Query: 183 KRCLNLNGRKRPTMKE 198
K+ L N KR T +E
Sbjct: 276 KKLLVFNPNKRLTAEE 291
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-09
Identities = 48/221 (21%), Positives = 91/221 (41%), Gaps = 42/221 (19%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFT--ITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
LV+E++ R + + E + + ++ A++Y HS I HRDIK
Sbjct: 77 LVFEYVE-----RTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKP 128
Query: 62 ANILLDDKFRAKISDFGASRYVTID-QTHLTTRVQGTFGYLDLEYFRS-------SQFTK 113
NIL+ + K+ DFG +R + + LT Y+ ++R+ + + K
Sbjct: 129 ENILVSESGVLKLCDFGFARALRARPASPLTD-------YVATRWYRAPELLVGDTNYGK 181
Query: 114 KGDVYSFGVVFVGLLTGQKPIRSTDTEED------KSLAGY-------FLRAMKENCL-- 158
DV++ G + LL G+ P+ D++ D K L F + +
Sbjct: 182 PVDVWAIGCIMAELLDGE-PLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240
Query: 159 FDMLDAQVLKEAKEEEIITVAM-LAKRCLNLNGRKRPTMKE 198
+ + L+ ++ + A+ K CL ++ ++R T E
Sbjct: 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 36/106 (33%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 36 AVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQ 95
A E++ AL YLHS + I +RD+K NILLD + ++DFG + I+ T+
Sbjct: 102 AAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFC 157
Query: 96 GTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE 141
GT YL E + + D + G V +L G P S +T E
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 63/225 (28%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 4 LVYEFIPNGTLYRYI--HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
+V E++P G L + +D E++ + EV AL +HS I HRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFY------TAEVVLALDAIHSMGLI---HRDVKP 170
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQT---HLTTRVQGTFGYLDLEYFRSS----QFTKK 114
N+LLD K++DFG + +D+T T V GT Y+ E +S + ++
Sbjct: 171 DNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRE 227
Query: 115 GDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK-ENCLFDMLDAQVLKEAKEE 173
D +S GV +L G P + SL G + + M +N L D ++ K AK
Sbjct: 228 CDWWSVGVFLFEMLVGDTPFYA------DSLVGTYSKIMDHKNSLNFPEDVEISKHAKN- 280
Query: 174 EIITVAMLAKRCLNL--NG----RKRPTMKEVAFELGGIRASIGP 212
+ A L R + L NG ++ P K + IR + P
Sbjct: 281 --LICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAP 323
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 45/143 (31%), Positives = 71/143 (49%), Gaps = 9/143 (6%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFT--ITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
LL+ E+ G L + I + +E +E+ L + ++ AL +HS + HRD+K
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL-LFYQIVLALDEVHSRK---MMHRDLK 196
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHL--TTRVQGTFGYLDLEYFRSSQFTKKGDVY 118
SANI L K+ DFG S+ + D L + GT YL E + +++KK D++
Sbjct: 197 SANIFLMPTGIIKLGDFGFSKQYS-DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMW 255
Query: 119 SFGVVFVGLLTGQKPIRSTDTEE 141
S GV+ LLT +P + E
Sbjct: 256 SLGVILYELLTLHRPFKGPSQRE 278
|
Length = 478 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-09
Identities = 39/130 (30%), Positives = 63/130 (48%), Gaps = 8/130 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
++ EF+ G L D + + E + V AL YLHS I HRDIKS +
Sbjct: 95 VLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQGVI---HRDIKSDS 147
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
ILL R K+SDFG ++ D + V GT ++ E + + + D++S G++
Sbjct: 148 ILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDIWSLGIM 206
Query: 124 FVGLLTGQKP 133
+ ++ G+ P
Sbjct: 207 VIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-09
Identities = 40/131 (30%), Positives = 65/131 (49%), Gaps = 10/131 (7%)
Query: 4 LVYEFIPNGTLYRYI-HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+V EF+ G L + H + E I + + V ALS+LH+ I HRDIKS
Sbjct: 93 VVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLAVLKALSFLHAQGVI---HRDIKSD 144
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
+ILL R K+SDFG V+ + + V GT ++ E + + D++S G+
Sbjct: 145 SILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLPYGTEVDIWSLGI 203
Query: 123 VFVGLLTGQKP 133
+ + ++ G+ P
Sbjct: 204 MVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-09
Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 25/203 (12%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV + P G+L ++ + ++ + L V+++ + YL + HR++ + N
Sbjct: 85 LVTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEHRMV---HRNLAARN 139
Query: 64 ILLDDKFRAKISDFG-ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
ILL +I+DFG A D+ + + + ++ LE ++T + DV+S+GV
Sbjct: 140 ILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGV 199
Query: 123 VFVGLLT-GQKPIRSTDTEEDKSLAGYFLR-AMKENCLFDMLDAQVLKEAKEEEIITVAM 180
+++ G +P E L R A + C D V M
Sbjct: 200 TVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTID-----------------VYM 242
Query: 181 LAKRCLNLNGRKRPTMKEVAFEL 203
+ +C ++ RPT KE+A E
Sbjct: 243 VMVKCWMIDENVRPTFKELANEF 265
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-09
Identities = 33/108 (30%), Positives = 54/108 (50%), Gaps = 17/108 (15%)
Query: 35 IAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYV--TIDQTHLTT 92
+A ++ ++YLH I HRDIK +N+L++ KI+DFG SR + T+D + +
Sbjct: 173 VARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV 229
Query: 93 RVQGTFGYL-------DLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKP 133
GT Y+ DL + + GD++S GV + G+ P
Sbjct: 230 ---GTIAYMSPERINTDLNHGAYDGYA--GDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-09
Identities = 44/173 (25%), Positives = 80/173 (46%), Gaps = 29/173 (16%)
Query: 2 PL-LVYEFIPNGTLYRYIH-----DQTEE-----------FTITWEISLRIAVEVSGALS 44
PL ++ E++ NG L +++ D+ E I++ L +A++++ +
Sbjct: 93 PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK 152
Query: 45 YLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQG----TFGY 100
YL +S+ HRD+ + N L+ + KI+DFG SR + + R+QG +
Sbjct: 153 YL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRW 206
Query: 101 LDLEYFRSSQFTKKGDVYSFGVVF--VGLLTGQKPIRSTDTEEDKSLAGYFLR 151
+ E +FT DV++FGV + +L ++P E+ AG F R
Sbjct: 207 MAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFR 259
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-09
Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAV-EVSGALSYLHSTTSIPIYHRDIKSA 62
L+ +++ G ++ +++ Q + F+ E +R E+ AL +LH + I +RDIK
Sbjct: 82 LILDYVSGGEMFTHLY-QRDNFS---EDEVRFYSGEIILALEHLHK---LGIVYRDIKLE 134
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFG 121
NILLD + ++DFG S+ ++ T GT Y+ E R K D +S G
Sbjct: 135 NILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLG 194
Query: 122 VVFVGLLTGQKPI-----RSTDTEEDKSL 145
++ LLTG P R+T +E + +
Sbjct: 195 ILIFELLTGASPFTLEGERNTQSEVSRRI 223
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-09
Identities = 39/133 (29%), Positives = 71/133 (53%), Gaps = 9/133 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V EF+ G+L ++ + ++ ++ + +A +++ ++Y+ I HRD+++AN
Sbjct: 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAAQIADGMAYIERMNYI---HRDLRAAN 132
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF--GYLDLEYFRSSQFTKKGDVYSFG 121
IL+ D KI+DFG +R I+ T R F + E +FT K DV+SFG
Sbjct: 133 ILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 190
Query: 122 VVFVGLLT-GQKP 133
++ L+T G+ P
Sbjct: 191 ILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-09
Identities = 37/110 (33%), Positives = 51/110 (46%), Gaps = 24/110 (21%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQT-HLTTRVQGTFGYL 101
L YLHS I HRDIK N+L++ KI DFG +R D++ H+T V
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV------ 166
Query: 102 DLEYFR-------SSQFTKKGDVYSFGVVFVGLLTG------QKPIRSTD 138
+Y+R S +T D++S G +F LL Q PI+ D
Sbjct: 167 -TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD 215
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-09
Identities = 46/203 (22%), Positives = 92/203 (45%), Gaps = 29/203 (14%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E + G L ++ + ++ L+ +++V+ + YL S + HRD+ + N
Sbjct: 75 IVMELMSKGNLVNFLRTRGRALVSVIQL-LQFSLDVAEGMEYLESKK---LVHRDLAARN 130
Query: 64 ILLDDKFRAKISDFGASRY--VTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
IL+ + AK+SDFG +R + +D + L + + E + +F+ K DV+S+G
Sbjct: 131 ILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKSDVWSYG 184
Query: 122 VVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
V+ + + G+ P Y ++KE + + ++ E E V +
Sbjct: 185 VLLWEVFSYGRAP--------------YPKMSLKE--VKECVEKGYRMEPPEGCPADVYV 228
Query: 181 LAKRCLNLNGRKRPTMKEVAFEL 203
L C +KRP+ ++ +L
Sbjct: 229 LMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 7e-09
Identities = 41/130 (31%), Positives = 67/130 (51%), Gaps = 8/130 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E++ G+L + TE +I+ + E AL +LHS I HRDIKS N
Sbjct: 93 VVMEYLAGGSLTDVV---TETCMDEGQIA-AVCRECLQALDFLHSNQVI---HRDIKSDN 145
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
ILL K++DFG +T +Q+ +T V GT ++ E + K D++S G++
Sbjct: 146 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIM 204
Query: 124 FVGLLTGQKP 133
+ ++ G+ P
Sbjct: 205 AIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-09
Identities = 40/145 (27%), Positives = 68/145 (46%), Gaps = 17/145 (11%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTI------------TWEISLRIAVEVSGALSYLHSTT 50
L+V+E++ +G L R++ + I T L IA +++ + YL
Sbjct: 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---A 139
Query: 51 SIPIYHRDIKSANILLDDKFRAKISDFGASRYV-TIDQTHLTTRVQGTFGYLDLEYFRSS 109
S+ HRD+ + N L+ KI DFG SR + + D + R ++ E
Sbjct: 140 SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR 199
Query: 110 QFTKKGDVYSFGVVFVGLLT-GQKP 133
+FT + D++SFGVV + T G++P
Sbjct: 200 KFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 41/137 (29%), Positives = 63/137 (45%), Gaps = 7/137 (5%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
V E+ G L+ ++ + E T E + E+ AL YLHS + +RDIK N
Sbjct: 72 FVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLEN 125
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
++LD KI+DFG + D + T GT YL E + + + D + GVV
Sbjct: 126 LMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVV 184
Query: 124 FVGLLTGQKPIRSTDTE 140
++ G+ P + D E
Sbjct: 185 MYEMMCGRLPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-08
Identities = 52/217 (23%), Positives = 98/217 (45%), Gaps = 30/217 (13%)
Query: 2 PL-LVYEFIPNGTLYRYIH--------DQTEEFTITWEISLRIAVEVSGALSYLHSTTSI 52
PL ++ E++ NG L +++ ++ + TI++ + +A +++ + YL +S+
Sbjct: 93 PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSL 149
Query: 53 PIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQG----TFGYLDLEYFRS 108
HRD+ + N L+ + KI+DFG SR + + R+QG ++ E
Sbjct: 150 NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMSWESILL 206
Query: 109 SQFTKKGDVYSFGVVFVGLLT--GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQV 166
+FT DV++FGV +LT ++P E+ G F R +
Sbjct: 207 GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQ-------VYL 259
Query: 167 LKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203
K A + + ML+ C N ++RP+ +E+ L
Sbjct: 260 PKPALCPDSLYKLMLS--CWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 34/107 (31%), Positives = 51/107 (47%), Gaps = 5/107 (4%)
Query: 30 EISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTH 89
E +L A E+ L LH ++ +RD+K NILLDD +ISD G + V I +
Sbjct: 102 ERALFYAAEILCGLEDLHRENTV---YRDLKPENILLDDYGHIRISDLGLA--VKIPEGE 156
Query: 90 LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRS 136
GT GY+ E + ++T D + G + ++ GQ P R
Sbjct: 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-08
Identities = 36/107 (33%), Positives = 55/107 (51%), Gaps = 5/107 (4%)
Query: 36 AVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQ 95
A EV+ AL +LH I +RD+K NILLD + K++DFG + I TT
Sbjct: 102 AAEVTLALMFLHRHGVI---YRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFC 157
Query: 96 GTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142
GT Y+ E + ++ D ++ GV+ ++ GQ P + D E+D
Sbjct: 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 43/139 (30%), Positives = 65/139 (46%), Gaps = 9/139 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
V E++ G L I Q F + A E++ L +LHS I +RD+K N
Sbjct: 78 FVMEYVNGGDLMYQIQ-QVGRFKEPHAVFY--AAEIAIGLFFLHSKG---IIYRDLKLDN 131
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRV-QGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
++LD + KI+DFG + D +TT+ GT Y+ E + K D ++FGV
Sbjct: 132 VMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 189
Query: 123 VFVGLLTGQKPIRSTDTEE 141
+ +L GQ P D +E
Sbjct: 190 LLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-08
Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 26/198 (13%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E++ G+L + TE +I+ + E AL +LHS I HRDIKS N
Sbjct: 94 VVMEYLAGGSLTDVV---TETCMDEGQIA-AVCRECLQALEFLHSNQVI---HRDIKSDN 146
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
ILL K++DFG +T +Q+ +T V GT ++ E + K D++S G++
Sbjct: 147 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIM 205
Query: 124 FVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM--L 181
+ ++ G+ P + + LRA+ ++ E + E ++
Sbjct: 206 AIEMIEGEPPYLNENP----------LRALY------LIATNGTPELQNPEKLSAIFRDF 249
Query: 182 AKRCLNLNGRKRPTMKEV 199
RCL+++ KR + KE+
Sbjct: 250 LNRCLDMDVEKRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-08
Identities = 48/179 (26%), Positives = 75/179 (41%), Gaps = 34/179 (18%)
Query: 33 LRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR----YVTIDQT 88
L A +V+ + YL I HRD+ + NIL+ + + AKI+DFG SR YV
Sbjct: 115 LHFAADVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 171
Query: 89 HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEE--DKSL 145
L R ++ +E S +T DV+S+GV+ +++ G P E +K
Sbjct: 172 RLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 225
Query: 146 AGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204
GY L NC D +V L ++C +RP+ ++ L
Sbjct: 226 QGYRLEKPL-NC-----DDEVYD------------LMRQCWREKPYERPSFAQILVSLN 266
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-08
Identities = 41/134 (30%), Positives = 67/134 (50%), Gaps = 14/134 (10%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAV---EVSGALSYLHSTTSIPIYHRDI 59
+V E++ G+L T+ T T +IA E AL +LH+ I HRDI
Sbjct: 92 FVVMEYLAGGSL-------TDVVTETCMDEAQIAAVCRECLQALEFLHANQVI---HRDI 141
Query: 60 KSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYS 119
KS N+LL K++DFG +T +Q+ +T V GT ++ E + K D++S
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 120 FGVVFVGLLTGQKP 133
G++ + ++ G+ P
Sbjct: 201 LGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-08
Identities = 39/138 (28%), Positives = 65/138 (47%), Gaps = 7/138 (5%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
V E++ G L+ ++ + E + + + E+ AL YLHS I +RD+K N
Sbjct: 72 FVMEYVNGGELFFHL---SRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLEN 125
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
++LD KI+DFG + D + T GT YL E + + + D + GVV
Sbjct: 126 LMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVV 184
Query: 124 FVGLLTGQKPIRSTDTEE 141
++ G+ P + D E+
Sbjct: 185 MYEMMCGRLPFYNQDHEK 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-08
Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 5/100 (5%)
Query: 36 AVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQ 95
A E++ L LH I +RD+K NILLDD +ISD G + + +T + RV
Sbjct: 108 AAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV- 162
Query: 96 GTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIR 135
GT GY+ E ++ ++T D + G + ++ G+ P R
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 29/108 (26%), Positives = 49/108 (45%), Gaps = 5/108 (4%)
Query: 36 AVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQ 95
A ++ L +LH I +RD+K N+LLDD +ISD G + + + R
Sbjct: 101 AAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELK-GGKKIKGRA- 155
Query: 96 GTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDK 143
GT GY+ E + + D ++ G ++ G+ P R + +K
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 34/136 (25%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 2 PLLVY-EFIPNGTLYRYIHDQTEEFTITWEISLRIAVE--VSGALSYLHSTTSIPIYHRD 58
L ++ E +P G+ + +++ E +R+ + G L YLH ++ HRD
Sbjct: 76 NLYIFLELVPGGS----LAKLLKKYGSFPEPVIRLYTRQILLG-LEYLHDRNTV---HRD 127
Query: 59 IKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDV 117
IK ANIL+D K++DFG ++ V +G+ ++ E + D+
Sbjct: 128 IKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIAQQGGYGLAADI 185
Query: 118 YSFGVVFVGLLTGQKP 133
+S G + + TG+ P
Sbjct: 186 WSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-08
Identities = 36/146 (24%), Positives = 72/146 (49%), Gaps = 8/146 (5%)
Query: 1 VPLLVYEFIPNGTLYRYI---HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHR 57
+P+++ F+ +G L+ ++ E FT+ + +R ++++ + YL S I HR
Sbjct: 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFI---HR 137
Query: 58 DIKSANILLDDKFRAKISDFGASRYV-TIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGD 116
D+ + N +L++ ++DFG S+ + + D + +L LE + +T D
Sbjct: 138 DLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSD 197
Query: 117 VYSFGVVFVGLLT-GQKPIRSTDTEE 141
V++FGV ++T GQ P + E
Sbjct: 198 VWAFGVTMWEIMTRGQTPYAGVENSE 223
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 42/165 (25%), Positives = 79/165 (47%), Gaps = 13/165 (7%)
Query: 2 PLLVYEFIPNGTLYRYIH-----DQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYH 56
P ++Y ++ G L ++ + ++ + + +A++++ +SYLH + H
Sbjct: 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIH 140
Query: 57 RDIKSANILLDDKFRAKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKG 115
+DI + N ++D++ + KI+D SR + H L ++ LE + +++
Sbjct: 141 KDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSAS 200
Query: 116 DVYSFGVVFVGLLT-GQKPIRSTDTEEDKS--LAGYFLRAMKENC 157
DV+SFGV+ L+T GQ P D E + GY L A NC
Sbjct: 201 DVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRL-AQPINC 244
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 1e-08
Identities = 42/130 (32%), Positives = 64/130 (49%), Gaps = 10/130 (7%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV E++P G L+ + ++ F + A +V AL YLHS I +RD+K N
Sbjct: 78 LVMEYVPGGELFSH-LRKSGRFPEPV--ARFYAAQVVLALEYLHSLD---IVYRDLKPEN 131
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
+LLD KI+DFG ++ V +T+ GT YL E S + K D ++ G++
Sbjct: 132 LLLDSDGYIKITDFGFAKRVK-GRTYTLC---GTPEYLAPEIILSKGYGKAVDWWALGIL 187
Query: 124 FVGLLTGQKP 133
+L G P
Sbjct: 188 IYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 35/135 (25%), Positives = 61/135 (45%), Gaps = 20/135 (14%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFT------ITWEISLRIAVEVSGALSYLHSTTSIPIYHR 57
LV+EF+ + LY+ I D+ +++ L+ L++ HS I HR
Sbjct: 75 LVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQL-LQ-------GLAFCHSHG---ILHR 122
Query: 58 DIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLE-YFRSSQFTKKGD 116
D+K N+L++ + K++DFG +R T V T Y E ++ D
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGDKGYSTPVD 181
Query: 117 VYSFGVVFVGLLTGQ 131
++S G +F LL+ +
Sbjct: 182 IWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 4/103 (3%)
Query: 36 AVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQ 95
A EV+ A+ YLHS + I +RD+K NILLD + ++DFG + ++ T+
Sbjct: 102 AAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTFC 157
Query: 96 GTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTD 138
GT YL E R + + D + G V +L G P S D
Sbjct: 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 36/107 (33%), Positives = 53/107 (49%), Gaps = 6/107 (5%)
Query: 36 AVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRV- 94
A E++ L +LHS I +RD+K N++LD + KI+DFG + TTR
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTF 161
Query: 95 QGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE 141
GT Y+ E + K D ++FGV+ +L GQ P D +E
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 1e-08
Identities = 38/107 (35%), Positives = 53/107 (49%), Gaps = 29/107 (27%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTID---QTHLT----TRV 94
L YLHS + HRD+K +NIL++ KI DFG +R V D + LT TR
Sbjct: 115 GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR- 170
Query: 95 QGTFGYLDLEYFR-------SSQFTKKGDVYSFGVVFVGLLTGQKPI 134
++R SS++TK D++S G +F LLT KP+
Sbjct: 171 ----------WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 47/201 (23%), Positives = 85/201 (42%), Gaps = 21/201 (10%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L++E+I L + + ++WE +IA+ ++ AL +LH S + ++
Sbjct: 760 LIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEK 813
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
I++D K + + D + Y+ E + T+K D+Y FG++
Sbjct: 814 IIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETKDITEKSDIYGFGLI 867
Query: 124 FVGLLTGQKPIRSTDTEE--DKSLAGYFLRAMKENCLFDM-LDAQVLKEA--KEEEIITV 178
+ LLTG+ P D E S+ + R +C DM +D + + + EI+ V
Sbjct: 868 LIELLTGKSP---ADAEFGVHGSIVEW-ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEV 923
Query: 179 AMLAKRCLNLNGRKRPTMKEV 199
LA C + RP +V
Sbjct: 924 MNLALHCTATDPTARPCANDV 944
|
Length = 968 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 32/107 (29%), Positives = 53/107 (49%), Gaps = 7/107 (6%)
Query: 36 AVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQ 95
A E+ L ++H+ + +RD+K ANILLD+ +ISD G + + + H +
Sbjct: 103 ATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 156
Query: 96 GTFGYLDLEYF-RSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE 141
GT GY+ E + + + D +S G + LL G P R T++
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 52/197 (26%), Positives = 85/197 (43%), Gaps = 23/197 (11%)
Query: 10 PNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK 69
P G Y + + E +T++ + A +V+ + YL S I HRD+ + N+L+ +
Sbjct: 114 PPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI---HRDLAARNVLVTED 170
Query: 70 FRAKISDFGASRYV-TIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLL 128
KI+DFG +R V ID TT + ++ E +T + DV+SFGV+ +
Sbjct: 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 230
Query: 129 T-GQKPIRSTDTEEDKSLAGYFLRAMK-ENCLFDMLDAQVLKEAKEEEIITVAMLAKRCL 186
T G P EE L R K NC ++ M+ + C
Sbjct: 231 TLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELY-----------------MIMRECW 273
Query: 187 NLNGRKRPTMKEVAFEL 203
+ +RPT K++ +L
Sbjct: 274 HAVPSQRPTFKQLVEDL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-08
Identities = 53/197 (26%), Positives = 83/197 (42%), Gaps = 18/197 (9%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISL-RIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+V E G L R I ++ + E ++ + V++ AL ++HS I HRDIK A
Sbjct: 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPA 135
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N+ + K+ D G R+ + T + V GT Y+ E + + K D++S G
Sbjct: 136 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGC 194
Query: 123 VFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLA 182
+ + Q P DK + Y L E C + L A E + L
Sbjct: 195 LLYEMAALQSPF-----YGDK-MNLYSLCKKIEKCDYPPLPADHYSEELRD-------LV 241
Query: 183 KRCLNLNGRKRPTMKEV 199
RC+N + KRP + V
Sbjct: 242 SRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 40/131 (30%), Positives = 64/131 (48%), Gaps = 10/131 (7%)
Query: 4 LVYEFIPNGTLYRYI-HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+V EF+ G L + H + E I + + V ALS LH+ I HRDIKS
Sbjct: 94 VVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQGVI---HRDIKSD 145
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
+ILL R K+SDFG V+ + + V GT ++ E + + D++S G+
Sbjct: 146 SILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVDIWSLGI 204
Query: 123 VFVGLLTGQKP 133
+ + ++ G+ P
Sbjct: 205 MVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 41/131 (31%), Positives = 65/131 (49%), Gaps = 10/131 (7%)
Query: 4 LVYEFIPNGTLYRYI-HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+V EF+ G L + H + E I + + V ALSYLH+ I HRDIKS
Sbjct: 96 VVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHNQGVI---HRDIKSD 147
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
+ILL R K+SDFG V+ + + V GT ++ E + + D++S G+
Sbjct: 148 SILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVDIWSLGI 206
Query: 123 VFVGLLTGQKP 133
+ + ++ G+ P
Sbjct: 207 MVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 21/99 (21%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLD 102
L Y+HS + HRD+K +NIL+++ KI DFG +R I +T GY+
Sbjct: 121 LKYVHSAGVV---HRDLKPSNILINENCDLKICDFGLAR---IQDPQMT-------GYVS 167
Query: 103 LEYFRSSQ-------FTKKGDVYSFGVVFVGLLTGQKPI 134
Y+R+ + + + D++S G +F +L G KP+
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 52/201 (25%), Positives = 86/201 (42%), Gaps = 21/201 (10%)
Query: 10 PNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK 69
P G Y Y Q E ++++ + A +V+ + YL S I HRD+ + N+L+ +
Sbjct: 120 PPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTED 176
Query: 70 FRAKISDFGASRYV-TIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLL 128
KI+DFG +R + ID TT + ++ E +T + DV+SFGV+ +
Sbjct: 177 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 236
Query: 129 T-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLN 187
T G P EE LF +L + + M+ + C +
Sbjct: 237 TLGGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWH 280
Query: 188 LNGRKRPTMKEVAFELGGIRA 208
+RPT K++ +L I A
Sbjct: 281 AVPSQRPTFKQLVEDLDRILA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-08
Identities = 34/118 (28%), Positives = 58/118 (49%), Gaps = 5/118 (4%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V F G LY + +Q + ++ + V+++ AL YLH I HRD+K+ N
Sbjct: 77 IVMGFCEGGDLYHKLKEQKGKLLPENQV-VEWFVQIAMALQYLHEKH---ILHRDLKTQN 132
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
+ L K+ D G +R V +Q + + + GT Y+ E F + + K DV++ G
Sbjct: 133 VFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALG 189
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 16/163 (9%)
Query: 2 PL-LVYEFIPNGTLYRYIHDQT--EEFTITWEIS-------LRIAVEVSGALSYLHSTTS 51
PL ++ E++ NG L +++ + FT I L +AV+++ + YL S
Sbjct: 91 PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---AS 147
Query: 52 IPIYHRDIKSANILLDDKFRAKISDFGASRYV-TIDQTHLTTRVQGTFGYLDLEYFRSSQ 110
+ HRD+ + N L+ + + KI+DFG SR + + D + R ++ E +
Sbjct: 148 LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK 207
Query: 111 FTKKGDVYSFGVVF--VGLLTGQKPIRSTDTEEDKSLAGYFLR 151
FT DV++FGV + L ++P E+ G F R
Sbjct: 208 FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFR 250
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-08
Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 27/207 (13%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
L++ E+ G L ++ + E F ++ L + +V+ +++L S I HRD+ +
Sbjct: 115 LVITEYCCYGDLLNFLRRKRESFLTLEDL-LSFSYQVAKGMAFLASKNCI---HRDLAAR 170
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGT----FGYLDLEYFRSSQFTKKGDVY 118
N+LL KI DFG +R + D ++ V+G ++ E + +T + DV+
Sbjct: 171 NVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVW 227
Query: 119 SFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIIT 177
S+G++ + + G P + F + +KE + M AQ E I
Sbjct: 228 SYGILLWEIFSLGSNPYPGMPVDSK------FYKLIKEG--YRM--AQPEHAPAEIYDIM 277
Query: 178 VAMLAKRCLNLNGRKRPTMKEVAFELG 204
K C + + KRPT K++ +G
Sbjct: 278 -----KTCWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 4e-08
Identities = 33/129 (25%), Positives = 57/129 (44%), Gaps = 7/129 (5%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV E++P L + D+ + ++Y+H+ I HRD+K AN
Sbjct: 76 LVMEYMP-SDLSEVLRDEERPLPEA--QVKSYMRMLLKGVAYMHANG---IMHRDLKPAN 129
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKG-DVYSFGV 122
+L+ KI+DFG +R + ++ L + T Y E ++ G D+++ G
Sbjct: 130 LLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGC 189
Query: 123 VFVGLLTGQ 131
+F LL G
Sbjct: 190 IFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-08
Identities = 38/138 (27%), Positives = 62/138 (44%), Gaps = 26/138 (18%)
Query: 4 LVYEFIPNGTLYRYIHD-------------QTEEFTITWEISLRIAVEVSGALSYLHSTT 50
L E+ P+G L ++ + T++ + L A +V+ + YL
Sbjct: 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 144
Query: 51 SIPIYHRDIKSANILLDDKFRAKISDFGASR----YVTIDQTHLTTRVQGTFGYLDLEYF 106
I HRD+ + NIL+ + + AKI+DFG SR YV L R ++ +E
Sbjct: 145 FI---HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR------WMAIESL 195
Query: 107 RSSQFTKKGDVYSFGVVF 124
S +T DV+S+GV+
Sbjct: 196 NYSVYTTNSDVWSYGVLL 213
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-08
Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 11/134 (8%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L+ + +P G L Y+ + + + L V+++ ++YL + HRD+ + N
Sbjct: 85 LITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYLEERR---LVHRDLAARN 139
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQG---TFGYLDLEYFRSSQFTKKGDVYSF 120
+L+ KI+DFG ++ + D+ +G ++ LE +T + DV+S+
Sbjct: 140 VLVKTPQHVKITDFGLAKLLGADEKEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSY 197
Query: 121 GVVFVGLLT-GQKP 133
GV L+T G KP
Sbjct: 198 GVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-08
Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 38 EVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGT 97
E+ A YLHS I +RD+K N+LLD+K K++DFG ++ V D+T + GT
Sbjct: 126 ELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-DRTF---TLCGT 178
Query: 98 FGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKP 133
YL E +S K D ++ GV+ + G P
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-08
Identities = 43/139 (30%), Positives = 67/139 (48%), Gaps = 9/139 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
V E++ G L +I Q +F + A E+S L +LH I +RD+K N
Sbjct: 78 FVMEYVNGGDLMYHIQ-QVGKFKEPQAVFY--AAEISVGLFFLHRRG---IIYRDLKLDN 131
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRV-QGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
++LD + KI+DFG + +D +TTR GT Y+ E + K D +++GV
Sbjct: 132 VMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGV 189
Query: 123 VFVGLLTGQKPIRSTDTEE 141
+ +L GQ P D +E
Sbjct: 190 LLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-08
Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 10 PNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK 69
P G Y Y + + +T++ + +V+ + YL S I HRD+ + N+L+ +
Sbjct: 117 PPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCI---HRDLAARNVLVTEN 173
Query: 70 FRAKISDFGASRYV-TIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLL 128
KI+DFG +R V ID TT + ++ E +T + DV+SFGV+ +
Sbjct: 174 NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 233
Query: 129 T-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLN 187
T G P EE + +KE D A E + M+ + C +
Sbjct: 234 TLGGSPYPGIPVEE-------LFKLLKEGHRMDK-PANCTNE--------LYMMMRDCWH 277
Query: 188 LNGRKRPTMKEVAFELGGI 206
RPT K++ +L I
Sbjct: 278 AIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 7e-08
Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 24/177 (13%)
Query: 4 LVYEFIPNGTLYRYI--HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
+V E++P G L + +D E++ + EV AL +HS I HRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPEKWARFY------TAEVVLALDAIHSMGFI---HRDVKP 170
Query: 62 ANILLDDKFRAKISDFGASRYVTID-QTHLTTRVQGTFGYLDLEYFRS----SQFTKKGD 116
N+LLD K++DFG + + T V GT Y+ E +S + ++ D
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECD 229
Query: 117 VYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK-ENCLFDMLDAQVLKEAKE 172
+S GV +L G P SL G + + M +N L D ++ K+AK+
Sbjct: 230 WWSVGVFLYEMLVGDTPFY------ADSLVGTYSKIMDHKNSLTFPDDIEISKQAKD 280
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 7e-08
Identities = 35/134 (26%), Positives = 66/134 (49%), Gaps = 8/134 (5%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
++V E++ NG+L ++ +FT+ + + + + + YL + HRD+ +
Sbjct: 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGI--ASGMKYLSDMGYV---HRDLAAR 135
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFG--YLDLEYFRSSQFTKKGDVYSF 120
NIL++ K+SDFG SR + D T G + E +FT DV+S+
Sbjct: 136 NILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSY 195
Query: 121 GVVFVGLLT-GQKP 133
G+V +++ G++P
Sbjct: 196 GIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-08
Identities = 39/131 (29%), Positives = 58/131 (44%), Gaps = 15/131 (11%)
Query: 4 LVYEFIPNGTLYRYIHDQ-----TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRD 58
+V ++ G LY+ I+ Q E+ + W V++ AL ++H I HRD
Sbjct: 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALKHVHDRK---ILHRD 126
Query: 59 IKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVY 118
IKS NI L K+ DFG +R V L GT YL E + + K D++
Sbjct: 127 IKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIW 185
Query: 119 SFGVVFVGLLT 129
+ G V + T
Sbjct: 186 ALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-08
Identities = 37/143 (25%), Positives = 68/143 (47%), Gaps = 15/143 (10%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEIS----------LRIAVEVSGALSYLHSTTSI 52
++V+E++ +G L +++ + + E + L IA +++ + YL S +
Sbjct: 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFV 142
Query: 53 PIYHRDIKSANILLDDKFRAKISDFGASRYV-TIDQTHLTTRVQGTFGYLDLEYFRSSQF 111
HRD+ + N L+ + KI DFG SR V + D + ++ E +F
Sbjct: 143 ---HRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF 199
Query: 112 TKKGDVYSFGVVFVGLLT-GQKP 133
T + DV+S GVV + T G++P
Sbjct: 200 TTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-08
Identities = 39/138 (28%), Positives = 72/138 (52%), Gaps = 14/138 (10%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEIS-LRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
+++ EF+ NG L ++ +FT+ + LR ++ + YL + HRD+ +
Sbjct: 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEMNYV---HRDLAA 134
Query: 62 ANILLDDKFRAKISDFGASRYV---TIDQTHLTTRVQGTFG--YLDLEYFRSSQFTKKGD 116
NIL++ K+SDFG SR++ T D T+ T+ + G + E +FT D
Sbjct: 135 RNILVNSNLVCKVSDFGLSRFLEDDTSDPTY-TSSLGGKIPIRWTAPEAIAYRKFTSASD 193
Query: 117 VYSFGVVFVGLLT-GQKP 133
V+S+G+V +++ G++P
Sbjct: 194 VWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 29/82 (35%), Positives = 45/82 (54%), Gaps = 2/82 (2%)
Query: 54 IYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTK 113
I +RD+K NILLDD+ +ISD G + + +T + RV GT GY+ E + ++T
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINNEKYTF 180
Query: 114 KGDVYSFGVVFVGLLTGQKPIR 135
D + G + ++ GQ P R
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 35/123 (28%), Positives = 53/123 (43%), Gaps = 18/123 (14%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFG-ASRYV-------TIDQTHLTTRV 94
L+ LH HRD+ ANI ++ K KI+DFG A RY + R
Sbjct: 132 LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 95 QGTFGYLDLEY------FRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGY 148
+ T + L Y + ++ D++S G +F LLTG KP+ + E D+ +
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPLFPGENEIDQLGRIF 247
Query: 149 FLR 151
L
Sbjct: 248 ELL 250
|
Length = 335 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-07
Identities = 40/167 (23%), Positives = 79/167 (47%), Gaps = 10/167 (5%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
++ EF+ G+L ++ E + + +++ ++++ I HRD+++AN
Sbjct: 77 IITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRNYI---HRDLRAAN 132
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF--GYLDLEYFRSSQFTKKGDVYSFG 121
IL+ KI+DFG +R I+ T R F + E FT K DV+SFG
Sbjct: 133 ILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFG 190
Query: 122 VVFVGLLT-GQKPIRS-TDTEEDKSLAGYFLRAMKENCLFDMLDAQV 166
++ + ++T G+ P ++ E ++L + ENC ++ + +
Sbjct: 191 ILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMM 237
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-07
Identities = 47/158 (29%), Positives = 65/158 (41%), Gaps = 30/158 (18%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISL--RIAVEVSGALSYLHSTTSIPIYHRDIK 60
LLV EF P G L Y+ + +T + + R+A E++ L +LH I H D+
Sbjct: 71 LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFI---HSDLA 127
Query: 61 SANILLDDKFRAKISDFGASR-------YVTIDQTHLTTR---------VQGTFGYLDLE 104
N LL KI D+G S YVT DQ + R V G +D
Sbjct: 128 LRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQ- 186
Query: 105 YFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEE 141
TK+ +V+S GV L G +P R E+
Sbjct: 187 -------TKESNVWSLGVTIWELFELGSQPYRHLSDEQ 217
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-07
Identities = 38/138 (27%), Positives = 65/138 (47%), Gaps = 6/138 (4%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
V E+ G L+ ++ + E + + + E+ AL YLHS ++ +RD+K N
Sbjct: 72 FVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLHSEKNV--VYRDLKLEN 126
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
++LD KI+DFG + D + T GT YL E + + + D + GVV
Sbjct: 127 LMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVV 185
Query: 124 FVGLLTGQKPIRSTDTEE 141
++ G+ P + D E+
Sbjct: 186 MYEMMCGRLPFYNQDHEK 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 35/108 (32%), Positives = 55/108 (50%), Gaps = 14/108 (12%)
Query: 33 LRIAVEVSGAL---SYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTH 89
+ IA GAL +YLHS I HRDIK+ NILL + K++DFG++ V+ +
Sbjct: 115 VEIAAICHGALQGLAYLHSHERI---HRDIKAGNILLTEPGTVKLADFGSASLVSPANSF 171
Query: 90 LTTRVQGTFGYLDLEYFRS---SQFTKKGDVYSFGVVFVGLLTGQKPI 134
+ GT ++ E + Q+ K DV+S G+ + L + P+
Sbjct: 172 V-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 43/134 (32%), Positives = 66/134 (49%), Gaps = 15/134 (11%)
Query: 4 LVYEFIPNGTLYRYIHDQTE----EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDI 59
L+ E++ G L+ +H + E E T + +S E+S AL +LH I +RD+
Sbjct: 77 LILEYLSGGELF--MHLEREGIFMEDTACFYLS-----EISLALEHLHQQG---IIYRDL 126
Query: 60 KSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYS 119
K NILLD + K++DFG + +I + +T GT Y+ E S K D +S
Sbjct: 127 KPENILLDAQGHVKLTDFGLCKE-SIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWS 185
Query: 120 FGVVFVGLLTGQKP 133
G + +LTG P
Sbjct: 186 LGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-07
Identities = 32/107 (29%), Positives = 52/107 (48%), Gaps = 7/107 (6%)
Query: 36 AVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQ 95
A E+ L ++H+ + +RD+K ANILLD+ +ISD G + + + H +
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 156
Query: 96 GTFGYLDLEYF-RSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE 141
GT GY+ E + + D +S G + LL G P R T++
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 31/126 (24%), Positives = 63/126 (50%), Gaps = 14/126 (11%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+V E +P G+L ++ + ++ +T + L+++++ + + YL S I HRD+ +
Sbjct: 68 YIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKNCI---HRDLAAR 122
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDL-----EYFRSSQFTKKGDV 117
N L+ + KISDFG SR ++ V + + E ++T + DV
Sbjct: 123 NCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178
Query: 118 YSFGVV 123
+S+G++
Sbjct: 179 WSYGIL 184
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 44/216 (20%), Positives = 90/216 (41%), Gaps = 35/216 (16%)
Query: 4 LVYEFIPNGTLYRYI--------------HDQTEEFTITWEISLRIAVEVSGALSYLHST 49
+++E++ G L+ ++ D T + ++ L IA++++ + YL S
Sbjct: 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH 143
Query: 50 TSIPIYHRDIKSANILLDDKFRAKISDFGASRYV-TIDQTHLTTRVQGTFGYLDLEYFRS 108
+ H+D+ + NIL+ ++ KISD G SR + + D + + ++ E
Sbjct: 144 FFV---HKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY 200
Query: 109 SQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVL 167
+F+ D++SFGVV + + G +P +E + +M+ + L
Sbjct: 201 GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE----------------VIEMVRKRQL 244
Query: 168 KEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203
E+ + L C +RP K++ L
Sbjct: 245 LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 51/197 (25%), Positives = 82/197 (41%), Gaps = 18/197 (9%)
Query: 4 LVYEFIPNGTLYRYI-HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+V E G L R I H + ++ I + + V++ AL ++HS + HRDIK A
Sbjct: 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPA 135
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N+ + K+ D G R+ + T + V GT Y+ E + + K D++S G
Sbjct: 136 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGC 194
Query: 123 VFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLA 182
+ + Q P DK + Y L E C + L + E + L
Sbjct: 195 LLYEMAALQSPFYG-----DK-MNLYSLCKKIEQCDYPPLPSDHYSEELRQ-------LV 241
Query: 183 KRCLNLNGRKRPTMKEV 199
C+N + KRP + V
Sbjct: 242 NMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 4/92 (4%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLD 102
L Y+HS + HRD+K +N+LL+ KI DFG +R + +T V +
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAP 177
Query: 103 LEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPI 134
S++T DV+S G +F LL G+KP+
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 46/175 (26%), Positives = 77/175 (44%), Gaps = 33/175 (18%)
Query: 33 LRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTT 92
+++A E++ ++YL++ + HRD+ + N ++ + F KI DFG +R D
Sbjct: 122 IQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDY 174
Query: 93 RVQGTFGYLDL-----EYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLA 146
+G G L + E + FT DV+SFGVV + T ++P + E+
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ----- 229
Query: 147 GYFLRAMKENCLFDMLD--AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
LR + E L D D +L E L + C N + RP+ E+
Sbjct: 230 --VLRFVMEGGLLDKPDNCPDMLFE-----------LMRMCWQYNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 27/220 (12%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E++P G L + + + + + + EV AL +HS I HRD+K N
Sbjct: 120 MVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMGFI---HRDVKPDN 172
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSS----QFTKKGDVYS 119
+LLD K++DFG + + GT Y+ E +S + ++ D +S
Sbjct: 173 MLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS 232
Query: 120 FGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK-ENCLFDMLDAQVLKEAKEEEIITV 178
GV +L G P + SL G + + M +N L D + KEAK +
Sbjct: 233 VGVFLYEMLVGDTPFYA------DSLVGTYSKIMNHKNSLTFPDDNDISKEAKN---LIC 283
Query: 179 AMLAKRCLNL--NG----RKRPTMKEVAFELGGIRASIGP 212
A L R + L NG ++ K + +R ++ P
Sbjct: 284 AFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAP 323
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 45/208 (21%), Positives = 91/208 (43%), Gaps = 26/208 (12%)
Query: 2 PLLVYEFIPNGTLYRYIH----DQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHR 57
P+++ F+ +G L+ ++ ++ T ++ ++ +++ + YL S + I HR
Sbjct: 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPT-QMLVKFMTDIASGMEYLSSKSFI---HR 136
Query: 58 DIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRV-QGTFGYLDLEYFRSSQFTKKGD 116
D+ + N +L++ ++DFG S+ + + R+ + ++ +E +T K D
Sbjct: 137 DLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSD 196
Query: 117 VYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEI 175
V+SFGV + T GQ P + E + Y + + D LD
Sbjct: 197 VWSFGVTMWEIATRGQTPYPGVENSE---IYDYLRQGNRLKQPPDCLDG----------- 242
Query: 176 ITVAMLAKRCLNLNGRKRPTMKEVAFEL 203
+ L C LN + RP+ + + EL
Sbjct: 243 --LYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-07
Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 16/101 (15%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
AL Y+H+ ++HRD+K NIL + + KI DFG +R D T + T Y+
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDT---PTAIFWT-DYV 167
Query: 102 DLEYFRS--------SQFTKKGDVYSFGVVFVGLLTGQKPI 134
++R+ S++T D++S G +F +LTG KP+
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-07
Identities = 29/121 (23%), Positives = 57/121 (47%), Gaps = 5/121 (4%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E +P G ++ + +E + ++ A++ + ++YL S I HRD+ + N
Sbjct: 69 IVMELVPGGDFLSFLRKKKDELKT--KQLVKFALDAAAGMAYLESKNCI---HRDLAARN 123
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
L+ + KISDFG SR + Q + E +++ + DV+S+G++
Sbjct: 124 CLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGIL 183
Query: 124 F 124
Sbjct: 184 L 184
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-07
Identities = 20/47 (42%), Positives = 23/47 (48%), Gaps = 3/47 (6%)
Query: 38 EVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVT 84
E L+YLH I HRDIK NILL K+ DFG S +
Sbjct: 121 ETLRGLAYLHENKVI---HRDIKGQNILLTKNAEVKLVDFGVSAQLD 164
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-07
Identities = 41/141 (29%), Positives = 66/141 (46%), Gaps = 10/141 (7%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKS 61
V EF+ G L +I ++ F E R A E++ AL +LH I +RD+K
Sbjct: 72 FFVMEFVNGGDLMFHIQ-KSRRFD---EARARFYAAEITSALMFLHDKG---IIYRDLKL 124
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
N+LLD + K++DFG + I T+ GT Y+ E + + D ++ G
Sbjct: 125 DNVLLDHEGHCKLADFGMCKE-GIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMG 183
Query: 122 VVFVGLLTGQKPIRSTDTEED 142
V+ +L G P + + E+D
Sbjct: 184 VLLYEMLCGHAPFEA-ENEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-07
Identities = 39/155 (25%), Positives = 72/155 (46%), Gaps = 9/155 (5%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
V E++ G L ++ Q + + E + + E+S AL+YLH I +RD+K
Sbjct: 72 FFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERG---IIYRDLKLD 125
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N+LLD + K++D+G + + T+ GT Y+ E R + D ++ GV
Sbjct: 126 NVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 184
Query: 123 VFVGLLTGQKP--IRSTDTEEDKSLAGYFLRAMKE 155
+ ++ G+ P I + D++ Y + + E
Sbjct: 185 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 219
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-07
Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 21/203 (10%)
Query: 10 PNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK 69
P G Y + + E ++++ + A +V+ + YL S I HRD+ + N+L+ +
Sbjct: 114 PPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCI---HRDLAARNVLVTED 170
Query: 70 FRAKISDFGASRYV-TIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLL 128
KI+DFG +R V ID T+ + ++ E +T + DV+SFG++ +
Sbjct: 171 NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIF 230
Query: 129 T-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLN 187
T G P EE LF +L + + ML + C +
Sbjct: 231 TLGGSPYPGIPVEE----------------LFKLLREGHRMDKPSNCTHELYMLMRECWH 274
Query: 188 LNGRKRPTMKEVAFELGGIRASI 210
+RPT K++ L + A++
Sbjct: 275 AVPTQRPTFKQLVEALDKVLAAV 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 5e-07
Identities = 43/138 (31%), Positives = 58/138 (42%), Gaps = 7/138 (5%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV FI G L+ H Q E A E+ AL LH I +RD+K N
Sbjct: 70 LVLAFINGGELFH--HLQREGRFDLSRARFYTA-ELLCALENLHKFNVI---YRDLKPEN 123
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
ILLD + + DFG + + + T GT YL E +TK D ++ GV+
Sbjct: 124 ILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVL 182
Query: 124 FVGLLTGQKPIRSTDTEE 141
+LTG P + E
Sbjct: 183 LYEMLTGLPPFYDENVNE 200
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-07
Identities = 47/191 (24%), Positives = 83/191 (43%), Gaps = 49/191 (25%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILLD-DKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
L Y+HS + HRD+K AN+ ++ + KI DFG +R V +H GYL
Sbjct: 127 LKYIHSANVL---HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK--------GYL 175
Query: 102 DL----EYFRS-------SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFL 150
+++RS + +TK D+++ G +F +LTG KP+ + E L
Sbjct: 176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAHE---------L 225
Query: 151 RAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210
M + + + V++E E++ V + N G R ++++ +
Sbjct: 226 EQM--QLILESV--PVVREEDRNELLNV--IPSFVRNDGGEPRRPLRDLLPGV------- 272
Query: 211 GPQNCEGIDFV 221
N E +DF+
Sbjct: 273 ---NPEALDFL 280
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 6e-07
Identities = 48/169 (28%), Positives = 70/169 (41%), Gaps = 39/169 (23%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQ------G 96
L+YLH T I HRDIK ANILL + K++DFG S LT + G
Sbjct: 114 LAYLHETGKI---HRDIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIG 163
Query: 97 TFGYLDLEYF---RSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAM 153
T ++ E R + K D+++ G+ + L Q P+ +RA
Sbjct: 164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP----------MRA- 212
Query: 154 KENCLFDM----LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKE 198
LF + LK+ KE+ K+CL + +KRPT +
Sbjct: 213 ----LFLISKSNFPPPKLKD-KEKWSPVFHDFIKKCLTKDPKKRPTATK 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-07
Identities = 41/207 (19%), Positives = 86/207 (41%), Gaps = 36/207 (17%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L+ E+ G L + +E ++++ L +A++ L L+ T+ P ++++ S +
Sbjct: 99 LILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVS 153
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRS--SQFTKKGDVYSFG 121
L+ + ++ KI I + V Y + S++T K D+YS G
Sbjct: 154 FLVTENYKLKI---ICHGLEKILSSPPFKNVN-FMVYFSYKMLNDIFSEYTIKDDIYSLG 209
Query: 122 VVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAML 181
VV + TG+ P + T+E ++D++ + + ++ L
Sbjct: 210 VVLWEIFTGKIPFENLTTKE----------------IYDLI----INKNNSLKLPLDCPL 249
Query: 182 -----AKRCLNLNGRKRPTMKEVAFEL 203
+ C + + KRP +KE+ + L
Sbjct: 250 EIKCIVEACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 6e-07
Identities = 49/184 (26%), Positives = 75/184 (40%), Gaps = 41/184 (22%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTR-VQGTFGYL 101
++YLH I HRDIK+ANIL+D++ KI+DFG +R + GT Y
Sbjct: 128 INYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184
Query: 102 DL---EYFRS-------SQFTKKGDVYSFGVVFVGLLTGQKPIR--STD----------- 138
+L ++R ++T D++ G VF + T +PI +D
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPILQGKSDIDQLHLIFKLC 243
Query: 139 ---TEED----KSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGR 191
TEE +SL G E + L+E + L + L+L+
Sbjct: 244 GTPTEETWPGWRSLPGC------EGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPY 297
Query: 192 KRPT 195
KR T
Sbjct: 298 KRLT 301
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 7e-07
Identities = 37/136 (27%), Positives = 61/136 (44%), Gaps = 7/136 (5%)
Query: 5 VYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANI 64
V E+ G L+ ++ + E + + + E+ AL YLHS + +RD+K N+
Sbjct: 73 VMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENL 126
Query: 65 LLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVF 124
+LD KI+DFG + I GT YL E + + + D + GVV
Sbjct: 127 MLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 185
Query: 125 VGLLTGQKPIRSTDTE 140
++ G+ P + D E
Sbjct: 186 YEMMCGRLPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-07
Identities = 38/153 (24%), Positives = 69/153 (45%), Gaps = 7/153 (4%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
LV E++ G L ++ Q + + E + A E+ AL++LH I +RD+K
Sbjct: 72 FLVIEYVNGGDLMFHMQRQRK---LPEEHARFYAAEICIALNFLHERG---IIYRDLKLD 125
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N+LLD K++D+G + + T+ GT Y+ E R ++ D ++ GV
Sbjct: 126 NVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGV 184
Query: 123 VFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE 155
+ ++ G+ P D + Y + + E
Sbjct: 185 LMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-07
Identities = 37/146 (25%), Positives = 67/146 (45%), Gaps = 18/146 (12%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEIS-------------LRIAVEVSGALSYLHST 49
++V+E++ +G L +++ + I + L IA +++ + YL S
Sbjct: 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ 142
Query: 50 TSIPIYHRDIKSANILLDDKFRAKISDFGASRYV-TIDQTHLTTRVQGTFGYLDLEYFRS 108
+ HRD+ + N L+ KI DFG SR V + D + ++ E
Sbjct: 143 HFV---HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 199
Query: 109 SQFTKKGDVYSFGVVFVGLLT-GQKP 133
+FT + DV+SFGV+ + T G++P
Sbjct: 200 RKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 9e-07
Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 44/218 (20%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFT--ITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
LV+EF+ + L D E++ + + ++ + + HS I HRDIK
Sbjct: 77 LVFEFVDHTVL-----DDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKP 128
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQF----TKKG-- 115
NIL+ K+ DFG +R + T Y+ ++R+ + TK G
Sbjct: 129 ENILVSQSGVVKLCDFGFARTLAAPGEVYTD-------YVATRWYRAPELLVGDTKYGRA 181
Query: 116 -DVYSFGVVFVGLLTGQKPIRSTDTEEDK-----SLAGYFLRAMKENCLFD---MLDAQV 166
D+++ G + +LTG+ P+ D++ D+ G + +E +F +
Sbjct: 182 VDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIKCLGNLIPRHQE--IFQKNPLFAGMR 238
Query: 167 LKEAKEEEII---------TVAMLAKRCLNLNGRKRPT 195
L E KE E + V LAK+CL ++ RP+
Sbjct: 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-07
Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 19/140 (13%)
Query: 4 LVYEFIPNGTLY----RYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDI 59
LV E+ P G L RY DQ +E + ++ E+ A+ +H + HRDI
Sbjct: 78 LVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLA-----ELVLAIHSVHQMGYV---HRDI 128
Query: 60 KSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKG---- 115
K N+L+D K++DFG++ +T ++ + GT Y+ E + KG
Sbjct: 129 KPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGV 188
Query: 116 --DVYSFGVVFVGLLTGQKP 133
D +S GV+ ++ G+ P
Sbjct: 189 ECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 36/130 (27%), Positives = 63/130 (48%), Gaps = 7/130 (5%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
V EF+ G L ++ Q + + E + + E+S AL++LH I +RD+K N
Sbjct: 73 FVIEFVSGGDLMFHMQRQRK---LPEEHARFYSAEISLALNFLHERG---IIYRDLKLDN 126
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
+LLD + K++D+G + I T+ GT Y+ E R + D ++ GV+
Sbjct: 127 VLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVL 185
Query: 124 FVGLLTGQKP 133
++ G+ P
Sbjct: 186 MFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 38/140 (27%), Positives = 61/140 (43%), Gaps = 30/140 (21%)
Query: 4 LVYEFIPNGTLY---RYIHDQTEEFT--ITWEISLRIAVEVSGALSYLHSTTSIPIYHRD 58
LV+E+ + L + E I W+ A+++ H I HRD
Sbjct: 77 LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQ--------AVNFCHKHNCI---HRD 125
Query: 59 IKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQF----TKK 114
+K NIL+ + + K+ DFG +R +T T Y+ ++R+ + T+
Sbjct: 126 VKPENILITKQGQIKLCDFGFARILTGPGDDYTD-------YVATRWYRAPELLVGDTQY 178
Query: 115 G---DVYSFGVVFVGLLTGQ 131
G DV++ G VF LLTGQ
Sbjct: 179 GPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-06
Identities = 32/102 (31%), Positives = 45/102 (44%), Gaps = 11/102 (10%)
Query: 23 EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82
E W I L + V Y+H I HRD+K+ NI L + KI DFG SR
Sbjct: 105 ENQVCEWFIQLLLGVH------YMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRL 154
Query: 83 VTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVF 124
+ + L T GT Y+ E + + K D++S G +
Sbjct: 155 L-MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-06
Identities = 27/108 (25%), Positives = 54/108 (50%), Gaps = 5/108 (4%)
Query: 36 AVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQ 95
+ +++ + +LHS + I +RD+K N+LLDD+ ++SD G + V + T+
Sbjct: 101 SAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRA 155
Query: 96 GTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDK 143
GT GY+ E + ++ D ++ G ++ G+ P + + K
Sbjct: 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 45/168 (26%), Positives = 65/168 (38%), Gaps = 38/168 (22%)
Query: 4 LVYEFIPNGTLYRY--IHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
LV E++P G L D E T + I+ E+ AL +H I HRDIK
Sbjct: 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIA-----ELVLALDSVHKLGFI---HRDIKP 129
Query: 62 ANILLDDKFRAKISDFGAS--------RYVTIDQTHLT---TRVQ--------------- 95
NIL+D K++DFG R ++ +H V
Sbjct: 130 DNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANS 189
Query: 96 --GTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE 141
GT Y+ E R + + + D +S GV+ +L G P S +E
Sbjct: 190 TVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 38/139 (27%), Positives = 57/139 (41%), Gaps = 20/139 (14%)
Query: 7 EFIPNGTLYRYIHD------QTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
E+ G L+ + D T F I + A YLH+ I +RD+K
Sbjct: 73 EYCLGGELWTILRDRGLFDEYTARFYIACVVL---------AFEYLHN---RGIIYRDLK 120
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
N+LLD K+ DFG ++ + Q T GT Y+ E + + D +S
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKTWT--FCGTPEYVAPEIILNKGYDFSVDYWSL 178
Query: 121 GVVFVGLLTGQKPIRSTDT 139
G++ LLTG+ P D
Sbjct: 179 GILLYELLTGRPPFGEDDE 197
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 5/99 (5%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLD 102
L+Y H + HRDIK +NILL++K + K++DFG +R +++ T T Y
Sbjct: 129 LNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 185
Query: 103 LEYFRSSQ-FTKKGDVYSFGVVFVGLLTGQKPIRSTDTE 140
E + + DV+S G + L T +KPI + E
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQE 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 38/185 (20%), Positives = 74/185 (40%), Gaps = 41/185 (22%)
Query: 27 ITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR----- 81
++ L IA +V+ ++YL + HRD+ + N L+ + KI+DFG SR
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFGLSRNIYSA 183
Query: 82 -YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDT 139
Y + ++ E +++T + DV+++GVV + + G +P
Sbjct: 184 DYYKASENDAI-----PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238
Query: 140 EEDKSLAGYFLR-----AMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP 194
EE Y++R + +NC ++ + L + C + RP
Sbjct: 239 EE----VIYYVRDGNVLSCPDNCPLELYN-----------------LMRLCWSKLPSDRP 277
Query: 195 TMKEV 199
+ +
Sbjct: 278 SFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 2e-06
Identities = 37/140 (26%), Positives = 63/140 (45%), Gaps = 12/140 (8%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+L+ ++I +G L+ + + E E+ I ++ AL+ LH I H DIK
Sbjct: 85 VLIMDYIKDGDLFDLL--KKEGKLSEAEVKK-IIRQLVEALNDLHKHNII---HNDIKLE 138
Query: 63 NILLDD-KFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
N+L D K R + D+G + + + GT Y E + + D ++ G
Sbjct: 139 NVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSPEKIKGHNYDVSFDWWAVG 193
Query: 122 VVFVGLLTGQKPIRSTDTEE 141
V+ LLTG+ P + + EE
Sbjct: 194 VLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 42/213 (19%)
Query: 3 LLVYEFIPNGTLYRYI-------HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIY 55
L+V E + +G L Y+ + T + +++A E++ ++YL++ +
Sbjct: 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFV--- 141
Query: 56 HRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDL-----EYFRSSQ 110
HRD+ + N ++ F KI DFG +R I +T + G G L + E +
Sbjct: 142 HRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRK--GGKGLLPVRWMAPESLKDGV 197
Query: 111 FTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSL---AGYFLRAMKENCLFDMLDAQV 166
FT D++SFGVV + + ++P + E+ GY + +NC
Sbjct: 198 FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP--DNC--------- 246
Query: 167 LKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
E + L + C N + RPT E+
Sbjct: 247 -----PERVTD---LMRMCWQFNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-06
Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 14/108 (12%)
Query: 33 LRIAVEVSGAL---SYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTH 89
+ IA GAL +YLHS I HRDIK+ NILL + + K++DFG++ + +
Sbjct: 125 VEIAAITHGALQGLAYLHSHNMI---HRDIKAGNILLTEPGQVKLADFGSASIASPANSF 181
Query: 90 LTTRVQGTFGYLDLEYFRS---SQFTKKGDVYSFGVVFVGLLTGQKPI 134
+ GT ++ E + Q+ K DV+S G+ + L + P+
Sbjct: 182 V-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-06
Identities = 28/106 (26%), Positives = 49/106 (46%), Gaps = 17/106 (16%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLD 102
L YLH+ I HRD+K+ NI ++D + I D GA+++ + L + GT
Sbjct: 170 LRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--LAGTVETNA 224
Query: 103 LEYFRSSQFTKKGDVYSFGVVFVGLL------------TGQKPIRS 136
E ++ K D++S G+V +L T ++ ++S
Sbjct: 225 PEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKS 270
|
Length = 357 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 27/93 (29%), Positives = 42/93 (45%), Gaps = 9/93 (9%)
Query: 35 IAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRV 94
I ++ L Y+H I H DIK NI++D R I D+G + + I H+
Sbjct: 131 IMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK 187
Query: 95 Q------GTFGYLDLEYFRSSQFTKKGDVYSFG 121
+ GT Y L+ + T++GD+ S G
Sbjct: 188 EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLG 220
|
Length = 294 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 34/98 (34%), Positives = 49/98 (50%), Gaps = 10/98 (10%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTID----QTHLTTRVQGT 97
L Y+HS + HRD+K N+L++ KI DFG +R + + +T V T
Sbjct: 117 GLKYIHSANVL---HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-AT 172
Query: 98 FGYLDLEYFRSSQ-FTKKGDVYSFGVVFVGLLTGQKPI 134
Y E S Q +TK DV+S G + LL G+KP+
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 33/101 (32%), Positives = 47/101 (46%), Gaps = 5/101 (4%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
AL +LH I +RD+K NILLD + DFG S+ + T GT YL
Sbjct: 108 ALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYL 163
Query: 102 DLEYFRSSQ-FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE 141
E + +TK D +S GV+ + G P + DT++
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ 204
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-06
Identities = 29/104 (27%), Positives = 50/104 (48%), Gaps = 20/104 (19%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
L Y+HS I HRD+K +N+ +++ KI DFG +R+ + T GY+
Sbjct: 132 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYV 178
Query: 102 DLEYFRSSQ-------FTKKGDVYSFGVVFVGLLTGQKPIRSTD 138
++R+ + + + D++S G + LLTG+ TD
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 4e-06
Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 25/105 (23%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
L Y+HS + HRD+K +N+LL+ KI DFG +R D H T G+L
Sbjct: 118 GLKYIHSANVL---HRDLKPSNLLLNTNCDLKICDFGLAR--IADPEHDHT------GFL 166
Query: 102 DLEY-----FR-------SSQFTKKGDVYSFGVVFVGLLTGQKPI 134
EY +R S +TK D++S G + +L+ +P+
Sbjct: 167 -TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 5e-06
Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
+++LH I HRD+K++N+LL+++ KI DFG +R T V T Y
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYR 173
Query: 102 DLE-YFRSSQFTKKGDVYSFGVVFVGLLTGQKPI 134
E + +++ D++S G +F LLT +KP+
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-06
Identities = 27/97 (27%), Positives = 46/97 (47%), Gaps = 4/97 (4%)
Query: 37 VEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQG 96
V++ A+ ++HS + HRDIK AN+ + K+ D G R+ + T + V G
Sbjct: 113 VQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-G 168
Query: 97 TFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKP 133
T Y+ E + + K D++S G + + Q P
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 6e-06
Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLT-TRVQGTFGYL 101
L +LH+ I HRD+K NIL+ + K++DFG +R I + T V T Y
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVVVTLWYR 174
Query: 102 DLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDK 143
E S + D++S G +F + +KP+ ++E D+
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 9e-06
Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 22/145 (15%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLR----IAVEVSGALSYLHSTTSIPIYHRDI 59
++ E + G L Y+ D E ++L+ I ++V+ YL I HRD+
Sbjct: 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFI---HRDL 132
Query: 60 KSANILLDDKFRA-----KISDFGASRYVTIDQTHLTTRVQGTFGYLDL-----EYFRSS 109
+ N L+ +K KI DFG +R + + R +G G L + E
Sbjct: 133 AARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGE-GLLPVRWMAPESLLDG 188
Query: 110 QFTKKGDVYSFGVVFVGLLT-GQKP 133
+FT + DV+SFGV+ +LT GQ+P
Sbjct: 189 KFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 46/172 (26%), Positives = 67/172 (38%), Gaps = 40/172 (23%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L+ EF+P G + + + T+T E + E A+ +H I HRDIK N
Sbjct: 78 LIMEFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLGFI---HRDIKPDN 131
Query: 64 ILLDDKFRAKISDFG-------ASR---YVTIDQT------------------------H 89
+LLD K K+SDFG A R Y ++ +
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 90 LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE 141
L GT Y+ E F + + K D +S GV+ +L G P S +E
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 48/196 (24%), Positives = 74/196 (37%), Gaps = 52/196 (26%)
Query: 27 ITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTID 86
+T E + + +V+ + +L S I HRD+ + NILL + KI DFG +R +
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDI--- 223
Query: 87 QTHLTTRVQGTFGYLDLEYFRSSQ-----------------FTKKGDVYSFGVVFVGLLT 129
Y D +Y R +T + DV+SFGV+ + +
Sbjct: 224 -------------YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
Query: 130 -GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNL 188
G P +E+ F R +KE ++ I ML C +
Sbjct: 271 LGASPYPGVQIDEE------FCRRLKEG-------TRMRAPEYATPEIYSIMLD--CWHN 315
Query: 189 NGRKRPTMKEVAFELG 204
N RPT E+ LG
Sbjct: 316 NPEDRPTFSELVEILG 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 14/108 (12%)
Query: 33 LRIAVEVSGAL---SYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTH 89
+ IA GAL +YLHS I HRDIK+ NILL + + K++DFG++ + +
Sbjct: 121 VEIAAITHGALQGLAYLHSHNMI---HRDIKAGNILLTEPGQVKLADFGSASKSSPANSF 177
Query: 90 LTTRVQGTFGYLDLEYFRS---SQFTKKGDVYSFGVVFVGLLTGQKPI 134
+ GT ++ E + Q+ K DV+S G+ + L + P+
Sbjct: 178 V-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 28/97 (28%), Positives = 47/97 (48%), Gaps = 20/97 (20%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
L Y+HS I HRD+K +NI +++ KI DFG +R+ + T GY+
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT----------GYV 176
Query: 102 DLEYFRSS-------QFTKKGDVYSFGVVFVGLLTGQ 131
++R+ + + D++S G + LLTG+
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 19/95 (20%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
+L ++H I+HRDIK NIL+ D K++DFG+ R I T Y+
Sbjct: 112 SLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTE------YI 159
Query: 102 DLEYFRSSQ-------FTKKGDVYSFGVVFVGLLT 129
++R+ + + K D+++ G VF +L+
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-05
Identities = 33/95 (34%), Positives = 43/95 (45%), Gaps = 9/95 (9%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILLDD-KFRAKISDFGAS-RYVTIDQTHLTTRVQGTFGY 100
L YLH I HRDIK N+L++ KISDFG S R I+ T GT Y
Sbjct: 121 LKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQY 175
Query: 101 LDLEYFRSSQ--FTKKGDVYSFGVVFVGLLTGQKP 133
+ E + D++S G V + TG+ P
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 41/174 (23%), Positives = 74/174 (42%), Gaps = 26/174 (14%)
Query: 33 LRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTT 92
LR + +V+ + +L S I HRD+ + N+LL D AKI DFG +R + D ++
Sbjct: 215 LRFSSQVAQGMDFLASKNCI---HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV-- 269
Query: 93 RVQGT----FGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAG 147
V+G ++ E +T + DV+S+G++ + + G+ P
Sbjct: 270 -VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK----- 323
Query: 148 YFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAF 201
F + +K D + + + K C NL +RPT +++
Sbjct: 324 -FYKMVKRGYQMSRPDFAPPE---------IYSIMKMCWNLEPTERPTFSQISQ 367
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-05
Identities = 39/135 (28%), Positives = 60/135 (44%), Gaps = 8/135 (5%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV EF G++ I + T+ T+ E I E+ LS+LH I HRDIK N
Sbjct: 86 LVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQHKVI---HRDIKGQN 141
Query: 64 ILLDDKFRAKISDFGAS----RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYS 119
+LL + K+ DFG S R V T + T + + + + K D++S
Sbjct: 142 VLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS 201
Query: 120 FGVVFVGLLTGQKPI 134
G+ + + G P+
Sbjct: 202 LGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (106), Expect = 2e-05
Identities = 24/82 (29%), Positives = 45/82 (54%), Gaps = 9/82 (10%)
Query: 4 LVYEFIPNGTLYRYIHDQTEE-FTITWEISLR-IAVEVSGALSYLHSTTSIPIYHRDIKS 61
V+E++ G LY+ + D+ + F+ E +R I ++ L+++H +HRD+K
Sbjct: 75 FVFEYM-EGNLYQLMKDRKGKPFS---ESVIRSIIYQILQGLAHIHKHG---FFHRDLKP 127
Query: 62 ANILLDDKFRAKISDFGASRYV 83
N+L+ KI+DFG +R +
Sbjct: 128 ENLLVSGPEVVKIADFGLAREI 149
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 30/123 (24%), Positives = 51/123 (41%), Gaps = 20/123 (16%)
Query: 33 LRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTT 92
L I ++ + Y+HS + HRD+K NILL I D+GA+ + +++ L
Sbjct: 116 LSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 93 -----------------RVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIR 135
++ GT Y+ E ++ D+Y+ GV+ +LT P R
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232
Query: 136 STD 138
Sbjct: 233 RKK 235
|
Length = 932 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-05
Identities = 26/101 (25%), Positives = 48/101 (47%), Gaps = 4/101 (3%)
Query: 36 AVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQ 95
++ L +LH I +RD+K N+LLD+ +ISD G + + Q+ T
Sbjct: 103 TAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYA 158
Query: 96 GTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRS 136
GT G++ E + ++ D ++ GV ++ + P R+
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-05
Identities = 38/175 (21%), Positives = 74/175 (42%), Gaps = 23/175 (13%)
Query: 33 LRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTT 92
+ + +++ + +L + + HRD+ + N L+ + K+S S+ V + +
Sbjct: 120 VALCTQIALGMDHLSNARFV---HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR 176
Query: 93 RVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEE--DKSLAGYF 149
+L E + F+ K DV+SFGV+ + T G+ P EE ++ AG
Sbjct: 177 NALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236
Query: 150 LRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204
+ E C ++ +++T RC +N + RP+ E+ LG
Sbjct: 237 ELPVPEGC-----------PSRLYKLMT------RCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 6/102 (5%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
L +LHS + HRD+K NIL+ + K++DFG +R + T V T Y
Sbjct: 122 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYR 176
Query: 102 DLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDK 143
E S + D++S G +F + +KP+ ++ D+
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 34/140 (24%), Positives = 63/140 (45%), Gaps = 28/140 (20%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEF----------TITWEISLRIAVEVSGALSYLHSTT 50
++ E++ NG L +++ Q ++++ L +A +++ + YL S
Sbjct: 93 PLCMIMEYMENGDLNQFL--QKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN 150
Query: 51 SIPIYHRDIKSANILLDDKFRAKISDFGASR------YVTID-QTHLTTRVQGTFGYLDL 103
+ HRD+ + N L+ + KI+DFG SR Y + + L R ++
Sbjct: 151 FV---HRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR------WMAW 201
Query: 104 EYFRSSQFTKKGDVYSFGVV 123
E +FT K DV++FGV
Sbjct: 202 ESVLLGKFTTKSDVWAFGVT 221
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 22/58 (37%), Positives = 38/58 (65%), Gaps = 4/58 (6%)
Query: 30 EISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQ 87
E++++ EV+ AL YLH I HRD+K N+L+ ++ K++DFG S+ VT+++
Sbjct: 104 EMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK-VTLNR 157
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 42/216 (19%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEF-TITWEISLRIAVEVSGALSYLHSTTSIP----IYHRD 58
++ EF G L R I + F I + I ++ AL+Y H+ P + HRD
Sbjct: 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRD 150
Query: 59 IKSANILLDDKFR-----------------AKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
+K NI L R AKI DFG S+ + I+ + GT Y
Sbjct: 151 LKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYW 208
Query: 102 DLEYF--RSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159
E + + K D+++ G + L +G+ P A F + + E L
Sbjct: 209 SPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK---------ANNFSQLISE--LK 257
Query: 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT 195
D + ++KE + +L K LNL+ ++RP+
Sbjct: 258 RGPDLPIKGKSKE-----LNILIKNLLNLSAKERPS 288
|
Length = 1021 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 14/108 (12%)
Query: 33 LRIAVEVSGAL---SYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTH 89
+ IA GAL +YLHS I HRD+K+ NILL + K+ DFG++ +
Sbjct: 115 VEIAAVTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF 171
Query: 90 LTTRVQGTFGYLDLEYFRS---SQFTKKGDVYSFGVVFVGLLTGQKPI 134
+ GT ++ E + Q+ K DV+S G+ + L + P+
Sbjct: 172 V-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-05
Identities = 27/89 (30%), Positives = 43/89 (48%), Gaps = 4/89 (4%)
Query: 54 IYHRDIKSANILLD-DKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLE-YFRSSQF 111
+ HRD+K N+L+D K KI+D G R +I T + T Y E S+ +
Sbjct: 131 VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYRAPEVLLGSTHY 189
Query: 112 TKKGDVYSFGVVFVGLLTGQKPIRSTDTE 140
+ D++S G +F + Q P+ D+E
Sbjct: 190 STPVDIWSVGCIFAEMSRKQ-PLFPGDSE 217
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 4e-05
Identities = 46/184 (25%), Positives = 82/184 (44%), Gaps = 26/184 (14%)
Query: 21 QTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80
+ +E + E L + +V+ +S+L S I HRD+ + NILL KI DFG +
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFLASKNCI---HRDLAARNILLTHGRITKICDFGLA 261
Query: 81 RYVTIDQTHLTTRVQGT----FGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIR 135
R + D ++ V+G ++ E + +T + DV+S+G++ + + G P
Sbjct: 262 RDIRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP 318
Query: 136 STDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT 195
+ F + +KE + ML E E+ + K C + + KRPT
Sbjct: 319 GMPVDSK------FYKMIKEG--YRMLSP----ECAPSEMYDI---MKSCWDADPLKRPT 363
Query: 196 MKEV 199
K++
Sbjct: 364 FKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 4e-05
Identities = 27/103 (26%), Positives = 49/103 (47%), Gaps = 20/103 (19%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLD 102
L Y+HS I HRD+K N+ +++ KI DFG +R+ + T GY+
Sbjct: 130 LKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT----------GYVV 176
Query: 103 LEYFRSSQ-------FTKKGDVYSFGVVFVGLLTGQKPIRSTD 138
++R+ + + + D++S G + +LTG+ + D
Sbjct: 177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 4e-05
Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 7/103 (6%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILLDDKFRA-KISDFGASRYVTIDQTHLTTRVQGTFGYL 101
++Y HS + HRD+K N+L+D + A K++DFG +R I T V T Y
Sbjct: 115 IAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYR 170
Query: 102 DLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDK 143
E S ++ D++S G +F ++ QKP+ D+E D+
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPLFPGDSEIDE 212
|
Length = 294 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-05
Identities = 39/146 (26%), Positives = 56/146 (38%), Gaps = 22/146 (15%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWE--ISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
LLV EF P G L Y+ + + R+A EV+ L +LH I H D+
Sbjct: 71 LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI---HSDLA 127
Query: 61 SANILLDDKFRAKISDFGA--SRY-----VTIDQTHLTTR-----VQGTFGYLDLEYFRS 108
N L KI D+G +Y +T D + R + G +
Sbjct: 128 LRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG----QDLLP 183
Query: 109 SQFTKKGDVYSFGVVFVGLLT-GQKP 133
TKK +++S GV L T +P
Sbjct: 184 KDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-05
Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 46 LHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEY 105
+HS + HRDIK N+LLD +++DFG+ + D T ++ GT Y+ E
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 106 FRS-----SQFTKKGDVYSFGVVFVGLLTGQKP 133
++ ++ + D +S GV +L G+ P
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 34/122 (27%), Positives = 52/122 (42%), Gaps = 16/122 (13%)
Query: 4 LVYEFIPNG---TLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
L+ E++P G TL TEE T + +A++ L Y+H RDIK
Sbjct: 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIH---------RDIK 128
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL--DLEYFRSSQFTKKGDVY 118
N+LLD K K+SDFG + ++H T + L + F S + K
Sbjct: 129 PDNLLLDAKGHIKLSDFGLCTGL--KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAE 186
Query: 119 SF 120
++
Sbjct: 187 TW 188
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-05
Identities = 45/172 (26%), Positives = 67/172 (38%), Gaps = 40/172 (23%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L+ EF+P G + + + T++ E + E A+ +H I HRDIK N
Sbjct: 78 LIMEFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLGFI---HRDIKPDN 131
Query: 64 ILLDDKFRAKISDFG-------ASR---YVTI------------------------DQTH 89
+LLD K K+SDFG A R Y + ++
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 90 LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE 141
L GT Y+ E F + + K D +S GV+ +L G P S +E
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-05
Identities = 22/47 (46%), Positives = 28/47 (59%), Gaps = 3/47 (6%)
Query: 38 EVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVT 84
E L+YLHS + HRDIK ANILL D K++DFG + +T
Sbjct: 114 ETLQGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKIT 157
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 5e-05
Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 11/102 (10%)
Query: 38 EVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS-RYVTIDQTHLTTRVQG 96
++ AL++LHS I HRD+K+ NILL K++DFG S + + Q T G
Sbjct: 111 QMLEALNFLHSHKVI---HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIG 165
Query: 97 TFGYL-----DLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKP 133
T ++ E F+ + + K D++S G+ + L + P
Sbjct: 166 TPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-05
Identities = 32/103 (31%), Positives = 50/103 (48%), Gaps = 7/103 (6%)
Query: 35 IAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRV 94
++ E L YLHS + HRDIK ANILL D K++DFG S +T + +
Sbjct: 111 VSRETLQGLYYLHSKGKM---HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI 167
Query: 95 QGTFGYLDLEYF---RSSQFTKKGDVYSFGVVFVGLLTGQKPI 134
GT ++ E R + + D+++ G+ + L Q P+
Sbjct: 168 -GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-05
Identities = 45/182 (24%), Positives = 77/182 (42%), Gaps = 20/182 (10%)
Query: 27 ITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTID 86
+T E + + +V+ + +L S I HRD+ + NILL + KI DFG +R + D
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYKD 232
Query: 87 QTHLTT-RVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKS 144
++ + ++ E +T + DV+SFGV+ + + G P +E+
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 290
Query: 145 LAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204
F R +KE D + + ML C + +RPT E+ LG
Sbjct: 291 ----FCRRLKEGTRMRAPDYTTPE-------MYQTML--DCWHGEPSQRPTFSELVEHLG 337
Query: 205 GI 206
+
Sbjct: 338 NL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 6e-05
Identities = 33/108 (30%), Positives = 53/108 (49%), Gaps = 10/108 (9%)
Query: 44 SYLHSTTSIPIY-------HRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQG 96
SYL+ ++ HRD+K N+L+D+K K++DFG +R I T V
Sbjct: 105 SYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV- 163
Query: 97 TFGYLDLEYFRSSQ-FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDK 143
T Y E S ++ D++S G +F + T +KP+ D+E D+
Sbjct: 164 TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDSEIDQ 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 6e-05
Identities = 20/57 (35%), Positives = 29/57 (50%), Gaps = 7/57 (12%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR---YVTIDQTHL-TTRV 94
L Y+H I HRD+K+ANIL+ K++DFG +R + + T RV
Sbjct: 131 GLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 7e-05
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVT---IDQTHLTTRVQGTFG 99
L Y+HS + HRD+K +N+L+++ +I DFG +R ++ + + T T
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 100 YLDLE-YFRSSQFTKKGDVYSFGVVFVGLLTGQKPI 134
Y E ++T D++S G +F +L G++ +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 7e-05
Identities = 28/101 (27%), Positives = 42/101 (41%), Gaps = 9/101 (8%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFG-ASRYVTIDQTHLTTRVQGTFGY 100
A+ LH + HRD+K N L+D K++DFG + VT + V G+ Y
Sbjct: 113 AVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDY 164
Query: 101 LDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE 141
+ E R + D +S G + L G P + E
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 9e-05
Identities = 34/101 (33%), Positives = 45/101 (44%), Gaps = 19/101 (18%)
Query: 33 LRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFR---AKISDFGASR-------Y 82
L A +V+ YL I HRDI + N LL K AKI+DFG +R Y
Sbjct: 119 LFCARDVAKGCKYLEENHFI---HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY 175
Query: 83 VTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
+ L + ++ E F FT K DV+SFGV+
Sbjct: 176 RKGGRAMLPIK------WMPPEAFLDGIFTSKTDVWSFGVL 210
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 9e-05
Identities = 27/103 (26%), Positives = 49/103 (47%), Gaps = 20/103 (19%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLD 102
L Y+H+ I HRD+K N+ +++ KI DFG +R + T GY+
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMT----------GYVV 177
Query: 103 LEYFRSSQ-------FTKKGDVYSFGVVFVGLLTGQKPIRSTD 138
++R+ + +T+ D++S G + +LTG+ + D
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 30/107 (28%), Positives = 44/107 (41%), Gaps = 5/107 (4%)
Query: 33 LRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY-VTIDQTHLT 91
L I V A+ YLH I HRDIK+ NI ++ + DFGA+ + V I+
Sbjct: 185 LAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 92 TRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTD 138
GT E + D++S G+V + T + D
Sbjct: 242 GWA-GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKD 287
|
Length = 391 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 33/105 (31%), Positives = 49/105 (46%), Gaps = 6/105 (5%)
Query: 35 IAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRV 94
I+ + GAL L + I HRD+K NILL + K+ DFG S +T + T V
Sbjct: 130 ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189
Query: 95 QGTFGYLDLEYFRSSQ-----FTKKGDVYSFGVVFVGLLTGQKPI 134
GT ++ E Q + + DV+S G+ + L G P+
Sbjct: 190 -GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 1e-04
Identities = 36/118 (30%), Positives = 57/118 (48%), Gaps = 11/118 (9%)
Query: 38 EVSGALSYLHSTTSIPIYHRDIKSANILL----DDKFRAKISDFGASRYVTIDQTHLTT- 92
++ + YLH+ + HRD+K ANIL+ ++ R KI+D G +R L
Sbjct: 116 QILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 93 -RVQGTFGYLDLEYFRSSQ-FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGY 148
V TF Y E ++ +TK D+++ G +F LLT + PI E+ K+ Y
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKTSNPY 229
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 27/101 (26%), Positives = 46/101 (45%), Gaps = 5/101 (4%)
Query: 46 LHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEY 105
+ S + HRDIK N+LLD +++DFG+ + D T + GT Y+ E
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 106 FRS-----SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE 141
++ ++ + D +S GV +L G+ P + E
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 31/98 (31%), Positives = 46/98 (46%), Gaps = 9/98 (9%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
L +LH +I HRD+K NILL + K+ DFG S +T + T V GT ++
Sbjct: 136 GLQHLHVNKTI---HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWM 191
Query: 102 DLEYFRSSQ-----FTKKGDVYSFGVVFVGLLTGQKPI 134
E Q + + DV+S G+ + L G P+
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 31/99 (31%), Positives = 48/99 (48%), Gaps = 11/99 (11%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILL----DDKFRAKISDFGASR-YVTIDQTHLT-TRVQG 96
+ YLHS + HRD+K ANIL+ ++ KI D G +R + + V
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177
Query: 97 TFGYLDLEYFRSSQ-FTKKGDVYSFGVVFVGLLTGQKPI 134
T Y E ++ +TK D+++ G +F LLT +PI
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 37/140 (26%), Positives = 69/140 (49%), Gaps = 8/140 (5%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV+EF+ + L +Y+ D + + + ++ ++Y HS + HRD+K N
Sbjct: 75 LVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQN 129
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLE-YFRSSQFTKKGDVYSFGV 122
+L+D + K++DFG +R + T V T Y E S Q++ D++S G
Sbjct: 130 LLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYSTPVDIWSIGC 188
Query: 123 VFVGLLTGQKPIRSTDTEED 142
+F ++ ++P+ D+E D
Sbjct: 189 IFAEMVN-RRPLFPGDSEID 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 37/149 (24%), Positives = 72/149 (48%), Gaps = 22/149 (14%)
Query: 4 LVYEFIPNGTLYRYI-HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+V EFIP T+++Y+ H + + + ++ AL+Y+HS I HRD+K
Sbjct: 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQ 199
Query: 63 NILLDDKFRA-KISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFR-------SSQFTKK 114
N+L+D K+ DFG+++ + Q ++ Y+ ++R ++ +T
Sbjct: 200 NLLIDPNTHTLKLCDFGSAKNLLAGQRSVS--------YICSRFYRAPELMLGATNYTTH 251
Query: 115 GDVYSFGVVFVGLLTGQKPIRSTDTEEDK 143
D++S G + ++ G PI S + D+
Sbjct: 252 IDLWSLGCIIAEMILGY-PIFSGQSSVDQ 279
|
Length = 440 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 11/114 (9%)
Query: 38 EVSGALSYLHSTTSIPIYHRDIKSANILL----DDKFRAKISDFGASRYVTIDQTHLTT- 92
++ + YLH+ + HRD+K ANIL+ ++ R KI+D G +R L
Sbjct: 116 QILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 93 -RVQGTFGYLDLEYFRSSQ-FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKS 144
V TF Y E ++ +TK D+++ G +F LLT + PI E+ K+
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKT 225
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 29/134 (21%), Positives = 60/134 (44%), Gaps = 17/134 (12%)
Query: 4 LVYEFIPNGTLYRYI-------------HDQTEEFTITWEISLRIAVEVSGALSYLHSTT 50
+++ + + L+ ++ D+T + T+ + I +++ + +L +
Sbjct: 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL---S 141
Query: 51 SIPIYHRDIKSANILLDDKFRAKISDFGASRYV-TIDQTHLTTRVQGTFGYLDLEYFRSS 109
S + H+D+ + N+L+ DK KISD G R V D L ++ E
Sbjct: 142 SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG 201
Query: 110 QFTKKGDVYSFGVV 123
+F+ D++S+GVV
Sbjct: 202 KFSIDSDIWSYGVV 215
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 14/158 (8%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV EF+ G + ++ + + F ++ A ++ YL S + I +RD+K N
Sbjct: 108 LVLEFVIGGEFFTFLR-RNKRFPN--DVGCFYAAQIVLIFEYLQS---LNIVYRDLKPEN 161
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
+LLD K++DFG ++ V T + GT Y+ E + K D ++ G+
Sbjct: 162 LLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIF 217
Query: 124 FVGLLTGQKPIRSTDTE--EDKSLAG--YFLRAMKENC 157
+L G P + + K L G YF + + NC
Sbjct: 218 IYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNC 255
|
Length = 340 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 42/211 (19%), Positives = 84/211 (39%), Gaps = 38/211 (18%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E++ G L ++H + ++ W+ L +A +++ AL YL + H ++ N
Sbjct: 77 MVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLEDKKLV---HGNVCGKN 131
Query: 64 ILL---DDKFR----AKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFR--SSQFTKK 114
IL+ K+SD G V + + R+ ++ E R + T
Sbjct: 132 ILVARYGLNEGYVPFIKLSDPGIPITV-LSREERVERIP----WIAPECIRNGQASLTIA 186
Query: 115 GDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEE 173
D +SFG + + + G++P+ + + E R ++ M D
Sbjct: 187 ADKWSFGTTLLEICSNGEEPLSTLSSSEK-------ERFYQDQHRLPMPD---------- 229
Query: 174 EIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204
+A L +C + KRP+ + + +L
Sbjct: 230 -CAELANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 2e-04
Identities = 32/123 (26%), Positives = 58/123 (47%), Gaps = 8/123 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E + G ++ +TE + + +++ + + YL S I HRD+ + N
Sbjct: 70 IVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKHCI---HRDLAARN 124
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTT--RVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
L+ +K KISDFG SR D + +T Q + E +++ + DV+SFG
Sbjct: 125 CLVTEKNVLKISDFGMSREEE-DGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFG 183
Query: 122 VVF 124
++
Sbjct: 184 ILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 2e-04
Identities = 30/86 (34%), Positives = 43/86 (50%), Gaps = 8/86 (9%)
Query: 41 GALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGY 100
AL+YLH I HRD+K+ NI LD+ A + DFGA+ +D T + G G
Sbjct: 196 EALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA--CKLDAHPDTPQCYGWSGT 250
Query: 101 LDL---EYFRSSQFTKKGDVYSFGVV 123
L+ E + K D++S G+V
Sbjct: 251 LETNSPELLALDPYCAKTDIWSAGLV 276
|
Length = 392 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 2e-04
Identities = 26/90 (28%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
LSY+H I HRD+K N+L+ D K++DFG +R ++ +H + T Y
Sbjct: 115 GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYR 170
Query: 102 DLE-YFRSSQFTKKGDVYSFGVVFVGLLTG 130
+ S++++ D++ G +FV ++ G
Sbjct: 171 PPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 25/102 (24%), Positives = 52/102 (50%), Gaps = 4/102 (3%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
L+Y H + HRD+K N+L++++ K++DFG +R ++ + V +
Sbjct: 116 GLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 172
Query: 102 DLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDK 143
SS+++ + D++ G +F + +G +P+ T ED+
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASG-RPLFPGSTVEDE 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 3e-04
Identities = 25/83 (30%), Positives = 42/83 (50%), Gaps = 5/83 (6%)
Query: 56 HRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRS-----SQ 110
HRDIK NIL+D +++DFG+ + D T ++ GT Y+ E ++ +
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGK 184
Query: 111 FTKKGDVYSFGVVFVGLLTGQKP 133
+ + D +S GV +L G+ P
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 26/102 (25%), Positives = 50/102 (49%), Gaps = 5/102 (4%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
L+Y H + HRD+K N+L++++ K++DFG +R +I + V T Y
Sbjct: 116 GLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYR 171
Query: 102 DLE-YFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142
+ S+ ++ + D++ G +F + TG+ + EE
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 4e-04
Identities = 34/135 (25%), Positives = 60/135 (44%), Gaps = 8/135 (5%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV EF G++ + + T+ + + I E+ L++LH+ I HRDIK N
Sbjct: 96 LVMEFCGAGSVTDLVKN-TKGNALKEDWIAYICREILRGLAHLHAHKVI---HRDIKGQN 151
Query: 64 ILLDDKFRAKISDFGAS----RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYS 119
+LL + K+ DFG S R V T + T + + + + + D++S
Sbjct: 152 VLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWS 211
Query: 120 FGVVFVGLLTGQKPI 134
G+ + + G P+
Sbjct: 212 LGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 4e-04
Identities = 26/90 (28%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTI-DQTHLTTRVQGTFGYL 101
L+Y+H I HRD+K N+L+ K++DFG +R +I QT+ + V +
Sbjct: 116 LAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPP 172
Query: 102 DLEYFRSSQFTKKGDVYSFGVVFVGLLTGQ 131
D+ ++ ++ D++ G +F+ +L GQ
Sbjct: 173 DV-LLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 34/117 (29%), Positives = 47/117 (40%), Gaps = 23/117 (19%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTR-------- 93
AL YLH+ I HRD+K N+L+ K++DFG S+ I LTT
Sbjct: 113 ALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSK---IGLMSLTTNLYEGHIEK 166
Query: 94 ---------VQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE 141
V GT Y+ E + K D ++ G++ L G P EE
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 5e-04
Identities = 23/89 (25%), Positives = 45/89 (50%), Gaps = 2/89 (2%)
Query: 54 IYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQ-FT 112
+ HRD+K N+L++ + K++DFG +R I + V T Y + S+ ++
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYS 179
Query: 113 KKGDVYSFGVVFVGLLTGQKPIRSTDTEE 141
D++S G + ++TG+ T+ E+
Sbjct: 180 TSIDIWSVGCIMAEMITGRPLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 5e-04
Identities = 17/40 (42%), Positives = 24/40 (60%), Gaps = 3/40 (7%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81
+ +LHS I HRD+K NIL+ + KI+DFG +R
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 5e-04
Identities = 29/107 (27%), Positives = 50/107 (46%), Gaps = 5/107 (4%)
Query: 38 EVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTT-RVQG 96
+V+ + +L S I HRD+ + NILL + KI DFG +R + D ++ +
Sbjct: 182 QVARGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 97 TFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEED 142
++ E +T + DV+SFGV+ + + G P E+
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 7e-04
Identities = 26/96 (27%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS----RYVTIDQTHLTTRVQGT 97
AL YLHS + I HRD+K+ N+LL K++DFG S + + + + T
Sbjct: 122 ALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMA 178
Query: 98 FGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKP 133
+ E + + + K D++S G+ + + + P
Sbjct: 179 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 8e-04
Identities = 25/96 (26%), Positives = 46/96 (47%), Gaps = 20/96 (20%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLD 102
L Y+HS I HRD+K +N+ +++ +I DFG +R + T GY+
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT----------GYVA 177
Query: 103 LEYFRSSQ-------FTKKGDVYSFGVVFVGLLTGQ 131
++R+ + + + D++S G + LL G+
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.001
Identities = 36/140 (25%), Positives = 54/140 (38%), Gaps = 24/140 (17%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV + G L+ +I I E R A E+ AL LH I RD+ N
Sbjct: 62 LVLQHAEGGKLWSHISKF---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNN 115
Query: 64 ILLDDKFRAKISDFGASRYV-------TIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGD 116
ILLDD+ +++ F V ++ + V G S+ T+ D
Sbjct: 116 ILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGI-----------SEETEACD 164
Query: 117 VYSFGVVFVGLLTGQKPIRS 136
+S G + LLTG+ +
Sbjct: 165 WWSLGAILFELLTGKTLVEC 184
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.001
Identities = 28/80 (35%), Positives = 38/80 (47%), Gaps = 12/80 (15%)
Query: 4 LVYEFIPNGTLYRY-IHDQT--EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
L+ EF+P G L I T E+ T + +A+E L ++H RDIK
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIH---------RDIK 128
Query: 61 SANILLDDKFRAKISDFGAS 80
NIL+D K+SDFG S
Sbjct: 129 PDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.002
Identities = 34/141 (24%), Positives = 69/141 (48%), Gaps = 8/141 (5%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV+EF+ + L +++ D + I + ++ L++ HS + HRD+K N
Sbjct: 76 LVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVL---HRDLKPQN 130
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQF-TKKGDVYSFGV 122
+L++ + K++DFG +R + T V T Y E ++ + D++S G
Sbjct: 131 LLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGC 189
Query: 123 VFVGLLTGQKPIRSTDTEEDK 143
+F ++T ++ + D+E D+
Sbjct: 190 IFAEMVT-RRALFPGDSEIDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.002
Identities = 24/88 (27%), Positives = 45/88 (51%), Gaps = 13/88 (14%)
Query: 54 IYHRDIKSANILLDDKFRAKISDFGASRYV--TIDQTHLTTRVQGTFGYLDLEYFRS--- 108
I HRD+K N+L++ + K+ DFG S + ++ +T++ G Y+ E +S
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGP 178
Query: 109 ---SQFTKKGDVYSFGVVFVGLLTGQKP 133
+T + DV+S G+ + + G+ P
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 7/96 (7%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS----RYVTIDQTHLTTRVQGT 97
AL+YLH I HRD+K+ NIL K++DFG S R + + + T
Sbjct: 115 ALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 171
Query: 98 FGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKP 133
+ E + + K DV+S G+ + + + P
Sbjct: 172 PEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.002
Identities = 18/40 (45%), Positives = 23/40 (57%), Gaps = 4/40 (10%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRA-KISDFGAS 80
AL LHST I HRD+K NI+ + + KI D GA+
Sbjct: 267 ALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.002
Identities = 27/104 (25%), Positives = 51/104 (49%), Gaps = 5/104 (4%)
Query: 43 LSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLD 102
LSY H I HRD+K N+L+++K K++DFG +R ++ + V T Y
Sbjct: 116 LSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRP 171
Query: 103 LE-YFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSL 145
+ S++++ D++ G + + TG+ + +E+ L
Sbjct: 172 PDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.002
Identities = 26/90 (28%), Positives = 44/90 (48%), Gaps = 1/90 (1%)
Query: 54 IYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTK 113
I HRDIK N+L+ K+ DFG +R ++ T T Y E + + K
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 114 KGDVYSFGVVFVGLLTGQKPIRSTDTEEDK 143
D++S G + +G L+ +P+ ++E D+
Sbjct: 181 AVDMWSVGCI-LGELSDGQPLFPGESEIDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.004
Identities = 24/96 (25%), Positives = 43/96 (44%), Gaps = 17/96 (17%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
+ +LHS I HRD+K +NI++ KI DFG +R +T Y+
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTP-------YV 178
Query: 102 DLEYFRSSQ------FTKKGDVYSFGVVFVGLLTGQ 131
Y+R+ + + + D++S G + ++ G
Sbjct: 179 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 253 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.98 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.98 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.98 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.98 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.98 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.98 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.98 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.98 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.98 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.98 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.98 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.98 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.98 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.98 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.96 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.93 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.87 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.87 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.85 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.85 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.75 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.62 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.61 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.57 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.56 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.54 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.53 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.42 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.42 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.35 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.3 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.28 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.26 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.23 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.21 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.21 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.18 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.11 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.05 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.96 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.94 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.92 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.81 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.79 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.77 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.71 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.69 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.58 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.51 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.51 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.35 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.3 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.21 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.14 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.09 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.93 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.64 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.51 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.05 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.58 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.58 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.46 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 96.44 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.37 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.17 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.16 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.67 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.52 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 95.29 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 93.95 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 93.86 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 93.6 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.48 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.45 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 93.45 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 92.87 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 92.56 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 92.54 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 92.32 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 92.16 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 91.98 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 91.72 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 91.32 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 91.06 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 91.06 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 90.62 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 90.61 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 90.23 | |
| PLN02236 | 344 | choline kinase | 90.06 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 90.05 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 90.02 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 89.63 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 88.15 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 87.73 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 84.58 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 84.55 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 84.53 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 84.4 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 82.85 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 82.52 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=270.61 Aligned_cols=180 Identities=26% Similarity=0.390 Sum_probs=148.6
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhh-CCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS-TTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++|+|.+++...+ ++++...-+++.+|++||.|||. ++ |+||||||+|||++..|.+||+|||.+.
T Consensus 154 sI~mEYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred EeehhhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccH
Confidence 68999999999999998764 59999999999999999999995 88 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...+. .....+||..||+||.+.+..|+.++||||||++++|+.+|+.||...... .......+.....+.
T Consensus 228 ~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~~~~Ll~~Iv~~p----- 298 (364)
T KOG0581|consen 228 ILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLDIFELLCAIVDEP----- 298 (364)
T ss_pred Hhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCCHHHHHHHHhcCC-----
Confidence 76433 445678999999999999999999999999999999999999999775211 111122222222111
Q ss_pred hchhhhhhhcH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKE-EEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~-~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.+..+. .+++++++++..||++||.+||+++++++|
T Consensus 299 -----pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 299 -----PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -----CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 112223 467789999999999999999999999987
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=263.75 Aligned_cols=205 Identities=41% Similarity=0.690 Sum_probs=173.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
++||+||+++|+|.+++...... .++|..+++|+.++|.||.|||....++|+|||||+.|||++.++..||+|||+++
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~ 225 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK 225 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence 58999999999999999886543 68999999999999999999999887789999999999999999999999999996
Q ss_pred cccCCCcceeeec-cccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRV-QGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..... ....... .||.+|++||+...+..+.++||||||+++.|+++|+.+.....+.....+..+.+..+......+
T Consensus 226 ~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~e 304 (361)
T KOG1187|consen 226 LGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLRE 304 (361)
T ss_pred cCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhh
Confidence 55321 1122222 799999999999988899999999999999999999988876654445557777777777778889
Q ss_pred hhchhhh-hhhcH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchh
Q 044510 161 MLDAQVL-KEAKE-EEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRA 208 (253)
Q Consensus 161 ~~~~~~~-~~~~~-~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 208 (253)
++|+.+. ...+. .....+..+..+|++.+|..||+|.+++++|+.+..
T Consensus 305 iiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 305 IVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred eeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 9999876 44443 677889999999999999999999999999965543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=262.51 Aligned_cols=192 Identities=33% Similarity=0.525 Sum_probs=155.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC-ceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF-RAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~-~~kl~Dfgl~ 80 (253)
.+|||||+++|+|.+++... .+..+++..+++|+.||+.|+.|||+.+. |+|||||++|||++.++ ++||+|||++
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccc
Confidence 37999999999999999874 23369999999999999999999999883 89999999999999997 9999999999
Q ss_pred ccccCCCcceeeeccccccccccchhc--cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFR--SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
+...... .......||+.|||||++. ...|+.++||||||+++|||+||..||........ .......
T Consensus 192 r~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~------~~~v~~~--- 261 (362)
T KOG0192|consen 192 REKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV------ASAVVVG--- 261 (362)
T ss_pred eeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhc---
Confidence 8664322 2223367999999999999 56899999999999999999999999988765221 1111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCC
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGP 212 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 212 (253)
..+...+...+..+..++.+||+.||.+||++.+++..|+.+......
T Consensus 262 ------~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 262 ------GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ------CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 112223333566788899999999999999999999999998886543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=248.22 Aligned_cols=188 Identities=22% Similarity=0.326 Sum_probs=150.4
Q ss_pred CCEEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHhhCC-CCCeEecCCCCCceeecCCCceEEcccC
Q 044510 1 VPLLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLHSTT-SIPIYHRDIKSANILLDDKFRAKISDFG 78 (253)
Q Consensus 1 ~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~-~~~i~H~dl~~~nili~~~~~~kl~Dfg 78 (253)
+.+||||||.+|+|.+.++..+ ++..+++..+|+++.|++.||.++|..- +-.|.||||||.||+++.+|.+||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 4579999999999999998743 3446999999999999999999999821 0128999999999999999999999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
|++.+.... ......+|||.||+||.+.+.+|++++||||+||++|||+.-+.||.+....+ +..++.....
T Consensus 174 L~r~l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~-------L~~KI~qgd~ 245 (375)
T KOG0591|consen 174 LGRFLSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS-------LCKKIEQGDY 245 (375)
T ss_pred hHhHhcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH-------HHHHHHcCCC
Confidence 999876433 33445789999999999999999999999999999999999999998874433 2223332211
Q ss_pred cchhchhhhhhhc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 159 FDMLDAQVLKEAK-EEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 159 ~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
+..+ ...+..+.++|..|+..||.+||+.-.++..++.
T Consensus 246 ---------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 ---------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ---------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1122 5667789999999999999999985444444443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=264.16 Aligned_cols=179 Identities=24% Similarity=0.342 Sum_probs=150.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.... +++.++..+++++++||+|||..| |+|||||.+||+++.++.+||+|||++.
T Consensus 345 LWVVMEym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCA 417 (550)
T ss_pred eEEEEeecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeee
Confidence 599999999999999997654 999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
.+.... ......+|||.|||||+.....|.+++||||||++++||+.|.+||-..++..... . +..+....
T Consensus 418 qi~~~~-~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly------L-Ia~ng~P~- 488 (550)
T KOG0578|consen 418 QISEEQ-SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------L-IATNGTPK- 488 (550)
T ss_pred cccccc-CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH------H-HhhcCCCC-
Confidence 765433 24456789999999999999999999999999999999999999997755433211 1 11121111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...+...+..+++|+.+||+.|+.+|++++||+++
T Consensus 489 ------lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 489 ------LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ------cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 12345566789999999999999999999999976
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=263.79 Aligned_cols=176 Identities=25% Similarity=0.399 Sum_probs=148.7
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
|||+|+|..++|..++++.+ ++++..+..++.||+.||.|||+++ |+|||||-.|+|++.+.+|||+|||||..
T Consensus 94 YivLELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~ 167 (592)
T KOG0575|consen 94 YIVLELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQ 167 (592)
T ss_pred EEEEEecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeee
Confidence 89999999999999998654 6999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccchh
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDML 162 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (253)
.... .....+.+|||.|+|||++.....+..+||||+||++|-|+.|++||+...-.+. +.+.....-
T Consensus 168 le~~-~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket------y~~Ik~~~Y----- 235 (592)
T KOG0575|consen 168 LEYD-GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET------YNKIKLNEY----- 235 (592)
T ss_pred ecCc-ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH------HHHHHhcCc-----
Confidence 6533 3445567899999999999988999999999999999999999999976544332 222111111
Q ss_pred chhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 163 DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..|...+.++.++|.++|+.||.+|||+++|+.+
T Consensus 236 ------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 ------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1122445578889999999999999999999975
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=254.10 Aligned_cols=180 Identities=25% Similarity=0.337 Sum_probs=146.5
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC---CceEEcccCC
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK---FRAKISDFGA 79 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~---~~~kl~Dfgl 79 (253)
||||||++||+|.+.+..++ .+.+.....++.|++.|+.|||+.| |+||||||+|||+..+ ..+||+|||+
T Consensus 252 YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred EEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccch
Confidence 89999999999999999876 4888888999999999999999999 9999999999999866 6799999999
Q ss_pred cccccCCCcceeeeccccccccccchhccCCC---CCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQF---TKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
++... ....+++.+|||.|.|||++.+..+ ..++|+||+||++|-+++|.+||....... .+ .+.+..+
T Consensus 326 AK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl----~eQI~~G 397 (475)
T KOG0615|consen 326 AKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SL----KEQILKG 397 (475)
T ss_pred hhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cH----HHHHhcC
Confidence 99875 4456677889999999999987653 358899999999999999999998754322 11 1112222
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.... .+....+.+.+.+++|.+||..||++|||++|++++
T Consensus 398 ~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 398 RYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred cccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1111 112234566788999999999999999999999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=249.06 Aligned_cols=178 Identities=25% Similarity=0.341 Sum_probs=145.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+|+||+.||.|...|++.+ .+++..+.-++.+|+.||.|||++| |+|||+||+|||++.+|.++|+||||++
T Consensus 100 LylVld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k 173 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCK 173 (357)
T ss_pred EEEEEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccch
Confidence 489999999999999999876 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
.... ....+...+||++|||||++.+.+|+.++|.||+|+++|+|++|.+||...+..+. .+.+...+
T Consensus 174 ~~~~-~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~-------~~~I~~~k---- 241 (357)
T KOG0598|consen 174 EDLK-DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM-------YDKILKGK---- 241 (357)
T ss_pred hccc-CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH-------HHHHhcCc----
Confidence 5432 23344557899999999999999999999999999999999999999988764331 11222221
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC----CHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP----TMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp----s~~~l~~~ 202 (253)
....+...+...++++.+.|..||.+|. ++.+|.++
T Consensus 242 -----~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 242 -----LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred -----CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 1111222445688899999999999995 45555543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=256.37 Aligned_cols=187 Identities=28% Similarity=0.447 Sum_probs=156.0
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
||||||++.|+|.++|+.. ....+...+.+.++.||++|++||++++ +|||||-+.||||+.+..+||+||||++.
T Consensus 277 yIVtE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred EEEEEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccc
Confidence 8999999999999999973 2335999999999999999999999999 99999999999999999999999999995
Q ss_pred ccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..++........-....|.|||.+..+.++.++||||||+++|||+| |+.|+......+ ..+.
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e----------------v~~~ 416 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE----------------VLEL 416 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH----------------HHHH
Confidence 54333322222233568999999999999999999999999999999 999988776544 2222
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
+..+.+-..|..++..+.++...||+.+|++|||++.+...|+.+...
T Consensus 417 le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 417 LERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 333344455666777899999999999999999999999999887654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=251.52 Aligned_cols=184 Identities=28% Similarity=0.395 Sum_probs=146.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC-CCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD-KFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~-~~~~kl~Dfgl~ 80 (253)
.++.|||+++|+|.+++.+.+. .+++..+...++||++||.|||++| ++||||||+|||++. ++.+||+|||++
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a 165 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLA 165 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccc
Confidence 4799999999999999998754 5999999999999999999999999 999999999999999 799999999998
Q ss_pred ccccC--CCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCC-ChhhhhhhHHHHHHHHhhc
Q 044510 81 RYVTI--DQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRST-DTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 81 ~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~~ 156 (253)
+.... ..........||+.|||||++..+ ....++||||+||++.||+||..||... ... ..+.......
T Consensus 166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~------~~~~~ig~~~ 239 (313)
T KOG0198|consen 166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA------EALLLIGRED 239 (313)
T ss_pred cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH------HHHHHHhccC
Confidence 76552 111223456799999999999953 2345999999999999999999999763 111 1111111111
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
..+..+...+....+++.+|+..||+.|||+.+++++.--
T Consensus 240 ---------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 240 ---------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred ---------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 1113444466678999999999999999999999988643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=252.64 Aligned_cols=178 Identities=29% Similarity=0.399 Sum_probs=148.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+|+||+++|+|.++|...+ .+.+..+...+.+|+.||.|||+.| |+||||||+|||++.+++++|+|||.++
T Consensus 149 LYFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 589999999999999999876 4999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcc------------eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH
Q 044510 82 YVTIDQTH------------LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF 149 (253)
Q Consensus 82 ~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 149 (253)
.+...... .....+||..|.+||.+.+...+..+|+|+|||++|+|+.|.+||.+.++-- .+
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl------iF 296 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL------IF 296 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH------HH
Confidence 77532111 1144789999999999999999999999999999999999999998765432 12
Q ss_pred HHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 150 LRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.+.+.-. -+.+..+++.+.+||.+.|..||.+|++..+|-++
T Consensus 297 qkI~~l~-----------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 297 QKIQALD-----------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHhc-----------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 2222211 11223334568889999999999999999999887
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=242.98 Aligned_cols=190 Identities=24% Similarity=0.338 Sum_probs=150.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||.||.+|++.+++...-.. ++++..+..|+++++.||.|||..| .+|||+|+.|||++.+|.|||+|||.+.
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSA 174 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeee
Confidence 59999999999999999886544 5999999999999999999999999 9999999999999999999999999776
Q ss_pred cccCCCcce---eeeccccccccccchhcc--CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 82 YVTIDQTHL---TTRVQGTFGYLDLEYFRS--SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 82 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
......... .+..+|++.|||||++.. ..|+.++||||||++..||.+|..||....+.+ .+...+.+.
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl~tLqn~ 248 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLLLTLQND 248 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHHHHhcCC
Confidence 554333221 145689999999999543 369999999999999999999999998876643 122233332
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... ..-.....+........+++++..||+.||.+|||+++++++
T Consensus 249 pp~-~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 249 PPT-LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CCC-cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 211 111122223344566689999999999999999999999865
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=240.65 Aligned_cols=133 Identities=30% Similarity=0.498 Sum_probs=119.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC------CceEEc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK------FRAKIS 75 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~------~~~kl~ 75 (253)
.|+|||||.||+|.+++++.+ ++++..+..++.|++.||++||+++ |+||||||+|||++.. ..+||+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIA 157 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIA 157 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEec
Confidence 489999999999999999876 5999999999999999999999999 9999999999999764 468999
Q ss_pred ccCCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhh
Q 044510 76 DFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142 (253)
Q Consensus 76 Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~ 142 (253)
|||+++... ......+.+|+|-|||||++...+|+.++|+||+|+++|++++|..||...+..+.
T Consensus 158 DFGfAR~L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL 222 (429)
T KOG0595|consen 158 DFGFARFLQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL 222 (429)
T ss_pred ccchhhhCC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence 999999765 33344557799999999999989999999999999999999999999988776553
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=247.59 Aligned_cols=194 Identities=22% Similarity=0.275 Sum_probs=153.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++|||||+. +|.+++++. ...+++..+..|+.||++||+|+|++| +.|||+||+|||+..+..+||+|||+++
T Consensus 85 L~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccc
Confidence 5899999955 999999886 336999999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc---
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC--- 157 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 157 (253)
..... ...+..+.|.+|+|||++.. +-|+.+.|+|++||+++|+.+-++.|.+..+.++.+.+-.+........
T Consensus 159 ev~Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 159 EVRSK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred ccccC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 77543 34556788999999999864 4589999999999999999999999999887665444432221111111
Q ss_pred ----------ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044510 158 ----------LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203 (253)
Q Consensus 158 ----------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 203 (253)
......+......-...+.++.+++.+||..||.+|||+.+++++-
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 1111111112222223667899999999999999999999999873
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=247.89 Aligned_cols=176 Identities=26% Similarity=0.394 Sum_probs=144.8
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC-CceEEcccCCcc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK-FRAKISDFGASR 81 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~-~~~kl~Dfgl~~ 81 (253)
|+||||+.||+|.+++...+ ++.+..+.+++.|++.|+.|+|++| |+||||||+|++++.+ +.+||+|||++.
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 79999999999999999844 5999999999999999999999999 9999999999999999 999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCC-CC-CCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQ-FT-KKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
... .........+|++.|+|||++.+.. |+ .++|+||+|+++|.|++|..||........ ...+.....
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l-------~~ki~~~~~- 240 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL-------YRKIRKGEF- 240 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH-------HHHHhcCCc-
Confidence 763 2334455678999999999999877 85 889999999999999999999987443221 111111111
Q ss_pred chhchhhhhhhcHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEE-IITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~-~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+... +..+..++.+||..||.+|+++.+|+++
T Consensus 241 ---------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 241 ---------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred ---------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 111122 5578889999999999999999999943
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=231.03 Aligned_cols=194 Identities=23% Similarity=0.299 Sum_probs=151.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|+|||++ ++.+-+.++.. +.+...+.+++.|++.|+.|+|+.+ ++||||||+|||++.++.+||||||+++
T Consensus 76 lhLVFE~~dh-TvL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR 149 (396)
T KOG0593|consen 76 LHLVFEYCDH-TVLHELERYPN--GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFAR 149 (396)
T ss_pred eEEEeeecch-HHHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhH
Confidence 3799999977 66666777654 5999999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHH--------H
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLR--------A 152 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~--------~ 152 (253)
.... .....+..+.|.+|+|||.+.| .+|...+|||++||++.||++|.+-|.+....++...+..... .
T Consensus 150 ~L~~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 150 TLSA-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred hhcC-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHH
Confidence 7764 3344556778999999999997 5799999999999999999999999998877665544433211 1
Q ss_pred Hhhcc------ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 153 MKENC------LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 153 ~~~~~------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...+. +++.-++..........+..+.+++.+||+.||.+|++-++++.+
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11111 111122222222223344578999999999999999999998865
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=243.82 Aligned_cols=195 Identities=23% Similarity=0.270 Sum_probs=159.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|||+|||++ +|.-++....- .|++.++..++.|++.||.|+|.+| |+|||||..||||+.+|.+||+||||++
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~v--kft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGV--KFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCc--ccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEecccccee
Confidence 4899999977 89999876433 4999999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc-
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF- 159 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 159 (253)
++........+..+-|.+|+|||.+.|. .|+.++|+||+||++.||++|+++|.+.++.++...+..+.....+..+.
T Consensus 267 ~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 267 FYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred eccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence 8876666666777789999999999975 69999999999999999999999999999888766665543332222221
Q ss_pred ------chhc-----hhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 ------DMLD-----AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ------~~~~-----~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+. .....+.....+....+|+..+|..||.+|.|+.++++.
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 1111 111222244456778999999999999999999988853
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=247.35 Aligned_cols=178 Identities=24% Similarity=0.349 Sum_probs=150.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|++||||.||++.+++.... .+.+..+.-++++++.||.|||.++ .+|||||+.||++..+|.+||+|||++.
T Consensus 86 LwiiMey~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAG 159 (467)
T ss_pred HHHHHHHhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceee
Confidence 578999999999999998654 3578888889999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
........ ....+|||.|||||++.+..|+.++||||||++.+||++|.+|+....+.. ...+
T Consensus 160 ql~~~~~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlfl 222 (467)
T KOG0201|consen 160 QLTNTVKR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFL 222 (467)
T ss_pred eeechhhc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEe
Confidence 66543333 367889999999999998899999999999999999999999998876632 2223
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
+..+..+......++.+++++..||+.||+.||++++++++
T Consensus 223 Ipk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 223 IPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 33333333444667789999999999999999999999875
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=246.30 Aligned_cols=181 Identities=24% Similarity=0.347 Sum_probs=155.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.+|||+||+||+|.+.+.+.. ...++++.+++|+.|++.|+.|||+.+ |+|||||+.|||++.++.++|+|||+++
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK 154 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAK 154 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhh
Confidence 589999999999999998865 335999999999999999999999888 9999999999999999999999999999
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... ......+||+.|++||++.+.+|..++|||||||++|||++-+++|...+.......+
T Consensus 155 ~l~~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki--------------- 218 (426)
T KOG0589|consen 155 ILNPED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKI--------------- 218 (426)
T ss_pred hcCCch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHH---------------
Confidence 876433 2455678999999999999999999999999999999999999999887765422111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 203 (253)
........+...+.+++.++..||+.+|..||++.+++.+.
T Consensus 219 -~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 219 -NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred -hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 11122334556667899999999999999999999999873
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=228.10 Aligned_cols=165 Identities=28% Similarity=0.414 Sum_probs=140.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.||||||.+||.|.+++++.+ ++++..+.-++.||+.||+|||+.+ |++||+||+||+++.+|.+||+|||+++
T Consensus 119 lymvmeyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK 192 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAK 192 (355)
T ss_pred EEEEEeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceE
Confidence 589999999999999998865 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
.... .+.+.+|||.|+|||++...+|..++|.|+||+++|||+.|..||...++.. .+....... +
T Consensus 193 ~v~~----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~------iY~KI~~~~-v--- 258 (355)
T KOG0616|consen 193 RVSG----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ------IYEKILEGK-V--- 258 (355)
T ss_pred EecC----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH------HHHHHHhCc-c---
Confidence 7642 3556789999999999999999999999999999999999999998876532 222222222 1
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCC
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKR 193 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R 193 (253)
..|...+..+++++.+.|+.|-.+|
T Consensus 259 -------~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 -------KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -------cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2233445578889999999999988
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=242.58 Aligned_cols=165 Identities=24% Similarity=0.411 Sum_probs=127.3
Q ss_pred CCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcccccCCCcce-eeeccccccccccc
Q 044510 26 TITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHL-TTRVQGTFGYLDLE 104 (253)
Q Consensus 26 ~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~~~~~y~aPE 104 (253)
++++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++......... .....+++.|+|||
T Consensus 170 ~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 246 (338)
T cd05102 170 PLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246 (338)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence 4778889999999999999999999 9999999999999999999999999987543222111 12233567899999
Q ss_pred hhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHH
Q 044510 105 YFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAK 183 (253)
Q Consensus 105 ~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 183 (253)
++.+..++.++|+|||||++|+|++ |..||......+. +.......... ..+...+..+.+++.
T Consensus 247 ~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~l~~li~ 311 (338)
T cd05102 247 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTRM---------RAPENATPEIYRIML 311 (338)
T ss_pred HhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCCC---------CCCCCCCHHHHHHHH
Confidence 9988889999999999999999997 9999976543211 11111111111 011223446888999
Q ss_pred HhcccCCCCCCCHHHHHHHHhhchh
Q 044510 184 RCLNLNGRKRPTMKEVAFELGGIRA 208 (253)
Q Consensus 184 ~cl~~dP~~Rps~~~l~~~l~~~~~ 208 (253)
+||+.||.+||++.++++.|+.+..
T Consensus 312 ~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 312 ACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=245.51 Aligned_cols=177 Identities=27% Similarity=0.423 Sum_probs=149.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+|.||++||.|++++.+.+ ++++..+++++.||+.|+.|+|..+ |+|||+||+|+|++..+.+||+|||++.
T Consensus 87 lylvlEyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAs 160 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMAS 160 (786)
T ss_pred EEEEEEecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceee
Confidence 489999999999999998876 5999999999999999999999999 9999999999999999899999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCC-CCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQF-TKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
... ......+.+|.|.|++||++.|.+| +.++||||.||++|.|++|..||.+.+.. .+..+...+..
T Consensus 161 Le~--~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir-------~LLlKV~~G~f-- 229 (786)
T KOG0588|consen 161 LEV--PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR-------VLLLKVQRGVF-- 229 (786)
T ss_pred ccc--CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH-------HHHHHHHcCcc--
Confidence 543 3445566789999999999999998 58999999999999999999999854432 22233322211
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 203 (253)
++|...+.++++|+.+||..||.+|.|+.+|++|-
T Consensus 230 --------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 230 --------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred --------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 23344556789999999999999999999999873
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=239.17 Aligned_cols=181 Identities=24% Similarity=0.326 Sum_probs=143.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+||||||++||++..+|.+.+ .+++..+...+.+.+.|+..||..| ++||||||+|+||+..|.+||+||||+.
T Consensus 216 LYLiMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred eEEEEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccc
Confidence 589999999999999999866 6999999999999999999999999 9999999999999999999999999975
Q ss_pred cccC---------------C--------Cc-----------------------ceeeeccccccccccchhccCCCCCCC
Q 044510 82 YVTI---------------D--------QT-----------------------HLTTRVQGTFGYLDLEYFRSSQFTKKG 115 (253)
Q Consensus 82 ~~~~---------------~--------~~-----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~ 115 (253)
-... . .. ......+|||.|+|||++.+..|...+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 3210 0 00 001125799999999999999999999
Q ss_pred CeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-
Q 044510 116 DVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP- 194 (253)
Q Consensus 116 Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp- 194 (253)
|.|||||++||||.|.+||.+.++.+....+..+...+. .+. ....+.++.++|.+||. ||.+|.
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~---fP~----------~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK---FPE----------EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc---CCC----------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999999999999887664333322111111 000 11222578889999999 999996
Q ss_pred --CHHHHHHH
Q 044510 195 --TMKEVAFE 202 (253)
Q Consensus 195 --s~~~l~~~ 202 (253)
.+.||-+|
T Consensus 436 ~~G~~EIK~H 445 (550)
T KOG0605|consen 436 SKGAEEIKKH 445 (550)
T ss_pred cccHHHHhcC
Confidence 47777655
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=234.54 Aligned_cols=180 Identities=20% Similarity=0.385 Sum_probs=144.1
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhC-CCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHST-TSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
++||||+++|+|.+++.... .+++...+.++.+++.||.|||.. + ++||||||+||+++.++.+||+|||+++
T Consensus 98 ~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 98 SLILEYCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEK 171 (283)
T ss_pred EEEEEeCCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHh
Confidence 79999999999999997653 588999999999999999999984 7 8899999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhcc--CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS--SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
...... ....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||......+. ...........
T Consensus 172 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~ 241 (283)
T PHA02988 172 ILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI------YDLIINKNNSL 241 (283)
T ss_pred hhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhcCCCC
Confidence 543211 22457889999999976 5789999999999999999999999986543321 11111111110
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhch
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 207 (253)
..+...+..+.+++.+||+.||.+|||++++++.|+.+.
T Consensus 242 ---------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 242 ---------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ---------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 111223456889999999999999999999999998765
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=228.39 Aligned_cols=185 Identities=24% Similarity=0.398 Sum_probs=144.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... ..+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccc
Confidence 4799999999999999876432 24899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
...............+..|++||.+.+..++.++|+|||||++|+|++ |..||......+. ........
T Consensus 153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~--- 222 (263)
T cd05052 153 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKGY--- 222 (263)
T ss_pred ccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCC---
Confidence 654322111111223567999999988889999999999999999998 9999876543321 11111110
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
....+...+..+.+++.+||+.||.+||++.+++++|+.+
T Consensus 223 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 ------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0111223345788899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=237.56 Aligned_cols=177 Identities=23% Similarity=0.318 Sum_probs=142.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 70 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~ 143 (323)
T cd05571 70 LCFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK 143 (323)
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 489999999999999997654 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... ........|++.|+|||++.+..++.++|+||+||++|+|++|..||........ .........
T Consensus 144 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-------~~~~~~~~~--- 212 (323)
T cd05571 144 EGISD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMEEI--- 212 (323)
T ss_pred ccccC-CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH-------HHHHHcCCC---
Confidence 43221 1122335689999999999988899999999999999999999999976543321 111111100
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+|| ++++++++
T Consensus 213 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 213 -------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred -------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 11223445688899999999999999 79999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=240.19 Aligned_cols=186 Identities=28% Similarity=0.440 Sum_probs=152.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|||||||..|-|..+|+... ++.......|..+|+.|+.|||.++ |+|||||.-||||+.+..|||+|||-++
T Consensus 187 yCIiMEfCa~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred eEEeeeccccccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchH
Confidence 489999999999999998754 5899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... ...-.+.||..|||||++...+.++++|||||||+||||+||..||.+-+.....+- ...+
T Consensus 261 e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG-------VGsN----- 326 (904)
T KOG4721|consen 261 ELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG-------VGSN----- 326 (904)
T ss_pred hhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEe-------ccCC-----
Confidence 65432 222346799999999999999999999999999999999999999977554321110 1111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
.+....+..++..+.-|++.||+-.|..||++.+|+.+|+-....+
T Consensus 327 ---sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 327 ---SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred ---cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 1122334445556777999999999999999999999998665554
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=225.17 Aligned_cols=193 Identities=21% Similarity=0.195 Sum_probs=154.5
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
|||||||++ +|.+++...++ ++...++..++.|++.|+.|||... |+|||||++|+|++..|.+||+|||+++.
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q--~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQ--PFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhh
Confidence 899999977 89999998765 5889999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCcceeeeccccccccccchhccCC-CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRSSQ-FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
+... ....+..+-|.+|+|||.+.+.+ |+.+.|+||+||++.||+++.+-|.+..+.++...+-.......+..+...
T Consensus 227 ygsp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 227 YGSP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred hcCC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 8654 33455567799999999999764 899999999999999999999999998877665555444332222222111
Q ss_pred h--------------chhhhhhhcHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 L--------------DAQVLKEAKEE-EIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~--------------~~~~~~~~~~~-~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ..++...+... ......+++..+|..||.+|.|+.+.+++
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1 11112222221 34678899999999999999999999865
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=229.95 Aligned_cols=195 Identities=20% Similarity=0.186 Sum_probs=141.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++++.+..+.... ..+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.+||+|||++.
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 148 (287)
T cd07848 75 LYLVFEYVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFAR 148 (287)
T ss_pred EEEEEecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcc
Confidence 48999999887666554332 25899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH--------HHHH
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF--------LRAM 153 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~~~~ 153 (253)
..............+++.|+|||++.+..++.++|+||+||++|+|++|..||......+........ ....
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07848 149 NLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLF 228 (287)
T ss_pred cccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhh
Confidence 65432222223356889999999998888999999999999999999999999875543221111100 0000
Q ss_pred hhcccc-chhc------hhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 154 KENCLF-DMLD------AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 154 ~~~~~~-~~~~------~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...... .... ...........+..+.+++.+||+.||.+|||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 229 YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 0000 000011112245679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=226.89 Aligned_cols=193 Identities=26% Similarity=0.334 Sum_probs=149.7
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
|+|+|+| +.+|..+++.+. .++.+.+..++.|++.||.|+|+.+ ++|||+||.|++++.+..+||+|||+++.
T Consensus 102 YiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred EEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 8999999 669999998764 4999999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCC-cceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 83 VTIDQ-THLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 83 ~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..... ....+..+.|.+|+|||++.. ..|+.+.||||+||++.||++|+.-|.+.+...+..+.........+..+..
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 75331 122345667999999999864 4699999999999999999999999999877665544433211111111100
Q ss_pred --------------hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 --------------MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 --------------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...+...........+...+++++||..||.+|+|++|++++
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 011111112222445678999999999999999999999987
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=228.42 Aligned_cols=182 Identities=25% Similarity=0.330 Sum_probs=145.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+|||||+||+|..+++++..+ .+++..+.-.+.+++.||+|||..| ||+|||||+||||-++|.+.|+||.|+.
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~-~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGK-RFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCC-ccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccc
Confidence 58999999999999999987654 5999999999999999999999999 9999999999999999999999999765
Q ss_pred cccCC--------------------------------C-c----------------------ceeeeccccccccccchh
Q 044510 82 YVTID--------------------------------Q-T----------------------HLTTRVQGTFGYLDLEYF 106 (253)
Q Consensus 82 ~~~~~--------------------------------~-~----------------------~~~~~~~~~~~y~aPE~~ 106 (253)
..... . . ......+||-+|+|||++
T Consensus 228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 33100 0 0 011225689999999999
Q ss_pred ccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhc
Q 044510 107 RSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCL 186 (253)
Q Consensus 107 ~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 186 (253)
.|...+.++|.|.||+++|||+.|..||.+.+..+. +.+.+..... .+. ....+..+++||++.|
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T------l~NIv~~~l~--------Fp~-~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET------LRNIVGQPLK--------FPE-EPEVSSAAKDLIRKLL 372 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh------HHHHhcCCCc--------CCC-CCcchhHHHHHHHHHh
Confidence 999999999999999999999999999988765431 1222211111 011 1155668999999999
Q ss_pred ccCCCCCCC----HHHHHHH
Q 044510 187 NLNGRKRPT----MKEVAFE 202 (253)
Q Consensus 187 ~~dP~~Rps----~~~l~~~ 202 (253)
.+||.+|.- +.||-++
T Consensus 373 vKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred ccChhhhhccccchHHhhcC
Confidence 999999988 7777665
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=229.94 Aligned_cols=189 Identities=22% Similarity=0.370 Sum_probs=148.3
Q ss_pred CEEEEeecCCCChhHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
+++||||+++++|.+++..... ...+++..++.++.|++.||.|||.++ ++|+||||+||+++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~ 158 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGA 158 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEcc
Confidence 5899999999999999976421 124889999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhH
Q 044510 69 KFRAKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLA 146 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~ 146 (253)
++.++|+|||++......... ......++..|+|||++.+..++.++|+||||+++|+|++ |..||......+.
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---- 234 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---- 234 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----
Confidence 999999999998754332211 1122345778999999998889999999999999999999 9999876544321
Q ss_pred HHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 147 GYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
........... .+...+..+.+++.+||+.||.+||++++++++|+++...
T Consensus 235 ---~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 235 ---IECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred ---HHHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11111111111 1122344688999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=229.34 Aligned_cols=185 Identities=24% Similarity=0.436 Sum_probs=145.8
Q ss_pred CEEEEeecCCCChhHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
.+++|||+++++|.+++..... ...+++..++.++.|++.||.|||..+ ++|+||||+||++++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcC
Confidence 4799999999999999976421 134888999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCc-ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhH
Q 044510 69 KFRAKISDFGASRYVTIDQT-HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLA 146 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~ 146 (253)
++.++|+|||+++....... .......+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+....+.
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~---- 235 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV---- 235 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH----
Confidence 99999999999875532221 11222345778999999988889999999999999999998 9999976554321
Q ss_pred HHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 147 GYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
...+...... ..+...+..+.+++.+||+.||.+||++.+|+++|+.
T Consensus 236 ---~~~i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 ---IEMIRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHHHHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1112111111 1223445678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=226.24 Aligned_cols=185 Identities=19% Similarity=0.383 Sum_probs=144.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+++++|.+++.... ...+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~ 151 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLAR 151 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccce
Confidence 589999999999999997643 225888999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............++..|+|||.+.+..++.++|+||||+++|+|++ |..||........ ..........
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~-------~~~~~~~~~~- 223 (261)
T cd05072 152 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV-------MSALQRGYRM- 223 (261)
T ss_pred ecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH-------HHHHHcCCCC-
Confidence 654322211222334668999999988888999999999999999998 9999976543321 1111111000
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
......+..+.+++.+||+.+|.+||+++++++.|+.+
T Consensus 224 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 --------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 01112334688899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=227.24 Aligned_cols=184 Identities=17% Similarity=0.320 Sum_probs=142.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccc
Confidence 5899999999999999976432 5899999999999999999999999 9999999999999999999999999765
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............++..|+|||.+.+..++.++|+|||||++|++++ |..||......+. ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~-------~~~~~~~~~~- 227 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV-------IKAVEDGFRL- 227 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH-------HHHHHCCCCC-
Confidence 432111111112234568999999998889999999999999999775 9999976544321 1111111110
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
..+...+..+.+++.+||+.+|.+||++++|.+.|+++
T Consensus 228 --------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 --------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11223445688899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=215.01 Aligned_cols=193 Identities=24% Similarity=0.239 Sum_probs=149.5
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
-||+||++. +|..++++... .++...+..++.++++||+|+|.+. |+|||+||.|+|++.+|.+|++|||+++.
T Consensus 77 ~lVfEfm~t-dLe~vIkd~~i--~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~ 150 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKDKNI--ILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARF 150 (318)
T ss_pred EEEEEeccc-cHHHHhccccc--ccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhc
Confidence 489999965 99999988543 5999999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc-
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD- 160 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 160 (253)
+....... ...+-|.+|+|||.+.|. .|+..+|+||+||++.||+-|.+.|.+....++...+-..........+.+
T Consensus 151 f~~p~~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~ 229 (318)
T KOG0659|consen 151 FGSPNRIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM 229 (318)
T ss_pred cCCCCccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence 86543332 334679999999999875 599999999999999999999998888776555443322221111211111
Q ss_pred --hhch--------hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 --MLDA--------QVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 --~~~~--------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
+.|. ..........+..+.+++.+||..||.+|+++.|++++
T Consensus 230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111 11111233445667999999999999999999999866
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=233.77 Aligned_cols=182 Identities=24% Similarity=0.291 Sum_probs=141.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 379999999999999997654 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............|++.|+|||.+.+. .++.++|+|||||++|+|++|..||.......... .+.......
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~~~~~~~---- 226 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVSRRILKC---- 226 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHHHHHhcC----
Confidence 6543333333345689999999999865 37889999999999999999999997543221111 111111110
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
+ ...+...+..+.+++.+||+.||.+|| ++++++++
T Consensus 227 --~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 --D----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --C----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0 011122344678899999999999999 77888865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=233.23 Aligned_cols=176 Identities=23% Similarity=0.321 Sum_probs=139.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 71 ~~lv~e~~~gg~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~ 144 (316)
T cd05592 71 LFFVMEYLNGGDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK 144 (316)
T ss_pred EEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCe
Confidence 479999999999999987654 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||......+. ...+....
T Consensus 145 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~-------~~~i~~~~---- 212 (316)
T cd05592 145 ENMNGE-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-------FDSILNDR---- 212 (316)
T ss_pred ECCCCC-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCC----
Confidence 543222 222345689999999999988899999999999999999999999987554321 11111110
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMK-EVAF 201 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~-~l~~ 201 (253)
...+...+..+.+++.+||+.||.+||++. ++++
T Consensus 213 ------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 213 ------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred ------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 011222344677899999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=229.51 Aligned_cols=182 Identities=24% Similarity=0.299 Sum_probs=142.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 75 ~~lv~e~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~ 150 (285)
T cd05631 75 LCLVLTIMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAV 150 (285)
T ss_pred EEEEEEecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcE
Confidence 4799999999999988865332 25899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||......... ..........
T Consensus 151 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~----- 220 (285)
T cd05631 151 QIPEG--ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKED----- 220 (285)
T ss_pred EcCCC--CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhcc-----
Confidence 64321 1223356899999999999888999999999999999999999999875432211 0111111100
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT-----MKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~~ 202 (253)
....+...+..+.+++.+||+.||.+||+ +++++++
T Consensus 221 -----~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 221 -----QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -----cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 01122234456888999999999999997 7888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=224.63 Aligned_cols=183 Identities=27% Similarity=0.385 Sum_probs=144.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+++++|.+++.... .+++..+..++.|++.||.|||..+ ++|+||||.||+++.++.++|+|||+++
T Consensus 70 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~ 143 (257)
T cd05116 70 WMLVMELAELGPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSK 143 (257)
T ss_pred cEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCcccc
Confidence 479999999999999997643 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCccee--eeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHLT--TRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
.......... ....++..|+|||.+....++.++|+|||||++|+|++ |..||......+. .........
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------~~~i~~~~~ 216 (257)
T cd05116 144 ALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV-------TQMIESGER 216 (257)
T ss_pred ccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHCCCC
Confidence 6543322111 11223578999999987788999999999999999998 9999976544321 111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
. ..+...+..+.+++.+||+.||.+||++.+|.+.|++.
T Consensus 217 ~---------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 M---------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred C---------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1 11223445688899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=233.78 Aligned_cols=177 Identities=22% Similarity=0.308 Sum_probs=140.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++
T Consensus 71 ~~iv~Ey~~~g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~ 144 (320)
T cd05590 71 LFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 144 (320)
T ss_pred EEEEEcCCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCe
Confidence 489999999999999987654 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||......+. ...+.....
T Consensus 145 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-------~~~i~~~~~--- 213 (320)
T cd05590 145 EGIFNG-KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL-------FEAILNDEV--- 213 (320)
T ss_pred ecCcCC-CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-------HHHHhcCCC---
Confidence 532221 122335689999999999988899999999999999999999999987654321 111111110
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTM------KEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~------~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+||++ ++++++
T Consensus 214 -------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 214 -------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred -------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 0111234467889999999999999998 555543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=244.69 Aligned_cols=187 Identities=22% Similarity=0.298 Sum_probs=151.9
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
+|.||||.||.|.+++....+. +|++..+++|+.|+++|+.+||... ++|+|||||.+|||++.++..||||||.+..
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 6899999999999999976554 4999999999999999999999987 5699999999999999999999999998764
Q ss_pred ccCCCccee--------eeccccccccccchhc---cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHH
Q 044510 83 VTIDQTHLT--------TRVQGTFGYLDLEYFR---SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLR 151 (253)
Q Consensus 83 ~~~~~~~~~--------~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~ 151 (253)
......... -...-|+-|++||.+. +.+.++++|||+|||+||.|+....||+......
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la---------- 265 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA---------- 265 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----------
Confidence 432221110 0123588999999874 5678999999999999999999999998764321
Q ss_pred HHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 152 AMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
+++.+..-......+..+.+||..||+.||.+||++-+++..+.++...-
T Consensus 266 ---------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 266 ---------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 22233322333566778999999999999999999999999999888764
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=229.65 Aligned_cols=194 Identities=22% Similarity=0.274 Sum_probs=142.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+. ++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++
T Consensus 84 ~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 84 LTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred EEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 479999995 589999876432 24899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc--
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF-- 159 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 159 (253)
..... .......+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+....+..................
T Consensus 159 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 159 IYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred eccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 65422 22233457899999999988889999999999999999999999998765433211110000000000000
Q ss_pred -----chh---chhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 -----DML---DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 -----~~~---~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... ............+..+.+++.+||+.||.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 0000011111234567899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=219.83 Aligned_cols=181 Identities=31% Similarity=0.473 Sum_probs=145.7
Q ss_pred CCEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 1 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
+.|+|+|.|+.|.|.|++...- +++++...+|++|+..|+.|||..+ |||||+||+|||++++.+++|+|||++
T Consensus 97 F~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 3578999999999999998654 6999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCcceeeeccccccccccchhcc------CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHh
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRS------SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK 154 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 154 (253)
+... ........+|||+|+|||++.. ..|+..+|.|+.|+++|.++.|.+||.-....- +.+.+-
T Consensus 171 ~~l~--~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml-------MLR~Im 241 (411)
T KOG0599|consen 171 CQLE--PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML-------MLRMIM 241 (411)
T ss_pred eccC--CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH-------HHHHHH
Confidence 8654 3444556789999999999853 247889999999999999999999985432211 112222
Q ss_pred hccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 155 ENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
++.. ..-.+ --.+.+.+..++|.+||+.||.+|.|++|++++
T Consensus 242 eGky-qF~sp-----eWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 242 EGKY-QFRSP-----EWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred hccc-ccCCc-----chhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 2211 11111 123445578889999999999999999999976
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=233.87 Aligned_cols=177 Identities=24% Similarity=0.332 Sum_probs=141.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 70 ~~lv~Ey~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~ 143 (328)
T cd05593 70 LCFVMEYVNGGELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCK 143 (328)
T ss_pred EEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCc
Confidence 489999999999999887654 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... ........|++.|+|||.+.+..++.++|+|||||++|+|++|..||......+. .........
T Consensus 144 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-------~~~~~~~~~--- 212 (328)
T cd05593 144 EGITD-AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMEDI--- 212 (328)
T ss_pred cCCCc-ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH-------HHHhccCCc---
Confidence 53221 1122335689999999999988899999999999999999999999976543321 111111100
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+|+ ++.+++++
T Consensus 213 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 213 -------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 11222345678899999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=232.25 Aligned_cols=177 Identities=25% Similarity=0.322 Sum_probs=140.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++
T Consensus 68 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~ 141 (312)
T cd05585 68 LYLVLAFINGGELFHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCK 141 (312)
T ss_pred EEEEEcCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccc
Confidence 489999999999999997654 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......|++.|+|||++.+..++.++|+||+||++|+|++|..||......+. ...... ...
T Consensus 142 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~------~~~~~~-~~~--- 210 (312)
T cd05585 142 LNMKDD-DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM------YRKILQ-EPL--- 210 (312)
T ss_pred cCccCC-CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH------HHHHHc-CCC---
Confidence 532211 122335689999999999988899999999999999999999999976543221 111111 100
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT---MKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps---~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+||+ +.+++.+
T Consensus 211 -------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 211 -------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred -------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 112233456888999999999999975 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=234.18 Aligned_cols=182 Identities=20% Similarity=0.288 Sum_probs=143.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++|++|.+++.... .+++..+..++.|++.||.|||..+ ++||||||+||+++.++.+||+|||++.
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~ 149 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK 149 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCc
Confidence 489999999999999997654 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
.... ......|++.|+|||++.+..++.++|+|||||++|+|++|..||......+..... ........
T Consensus 150 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i------~~~~~~~~- 218 (333)
T cd05600 150 GIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL------KYWKETLQ- 218 (333)
T ss_pred cccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH------Hhcccccc-
Confidence 5432 223356899999999999888999999999999999999999999876543321111 10000000
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...........+..+.+++.+||..+|.+||++++++++
T Consensus 219 --~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 --RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred --CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000012234568889999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=227.69 Aligned_cols=189 Identities=23% Similarity=0.377 Sum_probs=147.1
Q ss_pred CEEEEeecCCCChhHHhhccC----------CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT----------EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFR 71 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~ 71 (253)
+++||||+++++|.+++.... ....+++..++.++.|++.||.|||..+ ++||||||+||+++.++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 589999999999999997542 1124899999999999999999999999 999999999999999999
Q ss_pred eEEcccCCcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHH
Q 044510 72 AKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYF 149 (253)
Q Consensus 72 ~kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~ 149 (253)
++|+|||+++........ ......++..|+|||.+.+..++.++|+|||||++++|++ |..||......+.
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~------- 231 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV------- 231 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------
Confidence 999999998754322111 1122334678999999998889999999999999999998 8999876543221
Q ss_pred HHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 150 LRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
........... .+...+..+.+++.+||+.||.+||++.++.+.|+.+...
T Consensus 232 ~~~i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 232 IECITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11111111111 1112334688899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=231.96 Aligned_cols=176 Identities=24% Similarity=0.344 Sum_probs=139.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+.+|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++
T Consensus 71 ~~lv~E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~ 144 (316)
T cd05620 71 LFFVMEFLNGGDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK 144 (316)
T ss_pred EEEEECCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCe
Confidence 489999999999999987653 5899999999999999999999999 9999999999999999999999999886
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... ........|++.|+|||++.+..++.++|+||+||++|+|++|..||......+. ........
T Consensus 145 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~-------~~~~~~~~---- 212 (316)
T cd05620 145 ENVFG-DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-------FESIRVDT---- 212 (316)
T ss_pred ecccC-CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCC----
Confidence 43211 1223345689999999999988899999999999999999999999976543321 11111110
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMK-EVAF 201 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~-~l~~ 201 (253)
...+...+..+.+++.+||+.||.+||++. ++.+
T Consensus 213 ------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 213 ------PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred ------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 011112334678899999999999999974 5653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=243.89 Aligned_cols=182 Identities=26% Similarity=0.326 Sum_probs=142.8
Q ss_pred CEEEEeecCCCChhHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQ-TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.|+||||++||+|.+++... ....++++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla 216 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFS 216 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCc
Confidence 48999999999999988653 22335889999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCc-ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 81 RYVTIDQT-HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 81 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
+....... .......||+.|+|||++.+..++.++|+|||||++|+|++|..||......+. +....... ..
T Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~------~~~~~~~~-~~ 289 (478)
T PTZ00267 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI------MQQVLYGK-YD 289 (478)
T ss_pred eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC-CC
Confidence 86543221 122345689999999999988899999999999999999999999976543221 11111111 10
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+||++.+++.+
T Consensus 290 ---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 290 ---------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ---------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1112234568889999999999999999998753
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=229.12 Aligned_cols=174 Identities=27% Similarity=0.398 Sum_probs=140.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~ 149 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK 149 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcch
Confidence 489999999999999997654 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... .....|++.|+|||++.+..++.++|+|||||++|+|++|..||......+. ........ .
T Consensus 150 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~------~~~i~~~~-~--- 215 (291)
T cd05612 150 KLRDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI------YEKILAGK-L--- 215 (291)
T ss_pred hccCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC-c---
Confidence 55321 1234689999999999988899999999999999999999999977543321 11111111 0
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT-----MKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+||+ +++++++
T Consensus 216 -------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 -------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 112223446888999999999999995 8888865
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=227.36 Aligned_cols=187 Identities=25% Similarity=0.379 Sum_probs=144.9
Q ss_pred CEEEEeecCCCChhHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-------------EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
+++||||+++|+|.+++.... ....+++..+++++.|++.||.|||..+ ++|+||||+||+++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence 589999999999999996531 2235899999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCcce-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhH
Q 044510 69 KFRAKISDFGASRYVTIDQTHL-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLA 146 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~ 146 (253)
++.++|+|||+++......... .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||......+.
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---- 243 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL---- 243 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH----
Confidence 9999999999987654322111 111224567999999988889999999999999999997 9999876543321
Q ss_pred HHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhch
Q 044510 147 GYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207 (253)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 207 (253)
......... ...+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 244 ---~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 ---FKLLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ---HHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111111111 0112223446888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=223.64 Aligned_cols=184 Identities=22% Similarity=0.398 Sum_probs=144.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~ 152 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLAR 152 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchh
Confidence 4799999999999999987532 35899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
....... ......++..|++||...+..++.++|+||||+++++|++ |..||......+.. .. .....
T Consensus 153 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~------~~-~~~~~--- 221 (261)
T cd05148 153 LIKEDVY-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY------DQ-ITAGY--- 221 (261)
T ss_pred hcCCccc-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH------HH-HHhCC---
Confidence 5532211 1112234668999999988889999999999999999998 89999765432211 11 11110
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
....+...+..+.+++.+||+.||.+||+++++++.|+.+
T Consensus 222 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 ------RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0111223345688899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=223.22 Aligned_cols=185 Identities=21% Similarity=0.374 Sum_probs=143.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+++++|.+++.... ...+++..+..++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 151 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLAR 151 (261)
T ss_pred eeeeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEE
Confidence 589999999999999997654 225899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
...............+..|+|||...+..++.++|+||||+++++|++ |..||........ ..........
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~- 223 (261)
T cd05068 152 VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV-------LQQVDQGYRM- 223 (261)
T ss_pred EccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCCC-
Confidence 654221111111122357999999988889999999999999999999 9999976543221 1111111000
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
..+...+..+.+++.+||+.+|.+||+++++++.|+.+
T Consensus 224 --------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 --------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 01122345688899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=234.23 Aligned_cols=177 Identities=23% Similarity=0.324 Sum_probs=140.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhh-CCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS-TTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+ .+ ++||||||+||+++.++.+||+|||++
T Consensus 70 ~~lv~E~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~ 143 (325)
T cd05594 70 LCFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLC 143 (325)
T ss_pred EEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCC
Confidence 489999999999999887654 58999999999999999999997 78 999999999999999999999999998
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
+...... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||........ .........
T Consensus 144 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~-------~~~i~~~~~-- 213 (325)
T cd05594 144 KEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMEEI-- 213 (325)
T ss_pred eecCCCC-cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH-------HHHHhcCCC--
Confidence 6432211 122334689999999999988899999999999999999999999976544321 111111100
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+|+ ++.+++++
T Consensus 214 --------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 --------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred --------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 01122344678899999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=232.82 Aligned_cols=177 Identities=25% Similarity=0.324 Sum_probs=141.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|..++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 70 ~~lv~E~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~ 143 (323)
T cd05595 70 LCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 143 (323)
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhc
Confidence 489999999999999887654 5899999999999999999999999 9999999999999999999999999876
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||........ .........
T Consensus 144 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-------~~~~~~~~~--- 212 (323)
T cd05595 144 EGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-------FELILMEEI--- 212 (323)
T ss_pred cccCCC-CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHhcCCC---
Confidence 432211 122234689999999999988899999999999999999999999976544321 111111100
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+|+ ++.+++++
T Consensus 213 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 213 -------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred -------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 01222345678899999999999998 88888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=244.43 Aligned_cols=182 Identities=25% Similarity=0.341 Sum_probs=143.9
Q ss_pred CEEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 114 i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred EEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccC
Confidence 369999999999999987532 2235899999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCCc-ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 81 RYVTIDQT-HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 81 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
+....... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||......+. +....... .
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~------~~~~~~~~-~- 262 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV------MHKTLAGR-Y- 262 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHhcCC-C-
Confidence 76542211 122345689999999999988899999999999999999999999976543221 11111111 1
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...+...+..+.+++.+||+.||.+||++.+++++
T Consensus 263 --------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 --------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 01122334568889999999999999999999875
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=231.17 Aligned_cols=184 Identities=23% Similarity=0.378 Sum_probs=141.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++
T Consensus 71 ~~lv~e~~~~g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~ 144 (329)
T cd05588 71 LFFVIEFVSGGDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144 (329)
T ss_pred EEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccc
Confidence 489999999999999887654 5999999999999999999999999 9999999999999999999999999886
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhh--hhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE--DKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 159 (253)
..... ........|++.|+|||++.+..++.++|+|||||++|+|++|..||......+ .................
T Consensus 145 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 222 (329)
T cd05588 145 EGIRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI- 222 (329)
T ss_pred ccccC-CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-
Confidence 42211 112233568999999999998889999999999999999999999996433221 11111111222211111
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT------MKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps------~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+|++ +.+++++
T Consensus 223 ---------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 223 ---------RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred ---------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 111223446788999999999999997 6777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=250.80 Aligned_cols=195 Identities=22% Similarity=0.351 Sum_probs=157.3
Q ss_pred CEEEEeecCCCChhHHhhccC----CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEccc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT----EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDF 77 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Df 77 (253)
++|++|||+||+|..+|+... +...++....+.++.||++|+.||++++ +|||||...|+|++....+||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEccc
Confidence 689999999999999998751 1335899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCcceeeec-cccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhh
Q 044510 78 GASRYVTIDQTHLTTRV-QGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKE 155 (253)
Q Consensus 78 gl~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 155 (253)
|+++.+.....+..... .-...|||||.+..+.++.++|||||||++||++| |..||...+..+... ....+
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~g 920 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLEG 920 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHhC
Confidence 99996544333322222 23468999999999999999999999999999999 999998876644211 11222
Q ss_pred ccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCCCC
Q 044510 156 NCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNC 215 (253)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~ 215 (253)
+ +-..+..++..+.+++..||+.+|++||++..|++.+..+.........
T Consensus 921 g----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~ 970 (1025)
T KOG1095|consen 921 G----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIY 970 (1025)
T ss_pred C----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcc
Confidence 2 2233455566788999999999999999999999999888876544433
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=231.08 Aligned_cols=184 Identities=23% Similarity=0.341 Sum_probs=141.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|..++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 71 ~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~ 144 (327)
T cd05617 71 LFLVIEYVNGGDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK 144 (327)
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccce
Confidence 479999999999999887654 4999999999999999999999999 9999999999999999999999999886
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... ........|++.|+|||++.+..++.++|+|||||++|+|++|..||........................
T Consensus 145 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 220 (327)
T cd05617 145 EGLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI--- 220 (327)
T ss_pred eccCC-CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC---
Confidence 43211 12223456899999999999888999999999999999999999999654332222222222222222111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTM------KEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~------~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+|+++ .+++++
T Consensus 221 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 221 -------RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred -------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 1112233457889999999999999984 566655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=222.47 Aligned_cols=184 Identities=24% Similarity=0.389 Sum_probs=143.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+++++|.+++..... .+++..+++++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++.
T Consensus 69 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~ 143 (257)
T cd05115 69 LMLVMEMASGGPLNKFLSGKKD--EITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSK 143 (257)
T ss_pred eEEEEEeCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccc
Confidence 4799999999999999875432 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCccee--eeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHLT--TRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
.......... ....++..|+|||.+....++.++|+||||+++|++++ |..||......+. .........
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~ 216 (257)
T cd05115 144 ALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV-------MSFIEQGKR 216 (257)
T ss_pred cccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH-------HHHHHCCCC
Confidence 5432221111 11223568999999988888999999999999999996 9999976544321 111111110
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
...+...+..+.+++.+||+.||.+||++.++.+.|+..
T Consensus 217 ---------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 ---------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 011122345788899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=222.84 Aligned_cols=182 Identities=25% Similarity=0.401 Sum_probs=141.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+.+++|.+++..... .+++..++.++.|++.||.|||..+ ++|+||||.||+++.++.+||+|||.++
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~ 148 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSR 148 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccce
Confidence 4899999999999999976433 5899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............++..|++||...+..++.++|+||||+++|+|++ |..||......+. ..... .....
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~------~~~~~-~~~~~- 220 (256)
T cd05113 149 YVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET------VEKVS-QGLRL- 220 (256)
T ss_pred ecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH------HHHHh-cCCCC-
Confidence 553322111111234567999999988889999999999999999998 9999876553221 11111 11110
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
..+...+..+.+++.+||+.||.+||++.++++.|+
T Consensus 221 --------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 --------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011112456888999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=231.27 Aligned_cols=177 Identities=24% Similarity=0.330 Sum_probs=141.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|..++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 71 ~~lv~E~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~ 144 (321)
T cd05591 71 LFFVMEYVNGGDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK 144 (321)
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccce
Confidence 489999999999999987654 4899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||......+. +.........
T Consensus 145 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~------~~~i~~~~~~--- 214 (321)
T cd05591 145 EGILNG-VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL------FESILHDDVL--- 214 (321)
T ss_pred ecccCC-ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH------HHHHHcCCCC---
Confidence 532221 122334589999999999988899999999999999999999999987654321 1111111100
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-------TMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-------s~~~l~~~ 202 (253)
.+...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 215 --------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 --------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1111234678899999999999999 78888866
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=231.94 Aligned_cols=177 Identities=25% Similarity=0.336 Sum_probs=139.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.... .+++..+..++.|++.||.|||..+ ++||||||+||+++.++.++|+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK 149 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcce
Confidence 489999999999999997654 4899999999999999999999999 9999999999999999999999999886
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......|++.|+|||++.+..++.++|+||+||++|+|++|..||......+.. ........
T Consensus 150 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~-------~~i~~~~~--- 218 (324)
T cd05587 150 ENIFGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF-------QSIMEHNV--- 218 (324)
T ss_pred ecCCCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCCC---
Confidence 432111 2223456899999999999888999999999999999999999999765543211 11111100
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTM-----KEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~-----~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+|++. .++.++
T Consensus 219 -------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 219 -------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred -------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1112234467889999999999999976 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=224.30 Aligned_cols=187 Identities=22% Similarity=0.392 Sum_probs=145.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++++||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccce
Confidence 4689999999999999976432 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcce-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTHL-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
......... .....++..|++||.+.+..++.++|+||||+++|++++ |..||.+...... ......+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~ 230 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-------PDLLEKGERL 230 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCcC
Confidence 653322111 122345678999999988889999999999999999998 9999976544321 1111111110
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
. . +......+.+++.+||..||.+||++.++++.|..+...
T Consensus 231 ~--~-------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 231 A--Q-------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred C--C-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 0 0 111223567799999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=222.18 Aligned_cols=184 Identities=24% Similarity=0.414 Sum_probs=143.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.+++|||+++++|.+++.... ...+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~ 150 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLAR 150 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeee
Confidence 489999999999999997643 224899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............++..|+|||...+..++.++|+||||+++|+|++ |..||......+. ...+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~-- 221 (260)
T cd05070 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV-------LEQVERGYR-- 221 (260)
T ss_pred eccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCC--
Confidence 653322111112234567999999988888999999999999999999 8899976443221 111111100
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
...+...+..+.+++.+||+.+|.+|||+.++.+.|+.
T Consensus 222 -------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 -------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01122334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=221.87 Aligned_cols=184 Identities=23% Similarity=0.390 Sum_probs=143.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+.+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccce
Confidence 589999999999999997643 224889999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............++..|++||...+..++.++|+||||+++|+|++ |..||......+. ..........
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~- 222 (260)
T cd05069 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV-------LEQVERGYRM- 222 (260)
T ss_pred EccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCCC-
Confidence 553322211122234668999999988889999999999999999999 8999976543221 1111111000
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
..+...+..+.+++.+||+.||.+||+++++++.|++
T Consensus 223 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 --------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1122334568889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=232.01 Aligned_cols=174 Identities=25% Similarity=0.310 Sum_probs=140.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+.+++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 166 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK 166 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCce
Confidence 489999999999999998654 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... .....|++.|+|||++.+..++.++|+|||||++|+|++|..||......+. .........
T Consensus 167 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------~~~i~~~~~--- 232 (329)
T PTZ00263 167 KVPDR----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI-------YEKILAGRL--- 232 (329)
T ss_pred EcCCC----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH-------HHHHhcCCc---
Confidence 65322 1234689999999999988899999999999999999999999976543221 111111111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT-----MKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+||+ +++++++
T Consensus 233 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 -------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011112346788999999999999986 6888866
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=232.89 Aligned_cols=194 Identities=24% Similarity=0.338 Sum_probs=139.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+ +++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 79 ~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 79 IYVVFELM-ESDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEEEecC-CCCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccc
Confidence 48999999 568999987654 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcc--eeeeccccccccccchhcc--CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH--------
Q 044510 82 YVTIDQTH--LTTRVQGTFGYLDLEYFRS--SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF-------- 149 (253)
Q Consensus 82 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~-------- 149 (253)
........ ......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...............
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 54322111 1123568999999999875 56889999999999999999999999775543221111000
Q ss_pred HHHHhhccccch---hc---hhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 150 LRAMKENCLFDM---LD---AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 150 ~~~~~~~~~~~~---~~---~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
............ .. +..........+..+.+++.+||+.||.+||++++++++
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000 00 000000001123467889999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=231.41 Aligned_cols=177 Identities=25% Similarity=0.334 Sum_probs=140.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~ 149 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCce
Confidence 479999999999999987654 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||......... .... ....
T Consensus 150 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~------~~i~-~~~~--- 218 (323)
T cd05616 150 ENMWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF------QSIM-EHNV--- 218 (323)
T ss_pred ecCCCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH------HHHH-hCCC---
Confidence 432211 1223456899999999999888999999999999999999999999876543211 1111 1110
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTM-----KEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~-----~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+|++. .++.++
T Consensus 219 -------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 219 -------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred -------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 1122234567889999999999999974 666543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=222.10 Aligned_cols=184 Identities=26% Similarity=0.390 Sum_probs=144.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+.+++|.+++.... .+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||+++
T Consensus 70 ~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~ 143 (257)
T cd05060 70 LMLVMELAPLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSR 143 (257)
T ss_pred eEEEEEeCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccc
Confidence 479999999999999998754 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceee--eccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHLTT--RVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
........... ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+. .........
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~-------~~~~~~~~~ 216 (257)
T cd05060 144 ALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV-------IAMLESGER 216 (257)
T ss_pred eeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH-------HHHHHcCCc
Confidence 65432221111 1123457999999988889999999999999999998 9999976543221 111111110
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhch
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 207 (253)
. ..+...+..+.+++.+||+.+|.+||++.++++.|+++.
T Consensus 217 ~---------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 L---------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred C---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0 112223456888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=224.76 Aligned_cols=184 Identities=26% Similarity=0.425 Sum_probs=143.7
Q ss_pred CEEEEeecCCCChhHHhhccCC-----------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-----------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF 70 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~ 70 (253)
+++||||+++++|.+++...+. ...+++..+..++.|++.||.|||..+ ++|+||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCC
Confidence 5899999999999999976421 234788999999999999999999999 99999999999999999
Q ss_pred ceEEcccCCcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHH
Q 044510 71 RAKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGY 148 (253)
Q Consensus 71 ~~kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~ 148 (253)
.++|+|||+++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+.
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~------ 233 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV------ 233 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH------
Confidence 9999999998754322211 1122335678999999998889999999999999999998 9999876544321
Q ss_pred HHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 149 FLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
......+... ..+...+..+.+++.+||+.||.+||++.|+++.|+
T Consensus 234 -~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 234 -IECITQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -HHHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111111111 111223456888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=222.30 Aligned_cols=182 Identities=26% Similarity=0.412 Sum_probs=140.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++|+|.+++..... .+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++++|||.++
T Consensus 74 ~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~ 148 (256)
T cd05114 74 LYIVTEFMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTR 148 (256)
T ss_pred EEEEEEcCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCcc
Confidence 4899999999999999875432 4889999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+. ..........
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~------~~~i~~~~~~-- 220 (256)
T cd05114 149 YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV------VEMISRGFRL-- 220 (256)
T ss_pred ccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHCCCCC--
Confidence 543222111112234567999999988889999999999999999999 8999976543221 1111111110
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
. .+...+..+.+++.+||+.+|.+||+++++++.|.
T Consensus 221 -~-------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 -Y-------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -C-------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 11112346788999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=234.17 Aligned_cols=163 Identities=24% Similarity=0.377 Sum_probs=124.3
Q ss_pred CCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcccccCCCcce-eeeccccccccccc
Q 044510 26 TITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHL-TTRVQGTFGYLDLE 104 (253)
Q Consensus 26 ~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~~~~~y~aPE 104 (253)
.+++..+++++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||+++......... .....++..|+|||
T Consensus 210 ~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 286 (375)
T cd05104 210 ALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPE 286 (375)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChh
Confidence 4788889999999999999999999 9999999999999999999999999987654322111 11123456799999
Q ss_pred hhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHH
Q 044510 105 YFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAK 183 (253)
Q Consensus 105 ~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 183 (253)
.+.+..++.++|+|||||++|+|++ |..||........ ........... ..+...+..+.+++.
T Consensus 287 ~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~l~~li~ 351 (375)
T cd05104 287 SIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK------FYKMIKEGYRM---------LSPECAPSEMYDIMK 351 (375)
T ss_pred HhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH------HHHHHHhCccC---------CCCCCCCHHHHHHHH
Confidence 9998889999999999999999998 8889876443211 11111111100 011112346888999
Q ss_pred HhcccCCCCCCCHHHHHHHHhhc
Q 044510 184 RCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 184 ~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
+||+.||.+||++++++++|++.
T Consensus 352 ~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 352 SCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHccCChhHCcCHHHHHHHHHhh
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=230.92 Aligned_cols=190 Identities=24% Similarity=0.416 Sum_probs=142.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhC-CCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHST-TSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||.. + ++|+||||+||+++.++.++|+|||++
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 151 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVS 151 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCccc
Confidence 489999999999999997654 489999999999999999999975 6 999999999999999999999999998
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc----
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN---- 156 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~---- 156 (253)
...... ......+++.|+|||++.+..++.++|+|||||++|+|++|..||......+..... .......
T Consensus 152 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~~~ 225 (331)
T cd06649 152 GQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF---GRPVVDGEEGE 225 (331)
T ss_pred cccccc---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh---cccccccccCC
Confidence 754321 223346889999999999888999999999999999999999999765543211100 0000000
Q ss_pred c--------------------------ccchhc---hhhhhh-hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044510 157 C--------------------------LFDMLD---AQVLKE-AKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203 (253)
Q Consensus 157 ~--------------------------~~~~~~---~~~~~~-~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 203 (253)
. .....+ ...... .....+..+.+++.+||+.||++|||+++++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 226 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0 000000 000000 0112456789999999999999999999999774
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=226.24 Aligned_cols=198 Identities=25% Similarity=0.385 Sum_probs=144.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence 47999999999999999764 3899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcce--eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTHL--TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
......... .....++..|++||...+..++.++|+||||+++++|++|..||.......... ..............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~ 234 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM-IGPKQGQMTVVRLI 234 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhh-hcccccccchhhhh
Confidence 654222111 111234567999999988888999999999999999999999986543211000 00000000000000
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhch
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 207 (253)
...+.......+...+..+.+++.+||+.||.+||+++++++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 011111111112234457899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=221.30 Aligned_cols=185 Identities=22% Similarity=0.360 Sum_probs=144.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.++
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~ 150 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR 150 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCcee
Confidence 479999999999999997643 224889999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............++..|++||...+..++.++|+||||+++|+|++ |..||......+. .........
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-------~~~~~~~~~-- 221 (262)
T cd05071 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------LDQVERGYR-- 221 (262)
T ss_pred eccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-------HHHHhcCCC--
Confidence 654322222222335668999999988889999999999999999999 8888876543221 111111100
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
...+...+..+.+++.+||+.||.+||+++++++.|+..
T Consensus 222 -------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 -------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 011223445688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=222.18 Aligned_cols=184 Identities=21% Similarity=0.413 Sum_probs=144.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhh
Confidence 4899999999999999976433 5899999999999999999999999 9999999999999999999999999988
Q ss_pred cccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
........ ......++..|++||.+.+..++.++|+||||+++|+|++ |..||......+. ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~~ 227 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV-------IKAVEDGYRL 227 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH-------HHHHHcCCCC
Confidence 66421111 1112234568999999998889999999999999999998 9999865443221 1111111000
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
..+...+..+.+++.+||+.+|.+||++.+++++|+++
T Consensus 228 ---------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ---------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01122345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=228.96 Aligned_cols=176 Identities=25% Similarity=0.329 Sum_probs=139.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 71 ~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 144 (316)
T cd05619 71 LFFVMEYLNGGDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK 144 (316)
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcce
Confidence 479999999999999997643 4889999999999999999999999 9999999999999999999999999986
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... ........|++.|+|||++.+..++.++|+||+||++|+|++|..||......+. .........
T Consensus 145 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-------~~~i~~~~~--- 213 (316)
T cd05619 145 ENMLG-DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL-------FQSIRMDNP--- 213 (316)
T ss_pred ECCCC-CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCC---
Confidence 43211 1122345689999999999988899999999999999999999999977554321 111111100
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMK-EVAF 201 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~-~l~~ 201 (253)
..+...+..+.+++.+||+.||.+||++. ++.+
T Consensus 214 -------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 214 -------CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 01112334678899999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=228.22 Aligned_cols=192 Identities=24% Similarity=0.384 Sum_probs=147.3
Q ss_pred CEEEEeecCCCChhHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-------------EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
.+++|||+.+|+|.+++.... ....+++..++.++.|++.||.|||..+ ++|+||||+||+++.
T Consensus 93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~ 169 (334)
T cd05100 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTE 169 (334)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcC
Confidence 479999999999999997632 1224788899999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCcce-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhH
Q 044510 69 KFRAKISDFGASRYVTIDQTHL-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLA 146 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~ 146 (253)
++.++|+|||+++......... .....++..|+|||++.+..++.++|+||||+++|+|++ |..||......+.
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---- 245 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL---- 245 (334)
T ss_pred CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH----
Confidence 9999999999987553221111 111223467999999988889999999999999999998 8888876543321
Q ss_pred HHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCC
Q 044510 147 GYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGP 212 (253)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 212 (253)
.......... ..+...+..+.+++.+||+.+|.+||++.++++.|+++......
T Consensus 246 ---~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 246 ---FKLLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred ---HHHHHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 1111111111 11122334688899999999999999999999999998865443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=231.97 Aligned_cols=174 Identities=22% Similarity=0.309 Sum_probs=141.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+.+|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~ 179 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAK 179 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCe
Confidence 489999999999999998754 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... .....|++.|+|||++.+..++.++|+|||||++|+|++|..||........ ........ .
T Consensus 180 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~------~~~i~~~~-~--- 245 (340)
T PTZ00426 180 VVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI------YQKILEGI-I--- 245 (340)
T ss_pred ecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH------HHHHhcCC-C---
Confidence 64321 2235689999999999988899999999999999999999999986544321 11111111 0
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+|+ ++++++++
T Consensus 246 -------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01122334578899999999999995 89988876
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=224.57 Aligned_cols=185 Identities=23% Similarity=0.398 Sum_probs=141.6
Q ss_pred CEEEEeecCCCChhHHhhccCC-------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKI 74 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl 74 (253)
+++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 5899999999999999875321 123678889999999999999999999 999999999999999999999
Q ss_pred cccCCcccccCCCcce-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHH
Q 044510 75 SDFGASRYVTIDQTHL-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRA 152 (253)
Q Consensus 75 ~Dfgl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~ 152 (253)
+|||+++......... .....+++.|+|||++.+..++.++|+|||||++|+|++ |..||......+.. ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~-------~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL-------RF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HH
Confidence 9999987543221111 112234678999999998889999999999999999999 78898765433211 11
Q ss_pred HhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 153 MKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
....... ..+...+..+.+++.+||+.||.+||++.+++++|++
T Consensus 234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111111 1112234468889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=222.04 Aligned_cols=181 Identities=27% Similarity=0.427 Sum_probs=141.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~ 148 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLAR 148 (256)
T ss_pred eEEEEecCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccce
Confidence 4799999999999999976433 5899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+. .........
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~-- 219 (256)
T cd05059 149 YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV-------VESVSAGYR-- 219 (256)
T ss_pred ecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH-------HHHHHcCCc--
Confidence 553221111111223457999999998889999999999999999998 8999976543321 111111100
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 203 (253)
...+...+..+.+++.+||+.+|.+||++.++++.|
T Consensus 220 -------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 -------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 011122345788899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=225.67 Aligned_cols=188 Identities=23% Similarity=0.384 Sum_probs=144.9
Q ss_pred CEEEEeecCCCChhHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-------------EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
+|+||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~ 154 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGE 154 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECC
Confidence 589999999999999996532 1124889999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHH
Q 044510 69 KFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAG 147 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~ 147 (253)
++.+||+|||++...... ........+..|++||...+..++.++|+|||||++|+|++ |..||......+.
T Consensus 155 ~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~----- 227 (297)
T cd05089 155 NLASKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL----- 227 (297)
T ss_pred CCeEEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-----
Confidence 999999999987532111 01111122457999999988889999999999999999997 9999976554321
Q ss_pred HHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 148 YFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
........ ....+...+..+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus 228 --~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 228 --YEKLPQGY---------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred --HHHHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111110 01112223456888999999999999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=209.08 Aligned_cols=191 Identities=24% Similarity=0.323 Sum_probs=145.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCC-CCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEF-TITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.||+++|...|+|.+.+.....++ .+++.++++|+.++..||.+||.... ++.||||||.||++++++.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCc
Confidence 489999999999999998854443 59999999999999999999999873 5999999999999999999999999987
Q ss_pred ccccCCCcce--------eeeccccccccccchhccC---CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH
Q 044510 81 RYVTIDQTHL--------TTRVQGTFGYLDLEYFRSS---QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF 149 (253)
Q Consensus 81 ~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 149 (253)
.......... -.....|..|+|||.+.-. ..++++|||||||++|.|+.|..||+..-.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------- 246 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------- 246 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh----------
Confidence 6443211110 0112357899999999743 358999999999999999999999954221
Q ss_pred HHHHhhcccc-chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhch
Q 044510 150 LRAMKENCLF-DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207 (253)
Q Consensus 150 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 207 (253)
.++.+. ....+..........+..+.++|..||+.||++||++.+++..++.+.
T Consensus 247 ----~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 ----QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ----cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111111 111111111222236678999999999999999999999999988764
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=229.31 Aligned_cols=184 Identities=23% Similarity=0.371 Sum_probs=140.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|..++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++
T Consensus 71 ~~lv~E~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~ 144 (329)
T cd05618 71 LFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144 (329)
T ss_pred EEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccc
Confidence 489999999999999887654 5999999999999999999999999 9999999999999999999999999986
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhh--hhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED--KSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 159 (253)
...... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||........ ................
T Consensus 145 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~- 222 (329)
T cd05618 145 EGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI- 222 (329)
T ss_pred cccCCC-CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-
Confidence 432111 122335689999999999988899999999999999999999999964322111 1111111222111111
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT------MKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps------~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+||+ +.+++++
T Consensus 223 ---------~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 ---------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ---------CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 112233446788999999999999998 4666654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=236.97 Aligned_cols=170 Identities=27% Similarity=0.348 Sum_probs=139.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+.||++..+.+.. .+++..+.-++.+|+.||.|||++| |+|||||.+|||++..|.+||+|||+++
T Consensus 444 l~fvmey~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 48999999999954443322 4999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
.--. ....+.+..|||.|||||++.+..|+.++|.|+|||++|||+.|+.||.+.++++.-. .+....
T Consensus 517 e~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd------sI~~d~----- 584 (694)
T KOG0694|consen 517 EGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD------SIVNDE----- 584 (694)
T ss_pred ccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH------HHhcCC-----
Confidence 6432 2335667889999999999999999999999999999999999999999888765211 111111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTM 196 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~ 196 (253)
..+|...+.+..++++++|..+|++|.-+
T Consensus 585 ------~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 ------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11234455678889999999999999654
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=223.21 Aligned_cols=187 Identities=26% Similarity=0.451 Sum_probs=145.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++++||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCcee
Confidence 4689999999999999976432 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcce-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTHL-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
......... .....+++.|++||...+..++.++|+|||||++|+|++ |..||........ ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~ 230 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI-------PDLLEKGERL 230 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCcC
Confidence 654322211 111234568999999988889999999999999999998 8999876543221 1111111110
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
..+...+..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 231 ---------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 231 ---------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 01112334678899999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=220.66 Aligned_cols=181 Identities=23% Similarity=0.427 Sum_probs=142.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... ..+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++.
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~ 150 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 150 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccce
Confidence 4799999999999999976432 24889999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
...... .....+..|+|||++.+..++.++|+|||||++|+|++ |..||......+. .........
T Consensus 151 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~-- 217 (256)
T cd05082 151 EASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKGYK-- 217 (256)
T ss_pred eccccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHhcCCC--
Confidence 543211 12234567999999988889999999999999999997 9999875443221 111111100
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
...+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 218 -------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 -------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 011223345688899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=222.30 Aligned_cols=185 Identities=24% Similarity=0.396 Sum_probs=141.5
Q ss_pred CEEEEeecCCCChhHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-------------EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
+|+||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.
T Consensus 71 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~ 147 (270)
T cd05047 71 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 147 (270)
T ss_pred ceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcC
Confidence 589999999999999997532 1124789999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHH
Q 044510 69 KFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAG 147 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~ 147 (253)
++.++++|||++...... ........+..|+|||++.+..++.++|+||||+++++|++ |..||......+.
T Consensus 148 ~~~~kl~dfgl~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~----- 220 (270)
T cd05047 148 NYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----- 220 (270)
T ss_pred CCeEEECCCCCccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH-----
Confidence 999999999987532211 01111123457999999988888999999999999999997 9999966443221
Q ss_pred HHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhch
Q 044510 148 YFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207 (253)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 207 (253)
.......... ..+...+..+.+++.+||+.||.+||++.++++.|+++.
T Consensus 221 --~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 221 --YEKLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --HHHHhCCCCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111111000 111123346788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=225.89 Aligned_cols=192 Identities=21% Similarity=0.339 Sum_probs=140.9
Q ss_pred CEEEEeecCCCChhHHhhccCC----------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCcee
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE----------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANIL 65 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~----------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nil 65 (253)
.++||||+++++|.+++..... ...+++..+++++.|++.||.|||+.+ ++|+||||+||+
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlkp~Nil 170 (304)
T cd05096 94 LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCL 170 (304)
T ss_pred eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcchhheE
Confidence 4899999999999999865321 123678889999999999999999999 999999999999
Q ss_pred ecCCCceEEcccCCcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh--CCCCCCCCChhhh
Q 044510 66 LDDKFRAKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT--GQKPIRSTDTEED 142 (253)
Q Consensus 66 i~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt--g~~pf~~~~~~~~ 142 (253)
++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|+||||+++|+|++ +..||......+.
T Consensus 171 l~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~ 250 (304)
T cd05096 171 VGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQV 250 (304)
T ss_pred EcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHH
Confidence 999999999999998754322211 1122335678999999988889999999999999999987 5677766543221
Q ss_pred hhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 143 KSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
.. ............ . ....+...+..+.+++.+||+.||.+|||+.+|.+.|++
T Consensus 251 ~~---~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 251 IE---NAGEFFRDQGRQ-V-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred HH---HHHHHhhhcccc-c-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 11 111111111000 0 000111233468889999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=229.56 Aligned_cols=177 Identities=24% Similarity=0.318 Sum_probs=141.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++|++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 71 ~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 144 (318)
T cd05570 71 LFFVMEYVNGGDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK 144 (318)
T ss_pred EEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCe
Confidence 489999999999999987654 4999999999999999999999999 9999999999999999999999999886
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......+++.|+|||++.+..++.++|+|||||++|+|++|..||........ .........
T Consensus 145 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~-------~~~i~~~~~--- 213 (318)
T cd05570 145 EGILGG-VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL-------FQSILEDEV--- 213 (318)
T ss_pred ecCcCC-CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH-------HHHHHcCCC---
Confidence 432211 122234588999999999988899999999999999999999999976543221 111111110
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTM-----KEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~-----~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+||++ .+++++
T Consensus 214 -------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 -------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1112234568889999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=221.45 Aligned_cols=186 Identities=20% Similarity=0.376 Sum_probs=144.2
Q ss_pred CEEEEeecCCCChhHHhhccC---CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT---EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfg 78 (253)
+++||||+++++|..++.... ....+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCcc
Confidence 689999999999999985531 1235899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCccee-eeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 79 ASRYVTIDQTHLT-TRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 79 l~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
+++.......... .....+..|++||.+.+..++.++|+|||||++|+|++ |..||......+ ...... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~------~~~~~~-~~ 231 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE------IYDYLR-HG 231 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHH-cC
Confidence 9876543222111 11224568999999988889999999999999999999 889987654322 111111 11
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
... ..+...+..+.+++.+||+.||.+||++.++++.|+++
T Consensus 232 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 11223445788899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=229.07 Aligned_cols=176 Identities=26% Similarity=0.309 Sum_probs=139.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|..++... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 77 ~~lv~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05589 77 VCFVMEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCK 149 (324)
T ss_pred EEEEEcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCc
Confidence 48999999999999888643 4899999999999999999999999 9999999999999999999999999876
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... ........|++.|+|||.+.+..++.++|+|||||++|+|++|..||......+.. ....... .
T Consensus 150 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~------~~i~~~~-~--- 218 (324)
T cd05589 150 EGMGF-GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF------DSIVNDE-V--- 218 (324)
T ss_pred cCCCC-CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhCC-C---
Confidence 43221 12223456899999999999888999999999999999999999999876543211 1111111 0
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 219 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 -------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred -------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 01122344678899999999999999 57777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=232.96 Aligned_cols=181 Identities=24% Similarity=0.327 Sum_probs=142.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++.... .+++..++.++.|++.||.|||..| ++||||||+||+++.++.++|+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~ 149 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCK 149 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCc
Confidence 489999999999999998763 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCC----------------------------cceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCC
Q 044510 82 YVTIDQ----------------------------THLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKP 133 (253)
Q Consensus 82 ~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~p 133 (253)
...... ........|++.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P 229 (350)
T cd05573 150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229 (350)
T ss_pred cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCC
Confidence 654322 0112235689999999999988899999999999999999999999
Q ss_pred CCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 044510 134 IRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT-MKEVAFE 202 (253)
Q Consensus 134 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-~~~l~~~ 202 (253)
|........ ............. + .....+..+.+++.+||. ||.+||+ +++++++
T Consensus 230 f~~~~~~~~------~~~i~~~~~~~~~--p-----~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 230 FYSDTLQET------YNKIINWKESLRF--P-----PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCHHHH------HHHHhccCCcccC--C-----CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 987653321 1111110000000 0 000134568889999998 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=229.20 Aligned_cols=177 Identities=26% Similarity=0.337 Sum_probs=141.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++...+ .+.+..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 148 (323)
T cd05584 75 LYLILEYLSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK 148 (323)
T ss_pred EEEEEeCCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCe
Confidence 489999999999999997654 4888999999999999999999999 9999999999999999999999999986
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||....... ......... .
T Consensus 149 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~~~~~~-~--- 217 (323)
T cd05584 149 ESIHEG-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDKILKGK-L--- 217 (323)
T ss_pred ecccCC-CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCC-C---
Confidence 432221 12233568999999999998888999999999999999999999997654322 111111111 0
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 218 -------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 -------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred -------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 01112334678899999999999999 78888775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=226.13 Aligned_cols=188 Identities=23% Similarity=0.376 Sum_probs=144.5
Q ss_pred CEEEEeecCCCChhHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
+|+||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecC
Confidence 6899999999999999975421 225889999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHH
Q 044510 69 KFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAG 147 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~ 147 (253)
++.++|+|||++....... .......+..|+|||.+.+..++.++|+|||||++|+|++ |..||......+.
T Consensus 160 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----- 232 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----- 232 (303)
T ss_pred CCcEEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH-----
Confidence 9999999999886321110 1111223567999999988888999999999999999998 9999976543321
Q ss_pred HHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 148 YFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
........ ....+...+..+.+++.+||+.+|.+||++.++++.|.++....
T Consensus 233 --~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 233 --YEKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred --HHHHhcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111110 00111123446788999999999999999999999998876654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=228.37 Aligned_cols=172 Identities=26% Similarity=0.358 Sum_probs=135.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|...+.... .+++..+..++.||+.||.|||..+ ++||||||+||+++.++.+||+|||+++
T Consensus 71 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~ 144 (321)
T cd05603 71 LYFVLDYVNGGELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCK 144 (321)
T ss_pred EEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCc
Confidence 489999999999998887643 4889999999999999999999999 9999999999999999999999999886
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... ........|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.... .........
T Consensus 145 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------~~~i~~~~~--- 213 (321)
T cd05603 145 EGVEP-EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM-------YDNILHKPL--- 213 (321)
T ss_pred cCCCC-CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH-------HHHHhcCCC---
Confidence 43221 1122335689999999999988899999999999999999999999977543221 111111110
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMK 197 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~ 197 (253)
..+......+.+++.+||+.||.+||+..
T Consensus 214 -------~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 -------QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -------CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11122334678899999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=228.36 Aligned_cols=165 Identities=27% Similarity=0.430 Sum_probs=128.1
Q ss_pred CCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcccccCCCcce-eeeccccccccccc
Q 044510 26 TITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHL-TTRVQGTFGYLDLE 104 (253)
Q Consensus 26 ~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~~~~~y~aPE 104 (253)
++++..+..++.|++.||.|||+.+ |+||||||.||+++.++.++|+|||++.......... .....++..|+|||
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 5789999999999999999999999 9999999999999999999999999987653222111 12233467899999
Q ss_pred hhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHH
Q 044510 105 YFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAK 183 (253)
Q Consensus 105 ~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 183 (253)
++.+..++.++|+|||||++|+|++ |..||......+. +...+...... ..+......+.+++.
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~~~l~~ 310 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRM---------RAPEYATPEIYSIML 310 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCCC---------CCCccCCHHHHHHHH
Confidence 9998889999999999999999998 9999976433221 11111111110 111223456888999
Q ss_pred HhcccCCCCCCCHHHHHHHHhhchh
Q 044510 184 RCLNLNGRKRPTMKEVAFELGGIRA 208 (253)
Q Consensus 184 ~cl~~dP~~Rps~~~l~~~l~~~~~ 208 (253)
+||+.+|.+||++.+++++|+++..
T Consensus 311 ~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 311 DCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=222.14 Aligned_cols=186 Identities=20% Similarity=0.396 Sum_probs=142.8
Q ss_pred CEEEEeecCCCChhHHhhccC---CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT---EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfg 78 (253)
+++||||+.+|+|.+++.... ....+++..+..++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 579999999999998874321 1224889999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCccee-eeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 79 ASRYVTIDQTHLT-TRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 79 l~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
+++.......... ....+++.|++||...+..++.++|+||||+++|+|++ |..||......+. .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI-------YDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHcC
Confidence 9886543221111 11234678999999998889999999999999999999 8899876443221 1111111
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
.... .+...+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 231 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1100 1112334678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=233.32 Aligned_cols=164 Identities=23% Similarity=0.386 Sum_probs=124.9
Q ss_pred CCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcccccCCCccee-eeccccccccccc
Q 044510 26 TITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLT-TRVQGTFGYLDLE 104 (253)
Q Consensus 26 ~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~~~~~~~~~~-~~~~~~~~y~aPE 104 (253)
++++..+++++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++.......... ....++..|+|||
T Consensus 208 ~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 284 (374)
T cd05106 208 PLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 284 (374)
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHH
Confidence 4788899999999999999999999 99999999999999999999999999875432221111 1122456799999
Q ss_pred hhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHH
Q 044510 105 YFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAK 183 (253)
Q Consensus 105 ~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 183 (253)
++.+..++.++|+|||||++|+|++ |..||........ ........... ..+...+..+.+++.
T Consensus 285 ~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~l~~li~ 349 (374)
T cd05106 285 SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRGYQM---------SRPDFAPPEIYSIMK 349 (374)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHcccCc---------cCCCCCCHHHHHHHH
Confidence 9988889999999999999999997 9999976443211 11111111000 001112356888999
Q ss_pred HhcccCCCCCCCHHHHHHHHhhch
Q 044510 184 RCLNLNGRKRPTMKEVAFELGGIR 207 (253)
Q Consensus 184 ~cl~~dP~~Rps~~~l~~~l~~~~ 207 (253)
+||+.||.+||++.+++++|+++.
T Consensus 350 ~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 350 MCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHcCCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=229.84 Aligned_cols=172 Identities=27% Similarity=0.371 Sum_probs=137.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 71 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~ 144 (323)
T cd05575 71 LYFVLDYVNGGELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCK 144 (323)
T ss_pred EEEEEcCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCc
Confidence 489999999999999987654 5899999999999999999999999 9999999999999999999999999986
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... ........|++.|+|||++.+..++.++|+|||||++|+|++|..||......+. ..........
T Consensus 145 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~~~~-- 214 (323)
T cd05575 145 EGIEH-SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM-------YDNILNKPLR-- 214 (323)
T ss_pred ccccC-CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH-------HHHHHcCCCC--
Confidence 43221 1222335689999999999988899999999999999999999999977543321 1111111110
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMK 197 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~ 197 (253)
.+...+..+.+++.+||+.||.+||+++
T Consensus 215 --------~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 215 --------LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --------CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1112244688899999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=232.54 Aligned_cols=176 Identities=23% Similarity=0.381 Sum_probs=146.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+|.||+.| +|+.++.+.+ .++++.+..++.+++.||.|||+.+ |+|||+||.||+++..+.+|++|||+++
T Consensus 76 ~~vVte~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar 148 (808)
T KOG0597|consen 76 LWVVTEYAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLAR 148 (808)
T ss_pred EEEEehhhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhh
Confidence 4899999977 9999998765 5999999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
.+..+. ......-|||.|||||.+.+.+|+..+|.||+||++||+.+|++||....... +.+.+.....
T Consensus 149 ~m~~~t-~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~-------Lv~~I~~d~v--- 217 (808)
T KOG0597|consen 149 AMSTNT-SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ-------LVKSILKDPV--- 217 (808)
T ss_pred hcccCc-eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH-------HHHHHhcCCC---
Confidence 876533 33455679999999999999999999999999999999999999996543221 1222211111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+...+..+..+++..|..||.+|.+..+++.+
T Consensus 218 -------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 -------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1122556678899999999999999999999876
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=226.17 Aligned_cols=187 Identities=23% Similarity=0.438 Sum_probs=145.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++|+||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccc
Confidence 4789999999999999987532 4889999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCccee-eeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTHLT-TRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
.......... .....+..|++||.+.+..++.++|+||||+++|+|++ |..||.+....+. ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~ 230 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGERL 230 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHhCCCCC
Confidence 6543222111 11223567999999998889999999999999999998 9999976543321 1111111000
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
..+......+.+++.+||+.||.+||++.+++..+..+...
T Consensus 231 ---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 231 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 00111234578899999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=226.19 Aligned_cols=194 Identities=20% Similarity=0.263 Sum_probs=139.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+.+ +|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 78 ~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~ 151 (288)
T cd07871 78 LTLVFEYLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLAR 151 (288)
T ss_pred EEEEEeCCCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCccee
Confidence 4799999965 89998876432 4789999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc--
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL-- 158 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 158 (253)
...... .......+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||......+.................
T Consensus 152 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07871 152 AKSVPT-KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230 (288)
T ss_pred eccCCC-ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence 543221 11223457889999999875 45889999999999999999999999876544322111110000000000
Q ss_pred -------cchhchhh----hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 -------FDMLDAQV----LKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 -------~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.....+.. ........+..+.+++.+||+.||.+|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 231 ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 000111234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=219.67 Aligned_cols=184 Identities=21% Similarity=0.400 Sum_probs=143.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
++++|||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 150 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLAR 150 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCccee
Confidence 5899999999999999876432 35899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............++..|++||.+.+..++.++|+||||+++|+|++ |..||......+. ...+......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~~- 222 (260)
T cd05067 151 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV-------IQNLERGYRM- 222 (260)
T ss_pred ecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH-------HHHHHcCCCC-
Confidence 554222211222334678999999988888999999999999999998 9999976543221 1111111000
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
..+...+..+.+++.+||+.+|.+||++++++..|+.
T Consensus 223 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 --------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1112233468889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=219.81 Aligned_cols=182 Identities=23% Similarity=0.349 Sum_probs=139.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 68 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 142 (252)
T cd05084 68 IYIVMELVQGGDFLTFLRTEGP--RLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR 142 (252)
T ss_pred eEEEEeeccCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCc
Confidence 4799999999999999975432 4889999999999999999999999 9999999999999999999999999986
Q ss_pred cccCCCccee-eeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTHLT-TRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
.......... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||........ ....... .
T Consensus 143 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-------~~~~~~~-~- 213 (252)
T cd05084 143 EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-------REAIEQG-V- 213 (252)
T ss_pred ccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-------HHHHHcC-C-
Confidence 5432111100 01112456999999988889999999999999999998 8888865443221 1111111 0
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
....+...+..+.+++.+||+.+|.+||++.++.++|+
T Consensus 214 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 214 -------RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -------CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 00112233457888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=224.93 Aligned_cols=189 Identities=24% Similarity=0.383 Sum_probs=146.4
Q ss_pred CEEEEeecCCCChhHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
+|+||||+.+++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~ 172 (304)
T cd05101 96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTE 172 (304)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcC
Confidence 5899999999999999976421 124788889999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCcce-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhH
Q 044510 69 KFRAKISDFGASRYVTIDQTHL-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLA 146 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~ 146 (253)
++.++|+|||+++......... .....+++.|+|||++.+..++.++|+||||+++|+|++ |..||......+.
T Consensus 173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---- 248 (304)
T cd05101 173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL---- 248 (304)
T ss_pred CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH----
Confidence 9999999999987654322111 122334678999999988889999999999999999998 7888866543321
Q ss_pred HHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 147 GYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
.......... ..+...+..+.+++.+||+.+|.+||++.++++.|+++...
T Consensus 249 ---~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 249 ---FKLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ---HHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1111111110 11123345688899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=212.69 Aligned_cols=186 Identities=25% Similarity=0.328 Sum_probs=148.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec---CCCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD---DKFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~---~~~~~kl~Dfg 78 (253)
+.+|||+++||.|++.++.+++. .+++..+..|+.||..|+.|||+.+ |.||||||+|+|.+ .+..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~-afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQ-AFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcccc-cchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 47999999999999999987654 6999999999999999999999999 99999999999996 45679999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
+++..... ......+.||.|.|||++-..+|+..+|+||+||++|-|++|.+||.+..... ...+ +.+.+..+ .
T Consensus 210 FAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a--ispg-Mk~rI~~g-q 283 (400)
T KOG0604|consen 210 FAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPG-MKRRIRTG-Q 283 (400)
T ss_pred cccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc--CChh-HHhHhhcc-C
Confidence 99876432 23344567999999999988889999999999999999999999998755421 1111 12222222 1
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+.++. -...+...+++|+.+|..+|.+|.|+.+++++
T Consensus 284 y~FP~pE-----Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 YEFPEPE-----WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ccCCChh-----HhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1222222 24566788999999999999999999999865
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=233.11 Aligned_cols=178 Identities=26% Similarity=0.311 Sum_probs=138.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||..+ |+||||||+||+++.++.++|+|||+++
T Consensus 71 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~ 144 (330)
T cd05586 71 LYLVTDYMSGGELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSK 144 (330)
T ss_pred EEEEEcCCCCChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCc
Confidence 489999999999999987654 5899999999999999999999999 9999999999999999999999999986
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
...... .......|++.|+|||++.+. .++.++|+||+||++|+|++|..||......+. ......... .
T Consensus 145 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-------~~~i~~~~~-~ 215 (330)
T cd05586 145 ANLTDN-KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-------YRNIAFGKV-R 215 (330)
T ss_pred CCCCCC-CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-------HHHHHcCCC-C
Confidence 532221 122335689999999998754 478999999999999999999999976543221 111111110 0
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC----CHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP----TMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp----s~~~l~~~ 202 (253)
.. ....+..+.+++.+||+.||.+|| ++.+++++
T Consensus 216 ~~--------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 216 FP--------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CC--------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 00 011334678899999999999998 57777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=218.38 Aligned_cols=182 Identities=20% Similarity=0.379 Sum_probs=141.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+.+..++.++.+++.+|.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 67 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~ 141 (250)
T cd05085 67 IYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR 141 (250)
T ss_pred cEEEEECCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccce
Confidence 4899999999999999876432 4889999999999999999999999 9999999999999999999999999886
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............++..|+|||++.+..++.++|+||||+++|++++ |..||......... ........
T Consensus 142 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~-------~~~~~~~~-- 212 (250)
T cd05085 142 QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR-------EQVEKGYR-- 212 (250)
T ss_pred eccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH-------HHHHcCCC--
Confidence 543221111112233567999999988889999999999999999998 99999765433211 11111100
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
...+...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus 213 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 213 -------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred -------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0111223457888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=231.59 Aligned_cols=182 Identities=20% Similarity=0.314 Sum_probs=141.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++.+... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~ 150 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAA 150 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCe
Confidence 4899999999999999987532 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhc------cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR------SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE 155 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 155 (253)
..............+++.|+|||++. ...++.++|+|||||++|+|++|..||........ +......
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~ 224 (330)
T cd05601 151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNF 224 (330)
T ss_pred ECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcC
Confidence 65433332333356899999999986 34578899999999999999999999976543321 1111111
Q ss_pred ccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 156 NCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
........ ....+..+.+++.+||+ +|.+||++.+++++
T Consensus 225 ~~~~~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 225 QRFLKFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCccCCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 11111000 11234467889999998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=229.24 Aligned_cols=173 Identities=27% Similarity=0.349 Sum_probs=137.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++.... .+.+..+..++.|++.||.|||+.| ++||||||+||+++.++.++|+|||+++
T Consensus 71 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~ 144 (325)
T cd05602 71 LYFVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK 144 (325)
T ss_pred EEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCc
Confidence 489999999999999997654 4888899999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......|++.|+|||++.+..++.++|+||+||++|+|++|..||......+. +.. .......
T Consensus 145 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~-i~~~~~~-- 214 (325)
T cd05602 145 ENIEHN-GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------YDN-ILNKPLQ-- 214 (325)
T ss_pred ccccCC-CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH------HHH-HHhCCcC--
Confidence 532211 122345689999999999988899999999999999999999999986554321 111 1111110
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKE 198 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~ 198 (253)
.....+..+.+++.+||+.||.+|+++.+
T Consensus 215 --------~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 215 --------LKPNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred --------CCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 11123346788999999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=232.74 Aligned_cols=181 Identities=23% Similarity=0.319 Sum_probs=140.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEecccee
Confidence 48999999999999998654 3888999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccC----CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS----QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
..............|++.|+|||++.+. .++.++|+|||||++|+|++|..||........ +........
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~~ 264 (370)
T cd05596 191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMDHKN 264 (370)
T ss_pred eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH------HHHHHcCCC
Confidence 6543222222345689999999998653 378899999999999999999999987554221 111111110
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRK--RPTMKEVAFE 202 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~l~~~ 202 (253)
..... .....+..+.+++.+||+.+|.+ |+++++++++
T Consensus 265 ~~~~~-------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 SLTFP-------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred cCCCC-------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00000 01123457888999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=222.39 Aligned_cols=185 Identities=25% Similarity=0.375 Sum_probs=142.4
Q ss_pred CEEEEeecCCCChhHHhhccCC------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK 69 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~ 69 (253)
+++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCC
Confidence 5899999999999999976432 124889999999999999999999999 9999999999999999
Q ss_pred CceEEcccCCcccccCCCcce-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHH
Q 044510 70 FRAKISDFGASRYVTIDQTHL-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAG 147 (253)
Q Consensus 70 ~~~kl~Dfgl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~ 147 (253)
+.++|+|||++.......... .....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||......+..
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---- 234 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI---- 234 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH----
Confidence 999999999987543222111 112234678999999998889999999999999999998 89998665433211
Q ss_pred HHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 148 YFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
......... ..+...+..+.+++.+||+.||.+||++++|++.|++
T Consensus 235 --~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 --ECITQGREL----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred --HHHHcCccC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111111100 1111233467889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=221.71 Aligned_cols=184 Identities=23% Similarity=0.326 Sum_probs=140.6
Q ss_pred CEEEEeecCCCChhHHhhccCC----CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC---ceEE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE----EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF---RAKI 74 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~---~~kl 74 (253)
.++||||++|++|.+++..... ...+++..++.++.||+.||.|||..+ ++|+||||+||+++.++ .++|
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 4799999999999999976432 124899999999999999999999999 99999999999998654 5899
Q ss_pred cccCCcccccCCCcce-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHH
Q 044510 75 SDFGASRYVTIDQTHL-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRA 152 (253)
Q Consensus 75 ~Dfgl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~ 152 (253)
+|||+++......... ......+..|+|||++.+..++.++|+|||||++|+|++ |..||......+. ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~-------~~~ 233 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV-------MEF 233 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHH
Confidence 9999987653221111 111223467999999988889999999999999999997 9999976554321 111
Q ss_pred HhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 153 MKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
...... ...+...+..+.+++.+||+.+|.+||++.+++++|+
T Consensus 234 ~~~~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGGGR---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111100 0112223456888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=225.57 Aligned_cols=189 Identities=25% Similarity=0.387 Sum_probs=146.1
Q ss_pred CEEEEeecCCCChhHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
.|+||||+.+++|.+++..... ...+++..+++++.|++.||.|||+.+ ++|+||||+||+++.
T Consensus 99 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~ 175 (307)
T cd05098 99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTE 175 (307)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcC
Confidence 5899999999999999976421 124888999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCcce-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhH
Q 044510 69 KFRAKISDFGASRYVTIDQTHL-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLA 146 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~ 146 (253)
++.++|+|||++.......... .....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||......+.
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~---- 251 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL---- 251 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH----
Confidence 9999999999886543211111 111223468999999988889999999999999999998 8889866543221
Q ss_pred HHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 147 GYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
......... ...+...+..+.+++.+||+.+|.+||++.++++.|+++...
T Consensus 252 ---~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 252 ---FKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred ---HHHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 111111111 111223345788899999999999999999999999998776
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=218.17 Aligned_cols=184 Identities=21% Similarity=0.393 Sum_probs=143.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
++++|||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 150 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLAR 150 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCccee
Confidence 5899999999999999976432 24888899999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............++..|+|||.+.+..++.++|+||||+++|++++ |..||........ ..........
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~-------~~~~~~~~~~- 222 (260)
T cd05073 151 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-------IRALERGYRM- 222 (260)
T ss_pred eccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHhCCCCC-
Confidence 553222211222234567999999988888999999999999999998 9999976543221 1111111100
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
..+...+..+.+++.+||+.+|.+||+++++.+.|+.
T Consensus 223 --------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 --------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112234568889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=221.86 Aligned_cols=185 Identities=25% Similarity=0.409 Sum_probs=143.2
Q ss_pred CEEEEeecCCCChhHHhhccCC-------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKI 74 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl 74 (253)
.++||||+++++|.+++..... ...+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.++|
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 5899999999999999975321 123788899999999999999999999 999999999999999999999
Q ss_pred cccCCcccccCCCc-ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHH
Q 044510 75 SDFGASRYVTIDQT-HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRA 152 (253)
Q Consensus 75 ~Dfgl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~ 152 (253)
+|||+++....... .......++..|+|||.+.+..++.++|+|||||++|++++ |..||......+. ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-------~~~ 233 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV-------LKF 233 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH-------HHH
Confidence 99999875532221 11222345678999999988889999999999999999998 9999876544321 111
Q ss_pred HhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 153 MKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
........ .+...+..+.+++.+||+.+|.+|||+.++++.|++
T Consensus 234 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 234 VIDGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11111111 111224578889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=218.00 Aligned_cols=180 Identities=26% Similarity=0.391 Sum_probs=143.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||++|++|.+++.... ...+++..+++++.+++.||.|||..+ ++|+||+|+||+++.++.++|+|||+++
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~ 149 (256)
T cd08529 74 LNIVMEYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAK 149 (256)
T ss_pred EEEEEEeCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccce
Confidence 589999999999999998752 235899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
....... ......+++.|+|||+..+..++.++|+||||+++++|++|..||........ ........
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~---- 217 (256)
T cd08529 150 LLSDNTN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL-------ILKIIRGV---- 217 (256)
T ss_pred eccCccc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCC----
Confidence 6543221 12234578899999999988889999999999999999999999976553221 11111111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
....+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 218 -----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 218 -----FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -----CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111122344568889999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=219.69 Aligned_cols=187 Identities=26% Similarity=0.382 Sum_probs=146.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++..... .+++..++.++.+++.||.|||+.+ ++|+||||+||+++.++.++++|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~ 155 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSR 155 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceee
Confidence 4799999999999999976432 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............++..|+|||.+....++.++|+||||++++++++ |..||......+.. .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~------~~~~~~~~~-- 227 (270)
T cd05056 156 YLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI------GRIENGERL-- 227 (270)
T ss_pred ecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH------HHHHcCCcC--
Confidence 654332211222223467999999988889999999999999999986 99999765543211 111111101
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
..+...+..+.+++.+|+..+|.+||++.++++.|+++...
T Consensus 228 --------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 --------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11123345788899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=229.87 Aligned_cols=194 Identities=21% Similarity=0.238 Sum_probs=139.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|||++ +++|..++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++
T Consensus 158 ~~lv~e~~-~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~ 230 (391)
T PHA03212 158 TCLILPRY-KTDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAAC 230 (391)
T ss_pred eEEEEecC-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccc
Confidence 47899999 568988887643 4899999999999999999999999 9999999999999999999999999986
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhh-hhhhHHHHHHHHhh-ccc-
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE-DKSLAGYFLRAMKE-NCL- 158 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~-~~~- 158 (253)
..............||+.|+|||++.+..++.++|+|||||++|+|++|..||-...... .......+...... +..
T Consensus 231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p 310 (391)
T PHA03212 231 FPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP 310 (391)
T ss_pred ccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCCh
Confidence 543222222334568999999999998889999999999999999999998764432111 00000000000000 000
Q ss_pred -----------cch---------hchhhh--hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 -----------FDM---------LDAQVL--KEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 -----------~~~---------~~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... ..+... .......+..+.+++.+||+.||.+|||++|++++
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 311 NEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000 000000 00111345578899999999999999999999964
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=239.89 Aligned_cols=189 Identities=25% Similarity=0.424 Sum_probs=156.2
Q ss_pred CEEEEeecCCCChhHHhhccCC-----------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-----------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF 70 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~ 70 (253)
+++|+|||.+|+|.++|..... ..+++..+.+.|+.||+.|+.||.++. +|||||-..|+||+.+.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 4899999999999999976321 234888999999999999999999999 99999999999999999
Q ss_pred ceEEcccCCcccccCCCcceee-eccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHH
Q 044510 71 RAKISDFGASRYVTIDQTHLTT-RVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGY 148 (253)
Q Consensus 71 ~~kl~Dfgl~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~ 148 (253)
.|||+|||+++.......++.. ...-...|||||.+..++|+.++|||||||++||+++ |..|+.+...++.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV------ 714 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV------ 714 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH------
Confidence 9999999999977655444432 2334569999999999999999999999999999999 9999988766542
Q ss_pred HHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 149 FLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
.+.+..+.+ -..+...+..++.|...||+..|.+||+++||-..|+.....
T Consensus 715 -Ie~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 715 -IECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred -HHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 222222222 234566777899999999999999999999999999876544
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=223.78 Aligned_cols=190 Identities=23% Similarity=0.387 Sum_probs=146.1
Q ss_pred CEEEEeecCCCChhHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
.|+||||+++|+|.+++..... ...+++..+.+++.|++.||.|||+.+ ++|+||||+||+++.
T Consensus 93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~ 169 (314)
T cd05099 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTE 169 (314)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcC
Confidence 4899999999999999976321 124889999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCcce-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhH
Q 044510 69 KFRAKISDFGASRYVTIDQTHL-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLA 146 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~ 146 (253)
++.+||+|||+++......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+.
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---- 245 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL---- 245 (314)
T ss_pred CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH----
Confidence 9999999999987553221111 111223457999999988889999999999999999999 8889876543321
Q ss_pred HHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 147 GYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
.......... ..+...+..+.+++.+||+.+|.+||++.++++.|+++....
T Consensus 246 ---~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 246 ---FKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred ---HHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 1111111110 111223346778999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=216.81 Aligned_cols=201 Identities=20% Similarity=0.252 Sum_probs=151.2
Q ss_pred CEEEEeecCCCChhHHhhccCCC-CCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEE-FTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.++||||+ ..+|..++...... ..++...+..++.||+.||+|||+++ |+||||||+||+++++|.+||+|||++
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence 47999999 55999999875522 24777899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
+...... ....+.+.|.+|+|||++.+. .|+...|+||+||+++||++++.-|.+..+.++...+........+..+.
T Consensus 168 ra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 168 RAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 8664322 234556789999999999987 68999999999999999999999998877654433333222222222111
Q ss_pred chh-----c--------hhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhch
Q 044510 160 DML-----D--------AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE--LGGIR 207 (253)
Q Consensus 160 ~~~-----~--------~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~--l~~~~ 207 (253)
... + +...............+++.+||+.+|.+|.|++.++.+ +..+.
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 110 0 000111111122468889999999999999999999987 55543
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=222.62 Aligned_cols=189 Identities=25% Similarity=0.410 Sum_probs=145.8
Q ss_pred CEEEEeecCCCChhHHhhccC---------------------CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT---------------------EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~---------------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~ 60 (253)
+++|+||+.+++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|||||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dik 154 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLA 154 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhh
Confidence 589999999999999986421 1124788999999999999999999999 9999999
Q ss_pred CCceeecCCCceEEcccCCcccccCCCcce-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCC
Q 044510 61 SANILLDDKFRAKISDFGASRYVTIDQTHL-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTD 138 (253)
Q Consensus 61 ~~nili~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~ 138 (253)
|+||++++++.++|+|||+++......... .....++..|++||...+..++.++|+||||+++++|++ |..||....
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999999999987543222211 112234568999999988888999999999999999998 999997654
Q ss_pred hhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 139 TEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
..+. ......... ...+...+..+.+++.+||+.+|.+||+++++++.|+++..+
T Consensus 235 ~~~~-------~~~~~~~~~---------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 235 PERL-------FNLLKTGYR---------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHH-------HHHHhCCCC---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 4321 111111100 011223345688899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=221.48 Aligned_cols=185 Identities=22% Similarity=0.416 Sum_probs=142.0
Q ss_pred CEEEEeecCCCChhHHhhccCC--------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE--------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD 67 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~ 67 (253)
.|+||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIG 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEc
Confidence 4899999999999999864321 124788899999999999999999999 99999999999999
Q ss_pred CCCceEEcccCCcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhh
Q 044510 68 DKFRAKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSL 145 (253)
Q Consensus 68 ~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~ 145 (253)
.++.++|+|||+++........ ......++..|+|||++.+..++.++|+||||+++|+|++ |..||........
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~--- 235 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV--- 235 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---
Confidence 9999999999998755322211 1122334667999999988889999999999999999998 9899876543221
Q ss_pred HHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 146 AGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
........... .+...+..+.+++.+||+.||.+||++.+|.++|..
T Consensus 236 ----~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 ----IEMVRKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111111 112233467889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=226.28 Aligned_cols=171 Identities=26% Similarity=0.359 Sum_probs=136.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~ 149 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccccc
Confidence 479999999999999987654 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......|++.|+|||++.+..++.++|+||+||++|+|++|..||........ ..... ....
T Consensus 150 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~------~~~i~-~~~~--- 218 (323)
T cd05615 150 EHMVDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL------FQSIM-EHNV--- 218 (323)
T ss_pred ccCCCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHH-hCCC---
Confidence 532211 122334589999999999988899999999999999999999999987654321 11111 1111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTM 196 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~ 196 (253)
..+...+..+.+++.+||+.+|.+|++.
T Consensus 219 -------~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 -------SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1112234467889999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=217.25 Aligned_cols=184 Identities=29% Similarity=0.429 Sum_probs=145.9
Q ss_pred CEEEEeecCCCChhHHhhccCC------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKIS 75 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~ 75 (253)
.++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 71 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~ 147 (262)
T cd00192 71 LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKIS 147 (262)
T ss_pred eEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEc
Confidence 4899999999999999987521 136999999999999999999999999 9999999999999999999999
Q ss_pred ccCCcccccCCCc-ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHH
Q 044510 76 DFGASRYVTIDQT-HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAM 153 (253)
Q Consensus 76 Dfgl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~ 153 (253)
|||.+........ .......++..|+|||.+....++.++|+||+|+++++|++ |..||......+. ....
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~ 220 (262)
T cd00192 148 DFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-------LEYL 220 (262)
T ss_pred ccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHH
Confidence 9999886643321 11223446788999999988889999999999999999999 6999987643321 1111
Q ss_pred hhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 154 KENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
.... ....+...+..+.+++.+||+.+|.+||++.+++++|+
T Consensus 221 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 221 RKGY---------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HcCC---------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1110 11112233567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=235.82 Aligned_cols=195 Identities=21% Similarity=0.285 Sum_probs=139.7
Q ss_pred CEEEEeecCCCChhHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC-ceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQ-TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF-RAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~-~~kl~Dfgl 79 (253)
.++||||+++ +|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecccc
Confidence 3689999965 787776542 12235899999999999999999999999 99999999999998654 699999999
Q ss_pred cccccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHH--------
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFL-------- 150 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-------- 150 (253)
++...... ......+++.|+|||++.+. .++.++|+||+||++|+|++|.+||.+....+.........
T Consensus 218 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 218 AKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred chhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 97654222 22234678999999998754 58999999999999999999999998765432211111000
Q ss_pred HHHhhc----cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 151 RAMKEN----CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 151 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...... .........+....+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000000 0000111111122223345678999999999999999999999966
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=236.95 Aligned_cols=190 Identities=21% Similarity=0.229 Sum_probs=138.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhh-CCCCCeEecCCCCCceeecCCC----------
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS-TTSIPIYHRDIKSANILLDDKF---------- 70 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nili~~~~---------- 70 (253)
.|+|||++ |++|.+++.... .+++..+..++.||+.||.|||. .+ |+||||||+||+++.++
T Consensus 207 ~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 207 MCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred EEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccc
Confidence 47899988 789999887653 59999999999999999999997 58 99999999999998654
Q ss_pred ------ceEEcccCCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhh
Q 044510 71 ------RAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKS 144 (253)
Q Consensus 71 ------~~kl~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~ 144 (253)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|..||......+...
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred cCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 49999999875322 12234568999999999998899999999999999999999999998765433222
Q ss_pred hHHHHHH----HHhh--------------ccccchhchhhhh-------hhcHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 044510 145 LAGYFLR----AMKE--------------NCLFDMLDAQVLK-------EAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199 (253)
Q Consensus 145 ~~~~~~~----~~~~--------------~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l 199 (253)
....... .+.. .......++.... .........+++||.+||+.||.+|||++|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 1111100 0000 0000000000000 0001123567899999999999999999999
Q ss_pred HHH
Q 044510 200 AFE 202 (253)
Q Consensus 200 ~~~ 202 (253)
+++
T Consensus 436 L~H 438 (467)
T PTZ00284 436 TTH 438 (467)
T ss_pred hcC
Confidence 975
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=222.52 Aligned_cols=184 Identities=19% Similarity=0.253 Sum_probs=141.2
Q ss_pred CEEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 68 ~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~ 144 (280)
T cd05608 68 LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLA 144 (280)
T ss_pred EEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccc
Confidence 479999999999998875422 2335899999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
....... .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||......... ...........
T Consensus 145 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~--- 217 (280)
T cd05608 145 VELKDGQ-SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRILNDS--- 217 (280)
T ss_pred eecCCCC-ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---HHHHHhhcccC---
Confidence 7543222 1222346889999999999888999999999999999999999999764432110 00000000000
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
...+...+..+.+++.+||+.||.+|| ++++++++
T Consensus 218 -------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 218 -------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred -------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 011223455788899999999999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=207.78 Aligned_cols=181 Identities=25% Similarity=0.352 Sum_probs=142.1
Q ss_pred CCEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC---CCceEEccc
Q 044510 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD---KFRAKISDF 77 (253)
Q Consensus 1 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~---~~~~kl~Df 77 (253)
++|||+|+++|++|..-|... +.+++..+-..++||+.+|.|+|..+ |||||+||.|+++.. ..-+||+||
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~F 157 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADF 157 (355)
T ss_pred eeEEEEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeeccc
Confidence 479999999999996555433 24888899999999999999999999 999999999999963 345899999
Q ss_pred CCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 78 GASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 78 gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
|++.... ........+|||.||+||++...+|+..+|+|+.|+++|-++.|.+||.+.+.... +...+....
T Consensus 158 GvAi~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl------ye~I~~g~y 229 (355)
T KOG0033|consen 158 GLAIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------YEQIKAGAY 229 (355)
T ss_pred ceEEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH------HHHHhcccc
Confidence 9998765 33344557899999999999999999999999999999999999999988554331 112222111
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. +++. .-....+..++++++||..||.+|.|++|.+++
T Consensus 230 d---~~~~----~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 230 D---YPSP----EWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred C---CCCc----ccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1 1111 112334568889999999999999999888764
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=228.88 Aligned_cols=173 Identities=27% Similarity=0.340 Sum_probs=137.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 73 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 146 (318)
T cd05582 73 LYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK 146 (318)
T ss_pred EEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCc
Confidence 489999999999999997643 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||......+. ..... ....
T Consensus 147 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~------~~~i~-~~~~--- 215 (318)
T cd05582 147 ESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET------MTMIL-KAKL--- 215 (318)
T ss_pred ccCCCC-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH------HHHHH-cCCC---
Confidence 543221 223345689999999999988889999999999999999999999976543221 11111 1100
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKE 198 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~ 198 (253)
..+...+..+.+++.+||+.||.+||++.+
T Consensus 216 -------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 -------GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 112223456788999999999999999444
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=218.87 Aligned_cols=183 Identities=20% Similarity=0.285 Sum_probs=140.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||++|++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 68 ~~lv~e~~~g~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~ 143 (277)
T cd05607 68 LCLVMSLMNGGDLKYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAV 143 (277)
T ss_pred EEEEEecCCCCCHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeee
Confidence 4799999999999998865432 24889999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... .......+++.|+|||++.+..++.++|+||+||++|+|++|..||........ ............ .
T Consensus 144 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~-~--- 215 (277)
T cd05607 144 ELKDG--KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLEDE-V--- 215 (277)
T ss_pred ecCCC--ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhccc-c---
Confidence 55322 122334688999999999888899999999999999999999999976443211 111111111100 0
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ......+..+.+++.+||+.||.+||+++|+++.
T Consensus 216 -~-----~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 216 -K-----FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred -c-----cccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 0 0011234468889999999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=218.25 Aligned_cols=175 Identities=25% Similarity=0.415 Sum_probs=147.3
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
+|||||..+|.|.+++...+ .+++..+..+++||+.|+.|+|..+ ++|||||.+|||++.++.+||+|||++..
T Consensus 129 vivMEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEEEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhh
Confidence 68999999999999999876 4999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCcceeeeccccccccccchhccCCC-CCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRSSQF-TKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
+.. .....+++|+|-|.+||+++|.+| .+.+|.||||+++|-|+.|..||.+.+... +.+.+..+..++.
T Consensus 203 y~~--~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~-------lvrQIs~GaYrEP 273 (668)
T KOG0611|consen 203 YAD--KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR-------LVRQISRGAYREP 273 (668)
T ss_pred hcc--ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH-------HHHHhhcccccCC
Confidence 642 333456789999999999999998 588999999999999999999998876532 2233333333322
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 203 (253)
..+ ....-+|++||..+|.+|.|+.+|..+.
T Consensus 274 ~~P-----------SdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 ETP-----------SDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred CCC-----------chHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 222 2355699999999999999999998774
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=220.27 Aligned_cols=194 Identities=21% Similarity=0.230 Sum_probs=141.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+.+ +|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred EEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 4799999965 89988876432 24899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc--
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF-- 159 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 159 (253)
...... ......++..|+|||++.+..++.++|+||+||++|+|++|..||.........................
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 653221 2223457889999999988889999999999999999999999997654432211110000000000000
Q ss_pred --------chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 --------DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 --------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...............+..+.+++.+||+.||.+||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000111112334567899999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=222.52 Aligned_cols=191 Identities=27% Similarity=0.403 Sum_probs=141.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 4799999999999999976432 4899999999999999999999999 9999999999999999999999999988
Q ss_pred cccCCCccee--eeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhh---------hhHHHHH
Q 044510 82 YVTIDQTHLT--TRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDK---------SLAGYFL 150 (253)
Q Consensus 82 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~---------~~~~~~~ 150 (253)
.......... ....++..|+|||...+..++.++|+||||+++++|++|..++......... .....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 6543222111 1122344699999998888999999999999999999987765443211000 0000000
Q ss_pred HHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 151 RAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
...... .....+...+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 237 ~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNN---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcC---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111000 00011122345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=217.55 Aligned_cols=185 Identities=26% Similarity=0.422 Sum_probs=140.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+.+++|.+++..... ..++..+..++.|++.||.|||..+ ++|+||||+||+++.++.+||+|||+++
T Consensus 72 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~ 146 (262)
T cd05058 72 PLVVLPYMKHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLAR 146 (262)
T ss_pred cEEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccc
Confidence 5899999999999999976432 3677888999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcce---eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhC-CCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 82 YVTIDQTHL---TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTG-QKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 82 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
......... .....++..|+|||.+.+..++.++|+||||+++|+|++| ..||......+ .. ........
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~---~~~~~~~~ 220 (262)
T cd05058 147 DIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---IT---VYLLQGRR 220 (262)
T ss_pred cccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH---HHHhcCCC
Confidence 543221111 1122346689999999888899999999999999999995 56665433221 11 11111100
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhch
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 207 (253)
. ..+...+..+.+++.+||+.+|.+||++.++++.|+++.
T Consensus 221 ~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 221 L----------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred C----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0 001122346888999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=229.28 Aligned_cols=181 Identities=23% Similarity=0.327 Sum_probs=138.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence 48999999999999999654 3889999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCC----CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQ----FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
..............||+.|+|||++.+.. ++.++|+||+||++|+|++|..||........ +........
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~~~i~~~~~ 264 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------YSKIMDHKN 264 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCc
Confidence 65432222223456899999999997543 68899999999999999999999976543221 111111111
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRK--RPTMKEVAFE 202 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~l~~~ 202 (253)
..... .....+..+.+++..||..++.+ |+++.+++++
T Consensus 265 ~~~~p-------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 SLNFP-------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ccCCC-------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11000 01123456778999999855543 8899999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=221.94 Aligned_cols=186 Identities=24% Similarity=0.402 Sum_probs=144.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+.+++|.+++..... ..+++..++.++.+++.||.|||+.+ ++|+||||+||+++.++.++++|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 5899999999999999976432 23899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
........ ......++..|+|||.+.+..++.++|+||+||++|+|++ |..||........ +.........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~~~~~~~~~~- 262 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLIKEGYR- 262 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------HHHHHHcCCc-
Confidence 55332211 1112235678999999988889999999999999999998 9999876543221 1111111100
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
...+...+..+.+++.+||+.+|.+||++.++++.|++.
T Consensus 263 --------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 --------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 001112234688899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=227.77 Aligned_cols=193 Identities=23% Similarity=0.266 Sum_probs=140.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEEEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEecccccee
Confidence 479999995 58888886543 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH-----------
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF----------- 149 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~----------- 149 (253)
..............+++.|+|||.+.+. .++.++|+||+||++|+|++|..||...............
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 6543222222334578899999999864 4789999999999999999999999876654322111100
Q ss_pred -----HHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 150 -----LRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 150 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
......... ...............+..+.+++.+||+.||.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPH-KPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCC-CCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 0000000001112234578899999999999999999999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=220.27 Aligned_cols=185 Identities=19% Similarity=0.347 Sum_probs=141.8
Q ss_pred CEEEEeecCCCChhHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-------------EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
.++++||+.+++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||++++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFD 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecC
Confidence 368999999999999985321 1224788899999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCc-ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhH
Q 044510 69 KFRAKISDFGASRYVTIDQT-HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLA 146 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~ 146 (253)
++.+||+|||+++....... .......+++.|+|||.+.+..++.++|+|||||++|+|++ |..||......+.
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---- 235 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV---- 235 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH----
Confidence 99999999999875432221 11222345678999999988889999999999999999998 8888876543221
Q ss_pred HHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 147 GYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
.......... ..+...+..+.+++.+||+.+|.+||++++|+..|+.
T Consensus 236 ---~~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 ---IEMIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---HHHHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111111111 1122344568889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=216.38 Aligned_cols=180 Identities=24% Similarity=0.369 Sum_probs=142.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+++++|.+++..... ..+++..++.++.+++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 75 ~~lv~e~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~ 150 (257)
T cd08223 75 LYIVMGFCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR 150 (257)
T ss_pred EEEEecccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceE
Confidence 4799999999999999976432 24899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......+++.|+|||+..+..++.++|+||+|+++++|++|..||...+.... ... ......
T Consensus 151 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~-~~~~~~--- 219 (257)
T cd08223 151 VLENQC-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYR-IIEGKL--- 219 (257)
T ss_pred EecccC-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHH-HHhcCC---
Confidence 653222 222334578899999999988889999999999999999999999976543221 111 111111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...+...+..+.+++.+||+.||.+||++.+++++
T Consensus 220 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 ------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11123344578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=217.24 Aligned_cols=184 Identities=23% Similarity=0.412 Sum_probs=142.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||++.
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccce
Confidence 589999999999999997643 25899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceee--eccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHLTT--RVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
........... ....+..|++||.+.+..++.++|+|||||++|+|++ |..||......+ ....+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~~~~i~~~~~ 228 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAINDGFR 228 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhcCCC
Confidence 65432211111 1122457999999988888999999999999999997 999996654322 1111111100
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
...+...+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 229 ---------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 ---------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001112344678899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-33 Score=224.84 Aligned_cols=184 Identities=26% Similarity=0.283 Sum_probs=142.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCC-CCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFT-ITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~-~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.|||+|||..|.+...= ...+ +.+.++++++++++.||.|||.+| |+||||||+|+|++.+|++||+|||.+
T Consensus 185 ~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDFGVs 257 (576)
T KOG0585|consen 185 LYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDFGVS 257 (576)
T ss_pred eEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeecccee
Confidence 48999999988765432 2224 999999999999999999999999 999999999999999999999999998
Q ss_pred ccccCC----CcceeeeccccccccccchhccCC----CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHH
Q 044510 81 RYVTID----QTHLTTRVQGTFGYLDLEYFRSSQ----FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRA 152 (253)
Q Consensus 81 ~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 152 (253)
..+... ........+|||.|+|||.+.++. -+.+.|||++||++|-|+.|+.||-+....+ +..+
T Consensus 258 ~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~-------l~~K 330 (576)
T KOG0585|consen 258 NEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE-------LFDK 330 (576)
T ss_pred eecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH-------HHHH
Confidence 866221 111223478999999999998743 2688999999999999999999997654433 2223
Q ss_pred HhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhch
Q 044510 153 MKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207 (253)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 207 (253)
+.+..+... ...+....++++|.++|.+||.+|.+..+|..+.-...
T Consensus 331 Ivn~pL~fP--------~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 331 IVNDPLEFP--------ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred HhcCcccCC--------CcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 333322211 11234567889999999999999999999988764433
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=217.69 Aligned_cols=180 Identities=25% Similarity=0.361 Sum_probs=141.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++|+||+++++|.+++.... .+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||+++
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~ 152 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 152 (263)
T ss_pred EEEEEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccce
Confidence 589999999999999997654 4889999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCccee--eeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTHLT--TRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
.......... ....++..|+|||.+.+..++.++|+||+|+++|+|++|..||......... ....... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~-~- 224 (263)
T cd06625 153 RLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIATQP-T- 224 (263)
T ss_pred eccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH------HHHhccC-C-
Confidence 5432211111 2234678999999999888999999999999999999999999764332110 1111110 0
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
....+...+..+.+++.+||..+|.+||++.+++++
T Consensus 225 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 -------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111223344567889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=219.23 Aligned_cols=182 Identities=25% Similarity=0.313 Sum_probs=142.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++|+|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~ 150 (285)
T cd05605 75 LCLVLTLMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAV 150 (285)
T ss_pred EEEEEeccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCce
Confidence 5899999999999998865432 25899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... ......|++.|+|||++.+..++.++|+||+||++|+|++|..||.+........ .........
T Consensus 151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~---~~~~~~~~~----- 220 (285)
T cd05605 151 EIPEGE--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE---EVERRVKED----- 220 (285)
T ss_pred ecCCCC--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH---HHHHHhhhc-----
Confidence 643221 1223467899999999988889999999999999999999999998654322111 111111110
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
....+...+..+.+++.+||+.||.+|| ++++++++
T Consensus 221 -----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 -----QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -----ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0112233455688899999999999999 88888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=216.92 Aligned_cols=184 Identities=22% Similarity=0.373 Sum_probs=143.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... ..+++..+..++.+++.||.|||..+ ++|+||+|+||+++.++.++++|||++.
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~ 151 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLAR 151 (261)
T ss_pred eEEEEeccCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccce
Confidence 4899999999999999977532 25899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
...............+..|++||.+.+..++.++|+||+|++++++++ |..||........ ........ .
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-------~~~~~~~~-~- 222 (261)
T cd05034 152 LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV-------LEQVERGY-R- 222 (261)
T ss_pred eccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCC-C-
Confidence 654321111112224568999999998889999999999999999998 9999976543221 11111110 0
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
...+...+..+.+++.+||+.+|.+||+++++++.|+.
T Consensus 223 -------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 -------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01111224468889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=218.48 Aligned_cols=189 Identities=22% Similarity=0.389 Sum_probs=146.5
Q ss_pred CEEEEeecCCCChhHHhhccCCC-----CCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEE-----FTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISD 76 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~D 76 (253)
+++++||+.+++|.+++...... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 58999999999999998764321 35899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCcce-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHh
Q 044510 77 FGASRYVTIDQTHL-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMK 154 (253)
Q Consensus 77 fgl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 154 (253)
||+++.+....... .....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+. .....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM-------AAYLK 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH-------HHHHH
Confidence 99987653322111 112234667999999988889999999999999999999 9999976543221 11111
Q ss_pred hccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 155 ENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
.... . ......+..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 234 ~~~~--~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 234 DGYR--L-------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred cCCC--C-------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 1100 0 01112334688899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=215.90 Aligned_cols=181 Identities=27% Similarity=0.451 Sum_probs=143.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... ..+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||.++
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~ 150 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAK 150 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccc
Confidence 5899999999999999976542 24899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
....... ....+..|+|||.+.+..++.++|+||||+++++|++ |..||......+. .........
T Consensus 151 ~~~~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~-- 217 (256)
T cd05039 151 EASQGQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPHVEKGYR-- 217 (256)
T ss_pred ccccccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHhcCCC--
Confidence 6532111 2234567999999988888999999999999999997 9999976543321 111111100
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
...+...+..+.+++.+||+.+|.+||++++++++|+.+
T Consensus 218 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 218 -------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 011222345788899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=225.57 Aligned_cols=192 Identities=23% Similarity=0.408 Sum_probs=139.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhh-CCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS-TTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
+++||||+++++|.+++.... .+++..+..++.+++.||.|||. .+ ++|+||||+||+++.++.+||+|||++
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~ 151 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 151 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcc
Confidence 589999999999999997654 48899999999999999999997 46 999999999999999999999999998
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHH--------
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRA-------- 152 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~-------- 152 (253)
...... ......++..|+|||.+.+..++.++|+|||||++|+|++|..||..................
T Consensus 152 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (333)
T cd06650 152 GQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETS 228 (333)
T ss_pred hhhhhh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccC
Confidence 654321 122345789999999999888999999999999999999999999765432211100000000
Q ss_pred ------------Hhhcc-----ccchhchhh---hhhh-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 153 ------------MKENC-----LFDMLDAQV---LKEA-KEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 153 ------------~~~~~-----~~~~~~~~~---~~~~-~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..... .....+... .... ....+..+.+++.+||+.||.+||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00000 000000000 0000 00134568899999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=215.35 Aligned_cols=188 Identities=23% Similarity=0.311 Sum_probs=145.6
Q ss_pred CEEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.++||||+++++|.+++.... ....+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~ 153 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEecccee
Confidence 479999999999999987532 2235899999999999999999999999 999999999999999999999999988
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ..... .......
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~-~~~~~~~-- 225 (267)
T cd08224 154 RFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCK-KIEKCDY-- 225 (267)
T ss_pred eeccCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH----HHHHh-hhhcCCC--
Confidence 75432221 1122457888999999988889999999999999999999999986543211 11111 1111111
Q ss_pred hhchhhhhhhcH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhch
Q 044510 161 MLDAQVLKEAKE-EEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207 (253)
Q Consensus 161 ~~~~~~~~~~~~-~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 207 (253)
...+. ..+..+.+++.+||+.+|.+||++.+|+++|+.+.
T Consensus 226 -------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 -------PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -------CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11111 34456888999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-33 Score=221.45 Aligned_cols=182 Identities=33% Similarity=0.553 Sum_probs=135.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++|+|.+++.... ...+++..++.|+.|++.||.|||+.+ ++|++|+++||+++.++.+||+|||++.
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~ 151 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSR 151 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGE
T ss_pred ccccccccccccccccccccc-ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 379999999999999998862 225999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
........ ..........|+|||.+.+..++.++||||||+++|||++ |..||......+ ...........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-------~~~~~~~~~~~ 224 (259)
T PF07714_consen 152 PISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-------IIEKLKQGQRL 224 (259)
T ss_dssp ETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-------HHHHHHTTEET
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccccccccc
Confidence 65222111 1122345678999999998889999999999999999999 778886654322 11112111111
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 203 (253)
..+...+..+.+++..||+.||.+||++.++++.|
T Consensus 225 ---------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 ---------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11222344677899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=220.17 Aligned_cols=191 Identities=25% Similarity=0.382 Sum_probs=142.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||++|++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 4799999999999999876432 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcc--eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhh--------hhhHHHHHH
Q 044510 82 YVTIDQTH--LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED--------KSLAGYFLR 151 (253)
Q Consensus 82 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~--------~~~~~~~~~ 151 (253)
........ ......++..|+|||.+.+..++.++|+||||+++|+|+++..|......... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 65432221 11223456689999999888889999999999999999997765433211000 000000111
Q ss_pred HHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 152 AMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
....... ...+...+..+.+++.+||+.+|.+||+++++++.|+++
T Consensus 238 ~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111100 111222445788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=215.38 Aligned_cols=189 Identities=22% Similarity=0.310 Sum_probs=145.9
Q ss_pred CEEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
++++|||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~ 153 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhh
Confidence 579999999999999987522 2235899999999999999999999999 999999999999999999999999987
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||........ .. .........
T Consensus 154 ~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~-~~~~~~~~~-- 225 (267)
T cd08229 154 RFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SL-CKKIEQCDY-- 225 (267)
T ss_pred hccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH----HH-hhhhhcCCC--
Confidence 75532221 11234578899999999888889999999999999999999999965433211 00 001100000
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhch
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 207 (253)
+ .......+..+.+++.+||+.||.+|||+.+|++.++++.
T Consensus 226 ---~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 ---P---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ---C---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0 0011234557889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=214.48 Aligned_cols=184 Identities=25% Similarity=0.366 Sum_probs=144.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+++++|.+++.+... ..+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||+++
T Consensus 70 ~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~ 145 (257)
T cd05040 70 LMMVTELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMR 145 (257)
T ss_pred EEEEEEecCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccc
Confidence 5899999999999999987542 35899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcce--eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHL--TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
......... .....++..|++||.+.+..++.++|+|||||++|+|++ |..||......+... ........
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~------~~~~~~~~ 219 (257)
T cd05040 146 ALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK------KIDKEGER 219 (257)
T ss_pred cccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HHHhcCCc
Confidence 664322111 112345678999999988889999999999999999998 999997654432111 11100000
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
...+...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus 220 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 ---------LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0011223456888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=226.44 Aligned_cols=172 Identities=27% Similarity=0.390 Sum_probs=136.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|..++.... .+++..+..++.||+.||.|||+.| ++||||||+||+++.++.++|+|||+++
T Consensus 71 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~ 144 (325)
T cd05604 71 LYFVLDFVNGGELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCK 144 (325)
T ss_pred EEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcc
Confidence 489999999999999887644 5899999999999999999999999 9999999999999999999999999986
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||......+. +..... ... .
T Consensus 145 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~------~~~~~~-~~~--~ 214 (325)
T cd05604 145 EGIAQS-DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM------YDNILH-KPL--V 214 (325)
T ss_pred cCCCCC-CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH------HHHHHc-CCc--c
Confidence 432211 122335689999999999988899999999999999999999999977553321 111111 110 0
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMK 197 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~ 197 (253)
. ....+..+.+++.+||+.||.+||++.
T Consensus 215 ~--------~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 215 L--------RPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred C--------CCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 0 111234577899999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=224.65 Aligned_cols=182 Identities=23% Similarity=0.337 Sum_probs=138.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 48999999999999998654 3888999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCC----CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQ----FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
..............||+.|+|||++.+.. ++.++|+|||||++|+|++|..||....... .+........
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~~ 264 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMNHKN 264 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCC
Confidence 65433222233456899999999997543 7889999999999999999999998755422 1111111111
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRK--RPTMKEVAFEL 203 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~l~~~l 203 (253)
...... ....+..+.++|..||..++.+ |+++.+++++.
T Consensus 265 ~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 265 SLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111110 1123456788999999844433 78999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=215.00 Aligned_cols=185 Identities=25% Similarity=0.381 Sum_probs=141.8
Q ss_pred CEEEEeecCCCChhHHhhccC----CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC-----ce
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT----EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF-----RA 72 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~-----~~ 72 (253)
+++||||+++++|.+++.+.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .+
T Consensus 74 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~ 150 (269)
T cd05044 74 QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVV 150 (269)
T ss_pred eEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcce
Confidence 589999999999999997532 1224788999999999999999999999 99999999999999877 89
Q ss_pred EEcccCCcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHH
Q 044510 73 KISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFL 150 (253)
Q Consensus 73 kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~ 150 (253)
+++|||++......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+. .
T Consensus 151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~-------~ 223 (269)
T cd05044 151 KIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV-------L 223 (269)
T ss_pred EECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH-------H
Confidence 99999998754322111 1112234678999999998889999999999999999998 9999875543221 1
Q ss_pred HHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 151 RAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
......... ..+...+..+.+++.+||..+|.+||+++++++.|++
T Consensus 224 ~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 224 QHVTAGGRL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HHHhcCCcc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111100 1122334568889999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=228.29 Aligned_cols=181 Identities=26% Similarity=0.363 Sum_probs=139.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.... .+++..+..++.|++.||.|||..+ ++||||||+||+++.++.++|+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 149 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCT 149 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccce
Confidence 589999999999999997654 4899999999999999999999999 9999999999999999999999999886
Q ss_pred cccCCCcc-------------------------------------eeeeccccccccccchhccCCCCCCCCeehhHHHH
Q 044510 82 YVTIDQTH-------------------------------------LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVF 124 (253)
Q Consensus 82 ~~~~~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 124 (253)
........ .....+||+.|+|||++.+..++.++|+|||||++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 229 (364)
T cd05599 150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229 (364)
T ss_pred eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence 54211100 01123589999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 044510 125 VGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT---MKEVAF 201 (253)
Q Consensus 125 ~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps---~~~l~~ 201 (253)
|+|++|..||......+. ............... ....+..+.+++.+||. +|.+|++ ++++++
T Consensus 230 ~el~~G~~Pf~~~~~~~~------~~~i~~~~~~~~~~~-------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 230 YEMLVGYPPFCSDNPQET------YRKIINWKETLQFPD-------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred HHhhcCCCCCCCCCHHHH------HHHHHcCCCccCCCC-------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999999999987654321 111111110000000 11234467889999997 9999997 888887
Q ss_pred H
Q 044510 202 E 202 (253)
Q Consensus 202 ~ 202 (253)
+
T Consensus 296 h 296 (364)
T cd05599 296 H 296 (364)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=229.97 Aligned_cols=179 Identities=26% Similarity=0.388 Sum_probs=146.6
Q ss_pred EEEEeecCCCChhHHhhccCCCCCC--CHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec-CCCceEEcccCC
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTI--TWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD-DKFRAKISDFGA 79 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~--~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~-~~~~~kl~Dfgl 79 (253)
-|.||-.+||+|.+++... .+++ ++..+-...+||++||.|||... |||||||.+|||++ -+|.+||+|||-
T Consensus 648 kIFMEqVPGGSLSsLLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGT 722 (1226)
T KOG4279|consen 648 KIFMEQVPGGSLSSLLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGT 722 (1226)
T ss_pred EEEeecCCCCcHHHHHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEeccccc
Confidence 4789999999999999863 3355 88888889999999999999999 99999999999996 688999999998
Q ss_pred cccccCCCcceeeeccccccccccchhccC--CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSS--QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
++... .....+.+..||.-|||||++..+ .|..++|||||||++.||.||++||.........
T Consensus 723 sKRLA-ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-------------- 787 (1226)
T KOG4279|consen 723 SKRLA-GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-------------- 787 (1226)
T ss_pred chhhc-cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------------
Confidence 76542 122244557799999999999765 4899999999999999999999999765433210
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAF 201 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 201 (253)
.+..--....+.+|.+.+.+++.+|.+|+.+||.+||+++++++
T Consensus 788 MFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 788 MFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred hhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 11111233456778888999999999999999999999999985
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=220.87 Aligned_cols=192 Identities=20% Similarity=0.289 Sum_probs=136.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+. ++|.+++..... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 151 (303)
T cd07869 78 LTLVFEYVH-TDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR 151 (303)
T ss_pred EEEEEECCC-cCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcce
Confidence 489999995 688888865432 4889999999999999999999999 9999999999999999999999999886
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc---c
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN---C 157 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~ 157 (253)
...... .......+++.|+|||++.+. .++.++|+||+||++|+|++|..||.+....... ........... .
T Consensus 152 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~ 228 (303)
T cd07869 152 AKSVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ--LERIFLVLGTPNEDT 228 (303)
T ss_pred eccCCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhCCCChhh
Confidence 443211 122234578899999998754 4788999999999999999999999865332110 00000000000 0
Q ss_pred c------cch--------hchhhhhhh-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 L------FDM--------LDAQVLKEA-KEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~------~~~--------~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ... ......... ....+..+.+++.+||+.||.+|||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0 000 000000000 00122467889999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=226.73 Aligned_cols=182 Identities=21% Similarity=0.303 Sum_probs=137.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.+.. .+++..+..++.|++.||.|||..+ |+||||||+||+++.++.++|+|||++.
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~ 149 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCT 149 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence 489999999999999997654 4899999999999999999999999 9999999999999999999999999875
Q ss_pred cccCCCc----------------------------------------------ceeeeccccccccccchhccCCCCCCC
Q 044510 82 YVTIDQT----------------------------------------------HLTTRVQGTFGYLDLEYFRSSQFTKKG 115 (253)
Q Consensus 82 ~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~ 115 (253)
....... .......||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 229 (381)
T cd05626 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC 229 (381)
T ss_pred ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcc
Confidence 3311000 001124689999999999988899999
Q ss_pred CeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhc--ccCCCCC
Q 044510 116 DVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCL--NLNGRKR 193 (253)
Q Consensus 116 Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl--~~dP~~R 193 (253)
|+|||||++|+|++|..||......+.. ............ ......+..+.+++.+|+ ..+|..|
T Consensus 230 DiwSlG~il~elltG~~Pf~~~~~~~~~------~~i~~~~~~~~~-------~~~~~~s~~~~dli~~ll~~~~~~~~R 296 (381)
T cd05626 230 DWWSVGVILFEMLVGQPPFLAPTPTETQ------LKVINWENTLHI-------PPQVKLSPEAVDLITKLCCSAEERLGR 296 (381)
T ss_pred ceeehhhHHHHHHhCCCCCcCCCHHHHH------HHHHccccccCC-------CCCCCCCHHHHHHHHHHccCcccccCC
Confidence 9999999999999999999876543211 111110000000 001123446778898854 5666679
Q ss_pred CCHHHHHHH
Q 044510 194 PTMKEVAFE 202 (253)
Q Consensus 194 ps~~~l~~~ 202 (253)
+++++++++
T Consensus 297 ~~~~~~l~h 305 (381)
T cd05626 297 NGADDIKAH 305 (381)
T ss_pred CCHHHHhcC
Confidence 999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=218.79 Aligned_cols=187 Identities=23% Similarity=0.384 Sum_probs=142.6
Q ss_pred CEEEEeecCCCChhHHhhccCC-------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKI 74 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl 74 (253)
.++||||+++|+|.+++..... ...+....+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 4899999999999999975321 123567788999999999999999999 999999999999999999999
Q ss_pred cccCCcccccCCCcce-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHH
Q 044510 75 SDFGASRYVTIDQTHL-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRA 152 (253)
Q Consensus 75 ~Dfgl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~ 152 (253)
+|||+++......... .....++..|++||.+.+..++.++|+|||||++|+|++ |..||......+. ....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~------~~~~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV------LKFV 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHH
Confidence 9999987543221111 112234567999999988889999999999999999998 7889876543321 1111
Q ss_pred HhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhch
Q 044510 153 MKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207 (253)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 207 (253)
.... .. ..+...+..+.+++.+||+.||.+||++.++++.|+...
T Consensus 235 ~~~~-~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 MDGG-YL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HcCC-CC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111 10 011223457889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=213.25 Aligned_cols=182 Identities=22% Similarity=0.388 Sum_probs=141.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+++++|.+++..... .+++..+..++.+++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 67 ~~~v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~ 141 (251)
T cd05041 67 IYIVMELVPGGSLLTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR 141 (251)
T ss_pred eEEEEEcCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccc
Confidence 5899999999999999976432 4889999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCccee-eeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTHLT-TRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
.......... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||.......... ......
T Consensus 142 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~-------~~~~~~-- 212 (251)
T cd05041 142 EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE-------RIESGY-- 212 (251)
T ss_pred cccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH-------HHhcCC--
Confidence 5432111111 11223567999999988889999999999999999999 888887655432111 111110
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
....+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 213 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 213 -------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 00112233457888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=213.81 Aligned_cols=180 Identities=23% Similarity=0.420 Sum_probs=141.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 73 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~ 148 (254)
T cd05083 73 LYIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLAR 148 (254)
T ss_pred cEEEEECCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccce
Confidence 479999999999999997643 225889999999999999999999999 9999999999999999999999999886
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
...... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||......+. ..........
T Consensus 149 ~~~~~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~~- 216 (254)
T cd05083 149 VGSMGV----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV-------KECVEKGYRM- 216 (254)
T ss_pred eccccC----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH-------HHHHhCCCCC-
Confidence 532111 11223567999999988889999999999999999998 9999976554321 1111111110
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
..+...+..+.+++.+||+.+|.+||+++++++.|+.
T Consensus 217 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 --------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1112234567889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=225.95 Aligned_cols=182 Identities=26% Similarity=0.342 Sum_probs=136.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~ 149 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCT 149 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcc
Confidence 489999999999999998654 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCc----------------------------------ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHH
Q 044510 82 YVTIDQT----------------------------------HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGL 127 (253)
Q Consensus 82 ~~~~~~~----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 127 (253)
....... .......||+.|+|||++.+..++.++|+|||||++|+|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 229 (363)
T cd05628 150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229 (363)
T ss_pred cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHH
Confidence 5421100 001234689999999999988899999999999999999
Q ss_pred HhCCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 044510 128 LTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLN--LNGRKRPTMKEVAFE 202 (253)
Q Consensus 128 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~--~dP~~Rps~~~l~~~ 202 (253)
++|..||......+.. .......... ...+ ....+..+.+++.+++. .++..||++++|+++
T Consensus 230 l~G~~Pf~~~~~~~~~------~~i~~~~~~~-~~p~------~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 230 LIGYPPFCSETPQETY------KKVMNWKETL-IFPP------EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HhCCCCCCCCCHHHHH------HHHHcCcCcc-cCCC------cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9999999876543211 1111100000 0000 01123456778877654 334457899999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=215.12 Aligned_cols=180 Identities=23% Similarity=0.340 Sum_probs=141.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+++++|.+++..... ..+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.++++|||++.
T Consensus 73 ~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 73 LYIVMEYCDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EEEEEeeCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcce
Confidence 5899999999999998875432 24889999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||........ ... .......
T Consensus 149 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~-~~~~~~~-- 218 (255)
T cd08219 149 LLTSPG-AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILK-VCQGSYK-- 218 (255)
T ss_pred eecccc-cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHH-HhcCCCC--
Confidence 553221 122234578899999999888889999999999999999999999976543221 111 1111111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+||++.+++..
T Consensus 219 -------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 -------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1122234467889999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=215.10 Aligned_cols=184 Identities=22% Similarity=0.385 Sum_probs=143.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||++.
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSR 154 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccc
Confidence 5899999999999999976532 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeee--ccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHLTTR--VQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
............ ..++..|++||.+.+..++.++|+|+||+++|++++ |..||......+.. ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~-------~~~~~~~~ 227 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI-------KAIEEGYR 227 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH-------HHHhCCCc
Confidence 654332221111 123457999999998889999999999999999886 99998765433211 11111100
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
...+...+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 228 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 ---------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 001112344678899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=227.67 Aligned_cols=177 Identities=23% Similarity=0.377 Sum_probs=143.2
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC-CCceEEcccCCcc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD-KFRAKISDFGASR 81 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~-~~~~kl~Dfgl~~ 81 (253)
.+|+|.++.|+|+.++.+.+ ..+.+.+.+|++||+.||.|||++. +||+|||||.+||||++ .|.|||+|+||+.
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT 194 (632)
T ss_pred eeeeecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHH
Confidence 47999999999999999876 5999999999999999999999987 67999999999999985 5899999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
.... ...+..+|||+|||||.+. ..|.+.+||||||+.++||+|+..||.... +..+.+.. ...+..+..
T Consensus 195 l~r~---s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQIYKK-V~SGiKP~s 264 (632)
T KOG0584|consen 195 LLRK---SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQIYKK-VTSGIKPAA 264 (632)
T ss_pred Hhhc---cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHHHHHH-HHcCCCHHH
Confidence 7642 2344478999999999998 889999999999999999999999986533 33333333 322222111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
+ . .-..+++++||.+||.. ...|||+.|+++.
T Consensus 265 l-----~---kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 265 L-----S---KVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred h-----h---ccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 1 1 11134688899999999 9999999999965
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=227.42 Aligned_cols=165 Identities=21% Similarity=0.318 Sum_probs=126.4
Q ss_pred CCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcccccCCCcc-eeeeccccccccccc
Q 044510 26 TITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLE 104 (253)
Q Consensus 26 ~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE 104 (253)
.+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.+||+|||+++........ ......+++.|+|||
T Consensus 233 ~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 309 (400)
T cd05105 233 GLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE 309 (400)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChh
Confidence 3778888999999999999999999 999999999999999999999999998755322211 112234567899999
Q ss_pred hhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHH
Q 044510 105 YFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAK 183 (253)
Q Consensus 105 ~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 183 (253)
.+.+..++.++|+|||||++|+|++ |..||........ ........... ..+...+..+.+++.
T Consensus 310 ~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~l~~li~ 374 (400)
T cd05105 310 SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST------FYNKIKSGYRM---------AKPDHATQEVYDIMV 374 (400)
T ss_pred hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH------HHHHHhcCCCC---------CCCccCCHHHHHHHH
Confidence 9988889999999999999999997 8899875432211 11111111100 112233456888999
Q ss_pred HhcccCCCCCCCHHHHHHHHhhchh
Q 044510 184 RCLNLNGRKRPTMKEVAFELGGIRA 208 (253)
Q Consensus 184 ~cl~~dP~~Rps~~~l~~~l~~~~~ 208 (253)
+||+.||.+||++.+|.++|+++..
T Consensus 375 ~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 375 KCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHCccCHhHCcCHHHHHHHHHHHcC
Confidence 9999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-32 Score=215.50 Aligned_cols=189 Identities=20% Similarity=0.272 Sum_probs=145.3
Q ss_pred CEEEEeecCCCChhHHhhccCC-CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.++|+||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~ 153 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccc
Confidence 4799999999999998865321 224889999999999999999999999 999999999999999999999999988
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
........ ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||....... ... ...........
T Consensus 154 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~-~~~~~~~~~~~ 227 (267)
T cd08228 154 RFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSL-CQKIEQCDYPP 227 (267)
T ss_pred eeccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHH-HHHHhcCCCCC
Confidence 76532221 1122457789999999988888999999999999999999999986543211 111 11111111100
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhch
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 207 (253)
......+..+.+++.+||+.+|.+||++.++++.|++++
T Consensus 228 --------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 --------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111233456889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=218.05 Aligned_cols=132 Identities=25% Similarity=0.424 Sum_probs=107.5
Q ss_pred EEEEeecCCCChhHHhhccC------CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceee----cCCCce
Q 044510 3 LLVYEFIPNGTLYRYIHDQT------EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILL----DDKFRA 72 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili----~~~~~~ 72 (253)
|+||||+. ++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.+
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~ 151 (317)
T cd07868 76 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRV 151 (317)
T ss_pred EEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcE
Confidence 78999994 58988875421 1224889999999999999999999999 9999999999999 455789
Q ss_pred EEcccCCcccccCCCc--ceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCC
Q 044510 73 KISDFGASRYVTIDQT--HLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTD 138 (253)
Q Consensus 73 kl~Dfgl~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~ 138 (253)
||+|||+++....... .......+|+.|+|||++.+. .++.++|+||+||++|+|++|..||....
T Consensus 152 kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 152 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred EEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 9999999976543221 122345678999999999764 57899999999999999999999997644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=214.72 Aligned_cols=182 Identities=26% Similarity=0.467 Sum_probs=140.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .++++.++.++.+++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||+++
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 148 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTR 148 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCccee
Confidence 4799999999999999876432 4889999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............++..|+|||.+.+..++.++|+||+|+++|+|++ |..||......+. ........ .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~--~ 219 (256)
T cd05112 149 FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV-------VETINAGF--R 219 (256)
T ss_pred ecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH-------HHHHhCCC--C
Confidence 543221111112224568999999988889999999999999999998 9999976543221 11111110 0
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
... +...+..+.+++.+||+.+|.+||++.+++++|.
T Consensus 220 ~~~-------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 220 LYK-------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCC-------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 001 1112356888999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=216.52 Aligned_cols=192 Identities=21% Similarity=0.366 Sum_probs=142.5
Q ss_pred CEEEEeecCCCChhHHhhccCC--------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE--------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAK 73 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~k 73 (253)
.++||||+.+++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~~~~~ 170 (296)
T cd05051 94 LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIK 170 (296)
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecCCCceE
Confidence 5899999999999999976431 124899999999999999999999999 99999999999999999999
Q ss_pred EcccCCcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh--CCCCCCCCChhhhhhhHHHHH
Q 044510 74 ISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT--GQKPIRSTDTEEDKSLAGYFL 150 (253)
Q Consensus 74 l~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt--g~~pf~~~~~~~~~~~~~~~~ 150 (253)
|+|||+++........ ......+++.|+|||.+.+..++.++|+|||||++|+|++ +..||........ .....
T Consensus 171 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~---~~~~~ 247 (296)
T cd05051 171 IADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV---IENAG 247 (296)
T ss_pred EccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH---HHHHH
Confidence 9999998754322211 1222345678999999988889999999999999999998 6778765432221 11111
Q ss_pred HHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 151 RAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
........... ...+...+..+.+++.+||+.||.+||++.+|++.|++
T Consensus 248 ~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 248 HFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred hcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11000000000 00112233568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=226.15 Aligned_cols=190 Identities=21% Similarity=0.249 Sum_probs=138.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred EEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 4899999955 78877753 3788899999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHH--------HHHH-
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGY--------FLRA- 152 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~--------~~~~- 152 (253)
..... .......+++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....... +...
T Consensus 175 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 175 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 54322 122334678999999999988899999999999999999999999987654332111100 0000
Q ss_pred -------Hhhccccchh-----chhh----hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 153 -------MKENCLFDML-----DAQV----LKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 153 -------~~~~~~~~~~-----~~~~----~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.......... .+.. ...........+++++.+||+.||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000 0000 000111223568899999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=216.04 Aligned_cols=182 Identities=27% Similarity=0.314 Sum_probs=140.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||++|++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 75 ~~lv~e~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~ 150 (285)
T cd05630 75 LCLVLTLMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAV 150 (285)
T ss_pred EEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeecccee
Confidence 4799999999999999865432 24899999999999999999999999 9999999999999999999999999886
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.......... .........
T Consensus 151 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~---~~~~~~~~~----- 220 (285)
T cd05630 151 HVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLVKEV----- 220 (285)
T ss_pred ecCCCc--cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH---HHHhhhhhh-----
Confidence 543221 1223468899999999998889999999999999999999999997643221110 001100000
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT-----MKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~~ 202 (253)
....+......+.+++.+||+.||.+||+ +++++++
T Consensus 221 -----~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 221 -----QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred -----hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 01112223446788999999999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=224.86 Aligned_cols=190 Identities=21% Similarity=0.243 Sum_probs=137.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||..+ ++||||||+||+++.++.++|+|||+++
T Consensus 101 ~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 101 VYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred eEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 4899999965 67776642 3788899999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHH-------------
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGY------------- 148 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~------------- 148 (253)
..... .......+++.|+|||.+.+..++.++|+||+||++|+|++|..||...+..........
T Consensus 172 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 172 TACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 54321 122334678999999999988899999999999999999999999987654321110000
Q ss_pred ---HHHHHhhccccchhc-----hhh----hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 149 ---FLRAMKENCLFDMLD-----AQV----LKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 149 ---~~~~~~~~~~~~~~~-----~~~----~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
............... +.. ...........+.+++.+||+.||.+|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000000000 000 000111224568899999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=227.49 Aligned_cols=181 Identities=21% Similarity=0.319 Sum_probs=136.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++.+.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 489999999999999997654 4889999999999999999999999 9999999999999999999999999875
Q ss_pred cccCCC----------------------------------------------cceeeeccccccccccchhccCCCCCCC
Q 044510 82 YVTIDQ----------------------------------------------THLTTRVQGTFGYLDLEYFRSSQFTKKG 115 (253)
Q Consensus 82 ~~~~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 115 (253)
.+.... ........||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 229 (382)
T cd05625 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 229 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCee
Confidence 321000 0001124689999999999988899999
Q ss_pred CeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC
Q 044510 116 DVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT 195 (253)
Q Consensus 116 Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps 195 (253)
|+||+||++|+|++|..||......+.. ............ ......+..+.+++.+|+ .+|.+|++
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~------~~i~~~~~~~~~-------p~~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFLAQTPLETQ------MKVINWQTSLHI-------PPQAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred eEEechHHHHHHHhCCCCCCCCCHHHHH------HHHHccCCCcCC-------CCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence 9999999999999999999876543211 111110000000 001123345677888876 59999987
Q ss_pred ---HHHHHHH
Q 044510 196 ---MKEVAFE 202 (253)
Q Consensus 196 ---~~~l~~~ 202 (253)
+.+++++
T Consensus 296 ~~~~~ei~~h 305 (382)
T cd05625 296 KNGADEIKAH 305 (382)
T ss_pred CCCHHHHhcC
Confidence 8887764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=213.52 Aligned_cols=184 Identities=30% Similarity=0.520 Sum_probs=140.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+.+++|.+++.... .+++..++.++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||.+.
T Consensus 73 ~~~v~~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 73 LYIVMEYCPGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSV 146 (260)
T ss_dssp EEEEEEEETTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred ccccccccccccccccccccc---ccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 479999999999999998433 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhc-cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR-SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
... ..........++..|+|||.+. +..++.++|+||+|+++++|++|..||............. ...... .
T Consensus 147 ~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~~~-~-- 219 (260)
T PF00069_consen 147 KLS-ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILKRP-L-- 219 (260)
T ss_dssp EST-STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHHTH-H--
T ss_pred ccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hccccc-c--
Confidence 542 1222333456788999999998 7778999999999999999999999998763222111111 110000 0
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..... ........+.+++.+||+.||.+||++.+++++
T Consensus 220 --~~~~~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 220 --PSSSQ--QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp --HHHTT--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred --ccccc--ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 000011578899999999999999999999853
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=224.51 Aligned_cols=194 Identities=22% Similarity=0.299 Sum_probs=141.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|||++. ++|.+++.... .+++..++.++.|++.||.|||..+ |+||||||+||+++.++.++|+|||+++
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRSG---PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred EEEEehhcC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 479999994 68988885433 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc-
Q 044510 82 YVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF- 159 (253)
Q Consensus 82 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 159 (253)
........ ......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+..............+........
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 55432221 1223568999999999998889999999999999999999999997654322111111111111000000
Q ss_pred -c-----------hhchhhhhh-------hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 -D-----------MLDAQVLKE-------AKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 -~-----------~~~~~~~~~-------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ......... ........+.++|.+||..||.+||++.+++.+
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 000000000 001123467889999999999999999999976
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=215.12 Aligned_cols=187 Identities=25% Similarity=0.447 Sum_probs=145.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccc
Confidence 4799999999999999987533 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCccee-eeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTHLT-TRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
.......... ....++..|++||.+....++.++|+||||+++|++++ |..||......+.. .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~ 230 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP-------DLLEKGERL 230 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH-------HHHhCCCCC
Confidence 6542221111 11123467999999988888999999999999999998 99999776543311 111111000
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
..+...+..+.+++.+||..||.+||++.++++.|..+...
T Consensus 231 ---------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 231 ---------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 00111223577899999999999999999999999987553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=218.99 Aligned_cols=179 Identities=24% Similarity=0.372 Sum_probs=140.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+++++|.+++... .+++..+..++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++.
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred EEEeecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccch
Confidence 48999999999999998653 3789999999999999999999999 9999999999999999999999999877
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
....... ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||......... ....... ....
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~------~~~~~~~-~~~~ 236 (296)
T cd06654 165 QITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNG-TPEL 236 (296)
T ss_pred hcccccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH------HHHhcCC-CCCC
Confidence 5432211 112245788999999998888899999999999999999999999765432210 0001000 0000
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+......+.+++.+||..||.+||++.+++++
T Consensus 237 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 -------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1122344568889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=214.04 Aligned_cols=192 Identities=22% Similarity=0.354 Sum_probs=141.6
Q ss_pred CEEEEeecCCCChhHHhhccCC--------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE--------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAK 73 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~k 73 (253)
.++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~~~~~ 170 (296)
T cd05095 94 LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIK 170 (296)
T ss_pred cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCCCCEE
Confidence 4899999999999999976421 123777889999999999999999999 99999999999999999999
Q ss_pred EcccCCcccccCCCcce-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh--CCCCCCCCChhhhhhhHHHHH
Q 044510 74 ISDFGASRYVTIDQTHL-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT--GQKPIRSTDTEEDKSLAGYFL 150 (253)
Q Consensus 74 l~Dfgl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt--g~~pf~~~~~~~~~~~~~~~~ 150 (253)
|+|||+++......... ......+..|++||...++.++.++|+|||||++|+|++ |..||......+..... .
T Consensus 171 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~---~ 247 (296)
T cd05095 171 IADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENT---G 247 (296)
T ss_pred eccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHH---H
Confidence 99999987543222111 111233568999999888889999999999999999998 77888765443211111 1
Q ss_pred HHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 151 RAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
............ ..+...+..+.+++.+||+.||.+||++.+|++.|++
T Consensus 248 ~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 248 EFFRDQGRQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHhhccccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111110000000 0111233568889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=216.38 Aligned_cols=181 Identities=24% Similarity=0.318 Sum_probs=138.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+.+++|.+++.... ...+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCce
Confidence 479999999999999988643 225899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhcc-----CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-----SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
...... .......+++.|+|||++.+ ..++.++|+||+||++|+|++|..||.......... .....
T Consensus 160 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-------~~~~~ 231 (272)
T cd06637 160 QLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-------LIPRN 231 (272)
T ss_pred eccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-------HHhcC
Confidence 543221 12233457889999999862 357889999999999999999999996544322111 00111
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..... .....+..+.+++.+||+.||.+||++.+++++
T Consensus 232 ~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 PAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 11111 111233468889999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=213.66 Aligned_cols=184 Identities=22% Similarity=0.428 Sum_probs=141.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++.
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccc
Confidence 4899999999999999976432 4899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCccee-e-ecc--ccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 82 YVTIDQTHLT-T-RVQ--GTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 82 ~~~~~~~~~~-~-~~~--~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
.......... . ... .+..|++||.+.+..++.++|+||+||++|+|++ |..||......+. .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~-------~~~i~~~ 227 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-------INAIEQD 227 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH-------HHHHHcC
Confidence 5533221111 1 111 1347999999998889999999999999999886 9999876543221 1111111
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
. .. ..+...+..+.+++.+||+.+|.+||++.+++..|+++
T Consensus 228 -~-~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 -Y-RL-------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -C-cC-------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00 01112334578899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=217.18 Aligned_cols=201 Identities=25% Similarity=0.274 Sum_probs=148.8
Q ss_pred EEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC-CceEEcccCCc
Q 044510 3 LLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK-FRAKISDFGAS 80 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~-~~~kl~Dfgl~ 80 (253)
.+||||++. +|.++++... .+..++.-.+.-++.||..||.|||..+ |+||||||+|+|++.+ +.+||+|||.|
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcc
Confidence 378999977 8999998521 1124777888889999999999999999 9999999999999965 89999999999
Q ss_pred ccccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHH--------H
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFL--------R 151 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~--------~ 151 (253)
+....+. .+.....+..|+|||.+.|. .|+.+.||||.||++.||+-|++.|.+....++...+-.+. .
T Consensus 174 K~L~~~e--pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 174 KVLVKGE--PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eeeccCC--CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 8775433 33445568899999999875 59999999999999999999999999876654433332221 1
Q ss_pred HHhhc----cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhchhh
Q 044510 152 AMKEN----CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE--LGGIRAS 209 (253)
Q Consensus 152 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~--l~~~~~~ 209 (253)
.+..+ ....+..............+++.+++.++|..+|.+|.++.+++.+ +.+++..
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 11111 0111111111112344566789999999999999999999999876 4555443
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=225.89 Aligned_cols=181 Identities=24% Similarity=0.338 Sum_probs=137.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~ 149 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLST 149 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccc
Confidence 589999999999999997654 5899999999999999999999999 9999999999999999999999999986
Q ss_pred cccCCCcc----------------------------------------------eeeeccccccccccchhccCCCCCCC
Q 044510 82 YVTIDQTH----------------------------------------------LTTRVQGTFGYLDLEYFRSSQFTKKG 115 (253)
Q Consensus 82 ~~~~~~~~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~ 115 (253)
.+...... ......||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 229 (377)
T cd05629 150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce
Confidence 33210000 00123589999999999988899999
Q ss_pred CeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCC--
Q 044510 116 DVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKR-- 193 (253)
Q Consensus 116 Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R-- 193 (253)
|+|||||++|+|++|..||......+.. .............+ ....+..+.+++.+||. +|.+|
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~------~~i~~~~~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~ 295 (377)
T cd05629 230 DWWSLGAIMFECLIGWPPFCSENSHETY------RKIINWRETLYFPD-------DIHLSVEAEDLIRRLIT-NAENRLG 295 (377)
T ss_pred eeEecchhhhhhhcCCCCCCCCCHHHHH------HHHHccCCccCCCC-------CCCCCHHHHHHHHHHhc-CHhhcCC
Confidence 9999999999999999999765543211 11111000000000 01233467889999998 66665
Q ss_pred -CCHHHHHHH
Q 044510 194 -PTMKEVAFE 202 (253)
Q Consensus 194 -ps~~~l~~~ 202 (253)
+++.+++++
T Consensus 296 r~~~~~~l~h 305 (377)
T cd05629 296 RGGAHEIKSH 305 (377)
T ss_pred CCCHHHHhcC
Confidence 599999886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=225.58 Aligned_cols=190 Identities=19% Similarity=0.194 Sum_probs=138.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 97 ~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 97 VYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred eEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccc
Confidence 4899999965 67777643 3788999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHH-------------
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGY------------- 148 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~------------- 148 (253)
..... .......+++.|+|||++.+..++.++|+|||||++|+|++|..||.+....+.......
T Consensus 168 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 168 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 54322 122335688999999999988899999999999999999999999987654322110000
Q ss_pred ---HHHHHhhccc-cchhchhh--------hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 149 ---FLRAMKENCL-FDMLDAQV--------LKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 149 ---~~~~~~~~~~-~~~~~~~~--------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.......... .....+.. ...........+++++.+||+.||.+|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000 00000000 000111234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=216.19 Aligned_cols=185 Identities=21% Similarity=0.387 Sum_probs=141.1
Q ss_pred CEEEEeecCCCChhHHhhccCC-------------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-------------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~ 62 (253)
+++||||+++++|.+++..... ...+++..++.++.|++.||.|||..+ ++|+||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 4899999999999999974321 124788899999999999999999999 999999999
Q ss_pred ceeecCCCceEEcccCCcccccCCCcce-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChh
Q 044510 63 NILLDDKFRAKISDFGASRYVTIDQTHL-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTE 140 (253)
Q Consensus 63 nili~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~ 140 (253)
||+++.++.++|+|||++.......... ......+..|+|||...+..++.++|+|||||++|+|++ |..||.+....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999887543221111 111234567999999988889999999999999999997 88888655433
Q ss_pred hhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 141 EDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
+. .......... ..+...+..+.+++.+||+.||.+||++.|+++.|++
T Consensus 240 ~~-------~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 EV-------IYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HH-------HHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 21 1111111111 0112234568889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=217.74 Aligned_cols=184 Identities=21% Similarity=0.320 Sum_probs=137.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.+... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 150 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCL 150 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCcee
Confidence 4899999999999999976332 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhcc-----CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-----SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
..............|++.|+|||++.. ..++.++|+||+||++|+|++|..||......+. ........
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~ 224 (331)
T cd05597 151 RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHK 224 (331)
T ss_pred ecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCC
Confidence 554332222233458999999999863 3467899999999999999999999976543221 11111111
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRK--RPTMKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~l~~~ 202 (253)
..... . ......+..+.+++.+||..++++ |+++++++++
T Consensus 225 ~~~~~-~-----~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 225 EHFQF-P-----PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CcccC-C-----CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11110 0 001123456788999988654443 7899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=221.27 Aligned_cols=184 Identities=20% Similarity=0.315 Sum_probs=138.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++.+... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~ 150 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL 150 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchhe
Confidence 4899999999999999976432 4899999999999999999999999 9999999999999999999999999986
Q ss_pred cccCCCcceeeeccccccccccchhcc-----CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-----SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
..............|++.|+|||++.+ ..++.++|+|||||++|+|++|..||......+. +.......
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~ 224 (332)
T cd05623 151 KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHK 224 (332)
T ss_pred ecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHHhCCC
Confidence 543322222333568999999999862 3578899999999999999999999976543321 11111111
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRK--RPTMKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~l~~~ 202 (253)
.... .+......+..+.+++.+||..++.+ |+++.+++++
T Consensus 225 ~~~~------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 225 ERFQ------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cccc------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0000 01111233456888999998654444 6899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=224.46 Aligned_cols=177 Identities=23% Similarity=0.325 Sum_probs=132.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+.. ...+..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 147 ~~lv~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 147 IQVLLEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSR 216 (353)
T ss_pred EEEEEecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccce
Confidence 47999999999986532 3567788899999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccC-----CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-----QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
...... .......|+..|+|||.+... ..+.++|||||||++|+|++|..||......+. ...........
T Consensus 217 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~ 292 (353)
T PLN00034 217 ILAQTM-DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW---ASLMCAICMSQ 292 (353)
T ss_pred eccccc-ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH---HHHHHHHhccC
Confidence 653221 122335689999999987532 235689999999999999999999974332211 11001110000
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
....+...+..+.+++.+||+.||.+||+++|++++
T Consensus 293 ----------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 ----------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122344568899999999999999999999975
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=218.19 Aligned_cols=175 Identities=23% Similarity=0.297 Sum_probs=144.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||..|.||+|.-.|.+.+. +.++++.+.-.+.+|+.||.+||..+ ||+||+||+|||+++.|.++|+|+||+.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAV 335 (591)
T ss_pred eEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEE
Confidence 5899999999999999988764 46999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
.+... ......+||.+|||||++....|+...|.|++||++|+|+.|+.||........ . +.+.....
T Consensus 336 ei~~g--~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk---~----eEvdrr~~--- 403 (591)
T KOG0986|consen 336 EIPEG--KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK---R----EEVDRRTL--- 403 (591)
T ss_pred ecCCC--CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh---H----HHHHHHHh---
Confidence 77533 233345899999999999999999999999999999999999999976543221 0 01111101
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT 195 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps 195 (253)
....+.+..++++++++.+..|..||.+|.-
T Consensus 404 ---~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 404 ---EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred ---cchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 1122455677788999999999999999864
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=214.27 Aligned_cols=179 Identities=26% Similarity=0.438 Sum_probs=140.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 589999999999999997654 4889999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcc-----eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 82 YVTIDQTH-----LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 82 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
........ ......++..|+|||.+.+..++.++|+|++|+++|+|++|..||........ ...... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~-~ 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA------IFKIGE-N 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH------HHHHhc-c
Confidence 65421111 11123477899999999888889999999999999999999999976533211 011110 0
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ....+...+..+.+++.+||+.||.+||++.+++++
T Consensus 228 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 228 A---------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred C---------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0 111122334568889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=227.99 Aligned_cols=181 Identities=22% Similarity=0.328 Sum_probs=137.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++.... .+++..+..++.||+.||.|||..+ |+||||||+||+++.++.++|+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 489999999999999997654 4889999999999999999999999 9999999999999999999999999874
Q ss_pred cccCCC------------------------------------------cceeeeccccccccccchhccCCCCCCCCeeh
Q 044510 82 YVTIDQ------------------------------------------THLTTRVQGTFGYLDLEYFRSSQFTKKGDVYS 119 (253)
Q Consensus 82 ~~~~~~------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 119 (253)
.+.... ........||+.|+|||++.+..++.++|+||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 229 (376)
T cd05598 150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229 (376)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeee
Confidence 321000 00011246899999999999888999999999
Q ss_pred hHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC---CH
Q 044510 120 FGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP---TM 196 (253)
Q Consensus 120 lG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp---s~ 196 (253)
|||++|+|++|..||......+... ........... ......+..+.+++.+|+ .+|.+|+ ++
T Consensus 230 lGvilyell~G~~Pf~~~~~~~~~~------~i~~~~~~~~~-------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~ 295 (376)
T cd05598 230 VGVILYEMLVGQPPFLADTPAETQL------KVINWETTLHI-------PSQAKLSREASDLILRLC-CGAEDRLGKNGA 295 (376)
T ss_pred ccceeeehhhCCCCCCCCCHHHHHH------HHhccCccccC-------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCH
Confidence 9999999999999998765432111 11110000000 001123345677888876 5999999 89
Q ss_pred HHHHHH
Q 044510 197 KEVAFE 202 (253)
Q Consensus 197 ~~l~~~ 202 (253)
.+++++
T Consensus 296 ~ell~h 301 (376)
T cd05598 296 DEIKAH 301 (376)
T ss_pred HHHhCC
Confidence 999877
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=220.22 Aligned_cols=193 Identities=21% Similarity=0.367 Sum_probs=135.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|||++. ++|.+++..... .+++..++.++.||+.||.|||..+ |+||||||+||+++.++.++|+|||+++
T Consensus 132 ~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~ 205 (357)
T PHA03209 132 TCMVLPHYS-SDLYTYLTKRSR--PLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQ 205 (357)
T ss_pred eEEEEEccC-CcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccc
Confidence 479999994 589888866432 5899999999999999999999999 9999999999999999999999999986
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCC-CCCCChhhh---hhhHHHHHHHHhhcc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKP-IRSTDTEED---KSLAGYFLRAMKENC 157 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~p-f~~~~~~~~---~~~~~~~~~~~~~~~ 157 (253)
..... .......|++.|+|||++.+..++.++|+|||||++|+|+++..+ |........ ......+........
T Consensus 206 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~ 283 (357)
T PHA03209 206 FPVVA--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK 283 (357)
T ss_pred ccccC--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence 43211 122234589999999999988899999999999999999985544 443222110 001111111111000
Q ss_pred c-cchhc----hhhhh------------------hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 L-FDMLD----AQVLK------------------EAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~-~~~~~----~~~~~------------------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ..... ..... ......+..+.++|.+||+.||.+|||+.|++++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 284 VHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred cChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0 00000 00000 0001223456679999999999999999999865
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=212.50 Aligned_cols=175 Identities=21% Similarity=0.375 Sum_probs=134.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCc--------eE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFR--------AK 73 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~--------~k 73 (253)
.++||||+.+|+|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++. ++
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~ 148 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIK 148 (258)
T ss_pred cEEEEecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEE
Confidence 5799999999999999976543 4899999999999999999999999 999999999999987654 68
Q ss_pred EcccCCcccccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCC-CCCCCCChhhhhhhHHHHHH
Q 044510 74 ISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQ-KPIRSTDTEEDKSLAGYFLR 151 (253)
Q Consensus 74 l~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~-~pf~~~~~~~~~~~~~~~~~ 151 (253)
++|||++..... .....++..|+|||.+.+. .++.++|+||||+++|+|++|. .||..........
T Consensus 149 l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~------- 216 (258)
T cd05078 149 LSDPGISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ------- 216 (258)
T ss_pred ecccccccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-------
Confidence 999998764431 1223467889999999864 4789999999999999999984 6665443322110
Q ss_pred HHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 152 AMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
..... ...+......+.+++.+||+.||.+||+++++++.|+
T Consensus 217 ~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 217 FYEDR-----------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHcc-----------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 0111122245788999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=211.66 Aligned_cols=181 Identities=27% Similarity=0.370 Sum_probs=143.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
++++|||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 74 ~~~~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~ 149 (256)
T cd08221 74 LLIEMEYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISK 149 (256)
T ss_pred EEEEEEecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceE
Confidence 589999999999999997653 235899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+. ...... ....
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~~-~~~~-- 219 (256)
T cd08221 150 ILGSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VVKIVQ-GNYT-- 219 (256)
T ss_pred Ecccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHc-CCCC--
Confidence 6543221 22334578999999999888889999999999999999999999976443221 111111 1111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 203 (253)
..+...+..+.+++.+||+.+|.+||+++++++++
T Consensus 220 -------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 -------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11122344688899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=213.56 Aligned_cols=192 Identities=22% Similarity=0.318 Sum_probs=140.6
Q ss_pred CEEEEeecCCCChhHHhhccCC---------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCce
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE---------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRA 72 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~ 72 (253)
+++||||+.+++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~~~ 168 (295)
T cd05097 92 LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTI 168 (295)
T ss_pred cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCCCcE
Confidence 4899999999999999865321 113688899999999999999999999 9999999999999999999
Q ss_pred EEcccCCcccccCCCcce-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh--CCCCCCCCChhhhhhhHHHH
Q 044510 73 KISDFGASRYVTIDQTHL-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT--GQKPIRSTDTEEDKSLAGYF 149 (253)
Q Consensus 73 kl~Dfgl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt--g~~pf~~~~~~~~~~~~~~~ 149 (253)
||+|||++.......... .....++..|+|||.+.+..++.++|+||||+++++|++ +..||......+.....
T Consensus 169 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~--- 245 (295)
T cd05097 169 KIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENT--- 245 (295)
T ss_pred EecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHH---
Confidence 999999987543221111 112234678999999988889999999999999999988 66777665433211111
Q ss_pred HHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 150 LRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
........... ....+...+..+.+++.+||+.||.+||++++|++.|++
T Consensus 246 ~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 246 GEFFRNQGRQI------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHhhhhccccc------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111000000 000111123468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=216.79 Aligned_cols=178 Identities=23% Similarity=0.308 Sum_probs=139.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~ 145 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 145 (279)
T ss_pred EEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcce
Confidence 479999999999999987654 4999999999999999999999999 9999999999999999999999999986
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
...... .....++..|+|||.+.. ..++.++|+||+||++++|++|..||.......... ........
T Consensus 146 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~~---- 214 (279)
T cd05633 146 DFSKKK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTV---- 214 (279)
T ss_pred eccccC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhhcC----
Confidence 543221 122458899999999863 457899999999999999999999997654322111 11110000
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
....+...+..+.+++.+||+.||.+|| ++++++++
T Consensus 215 ------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 ------NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ------CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0112233445788899999999999999 69999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=214.10 Aligned_cols=177 Identities=25% Similarity=0.360 Sum_probs=140.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+++++|.+++... .+++..+..++.|++.|+.|||..+ ++|+||+|+||+++.++.++++|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06642 77 LWIIMEYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred eEEEEEccCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccc
Confidence 58999999999999988643 4889999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
....... ......++..|++||++.+..++.++|+||||+++|+|++|..||.......... ......
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~~~---- 217 (277)
T cd06642 150 QLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-------LIPKNS---- 217 (277)
T ss_pred cccCcch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-------hhhcCC----
Confidence 5432211 1122346788999999998888999999999999999999999987544322110 000000
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
........+..+.+++.+||+.+|.+||++.+++++
T Consensus 218 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 218 -----PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -----CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 011122334568889999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=213.29 Aligned_cols=177 Identities=24% Similarity=0.326 Sum_probs=141.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++|++|.+++... .+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++++|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~ 149 (277)
T cd06640 77 LWIIMEYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred EEEEEecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccce
Confidence 48999999999999998653 4889999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... ....
T Consensus 150 ~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~------ 215 (277)
T cd06640 150 QLTDTQ-IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-------LIPK------ 215 (277)
T ss_pred eccCCc-cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-------hhhc------
Confidence 553222 12222456788999999988888999999999999999999999997654322110 0000
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..........+..+.+++.+||+.+|.+||++.+++.+
T Consensus 216 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 216 ---NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ---CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 00112233456678899999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=214.38 Aligned_cols=177 Identities=25% Similarity=0.347 Sum_probs=141.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+|+||+++++|.+++... .+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||+++
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 146 (274)
T cd06609 74 LWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSG 146 (274)
T ss_pred EEEEEEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccce
Confidence 58999999999999998764 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......+++.|++||.+.+..++.++|+||||+++|+|++|..||........ ...........
T Consensus 147 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-------~~~~~~~~~~~- 217 (274)
T cd06609 147 QLTSTM-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-------LFLIPKNNPPS- 217 (274)
T ss_pred eecccc-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-------HHHhhhcCCCC-
Confidence 664321 122334578889999999988899999999999999999999999976543211 01111110100
Q ss_pred hchhhhhhhcHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEE-EIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~-~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.... .+..+.+++.+||..+|.+||++++++++
T Consensus 218 --------~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 --------LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred --------CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0111 34468889999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=211.02 Aligned_cols=181 Identities=24% Similarity=0.326 Sum_probs=141.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+++||+.+++|.+++..... .+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 73 ~~l~~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~ 147 (256)
T cd06612 73 LWIVMEYCGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSG 147 (256)
T ss_pred EEEEEecCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccch
Confidence 4799999999999999975432 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
....... ......++..|++||++.+..++.++|+||||+++|+|++|..||.......... ........
T Consensus 148 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~-- 217 (256)
T cd06612 148 QLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-------MIPNKPPP-- 217 (256)
T ss_pred hcccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-------hhccCCCC--
Confidence 6543221 2223447889999999988889999999999999999999999997654322100 00000000
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
....+......+.+++.+||+.||.+||++++++++
T Consensus 218 -----~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 218 -----TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred -----CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 001122234568889999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=209.08 Aligned_cols=174 Identities=22% Similarity=0.390 Sum_probs=133.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCc-------eEE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFR-------AKI 74 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~-------~kl 74 (253)
.++||||+++++|..++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++. +++
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEe
Confidence 4799999999999988875432 4899999999999999999999999 999999999999986553 899
Q ss_pred cccCCcccccCCCcceeeeccccccccccchhc-cCCCCCCCCeehhHHHHHHHH-hCCCCCCCCChhhhhhhHHHHHHH
Q 044510 75 SDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFR-SSQFTKKGDVYSFGVVFVGLL-TGQKPIRSTDTEEDKSLAGYFLRA 152 (253)
Q Consensus 75 ~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll-tg~~pf~~~~~~~~~~~~~~~~~~ 152 (253)
+|||++...... ....++..|+|||.+. +..++.++|+|||||++|+|+ +|..||......+...
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-------- 220 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-------- 220 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH--------
Confidence 999987644211 2234678899999986 456889999999999999997 5888886544322111
Q ss_pred HhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044510 153 MKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203 (253)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 203 (253)
...... ... ......+.+++.+||+.||.+||++.+|++.+
T Consensus 221 ~~~~~~-~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 221 FYEGQC-MLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHhcCc-cCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 001100 000 01124578899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=210.90 Aligned_cols=175 Identities=21% Similarity=0.400 Sum_probs=136.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC-------ceEE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF-------RAKI 74 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~-------~~kl 74 (253)
.++||||+++|+|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .++|
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEe
Confidence 4899999999999999987543 4899999999999999999999999 99999999999999877 7999
Q ss_pred cccCCcccccCCCcceeeeccccccccccchhccC--CCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHH
Q 044510 75 SDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSS--QFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLR 151 (253)
Q Consensus 75 ~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~ 151 (253)
+|||++..... .....++..|+|||++.+. .++.++|+||||+++|+|++ |..||......+....
T Consensus 150 ~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~------ 218 (259)
T cd05037 150 SDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF------ 218 (259)
T ss_pred CCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH------
Confidence 99999875432 1223456789999999876 68899999999999999999 5777766543221110
Q ss_pred HHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 152 AMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
........ ......+.+++.+||..+|.+||++.++++.|+
T Consensus 219 -~~~~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 -YQDQHRLP-----------MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -HhcCCCCC-----------CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000000 000156788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=217.47 Aligned_cols=186 Identities=27% Similarity=0.478 Sum_probs=143.9
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
++++||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence 589999999999999876432 4889999999999999999999999 99999999999999999999999999876
Q ss_pred ccCCCcce-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 83 VTIDQTHL-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 83 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
........ .....++..|++||.+.+..++.++|+||||+++|+|++ |..||........ ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~~ 231 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-------PDLLEKGERLP 231 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHCCCCCC
Confidence 54222111 112234668999999988889999999999999999997 8899876543221 11111111000
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
.+......+.+++.+||..+|.+||+++++++.|+++...
T Consensus 232 ---------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 232 ---------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0111234678899999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=213.07 Aligned_cols=185 Identities=22% Similarity=0.343 Sum_probs=142.2
Q ss_pred CEEEEeecCCCChhHHhhccCCC------CCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEE------FTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKIS 75 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~ 75 (253)
.|+||||+++++|.+++...... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEc
Confidence 58999999999999999765421 14899999999999999999999999 9999999999999999999999
Q ss_pred ccCCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHh
Q 044510 76 DFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMK 154 (253)
Q Consensus 76 Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 154 (253)
|||++...............++..|++||.+.+..++.++|+||||+++++|++ |..||....... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------~~~~~~ 232 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQ 232 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------HHHHHH
Confidence 999876443222222223345677999999988888999999999999999998 788886543221 111111
Q ss_pred hccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 155 ENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
...... ..+...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus 233 ~~~~~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 AGKLEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCcCC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111110 011223346888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=215.14 Aligned_cols=196 Identities=21% Similarity=0.254 Sum_probs=138.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+. ++|.+++........+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 74 ~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 149 (285)
T cd07861 74 LYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLAR 149 (285)
T ss_pred EEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECccccee
Confidence 489999996 589888876544346899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHH--------H-
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFL--------R- 151 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~--------~- 151 (253)
...... .......+++.|+|||.+.+. .++.++|+||||+++++|++|..||................ .
T Consensus 150 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd07861 150 AFGIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG 228 (285)
T ss_pred ecCCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence 543221 112223467889999998754 46889999999999999999999997654322111000000 0
Q ss_pred ---HHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 152 ---AMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 152 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.......................+..+.+++.+||+.||.+|||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000000011111234567899999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=219.83 Aligned_cols=184 Identities=22% Similarity=0.285 Sum_probs=136.2
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
|+++|++ +++|.+++... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 96 YLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred EEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcccee
Confidence 7899988 88999887643 4999999999999999999999999 99999999999999999999999999875
Q ss_pred ccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
.... .....+++.|+|||++.+ ..++.++|+||+||++|+|++|..||............ .... .......
T Consensus 168 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~---~~~~-~~~~~~~ 239 (343)
T cd07878 168 ADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI---MEVV-GTPSPEV 239 (343)
T ss_pred cCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH---HHHh-CCCCHHH
Confidence 4321 223457899999999976 45789999999999999999999999765432211100 0000 0000000
Q ss_pred ------------------hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 ------------------LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ------------------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
................+.+++.+||+.||.+|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000001123457889999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=223.07 Aligned_cols=191 Identities=26% Similarity=0.463 Sum_probs=148.5
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
.||+-+|+|.+|..+++.... .+.....+.|++|+++|+.|||.++ |+|+|||..|||+..++.|||+|||++..
T Consensus 463 AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence 588999999999999987543 4888899999999999999999999 99999999999999999999999999865
Q ss_pred ccCC-Ccceeeeccccccccccchhcc---CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 83 VTID-QTHLTTRVQGTFGYLDLEYFRS---SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 83 ~~~~-~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
...- .........|...|||||++.. .+|++.+|||+||+++|||++|..||.....+...+.+ ..+.+
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV-------GrG~l 610 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV-------GRGYL 610 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe-------ccccc
Confidence 4321 2222334557789999999864 36899999999999999999999999843332211111 00000
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
..+ .........+++++|+..||..++++||.+.+|+..|+.+..+.
T Consensus 611 --~pd---~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 611 --MPD---LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred --Ccc---chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 011 11222345567888999999999999999999999999888763
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=218.35 Aligned_cols=194 Identities=20% Similarity=0.323 Sum_probs=139.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+.+ +|.+++..... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 79 LTLVFEYLDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred EEEEEeCCCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccce
Confidence 4799999965 88888866432 4889999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHH--------HH
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFL--------RA 152 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~--------~~ 152 (253)
....... ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||......+......... ..
T Consensus 153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 153 AKSVPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred ecCCCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 5432211 1223457889999999875 357899999999999999999999998765433211111100 00
Q ss_pred Hhhccccchhc-----hhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 153 MKENCLFDMLD-----AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 153 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..........+ +..........+..+.+++.+||+.||.+|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 232 ISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000000000 000000111234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=213.84 Aligned_cols=181 Identities=22% Similarity=0.268 Sum_probs=138.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+++++|..++.+.. .++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 77 ~~~v~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~ 151 (282)
T cd06643 77 LWILIEFCAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSA 151 (282)
T ss_pred EEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccc
Confidence 489999999999999876532 25899999999999999999999999 9999999999999999999999999986
Q ss_pred cccCCCcceeeeccccccccccchhc-----cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR-----SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
...... .......+++.|++||.+. +..++.++|+||+||++|+|++|..||......+. ........
T Consensus 152 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~ 224 (282)
T cd06643 152 KNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSE 224 (282)
T ss_pred cccccc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHHhhcC
Confidence 543211 1222345788999999984 34467899999999999999999999976543221 11111111
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ... ..+...+..+.+++.+||+.||.+||++.+++++
T Consensus 225 ~-~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 225 P-PTL-------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred C-CCC-------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000 0112234568889999999999999999998855
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=210.99 Aligned_cols=188 Identities=25% Similarity=0.337 Sum_probs=136.1
Q ss_pred CEEEEeecCCCChhHHhhccCC--CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE--EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl 79 (253)
.++||||+++|+|.+++..... ....++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 70 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~ 146 (269)
T cd05087 70 YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGL 146 (269)
T ss_pred cEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccc
Confidence 4799999999999999975321 224667788899999999999999999 99999999999999999999999998
Q ss_pred cccccCCCccee-eeccccccccccchhccC-------CCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHH
Q 044510 80 SRYVTIDQTHLT-TRVQGTFGYLDLEYFRSS-------QFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFL 150 (253)
Q Consensus 80 ~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~ 150 (253)
++.......... ....++..|+|||++.+. .++.++|+||||+++|+|++ |..||......+...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~------ 220 (269)
T cd05087 147 SHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT------ 220 (269)
T ss_pred cccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH------
Confidence 865432211111 123457789999998642 35789999999999999996 999997654432111
Q ss_pred HHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 151 RAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
.... ........+.. .......+.+++..|+ .+|.+||++++|++.|+
T Consensus 221 ~~~~-~~~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 221 YTVR-EQQLKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHhh-cccCCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0011 11111111111 1112335777999998 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=214.85 Aligned_cols=181 Identities=21% Similarity=0.286 Sum_probs=138.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|++|||+.+|+|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 4899999999999999976432 24888899999999999999999999 9999999999999999999999999876
Q ss_pred cccCCCcceeeeccccccccccchhc-----cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR-----SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
....... ......+++.|+|||.+. ...++.++|+|||||++|+|++|..||.......... .... .
T Consensus 170 ~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~------~~~~-~ 241 (282)
T cd06636 170 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF------LIPR-N 241 (282)
T ss_pred hhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh------hHhh-C
Confidence 5432111 122345788999999975 2357889999999999999999999996544321110 0000 0
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.. ........+..+.+++.+||+.||.+||++.+|+++
T Consensus 242 ~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 242 PP--------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred CC--------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00 000112234568889999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=222.41 Aligned_cols=192 Identities=21% Similarity=0.298 Sum_probs=145.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC--CCceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD--KFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~--~~~~kl~Dfgl 79 (253)
+|||+|.+ ..+|.++++.+.- .+++...+..++.||+.||..||..+ |+|+||||+|||+.. ...+||+|||.
T Consensus 263 lciVfELL-~~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccc
Confidence 48999999 6699999998753 36999999999999999999999999 999999999999964 34799999999
Q ss_pred cccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHH-----Hh
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRA-----MK 154 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~-----~~ 154 (253)
++.... ... ...-+..|+|||++.|.+|+.+.|+|||||+++||++|.+-|.+..+.++...+...... +.
T Consensus 338 Sc~~~q---~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~ 413 (586)
T KOG0667|consen 338 SCFESQ---RVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD 413 (586)
T ss_pred ccccCC---cce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 986532 122 345678899999999999999999999999999999999999888876654433222110 00
Q ss_pred h----ccccch-----------------------------h----ch----hhhhhhcHHHHHHHHHHHHHhcccCCCCC
Q 044510 155 E----NCLFDM-----------------------------L----DA----QVLKEAKEEEIITVAMLAKRCLNLNGRKR 193 (253)
Q Consensus 155 ~----~~~~~~-----------------------------~----~~----~~~~~~~~~~~~~~~~li~~cl~~dP~~R 193 (253)
. ....+. . .+ .+...........+.+++.+||..||.+|
T Consensus 414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R 493 (586)
T KOG0667|consen 414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER 493 (586)
T ss_pred hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence 0 000000 0 00 00001111334568999999999999999
Q ss_pred CCHHHHHHH
Q 044510 194 PTMKEVAFE 202 (253)
Q Consensus 194 ps~~~l~~~ 202 (253)
+|..+++++
T Consensus 494 ~tp~qal~H 502 (586)
T KOG0667|consen 494 ITPAQALNH 502 (586)
T ss_pred CCHHHHhcC
Confidence 999999987
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=218.86 Aligned_cols=178 Identities=25% Similarity=0.361 Sum_probs=148.4
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC----CceEEcccC
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK----FRAKISDFG 78 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~----~~~kl~Dfg 78 (253)
++|||+|.||.|.+.+... .+++..+..++.|++.++.|||..| ++|||+||+|+|+... +.++++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 7999999999999999876 2999999999999999999999999 9999999999999633 479999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
++..... .......+||+.|+|||++.+..|+..+|+||+|+++|.|++|..||.+........ .......
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~~- 255 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGDF- 255 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCCC-
Confidence 9987754 455667889999999999999999999999999999999999999998877543222 1111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..........+..+.++|..||..||.+|+++.+++++
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11112233445678999999999999999999999985
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=212.32 Aligned_cols=183 Identities=25% Similarity=0.330 Sum_probs=142.9
Q ss_pred CEEEEeecCCCChhHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHhHhh-CCCCCeEecCCCCCceeecCCCceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQ-TEEFTITWEISLRIAVEVSGALSYLHS-TTSIPIYHRDIKSANILLDDKFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl 79 (253)
+++||||++|++|.+++... .....+++..++.++.|++.||.|||. .+ ++|+||+|.||+++.++.++|+|||+
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 84 LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccc
Confidence 58999999999999988542 122358999999999999999999995 67 99999999999999999999999999
Q ss_pred cccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
+....... ......++..|++||.+.+..++.++|+||||+++|+|++|..||........ ..........
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~ 231 (269)
T cd08528 161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL-------ATKIVEAVYE 231 (269)
T ss_pred eeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH-------HHHHhhccCC
Confidence 87654332 22334578899999999988889999999999999999999999965543221 1111111110
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
. ......+..+.+++.+||+.||.+||++.++.++++
T Consensus 232 ~--------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 P--------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred c--------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 001123356888999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=212.85 Aligned_cols=183 Identities=25% Similarity=0.295 Sum_probs=138.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+|++|+||+++.++.++|+|||++.
T Consensus 81 ~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~ 154 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAA 154 (267)
T ss_pred EEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccce
Confidence 479999999999999987543 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhc---cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR---SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
...... .......+++.|+|||.+. ...++.++|+||+||++|+|++|..||......+... . ......
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~-~~~~~~ 226 (267)
T cd06646 155 KITATI-AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------L-MSKSNF 226 (267)
T ss_pred eecccc-cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------e-eecCCC
Confidence 553221 1122345788999999984 3447789999999999999999999986543221100 0 000000
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 203 (253)
..+.. ......+..+.+++.+||+.+|.+||++++++++|
T Consensus 227 ---~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 ---QPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ---CCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00000 01112345788999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=211.70 Aligned_cols=188 Identities=24% Similarity=0.326 Sum_probs=135.7
Q ss_pred CEEEEeecCCCChhHHhhccCC--CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE--EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl 79 (253)
.|+||||+++|+|.+++..... ....++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 70 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~ 146 (269)
T cd05042 70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGL 146 (269)
T ss_pred eEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccc
Confidence 5899999999999999976432 123567888999999999999999999 99999999999999999999999998
Q ss_pred cccccCCCcce-eeeccccccccccchhcc-------CCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHH
Q 044510 80 SRYVTIDQTHL-TTRVQGTFGYLDLEYFRS-------SQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFL 150 (253)
Q Consensus 80 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~ 150 (253)
+.......... .....++..|+|||++.. ..++.++|+|||||++|+|++ |..||......+. ..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~ 220 (269)
T cd05042 147 ALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV------LK 220 (269)
T ss_pred ccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH------HH
Confidence 86432211111 122334667999999753 346789999999999999999 7888876543221 11
Q ss_pred HHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 151 RAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
...... ......+. .+...+..+.+++..|+ .||.+||++++|++.|.
T Consensus 221 ~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 221 QVVREQ-DIKLPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHhhcc-CccCCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111 11111111 12233445677888898 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=215.23 Aligned_cols=191 Identities=25% Similarity=0.390 Sum_probs=144.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 5899999999999999976542 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCccee--eeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhh--------hhHHHHHH
Q 044510 82 YVTIDQTHLT--TRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDK--------SLAGYFLR 151 (253)
Q Consensus 82 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~--------~~~~~~~~ 151 (253)
.......... ....++..|++||...+..++.++|+||||+++++|++|..|+......... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 6542222111 1123455699999998888999999999999999999999998654322111 00111111
Q ss_pred HHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 152 AMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
....... ...+...+..+.+++.+||+.+|.+||++.+++++|+++
T Consensus 238 ~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGER---------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCc---------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111110 011122335688899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=216.77 Aligned_cols=184 Identities=21% Similarity=0.322 Sum_probs=138.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~ 150 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCL 150 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEecccee
Confidence 4899999999999999986432 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhcc-----CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-----SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
..............|++.|+|||++.+ ..++.++|+|||||++|+|++|..||......+. ........
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~ 224 (331)
T cd05624 151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHE 224 (331)
T ss_pred eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------HHHHHcCC
Confidence 654332222233568999999999875 4578899999999999999999999976543221 11111111
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRK--RPTMKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~l~~~ 202 (253)
.... .. ......+..+.+++.+||..++.+ |+++++++++
T Consensus 225 ~~~~-~p-----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 225 ERFQ-FP-----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred Cccc-CC-----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0000 00 011123456888999999865544 4688888766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=222.95 Aligned_cols=164 Identities=20% Similarity=0.346 Sum_probs=125.2
Q ss_pred CCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcccccCCCcc-eeeeccccccccccc
Q 044510 26 TITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLE 104 (253)
Q Consensus 26 ~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE 104 (253)
.+++..++.++.|++.||.|||..+ ++|+||||.||+++.++.++|+|||+++........ ......+++.|++||
T Consensus 235 ~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 311 (401)
T cd05107 235 ALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPE 311 (401)
T ss_pred CCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChH
Confidence 3677788999999999999999999 999999999999999999999999998754322111 112234577899999
Q ss_pred hhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHH
Q 044510 105 YFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAK 183 (253)
Q Consensus 105 ~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 183 (253)
.+.+..++.++|+||||+++|+|++ |..||......+. .......... ...+...+..+.+++.
T Consensus 312 ~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~------~~~~~~~~~~---------~~~p~~~~~~l~~li~ 376 (401)
T cd05107 312 SIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ------FYNAIKRGYR---------MAKPAHASDEIYEIMQ 376 (401)
T ss_pred HhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH------HHHHHHcCCC---------CCCCCCCCHHHHHHHH
Confidence 9988888999999999999999998 8889866443221 1111111100 0111223457888999
Q ss_pred HhcccCCCCCCCHHHHHHHHhhch
Q 044510 184 RCLNLNGRKRPTMKEVAFELGGIR 207 (253)
Q Consensus 184 ~cl~~dP~~Rps~~~l~~~l~~~~ 207 (253)
+||+.+|.+||++++|++.|+++.
T Consensus 377 ~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 377 KCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHcCCChhHCcCHHHHHHHHHHHh
Confidence 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=216.98 Aligned_cols=197 Identities=21% Similarity=0.326 Sum_probs=134.8
Q ss_pred CEEEEeecCCCChhHHhhcc------CCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceee----cCCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQ------TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILL----DDKFR 71 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili----~~~~~ 71 (253)
.|+||||+. ++|.+++... .....+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 150 (317)
T cd07867 75 VWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGR 150 (317)
T ss_pred EEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCc
Confidence 379999995 4888877532 11224889999999999999999999999 9999999999999 45678
Q ss_pred eEEcccCCcccccCCCcc--eeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhh---h
Q 044510 72 AKISDFGASRYVTIDQTH--LTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKS---L 145 (253)
Q Consensus 72 ~kl~Dfgl~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~---~ 145 (253)
+||+|||+++........ ......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.......... .
T Consensus 151 ~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~ 230 (317)
T cd07867 151 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFH 230 (317)
T ss_pred EEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccccccccccccc
Confidence 999999999865432211 12234678999999999764 47899999999999999999999997543321100 0
Q ss_pred HHHHHHHHhh--------------cc-ccchh---------chhh---hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 044510 146 AGYFLRAMKE--------------NC-LFDML---------DAQV---LKEAKEEEIITVAMLAKRCLNLNGRKRPTMKE 198 (253)
Q Consensus 146 ~~~~~~~~~~--------------~~-~~~~~---------~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~ 198 (253)
.......... .. ..... .... ...........+.+++.+||+.||.+|||+.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e 310 (317)
T cd07867 231 HDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQ 310 (317)
T ss_pred HHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHH
Confidence 0000000000 00 00000 0000 00001112345788999999999999999999
Q ss_pred HHHH
Q 044510 199 VAFE 202 (253)
Q Consensus 199 l~~~ 202 (253)
++++
T Consensus 311 ~l~h 314 (317)
T cd07867 311 ALQD 314 (317)
T ss_pred HhcC
Confidence 9864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=224.73 Aligned_cols=190 Identities=26% Similarity=0.354 Sum_probs=150.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++|||+|.||+|.++|+.++. .++..+...++.+++.||+|||.++ ++||||-.+|+|++.++.+||+|||+++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 3899999999999999998764 4999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
....... ......-...|+|||.+...-|++++|||||||++||+.+ |..||.+....+. ...+..+..
T Consensus 311 ~~~~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v-------~~kI~~~~~-- 380 (474)
T KOG0194|consen 311 AGSQYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV-------KAKIVKNGY-- 380 (474)
T ss_pred CCcceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH-------HHHHHhcCc--
Confidence 5431111 1101123568999999999999999999999999999998 8889988765431 112211111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCC
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGP 212 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 212 (253)
+...+...+..+..+..+|+..||++||+|.++.+.|+.+......
T Consensus 381 ------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 381 ------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 1112223444677789999999999999999999999999877544
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=218.49 Aligned_cols=165 Identities=25% Similarity=0.397 Sum_probs=124.6
Q ss_pred CCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcccccCCCcc-eeeeccccccccccc
Q 044510 26 TITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLE 104 (253)
Q Consensus 26 ~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE 104 (253)
.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......... ......++..|+|||
T Consensus 175 ~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 251 (343)
T cd05103 175 VLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251 (343)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcH
Confidence 3678888999999999999999999 999999999999999999999999998754322111 111223456799999
Q ss_pred hhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHH
Q 044510 105 YFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAK 183 (253)
Q Consensus 105 ~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 183 (253)
.+.+..++.++|+||||+++|+|++ |..||........ ............ .+...+..+.+++.
T Consensus 252 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~~~~~~ 316 (343)
T cd05103 252 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMR---------APDYTTPEMYQTML 316 (343)
T ss_pred HhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhccCCCC---------CCCCCCHHHHHHHH
Confidence 9988889999999999999999997 8999866432211 111111111110 01112345788999
Q ss_pred HhcccCCCCCCCHHHHHHHHhhchh
Q 044510 184 RCLNLNGRKRPTMKEVAFELGGIRA 208 (253)
Q Consensus 184 ~cl~~dP~~Rps~~~l~~~l~~~~~ 208 (253)
.||+.||.+||++.+|+++|+.+..
T Consensus 317 ~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 317 DCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=207.71 Aligned_cols=188 Identities=20% Similarity=0.292 Sum_probs=135.2
Q ss_pred CEEEEeecCCCChhHHhhccCC-CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.|+||||+++|+|.+++..... ....++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 70 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~ 146 (268)
T cd05086 70 YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIG 146 (268)
T ss_pred cEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccc
Confidence 4899999999999999976432 123677788899999999999999999 999999999999999999999999987
Q ss_pred ccccCCC-cceeeeccccccccccchhcc-------CCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHH
Q 044510 81 RYVTIDQ-THLTTRVQGTFGYLDLEYFRS-------SQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLR 151 (253)
Q Consensus 81 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~ 151 (253)
....... ........++..|+|||++.. ..++.++|+||||+++|+|++ |..||......+ .+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~ 220 (268)
T cd05086 147 PSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNH 220 (268)
T ss_pred cccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH
Confidence 5422111 111123456788999999753 235789999999999999997 567876544322 1111
Q ss_pred HHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 152 AMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
..... .....++... ......+.+++..|| .+|.+||+++++++.|.
T Consensus 221 ~~~~~-~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 221 VIKDQ-QVKLFKPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHhhc-ccccCCCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11111 1111222111 123346777999999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=209.69 Aligned_cols=182 Identities=27% Similarity=0.442 Sum_probs=141.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.+++|||+++++|.+++...... .+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++++|||++.
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~ 151 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSR 151 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCce
Confidence 58999999999999999765421 2899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............+++.|++||...+..++.++|+|++|+++++|++ |..||........ ..........
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~~- 223 (258)
T smart00219 152 DLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV-------LEYLKKGYRL- 223 (258)
T ss_pred ecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHhcCCCC-
Confidence 654332222112235688999999987888999999999999999998 7888876433221 1111111110
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 203 (253)
..+...+..+.+++.+||+.||.+|||+.++++.|
T Consensus 224 --------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 --------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11112445688899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=211.88 Aligned_cols=177 Identities=23% Similarity=0.374 Sum_probs=139.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC-ceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF-RAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~-~~kl~Dfgl~ 80 (253)
.|+||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 589999999999999997754 5999999999999999999999999 99999999999999888 9999999987
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
...... ....++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... ..... +.... ..
T Consensus 158 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~-~~~~~-~~---- 225 (267)
T PHA03390 158 KIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLES-LLKRQ-QK---- 225 (267)
T ss_pred eecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHH-HHHhh-cc----
Confidence 654321 12357889999999998889999999999999999999999997543322 11111 11111 00
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT-MKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-~~~l~~~ 202 (253)
........+..+.+++.+||+.+|.+||+ +++++++
T Consensus 226 ------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 226 ------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 00111234557888999999999999995 6988853
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=211.46 Aligned_cols=182 Identities=24% Similarity=0.277 Sum_probs=140.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+.+++|.+++..... ..+++..+..++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++.
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~ 150 (285)
T cd05632 75 LCLVLTIMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAV 150 (285)
T ss_pred EEEEEEeccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcce
Confidence 4799999999999998876432 25999999999999999999999999 9999999999999999999999999886
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||........... .........
T Consensus 151 ~~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~~~~~~---- 221 (285)
T cd05632 151 KIPEGE--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRRVLETE---- 221 (285)
T ss_pred ecCCCC--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhhhccc----
Confidence 543211 12234688999999999888899999999999999999999999976543321111 111111100
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT-----MKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~~ 202 (253)
...+...+..+.+++.+||+.||.+||+ +.+++++
T Consensus 222 ------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 222 ------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0111223345778999999999999999 6777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=222.89 Aligned_cols=181 Identities=25% Similarity=0.345 Sum_probs=136.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~ 149 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCT 149 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCc
Confidence 489999999999999997654 5899999999999999999999999 9999999999999999999999999876
Q ss_pred cccCCCc----------------------------------ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHH
Q 044510 82 YVTIDQT----------------------------------HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGL 127 (253)
Q Consensus 82 ~~~~~~~----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 127 (253)
....... .......||+.|+|||++.+..++.++|+|||||++|+|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel 229 (360)
T cd05627 150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229 (360)
T ss_pred ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeec
Confidence 4321100 001124689999999999988899999999999999999
Q ss_pred HhCCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 044510 128 LTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT---MKEVAFE 202 (253)
Q Consensus 128 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps---~~~l~~~ 202 (253)
++|..||......... ........... ..+ ....+..+.+++.+++. ||.+|++ +.+++++
T Consensus 230 ~tG~~Pf~~~~~~~~~------~~i~~~~~~~~-~p~------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 230 LIGYPPFCSETPQETY------RKVMNWKETLV-FPP------EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred ccCCCCCCCCCHHHHH------HHHHcCCCcee-cCC------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 9999999876543211 11111110000 000 01123467778888764 9999985 6677665
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=212.95 Aligned_cols=184 Identities=23% Similarity=0.287 Sum_probs=139.0
Q ss_pred CEEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
+++||||+++++|.+++.... ....+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCce
Confidence 589999999999999876421 2235889999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCCcceeeeccccccccccchhcc-----CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRS-----SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE 155 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 155 (253)
+...... .......+++.|+|||++.. ..++.++|+||+||++|+|++|..||......... .. ...
T Consensus 172 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~------~~-~~~ 243 (286)
T cd06638 172 AQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL------FK-IPR 243 (286)
T ss_pred eecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH------hh-ccc
Confidence 7553221 12223458899999999853 34788999999999999999999999765432210 00 000
Q ss_pred ccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044510 156 NCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203 (253)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 203 (253)
........ +......+.+++.+||+.||.+||++.++++++
T Consensus 244 ~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 244 NPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00000001 111234688899999999999999999999764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=210.91 Aligned_cols=179 Identities=25% Similarity=0.374 Sum_probs=137.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++++||+++++|.+++.... .+++...+.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 478999999999999997654 4889999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCC--cceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQ--THLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
...... ........++..|+|||.+.+..++.++|+||+||++|+|++|..||........ ........ .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~~~~-~- 226 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIATQP-T- 226 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHhcCC-C-
Confidence 543211 1111224478899999999888889999999999999999999999976533211 01111000 0
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
....+......+.+++ .||..+|.+||++++++++
T Consensus 227 -------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 227 -------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0111223344566677 6888999999999999854
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=214.49 Aligned_cols=179 Identities=25% Similarity=0.370 Sum_probs=139.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 94 ~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~ 166 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCA 166 (292)
T ss_pred EEEEEeCCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchh
Confidence 48999999999999988543 3889999999999999999999999 9999999999999999999999999886
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......... .. .... .
T Consensus 167 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~~-~~~~-~--- 234 (292)
T cd06658 167 QVSKEVP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM------RR-IRDN-L--- 234 (292)
T ss_pred hcccccc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HH-HHhc-C---
Confidence 5432211 122345788999999998888899999999999999999999999765432211 11 1000 0
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.+.. ......+..+.+++.+||..||.+||++++++++
T Consensus 235 -~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 235 -PPRV--KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -CCcc--ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0000 0111234467789999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=210.98 Aligned_cols=175 Identities=21% Similarity=0.367 Sum_probs=133.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC-------ceEE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF-------RAKI 74 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~-------~~kl 74 (253)
.++||||+++|+|..++..... .+++..+..++.|++.||.|||..+ ++||||||+||+++..+ .+++
T Consensus 91 ~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~~~~~~kl 165 (274)
T cd05076 91 NIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKL 165 (274)
T ss_pred eEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccCccceeee
Confidence 4899999999999999875332 5889999999999999999999999 99999999999997543 4799
Q ss_pred cccCCcccccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHH-hCCCCCCCCChhhhhhhHHHHHHH
Q 044510 75 SDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLL-TGQKPIRSTDTEEDKSLAGYFLRA 152 (253)
Q Consensus 75 ~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll-tg~~pf~~~~~~~~~~~~~~~~~~ 152 (253)
+|||++...... ....++..|+|||.+.+ ..++.++|+||||+++|+|+ +|..||......+....
T Consensus 166 ~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~------- 233 (274)
T cd05076 166 SDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF------- 233 (274)
T ss_pred cCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH-------
Confidence 999987543211 12346778999998875 45789999999999999985 69999876544321110
Q ss_pred HhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 153 MKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
...... .+......+.+++.+||+.+|.+||+++++++.|.
T Consensus 234 ~~~~~~-----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 234 YEKKHR-----------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHhccC-----------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 000000 00111235788999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=215.01 Aligned_cols=179 Identities=23% Similarity=0.363 Sum_probs=140.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+|+||+++++|.+++... .+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~ 163 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCA 163 (296)
T ss_pred EEEEEEecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccch
Confidence 48999999999999988653 3899999999999999999999999 9999999999999999999999999877
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
....... ......++..|+|||.+.+..++.++|+|||||++|+|++|..||.......... ...... ....
T Consensus 164 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~------~~~~~~-~~~~ 235 (296)
T cd06655 164 QITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG-TPEL 235 (296)
T ss_pred hcccccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhcC-Cccc
Confidence 5432211 1223457889999999988888999999999999999999999997765432111 001000 0000
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+...+..+.+++.+||..||.+||++.+++.+
T Consensus 236 -------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 236 -------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred -------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0112234467889999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=209.19 Aligned_cols=182 Identities=26% Similarity=0.290 Sum_probs=138.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++.... .+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++.
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd06645 81 LWICMEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSA 154 (267)
T ss_pred EEEEEeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeee
Confidence 489999999999999987654 5899999999999999999999999 9999999999999999999999999886
Q ss_pred cccCCCcceeeeccccccccccchhc---cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR---SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
...... .......+++.|+|||.+. ...++.++|+||+||++|+|++|..||......... .........
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~~~~~~~~ 227 (267)
T cd06645 155 QITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMTKSNFQ 227 (267)
T ss_pred EccCcc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------HhhhccCCC
Confidence 543221 1223346889999999974 345788999999999999999999998654432211 000001100
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..... .....+..+.+++.+||+.+|.+||++++++++
T Consensus 228 ~~~~~------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 228 PPKLK------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCccc------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00000 001123457889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=209.87 Aligned_cols=187 Identities=25% Similarity=0.362 Sum_probs=143.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+|||++++++|.+++........+++..+..++.|++.||.+||..+ ++|+||+|+||++++++.++|+|||++.
T Consensus 74 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~ 150 (267)
T cd06610 74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSA 150 (267)
T ss_pred EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHH
Confidence 4799999999999999977533235899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcc---eeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 82 YVTIDQTH---LTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 82 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
........ ......++..|++||++... .++.++|+||||+++++|++|..||......+. +........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~~~~ 224 (267)
T cd06610 151 SLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTLQNDP 224 (267)
T ss_pred HhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh------HHHHhcCCC
Confidence 65433222 12334578899999998766 688999999999999999999999976543221 111111110
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. .... .......+..+.+++.+||+.||.+||++++++++
T Consensus 225 ~--~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 P--SLET---GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred C--CcCC---ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 0000 00012344568899999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=221.81 Aligned_cols=195 Identities=21% Similarity=0.329 Sum_probs=138.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|||++ .++|.+++..... .+++..++.++.|++.||.|||..+ |+||||||+||+++.++.++|+|||+++
T Consensus 235 ~~lv~e~~-~~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~ 308 (461)
T PHA03211 235 TCLVLPKY-RSDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAAC 308 (461)
T ss_pred EEEEEEcc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCce
Confidence 47999999 5689888866432 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCC-hhhhhhhHHHHHHHHhhccc-
Q 044510 82 YVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTD-TEEDKSLAGYFLRAMKENCL- 158 (253)
Q Consensus 82 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~- 158 (253)
........ ......||+.|++||++.+..++.++|+|||||++|||++|..++-... ..........+.+.+.....
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 65322211 1223468999999999998889999999999999999999776543221 11111111111111111100
Q ss_pred ----cchhchhhhhh-------------------hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 ----FDMLDAQVLKE-------------------AKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ----~~~~~~~~~~~-------------------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.......+... ........+.++|.+||+.||.+|||+.|++++
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000000000 001223468889999999999999999999975
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=210.57 Aligned_cols=181 Identities=26% Similarity=0.370 Sum_probs=143.3
Q ss_pred CEEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHh-----hCCCCCeEecCCCCCceeecCCCceEEc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLH-----STTSIPIYHRDIKSANILLDDKFRAKIS 75 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh-----~~~~~~i~H~dl~~~nili~~~~~~kl~ 75 (253)
++++|||+++++|.+++.... ....+++..++.++.+++.||.||| +.+ ++|+||+|+||+++.++.++|+
T Consensus 76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEe
Confidence 479999999999999997632 1235899999999999999999999 777 9999999999999999999999
Q ss_pred ccCCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh
Q 044510 76 DFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE 155 (253)
Q Consensus 76 Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 155 (253)
|||++........ ......+++.|++||.+.+..++.++|+|+||+++++|++|..||....... .......
T Consensus 153 d~g~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~ 224 (265)
T cd08217 153 DFGLAKILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-------LASKIKE 224 (265)
T ss_pred cccccccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-------HHHHHhc
Confidence 9999876543221 1223457889999999988888999999999999999999999997655322 1111111
Q ss_pred ccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 156 NCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... ...+...+..+.+++.+||+.+|.+||++++|+++
T Consensus 225 ~~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 GKF---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCC---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111 11223345578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=212.85 Aligned_cols=183 Identities=22% Similarity=0.282 Sum_probs=138.7
Q ss_pred CEEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
+|+||||+++++|.+++.... ....+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++
T Consensus 99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccc
Confidence 589999999999999886421 1235899999999999999999999999 999999999999999999999999988
Q ss_pred ccccCCCcceeeeccccccccccchhccC-----CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSS-----QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE 155 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 155 (253)
........ ......++..|++||.+... .++.++|+|||||++|+|++|..||........ ... ...
T Consensus 176 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~------~~~-~~~ 247 (291)
T cd06639 176 AQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT------LFK-IPR 247 (291)
T ss_pred hhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH------HHH-Hhc
Confidence 75432211 11224578899999998643 257899999999999999999999976543221 111 111
Q ss_pred ccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 156 NCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
....... .+......+.+++.+||+.+|.+||++.+++++
T Consensus 248 ~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 248 NPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111111 112233468889999999999999999999865
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=215.65 Aligned_cols=177 Identities=23% Similarity=0.389 Sum_probs=148.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceee-cCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILL-DDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili-~~~~~~kl~Dfgl~ 80 (253)
.|+|+|.=.+|+|.++|..+.. ++.++.+.+.+.||+.|+.|+|... +|||||||+||.+ .+-|-|||.|||++
T Consensus 92 lyLiLELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFS 166 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFS 166 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeecccc
Confidence 4899999999999999987543 6999999999999999999999999 9999999999876 57789999999998
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCC-CCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFT-KKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
..+. ........+|...|-|||++.|..|. +++||||||+++|.|++|+.||+..+..+...++
T Consensus 167 Nkf~--PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI------------- 231 (864)
T KOG4717|consen 167 NKFQ--PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI------------- 231 (864)
T ss_pred ccCC--CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh-------------
Confidence 7664 34445567899999999999999885 7899999999999999999999876655422211
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.|-. -..|...+.+++++|..||..||.+|.+.++|+..
T Consensus 232 --mDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 232 --MDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred --hccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 1111 12456777899999999999999999999998854
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=211.27 Aligned_cols=180 Identities=21% Similarity=0.362 Sum_probs=140.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+++++|.+++.+.. .+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 150 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150 (265)
T ss_pred EEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhH
Confidence 589999999999999997654 4889999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCC-----cceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 82 YVTIDQ-----THLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 82 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
...... ........++..|+|||.+.+..++.++|+||||+++++|++|..||......... .......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~~~ 224 (265)
T cd06631 151 RLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM------FYIGAHR 224 (265)
T ss_pred hhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH------HHhhhcc
Confidence 542111 11112345788999999999888899999999999999999999999765432211 0000000
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAF 201 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 201 (253)
.. ....+......+.+++++||+.+|.+||++.++++
T Consensus 225 ~~--------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 GL--------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CC--------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 01112233456788999999999999999999885
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=211.50 Aligned_cols=194 Identities=23% Similarity=0.298 Sum_probs=139.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|..++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 75 ~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (286)
T cd07847 75 LHLVFEYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFAR 148 (286)
T ss_pred EEEEEeccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccce
Confidence 479999999988887765433 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHH--------H
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLR--------A 152 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~--------~ 152 (253)
....... ......++..|++||.+.+ ..++.++|+||||+++|+|++|..||.+....+.......... .
T Consensus 149 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07847 149 ILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227 (286)
T ss_pred ecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 6543221 1222346788999999876 4578899999999999999999999987654322111110000 0
Q ss_pred Hhhcccc---chhchhh---hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 153 MKENCLF---DMLDAQV---LKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 153 ~~~~~~~---~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
....... ....+.. ........+..+.+++.+||+.||.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000 0000000 000111234678899999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=209.98 Aligned_cols=183 Identities=19% Similarity=0.260 Sum_probs=136.6
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
++++|++ ..++.+.+.... ..++..+..++.|++.||.|||..+ ++||||||+||+++.++.++|+|||+++.
T Consensus 103 ~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l~DFGla~~ 175 (294)
T PHA02882 103 FILLEKL-VENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASH 175 (294)
T ss_pred EEEEehh-ccCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEEEEcCCcee
Confidence 5777877 447777766533 3678889999999999999999999 99999999999999999999999999876
Q ss_pred ccCCCcc------eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhh-hhhH-HHHHHHHh
Q 044510 83 VTIDQTH------LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED-KSLA-GYFLRAMK 154 (253)
Q Consensus 83 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~-~~~~-~~~~~~~~ 154 (253)
....... ......||+.|+|||+..+..++.++|+|||||++++|++|..||........ .... ..+...+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 255 (294)
T PHA02882 176 FIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLH 255 (294)
T ss_pred eccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhh
Confidence 5422211 11223589999999999988899999999999999999999999987633211 1100 00111111
Q ss_pred hccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044510 155 ENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203 (253)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 203 (253)
.... .....+..+.+++..|+..+|.+||++.+|++.+
T Consensus 256 ~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 256 EGKI-----------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hhhh-----------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1100 0011235688899999999999999999999876
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=212.30 Aligned_cols=195 Identities=21% Similarity=0.265 Sum_probs=141.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++.
T Consensus 74 ~~~v~e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~ 147 (286)
T cd07832 74 FVLVMEYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLAR 147 (286)
T ss_pred eEEEeccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecc
Confidence 48999999 999999987643 25899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH--------HHH
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF--------LRA 152 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~~~ 152 (253)
..............++..|+|||.+.+. .++.++|+||+|+++++|++|.++|......+........ +..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 148 LFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred cccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhh
Confidence 6643332223334578899999998654 4689999999999999999998888765433211110000 000
Q ss_pred Hh-----hccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 153 MK-----ENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 153 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.. .......................+.+++.+||+.||.+||++++++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000000000000011112234678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=214.60 Aligned_cols=179 Identities=24% Similarity=0.364 Sum_probs=140.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~ 163 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (297)
T ss_pred EEEeecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccce
Confidence 48999999999999998653 3889999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
....... ......+++.|++||.+.+..++.++|+||||+++|+|++|..||........... ..... ...
T Consensus 164 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~-~~~- 234 (297)
T cd06656 164 QITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG-TPE- 234 (297)
T ss_pred EccCCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC-CCC-
Confidence 5432221 11224578899999999988889999999999999999999999976543221000 00000 000
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...+...+..+.+++.+||+.+|.+||++++++++
T Consensus 235 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 235 ------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122334567889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=211.50 Aligned_cols=178 Identities=22% Similarity=0.309 Sum_probs=139.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+.|++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~~v~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~ 145 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 145 (278)
T ss_pred EEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCcc
Confidence 479999999999999887543 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
...... .....|+..|+|||.+.++ .++.++|+||+|+++|+|++|..||........... .......
T Consensus 146 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~---- 214 (278)
T cd05606 146 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTM---- 214 (278)
T ss_pred ccCccC---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhhcc----
Confidence 543221 1234588999999999754 588999999999999999999999976533211110 1111000
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
....+...+..+.+++.+||..+|.+|| ++.+++++
T Consensus 215 ------~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 215 ------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ------CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 0011222345788899999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=214.33 Aligned_cols=190 Identities=17% Similarity=0.232 Sum_probs=137.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+++.||+...
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 74 LWVVTSFMAYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred EEEEEeccCCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhh
Confidence 4799999999999999976432 24899999999999999999999999 9999999999999999999999997543
Q ss_pred cccCCCcc------eeeeccccccccccchhcc--CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHH
Q 044510 82 YVTIDQTH------LTTRVQGTFGYLDLEYFRS--SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAM 153 (253)
Q Consensus 82 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 153 (253)
........ ......++..|+|||++.+ ..++.++|+|||||++|+|++|..||......... ....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~~~ 223 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML------LEKL 223 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH------HHHh
Confidence 32211110 0112345678999999975 35889999999999999999999999754322110 0000
Q ss_pred hhccccchh------------------------------------chhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 044510 154 KENCLFDML------------------------------------DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMK 197 (253)
Q Consensus 154 ~~~~~~~~~------------------------------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~ 197 (253)
. ....... ............+..+.+++.+||+.||.+|||++
T Consensus 224 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 302 (327)
T cd08227 224 N-GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSAS 302 (327)
T ss_pred c-CCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHH
Confidence 0 0000000 00000111223456788999999999999999999
Q ss_pred HHHHH
Q 044510 198 EVAFE 202 (253)
Q Consensus 198 ~l~~~ 202 (253)
+++++
T Consensus 303 ell~~ 307 (327)
T cd08227 303 TLLNH 307 (327)
T ss_pred HHhcC
Confidence 99974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=209.58 Aligned_cols=186 Identities=24% Similarity=0.422 Sum_probs=142.0
Q ss_pred CEEEEeecCCCChhHHhhccC---CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT---EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfg 78 (253)
+++++||+.+|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECccc
Confidence 578999999999998875321 1224788999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 79 ASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 79 l~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
+++........ ......+++.|++||...+..++.++|+|||||++|+|++ |..||......+.. .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~------~~~~~~~ 232 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY------NYLIKGN 232 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHH------HHHHcCC
Confidence 98765322211 1112234568999999988888999999999999999999 88998765432211 1111111
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
... .+...+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 233 ~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 RLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 0112334688899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=208.63 Aligned_cols=180 Identities=24% Similarity=0.377 Sum_probs=141.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... ..+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++++|||++.
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~ 149 (256)
T cd08218 74 LYIVMDYCEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIAR 149 (256)
T ss_pred EEEEEecCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeecccee
Confidence 4799999999999999876432 24789999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......+++.|+|||.+.+..++.++|+||||+++++|++|..||......+ ......... .
T Consensus 150 ~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~~~~-~--- 218 (256)
T cd08218 150 VLNSTV-ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLKIIRGS-Y--- 218 (256)
T ss_pred ecCcch-hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHHHhcCC-C---
Confidence 553221 11223457888999999988888999999999999999999999987543322 111111111 0
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...+...+..+.+++.+||+.+|.+||++++++++
T Consensus 219 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 ------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11122344568889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=207.81 Aligned_cols=183 Identities=25% Similarity=0.298 Sum_probs=141.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|++|||+.+++|.+++..... .+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 149 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTRG--PLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSA 149 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccch
Confidence 4899999999999999876522 5899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccC---CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS---QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
...... .......++..|++||.+.+. .++.++|+||||+++|+|++|..||......+... ...... .
T Consensus 150 ~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~------~~~~~~-~ 221 (262)
T cd06613 150 QLTATI-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF------LISKSN-F 221 (262)
T ss_pred hhhhhh-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhcc-C
Confidence 553221 122234577889999999766 78899999999999999999999997655332111 000010 0
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ... .......+..+.+++.+||..+|.+||++.+++.+
T Consensus 222 ~---~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 222 P---PPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred C---Ccc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000 01122344568899999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=210.20 Aligned_cols=182 Identities=21% Similarity=0.329 Sum_probs=138.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhh-CCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS-TTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
+++||||+++++|.+++........+++..+..++.+++.||.|||. .+ ++|+||+|+||+++.++.++|+|||++
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 150 (286)
T cd06622 74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVS 150 (286)
T ss_pred EEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCc
Confidence 58999999999999988764223358999999999999999999996 57 999999999999999999999999988
Q ss_pred ccccCCCcceeeeccccccccccchhccCC------CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHh
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQ------FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK 154 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 154 (253)
...... ......+++.|++||.+.+.. ++.++|+||+||++|+|++|..||........ ........
T Consensus 151 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~- 223 (286)
T cd06622 151 GNLVAS---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQLSAIV- 223 (286)
T ss_pred ccccCC---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHHHHHHh-
Confidence 654221 122345778899999986543 47899999999999999999999965432211 11111111
Q ss_pred hccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 155 ENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... ....+...+..+.+++.+||+.+|.+||++++++++
T Consensus 224 ~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 224 DGD---------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hcC---------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 110 011222355678889999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=212.31 Aligned_cols=195 Identities=22% Similarity=0.273 Sum_probs=141.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+.++.+..+..... .+++..++.++.+++.||.|||..+ ++|+|++|+||+++.++.++|+|||++.
T Consensus 75 ~~iv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~ 148 (288)
T cd07833 75 LYLVFEYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFAR 148 (288)
T ss_pred EEEEEecCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeeccc
Confidence 589999998876666554432 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHH--------HH
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFL--------RA 152 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~--------~~ 152 (253)
..............++..|+|||.+.+. .++.++|+||||+++|+|++|..||......+......... ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07833 149 ALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL 228 (288)
T ss_pred ccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhh
Confidence 6544332223334578889999999877 78899999999999999999999997654432111110000 00
Q ss_pred Hhhc------cccchhchh-hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 153 MKEN------CLFDMLDAQ-VLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 153 ~~~~------~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.... ......... .....+...+..+.+++.+||+.+|.+||++++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000 000000000 0111122336779999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=215.00 Aligned_cols=194 Identities=22% Similarity=0.312 Sum_probs=139.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+. ++|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 152 (301)
T cd07873 79 LTLVFEYLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR 152 (301)
T ss_pred EEEEEeccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchh
Confidence 479999996 589998876432 4889999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH--------HHH
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF--------LRA 152 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~~~ 152 (253)
....... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+........ +..
T Consensus 153 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 153 AKSIPTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231 (301)
T ss_pred ccCCCCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence 5432211 11223467899999998754 4788999999999999999999999876543321111100 000
Q ss_pred Hhhc-cccchhchh----hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 153 MKEN-CLFDMLDAQ----VLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 153 ~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.... .......+. .........+..+.++|.+||+.||.+|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 232 ILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 000000000 0011112234568899999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=231.02 Aligned_cols=187 Identities=20% Similarity=0.397 Sum_probs=156.7
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
+||.|||++|+|..+|+.+.. .+++-+...+++.|+.|++||...+ +|||||-..|||++.+-.+||+|||+++.
T Consensus 706 MIiTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceee
Confidence 689999999999999998654 5899999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCcceeeeccc--cccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 83 VTIDQTHLTTRVQG--TFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 83 ~~~~~~~~~~~~~~--~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
..++.........| ...|.|||.+...+++.++|+||+|+++||.++ |..||-+....+ ..
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd----------------VI 844 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----------------VI 844 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH----------------HH
Confidence 75544333332222 458999999999999999999999999999887 999987655433 12
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
..+....+...|..++..|.+|...||++|-+.||.+.+|+.+|.++...-
T Consensus 845 kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 845 KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 222333344456667788999999999999999999999999999998764
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=207.87 Aligned_cols=179 Identities=24% Similarity=0.324 Sum_probs=139.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 468999999999999987653 4888999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCc--ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQT--HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
....... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ..... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~-~~~~- 226 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIA-TQPT- 226 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH------HHHHh-cCCC-
Confidence 5432111 112224578899999999888889999999999999999999999975432211 11111 0000
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
....+......+.+++.+|+. +|.+||++++++++
T Consensus 227 -------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 -------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 112234455678889999995 99999999999854
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=207.50 Aligned_cols=179 Identities=27% Similarity=0.435 Sum_probs=139.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC-CceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK-FRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~-~~~kl~Dfgl~ 80 (253)
.++||||+++++|.+++.... ...+++..++.++.+++.+|.|||+.+ ++|+||+|+||+++.+ +.++|+|||++
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~ 149 (256)
T cd08220 74 LMIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGIS 149 (256)
T ss_pred EEEEEecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCc
Confidence 489999999999999997643 224899999999999999999999999 9999999999999854 46799999998
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ........ ..
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~------~~~~~~~~-~~- 219 (256)
T cd08220 150 KILSSKS--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL------VLKIMSGT-FA- 219 (256)
T ss_pred eecCCCc--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH------HHHHHhcC-CC-
Confidence 7654322 12234578899999999988889999999999999999999999976543221 11111111 10
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 220 --------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 220 --------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1112234568889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=219.56 Aligned_cols=171 Identities=23% Similarity=0.313 Sum_probs=137.4
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceee-cCCCceEEcccCCcc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILL-DDKFRAKISDFGASR 81 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili-~~~~~~kl~Dfgl~~ 81 (253)
|+|||.+.|+-|.+.+..... +. ..+..|+.+|+.++.|||.+| ++|||+||+|||+ +..+.++|+|||.++
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred eeeehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhh
Confidence 899999999988888876542 33 677789999999999999999 9999999999999 588899999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... .....-|..|.|||+.....|++++|+||||+++|+|++|+.||....... . +...+..
T Consensus 465 ~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~-----e-i~~~i~~------ 528 (612)
T KOG0603|consen 465 ELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI-----E-IHTRIQM------ 528 (612)
T ss_pred hCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH-----H-HHHhhcC------
Confidence 65433 112234778999999998899999999999999999999999997755431 0 1111111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
+......+..+++++.+||+.||.+|++++++..+
T Consensus 529 ------~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 529 ------PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ------CccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 11225566688999999999999999999999865
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=208.95 Aligned_cols=180 Identities=24% Similarity=0.382 Sum_probs=136.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|..+. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 74 ~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~ 143 (279)
T cd06619 74 ISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVST 143 (279)
T ss_pred EEEEEecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence 47899999999986542 3788899999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........................
T Consensus 144 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (279)
T cd06619 144 QLVNS---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL 220 (279)
T ss_pred ecccc---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC
Confidence 54322 122346788999999999888999999999999999999999999764322211111111111111100000
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.....+..+.+++.+||+.+|.+||++++++++
T Consensus 221 --------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 --------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011233467889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=212.98 Aligned_cols=179 Identities=23% Similarity=0.334 Sum_probs=139.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++... .+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 93 ~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~ 165 (297)
T cd06659 93 LWVLMEFLQGGALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCA 165 (297)
T ss_pred EEEEEecCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHh
Confidence 48999999999999987553 4899999999999999999999999 9999999999999999999999999886
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
....... ......++..|+|||.+.+..++.++|+||||+++++|++|..||......+.. . .........
T Consensus 166 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~-~~~~~~~~~- 236 (297)
T cd06659 166 QISKDVP-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------K-RLRDSPPPK- 236 (297)
T ss_pred hcccccc-cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------H-HHhccCCCC-
Confidence 5432211 122345788999999998888999999999999999999999999765433211 1 111110000
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.......+..+.+++.+||+.+|.+||++++++++
T Consensus 237 ------~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 237 ------LKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ------ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00111223457889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=210.70 Aligned_cols=181 Identities=22% Similarity=0.302 Sum_probs=137.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+++++|..++.+... .+++..++.++.|++.+|.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccce
Confidence 5899999999999988765432 4899999999999999999999999 9999999999999999999999999876
Q ss_pred cccCCCcceeeeccccccccccchhc-----cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR-----SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
...... .......+++.|++||.+. ...++.++|+|||||++|+|++|..||....... .........
T Consensus 159 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~ 231 (292)
T cd06644 159 KNVKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSE 231 (292)
T ss_pred eccccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHHHhcCC
Confidence 532211 1122345788999999984 3346789999999999999999999987644321 111111110
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.... ..+...+..+.+++.+||+.||.+||++.+++++
T Consensus 232 -~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 232 -PPTL-------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -CccC-------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 0112233467889999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=209.10 Aligned_cols=178 Identities=25% Similarity=0.266 Sum_probs=138.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+|+||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 145 (260)
T cd05611 72 LYLVMEYLNGGDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSR 145 (260)
T ss_pred EEEEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccce
Confidence 589999999999999997654 4899999999999999999999999 9999999999999999999999999886
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
.... .....+++.|++||.+.+..++.++|+||+|+++|+|++|..||........ ..........
T Consensus 146 ~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~-- 211 (260)
T cd05611 146 NGLE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-------FDNILSRRIN-- 211 (260)
T ss_pred eccc-----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhcccC--
Confidence 5432 2224577899999999887789999999999999999999999976543221 1111111000
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 203 (253)
.........+..+.+++.+||+.+|.+||++.++.+.|
T Consensus 212 ----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 212 ----WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ----CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 00011112345688999999999999999775554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=213.26 Aligned_cols=193 Identities=24% Similarity=0.412 Sum_probs=139.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhh-CCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS-TTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
+++||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++
T Consensus 74 ~~lv~ey~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (308)
T cd06615 74 ISICMEHMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 147 (308)
T ss_pred EEEEeeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCc
Confidence 479999999999999997653 58999999999999999999997 57 999999999999999999999999987
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc-c--
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN-C-- 157 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~-- 157 (253)
...... ......++..|+|||.+.+..++.++|+||||+++++|++|..||...................... .
T Consensus 148 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (308)
T cd06615 148 GQLIDS---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR 224 (308)
T ss_pred cccccc---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcc
Confidence 654221 1223457889999999988888999999999999999999999986544222111000000000000 0
Q ss_pred --------------ccchhch---hhhhhhc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044510 158 --------------LFDMLDA---QVLKEAK-EEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203 (253)
Q Consensus 158 --------------~~~~~~~---~~~~~~~-~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 203 (253)
..+..+. ...+..+ ...+..+.+++.+||+.||.+||++++++++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000000 0000000 11345688999999999999999999999773
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=213.99 Aligned_cols=182 Identities=25% Similarity=0.375 Sum_probs=140.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+.+++|.+++.... ...+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 151 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSK 151 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhh
Confidence 489999999999999987643 225899999999999999999999999 9999999999999999999999999876
Q ss_pred cccCCCcc----------------------------eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCC
Q 044510 82 YVTIDQTH----------------------------LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKP 133 (253)
Q Consensus 82 ~~~~~~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~p 133 (253)
........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~p 231 (316)
T cd05574 152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231 (316)
T ss_pred cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCC
Confidence 54321100 01123578889999999988889999999999999999999999
Q ss_pred CCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 044510 134 IRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT----MKEVAFE 202 (253)
Q Consensus 134 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps----~~~l~~~ 202 (253)
|........ +.......... ......+..+.+++.+||+.||.+||+ +++++++
T Consensus 232 f~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 232 FKGSNRDET------FSNILKKEVTF---------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCCCchHHH------HHHHhcCCccC---------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 976554321 11111111000 001114557899999999999999999 7777653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=210.56 Aligned_cols=179 Identities=23% Similarity=0.339 Sum_probs=139.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|+||+++++|.+++... ++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||.+.
T Consensus 91 ~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~ 163 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCA 163 (285)
T ss_pred EEEEEeccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccch
Confidence 47999999999999998762 4899999999999999999999999 9999999999999999999999999876
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
....... ......+++.|++||...+..++.++|+||||+++|+|++|..||......... . ..........
T Consensus 164 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~------~-~~~~~~~~~~ 235 (285)
T cd06648 164 QVSKEVP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------K-RIRDNLPPKL 235 (285)
T ss_pred hhccCCc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH------H-HHHhcCCCCC
Confidence 5432211 122345788999999998888899999999999999999999999764432211 1 1111100000
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
......+..+.+++.+||+.+|.+||++.+++++
T Consensus 236 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 236 -------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred -------cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 0011234568899999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=209.45 Aligned_cols=183 Identities=24% Similarity=0.337 Sum_probs=138.8
Q ss_pred CEEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
+|+||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccc
Confidence 489999999999999987632 1235899999999999999999999999 999999999999999999999999988
Q ss_pred ccccCCCcceeeeccccccccccchhcc-----CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRS-----SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE 155 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 155 (253)
....... .......++..|+|||.+.. ..++.++|+||||+++++|++|..||........ ... ...
T Consensus 161 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~-~~~ 232 (275)
T cd06608 161 AQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA------LFK-IPR 232 (275)
T ss_pred eecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH------HHH-hhc
Confidence 6543221 12223457889999998753 2367889999999999999999999975432211 111 111
Q ss_pred ccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 156 NCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...... ..+...+..+.+++.+||..||.+|||+.+++++
T Consensus 233 ~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 233 NPPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred cCCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111110 1112244578899999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=209.61 Aligned_cols=192 Identities=22% Similarity=0.299 Sum_probs=135.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|+||+. ++|.+++..... .+++..++.++.||+.||.|||..+ ++|+||||+||+++.++.++|+|||+++
T Consensus 74 ~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~ 147 (284)
T cd07839 74 LTLVFEYCD-QDLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR 147 (284)
T ss_pred eEEEEecCC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhh
Confidence 489999996 588887765322 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCC-CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHH-------
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQ-FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAM------- 153 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~------- 153 (253)
...... .......+++.|+|||.+.+.. ++.++|+|||||++|+|++|..|+........ .. .......
T Consensus 148 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~ 224 (284)
T cd07839 148 AFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QL-KRIFRLLGTPTEES 224 (284)
T ss_pred ccCCCC-CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HH-HHHHHHhCCCChHH
Confidence 543221 1122234678999999987644 68999999999999999999888643222110 00 0000000
Q ss_pred ----hhc---cccchhch-hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 154 ----KEN---CLFDMLDA-QVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 154 ----~~~---~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... ........ ..........+..+.+++.+||+.||.+|||+++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 225 WPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000 00000000 00011112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=205.06 Aligned_cols=177 Identities=25% Similarity=0.308 Sum_probs=144.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||..||.|.-.+.+.. .+++..+.-...+|+.||.|||+.+ ||+||+|.+|.+++.+|.+||.|||+++
T Consensus 243 lCFVMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCK 316 (516)
T ss_pred EEEEEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccch
Confidence 489999999999999998754 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
.-.. .....+..+|||+|+|||++....|..++|.|.+|+++|||++|+.||...+....-. .+....
T Consensus 317 E~I~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFe-------LIl~ed---- 384 (516)
T KOG0690|consen 317 EEIK-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFE-------LILMED---- 384 (516)
T ss_pred hccc-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHH-------HHHhhh----
Confidence 6443 2345567889999999999999999999999999999999999999998876543211 111110
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
...|...+++...++...|..||.+|. +++||.++
T Consensus 385 ------~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 385 ------LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ------ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 112344455677899999999999995 35666544
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=208.88 Aligned_cols=178 Identities=21% Similarity=0.338 Sum_probs=138.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+++++|.+++... .+++..++.++.+++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAA 149 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCcee
Confidence 47999999999999998653 4899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
....... ......++..|+|||.+.++ .++.++|+||||+++|+|++|..||.......... .......
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------~~~~~~~-- 219 (277)
T cd06917 150 LLNQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------LIPKSKP-- 219 (277)
T ss_pred ecCCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------ccccCCC--
Confidence 6543321 22234578899999998754 46899999999999999999999997654322100 0000000
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
+... ....+..+.+++.+||+.||.+||++.+++.+
T Consensus 220 ---~~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 220 ---PRLE---DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ---CCCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0000 01134568889999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=208.37 Aligned_cols=195 Identities=17% Similarity=0.228 Sum_probs=140.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.+++|||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++++||+.+.
T Consensus 74 ~~~~~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~ 149 (314)
T cd08216 74 LYVVSPLMAYGSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSV 149 (314)
T ss_pred EEEEEeccCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccce
Confidence 4899999999999999986432 24889999999999999999999999 9999999999999999999999999876
Q ss_pred cccCCCcc------eeeeccccccccccchhccC--CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHH
Q 044510 82 YVTIDQTH------LTTRVQGTFGYLDLEYFRSS--QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAM 153 (253)
Q Consensus 82 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 153 (253)
........ ......++..|+|||.+.+. .++.++|+||+||++|+|++|..||........ .........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~ 227 (314)
T cd08216 150 SMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTV 227 (314)
T ss_pred eeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccC
Confidence 54322111 11223466789999998753 578999999999999999999999976543221 000000000
Q ss_pred ----hhc-------ccc--------chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 154 ----KEN-------CLF--------DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 154 ----~~~-------~~~--------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... ... ..................+.+++.+||+.||.+||++++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 228 PCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred ccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 000 0000011111223445678899999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=207.79 Aligned_cols=185 Identities=26% Similarity=0.403 Sum_probs=141.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhh-CCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS-TTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
+++||||+++++|.+++...+ .+++..+..++.+++.||.|||. .+ ++|+||+|+||+++.++.++|+|||++
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~ 151 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVS 151 (284)
T ss_pred EEEEEecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcc
Confidence 489999999999999987643 58999999999999999999996 57 999999999999999999999999987
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhh-----hHHHHHHHHhh
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKS-----LAGYFLRAMKE 155 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~-----~~~~~~~~~~~ 155 (253)
...... ......++..|++||.+.+..++.++|+|||||++|+|++|..||......+... ...........
T Consensus 152 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd06620 152 GELINS---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE 228 (284)
T ss_pred cchhhh---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc
Confidence 644221 1123457889999999988888999999999999999999999998654321110 01111111111
Q ss_pred ccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 156 NCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
. .... .....+..+.+++.+||+.||.+||++++++++.-
T Consensus 229 ~-~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 229 P-PPRL--------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred c-CCCC--------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0 0000 01123456888999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=206.76 Aligned_cols=183 Identities=22% Similarity=0.344 Sum_probs=136.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC-CCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD-KFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~-~~~~kl~Dfgl~ 80 (253)
.++|+||+++++|.+++.........++..+..++.|++.||.|||..+ ++|+||||+||+++. ++.++|+|||++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 4799999999999999976432211278888999999999999999999 999999999999976 678999999988
Q ss_pred ccccCCCcceeeeccccccccccchhccCC--CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQ--FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
....... .......+++.|+|||.+.... ++.++|+||+|+++|+|++|..||.......... ......
T Consensus 157 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~-----~~~~~~--- 227 (268)
T cd06624 157 KRLAGIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM-----FKVGMF--- 227 (268)
T ss_pred eecccCC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH-----hhhhhh---
Confidence 6543211 1122235788999999986543 7889999999999999999999986543221100 000000
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
......+......+.+++.+||+.+|.+||++.+++++
T Consensus 228 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 ------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111223344568889999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=219.07 Aligned_cols=174 Identities=24% Similarity=0.302 Sum_probs=137.4
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
|+|||||-| +-.|++.-... ++.+..+..|+-+.++||.|||+++ .+|||||..|||+++.|.|||+|||.+..
T Consensus 102 WLVMEYClG-SAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi 175 (948)
T KOG0577|consen 102 WLVMEYCLG-SASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASI 175 (948)
T ss_pred HHHHHHHhc-cHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhh
Confidence 899999955 88888877543 6999999999999999999999999 99999999999999999999999998865
Q ss_pred ccCCCcceeeeccccccccccchhc---cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFR---SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
.. +...++|||.|||||++. .+.|+-++||||||++..|+...++|+-..+... .+..+ ..+..+
T Consensus 176 ~~-----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS------ALYHI-AQNesP 243 (948)
T KOG0577|consen 176 MA-----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHI-AQNESP 243 (948)
T ss_pred cC-----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH------HHHHH-HhcCCC
Confidence 43 445678999999999985 4679999999999999999999999864433211 11111 111111
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.+- ..+-+..+++|+..||+.-|.+|||..+++.+
T Consensus 244 tLq--------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 244 TLQ--------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCC--------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 111 23344578889999999999999998777654
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=206.50 Aligned_cols=184 Identities=22% Similarity=0.362 Sum_probs=140.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||+++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred eEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 479999999999999997753 5899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcc-eeeeccccccccccchhccCC--CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTH-LTTRVQGTFGYLDLEYFRSSQ--FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
........ ......++..|++||.+.... ++.++|+||||++++++++|..||........ ..... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~-~~~~ 229 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA------MFKLG-NKRS 229 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH------HHHhh-cccc
Confidence 54321111 122345788999999987654 78999999999999999999999965433211 01111 1111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...... ......+..+.+++.+||+.+|.+||++++++++
T Consensus 230 ~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111 1112345678889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=227.03 Aligned_cols=181 Identities=24% Similarity=0.363 Sum_probs=147.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||++||+|..++.... ++++..+...+.+|+.||.-||+.| +|||||||+|||++..|.+||+|||.+.
T Consensus 150 LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHH
Confidence 599999999999999998765 5999999999999999999999999 9999999999999999999999999888
Q ss_pred cccCCCcceeeeccccccccccchhc----c-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR----S-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
.+..++.-.....+|||.|++||++. + +.|+..+|.||+||++|||+.|..||... .+.+.+..++...
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY~KIm~hk 297 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETYGKIMNHK 297 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHHHHHhchh
Confidence 77766655666788999999999995 2 45899999999999999999999999753 3444555555443
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT---MKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps---~~~l~~~ 202 (253)
....+.+ ....+.+..++|++.+. +|..|.. +.++-.|
T Consensus 298 ~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 298 ESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred hhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 2222221 12256678889988765 5677766 8887765
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=231.61 Aligned_cols=190 Identities=20% Similarity=0.288 Sum_probs=141.4
Q ss_pred CEEEEeecCCCChhHHhhccCC--------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE--------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAK 73 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~k 73 (253)
+|+||||++|++|.+++..... ....++..+++++.|++.||.|||+.+ ++||||||+||+++.++.++
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEE
Confidence 4899999999999999865211 123566788899999999999999999 99999999999999999999
Q ss_pred EcccCCcccccCCCc-----------------ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCC
Q 044510 74 ISDFGASRYVTIDQT-----------------HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRS 136 (253)
Q Consensus 74 l~Dfgl~~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~ 136 (253)
|+|||+++....... .......||+.|+|||++.+..++.++|+||+||++|+|++|..||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999876521110 011124689999999999988899999999999999999999999976
Q ss_pred CChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhchh
Q 044510 137 TDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-TMKEVAFELGGIRA 208 (253)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-s~~~l~~~l~~~~~ 208 (253)
....... ...... .+... ......+..+.+++.+||+.||.+|| +++++.+.|+....
T Consensus 234 ~~~~ki~----------~~~~i~---~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 234 KKGRKIS----------YRDVIL---SPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred cchhhhh----------hhhhcc---Chhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 4322110 000000 00000 00112344678899999999999995 67777777776654
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=210.08 Aligned_cols=194 Identities=20% Similarity=0.222 Sum_probs=138.2
Q ss_pred CEEEEeecCCCChhHHhhccCC--CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC-CCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE--EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD-KFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~-~~~~kl~Dfg 78 (253)
.|+||||+.+ +|.+++..... ...+++..++.++.||+.||.|||..+ ++|+||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 4899999975 89888865432 235899999999999999999999999 999999999999998 8899999999
Q ss_pred CcccccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHH--hh
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAM--KE 155 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~--~~ 155 (253)
+++....... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... ....... ..
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~--~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL--HIFKLLGTPTE 233 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH--HHHHHhCCCCh
Confidence 8875432211 1122346788999999865 347899999999999999999999997654332111 0000000 00
Q ss_pred ccccc-----------hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 156 NCLFD-----------MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 156 ~~~~~-----------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..... ...+..........+..+.++|.+||+.||.+||++++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 000000111112345678899999999999999999999854
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=216.29 Aligned_cols=181 Identities=22% Similarity=0.272 Sum_probs=135.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.||||||= .-+|..+|+.... .++...+..+..|+++++.++|.+| |||.||||.|.++.. |.+||+|||.+.
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~~--~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~ 507 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKKS--IDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIAN 507 (677)
T ss_pred EEEEeecc-cccHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhc
Confidence 68999988 4599999987653 2444477888999999999999999 999999999999876 499999999998
Q ss_pred cccCCCccee-eeccccccccccchhccC-----------CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH
Q 044510 82 YVTIDQTHLT-TRVQGTFGYLDLEYFRSS-----------QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF 149 (253)
Q Consensus 82 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~-----------~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 149 (253)
.+........ ...+||+.||+||.+... +.+.++||||+||++|+|+.|+.||.... +.+..+
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~aKl 582 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQIAKL 582 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHHHHH
Confidence 7765544432 347799999999998532 24689999999999999999999996432 222222
Q ss_pred HHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 150 LRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
......+...+. +..+.. .++.++...||..||.+||+..+++++
T Consensus 583 ~aI~~P~~~Ief------p~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 583 HAITDPNHEIEF------PDIPEN--DELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HhhcCCCccccc------cCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 222222211110 011111 128889999999999999999999975
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=205.41 Aligned_cols=182 Identities=25% Similarity=0.386 Sum_probs=140.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhh-CCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS-TTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
+++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~ 148 (265)
T cd06605 74 ISICMEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVS 148 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 589999999999999998753 258999999999999999999999 88 999999999999999999999999987
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
........ ....++..|++||.+.+..++.++|+||||+++++|++|..||....... .............. ..
T Consensus 149 ~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~-~~- 222 (265)
T cd06605 149 GQLVNSLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEP-PP- 222 (265)
T ss_pred hhhHHHHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCC-CC-
Confidence 65432111 11557889999999998889999999999999999999999996643211 11111111111111 00
Q ss_pred hhchhhhhhhcHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEE-EIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~-~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+.. .+..+.++|.+||..||.+||++.+++.+
T Consensus 223 --------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 --------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred --------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 01111 45568899999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=205.69 Aligned_cols=178 Identities=21% Similarity=0.333 Sum_probs=140.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++|+||+++++|.+++.+.. .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~ 150 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAK 150 (258)
T ss_pred EEEEEEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccce
Confidence 489999999999999997654 4889999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCC-CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQ-FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
...... ......++..|++||.+.... ++.++|+||||+++|+|++|..||......... .........
T Consensus 151 ~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~~~-- 220 (258)
T cd06632 151 QVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV------FKIGRSKEL-- 220 (258)
T ss_pred eccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH------HHHHhcccC--
Confidence 543222 223345788899999987666 889999999999999999999999765422111 111110001
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...+......+.+++.+||+.+|.+||++++++.+
T Consensus 221 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 -------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11122234567889999999999999999999853
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=209.15 Aligned_cols=174 Identities=26% Similarity=0.351 Sum_probs=139.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||++.
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~ 149 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAK 149 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCcc
Confidence 589999999999999997653 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... .....+++.|++||.+.+...+.++|+||||+++|+|++|..||........ ..... ....
T Consensus 150 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~-~~~~--- 215 (290)
T cd05580 150 RVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI------YEKIL-EGKV--- 215 (290)
T ss_pred ccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHh-cCCc---
Confidence 65432 2234578899999999888888999999999999999999999976552211 11111 1100
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
..+...+..+.+++.+||..||.+|+ ++++++++
T Consensus 216 -------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 216 -------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 11122245678899999999999998 77777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=193.21 Aligned_cols=176 Identities=28% Similarity=0.373 Sum_probs=145.3
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
|+++||..+|+|...+...... ++++..++.++.|++.||.|+|.++ ++||||||+|+|++..+.+|++|||-+..
T Consensus 98 yLilEya~~gel~k~L~~~~~~-~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMK-RFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred EEEEEecCCchHHHHHHhcccc-cccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceee
Confidence 8999999999999999854322 5999999999999999999999999 99999999999999999999999998875
Q ss_pred ccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccchh
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDML 162 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (253)
.. .......+||..|++||...+..++..+|+|++|++.||++.|..||......+. +.+..... .
T Consensus 174 ~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et------YkrI~k~~----~- 239 (281)
T KOG0580|consen 174 AP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET------YKRIRKVD----L- 239 (281)
T ss_pred cC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH------HHHHHHcc----c-
Confidence 43 2334456799999999999999999999999999999999999999987653321 12221111 1
Q ss_pred chhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 163 DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+...+..+.++|-+||..+|.+|.+..|++++
T Consensus 240 ------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 ------KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ------cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1123344568889999999999999999999876
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=213.26 Aligned_cols=196 Identities=24% Similarity=0.299 Sum_probs=141.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+|+||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 489999994 68999887653 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc--
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL-- 158 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 158 (253)
...... .......++..|+|||.+.. ..++.++|+|||||++|+|++|..||........................
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 654321 12223456888999999865 45889999999999999999999999765432211111000000000000
Q ss_pred -------------cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhc
Q 044510 159 -------------FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE--LGGI 206 (253)
Q Consensus 159 -------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~--l~~~ 206 (253)
....... ........+..+.+++.+||+.+|.+||++++++++ +..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQS-FARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred cCchhhhHHHHhcCcccccC-HHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000000 011112345678899999999999999999999987 5443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=206.24 Aligned_cols=179 Identities=25% Similarity=0.304 Sum_probs=140.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 68 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~ 141 (262)
T cd05572 68 IYMLMEYCLGGELWTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAK 141 (262)
T ss_pred cEEEEecCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCccc
Confidence 589999999999999997653 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... ......+++.|++||.+.+..++.++|+|++|+++|+|++|..||....... ............
T Consensus 142 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~---- 211 (262)
T cd05572 142 KLKSGQ--KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILKGNG---- 211 (262)
T ss_pred ccCccc--ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhccCC----
Confidence 654322 2223457889999999988888999999999999999999999997765311 111111111000
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT-----MKEVAF 201 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~ 201 (253)
....+...+..+.+++.+||+.+|.+||+ ++|+++
T Consensus 212 -----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 212 -----KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred -----CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 01112222457889999999999999999 777775
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=204.77 Aligned_cols=179 Identities=23% Similarity=0.339 Sum_probs=143.2
Q ss_pred CEEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.++||||+++++|.+++.+.. ....+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~ 150 (256)
T cd08530 74 LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGIS 150 (256)
T ss_pred EEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccch
Confidence 489999999999999987622 1235899999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
...... ......+++.|++||.+.+..++.++|+||+|+++++|++|..||...+..+.. ........
T Consensus 151 ~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~-------~~~~~~~~-- 218 (256)
T cd08530 151 KVLKKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR-------YKVQRGKY-- 218 (256)
T ss_pred hhhccC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcCCC--
Confidence 765433 222245788999999999888899999999999999999999999776543211 11111111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...+......+.+++.+||+.+|.+||++.+++++
T Consensus 219 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 -------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11222445668899999999999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=208.44 Aligned_cols=181 Identities=22% Similarity=0.302 Sum_probs=138.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~ 151 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSA 151 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccch
Confidence 4899999999999999876432 5899999999999999999999999 9999999999999999999999999876
Q ss_pred cccCCCcceeeeccccccccccchhc-----cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR-----SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
....... ......+++.|++||.+. ...++.++|+||||+++|+|++|..||........ ... ....
T Consensus 152 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~------~~~-~~~~ 223 (280)
T cd06611 152 KNKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV------LLK-ILKS 223 (280)
T ss_pred hhccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH------HHH-HhcC
Confidence 5432211 122345788999999975 23467899999999999999999999976543221 111 1111
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..... ..+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 224 ~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 224 EPPTL-------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCCCc-------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00000 0112234467889999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=208.62 Aligned_cols=179 Identities=25% Similarity=0.360 Sum_probs=140.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+|+||+++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~ 163 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (293)
T ss_pred EEEEEecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCccee
Confidence 58999999999999998754 3788999999999999999999999 9999999999999999999999999876
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
....... ......+++.|++||.+.+..++.++|+||||+++|++++|..||........... ..... .
T Consensus 164 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~-~--- 232 (293)
T cd06647 164 QITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG-T--- 232 (293)
T ss_pred ccccccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCC-C---
Confidence 5432221 12224578889999999888889999999999999999999999976543221110 00000 0
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.....+...+..+.+++.+||..+|.+||++.+++.+
T Consensus 233 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 ----PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ----CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001122334568889999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=208.23 Aligned_cols=194 Identities=21% Similarity=0.288 Sum_probs=139.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|..+..... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~ 148 (286)
T cd07846 75 LYLVFEFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 148 (286)
T ss_pred EEEEEecCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeee
Confidence 489999999988888765433 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH--------HHH
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF--------LRA 152 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~~~ 152 (253)
...... .......++..|++||++.+. .++.++|+||||+++|+|++|..||......+........ ...
T Consensus 149 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07846 149 TLAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI 227 (286)
T ss_pred eccCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHH
Confidence 553322 222234578899999998754 4678999999999999999999999765432211110000 000
Q ss_pred Hhhc------cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 153 MKEN------CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 153 ~~~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.... ..................+..+.+++.+||+.+|.+||++++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000 0000000000001112335678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=203.52 Aligned_cols=180 Identities=27% Similarity=0.374 Sum_probs=141.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++++||+++++|.+++.... ..+++..+..++.+++.||.+||..+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~ 146 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSA 146 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccc
Confidence 479999999999999997753 25899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
....... .....++..|++||.+.+..++.++|+|+||+++++|++|..||.......... . .........
T Consensus 147 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~-~~~~~~~~~ 217 (253)
T cd05122 147 QLSDTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF------K-IATNGPPGL 217 (253)
T ss_pred ccccccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH------H-HHhcCCCCc
Confidence 6543221 233557889999999988888999999999999999999999997654322111 0 000111111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.. ....+..+.+++.+||+.||.+||++.+++++
T Consensus 218 ~~-------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 218 RN-------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred Cc-------ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 10 11124468889999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=233.64 Aligned_cols=183 Identities=25% Similarity=0.370 Sum_probs=136.5
Q ss_pred CEEEEeecCCCChhHHhhccCC-CCCCCHHHHHHHHHHHHHHHHhHhhCCC----CCeEecCCCCCceeecC--------
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-EFTITWEISLRIAVEVSGALSYLHSTTS----IPIYHRDIKSANILLDD-------- 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~----~~i~H~dl~~~nili~~-------- 68 (253)
.||||||+.+++|.++|..... ...+++..++.|+.||+.||.|||..+. .+|+|+||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 4799999999999999976321 2359999999999999999999998431 12999999999999964
Q ss_pred ---------CCceEEcccCCcccccCCCcceeeeccccccccccchhcc--CCCCCCCCeehhHHHHHHHHhCCCCCCCC
Q 044510 69 ---------KFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRS--SQFTKKGDVYSFGVVFVGLLTGQKPIRST 137 (253)
Q Consensus 69 ---------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~lltg~~pf~~~ 137 (253)
...+||+|||++....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2348999999987653221 2233568999999999864 34789999999999999999999999754
Q ss_pred ChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 138 DTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.... .+...+....... ....+..+.+||..||+.+|.+||++.+++.+
T Consensus 247 ~~~~------qli~~lk~~p~lp----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 247 NNFS------QLISELKRGPDLP----------IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CcHH------HHHHHHhcCCCCC----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 3221 1111111111000 01123468889999999999999999999853
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=208.88 Aligned_cols=194 Identities=20% Similarity=0.215 Sum_probs=140.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+. ++|.+++..... .+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~lv~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~ 154 (293)
T cd07843 81 IYMVMEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154 (293)
T ss_pred EEEEehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCcee
Confidence 589999996 499999876432 5899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCC-CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH--------HHH
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQ-FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF--------LRA 152 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~~~ 152 (253)
...... .......+++.|+|||.+.+.. ++.++|+||+|+++++|++|..||............... +..
T Consensus 155 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 155 EYGSPL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred eccCCc-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHH
Confidence 654322 1122244678899999987654 688999999999999999999999876543221111000 000
Q ss_pred Hhh------ccccchhchhhhhhhcHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 153 MKE------NCLFDMLDAQVLKEAKEE-EIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 153 ~~~------~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... ...............+.. .+..+.+++.+||+.||.+||+++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 000000001111111111 35568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=206.30 Aligned_cols=170 Identities=26% Similarity=0.349 Sum_probs=142.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+.||+|-..+++.+ .+.+..+.-.+.+|+-||-+||++| |++||||.+||+++..|.+||+|||+++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeeEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccc
Confidence 589999999999999998876 4888999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
.-.. ....+++..|||.|+|||++...+|+.++|.|++|+++|||+.|+.||.+.++++.-. ..+..+
T Consensus 499 Eni~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~------aI~ehn----- 566 (683)
T KOG0696|consen 499 ENIF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ------AIMEHN----- 566 (683)
T ss_pred cccc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH------HHHHcc-----
Confidence 5332 2334566789999999999999999999999999999999999999999988765211 111111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT 195 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps 195 (253)
-.++...+.+...++...|...|.+|.-
T Consensus 567 ------vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 567 ------VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ------CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 1235556667888999999999999853
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=239.05 Aligned_cols=179 Identities=23% Similarity=0.319 Sum_probs=140.5
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
+|-||||+||+|.+++.... -..+........|++.|+.|||++| ||||||||.||+++.+|.+|++|||.++.
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 46799999999999997643 2555555667889999999999999 99999999999999999999999999987
Q ss_pred ccCCCcce---eeeccccccccccchhccCC---CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 83 VTIDQTHL---TTRVQGTFGYLDLEYFRSSQ---FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 83 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
...+.... .+...||+.|||||++.+.. -..+.||||+||++.||+||+.||...+.+ +..+.. .
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-----~aIMy~-V--- 1454 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-----WAIMYH-V--- 1454 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-----hHHHhH-H---
Confidence 75543221 23467999999999997643 467899999999999999999999765543 111111 1
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
-..-.+..|...+.+-++++..||+.||.+|-++.||+++
T Consensus 1455 ------~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 ------AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ------hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1111234455677788999999999999999888877754
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=211.36 Aligned_cols=184 Identities=23% Similarity=0.301 Sum_probs=138.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||++|++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|.||+++.++.++++|||+++
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~ 149 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSK 149 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCcc
Confidence 489999999999999997654 5899999999999999999999999 9999999999999999999999999876
Q ss_pred cccCCCc--------------ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHH
Q 044510 82 YVTIDQT--------------HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAG 147 (253)
Q Consensus 82 ~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~ 147 (253)
....... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+....+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------ 223 (305)
T cd05609 150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------ 223 (305)
T ss_pred ccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------
Confidence 3211000 01112346778999999988889999999999999999999999997654322
Q ss_pred HHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 148 YFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
......... .. .+. .....+..+.+++.+||+.||.+||+..++.+.|+.
T Consensus 224 ~~~~~~~~~-~~---~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 224 LFGQVISDD-IE---WPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHHhcc-cC---CCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111111111 00 000 011234467889999999999999996555555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=206.83 Aligned_cols=194 Identities=21% Similarity=0.236 Sum_probs=141.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 73 ~~~v~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~ 146 (283)
T cd05118 73 LYLVFEFMDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLAR 146 (283)
T ss_pred EEEEEeccCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence 5899999965 8888887643 25899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
...... .......++..|++||.+.+. .++.++|+||+|+++|+|++|+.||......+...................
T Consensus 147 ~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd05118 147 SFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPK 225 (283)
T ss_pred ecCCCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhccc
Confidence 654332 112234567889999998766 678999999999999999999999977654332111100000000000000
Q ss_pred -----------h--hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 -----------M--LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 -----------~--~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. .............+..+.+++.+||+.||.+||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 226 FTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred chhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 00000111223456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=214.19 Aligned_cols=190 Identities=19% Similarity=0.250 Sum_probs=138.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+. ++|.+.+... +++..+..++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||+++
T Consensus 96 ~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 96 VYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred EEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccce
Confidence 489999995 5888887542 788899999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHH--------HHH--
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGY--------FLR-- 151 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~--------~~~-- 151 (253)
...... ......++..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......... +..
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 167 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred eCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 653221 12234578899999999988899999999999999999999999977654221110000 000
Q ss_pred ------HHhhcccc------chhc----hhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 152 ------AMKENCLF------DMLD----AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 152 ------~~~~~~~~------~~~~----~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
........ .... +.............+.+++.+||+.||.+||++.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0000 000000012345568899999999999999999999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=204.91 Aligned_cols=181 Identities=25% Similarity=0.381 Sum_probs=138.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++|+||+++++|.+++.... .+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~ 147 (264)
T cd06626 74 VYIFMEYCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAV 147 (264)
T ss_pred EEEEEecCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccccccc
Confidence 479999999999999997643 4888999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCccee---eeccccccccccchhccCC---CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh
Q 044510 82 YVTIDQTHLT---TRVQGTFGYLDLEYFRSSQ---FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE 155 (253)
Q Consensus 82 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 155 (253)
.......... ....+++.|++||.+.+.. ++.++|+|+||++++++++|..||....... ....... .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~~~-~ 221 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFHVG-A 221 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHHHh-c
Confidence 6543222111 1245678999999998765 7899999999999999999999997543211 1111111 1
Q ss_pred ccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044510 156 NCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAF 201 (253)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 201 (253)
...... . ........+.+++.+||+.+|.+||++.+++.
T Consensus 222 ~~~~~~-~------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 GHKPPI-P------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCC-C------cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111000 0 01122456778999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=221.60 Aligned_cols=197 Identities=19% Similarity=0.250 Sum_probs=134.3
Q ss_pred CEEEEeecCCCChhHHhhccCC--CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE--EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl 79 (253)
.|+|+|++ +++|.+++..... ........+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 238 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~~~vkL~DFGl 313 (501)
T PHA03210 238 TYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGT 313 (501)
T ss_pred eEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEeCCC
Confidence 47899999 4578777754321 112446678889999999999999999 99999999999999999999999999
Q ss_pred cccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCC-CCCCCChhhhhhhHHHHHHHHh-hcc
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQK-PIRSTDTEEDKSLAGYFLRAMK-ENC 157 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~-pf~~~~~~~~~~~~~~~~~~~~-~~~ 157 (253)
++.+............|++.|+|||++.+..++.++|||||||++|+|++|.. |+.................... ...
T Consensus 314 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (501)
T PHA03210 314 AMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEE 393 (501)
T ss_pred ceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhh
Confidence 98664333223334568999999999998889999999999999999999875 4433222111111111100000 000
Q ss_pred c-------cchhch--------hhhh-hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 L-------FDMLDA--------QVLK-EAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~-------~~~~~~--------~~~~-~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. .+.+.. .... .........+.+++.+||+.||.+||++.|++++
T Consensus 394 ~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 394 FPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred cCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 000000 0000 0001122356778999999999999999999975
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=206.14 Aligned_cols=192 Identities=22% Similarity=0.250 Sum_probs=137.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+. ++|.+.+.... ..+++..++.++.|++.||.|||..+ ++|+||+|+||+++. +.++|+|||+++
T Consensus 75 ~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~ 147 (282)
T cd07831 75 LALVFELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCR 147 (282)
T ss_pred EEEEEecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccc
Confidence 589999996 58888886543 25899999999999999999999999 999999999999999 999999999987
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH--------HHH
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF--------LRA 152 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~~~ 152 (253)
...... ......++..|+|||.+.. ..++.++|+||+||++|+|++|..||...+..+........ ...
T Consensus 148 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 148 GIYSKP--PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred ccccCC--CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 553221 1122456889999998754 44688999999999999999999999776543211111000 000
Q ss_pred Hhhccccchhch----hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 153 MKENCLFDMLDA----QVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 153 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...........+ ..........+..+.+++.+||+.+|.+||++++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000000 00011112346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=212.09 Aligned_cols=194 Identities=20% Similarity=0.284 Sum_probs=140.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+. ++|.+++.... .+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 379999995 68999887543 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcce---eeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH--------
Q 044510 82 YVTIDQTHL---TTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF-------- 149 (253)
Q Consensus 82 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~-------- 149 (253)
......... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 553322111 123457889999999865 45789999999999999999999999776543221111100
Q ss_pred HHHHhhccccchh------chhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 150 LRAMKENCLFDML------DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 150 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
............. ............+..+.+++.+||+.+|.+||++++++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000000 0000011112245678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=204.99 Aligned_cols=181 Identities=24% Similarity=0.356 Sum_probs=142.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhh-CCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS-TTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
+++||||+++++|.+++.... .+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~ 147 (264)
T cd06623 74 ISIVLEYMDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGIS 147 (264)
T ss_pred EEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccc
Confidence 589999999999999998653 58999999999999999999999 99 999999999999999999999999988
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
......... .....++..|+|||.+.+..++.++|+|+||+++|+|++|..||............ .... .....
T Consensus 148 ~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~---~~~~-~~~~~- 221 (264)
T cd06623 148 KVLENTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM---QAIC-DGPPP- 221 (264)
T ss_pred eecccCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH---HHHh-cCCCC-
Confidence 765432221 12345788999999998888899999999999999999999999776431111111 1111 11111
Q ss_pred hhchhhhhhhcHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEE-EIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~-~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+.. .+..+.+++.+||+.+|.+||++.+++++
T Consensus 222 --------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 --------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111 44578889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=207.29 Aligned_cols=181 Identities=24% Similarity=0.274 Sum_probs=139.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++..... ..+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 68 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~ 143 (277)
T cd05577 68 LCLVMTLMNGGDLKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAV 143 (277)
T ss_pred EEEEEecCCCCcHHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchh
Confidence 4899999999999999976543 25899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
.... ........++..|++||.+.+..++.++|+||+|+++++|++|..||.......... .+.......
T Consensus 144 ~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~----- 213 (277)
T cd05577 144 ELKG--GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELKRRTLEM----- 213 (277)
T ss_pred hhcc--CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHHhccccc-----
Confidence 5432 112223456789999999988888999999999999999999999997654321100 001100000
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAF 201 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~ 201 (253)
....+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 214 -----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 214 -----AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred -----cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 0111222355688899999999999999 6666765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=204.24 Aligned_cols=164 Identities=25% Similarity=0.220 Sum_probs=130.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||.+.
T Consensus 60 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~ 133 (237)
T cd05576 60 VFLVLQHAEGGKLWSHISKFL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWS 133 (237)
T ss_pred EEEEEecCCCCCHHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchh
Confidence 489999999999999987653 4899999999999999999999999 9999999999999999999999999775
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... .....++..|++||...+..++.++|+||+|+++|+|++|..|+....... ... .
T Consensus 134 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~--~-- 193 (237)
T cd05576 134 EVEDS----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTH--T-- 193 (237)
T ss_pred ccccc----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccc--c--
Confidence 44321 112234667999999987888999999999999999999998864322110 000 0
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTM 196 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~ 196 (253)
....+...+..+.+++.+||+.||.+||++
T Consensus 194 -----~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 194 -----TLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred -----ccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 001122234568889999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=203.43 Aligned_cols=183 Identities=24% Similarity=0.417 Sum_probs=140.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC-ceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF-RAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~-~~kl~Dfgl~ 80 (253)
.++||||+++++|.+++.+.. .+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++ .++|+|||++
T Consensus 78 ~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~ 151 (268)
T cd06630 78 FNLFVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAA 151 (268)
T ss_pred EEEEEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccc
Confidence 479999999999999997654 5889999999999999999999999 99999999999998765 5999999988
Q ss_pred ccccCCCcc---eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 81 RYVTIDQTH---LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 81 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
......... ......++..|+|||.+.+..++.++|+|++|+++++|++|..||.......... .........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~- 227 (268)
T cd06630 152 ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIFKIASAT- 227 (268)
T ss_pred cccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHHHHhccC-
Confidence 765432111 1122457889999999988888999999999999999999999996543321111 111110000
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.....+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 228 --------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 228 --------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred --------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0112233455678889999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=208.08 Aligned_cols=191 Identities=25% Similarity=0.276 Sum_probs=139.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+ +++|.+++.... ..+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 77 ~~lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~ 150 (298)
T cd07841 77 INLVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR 150 (298)
T ss_pred EEEEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeee
Confidence 48999999 889999997654 25899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHh------
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK------ 154 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~------ 154 (253)
...... .......+++.|+|||.+.+ ..++.++|+|||||++++|++|..+|......+.... . .....
T Consensus 151 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~--~-~~~~~~~~~~~ 226 (298)
T cd07841 151 SFGSPN-RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGK--I-FEALGTPTEEN 226 (298)
T ss_pred eccCCC-ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHH--H-HHHcCCCchhh
Confidence 654322 12222345778999999865 3578899999999999999999888876543221110 0 00000
Q ss_pred ---hccccchhc-----hhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 155 ---ENCLFDMLD-----AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 155 ---~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
......... ...........+..+.+++.+||+.||.+||++++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000 000011122335678899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=206.19 Aligned_cols=177 Identities=25% Similarity=0.349 Sum_probs=139.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+.+++|.+++... .+++..+..++.+++.++.+||..+ ++|+||+|+||+++.++.++++|||++.
T Consensus 77 ~~lv~e~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 77 LWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAG 149 (277)
T ss_pred EEEEEEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccce
Confidence 58999999999999998643 4899999999999999999999999 9999999999999999999999999886
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......++..|++||.+.+..++.++|+||+||++|+|++|..||......... ........
T Consensus 150 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~~--- 218 (277)
T cd06641 150 QLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL-------FLIPKNNP--- 218 (277)
T ss_pred ecccch-hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH-------HHHhcCCC---
Confidence 543221 1122235678899999998888899999999999999999999999754432110 01111110
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.......+..+.+++.+||+.+|.+||++.+++++
T Consensus 219 ------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 ------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01122234567889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=204.49 Aligned_cols=190 Identities=24% Similarity=0.285 Sum_probs=140.2
Q ss_pred CEEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
+++||||+++++|.+++.... ....+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~ 152 (287)
T cd06621 76 IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVS 152 (287)
T ss_pred EEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccc
Confidence 479999999999999876422 2235889999999999999999999999 999999999999999999999999987
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
....... .....++..|++||.+.+..++.++|+|++|+++|+|++|..||....... ...... ...........
T Consensus 153 ~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~-~~~~~~~~~~~ 227 (287)
T cd06621 153 GELVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIEL-LSYIVNMPNPE 227 (287)
T ss_pred ccccccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHH-HHHHhcCCchh
Confidence 6543211 112346788999999988889999999999999999999999997653210 011111 11111111110
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... . .......+..+.+++.+||+.+|.+|||+.|++++
T Consensus 228 ~~~-~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 228 LKD-E--PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred hcc-C--CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000 0 00001234568899999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=194.48 Aligned_cols=195 Identities=17% Similarity=0.241 Sum_probs=151.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||++|++ +|..++.+... +++...+.+++.++..||.|+|... |+|||+|+.|+||+.++.+||+|||+++
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~v--r~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRKV--RFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCccc--cccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccc
Confidence 3799999977 89999987544 5899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcc---eeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 82 YVTIDQTH---LTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 82 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
.++..... ..+..+-|.+|++||.+.|. .|+++.|+|+.||++.+|+++.+.|++..+..+...+..+...+....
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 76533211 22334568999999999875 589999999999999999999999998887776666666544433332
Q ss_pred ccchhchhhhhhh------------------cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 LFDMLDAQVLKEA------------------KEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~~~~~~~~~~~~~------------------~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
++....-.+.... +..-.....+++.++|..||.+|+++++++.+
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 2222111111111 00112468899999999999999999988865
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-30 Score=205.79 Aligned_cols=181 Identities=24% Similarity=0.364 Sum_probs=141.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+|+||+++++|.+++.... ..+++..+..++.+++.||.|||..| ++|+||+|+||+++.++.++|+|||++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 164 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAA 164 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhh
Confidence 489999999999999998754 25899999999999999999999999 9999999999999999999999999876
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
....... ......++..|++||.+.+..++.++|+||||+++|+|++|..||......... .. .........
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~------~~-~~~~~~~~~ 236 (286)
T cd06614 165 QLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL------FL-ITTKGIPPL 236 (286)
T ss_pred hhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH------HH-HHhcCCCCC
Confidence 5432211 112334678899999998888899999999999999999999999765433211 01 111111110
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. .....+..+.+++.+||+.+|.+||++.+++++
T Consensus 237 ~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 237 K-------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred c-------chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0 011134468889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=216.35 Aligned_cols=187 Identities=25% Similarity=0.419 Sum_probs=154.0
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
|||+|||..|+|.++|++.... ..+.-..+.++.||..|+.||..++ ++||||-..|+|+..+..|||+||||+++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 8999999999999999885432 4777788899999999999999999 99999999999999999999999999998
Q ss_pred ccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
+...........-....|.|||-+....++.++|||+||+++||+.| |-.||.+.+... ...+
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq----------------VY~L 478 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYGL 478 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH----------------HHHH
Confidence 86544333222234568999999998889999999999999999998 888887765433 1122
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
+....+-+.++.+++.+.++++.||+.+|.+||++.|+-+.++.+..+
T Consensus 479 LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 479 LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 223334455667778899999999999999999999999999866543
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=212.47 Aligned_cols=193 Identities=23% Similarity=0.314 Sum_probs=137.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+|+||+. ++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 83 VYIVQELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEEehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 479999995 4888887543 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcc--eeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTH--LTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
........ ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 65322211 1122457889999998754 45789999999999999999999999765432211111000000000000
Q ss_pred cchhchh--------------hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQ--------------VLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~--------------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+.+.. .........+..+.+++.+||+.||.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0000011234568899999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=202.75 Aligned_cols=181 Identities=28% Similarity=0.373 Sum_probs=142.6
Q ss_pred CEEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
+++|+||+++++|.+++.... ....+++..++.++.+++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~ 150 (258)
T cd08215 74 LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGIS 150 (258)
T ss_pred EEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccce
Confidence 479999999999999997742 1236999999999999999999999999 999999999999999999999999988
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
....... .......+++.|+|||...+..++.++|+|++|+++++|++|..||....... ...... .....
T Consensus 151 ~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~- 221 (258)
T cd08215 151 KVLSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALKIL-KGQYP- 221 (258)
T ss_pred eecccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHHHh-cCCCC-
Confidence 7654332 12233457889999999988888999999999999999999999986654321 111111 11111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 222 --------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 222 --------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1112334568889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=209.32 Aligned_cols=194 Identities=24% Similarity=0.248 Sum_probs=138.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+.+ +|.+++.... ..+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~ 156 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156 (309)
T ss_pred EEEEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceee
Confidence 4899999964 8988887643 25899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc---
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC--- 157 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 157 (253)
....... ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||......+................
T Consensus 157 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 157 TYGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred ecCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence 6543221 1222335778999999875 4578999999999999999999999987654332111111000000000
Q ss_pred --------ccchh--chhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 --------LFDML--DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 --------~~~~~--~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..... ............+..+.+++.+||+.||.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 0000000111235667889999999999999999999965
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-30 Score=203.29 Aligned_cols=180 Identities=26% Similarity=0.374 Sum_probs=139.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC-ceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF-RAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~-~~kl~Dfgl~ 80 (253)
+++|+||+++++|.+++..... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++ .++++|||.+
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~ 149 (257)
T cd08225 74 LFIVMEYCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIA 149 (257)
T ss_pred EEEEEecCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccc
Confidence 5899999999999999976432 24799999999999999999999999 99999999999998775 4699999988
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
........ ......+++.|+|||.+.+..++.++|+||||+++++|++|..||......+ ....... ....
T Consensus 150 ~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-~~~~- 220 (257)
T cd08225 150 RQLNDSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQ-GYFA- 220 (257)
T ss_pred hhccCCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhc-ccCC-
Confidence 76543221 2223457889999999988888999999999999999999999997544321 1111111 1111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
......+..+.+++.+||+.+|.+||++.+++++
T Consensus 221 --------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 --------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111233468889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-31 Score=203.72 Aligned_cols=181 Identities=21% Similarity=0.281 Sum_probs=146.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|||||||-.|++.++++.... ++.+..+..++++-+.||.|||... -+|||||..|||++.+|..||+|||++-
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAG 177 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAG 177 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccc
Confidence 5999999999999999876433 7999999999999999999999988 8999999999999999999999999876
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...+ .........|||.|||||++..-.|..+.||||+|++..||..|++||.+..+.....+ +..++...
T Consensus 178 QLTD-TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-------IPT~PPPT- 248 (502)
T KOG0574|consen 178 QLTD-TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-------IPTKPPPT- 248 (502)
T ss_pred hhhh-hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-------ccCCCCCC-
Confidence 4432 22233457799999999999988999999999999999999999999987665332111 01111111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
-..+..-+..+-+++++||..+|++|.|+-+++++
T Consensus 249 ------F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 ------FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ------CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 12244556678889999999999999998888775
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=215.97 Aligned_cols=185 Identities=25% Similarity=0.412 Sum_probs=157.8
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
|||||.++-|.|..+++++.. .++.......+.||..||.|||+.. .|||||-..|||+....-|||+|||+++.
T Consensus 466 WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence 899999999999999998765 4888899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
......+......-...||+||-++-..++.++|||.||+.+||++. |..||.+-...+ ..-.
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------VI~~ 604 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------VIGH 604 (974)
T ss_pred ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------eEEE
Confidence 87666555444444668999999999999999999999999999987 999998755433 2222
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchh
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRA 208 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 208 (253)
+..+.+...+..+++.+..+..+||..+|.+||.+.+|...|+.+..
T Consensus 605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 23333445567778889999999999999999999999999887766
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=203.27 Aligned_cols=192 Identities=24% Similarity=0.275 Sum_probs=140.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.+++|||+.+ +|.+++..... ..+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 5899999964 89998876432 24899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHh--hcccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK--ENCLF 159 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~ 159 (253)
...... ......++..|++||.+.+..++.++|+|||||++|+|++|..||......+..... ...... .....
T Consensus 156 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 231 (287)
T cd07838 156 IYSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI--FDVIGLPSEEEWP 231 (287)
T ss_pred eccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHH--HHHcCCCChHhcC
Confidence 653221 112234678899999999888999999999999999999999999765543221111 000000 00000
Q ss_pred ----------chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 ----------DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ----------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..................+.+++.+||+.||.+||++++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000111122345678899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=233.61 Aligned_cols=195 Identities=23% Similarity=0.381 Sum_probs=142.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+++|+|.+++.. +++..+.+++.|++.||.|||.....+++|||+||+||+++.++..++. ++...
T Consensus 758 ~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830 (968)
T ss_pred CEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence 5899999999999999952 7899999999999999999995433339999999999999988887765 55443
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
.... .....+++.|+|||++.+..++.++|||||||++|||++|+.||...... ......+.............
T Consensus 831 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 904 (968)
T PLN00113 831 LLCT-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMW 904 (968)
T ss_pred cccc-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhhe
Confidence 2211 11235788999999999888999999999999999999999998543221 11122222111111111122
Q ss_pred hchhhhh--hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 162 LDAQVLK--EAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 162 ~~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
.++.... ....++...+.+++.+||+.||.+||+++++++.|+++...
T Consensus 905 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred eCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 2222211 22345566788999999999999999999999999988664
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=207.73 Aligned_cols=194 Identities=19% Similarity=0.234 Sum_probs=137.2
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
++||||+. ++|.+.+..... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 95 ~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 95 YLVFEFCE-HDLAGLLSNKNV--KFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred EEEEcCCC-cCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 89999995 588888865432 4899999999999999999999999 99999999999999999999999999876
Q ss_pred ccCCCcc---eeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 83 VTIDQTH---LTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 83 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
....... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||..............+.........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 5432211 11223467889999998754 3688999999999999999999999776543322211111100000000
Q ss_pred cc--------------hhchhhhhh-hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FD--------------MLDAQVLKE-AKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~--------------~~~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.. ......... .+......+.+++.+||+.||.+||++++++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00 000000000 000123457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=204.66 Aligned_cols=195 Identities=21% Similarity=0.224 Sum_probs=140.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+++ +|.+++.... ..+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 75 IYMVFEYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred EEEEeccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEcccccee
Confidence 5899999965 8998887643 25899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc---
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC--- 157 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 157 (253)
..............++..|+|||.+.+. .++.++|+||||+++|+|++|..||.......................
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 149 PYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPG 228 (287)
T ss_pred eccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccc
Confidence 6643322122233467789999987653 578999999999999999999999977654322111110000000000
Q ss_pred -----------ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 -----------LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 -----------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
................++..+.+++.+||+.+|.+||++++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000001111111111136678999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=204.03 Aligned_cols=193 Identities=19% Similarity=0.249 Sum_probs=137.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+. ++|.+++.... ...+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 74 ~~~v~e~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~ 148 (284)
T cd07860 74 LYLVFEFLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 148 (284)
T ss_pred EEEEeeccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchh
Confidence 489999995 58999887643 235899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCC-CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh-----
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQ-FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE----- 155 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~----- 155 (253)
...... .......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......+.. ..........
T Consensus 149 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~ 225 (284)
T cd07860 149 AFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL--FRIFRTLGTPDEVVW 225 (284)
T ss_pred hcccCc-cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCChhhh
Confidence 543221 1122234578899999987654 588899999999999999999999765432211 1100000000
Q ss_pred ---------ccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 156 ---------NCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 156 ---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...................+..+.++|.+||+.||.+||++++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000011111234567889999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-30 Score=206.67 Aligned_cols=192 Identities=20% Similarity=0.329 Sum_probs=135.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+.+ +|.+++.+... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++
T Consensus 78 ~~lv~e~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 151 (291)
T cd07844 78 LTLVFEYLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLAR 151 (291)
T ss_pred EEEEEecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccc
Confidence 5899999975 99998876543 5899999999999999999999999 9999999999999999999999999886
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh---cc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE---NC 157 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~ 157 (253)
........ .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||......... .....+.+.. ..
T Consensus 152 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 228 (291)
T cd07844 152 AKSVPSKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ--LHKIFRVLGTPTEET 228 (291)
T ss_pred ccCCCCcc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHhcCCCChhh
Confidence 44321111 112235778999999875 45789999999999999999999999765421110 0000000000 00
Q ss_pred c-------------cchhchhhhhhhcHHH--HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 L-------------FDMLDAQVLKEAKEEE--IITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~-------------~~~~~~~~~~~~~~~~--~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. .....+.......... ...+.+++.+||+.+|.+||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 229 WPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 0000000000000011 2567889999999999999999998853
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=204.66 Aligned_cols=185 Identities=23% Similarity=0.276 Sum_probs=140.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+.+++|.+++.... .+++..+..++.|++.+|.|||..+ ++|+||+|+||+++.++.++|+|||+++
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 479999999999999987643 4899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCC--CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQ--FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
..............++..|++||.+.+.. .+.++|+||||+++++|++|..||........ ... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~-~~~~~~~~--- 227 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSE-ISRRILKS--- 227 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHH-HHHHHHcc---
Confidence 65433222222345788999999987654 68899999999999999999999964322110 011 01111000
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
....+......+.+++.+||+.||.+|||++++.+.|+.
T Consensus 228 -------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 -------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 011122234567889999999999999998888776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-30 Score=201.65 Aligned_cols=191 Identities=19% Similarity=0.338 Sum_probs=142.2
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC--------------
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD-------------- 68 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~-------------- 68 (253)
|||+|.+ |-++.+++..+.-. +++...+..++.|++.++++||+.+ ++|.||||+||++.+
T Consensus 167 Civfell-G~S~~dFlk~N~y~-~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYI-PFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccCCcc-ccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 6899988 88999999886533 6999999999999999999999999 999999999999832
Q ss_pred ------CCceEEcccCCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhh
Q 044510 69 ------KFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142 (253)
Q Consensus 69 ------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~ 142 (253)
+..++|+|||.+...... ....+.|..|+|||++.+-+++.++||||+||+++|+.+|..-|+.-...+.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 245899999998754322 2456789999999999999999999999999999999999999987654332
Q ss_pred hhhHHHH--------HHHH-h-----hccc--------------cchhch-hhhhhhcHHHHHHHHHHHHHhcccCCCCC
Q 044510 143 KSLAGYF--------LRAM-K-----ENCL--------------FDMLDA-QVLKEAKEEEIITVAMLAKRCLNLNGRKR 193 (253)
Q Consensus 143 ~~~~~~~--------~~~~-~-----~~~~--------------~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~R 193 (253)
..+.+.. .... . .+.+ .+...+ ...-.....+..++.+++++||..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 2111100 0000 0 0000 000000 00111223556779999999999999999
Q ss_pred CCHHHHHHH
Q 044510 194 PTMKEVAFE 202 (253)
Q Consensus 194 ps~~~l~~~ 202 (253)
+|++|++.+
T Consensus 398 iTl~EAL~H 406 (415)
T KOG0671|consen 398 ITLREALSH 406 (415)
T ss_pred ccHHHHhcC
Confidence 999999865
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-30 Score=210.28 Aligned_cols=199 Identities=27% Similarity=0.316 Sum_probs=144.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+. ++|.+++.+.. .+++..++.++.+++.||.+||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred eEEEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 489999996 58999887654 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCc--ceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQT--HLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
....... .......++..|+|||.+.+. .++.++|+||+|+++++|++|..||......+.................
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence 6543321 112234568889999999877 7899999999999999999999999877654321111100000000000
Q ss_pred --------cchh------chhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhch
Q 044510 159 --------FDML------DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE--LGGIR 207 (253)
Q Consensus 159 --------~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~--l~~~~ 207 (253)
...+ ............+..+.+++.+||+.+|.+||++.+++.+ ++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0000 0000011112245678999999999999999999999976 44443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=203.00 Aligned_cols=181 Identities=27% Similarity=0.355 Sum_probs=139.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+++++|.+++.+.. .+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 68 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~ 141 (265)
T cd05579 68 LYLVMEYLPGGDLASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSK 141 (265)
T ss_pred EEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccch
Confidence 489999999999999998654 5899999999999999999999999 9999999999999999999999999877
Q ss_pred cccCCCc-------ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHh
Q 044510 82 YVTIDQT-------HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK 154 (253)
Q Consensus 82 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 154 (253)
....... .......++..|++||.......+.++|+||||++++++++|..||......+. ... ..
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~-~~ 214 (265)
T cd05579 142 VGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI------FQN-IL 214 (265)
T ss_pred hcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-Hh
Confidence 5432211 012234567889999999888889999999999999999999999976553321 111 11
Q ss_pred hccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044510 155 ENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203 (253)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 203 (253)
...... +. ....+..+.+++.+||+.+|.+||++.++.+.|
T Consensus 215 ~~~~~~---~~-----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 215 NGKIEW---PE-----DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred cCCcCC---Cc-----cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 111100 00 001245688899999999999999995555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=206.87 Aligned_cols=197 Identities=21% Similarity=0.262 Sum_probs=138.0
Q ss_pred CEEEEeecCCCChhHHhhccCC--CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC----CCceEEc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE--EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD----KFRAKIS 75 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~----~~~~kl~ 75 (253)
.|+||||+.+ +|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++. ++.+||+
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEEC
Confidence 4899999965 78887754322 225899999999999999999999999 999999999999998 8999999
Q ss_pred ccCCcccccCCCc--ceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhh---hHHHH
Q 044510 76 DFGASRYVTIDQT--HLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKS---LAGYF 149 (253)
Q Consensus 76 Dfgl~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~---~~~~~ 149 (253)
|||++........ .......+++.|+|||.+.+. .++.++|+||||+++++|++|..||.......... ....+
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence 9999876543222 112234568889999988764 47899999999999999999999997654432000 00000
Q ss_pred H---HHHh---------------------hccccchhchhhhhhhcH--HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 150 L---RAMK---------------------ENCLFDMLDAQVLKEAKE--EEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 150 ~---~~~~---------------------~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ..+. .................. .....+.+++.+||+.||.+|||+.+++++
T Consensus 235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 0000 000000000001111111 344568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=204.10 Aligned_cols=196 Identities=18% Similarity=0.257 Sum_probs=141.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++ +|.+++........+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++.
T Consensus 73 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~ 148 (284)
T cd07836 73 LMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLAR 148 (284)
T ss_pred EEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhh
Confidence 4899999975 89998876554446899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH--------HHH
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF--------LRA 152 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~~~ 152 (253)
....... ......++..|++||.+.+. .++.++|+|+||+++|+|++|..||......+........ +..
T Consensus 149 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07836 149 AFGIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPG 227 (284)
T ss_pred hhcCCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHH
Confidence 5432211 11223467889999998754 4688999999999999999999999876543321111000 000
Q ss_pred Hhh-ccccch---hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 153 MKE-NCLFDM---LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 153 ~~~-~~~~~~---~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... ...... .............+..+.+++.+||+.||.+||++++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 228 ISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 000000 00011111122345678899999999999999999999853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-31 Score=199.16 Aligned_cols=178 Identities=26% Similarity=0.404 Sum_probs=133.4
Q ss_pred EEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccccc
Q 044510 5 VYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVT 84 (253)
Q Consensus 5 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~~~ 84 (253)
.||.| ...+..++.+..+ ++++..+=++...++.||.||.++.. |+|||+||+|||++..|.+|++|||.+-...
T Consensus 169 cMelM-s~C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 169 CMELM-STCAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHHHH-HHHHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceee
Confidence 34444 3345566665433 58988888999999999999996653 9999999999999999999999999886554
Q ss_pred CCCcceeeeccccccccccchhcc---CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 85 IDQTHLTTRVQGTFGYLDLEYFRS---SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 85 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
+.. ......|.+.|||||.+.- .+|..++||||||++++||.||+.||.+.+.+- +.+-....+.+
T Consensus 244 dSk--AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-----e~ltkvln~eP---- 312 (391)
T KOG0983|consen 244 DSK--AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-----EVLTKVLNEEP---- 312 (391)
T ss_pred ccc--ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-----HHHHHHHhcCC----
Confidence 322 3344568899999999853 358899999999999999999999998865431 11111121111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
+.+. ....+++.+++++..||..|+.+||...+++++
T Consensus 313 --P~L~--~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 313 --PLLP--GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --CCCC--cccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1111 122367789999999999999999999999876
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=205.28 Aligned_cols=179 Identities=25% Similarity=0.341 Sum_probs=138.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+++++|.+++... .+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~ 164 (292)
T cd06657 92 LWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA 164 (292)
T ss_pred EEEEEecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccce
Confidence 48999999999999987543 3889999999999999999999999 9999999999999999999999999876
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
....... ......+++.|++||.+.+..++.++|+||+|+++|+|++|..||......+... ..... ....
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~-------~~~~~-~~~~ 235 (292)
T cd06657 165 QVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-------MIRDN-LPPK 235 (292)
T ss_pred ecccccc-cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhh-CCcc
Confidence 5432211 1223457889999999987788999999999999999999999997654332111 01000 0000
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ......+..+.+++.+||+.||.+||++.+++++
T Consensus 236 ~------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 236 L------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred c------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 0 0011233457789999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=207.33 Aligned_cols=191 Identities=19% Similarity=0.267 Sum_probs=138.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+.+++|.+++.+.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+++.||+...
T Consensus 74 ~~~v~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~ 149 (328)
T cd08226 74 LWVISPFMAYGSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLY 149 (328)
T ss_pred eEEEEecccCCCHHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHh
Confidence 47999999999999998875322 4899999999999999999999999 9999999999999999999999997543
Q ss_pred cccCCCcce------eeeccccccccccchhccC--CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHH
Q 044510 82 YVTIDQTHL------TTRVQGTFGYLDLEYFRSS--QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAM 153 (253)
Q Consensus 82 ~~~~~~~~~------~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 153 (253)
......... .....++..|++||++.+. .++.++|+||+||++|+|++|..||......... ....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~------~~~~ 223 (328)
T cd08226 150 SLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML------LQKL 223 (328)
T ss_pred hhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH------HHHh
Confidence 222111100 0112245679999999763 4789999999999999999999999765432110 0000
Q ss_pred hhcc------------------------------------ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 044510 154 KENC------------------------------------LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMK 197 (253)
Q Consensus 154 ~~~~------------------------------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~ 197 (253)
.... ................+...+.+++.+||+.||.+|||++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~ 303 (328)
T cd08226 224 KGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSAS 303 (328)
T ss_pred cCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHH
Confidence 0000 0000111111222344667889999999999999999999
Q ss_pred HHHHH
Q 044510 198 EVAFE 202 (253)
Q Consensus 198 ~l~~~ 202 (253)
+++++
T Consensus 304 e~l~~ 308 (328)
T cd08226 304 SLLSH 308 (328)
T ss_pred HHhhC
Confidence 99865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=205.13 Aligned_cols=181 Identities=27% Similarity=0.401 Sum_probs=135.3
Q ss_pred CEEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHhhC-CCCCeEecCCCCCceeecCCCceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLHST-TSIPIYHRDIKSANILLDDKFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dl~~~nili~~~~~~kl~Dfgl 79 (253)
.|+||||++ ++|.+++.... ....+++..++.++.|++.||.|||+. + ++|+||||+||+++.++.+||+|||+
T Consensus 75 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~ 150 (283)
T cd06617 75 VWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGI 150 (283)
T ss_pred EEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 479999996 58988876522 223589999999999999999999987 8 99999999999999999999999999
Q ss_pred cccccCCCcceeeeccccccccccchhcc----CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRS----SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE 155 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 155 (253)
+....... ......++..|+|||.+.+ ..++.++|+|+|||++|+|++|..||...... ..........
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~ 223 (283)
T cd06617 151 SGYLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVVEE 223 (283)
T ss_pred cccccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHHhc
Confidence 87543211 1122457888999999865 34688999999999999999999999653221 0111111111
Q ss_pred ccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 156 NCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ..... ....+..+.+++.+||..+|.+||++++++++
T Consensus 224 ~-~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 224 P-SPQLP--------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred C-CCCCC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 11000 11234568889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=195.10 Aligned_cols=203 Identities=22% Similarity=0.245 Sum_probs=145.5
Q ss_pred EEEEeecCCCChhHHhhccCC--CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC----CceEEcc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTE--EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK----FRAKISD 76 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~----~~~kl~D 76 (253)
|+++||.++ +|..+|+.+.. ...++...+..|+.||+.|+.|||+.- |+||||||.||++..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 799999987 89999876332 235899999999999999999999998 9999999999999877 8999999
Q ss_pred cCCcccccCCCcce--eeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhh---hhhHHHHH
Q 044510 77 FGASRYVTIDQTHL--TTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED---KSLAGYFL 150 (253)
Q Consensus 77 fgl~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~---~~~~~~~~ 150 (253)
+|+++.+.+.-... ....+-|.+|+|||.+.|. .|+.+.|+|++||++.||++-.+.|.+...... ..-.+++.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999886432211 2234568999999999875 589999999999999999999888876543211 22223333
Q ss_pred HHHhhcc------ccchh----------chh--------hhhhhcH--HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 151 RAMKENC------LFDML----------DAQ--------VLKEAKE--EEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 151 ~~~~~~~------~~~~~----------~~~--------~~~~~~~--~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
+...--. +.++. +.. +...... .-++...+++.++|..||.+|.|+++.+++.-
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 3222110 11000 000 0000000 01233788999999999999999999998754
Q ss_pred hchhh
Q 044510 205 GIRAS 209 (253)
Q Consensus 205 ~~~~~ 209 (253)
-..+.
T Consensus 340 F~~d~ 344 (438)
T KOG0666|consen 340 FTEDP 344 (438)
T ss_pred cccCC
Confidence 44443
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=201.39 Aligned_cols=177 Identities=28% Similarity=0.315 Sum_probs=140.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++|+||+.|++|.+++.... .+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~ 148 (258)
T cd05578 75 MYLVVDLLLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIAT 148 (258)
T ss_pred EEEEEeCCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeeccccc
Confidence 589999999999999997652 5899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... ......++..|++||.+.+..++.++|+||+|+++|+|++|..||.......... +...... .
T Consensus 149 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~--~--- 217 (258)
T cd05578 149 KVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ----IRAKQET--A--- 217 (258)
T ss_pred ccCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH----HHHHhcc--c---
Confidence 654322 1223457788999999988888999999999999999999999998765421111 1111110 0
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTM--KEVA 200 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~--~~l~ 200 (253)
....+...+..+.+++.+||+.||.+||++ ++++
T Consensus 218 -----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 -----DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -----cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 011122234678889999999999999999 6665
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=201.20 Aligned_cols=179 Identities=24% Similarity=0.328 Sum_probs=139.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++++||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 478999999999999987644 4889999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCC--cceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQ--THLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
...... ........++..|+|||.+.+..++.++|+|||||++++|++|..||........ ..... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~-~~~-- 225 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA------IFKIA-TQP-- 225 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH------HHHHH-cCC--
Confidence 543211 1111234578899999999888889999999999999999999999976432211 11111 110
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.....+......+.+++.+||+ +|.+||++.+++.+
T Consensus 226 ------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 ------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1112234455678889999999 57999999988864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=200.38 Aligned_cols=181 Identities=25% Similarity=0.383 Sum_probs=143.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|+||+++++|.+++.... .+++..++.++.+++.||.|||+.+ ++|+|++|+||+++.++.++|+|||.+.
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~ 149 (260)
T cd06606 76 LNIFLEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAK 149 (260)
T ss_pred EEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEE
Confidence 479999999999999998754 5999999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
........ ......++..|++||...+..++.++|+|+||+++++|++|..||...... .........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~------ 218 (260)
T cd06606 150 RLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYKIGS------ 218 (260)
T ss_pred ecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHhccc------
Confidence 66433221 122345788999999998888899999999999999999999999775511 111111110
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.......+...+..+.+++.+||..||.+||++.+++.+
T Consensus 219 ---~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 219 ---SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ---cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 011112233335678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=211.44 Aligned_cols=181 Identities=23% Similarity=0.345 Sum_probs=141.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+||+.|||.||.+..++-..+. .+.+.++..++.|++.||.|||+.+ |+|||||..|||++-+|.++|+|||++.
T Consensus 104 LwiliEFC~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSA 178 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSA 178 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccc
Confidence 5899999999999888877543 6999999999999999999999999 9999999999999999999999999875
Q ss_pred cccCCCcceeeeccccccccccchh-----ccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYF-----RSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
.-. ......-.+.|||.|||||+. .+.+|+.++||||||+++.+|..+.+|-....+.. .+.......
T Consensus 179 Kn~-~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR------VllKiaKSe 251 (1187)
T KOG0579|consen 179 KNK-STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSE 251 (1187)
T ss_pred cch-hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH------HHHHHhhcC
Confidence 321 112223346799999999986 45689999999999999999999999976544321 111111111
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.+.+.- |-.-+..+.+++.+||..||..||++.+|+++
T Consensus 252 -PPTLlq-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 252 -PPTLLQ-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -CCcccC-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 111111 22334467889999999999999999999865
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=185.90 Aligned_cols=170 Identities=19% Similarity=0.218 Sum_probs=126.9
Q ss_pred CChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcccccCCCccee
Q 044510 12 GTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLT 91 (253)
Q Consensus 12 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~~~~~~~~~~ 91 (253)
|+|.+++...+. .+++..++.++.|++.||.|||..+ ||+||+++.++.+++ ||+++......
T Consensus 1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 689999976432 5999999999999999999999864 999999999999999 99887553211
Q ss_pred eeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhc
Q 044510 92 TRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAK 171 (253)
Q Consensus 92 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (253)
..+++.|+|||++.+..++.++|||||||++|+|++|..||....... ............. .+... ...
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~------~~~~~-~~~ 132 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPAD------DPRDR-SNL 132 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccC------Ccccc-ccH
Confidence 257899999999998899999999999999999999999996543211 1111111111100 00000 011
Q ss_pred HHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 172 EEEII--TVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 172 ~~~~~--~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
..... .+.+++.+||+.||.+||++.++++++.....+
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 12222 589999999999999999999999998776543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=203.22 Aligned_cols=178 Identities=28% Similarity=0.434 Sum_probs=141.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+++++|.+++.... .+++..++.++.|++.||.+||..+ ++|+||+|+||+++.++.++++|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~ 150 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAK 150 (280)
T ss_pred EEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCcccc
Confidence 589999999999999998754 5999999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCc-------------------ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhh
Q 044510 82 YVTIDQT-------------------HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142 (253)
Q Consensus 82 ~~~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~ 142 (253)
....... .......++..|++||...+..++.++|+|+||++++++++|..||........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 230 (280)
T cd05581 151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230 (280)
T ss_pred ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 6543221 112234567899999999888889999999999999999999999987653211
Q ss_pred hhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 044510 143 KSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTM----KEVAFE 202 (253)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~----~~l~~~ 202 (253)
+....... ...+...+..+.+++.+||+.+|.+||++ ++++++
T Consensus 231 ------~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 231 ------FQKILKLE-----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred ------HHHHHhcC-----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 11111000 01112224567889999999999999999 887753
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=203.13 Aligned_cols=193 Identities=21% Similarity=0.265 Sum_probs=138.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+ +++|.+++..... ..+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 73 ~~iv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 73 LYLVFEFL-DLDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred EEEEEecc-CcCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 58999999 4689999876542 24899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh--c--
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE--N-- 156 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~--~-- 156 (253)
....... ......++..|+|||++.+. .++.++|+||||+++|+|++|..||.......... ......... .
T Consensus 148 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~ 224 (283)
T cd07835 148 AFGVPVR-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF--RIFRTLGTPDEDVW 224 (283)
T ss_pred ccCCCcc-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCChHHh
Confidence 5432211 11223457889999988764 46889999999999999999999997654422111 000000000 0
Q ss_pred ----cc------cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 157 ----CL------FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 157 ----~~------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.. ................+..+.+++.+||+.||.+||++++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 225 PGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 00000000011112233568899999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=208.91 Aligned_cols=193 Identities=26% Similarity=0.323 Sum_probs=138.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+. ++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 589999996 5999988654 4888999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCc----ceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHH------
Q 044510 82 YVTIDQT----HLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFL------ 150 (253)
Q Consensus 82 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~------ 150 (253)
....... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 6543221 12223457889999998865 347889999999999999999999997655432211100000
Q ss_pred --HHHhhc---cccchhc---hhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 151 --RAMKEN---CLFDMLD---AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 151 --~~~~~~---~~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+... ....... ...........+..+.+++.+||+.||.+||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000 0000000 000001111135678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=218.32 Aligned_cols=194 Identities=21% Similarity=0.207 Sum_probs=127.8
Q ss_pred CEEEEeecCCCChhHHhhccCCC-----------------CCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCce
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEE-----------------FTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANI 64 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~-----------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~ni 64 (253)
.|+||||+.+++|.+++...... .......+..++.|++.||.|||+.+ |+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHE
Confidence 48999999999999998753210 01123446689999999999999999 99999999999
Q ss_pred eecC-CCceEEcccCCcccccCCCcceeeeccccccccccchhccC----------------------CCCCCCCeehhH
Q 044510 65 LLDD-KFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSS----------------------QFTKKGDVYSFG 121 (253)
Q Consensus 65 li~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~slG 121 (253)
+++. ++.+||+|||+++..............+++.|+|||.+... .+..++||||+|
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9985 57899999999976543333333445688999999976422 133456999999
Q ss_pred HHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHh-hccccchhchhhhh------hhcHHHHHHHHHHHHHhcccCCCCCC
Q 044510 122 VVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK-ENCLFDMLDAQVLK------EAKEEEIITVAMLAKRCLNLNGRKRP 194 (253)
Q Consensus 122 ~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~dP~~Rp 194 (253)
|++|+|+++..++.... ......+...-. ...+.....+.... ...........+|+.+||+.||.+||
T Consensus 367 viL~el~~~~~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ 442 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNL----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI 442 (566)
T ss_pred HHHHHHHhCcCCCchHH----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence 99999998766543211 111110000000 00000000000000 00011122456899999999999999
Q ss_pred CHHHHHHH
Q 044510 195 TMKEVAFE 202 (253)
Q Consensus 195 s~~~l~~~ 202 (253)
|+++++++
T Consensus 443 ta~e~L~H 450 (566)
T PLN03225 443 SAKAALAH 450 (566)
T ss_pred CHHHHhCC
Confidence 99999976
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=199.90 Aligned_cols=177 Identities=24% Similarity=0.341 Sum_probs=140.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+++++|.+++.... .+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 147 (254)
T cd06627 74 LYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVAT 147 (254)
T ss_pred EEEEEecCCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccce
Confidence 479999999999999997753 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
........ .....++..|++||...+..++.++|+|++|+++++|++|..||......... .... ....
T Consensus 148 ~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~------~~~~-~~~~--- 216 (254)
T cd06627 148 KLNDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL------FRIV-QDDH--- 216 (254)
T ss_pred ecCCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH------HHHh-ccCC---
Confidence 65432221 22345788999999998777899999999999999999999999765432111 1111 0100
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAF 201 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 201 (253)
...+...+..+.+++.+||..+|.+||++.+++.
T Consensus 217 ------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 ------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1112223456788999999999999999999884
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=205.00 Aligned_cols=194 Identities=22% Similarity=0.257 Sum_probs=137.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|+||+++ ++.+.+.... ..+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 91 ~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 91 FYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred EEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccccc
Confidence 4799999976 7777776542 25899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............++..|++||.+.+. .++.++|+||+||++++|++|..||......+...................
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD 244 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 6543222222223457789999988654 468899999999999999999999976443221111110000000000000
Q ss_pred hh--------c------hhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 ML--------D------AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~--------~------~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.. + .... ......+..+.+++.+||+.||.+||++++++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 245 VIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0 0000 0111235678999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=199.97 Aligned_cols=194 Identities=20% Similarity=0.257 Sum_probs=139.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+ +++|.+++.... ...+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 73 ~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 73 LYFVFEYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred EEEEEecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccce
Confidence 58999999 889999887653 225899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH---------HH
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF---------LR 151 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~---------~~ 151 (253)
...... ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||......+........ ..
T Consensus 148 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07830 148 EIRSRP--PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE 225 (283)
T ss_pred eccCCC--CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhh
Confidence 553221 1123457788999998854 45789999999999999999999999766543221110000 00
Q ss_pred -HHhhccccchh---chhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 152 -AMKENCLFDML---DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 152 -~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
........... ...............+.+++.+||+.||.+||+++|++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000000 0000011111124568899999999999999999999854
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=198.58 Aligned_cols=180 Identities=22% Similarity=0.294 Sum_probs=139.0
Q ss_pred CEEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
+++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~ 152 (260)
T cd08222 77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVS 152 (260)
T ss_pred eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCce
Confidence 479999999999999886522 2235899999999999999999999999 999999999999975 56999999988
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
........ ......+++.|++||.+.+..++.++|+||||+++|+|++|..||....... ...... ...
T Consensus 153 ~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~-~~~--- 221 (260)
T cd08222 153 RLLMGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLRIV-EGP--- 221 (260)
T ss_pred eecCCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHH-cCC---
Confidence 76532221 2223457889999999988788899999999999999999999986543211 111111 110
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
....+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 222 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 222 ------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 111223445578889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=202.92 Aligned_cols=184 Identities=27% Similarity=0.345 Sum_probs=134.3
Q ss_pred CEEEEeecCCCChhHHhhcc--CCCCCCCHHHHHHHHHHHHHHHHhHhhC-CCCCeEecCCCCCceeecCCCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQ--TEEFTITWEISLRIAVEVSGALSYLHST-TSIPIYHRDIKSANILLDDKFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dl~~~nili~~~~~~kl~Dfg 78 (253)
.+++|||+. ++|.++.... .....+++..+..++.+++.||.|||.. + ++||||||+||+++.++.++|+|||
T Consensus 78 ~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 153 (288)
T cd06616 78 CWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFG 153 (288)
T ss_pred EEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecc
Confidence 378999985 4666544321 1122589999999999999999999974 7 9999999999999999999999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccC---CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSS---QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE 155 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 155 (253)
++....... ......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||..... ...........
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~ 226 (288)
T cd06616 154 ISGQLVDSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKG 226 (288)
T ss_pred hhHHhccCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcCC
Confidence 987543221 11223578899999999765 588999999999999999999999975431 11111111111
Q ss_pred ccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 156 NCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. . +..........+..+.+++.+||+.||.+||++++++++
T Consensus 227 ~-~-----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 D-P-----PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred C-C-----CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 0 111111112345578899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=203.84 Aligned_cols=194 Identities=22% Similarity=0.237 Sum_probs=136.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+.+ +|...+.... ..+++..+..++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||+++
T Consensus 90 ~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 90 VYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred EEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccch
Confidence 4899999955 7877776532 25999999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcc----------eeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHH
Q 044510 82 YVTIDQTH----------LTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFL 150 (253)
Q Consensus 82 ~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~ 150 (253)
........ ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+..............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 55322111 11223467889999988654 47899999999999999999999997655432211111000
Q ss_pred HHHhh------ccccc--------hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 151 RAMKE------NCLFD--------MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 151 ~~~~~------~~~~~--------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..... ..... ...+... .........+.+++.+||+.||.+|||+.+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLE-ERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHH-HHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00000 00000 0000000 0111223568899999999999999999998853
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=203.17 Aligned_cols=175 Identities=23% Similarity=0.310 Sum_probs=134.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+. |+|.+++..... .+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 90 ~~lv~e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~ 163 (307)
T cd06607 90 AWLVMEYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSAS 163 (307)
T ss_pred EEEEHHhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcce
Confidence 479999996 578777765332 5899999999999999999999999 9999999999999999999999999886
Q ss_pred cccCCCcceeeeccccccccccchhc---cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR---SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
..... ....+++.|+|||.+. ...++.++|+||||+++|+|++|..||........ ..... ....
T Consensus 164 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~-~~~~ 231 (307)
T cd06607 164 LVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIA-QNDS 231 (307)
T ss_pred ecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHh-cCCC
Confidence 54321 2235678899999874 34578899999999999999999999876543221 00110 0000
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.. ......+..+.+++.+||+.||.+||++.+++.+
T Consensus 232 ~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 PT--------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CC--------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 0112234568899999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=203.15 Aligned_cols=180 Identities=23% Similarity=0.297 Sum_probs=137.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+.| +|.+++..... .+++..+..++.+++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 100 ~~lv~e~~~g-~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~ 173 (317)
T cd06635 100 AWLVMEYCLG-SASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS 173 (317)
T ss_pred EEEEEeCCCC-CHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCcc
Confidence 5899999965 78887765332 5899999999999999999999999 9999999999999999999999999876
Q ss_pred cccCCCcceeeeccccccccccchhc---cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR---SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
.... .....+++.|+|||.+. ...++.++|+|||||++|+|++|..||......... ....... .
T Consensus 174 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~~-~ 241 (317)
T cd06635 174 IASP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNE-S 241 (317)
T ss_pred ccCC-----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH------HHHHhcc-C
Confidence 4332 12235788899999974 345789999999999999999999998664322110 1111111 0
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhch
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 207 (253)
. .......+..+.+++.+||+.+|.+||++.++++++-...
T Consensus 242 ~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 242 P--------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred C--------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0 0011223446888999999999999999999998764433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=207.97 Aligned_cols=178 Identities=24% Similarity=0.286 Sum_probs=148.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
-|+.||-|-||.|+..+.+.+ .+....+.-++..+++|+.|||.++ |++|||||+|++++.+|-+||.|||+++
T Consensus 495 vYmLmEaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAK 568 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAK 568 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHH
Confidence 378999999999999998876 4888999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .+.+.+|||+|.|||++.....+.++|.|+||+++|||++|.+||++.++....+.+ +.+.
T Consensus 569 ki~~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------LkGi----- 635 (732)
T KOG0614|consen 569 KIGSGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------LKGI----- 635 (732)
T ss_pred HhccCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------Hhhh-----
Confidence 876544 444578999999999999888999999999999999999999999998875543322 1111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT-----MKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~~ 202 (253)
..-..|........+++++....+|.+|.- +.+|.++
T Consensus 636 ----d~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 636 ----DKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred ----hhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 112234445556778999999999999965 5666655
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=199.37 Aligned_cols=192 Identities=19% Similarity=0.282 Sum_probs=134.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+. ++|.+.+..... .+++..+..++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||+++
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 151 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR 151 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccc
Confidence 489999995 678777755322 4788889999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh---c-
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE---N- 156 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~---~- 156 (253)
........ .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||........ .... .+..... .
T Consensus 152 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~-~~~~~~~~~~~~ 228 (291)
T cd07870 152 AKSIPSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEK-IWTVLGVPTEDT 228 (291)
T ss_pred ccCCCCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHH-HHHHcCCCChhh
Confidence 54322111 1223468899999998754 478899999999999999999999976543210 0000 0000000 0
Q ss_pred -----ccc----ch---hchhhhhhh--cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 157 -----CLF----DM---LDAQVLKEA--KEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 157 -----~~~----~~---~~~~~~~~~--~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... .. ..+...... .......+.+++.+|+..||.+|||+++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000 00 000000000 00123567889999999999999999998853
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=206.19 Aligned_cols=194 Identities=21% Similarity=0.249 Sum_probs=137.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+++||+. ++|.+++.... .+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 478889884 68999886543 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcc---eeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH--------
Q 044510 82 YVTIDQTH---LTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF-------- 149 (253)
Q Consensus 82 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~-------- 149 (253)
........ ......+++.|+|||...+ ..++.++|+||+|+++|+|++|..||...............
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 65422211 1123457889999998865 45789999999999999999999999775532211100000
Q ss_pred HHHHhhccccc------hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 150 LRAMKENCLFD------MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 150 ~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
........... .................+.+++.+||+.||.+||++++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000 000000000111124568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=207.24 Aligned_cols=189 Identities=23% Similarity=0.285 Sum_probs=137.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|+||+ +++|.+++... ++++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 95 ~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 95 VYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred EEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccc
Confidence 47999999 77999998753 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH--------HHH
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF--------LRA 152 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~~~ 152 (253)
..... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||............... ...
T Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 167 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred ccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 54322 2234567889999998653 5789999999999999999999999765432211100000 000
Q ss_pred Hhhccccch------hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 153 MKENCLFDM------LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 153 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
......... .............+..+.+++.+||+.||.+|||+.+|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000 00000001111235678999999999999999999999865
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=200.75 Aligned_cols=182 Identities=26% Similarity=0.320 Sum_probs=137.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 379999999999999997654 4889999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccC--CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS--QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
..............++..|++||.+.+. .++.++|+||||+++|+|++|..||........ ............
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~--- 228 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE--- 228 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhccC---
Confidence 6543322222334578899999998753 367899999999999999999999864322111 111111111110
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
...+......+.+++.+||+.||.+|| ++.+++.+
T Consensus 229 --------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 --------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred --------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 011222345678899999999999997 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=196.33 Aligned_cols=173 Identities=29% Similarity=0.350 Sum_probs=136.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+++++|.+++.... .+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 68 ~~~v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~ 141 (250)
T cd05123 68 LYLVLEYAPGGELFSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAK 141 (250)
T ss_pred eEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcce
Confidence 589999999999999998754 4899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......++..|++||...+...+.++|+|+||+++|++++|..||........ ........
T Consensus 142 ~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-------~~~~~~~~---- 209 (250)
T cd05123 142 ELSSEG-SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI-------YEKILKDP---- 209 (250)
T ss_pred ecccCC-CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHhcCC----
Confidence 653321 112234577899999999888788999999999999999999999976543211 11111110
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKE 198 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~ 198 (253)
...+...+..+.+++.+||..||.+||++++
T Consensus 210 ------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 210 ------LRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ------CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 0111222456788999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=197.92 Aligned_cols=194 Identities=23% Similarity=0.268 Sum_probs=139.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+. ++|.+++.... ..+++..++.++.+++.||.+||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 73 ~~~v~e~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~ 146 (282)
T cd07829 73 LYLVFEYCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLAR 146 (282)
T ss_pred eEEEecCcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCccc
Confidence 589999996 58999998753 25999999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH--------HHH
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF--------LRA 152 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~~~ 152 (253)
....... ......++..|+|||.+.+. .++.++|+|+||+++++|++|..||......+........ +..
T Consensus 147 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07829 147 AFGIPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPG 225 (282)
T ss_pred ccCCCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHh
Confidence 6543221 12223456789999998766 6889999999999999999999999775533221111000 000
Q ss_pred Hhhc----cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 153 MKEN----CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 153 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.... ..................+..+.+++.+||..||.+||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 226 VTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred hcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000 0000000000001111225678999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=228.16 Aligned_cols=176 Identities=15% Similarity=0.152 Sum_probs=125.1
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC-------------
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK------------- 69 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~------------- 69 (253)
+.+|||+ +++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++..
T Consensus 56 ~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~ 129 (793)
T PLN00181 56 VRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG---IVVHNVRPSCFVMSSFNHVSFIESASCSD 129 (793)
T ss_pred hhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---eeeccCCchhEEEcccCcEEEeeccccCc
Confidence 4678887 669999997532 25999999999999999999999999 9999999999999653
Q ss_pred ------CceEEcccCCcccccCCCc---------------ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHH
Q 044510 70 ------FRAKISDFGASRYVTIDQT---------------HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLL 128 (253)
Q Consensus 70 ------~~~kl~Dfgl~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll 128 (253)
+.+|++|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 130 ~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl 209 (793)
T PLN00181 130 SGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELF 209 (793)
T ss_pred ccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHh
Confidence 4456666666653211000 0001134788899999999889999999999999999999
Q ss_pred hCCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 129 TGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 129 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
+|..|+...... . ....... ..+.. .........++.+||+.+|.+||++.+++++
T Consensus 210 ~~~~~~~~~~~~-----~----~~~~~~~----~~~~~-----~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 210 CPVSSREEKSRT-----M----SSLRHRV----LPPQI-----LLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred hCCCchhhHHHH-----H----HHHHHhh----cChhh-----hhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 988876421110 0 0010000 11111 1112335578899999999999999999864
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=215.82 Aligned_cols=182 Identities=21% Similarity=0.305 Sum_probs=149.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|||||||.||+..|+++.-. ...+.|..+..|+..++.||.+||... ++|||+|-.|||++.++.||++|||++.
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred EEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeee
Confidence 599999999999999998865 446999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccC-----CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-----QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
... .......+.+|||.|||||++... .|+.++|+||||++..||.-|.+|+-+..+.....+
T Consensus 172 Qld-sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~----------- 239 (953)
T KOG0587|consen 172 QLD-STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----------- 239 (953)
T ss_pred eee-cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc-----------
Confidence 543 334455667899999999998643 367899999999999999999999977665432111
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ..+|......+..-+.++.++|..||..|-.+||++.+++++
T Consensus 240 -I--pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 240 -I--PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -C--CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1 112222233355666788889999999999999999988865
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=201.17 Aligned_cols=177 Identities=21% Similarity=0.272 Sum_probs=135.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+. |+|.+++..... .+++..+..++.+++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~~~--~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 163 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS 163 (308)
T ss_pred eEEEEEccC-CCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccce
Confidence 589999996 588887765332 4889999999999999999999999 9999999999999999999999999876
Q ss_pred cccCCCcceeeeccccccccccchhc---cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR---SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
..... ....+++.|+|||.+. ...++.++|+|||||++|+|++|..||......+.. .. ......
T Consensus 164 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~-~~~~~~ 231 (308)
T cd06634 164 IMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YH-IAQNES 231 (308)
T ss_pred eecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH------HH-HhhcCC
Confidence 54321 2235788999999975 345788999999999999999999998664332111 00 111100
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
.. ......+..+.+++.+||+.+|.+||++.+++++.-
T Consensus 232 ~~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 232 PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred CC--------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 00 011233456788999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=216.61 Aligned_cols=188 Identities=25% Similarity=0.357 Sum_probs=150.0
Q ss_pred CEEEEeecCCCChhHHhhccC-----CC--------CCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-----EE--------FTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-----~~--------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
.++|+||+.+|+|..++.... .. ..+.....+.++.||+.|++||++.. ++|||+-..|||+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecC
Confidence 479999999999999998765 00 13888999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCcceeeeccc--cccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhh
Q 044510 69 KFRAKISDFGASRYVTIDQTHLTTRVQG--TFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSL 145 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~--~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~ 145 (253)
+..+|++|||+++..........+...+ ...|||||.+....|+.++||||||+++|||++ |..||.+.....
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~---- 529 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE---- 529 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH----
Confidence 9999999999998655444333332332 346999999999889999999999999999999 889997633111
Q ss_pred HHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhch
Q 044510 146 AGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207 (253)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 207 (253)
+ +... +..+.+.+.|.....++.++.+.||+.+|.+||++.++++.++...
T Consensus 530 -~-l~~~---------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 530 -E-LLEF---------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred -H-HHHH---------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 0 1111 1222233445556677889999999999999999999999999854
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=200.43 Aligned_cols=192 Identities=20% Similarity=0.269 Sum_probs=135.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC-CCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD-KFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~-~~~~kl~Dfgl~ 80 (253)
+|+||||+. ++|.+.+..... ..+++..+..++.|++.||.|||..+ ++|+||+|+||+++. ++.+||+|||++
T Consensus 76 ~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~ 150 (294)
T PLN00009 76 LYLVFEYLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLA 150 (294)
T ss_pred EEEEEeccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccc
Confidence 589999995 588888765432 24688889999999999999999999 999999999999985 557999999998
Q ss_pred ccccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh---c
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE---N 156 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~---~ 156 (253)
....... .......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||......+..... ...... .
T Consensus 151 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~ 226 (294)
T PLN00009 151 RAFGIPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI---FRILGTPNEE 226 (294)
T ss_pred cccCCCc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCChh
Confidence 7543221 111233567899999998754 4788999999999999999999999765443211110 000000 0
Q ss_pred cc------cc------hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 157 CL------FD------MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 157 ~~------~~------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.. .. ..............+..+.+++.+||+.+|.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00 000000001112234568889999999999999999999864
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=203.41 Aligned_cols=193 Identities=22% Similarity=0.277 Sum_probs=134.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC-CCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD-KFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~-~~~~kl~Dfgl~ 80 (253)
.|+||||+. ++|.+++... .+++..++.++.|++.||.|||..+ ++|+||||+||+++. ++.++++|||++
T Consensus 91 ~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~ 162 (342)
T cd07854 91 VYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLA 162 (342)
T ss_pred EEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccc
Confidence 479999996 5898888643 4899999999999999999999999 999999999999974 557899999998
Q ss_pred ccccCCCcc--eeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHH---------
Q 044510 81 RYVTIDQTH--LTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGY--------- 148 (253)
Q Consensus 81 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~--------- 148 (253)
......... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||......+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07854 163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242 (342)
T ss_pred eecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 754321111 1122346788999998764 4578899999999999999999999976654322111000
Q ss_pred ---HHHHHhhccc-cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 149 ---FLRAMKENCL-FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 149 ---~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.......... ................+..+.+++.+||+.||.+||++.+++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 243 RNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000000000 00000000001111234568899999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=218.95 Aligned_cols=180 Identities=25% Similarity=0.351 Sum_probs=132.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+||=||||+..+|.+++.++... -....+|+++++|+.||.|+|..| |+||||||.|||++.++.|||+|||++.
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt 745 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLAT 745 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccch
Confidence 58899999998888888776421 146789999999999999999999 9999999999999999999999999998
Q ss_pred ccc------CC-----------CcceeeeccccccccccchhccCC---CCCCCCeehhHHHHHHHHhCCCCCCCCChhh
Q 044510 82 YVT------ID-----------QTHLTTRVQGTFGYLDLEYFRSSQ---FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE 141 (253)
Q Consensus 82 ~~~------~~-----------~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~lltg~~pf~~~~~~~ 141 (253)
... .. .....+..+||.-|+|||.+.+.. |+.++|+||+|++++||+. ||...-+ .
T Consensus 746 ~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME-R 821 (1351)
T KOG1035|consen 746 DLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME-R 821 (1351)
T ss_pred hhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH-H
Confidence 621 00 011234467999999999997654 9999999999999999975 4643221 1
Q ss_pred hhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044510 142 DKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAF 201 (253)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 201 (253)
...+.. +..+.++.. ........+.-..+|+++++.||++|||+.|+++
T Consensus 822 ----a~iL~~-LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 822 ----ASILTN-LRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ----HHHHHh-cccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 111111 111111111 1122333344567999999999999999999985
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=200.80 Aligned_cols=175 Identities=23% Similarity=0.321 Sum_probs=133.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+. ++|.+++..... .+++..++.++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 96 ~~lv~e~~~-~~l~~~l~~~~~--~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~ 169 (313)
T cd06633 96 AWLVMEYCL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS 169 (313)
T ss_pred EEEEEecCC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCc
Confidence 489999995 578888765432 5899999999999999999999999 9999999999999999999999999875
Q ss_pred cccCCCcceeeeccccccccccchhc---cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR---SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
... ......++..|+|||.+. ...++.++|+||||+++|+|++|..||......... ....... .
T Consensus 170 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~~-~ 237 (313)
T cd06633 170 KSS-----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQND-S 237 (313)
T ss_pred ccC-----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhcC-C
Confidence 432 112345788999999984 345788999999999999999999998765432211 1111111 1
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... .....+..+.+++.+||+.+|.+||++.+++.+
T Consensus 238 ~~~--------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 PTL--------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 011223457889999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=206.33 Aligned_cols=201 Identities=23% Similarity=0.324 Sum_probs=147.1
Q ss_pred CCEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec--CCC--ceEEcc
Q 044510 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD--DKF--RAKISD 76 (253)
Q Consensus 1 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~--~~~--~~kl~D 76 (253)
.|++|||||.||+|..++.+-...+++++...+.++.+++.||.|||..| |+||||||.||++- .+| ..||+|
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeec
Confidence 47899999999999999998666678999999999999999999999999 99999999999984 223 479999
Q ss_pred cCCcccccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh
Q 044510 77 FGASRYVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE 155 (253)
Q Consensus 77 fgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 155 (253)
||.++....+. .....+||+.|++||.+.. ..|+..+|.|||||++|+.+||..||........ .....+.....
T Consensus 168 fG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~--~~~~~~~~~tk 243 (732)
T KOG4250|consen 168 FGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN--NKEIMWHIITK 243 (732)
T ss_pred ccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc--cchhhhhhhcc
Confidence 99999776443 5667889999999999984 7899999999999999999999999976544321 11111222211
Q ss_pred cccc-------chh---ch----hhhhhhcHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHhhchh
Q 044510 156 NCLF-------DML---DA----QVLKEAKEEEIITVAMLAKRCLNLNGRKRP--TMKEVAFELGGIRA 208 (253)
Q Consensus 156 ~~~~-------~~~---~~----~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp--s~~~l~~~l~~~~~ 208 (253)
.+.. ... .. .............+-.++..+|..+|.+|- ...+....+..+..
T Consensus 244 kp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 244 KPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred CCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1100 000 00 001112233445566788888999999997 55555555444433
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=207.55 Aligned_cols=176 Identities=26% Similarity=0.400 Sum_probs=145.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+.+|.+++++..++ ...+..+.....|++.|++|+|.++ |+|||||++|++++.+..+||+|||++.
T Consensus 130 lylV~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred eEEEEEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccce
Confidence 689999999999999999876 4777889999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCC-CCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQF-TKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
.+. .........|++.|+|||.+.+.+| .+.+|+|++|+++|-|+.|..||.+....+. ....+..
T Consensus 204 ~~~--~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-----------r~rvl~g 270 (596)
T KOG0586|consen 204 FFD--YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-----------RPRVLRG 270 (596)
T ss_pred eec--ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-----------cchheee
Confidence 775 3334455779999999999999887 6899999999999999999999987554321 1111111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.+ .++.-.+.++.++++++|.++|.+|++.+++.+.
T Consensus 271 k~------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 271 KY------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ee------cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 00 1122334568889999999999999999998865
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=197.28 Aligned_cols=180 Identities=27% Similarity=0.421 Sum_probs=134.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhh-CCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS-TTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.|+||||+ +++|.+++..... .+++..+..++.|++.||.|||. .+ ++|+||+|+||+++.++.++|+|||++
T Consensus 89 ~~~v~e~~-~~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~ 162 (296)
T cd06618 89 VFICMELM-STCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGIS 162 (296)
T ss_pred EEEEeecc-CcCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccc
Confidence 47999998 4588887766332 58999999999999999999997 57 999999999999999999999999988
Q ss_pred ccccCCCcceeeeccccccccccchhccCC----CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQ----FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
....... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||....... ..+.......
T Consensus 163 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~ 235 (296)
T cd06618 163 GRLVDSK--AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVLTKILQEE 235 (296)
T ss_pred hhccCCC--cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----HHHHHHhcCC
Confidence 6543211 112234678899999987543 7889999999999999999999996532211 1111111111
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..... ........+.+++.+||+.||.+||++.+++++
T Consensus 236 -~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 236 -PPSLP-------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -CCCCC-------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 001233468889999999999999999999866
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=202.79 Aligned_cols=194 Identities=23% Similarity=0.231 Sum_probs=138.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+. ++|.+++.... .+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 95 ~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 95 INLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred EEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCcccee
Confidence 479999996 58999987643 4899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCC-------------cceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHH
Q 044510 82 YVTIDQ-------------THLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAG 147 (253)
Q Consensus 82 ~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~ 147 (253)
...... ........+++.|+|||.+.+. .++.++|+||+||++|+|++|..||...+..+......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~ 247 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 554111 0111123357789999998764 36889999999999999999999998765433211110
Q ss_pred HHHHHHhhccccc--------h---hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 148 YFLRAMKENCLFD--------M---LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 148 ~~~~~~~~~~~~~--------~---~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
............. . ..+..........+..+.+++.+||+.+|.+||++++++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 0000000000000 0 00000011112234568899999999999999999999964
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=202.61 Aligned_cols=189 Identities=22% Similarity=0.262 Sum_probs=135.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|++++++ +++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 97 ~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 97 VYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred EEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccccc
Confidence 36788877 88999888643 3899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
.... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||..........................
T Consensus 169 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 169 HTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred cccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 5422 1223457889999999876 4578899999999999999999999976544321111000000000000000
Q ss_pred hhch---hh-----------hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDA---QV-----------LKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~---~~-----------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+. .. ........+..+.+++.+||+.||.+||++.+++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 00 000001124568899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=207.10 Aligned_cols=180 Identities=23% Similarity=0.383 Sum_probs=150.1
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
.||||.++.|+|.+.|+.. ....+.......++.||+.|+.||..++ +||||+-..|+++.....|||+||||.+.
T Consensus 186 mMV~ELaplGSLldrLrka-~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKA-KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred hHHhhhcccchHHHHHhhc-cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceec
Confidence 5899999999999999883 3345888899999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCcceeee--ccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 83 VTIDQTHLTTR--VQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 83 ~~~~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
...+....... .--...|-|||.+....++.++|+|+|||++|||++ |..||.+..... +.
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL 325 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------IL 325 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HH
Confidence 76554433211 112457899999999999999999999999999999 889998876543 22
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+|...+-..++.++..+++++..||..+|.+||++..|.+.
T Consensus 326 ~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 326 KNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred HhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 3344444556677788899999999999999999999999744
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=200.78 Aligned_cols=188 Identities=20% Similarity=0.286 Sum_probs=136.1
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
++||||+ +++|.+++... .+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++++|||++..
T Consensus 96 ~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 96 YLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred EEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 7999999 78999888643 4899999999999999999999999 99999999999999999999999999875
Q ss_pred ccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHH--------HHHHHH
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAG--------YFLRAM 153 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~--------~~~~~~ 153 (253)
.... .....+++.|++||.+.+ ..++.++|+||+|+++|++++|..||............. .+...+
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 168 TDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 4321 122346789999999875 347889999999999999999999998654322110000 000000
Q ss_pred hhccccch------hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 154 KENCLFDM------LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 154 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
........ ..+.............+.+++.+||+.||.+||++.+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00000011112334568899999999999999999999954
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=197.59 Aligned_cols=189 Identities=21% Similarity=0.302 Sum_probs=135.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++|+||+ +++|.+++... ++++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 47999999 66899888643 3788889999999999999999999 9999999999999999999999999886
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHH--------HHHH
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGY--------FLRA 152 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~--------~~~~ 152 (253)
.... ......++..|++||.+.+ ..++.++|+||||+++|+|++|..||.............. ....
T Consensus 157 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDP----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCC----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 4322 1122346788999998865 4678999999999999999999999976543221110000 0000
Q ss_pred Hhhccccchh------chhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 153 MKENCLFDML------DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 153 ~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.......... .+.............+.+++.+||+.+|.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 0000000111234678899999999999999999999866
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=199.68 Aligned_cols=193 Identities=20% Similarity=0.296 Sum_probs=136.1
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
|+|+||+. .+|.+++.. .+++..+..++.|++.||.|||..+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 96 ~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 96 YLVMPYMQ-TDLQKIMGH-----PLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEEecccc-cCHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 79999995 477766521 4889999999999999999999999 99999999999999999999999999875
Q ss_pred ccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHH--------HHHHH
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGY--------FLRAM 153 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~--------~~~~~ 153 (253)
.... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.............. +....
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 167 ADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred CCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 4221 122346788999999875 4578899999999999999999999987543221110000 00000
Q ss_pred hhccccch------hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhchh
Q 044510 154 KENCLFDM------LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE--LGGIRA 208 (253)
Q Consensus 154 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~--l~~~~~ 208 (253)
........ ................+.+++.+||+.||.+||++++++.+ ++..+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000000 00000000001234567899999999999999999999966 666554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=190.92 Aligned_cols=191 Identities=23% Similarity=0.349 Sum_probs=154.0
Q ss_pred CCEEEEeecCCCChhHHhh-----ccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEc
Q 044510 1 VPLLVYEFIPNGTLYRYIH-----DQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKIS 75 (253)
Q Consensus 1 ~~~lv~e~~~~~sL~~~l~-----~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~ 75 (253)
.|++++.++.-|+|+.++. +......++..+...++.|++.|+.|||+++ ++|.||-..|++|++.-++||+
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEec
Confidence 4899999999999999998 2222234667788899999999999999999 9999999999999999999999
Q ss_pred ccCCcccccCCCcceeee-ccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHH
Q 044510 76 DFGASRYVTIDQTHLTTR-VQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAM 153 (253)
Q Consensus 76 Dfgl~~~~~~~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~ 153 (253)
|-.+++............ ......||+||.+....|+.++|+||||+++|||+| |+.|+..-++.+....
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y-------- 510 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY-------- 510 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH--------
Confidence 999988654433332222 224568999999999999999999999999999998 9999988777663221
Q ss_pred hhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 154 KENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
+..+.+..-|.+++.++..+..-||..+|++||++.+++..|.+.-..+
T Consensus 511 --------lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 511 --------LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred --------HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 1222233345556678889999999999999999999999998876543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=187.55 Aligned_cols=179 Identities=28% Similarity=0.372 Sum_probs=139.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++++||+.+++|.+++.... .+++..++.++.+++.++.+||..+ ++|+||+|.||+++.++.++++|||.+.
T Consensus 62 ~~l~~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~ 135 (244)
T smart00220 62 LYLVMEYCDGGDLFDLLKKRG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLAR 135 (244)
T ss_pred EEEEEeCCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEcccccee
Confidence 479999999999999997654 2889999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... ......++..|++||...+..++.++|+|++|+++++|++|..||........ .............
T Consensus 136 ~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~------~~~~~~~~~~~~~ 207 (244)
T smart00220 136 QLDPGG--LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE------LFKKIGKPKPPFP 207 (244)
T ss_pred eecccc--ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH------HHHHHhccCCCCc
Confidence 654321 22334578899999999888889999999999999999999999976322110 1111111111000
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAF 201 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 201 (253)
.. ....+..+.+++.+||..+|.+||++.++++
T Consensus 208 ~~-------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 208 PP-------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cc-------cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 00 0003346888999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-27 Score=189.91 Aligned_cols=202 Identities=23% Similarity=0.292 Sum_probs=147.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCC------CCCeEecCCCCCceeecCCCceEEc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTT------SIPIYHRDIKSANILLDDKFRAKIS 75 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~------~~~i~H~dl~~~nili~~~~~~kl~ 75 (253)
+|||+||.+.|+|.++|..+. ++|....+++..+++||+|||+.- .++|+|||||..|||+..++++.|+
T Consensus 283 ywLVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred eeEEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 589999999999999998874 999999999999999999999632 4679999999999999999999999
Q ss_pred ccCCcccccCCC-cceeeeccccccccccchhccCC-CC-----CCCCeehhHHHHHHHHhCCCCCC-CCC-hhhhhh--
Q 044510 76 DFGASRYVTIDQ-THLTTRVQGTFGYLDLEYFRSSQ-FT-----KKGDVYSFGVVFVGLLTGQKPIR-STD-TEEDKS-- 144 (253)
Q Consensus 76 Dfgl~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~-----~~~Di~slG~~l~~lltg~~pf~-~~~-~~~~~~-- 144 (253)
|||++..+.... .......+||..|||||++.+.- +. .+.|+||+|.++|||++....+. +.. +.....
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 999998775322 22333478999999999998542 22 36899999999999998554332 111 100000
Q ss_pred ------hHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 145 ------LAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 145 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
-.+.++......+.+..+....... .....+++.+..||..||+.|.|+.=+.+.+.++....
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 0111222222222222222222221 34556889999999999999999998888888776553
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=191.57 Aligned_cols=198 Identities=25% Similarity=0.343 Sum_probs=148.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhh-----CCCCCeEecCCCCCceeecCCCceEEcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS-----TTSIPIYHRDIKSANILLDDKFRAKISD 76 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-----~~~~~i~H~dl~~~nili~~~~~~kl~D 76 (253)
+|||.+|.++|+|.|+|.++ +++.+..++++..++.||+|||. +|.+.|.|||||..||++.+++.+.|+|
T Consensus 284 LwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 58999999999999999885 49999999999999999999993 5667899999999999999999999999
Q ss_pred cCCcccccCCCcc---eeeeccccccccccchhccCC----C--CCCCCeehhHHHHHHHHh----------CCCCCCCC
Q 044510 77 FGASRYVTIDQTH---LTTRVQGTFGYLDLEYFRSSQ----F--TKKGDVYSFGVVFVGLLT----------GQKPIRST 137 (253)
Q Consensus 77 fgl~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~----~--~~~~Di~slG~~l~~llt----------g~~pf~~~ 137 (253)
+||+......... ..+..+||..|||||++...- + =..+||||||.++||+.- .+.||.+.
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999877544322 345678999999999996432 1 146899999999999975 23677654
Q ss_pred ChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchh
Q 044510 138 DTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRA 208 (253)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 208 (253)
-+.+. ...+ +....-..++...++.. ....+....+.++++.||..+|..|.|+--|-+.|.++..
T Consensus 440 Vp~DP-s~ee-MrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 440 VPSDP-SFEE-MRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCC-CHHH-HhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 33221 1111 11111111122222211 2234566678889999999999999999999998888764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=201.76 Aligned_cols=192 Identities=22% Similarity=0.359 Sum_probs=147.6
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
++|+||+++|+|.+++..+... ...-....+|+.||+.|++||.+.+ +||||+.+.|+|++.++++||+|||+++.
T Consensus 611 cmI~EYmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccc
Confidence 6899999999999999886321 2455566789999999999999999 99999999999999999999999999986
Q ss_pred ccCCCccee-eeccccccccccchhccCCCCCCCCeehhHHHHHHHHh--CCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 83 VTIDQTHLT-TRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT--GQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 83 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
......+.. ...+-...|||+|.+.-++++.++|+|+||+++||+++ ...||+....+. ..+.........
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~--- 760 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQ--- 760 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCC---
Confidence 544333332 23445679999999998999999999999999999865 778887655432 111111111111
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhch
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 207 (253)
........|..++..+.+++.+||+.|-.+||+++++...|++..
T Consensus 761 ---~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 761 ---GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ---CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 111122334556667889999999999999999999999998754
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=186.32 Aligned_cols=187 Identities=21% Similarity=0.317 Sum_probs=141.3
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCc---eEEcccCC
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFR---AKISDFGA 79 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~---~kl~Dfgl 79 (253)
|+|||-+.||.|.+.|+... .+++..+-++..+|+.||.+||.+| |.|||+||+|||....+. +||+||.+
T Consensus 152 YLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccc
Confidence 89999999999999998765 4999999999999999999999999 999999999999986654 79999987
Q ss_pred cccccCCC------cceeeeccccccccccchhc---c--CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhh---
Q 044510 80 SRYVTIDQ------THLTTRVQGTFGYLDLEYFR---S--SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSL--- 145 (253)
Q Consensus 80 ~~~~~~~~------~~~~~~~~~~~~y~aPE~~~---~--~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~--- 145 (253)
..-+..+. .......+|+.+|||||+.. + ..|+.++|.||||+++|-|++|++||.+.-..+..|-
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 65432211 11123456888999999874 2 3478999999999999999999999987544332221
Q ss_pred -----HHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044510 146 -----AGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAF 201 (253)
Q Consensus 146 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 201 (253)
...+.+.+.++.. +..+. .--..+.+..++|...|..|+.+|.++.++++
T Consensus 306 ~Cr~CQ~~LFesIQEGkY-eFPdk-----dWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQEGKY-EFPDK-----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccHHHHHHHHHHHhccCC-cCChh-----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1222223333321 11121 12345567888999999999999999998887
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=198.94 Aligned_cols=194 Identities=19% Similarity=0.199 Sum_probs=148.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC-CCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD-KFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~-~~~~kl~Dfgl~ 80 (253)
+|||+|-+ ..+|.++|...+...++....+...+.|+..||..|..+| |+|.||||+|||++. ...+||||||.+
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 58999999 7799999999888888999999999999999999999999 999999999999985 567899999998
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHh-----h
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK-----E 155 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-----~ 155 (253)
.....+...+. .-+..|.|||++.|.+|+...|+||+||+|||+.||+.-|.+.+...+..+...+..... .
T Consensus 585 ~~~~eneitPY---LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 585 SFASENEITPY---LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred cccccccccHH---HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 77655443322 224579999999999999999999999999999999999998876654433322211100 0
Q ss_pred cc---------------------------ccchhch-----------hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 044510 156 NC---------------------------LFDMLDA-----------QVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMK 197 (253)
Q Consensus 156 ~~---------------------------~~~~~~~-----------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~ 197 (253)
+. ....+.| ...+........++.+|+.+||..||.+|.+..
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 00 0000111 001111223456789999999999999999999
Q ss_pred HHHHH
Q 044510 198 EVAFE 202 (253)
Q Consensus 198 ~l~~~ 202 (253)
+++++
T Consensus 742 qAL~H 746 (752)
T KOG0670|consen 742 QALKH 746 (752)
T ss_pred HHhcC
Confidence 98865
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=189.88 Aligned_cols=183 Identities=28% Similarity=0.389 Sum_probs=138.5
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec---CCCceEEcccCC
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD---DKFRAKISDFGA 79 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~---~~~~~kl~Dfgl 79 (253)
|-|+|||+|.+|.-++..+. -+++..+..|+.||+.||.||.... +||+|-||||.|||+. ..|.+||.||||
T Consensus 544 CTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred eeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecch
Confidence 67999999999999998865 4999999999999999999999876 5699999999999995 357899999999
Q ss_pred cccccCCCc------ceeeeccccccccccchhccC----CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH
Q 044510 80 SRYVTIDQT------HLTTRVQGTFGYLDLEYFRSS----QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF 149 (253)
Q Consensus 80 ~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~----~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 149 (253)
++++..... ..+....||.+|+|||.+.-+ +.+.++||||+||++|..+.|+.||....... ..+. .
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-dILq--e 696 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-DILQ--E 696 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-HHHh--h
Confidence 998864322 233456799999999998644 36889999999999999999999997643221 1100 0
Q ss_pred HHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 044510 150 LRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVA 200 (253)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~ 200 (253)
...+.......... ...+.+...+|++||...-++|.++-++.
T Consensus 697 NTIlkAtEVqFP~K--------PvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 697 NTILKATEVQFPPK--------PVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hchhcceeccCCCC--------CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 01111111111111 12344677899999999999998887765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-28 Score=187.08 Aligned_cols=190 Identities=21% Similarity=0.264 Sum_probs=143.4
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
|+|||++ ..+|..++.- .+.-+.+.++..|++.|++|||+.| |+||||||+||++..+..+||.|||+++.
T Consensus 97 y~v~e~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 97 YLVMELM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHhh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcc
Confidence 6899999 5599998873 3677888999999999999999999 99999999999999999999999999975
Q ss_pred ccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHH--------HHHh
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFL--------RAMK 154 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~--------~~~~ 154 (253)
-. .....+..+.+..|.|||+..+..+.+.+||||+||++.||++|..-|.+.+..++........ ..+.
T Consensus 168 e~--~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 168 ED--TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cC--cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 43 2234556778889999999999889999999999999999999999998776655443332211 0000
Q ss_pred h--------c------cccchhchhhhh---hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044510 155 E--------N------CLFDMLDAQVLK---EAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203 (253)
Q Consensus 155 ~--------~------~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 203 (253)
. . ...+.+...... +.+......+++++.+||..||++|.++++++.+-
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 0 0 000111111110 11112235588999999999999999999999873
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=184.05 Aligned_cols=177 Identities=23% Similarity=0.364 Sum_probs=140.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+|.||.+||+|--.++++. .++++.+.....+|..||.|||++| |++||+|.+||+++..|.+|+.|+|+.+
T Consensus 326 lffvieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhh
Confidence 478999999999998888765 4999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhh-hhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE-DKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~ 160 (253)
.-. .....+.+..|||.|+|||++.+..|.+.+|.|++|++++||+.|+.||.--...+ ..+-.+++...+.+....
T Consensus 400 e~l-~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir- 477 (593)
T KOG0695|consen 400 EGL-GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR- 477 (593)
T ss_pred cCC-CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc-
Confidence 543 23334556789999999999999999999999999999999999999997644332 223344444443333221
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT 195 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps 195 (253)
++...+-....++..-|++||.+|.-
T Consensus 478 ---------iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 ---------IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ---------ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 11222234556889999999998843
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-27 Score=195.91 Aligned_cols=135 Identities=26% Similarity=0.422 Sum_probs=116.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||++||++-++|.+.+ -|++..+...+.++..|+++.|..| ++||||||+||||+.+|.+||.||||+.
T Consensus 704 LYFVMdYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccc
Confidence 589999999999999999876 4888888889999999999999999 9999999999999999999999999976
Q ss_pred ccc---CC-----C-----------------cc----------------eeeeccccccccccchhccCCCCCCCCeehh
Q 044510 82 YVT---ID-----Q-----------------TH----------------LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120 (253)
Q Consensus 82 ~~~---~~-----~-----------------~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 120 (253)
-+. +. . .. .....+||+.|+|||++....|+..+|.|+.
T Consensus 778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~ 857 (1034)
T KOG0608|consen 778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV 857 (1034)
T ss_pred cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence 442 00 0 00 0012569999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhhh
Q 044510 121 GVVFVGLLTGQKPIRSTDTEED 142 (253)
Q Consensus 121 G~~l~~lltg~~pf~~~~~~~~ 142 (253)
|++||||+.|++||....+.+.
T Consensus 858 gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 858 GVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred hHHHHHHhhCCCCccCCCCCcc
Confidence 9999999999999988776553
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.5e-28 Score=206.23 Aligned_cols=182 Identities=26% Similarity=0.365 Sum_probs=134.7
Q ss_pred CCEEEEeecCCCChhHHhhccCCCCC-CCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC---C--CceEE
Q 044510 1 VPLLVYEFIPNGTLYRYIHDQTEEFT-ITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD---K--FRAKI 74 (253)
Q Consensus 1 ~~~lv~e~~~~~sL~~~l~~~~~~~~-~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~---~--~~~kl 74 (253)
+.||+.|.|.- +|.+++........ ...-..+..+.|++.||++||+.+ ||||||||+||||+. + .+++|
T Consensus 577 F~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~i 652 (903)
T KOG1027|consen 577 FLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKI 652 (903)
T ss_pred eEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEe
Confidence 46999999954 99999987411111 111345678889999999999999 999999999999975 2 46899
Q ss_pred cccCCcccccCCCcc--eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHH
Q 044510 75 SDFGASRYVTIDQTH--LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLR 151 (253)
Q Consensus 75 ~Dfgl~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~ 151 (253)
+|||+++........ ......||-+|+|||++.......++||||+||++|+.++ |.+||.+.-..+ .+
T Consensus 653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------~N 724 (903)
T KOG1027|consen 653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------AN 724 (903)
T ss_pred cccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------hh
Confidence 999999876543322 2345678999999999998888889999999999999988 589997754322 12
Q ss_pred HHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 152 AMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.+.++.....+.+ ... ....++|.+|+++||..||++.+++.+
T Consensus 725 Il~~~~~L~~L~~-----~~d---~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 725 ILTGNYTLVHLEP-----LPD---CEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred hhcCccceeeecc-----Cch---HHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 2222211111111 011 167889999999999999999999754
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=203.02 Aligned_cols=187 Identities=27% Similarity=0.459 Sum_probs=152.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+.||++|+++|+|.++++.++. .+-.+..+.|..||++|+.|||.++ +|||||-..|||+.....+|+.|||+++
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ 846 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAK 846 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhh
Confidence 3578999999999999998654 5889999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeee-ccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTHLTTR-VQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
............ ..-.+.|||-|.+....|+.++|||||||++||++| |..|+.+....+...
T Consensus 847 ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d--------------- 911 (1177)
T KOG1025|consen 847 LLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD--------------- 911 (1177)
T ss_pred ccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH---------------
Confidence 765443332222 112458999999998999999999999999999999 999988776655222
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
++....+-.-+......+..++.+||..|+..||+++++...+.+....
T Consensus 912 -lle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 912 -LLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred -HHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 2222222233445566788899999999999999999999988876654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-26 Score=193.43 Aligned_cols=190 Identities=20% Similarity=0.140 Sum_probs=130.6
Q ss_pred CEEEEeecCCCChhHHhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE---------------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~ 60 (253)
.|+||||+.+++|.+++..... ...+.+..+..++.|++.+|.|||..+ ++|||||
T Consensus 260 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLK 336 (507)
T PLN03224 260 QWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIK 336 (507)
T ss_pred eEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCc
Confidence 4899999999999999874211 112456788899999999999999999 9999999
Q ss_pred CCceeecCCCceEEcccCCcccccCCCcceeeeccccccccccchhccCC----------------------CCCCCCee
Q 044510 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQ----------------------FTKKGDVY 118 (253)
Q Consensus 61 ~~nili~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----------------------~~~~~Di~ 118 (253)
|+||+++.++.++|+|||+++..............+++.|++||.+.... ...+.|+|
T Consensus 337 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~Dvw 416 (507)
T PLN03224 337 PENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSY 416 (507)
T ss_pred hHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchh
Confidence 99999999999999999998754322211112233478999999975322 12347999
Q ss_pred hhHHHHHHHHhCCC-CCCCCChhhhhh----hHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCC---
Q 044510 119 SFGVVFVGLLTGQK-PIRSTDTEEDKS----LAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNG--- 190 (253)
Q Consensus 119 slG~~l~~lltg~~-pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP--- 190 (253)
|+||++++|+++.. ||.......... .....++...... .+.. .....+....+++.++|..+|
T Consensus 417 SlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~----~~~~----~~d~~s~~~~dLi~~LL~~~~~~~ 488 (507)
T PLN03224 417 TAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK----YDFS----LLDRNKEAGWDLACKLITKRDQAN 488 (507)
T ss_pred hHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC----CCcc----cccccChHHHHHHHHHhccCCCCc
Confidence 99999999999875 665432111100 0000111111111 1111 122334568889999999766
Q ss_pred CCCCCHHHHHHH
Q 044510 191 RKRPTMKEVAFE 202 (253)
Q Consensus 191 ~~Rps~~~l~~~ 202 (253)
.+|+|++|+++|
T Consensus 489 ~~RlSa~eaL~H 500 (507)
T PLN03224 489 RGRLSVGQALSH 500 (507)
T ss_pred ccCCCHHHHhCC
Confidence 689999999965
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=182.74 Aligned_cols=201 Identities=23% Similarity=0.281 Sum_probs=142.8
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
|+|+|.+ ..+|..+|..- + .++.+.+.-++.||+.||.|||+.+ |.||||||.|.+++.+..+||+|||+++.
T Consensus 133 YV~TELm-QSDLHKIIVSP-Q--~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIVSP-Q--ALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHH-HhhhhheeccC-C--CCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 3445555 33566555432 2 5888999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHH--------HHH
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFL--------RAM 153 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~--------~~~ 153 (253)
.........+..+-|..|+|||++.|. .|+.+.||||+||++.|++..+.-|....+.++..++..+. +..
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 665555555666678899999999875 58999999999999999999888888777666544443221 111
Q ss_pred hhccccchhch-------hhh-h-hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 154 KENCLFDMLDA-------QVL-K-EAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 154 ~~~~~~~~~~~-------~~~-~-~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
-++....++.. ... . ..+.....+...+...++..||.+|.+..+.+.++..-...+
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence 11110000000 000 0 001112234566788899999999999999998865544444
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=204.86 Aligned_cols=74 Identities=34% Similarity=0.540 Sum_probs=68.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+.|++|.+++.... .+++..++.++.||+.||.|||..+ |+||||||+||+++.++.++|+|||+++
T Consensus 79 ~~lVmEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 489999999999999997654 4889999999999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-27 Score=181.40 Aligned_cols=186 Identities=23% Similarity=0.303 Sum_probs=135.2
Q ss_pred CEEEEeecCCCChhHHhhc--cCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHD--QTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl 79 (253)
-||.||.| ..+|..+-.. ..++..+++...-+|..-.+.||.||.+.-. |+|||+||+|||++..|.+||+|||.
T Consensus 138 cWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGI 214 (361)
T KOG1006|consen 138 CWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGI 214 (361)
T ss_pred eeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccc
Confidence 38999999 5577655433 1123369999888999999999999985431 99999999999999999999999998
Q ss_pred cccccCCCcceeeeccccccccccchhcc--CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRS--SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
+-..-. ....+...|...|||||.+.. ..|..++|+||||++++|+.||..|+...+.. .+++.....+..
T Consensus 215 cGqLv~--SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----feql~~Vv~gdp 287 (361)
T KOG1006|consen 215 CGQLVD--SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FEQLCQVVIGDP 287 (361)
T ss_pred hHhHHH--HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HHHHHHHHcCCC
Confidence 643321 112233567889999999853 35899999999999999999999998765431 122222222211
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ++. ......+.+..+..+|..||.+|-..||..+++.++
T Consensus 288 -p-~l~---~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 288 -P-ILL---FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -C-eec---CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1 111 111223466778999999999999999999999865
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-26 Score=163.56 Aligned_cols=193 Identities=21% Similarity=0.284 Sum_probs=143.3
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
-+|+||| +.+|..+...... .+..+.+..++.|++.||.++|+++ +.|||+||+|.+|+.+|.+|++|||+++.
T Consensus 77 tlvfe~c-dqdlkkyfdslng--~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglara 150 (292)
T KOG0662|consen 77 TLVFEFC-DQDLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARA 150 (292)
T ss_pred EEeHHHh-hHHHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhh
Confidence 4799999 5589888876433 4899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCcceeeeccccccccccchhccCC-CCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRSSQ-FTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
+... .......+-|.+|++|.++.+.+ |+...|+||.||++.|+.. |.+-|.+.+..++...+-.......+..+..
T Consensus 151 fgip-vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps 229 (292)
T KOG0662|consen 151 FGIP-VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPS 229 (292)
T ss_pred cCCc-eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCc
Confidence 7532 22333445688999999998765 7999999999999999987 6666777665544333333222222222221
Q ss_pred h---hchhhh---------hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 M---LDAQVL---------KEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~---~~~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
+ .|.... ...-......-++++++.|.-+|.+|.++++.+++
T Consensus 230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1 111111 11222334557889999999999999999988754
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-26 Score=188.48 Aligned_cols=178 Identities=24% Similarity=0.325 Sum_probs=136.7
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC---CceEEcccCC
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK---FRAKISDFGA 79 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~---~~~kl~Dfgl 79 (253)
|+|||-+.| +....|-.. .++++++.....++.||+.||+|||-++ |+|+|+||+|||+... .++||+|||+
T Consensus 639 FVVMEKl~G-DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGf 713 (888)
T KOG4236|consen 639 FVVMEKLHG-DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGF 713 (888)
T ss_pred EEEehhhcc-hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccc
Confidence 789999955 554444333 2336999999999999999999999999 9999999999999754 4799999999
Q ss_pred cccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
++++... .-....+|||.|+|||++....|...-|+||+|+++|--++|..||....... ++ +.+. .
T Consensus 714 ARiIgEk--sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn-----dQ----IQNA--a 780 (888)
T KOG4236|consen 714 ARIIGEK--SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN-----DQ----IQNA--A 780 (888)
T ss_pred eeecchh--hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh-----HH----hhcc--c
Confidence 9988643 23345789999999999999999999999999999999999999996543321 11 1111 1
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.++.++... +.+....++|...|+..-.+|.+++..+.+
T Consensus 781 FMyPp~PW~----eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 781 FMYPPNPWS----EISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred cccCCCchh----hcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 122333332 344568889999999999999998766543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-25 Score=167.35 Aligned_cols=183 Identities=23% Similarity=0.286 Sum_probs=131.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec--CCCceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD--DKFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~--~~~~~kl~Dfgl 79 (253)
.++++||++.|+|.+-+...+ +-+....+++.|+++|+.|||+++ +||||||.+||||- +..++||+|||+
T Consensus 97 YvF~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred EEEeeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccc
Confidence 468999999999999997754 889999999999999999999999 99999999999994 334899999998
Q ss_pred cccccCCCcceeeeccccccccccchhccC-----CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHh
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSS-----QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK 154 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 154 (253)
.+.... ......-+..|-+||..... ...+.+|+|+||++++.++||..||+..... +...+.+....
T Consensus 170 t~k~g~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~~~w~-- 242 (378)
T KOG1345|consen 170 TRKVGT----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEWEQWL-- 242 (378)
T ss_pred ccccCc----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHHHHHh--
Confidence 865432 11122235568888876432 2367899999999999999999999843332 22233322221
Q ss_pred hccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 155 ENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
.+.... .+.....++..+..+.++-|..+|++|--..+.-++..
T Consensus 243 ~rk~~~------~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 243 KRKNPA------LPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred cccCcc------CchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 111111 11122334556778999999999999955555554433
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-25 Score=162.57 Aligned_cols=132 Identities=30% Similarity=0.438 Sum_probs=105.5
Q ss_pred EEEEeecCCCChhHHhhc-cCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 3 LLVYEFIPNGTLYRYIHD-QTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
||.||.+ ..+|..+-.. ..+...+++...=+|+..++.||.|||++-+ ++|||+||+|||++..|++|+||||.+-
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccce
Confidence 7889998 4477665443 2233369999999999999999999998653 9999999999999999999999999876
Q ss_pred cccCCCcceeeeccccccccccchhcc----CCCCCCCCeehhHHHHHHHHhCCCCCCCCCh
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS----SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDT 139 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~lltg~~pf~~~~~ 139 (253)
...+.- ..+...|...|||||.... ..|+.++||||||++++||.+++.||.....
T Consensus 198 ~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 198 YLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred eehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 443221 1112457788999999853 3689999999999999999999999977543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=160.58 Aligned_cols=148 Identities=33% Similarity=0.544 Sum_probs=126.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC-CCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD-KFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~-~~~~kl~Dfgl~ 80 (253)
.++++||+.+++|.+++.... ..+++..++.++.+++.++.+||..+ ++|+||+|.||+++. ++.++++||+.+
T Consensus 66 ~~~~~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~ 140 (215)
T cd00180 66 LYLVMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLS 140 (215)
T ss_pred EEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCce
Confidence 479999999899999997652 24899999999999999999999999 999999999999999 899999999988
Q ss_pred ccccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
........ ......+...|++||..... .++.+.|+|++|+++++|
T Consensus 141 ~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------- 187 (215)
T cd00180 141 KLLTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------- 187 (215)
T ss_pred EEccCCcc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------
Confidence 76543221 12224467889999999876 778999999999999998
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 203 (253)
..+.+++.+|++.+|.+||++.++++.+
T Consensus 188 ----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2467799999999999999999998653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=170.87 Aligned_cols=60 Identities=28% Similarity=0.465 Sum_probs=54.1
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceee
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILL 66 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili 66 (253)
|||+|++ |.+|..+|.....+ +++...+..|+.||+.||.|||.... |+|.||||+|||+
T Consensus 162 CMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl 221 (590)
T KOG1290|consen 162 CMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL 221 (590)
T ss_pred EEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence 7999999 88999999886543 59999999999999999999997652 9999999999998
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.4e-23 Score=179.47 Aligned_cols=182 Identities=20% Similarity=0.275 Sum_probs=141.1
Q ss_pred EEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccccc
Q 044510 5 VYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVT 84 (253)
Q Consensus 5 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~~~ 84 (253)
+||||++ +|..++.... .+....+..++.|++.|++|||..| +.|||+|++|++++.++.+|++|||.+..+.
T Consensus 399 ~mE~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hhhcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeec
Confidence 3899999 9999998763 4888899999999999999999999 9999999999999999999999999887665
Q ss_pred CCCc---ceeeeccccccccccchhccCCCC-CCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 85 IDQT---HLTTRVQGTFGYLDLEYFRSSQFT-KKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 85 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
.... .......|+..|+|||.+.+..|. ...|+||.|+++..|++|+.||......++.... ... ...
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~------~~~--~~~ 543 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT------NNY--SDQ 543 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh------hcc--ccc
Confidence 3332 233456788999999999988885 5799999999999999999999877655433200 000 000
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAF 201 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 201 (253)
..............+...+.++.++|+.||.+|.|+++|++
T Consensus 544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00011111122334456778999999999999999999985
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=171.62 Aligned_cols=181 Identities=24% Similarity=0.277 Sum_probs=137.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|++||||-||+|.+.-+..+ ++++.++....++.++||+|||+.+ -+|||||-.||++++.+.+|+.|||.+.
T Consensus 87 lwicMEycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsa 160 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSA 160 (829)
T ss_pred cEEEEEecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchh
Confidence 589999999999999776554 5999999999999999999999999 8999999999999999999999999876
Q ss_pred cccCCCcceeeeccccccccccchhc---cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc-
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR---SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC- 157 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~- 157 (253)
.+.. .....+...||+.|||||+.. .+.|...+|+|++|++..|+-.-+.|.-...+... +.-....+.
T Consensus 161 qita-ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~------l~LmTkS~~q 233 (829)
T KOG0576|consen 161 QITA-TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA------LFLMTKSGFQ 233 (829)
T ss_pred hhhh-hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH------HHHhhccCCC
Confidence 5532 222345578999999999973 35689999999999999999777776543333211 111111111
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..... ....-...+-++++.||-.+|.+||++..++.+
T Consensus 234 pp~lk-------Dk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 234 PPTLK-------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CCccc-------CCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 11111 122333457779999999999999998877653
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-22 Score=149.45 Aligned_cols=188 Identities=20% Similarity=0.248 Sum_probs=131.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC-CCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD-KFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~-~~~~kl~Dfgl~ 80 (253)
|-+|+||..+.+...+-. +++...+...+.+++.||.|+|+.| |.|||+||.|++|+. ...++|+|+|++
T Consensus 110 paLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred chhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchH
Confidence 568899998877776643 3777788889999999999999999 999999999999995 457999999999
Q ss_pred ccccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCC-CCChhhhhhhHHHHH------HH
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIR-STDTEEDKSLAGYFL------RA 152 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~-~~~~~~~~~~~~~~~------~~ 152 (253)
..+...... ...+.+..|--||.+..- .|...-|+|||||++..|+..+.||- +.+..++...+.... .-
T Consensus 181 EFYHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 181 EFYHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAY 258 (338)
T ss_pred hhcCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHH
Confidence 877644332 223456678899998764 47888999999999999999888873 333322221111110 00
Q ss_pred Hhhccccchhchhhhh---------------hhcH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 153 MKENCLFDMLDAQVLK---------------EAKE-EEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 153 ~~~~~~~~~~~~~~~~---------------~~~~-~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
+... .-.+++.... .... -..+++.+++.+.|..|..+|+|++|...+
T Consensus 259 l~KY--~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 259 LNKY--QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHH--ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0000 0001111100 0111 123678999999999999999999999865
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.4e-21 Score=155.72 Aligned_cols=190 Identities=23% Similarity=0.298 Sum_probs=132.0
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC-CCceEEcccCCcc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD-KFRAKISDFGASR 81 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~-~~~~kl~Dfgl~~ 81 (253)
.+|+||+++....++... ++...+...+..++.||.++|..| |+||||||.|++.+. .+.-.|.|||++.
T Consensus 111 ~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence 589999999999998764 667888999999999999999999 999999999999984 5678999999987
Q ss_pred cccCC--------------------------------C-c----------ceeeeccccccccccchhccC-CCCCCCCe
Q 044510 82 YVTID--------------------------------Q-T----------HLTTRVQGTFGYLDLEYFRSS-QFTKKGDV 117 (253)
Q Consensus 82 ~~~~~--------------------------------~-~----------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di 117 (253)
..... . . .......||++|+|||++... .-++++|+
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 21100 0 0 001124689999999999754 35889999
Q ss_pred ehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH-------HHHH--hhcc--cc---------------chhc-hhh----
Q 044510 118 YSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF-------LRAM--KENC--LF---------------DMLD-AQV---- 166 (253)
Q Consensus 118 ~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~-------~~~~--~~~~--~~---------------~~~~-~~~---- 166 (253)
||.|+++..++++..||-....+-. .+.... .++. ..+. +. +.++ ...
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~-al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDAD-ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeccceeehhhccccccccCccccc-hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 9999999999999999854332211 000000 0000 0000 00 0000 000
Q ss_pred -----hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 167 -----LKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 167 -----~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
........+..+.+++.+||..||.+|.++++.+++
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 001111223478999999999999999999999976
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.8e-21 Score=147.85 Aligned_cols=130 Identities=33% Similarity=0.510 Sum_probs=110.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++++||+.+++|.+++..... .+++..+..++.+++.++.+||..+ ++|+|+++.||+++.++.++|+|||.+.
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~ 146 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLAR 146 (225)
T ss_pred eEEEEeccCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceee
Confidence 4799999999999999986542 1789999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchh-ccCCCCCCCCeehhHHHHHHHHhCCCCCCC
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYF-RSSQFTKKGDVYSFGVVFVGLLTGQKPIRS 136 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~lltg~~pf~~ 136 (253)
..............++..|++||.+ ....++.++|+|+||+++++|++|..||..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 147 FIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred EecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 6643321122234567789999998 556678899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-21 Score=161.03 Aligned_cols=171 Identities=23% Similarity=0.391 Sum_probs=128.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+||.|++|.-.+|.+++.+.......++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||+|||+..
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhee
Confidence 58999999999999999865555568888999999999999999 77 8999999999999999999999999876
Q ss_pred cccCCC-----cceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhh
Q 044510 82 YVTIDQ-----THLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKE 155 (253)
Q Consensus 82 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 155 (253)
...... .......+||..||+||++.+..|+.++|||+||++++|++. -...|..... ...+..
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t----------~~d~r~ 474 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT----------LTDIRD 474 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh----------hhhhhc
Confidence 554333 223345679999999999999999999999999999999987 2222211100 011111
Q ss_pred ccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 044510 156 NCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMK 197 (253)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~ 197 (253)
+ .+++....+.+. -..++++++...|.+||++.
T Consensus 475 g----~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 475 G----IIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred C----CCChHHhhcCcH-----HHHHHHHhcCCCcccCchHH
Confidence 1 122222222222 34589999999999999433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-19 Score=147.20 Aligned_cols=202 Identities=21% Similarity=0.225 Sum_probs=145.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC-----CceEEcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK-----FRAKISD 76 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~-----~~~kl~D 76 (253)
.|+||+.+ |.+|.++..... ...++...++.++.|++.+|.+||+.| ++||||||.|+.++.. ..+.+.|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred eEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEe
Confidence 48999988 999999987665 346999999999999999999999999 9999999999999854 4689999
Q ss_pred cCCcc--cccCCCc---c---e-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHH
Q 044510 77 FGASR--YVTIDQT---H---L-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAG 147 (253)
Q Consensus 77 fgl~~--~~~~~~~---~---~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~ 147 (253)
||+++ .+..... . . .....||..|.++....+...+.+.|+||++.++.++..|..||.............
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 99998 3321111 0 1 122448999999999999999999999999999999999999997655432211111
Q ss_pred HHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCCCCCCCcc
Q 044510 148 YFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNCEGIDF 220 (253)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~ 220 (253)
....... ... .....+..+.++...+-..+...+|....+...++......+.......+|
T Consensus 251 ~~~~~~~---~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw 311 (322)
T KOG1164|consen 251 KDPRKLL---TDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDW 311 (322)
T ss_pred HHhhhhc---ccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcc
Confidence 1111100 000 011112234445555555899999999999999988877754444333443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.5e-21 Score=158.10 Aligned_cols=125 Identities=23% Similarity=0.354 Sum_probs=108.9
Q ss_pred CEEEEeec-CCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFI-PNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~-~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.||+||.. +|-+|+++|.... .+.+..+..|+.||+.|+++||..| |+|||||-+||.++.+|-+||+|||.+
T Consensus 644 yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 644 YYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred eEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccch
Confidence 46788855 3678999998765 5999999999999999999999999 999999999999999999999999988
Q ss_pred ccccCCCcceeeeccccccccccchhccCCC-CCCCCeehhHHHHHHHHhCCCCCC
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQF-TKKGDVYSFGVVFVGLLTGQKPIR 135 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~lltg~~pf~ 135 (253)
..+.. .+.-..+||..|.|||++.|.+| ....|||++|+++|.++....||.
T Consensus 718 a~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 76542 23344679999999999999887 577999999999999998888875
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.4e-19 Score=139.86 Aligned_cols=207 Identities=18% Similarity=0.240 Sum_probs=160.1
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC-----CceEEccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK-----FRAKISDF 77 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~-----~~~kl~Df 77 (253)
.||+|.+ |.+|.|+..-.+. +++.+.++.++.|++.-++|+|++. +++|||||+|.||... ..+.++||
T Consensus 100 iLVidLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEec
Confidence 3789988 9999999876554 5999999999999999999999999 9999999999999743 45899999
Q ss_pred CCcccccCCCcce------eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHH
Q 044510 78 GASRYVTIDQTHL------TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLR 151 (253)
Q Consensus 78 gl~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~ 151 (253)
|+++.+.+..... .+...||..||+.....|..-+.+.|+-++|-++.+.+-|..||.+......+...+.+..
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 9999886543221 2346799999999999999999999999999999999999999999877665544433322
Q ss_pred HHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCCCCCCCcccCCc
Q 044510 152 AMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNCEGIDFVGGN 224 (253)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~~~ 224 (253)
......+ . ......+.++..-+.-.-..+-.+-|+.+-+...+..+.+..+.......+|..-+
T Consensus 254 ~Kr~T~i----~-----~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 254 TKRSTPI----E-----VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred ccccCCH----H-----HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 2222211 1 12222333444455555566777889999999999999999888888888887655
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.9e-18 Score=145.25 Aligned_cols=196 Identities=24% Similarity=0.442 Sum_probs=141.9
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCe-EecCCCCCceeecCCCceEEcccCCcc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPI-YHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i-~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
++|-+||..|+|.+.+..... .+.+.....++++++.||.|+|... | .|+.++..|++++....+|+.|||+..
T Consensus 23 ~~i~~~c~rGsl~D~i~~~~~--~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~s~nClvd~~w~lklt~~Gl~~ 97 (484)
T KOG1023|consen 23 IVIWEYCSRGSLLDILSNEDI--KLDYFFILSFIRDISKGLAYLHNSP---IGYHGALKSSNCLVDSRWVLKLTDFGLNS 97 (484)
T ss_pred EEEEeeecCccHHhHHhcccc--CccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeeccccceeeeeEEEEechhhhcc
Confidence 578999999999999988433 4888888999999999999999876 5 999999999999999999999999876
Q ss_pred cccCC-CcceeeeccccccccccchhccCC-------CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHH
Q 044510 82 YVTID-QTHLTTRVQGTFGYLDLEYFRSSQ-------FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAM 153 (253)
Q Consensus 82 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 153 (253)
..... ............-|.|||.+.+.. .+.+.|+||||++++|+++...||......... .+.... +
T Consensus 98 ~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~--~eii~~-~ 174 (484)
T KOG1023|consen 98 LLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDP--DEIILR-V 174 (484)
T ss_pred cccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCCh--HHHHHH-H
Confidence 54320 001111122345789999997541 366799999999999999999999875544332 111111 1
Q ss_pred hhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 154 KENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
.. .......|...... +....+..+++.||..+|.+||+++.+...++.+...
T Consensus 175 ~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 175 KK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred Hh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 11 01111111111111 3334688899999999999999999999888777654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.7e-19 Score=133.00 Aligned_cols=205 Identities=18% Similarity=0.185 Sum_probs=159.9
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC---CCceEEcccCC
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD---KFRAKISDFGA 79 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~---~~~~kl~Dfgl 79 (253)
.+|||.+ |.+|.++.+-... .++...++-++.|++.-++|+|.++ ++||||||+|.|..- ...+.++|||+
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred eeeeecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccc
Confidence 6899998 9999999987543 5899999999999999999999999 999999999999863 35789999999
Q ss_pred cccccCCCcc------eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHH
Q 044510 80 SRYVTIDQTH------LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAM 153 (253)
Q Consensus 80 ~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 153 (253)
++.+.+.... ......||..|.+-....+...+.+.|.-|+|.++.++.-|..||++.......+..+...++.
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 9987653322 2234668999998888887777899999999999999999999999988766555544433332
Q ss_pred hhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCCCCCCCcccC
Q 044510 154 KENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNCEGIDFVG 222 (253)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~ 222 (253)
..... .......+.++...+.-|-..--++-|+..-+.+.++-+...+.....-..+|+.
T Consensus 241 ~s~~i---------e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~ 300 (341)
T KOG1163|consen 241 MSTPI---------EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTM 300 (341)
T ss_pred cCCCH---------HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHH
Confidence 22211 1122234445666888888888889999999999999998887777666666664
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=139.39 Aligned_cols=180 Identities=19% Similarity=0.190 Sum_probs=130.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec--CC--CceEEccc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD--DK--FRAKISDF 77 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~--~~--~~~kl~Df 77 (253)
.|+||.-... +|..++-.+. .+.....-++.|+++|+.|||.+| +.|||+|.+||++. ++ ..+.|+||
T Consensus 318 lylvMkrY~~-tLr~yl~~~~----~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDF 389 (598)
T KOG4158|consen 318 LYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADF 389 (598)
T ss_pred EEEehhcchh-hHHHHHhcCC----CchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEccc
Confidence 4889998855 8999997754 677777889999999999999999 99999999999994 33 35789999
Q ss_pred CCcccccCCC-----cceeeeccccccccccchhccCC------CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhH
Q 044510 78 GASRYVTIDQ-----THLTTRVQGTFGYLDLEYFRSSQ------FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLA 146 (253)
Q Consensus 78 gl~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~ 146 (253)
|.+....... ........|.-..||||+....+ .-.+.|.|+.|.+.||+++...||.+..+.-....
T Consensus 390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r- 468 (598)
T KOG4158|consen 390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR- 468 (598)
T ss_pred ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh-
Confidence 9764332111 11222334667789999987432 12589999999999999999999987443211000
Q ss_pred HHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 147 GYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
.+-..-.+..+..+++.+++++...|+.||++|++..-..+.|+
T Consensus 469 --------------~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 469 --------------TYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred --------------hhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 01111223445566677899999999999999998765555443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.8e-19 Score=140.19 Aligned_cols=162 Identities=20% Similarity=0.285 Sum_probs=106.3
Q ss_pred EEEEeecCCCChhHHhhc---cCC-CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccC
Q 044510 3 LLVYEFIPNGTLYRYIHD---QTE-EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFG 78 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~---~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfg 78 (253)
+++|+-+ .++|.+++.- ... ...+.....+.+..|+++.+++||..| ++|+||+|+|++++.+|.++|+||+
T Consensus 115 ~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F~ 190 (288)
T PF14531_consen 115 FLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDFS 190 (288)
T ss_dssp EEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--GG
T ss_pred hhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcChH
Confidence 5677777 4588877643 111 112444556677789999999999999 9999999999999999999999998
Q ss_pred CcccccCCCcceeeeccccccccccchhccC--------CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHH
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSS--------QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFL 150 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~ 150 (253)
...... ........+..|.|||..... .++.+.|.|++|+++|.|+++..||...........
T Consensus 191 ~~~r~g----~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~----- 261 (288)
T PF14531_consen 191 SLVRAG----TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW----- 261 (288)
T ss_dssp GEEETT----EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-----
T ss_pred HHeecC----ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-----
Confidence 655432 111113345778999987432 468899999999999999999999987654321111
Q ss_pred HHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCC
Q 044510 151 RAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKR 193 (253)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R 193 (253)
...... +.+..++.+|..+|+.||.+|
T Consensus 262 ---------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 ---------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ---------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ---------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 111222 556678889999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.8e-19 Score=157.91 Aligned_cols=177 Identities=22% Similarity=0.250 Sum_probs=124.0
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
|||=+|..+ +|.|.+...+ -+..-..+.|+-|++.||..+|+.| |+|||||.+|||++.=+.+.|+||...+.
T Consensus 97 ylvRqyvkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 97 YLVRQYVKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKP 169 (1431)
T ss_pred HHHHHHHhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCC
Confidence 345567755 8888887643 3677788889999999999999999 99999999999999999999999987765
Q ss_pred ccCCCcce--eee----ccccccccccchhccC----------C-CCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhh
Q 044510 83 VTIDQTHL--TTR----VQGTFGYLDLEYFRSS----------Q-FTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKS 144 (253)
Q Consensus 83 ~~~~~~~~--~~~----~~~~~~y~aPE~~~~~----------~-~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~ 144 (253)
+......+ ... ......|+|||.+... . .+++=||||+||+++|+++ |+++|.-..-
T Consensus 170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL----- 244 (1431)
T KOG1240|consen 170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL----- 244 (1431)
T ss_pred ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH-----
Confidence 53322221 111 1123479999998642 1 4578899999999999988 7888843111
Q ss_pred hHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 145 LAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ....++ ..........+ +...+++++..|++.||.+|.++++.++.
T Consensus 245 -~----aYr~~~---~~~~e~~Le~I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 245 -L----AYRSGN---ADDPEQLLEKI---EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred -H----hHhccC---ccCHHHHHHhC---cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0 000000 00001111111 12257889999999999999999999877
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.1e-17 Score=134.22 Aligned_cols=193 Identities=26% Similarity=0.339 Sum_probs=138.8
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC-ceEEcccCCcc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF-RAKISDFGASR 81 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~-~~kl~Dfgl~~ 81 (253)
+++++++.++++.+++........+.......++.|++.++.|+|..+ ++|||+||+||+++..+ .+++.|||.+.
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~ 150 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAK 150 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence 789999999999977765431124889999999999999999999999 99999999999999888 79999999987
Q ss_pred cccCCCcc-----eeeeccccccccccchhcc---CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHH
Q 044510 82 YVTIDQTH-----LTTRVQGTFGYLDLEYFRS---SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAM 153 (253)
Q Consensus 82 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 153 (253)
........ ......++..|++||...+ ..++...|+|++|++++++++|..||...... ..........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~ 227 (384)
T COG0515 151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKII 227 (384)
T ss_pred ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHH
Confidence 54432221 2345678999999999987 46789999999999999999999997665431 0001111111
Q ss_pred hhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 154 KENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...... .................+.+++..|+..+|..|.+..+....
T Consensus 228 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 228 LELPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HhcCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111110 000000000001223457779999999999999998887765
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.6e-18 Score=131.77 Aligned_cols=181 Identities=19% Similarity=0.321 Sum_probs=134.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEc--ccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKIS--DFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~--Dfgl 79 (253)
+.+|..|++.|+|..+++... .......++.+++.+++.|+.|||+.... |.--.++...|+++++.+.+|. |--+
T Consensus 262 lv~isq~mp~gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad~kf 339 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMADTKF 339 (448)
T ss_pred ceEeeeeccchHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheeccccee
Confidence 478999999999999998764 33467778999999999999999987632 4455688999999988776653 3222
Q ss_pred cccccCCCcceeeeccccccccccchhccCCC---CCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQF---TKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
+. +. ....-.|.|++||.+...+- -.++|+|||.+++||+.|...||....+.+...
T Consensus 340 sf----qe----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm------------ 399 (448)
T KOG0195|consen 340 SF----QE----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM------------ 399 (448)
T ss_pred ee----ec----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh------------
Confidence 11 11 11123678999999986542 368999999999999999999998877654221
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhch
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 207 (253)
.+.-..++..++...+....+++.-|++.||.+||.++.++-.|+++.
T Consensus 400 ---kialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 400 ---KIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ---hhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 111223333445555566778999999999999999999998888754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.2e-18 Score=143.76 Aligned_cols=160 Identities=26% Similarity=0.309 Sum_probs=127.2
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
+++++|..||.|...+.... .+.+.........++.++.++|..+ ++|+|+|++||+++.+|.+++.|||+++.
T Consensus 73 ~l~ld~~rgg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske 146 (612)
T KOG0603|consen 73 YLILDFLRGGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKE 146 (612)
T ss_pred hHhhhhcccchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhH
Confidence 56788888888888877654 4777778888889999999999999 99999999999999999999999999886
Q ss_pred ccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccchh
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDML 162 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (253)
.-..... +|+..|||||+.+ ....+.|.||||++.++|++|..||... ...+.+..
T Consensus 147 ~v~~~~~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~----------~~~~Il~~------- 202 (612)
T KOG0603|consen 147 AVKEKIA-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD----------TMKRILKA------- 202 (612)
T ss_pred hHhhhhc-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH----------HHHHHhhh-------
Confidence 5432222 6899999999999 4578899999999999999999999761 11111111
Q ss_pred chhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 044510 163 DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTM 196 (253)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~ 196 (253)
....+.+....+.+++..++..+|..|.-.
T Consensus 203 ----~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 203 ----ELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred ----ccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 122455566677888999999999998543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-17 Score=147.81 Aligned_cols=140 Identities=26% Similarity=0.318 Sum_probs=108.6
Q ss_pred HHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcccccCCC--------------cceeeecccccccccc
Q 044510 38 EVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQ--------------THLTTRVQGTFGYLDL 103 (253)
Q Consensus 38 ~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~~~~~~--------------~~~~~~~~~~~~y~aP 103 (253)
+++.+++|+|..+ |+|||+||+|.+|+.-|.+|+.|||+++...... ....+..+|||.|+||
T Consensus 151 dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaP 227 (1205)
T KOG0606|consen 151 DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAP 227 (1205)
T ss_pred hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccCh
Confidence 3478899999999 9999999999999999999999999987553221 1123346799999999
Q ss_pred chhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHH
Q 044510 104 EYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAK 183 (253)
Q Consensus 104 E~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 183 (253)
|+.....|...+|.|++|+++|+.+.|..||.+.++++.-... .. +.....+.......++++++.
T Consensus 228 eVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v---is-----------d~i~wpE~dea~p~Ea~dli~ 293 (1205)
T KOG0606|consen 228 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV---IS-----------DDIEWPEEDEALPPEAQDLIE 293 (1205)
T ss_pred hhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh---hh-----------hhccccccCcCCCHHHHHHHH
Confidence 9999889999999999999999999999999888776521111 00 011111223344456888999
Q ss_pred HhcccCCCCCC
Q 044510 184 RCLNLNGRKRP 194 (253)
Q Consensus 184 ~cl~~dP~~Rp 194 (253)
+.|+.+|..|-
T Consensus 294 ~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 294 QLLRQNPLCRL 304 (1205)
T ss_pred HHHHhChHhhc
Confidence 99999999994
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.4e-15 Score=133.54 Aligned_cols=124 Identities=24% Similarity=0.266 Sum_probs=107.7
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec-------CCCceEEc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD-------DKFRAKIS 75 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~-------~~~~~kl~ 75 (253)
++|+||.+.|+|.++++..+ .+++..+..+..|++..+.+||..+ |||+||||+|.++. ++..++|+
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~---~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNK---VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeeccccccHHHhhccCC---CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 68999999999999998544 5999999999999999999999999 99999999999993 34568999
Q ss_pred ccCCcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCC
Q 044510 76 DFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQK 132 (253)
Q Consensus 76 Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~ 132 (253)
|||.+..+...... ..+...+|-.+-++|...|.+++...|.|.++.+++-|+.|+.
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99988766443332 4455667888999999999999999999999999999999875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.4e-15 Score=125.48 Aligned_cols=94 Identities=17% Similarity=0.070 Sum_probs=72.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCC-CCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDI-KSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl-~~~nili~~~~~~kl~Dfgl~ 80 (253)
.|+||||++|++|... .. .. ...++.+++++|.|||..| |+|||| ||+||+++.++.++|+|||++
T Consensus 93 ~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred cEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 4899999999999732 11 11 1457889999999999999 999999 999999998899999999999
Q ss_pred ccccCCCcce-------eeeccccccccccchhcc
Q 044510 81 RYVTIDQTHL-------TTRVQGTFGYLDLEYFRS 108 (253)
Q Consensus 81 ~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~ 108 (253)
+.+....... .....+++.|.+||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 8764322111 124557778899998853
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=4.8e-15 Score=112.02 Aligned_cols=123 Identities=15% Similarity=0.080 Sum_probs=90.3
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCC-CCCceeecCCCceEEcccCCcc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDI-KSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl-~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++|||+.|.+|.+.+.. ....++.+++.+|.++|..| |+|||| ||+||+++.++.++|+|||++.
T Consensus 74 ~lvmeyI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~ 140 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAV 140 (218)
T ss_pred EEEEeeecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCce
Confidence 799999999988654321 11346779999999999999 999999 7999999999999999999998
Q ss_pred cccCCCcc----e--------eeeccccccccccchhccC-CCC-CCCCeehhHHHHHHHHhCCCCCCCCC
Q 044510 82 YVTIDQTH----L--------TTRVQGTFGYLDLEYFRSS-QFT-KKGDVYSFGVVFVGLLTGQKPIRSTD 138 (253)
Q Consensus 82 ~~~~~~~~----~--------~~~~~~~~~y~aPE~~~~~-~~~-~~~Di~slG~~l~~lltg~~pf~~~~ 138 (253)
........ . ......++.|+.|+...-. ..+ .+.+.++.|+-+|.++|+..+.-+..
T Consensus 141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 65432210 0 0011246777878765432 233 55677899999999999988765443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=8.2e-15 Score=111.14 Aligned_cols=74 Identities=19% Similarity=0.199 Sum_probs=63.2
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhH-hhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYL-HSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|||||+.|+++........ +++...+..++.|++.+|.++ |..| ++||||||+||+++ ++.++|+|||++.
T Consensus 93 ~iVmE~i~g~~l~~~~~~~~---~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v~LiDFG~a~ 165 (190)
T cd05147 93 VLVMEFIGDDGWAAPRLKDA---PLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKLYIIDVSQSV 165 (190)
T ss_pred EEEEEEeCCCCCcchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcEEEEEccccc
Confidence 79999998877765533222 588999999999999999999 7999 99999999999998 4789999999986
Q ss_pred cc
Q 044510 82 YV 83 (253)
Q Consensus 82 ~~ 83 (253)
..
T Consensus 166 ~~ 167 (190)
T cd05147 166 EH 167 (190)
T ss_pred cC
Confidence 43
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.9e-15 Score=114.66 Aligned_cols=98 Identities=13% Similarity=0.230 Sum_probs=74.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||++|.+|.++.. +++. .+.+++.++..+|..| ++|||++|.|+++++++ ++++|||...
T Consensus 118 ~~lvmEyi~G~tL~~~~~-------~~~~----~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~ 182 (232)
T PRK10359 118 YIMLIEYIEGVELNDMPE-------ISED----VKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKR 182 (232)
T ss_pred eEEEEEEECCccHHHhhh-------ccHH----HHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCcc
Confidence 479999999999988731 3332 4558999999999999 99999999999999888 9999999775
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHH
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGL 127 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 127 (253)
........ ..+.....+..+.|+|+||+++...
T Consensus 183 ~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 183 CTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred cccchhhH-------------HHHHHHhHhcccccccceeEeehHH
Confidence 44211100 1133445567889999999987754
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=3e-14 Score=108.30 Aligned_cols=75 Identities=20% Similarity=0.178 Sum_probs=63.1
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhh-CCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS-TTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
|+||||++|+++........ .++...+..++.+++.++.++|. .| ++||||||+||+++ ++.++|+|||++.
T Consensus 93 ~lVmE~~~g~~~~~~~l~~~---~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~~liDFG~a~ 165 (190)
T cd05145 93 VLVMEFIGDDGSPAPRLKDV---PLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKPYIIDVSQAV 165 (190)
T ss_pred EEEEEEecCCCchhhhhhhc---cCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCEEEEEcccce
Confidence 79999998875543322222 47888999999999999999999 99 99999999999999 7899999999987
Q ss_pred ccc
Q 044510 82 YVT 84 (253)
Q Consensus 82 ~~~ 84 (253)
...
T Consensus 166 ~~~ 168 (190)
T cd05145 166 ELD 168 (190)
T ss_pred ecC
Confidence 543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.4e-13 Score=106.43 Aligned_cols=180 Identities=16% Similarity=0.270 Sum_probs=119.7
Q ss_pred EEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 3 LLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++.||+..|+|.++|++.. ....+....-.+|+.||+.||.|||+.. ++++|+++..+.|++..++-+|++--.-.
T Consensus 148 iFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-PpiihgnlTc~tifiq~ngLIkig~~ap~- 225 (458)
T KOG1266|consen 148 IFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PPIIHGNLTCDTIFIQHNGLIKIGSVAPD- 225 (458)
T ss_pred EEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-CccccCCcchhheeecCCceEEecccCcc-
Confidence 47899999999999998832 2235777888899999999999999987 56999999999999999988888542211
Q ss_pred cccCC----CcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 82 YVTID----QTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 82 ~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
.+... ...-.....+.++|-+||.=...+...++|||+||....+|..+..--..... . ..... ...+.
T Consensus 226 s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS-~-~~~ee-----~ia~~ 298 (458)
T KOG1266|consen 226 STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSES-K-VEVEE-----NIANV 298 (458)
T ss_pred ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcc-e-eehhh-----hhhhh
Confidence 11100 00011112346788888887666778899999999999999776542111100 0 00000 00000
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 203 (253)
....-++ .-+.++.+|++..|+.||++.+++.+.
T Consensus 299 i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 299 IIGLENG------------LQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred eeeccCc------------cccCcCcccccCCCCCCcchhhhhcCc
Confidence 1111011 123389999999999999999988764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.5e-14 Score=125.43 Aligned_cols=183 Identities=25% Similarity=0.297 Sum_probs=134.6
Q ss_pred CEEEEeecCCCChhHHh-hccCCCCCCCHHHHHHHHHHHHHHHHhHh-hCCCCCeEecCCCCCceeecCCC-ceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYI-HDQTEEFTITWEISLRIAVEVSGALSYLH-STTSIPIYHRDIKSANILLDDKF-RAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l-~~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~~i~H~dl~~~nili~~~~-~~kl~Dfg 78 (253)
.+++++|..|+++.+.+ ..... ..+...+...+.|+..++.|+| ..+ +.|+|+||+|.+++.++ ..++.|||
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~ 170 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFG 170 (601)
T ss_pred cccccCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCch
Confidence 47889999999999988 33221 3566677788899999999999 888 99999999999999998 99999999
Q ss_pred CcccccC-CC-cceeeeccc-cccccccchhccCC-CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHh
Q 044510 79 ASRYVTI-DQ-THLTTRVQG-TFGYLDLEYFRSSQ-FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK 154 (253)
Q Consensus 79 l~~~~~~-~~-~~~~~~~~~-~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 154 (253)
++..+.. +. ........| ++.|++||...+.. ..+..|+||.|+++..+++|..|+........... . ..
T Consensus 171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~-~-----~~ 244 (601)
T KOG0590|consen 171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS-S-----WK 244 (601)
T ss_pred hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce-e-----ec
Confidence 9987765 22 223344567 99999999999754 46889999999999999999999876654431110 0 00
Q ss_pred hccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044510 155 ENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAF 201 (253)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 201 (253)
..+.. ..............+++.+++..+|..|.+.+++..
T Consensus 245 ~~~~~------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 245 SNKGR------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccccc------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00000 000111222335667899999999999999887764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.8e-11 Score=100.06 Aligned_cols=183 Identities=16% Similarity=0.167 Sum_probs=128.1
Q ss_pred CCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcccccCCCcceeeeccccccccccc
Q 044510 25 FTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLE 104 (253)
Q Consensus 25 ~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE 104 (253)
....|...++.++.++.+...||..| .+-+|++++|+++++++.|.|.|-...... .........+|..+|.+||
T Consensus 112 P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~--~ng~~~~cpVg~~eftPPE 186 (637)
T COG4248 112 PHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN--ANGTLHLCPVGVSEFTPPE 186 (637)
T ss_pred CccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec--cCCceEecccCccccCCHH
Confidence 35889999999999999999999999 889999999999999999999987655443 2333445577899999999
Q ss_pred hhc-----cCCCCCCCCeehhHHHHHHHHhC-CCCCCCCChhh-hhhhHHHHHHHHhhccc------cchhchhhhhhhc
Q 044510 105 YFR-----SSQFTKKGDVYSFGVVFVGLLTG-QKPIRSTDTEE-DKSLAGYFLRAMKENCL------FDMLDAQVLKEAK 171 (253)
Q Consensus 105 ~~~-----~~~~~~~~Di~slG~~l~~lltg-~~pf~~~~~~~-~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~ 171 (253)
.-. +-.-+...|.|.+|+++++++.| .+||.+-.... .....+ ..+..+.. ..-..+.......
T Consensus 187 lQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia~g~f~ya~~~~~g~~p~P~~~P~ 263 (637)
T COG4248 187 LQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIAHGRFAYASDQRRGLKPPPRSIPL 263 (637)
T ss_pred HhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhhcceeeechhccCCCCCCCCCCCh
Confidence 865 23346789999999999999885 99997743211 111110 00010100 0011111111122
Q ss_pred HHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHHhhchhhcCCCCC
Q 044510 172 EEEIITVAMLAKRCLNL--NGRKRPTMKEVAFELGGIRASIGPQNC 215 (253)
Q Consensus 172 ~~~~~~~~~li~~cl~~--dP~~Rps~~~l~~~l~~~~~~~~~~~~ 215 (253)
...++.+..+..+|+.. .+.-||+++.++..|.++.+++..+..
T Consensus 264 ~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v 309 (637)
T COG4248 264 SMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTV 309 (637)
T ss_pred hhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhh
Confidence 23445677788899873 366899999999999999998766543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.30 E-value=5.5e-12 Score=98.91 Aligned_cols=76 Identities=21% Similarity=0.188 Sum_probs=62.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+.|++|........ .+....+..++.|++.++.+||..|. ++|+||||+||+++ ++.++|+|||.+.
T Consensus 123 ~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NIli~-~~~i~LiDFg~a~ 196 (237)
T smart00090 123 NVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNILVH-DGKVVIIDVSQSV 196 (237)
T ss_pred ceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhEEEE-CCCEEEEEChhhh
Confidence 379999999988876543322 35666778999999999999998873 99999999999999 7899999999876
Q ss_pred cc
Q 044510 82 YV 83 (253)
Q Consensus 82 ~~ 83 (253)
..
T Consensus 197 ~~ 198 (237)
T smart00090 197 EL 198 (237)
T ss_pred cc
Confidence 43
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.1e-11 Score=97.32 Aligned_cols=69 Identities=22% Similarity=0.340 Sum_probs=58.7
Q ss_pred EEEEeecCC-CChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 3 LLVYEFIPN-GTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 3 ~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
++|||+++| .+|.+++... .++... +.+++.+|.+||..| |+|+||||.||+++.++.++|+|||.+.
T Consensus 122 ~lV~e~l~G~~~L~~~l~~~----~l~~~~----~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 122 DILIERIEGARDLVALLQEA----PLSEEQ----WQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred eEEEEecCCCCCHHHHHhcC----CCCHHH----HHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 599999997 6899888643 255443 468999999999999 9999999999999988899999999876
Q ss_pred c
Q 044510 82 Y 82 (253)
Q Consensus 82 ~ 82 (253)
.
T Consensus 191 ~ 191 (239)
T PRK01723 191 L 191 (239)
T ss_pred c
Confidence 4
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.2e-11 Score=94.72 Aligned_cols=70 Identities=26% Similarity=0.244 Sum_probs=59.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||++|++|..+... .....++.+++.++.++|..+ ++|+||+|.||+++.++.++|+|||.+.
T Consensus 106 ~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~liDfg~~~ 173 (198)
T cd05144 106 HAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIYIIDWPQMV 173 (198)
T ss_pred ceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEEEEECCccc
Confidence 4799999999998765421 234567889999999999999 9999999999999999999999999886
Q ss_pred cc
Q 044510 82 YV 83 (253)
Q Consensus 82 ~~ 83 (253)
..
T Consensus 174 ~~ 175 (198)
T cd05144 174 ST 175 (198)
T ss_pred cC
Confidence 44
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.6e-11 Score=93.64 Aligned_cols=70 Identities=26% Similarity=0.447 Sum_probs=61.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||++|++|.+++.... . ....++.+++.+|.++|..+ ++|+|++|.||+++ ++.++|+|||.+.
T Consensus 74 ~~lv~e~~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred CEEEEEEeCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCccc
Confidence 378999999999999986432 2 77889999999999999999 99999999999999 7889999999875
Q ss_pred c
Q 044510 82 Y 82 (253)
Q Consensus 82 ~ 82 (253)
.
T Consensus 143 ~ 143 (211)
T PRK14879 143 F 143 (211)
T ss_pred C
Confidence 3
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.6e-11 Score=93.00 Aligned_cols=68 Identities=19% Similarity=0.224 Sum_probs=54.2
Q ss_pred EEEEee--cCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHH-HhHhhCCCCCeEecCCCCCceeecC----CCceEEc
Q 044510 3 LLVYEF--IPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGAL-SYLHSTTSIPIYHRDIKSANILLDD----KFRAKIS 75 (253)
Q Consensus 3 ~lv~e~--~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l-~~lh~~~~~~i~H~dl~~~nili~~----~~~~kl~ 75 (253)
.+|+|| +.+++|.+++.+. .+++. ..++.+++.++ .|||+.+ |+||||||+||+++. +..++|+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEE
Confidence 378999 5579999999663 25555 35677888777 9999999 999999999999974 3479999
Q ss_pred ccCC
Q 044510 76 DFGA 79 (253)
Q Consensus 76 Dfgl 79 (253)
|++.
T Consensus 152 Dg~G 155 (210)
T PRK10345 152 DNIG 155 (210)
T ss_pred ECCC
Confidence 9543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.21 E-value=3e-11 Score=92.51 Aligned_cols=66 Identities=26% Similarity=0.449 Sum_probs=58.4
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
++||||++|++|.+++.... . .++.+++.+|.+||..+ ++|+|++|.||+++ ++.+++.|||++..
T Consensus 73 ~lv~e~~~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 73 TIVMEYIEGKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEEECCccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 79999999999999875432 1 67889999999999999 99999999999999 78999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.7e-11 Score=105.41 Aligned_cols=66 Identities=24% Similarity=0.410 Sum_probs=58.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||++|++|.+++. ....++.+++.+|.+||..+ ++|||+||+||++ .++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 379999999999998875 34568889999999999999 9999999999999 67799999999886
Q ss_pred c
Q 044510 82 Y 82 (253)
Q Consensus 82 ~ 82 (253)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 4
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.5e-11 Score=107.78 Aligned_cols=175 Identities=26% Similarity=0.313 Sum_probs=129.8
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
+++++|+.+++|...++..+ ....+.+...+..+++++++||... +.|+|++|.|.++..++..++.||+....
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred chhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence 68999999999999998765 3566666667778999999999987 89999999999999999999999972221
Q ss_pred cc-C-----C----------------------Cc--ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCC
Q 044510 83 VT-I-----D----------------------QT--HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQK 132 (253)
Q Consensus 83 ~~-~-----~----------------------~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~ 132 (253)
.. . . .. .......+|+.|++||...+.......|.|++|+++++.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 10 0 0 00 11223568999999999999888999999999999999999999
Q ss_pred CCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 044510 133 PIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMK 197 (253)
Q Consensus 133 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~ 197 (253)
||....+... +.++... .+ .....+...+....+++...+..+|.+|..+.
T Consensus 1034 p~na~tpq~~------f~ni~~~----~~----~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQI------FENILNR----DI----PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCcchhhh------hhccccC----CC----CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9987765431 1111111 11 11223344555677899999999999997765
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.8e-10 Score=87.27 Aligned_cols=73 Identities=22% Similarity=0.251 Sum_probs=58.0
Q ss_pred CEEEEeecCCCChhH-HhhccCCCCCCCHHHHHHHHHHHHHHHHhHhh-CCCCCeEecCCCCCceeecCCCceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYR-YIHDQTEEFTITWEISLRIAVEVSGALSYLHS-TTSIPIYHRDIKSANILLDDKFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~-~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl 79 (253)
+++||||++++++.. .+.... .. ..+..++.+++.++.++|. .+ ++|+||+|+||+++ ++.++++|||.
T Consensus 90 ~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~liDfg~ 160 (187)
T cd05119 90 HVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYIIDVPQ 160 (187)
T ss_pred CEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEEECcc
Confidence 479999999855432 122111 11 5677899999999999999 98 99999999999999 88999999998
Q ss_pred cccc
Q 044510 80 SRYV 83 (253)
Q Consensus 80 ~~~~ 83 (253)
+...
T Consensus 161 a~~~ 164 (187)
T cd05119 161 AVEI 164 (187)
T ss_pred cccc
Confidence 8644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.3e-10 Score=96.16 Aligned_cols=178 Identities=21% Similarity=0.258 Sum_probs=125.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHH----HHHhHhhCCCCCeEecCCCCCceeecCC-CceEEcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSG----ALSYLHSTTSIPIYHRDIKSANILLDDK-FRAKISD 76 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~----~l~~lh~~~~~~i~H~dl~~~nili~~~-~~~kl~D 76 (253)
.++-+|.| +.+|.++...-.. -++...++....+..+ ||.++|..+ ++|-|+||.||+...+ ..++++|
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred ceeeeccc-cchhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 46777888 6688877765321 2777888888888888 999999999 9999999999999998 8899999
Q ss_pred cCCcccccCCCcc----eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHH
Q 044510 77 FGASRYVTIDQTH----LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRA 152 (253)
Q Consensus 77 fgl~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 152 (253)
||+...+....-. ......+...|++||..+ +-++...|+|++|.++.+..++........... |..
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------W~~ 337 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS--------WSQ 337 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC--------ccc
Confidence 9988777654321 122335677899999998 457899999999999999888776654431111 000
Q ss_pred HhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 153 MKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..... ...+........+...+..+++.+|..|++...+.++
T Consensus 338 ~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 338 LRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 00000 0111111222345558899999999999998877644
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.5e-09 Score=80.86 Aligned_cols=74 Identities=20% Similarity=0.206 Sum_probs=57.1
Q ss_pred CEEEEeecCCCChh-HHhhccCCCCCCCHHHHHHHHHHHHHHHHhH-hhCCCCCeEecCCCCCceeecCCCceEEcccCC
Q 044510 2 PLLVYEFIPNGTLY-RYIHDQTEEFTITWEISLRIAVEVSGALSYL-HSTTSIPIYHRDIKSANILLDDKFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~-~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl 79 (253)
.+|||||+.++.+. ..+.+. .++.+....+..+++.+|..| |..+ ++|+|+++.||++.+ +.+.|+|||.
T Consensus 99 ~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~NIL~~~-~~v~iIDF~q 170 (197)
T cd05146 99 HVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYNMLWHD-GKVWFIDVSQ 170 (197)
T ss_pred CEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEC-CcEEEEECCC
Confidence 37999999664342 223221 255566677889999999998 8999 999999999999974 6899999998
Q ss_pred cccc
Q 044510 80 SRYV 83 (253)
Q Consensus 80 ~~~~ 83 (253)
+...
T Consensus 171 av~~ 174 (197)
T cd05146 171 SVEP 174 (197)
T ss_pred ceeC
Confidence 7654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.9e-10 Score=98.11 Aligned_cols=155 Identities=19% Similarity=0.196 Sum_probs=105.0
Q ss_pred HHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcccccCCCccee--------eeccccccccc
Q 044510 31 ISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLT--------TRVQGTFGYLD 102 (253)
Q Consensus 31 ~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~~~~~~~~~~--------~~~~~~~~y~a 102 (253)
....=+.+++.|+.++|..-. +||++|.|++|.++.++..|++.|+.+........... ........|.+
T Consensus 100 ~~f~nl~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~a 177 (700)
T KOG2137|consen 100 DGFANLGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLA 177 (700)
T ss_pred HhhhhhhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCccccc
Confidence 333445677899999997653 99999999999999999999999987765433111111 11223568999
Q ss_pred cchhccCCCCCCCCeehhHHHHHHHH-hCCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHH
Q 044510 103 LEYFRSSQFTKKGDVYSFGVVFVGLL-TGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAML 181 (253)
Q Consensus 103 PE~~~~~~~~~~~Di~slG~~l~~ll-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 181 (253)
||++.+.....++|+||+|+++|.+. .|+..+............ ...+.........+.+.++++-
T Consensus 178 pE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-------------~~~~~~~~~~~s~~~p~el~~~ 244 (700)
T KOG2137|consen 178 PEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-------------RNLLNAGAFGYSNNLPSELRES 244 (700)
T ss_pred chhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-------------hcccccccccccccCcHHHHHH
Confidence 99999877889999999999999887 455555443221110000 0011111112234555678889
Q ss_pred HHHhcccCCCCCCCHHHHH
Q 044510 182 AKRCLNLNGRKRPTMKEVA 200 (253)
Q Consensus 182 i~~cl~~dP~~Rps~~~l~ 200 (253)
+.+++..++..||++.++.
T Consensus 245 l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 245 LKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHHHhcCCcccCcchhhhh
Confidence 9999999999999776654
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.6e-09 Score=76.80 Aligned_cols=71 Identities=30% Similarity=0.368 Sum_probs=57.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.+++|||+.|+.+..+ +......++.+++.++.++|......++|+|++|.||++++.+.+++.||+.+.
T Consensus 68 ~~~v~e~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 68 SYLLMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred cEEEEEecCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 5899999988776654 345556778899999999998532239999999999999998999999999875
Q ss_pred c
Q 044510 82 Y 82 (253)
Q Consensus 82 ~ 82 (253)
.
T Consensus 138 ~ 138 (155)
T cd05120 138 Y 138 (155)
T ss_pred C
Confidence 3
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.1e-08 Score=87.40 Aligned_cols=75 Identities=17% Similarity=0.223 Sum_probs=58.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHH-HHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSG-ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~-~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.++||||++|++|.++...... ... ...++..++. .+..+|..| ++|+|++|.||+++.++.++++|||++
T Consensus 233 ~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~ 304 (437)
T TIGR01982 233 RVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIV 304 (437)
T ss_pred ceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCe
Confidence 3699999999999887653211 122 2345555555 478889999 999999999999999999999999988
Q ss_pred cccc
Q 044510 81 RYVT 84 (253)
Q Consensus 81 ~~~~ 84 (253)
....
T Consensus 305 ~~l~ 308 (437)
T TIGR01982 305 GRLS 308 (437)
T ss_pred eECC
Confidence 6553
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.7e-08 Score=74.26 Aligned_cols=66 Identities=27% Similarity=0.433 Sum_probs=55.8
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
.|+|||++|..|.+.+... ...++..+-.-+.-||..| |+|+|+.++|+++...+ +.++||||+..
T Consensus 75 ~I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 75 LIVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 4899999999999898764 1345667777788899999 99999999999999874 99999999853
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.7e-08 Score=79.27 Aligned_cols=75 Identities=17% Similarity=0.225 Sum_probs=62.3
Q ss_pred EEEEeecCCC-ChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC-------CCceEE
Q 044510 3 LLVYEFIPNG-TLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD-------KFRAKI 74 (253)
Q Consensus 3 ~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~-------~~~~kl 74 (253)
++|||++++. +|.+++..... ..........++.+++..+..||..| ++|+|+++.||+++. +..+.+
T Consensus 111 ~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~L 186 (268)
T PRK15123 111 FIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSV 186 (268)
T ss_pred EEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEE
Confidence 6999999886 89999864211 13566777889999999999999999 999999999999974 467899
Q ss_pred cccCCcc
Q 044510 75 SDFGASR 81 (253)
Q Consensus 75 ~Dfgl~~ 81 (253)
+||+.+.
T Consensus 187 IDl~r~~ 193 (268)
T PRK15123 187 IDLHRAQ 193 (268)
T ss_pred EECCccc
Confidence 9999764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.7e-09 Score=89.87 Aligned_cols=177 Identities=20% Similarity=0.264 Sum_probs=117.9
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC-CceEEcccCCcc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK-FRAKISDFGASR 81 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~-~~~kl~Dfgl~~ 81 (253)
|+=.|||+++++...+.-.. .+.+...+++..|++.++.++|+.. ++|+|++|.||++..+ +..+++||+...
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~---~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQ---MLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhhHHHH---hcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 34568998888876663322 4778888999999999999999998 9999999999999876 788999999875
Q ss_pred cccCCCcceeeeccccccc-cccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGY-LDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y-~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
... .........+..| .+++......+..+.|+++||..+.+.+++..--...... ..+..+..
T Consensus 416 ~~~---~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~----------~~i~~~~~-- 480 (524)
T KOG0601|consen 416 RLA---FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS----------LTIRSGDT-- 480 (524)
T ss_pred ccc---eecccccccccccccchhhccccccccccccccccccccccccCcccCcccccc----------eeeecccc--
Confidence 311 0111111122233 3455555566788999999999999988876532221110 00000101
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRA 208 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 208 (253)
...+... ..+..+...++..++..||.+.++..+.+...+
T Consensus 481 -------p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 481 -------PNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred -------cCCCchH-HhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 1111111 356668889999999999999988877665544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.71 E-value=2.2e-08 Score=74.45 Aligned_cols=68 Identities=26% Similarity=0.346 Sum_probs=52.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCC--CCCeEecCCCCCceeecCCCceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTT--SIPIYHRDIKSANILLDDKFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~~i~H~dl~~~nili~~~~~~kl~Dfgl 79 (253)
.++||||++|.++.+. . .. ...++.+++.+|..||..+ ...++|+|++|.||+++ ++.++++||+.
T Consensus 66 ~~lv~e~i~G~~l~~~--~------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~ 133 (170)
T cd05151 66 GVLITEFIEGSELLTE--D------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY 133 (170)
T ss_pred CeEEEEecCCCccccc--c------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence 3789999999887643 0 11 1234568999999999887 11249999999999999 56899999997
Q ss_pred cc
Q 044510 80 SR 81 (253)
Q Consensus 80 ~~ 81 (253)
+.
T Consensus 134 a~ 135 (170)
T cd05151 134 AG 135 (170)
T ss_pred cc
Confidence 64
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.69 E-value=5.8e-08 Score=74.68 Aligned_cols=74 Identities=23% Similarity=0.388 Sum_probs=63.4
Q ss_pred EEEEeecCCC-ChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC---ceEEcccC
Q 044510 3 LLVYEFIPNG-TLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF---RAKISDFG 78 (253)
Q Consensus 3 ~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~---~~kl~Dfg 78 (253)
++|+|++++. +|.+++..... .+......++.+++..+.-||..| ++|+|+++.|||+..++ .+.++||+
T Consensus 93 ~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld 166 (206)
T PF06293_consen 93 YLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLD 166 (206)
T ss_pred EEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcch
Confidence 6899999884 79999876432 566677889999999999999999 99999999999999876 79999998
Q ss_pred Cccc
Q 044510 79 ASRY 82 (253)
Q Consensus 79 l~~~ 82 (253)
.++.
T Consensus 167 ~~~~ 170 (206)
T PF06293_consen 167 RMRF 170 (206)
T ss_pred hcee
Confidence 6653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=9.4e-08 Score=71.97 Aligned_cols=72 Identities=29% Similarity=0.374 Sum_probs=47.6
Q ss_pred EEEEeecC--CCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHh-HhhCCCCCeEecCCCCCceeecCCCceEEcccCC
Q 044510 3 LLVYEFIP--NGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSY-LHSTTSIPIYHRDIKSANILLDDKFRAKISDFGA 79 (253)
Q Consensus 3 ~lv~e~~~--~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~-lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl 79 (253)
+|||||+. |..+..+.... ++.+....++.+++..+.. +|..| ++|+|+.+.||+++++ .+.++|||.
T Consensus 82 ~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 82 VIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp EEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--GTT
T ss_pred EEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEecCc
Confidence 69999998 54454433221 2233445566677775554 57999 9999999999999988 999999998
Q ss_pred cccc
Q 044510 80 SRYV 83 (253)
Q Consensus 80 ~~~~ 83 (253)
+...
T Consensus 153 av~~ 156 (188)
T PF01163_consen 153 AVDS 156 (188)
T ss_dssp EEET
T ss_pred ceec
Confidence 7644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=4.3e-07 Score=66.94 Aligned_cols=76 Identities=28% Similarity=0.365 Sum_probs=58.8
Q ss_pred EEEEeecCC-CChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC---ceEEcccC
Q 044510 3 LLVYEFIPN-GTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF---RAKISDFG 78 (253)
Q Consensus 3 ~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~---~~kl~Dfg 78 (253)
.|+|||++| .++.+++...... ....+....++..|-+.+.-||..+ ++|+||..+||++.+++ .+.++|||
T Consensus 86 ~i~ME~~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfg 161 (229)
T KOG3087|consen 86 QIYMEFIDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFG 161 (229)
T ss_pred eEEEEeccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeec
Confidence 589999966 4788888764332 2333333678889999999999999 99999999999997554 34899999
Q ss_pred Cccc
Q 044510 79 ASRY 82 (253)
Q Consensus 79 l~~~ 82 (253)
++..
T Consensus 162 ls~~ 165 (229)
T KOG3087|consen 162 LSSV 165 (229)
T ss_pred chhc
Confidence 8753
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.3e-06 Score=74.29 Aligned_cols=115 Identities=16% Similarity=0.161 Sum_probs=77.3
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
|||+|-+ . -|..++.+. ....+...+.||+.||.+||..+. ++|+++..+.|+++..|.-||++|.+...
T Consensus 85 ylvTErV-~-Pl~~~lk~l------~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~ 154 (690)
T KOG1243|consen 85 YLVTERV-R-PLETVLKEL------GKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSK 154 (690)
T ss_pred EEEeecc-c-cHHHHHHHh------HHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEec
Confidence 6666665 2 455555543 355667778899999999985442 99999999999999999999999987643
Q ss_pred ccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhC
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTG 130 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg 130 (253)
...... ........-.|..|+...... -..|.|.|||++++++.|
T Consensus 155 ~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 155 ASGFNA-PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccCCc-ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 321111 111111112344554433221 345999999999999998
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.35 E-value=5.9e-07 Score=78.10 Aligned_cols=72 Identities=14% Similarity=0.110 Sum_probs=49.9
Q ss_pred EEEEeecCCCChhHHh--hccCC-CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC----ceEEc
Q 044510 3 LLVYEFIPNGTLYRYI--HDQTE-EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF----RAKIS 75 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l--~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~----~~kl~ 75 (253)
+|||||++|+.+.++- ...+. ...+....+..++.| +...| ++|+|++|.||+++.++ ++++.
T Consensus 237 VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if~~G---ffHaDpHPGNIlv~~~g~~~~~i~ll 306 (537)
T PRK04750 237 VMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VFRDG---FFHADMHPGNIFVSYDPPENPRYIAL 306 (537)
T ss_pred eEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HHhCC---eeeCCCChHHeEEecCCCCCCeEEEE
Confidence 5999999999998742 22210 001333333333333 44577 99999999999999887 99999
Q ss_pred ccCCccccc
Q 044510 76 DFGASRYVT 84 (253)
Q Consensus 76 Dfgl~~~~~ 84 (253)
|||+.....
T Consensus 307 DFGivg~l~ 315 (537)
T PRK04750 307 DFGIVGSLN 315 (537)
T ss_pred ecceEEECC
Confidence 999876553
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.5e-06 Score=66.39 Aligned_cols=64 Identities=27% Similarity=0.391 Sum_probs=51.1
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
++||||++|..|.+... +++ .+...+++++.-||..| ++|+|..|.|++++++ .+++.||+..+
T Consensus 119 ~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 119 VLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred EEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECcccc
Confidence 58999999988776532 332 24456778899999999 9999999999998865 59999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.21 E-value=7e-06 Score=62.53 Aligned_cols=75 Identities=20% Similarity=0.158 Sum_probs=61.1
Q ss_pred EEEEeecCC-CChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCc--eEEcccCC
Q 044510 3 LLVYEFIPN-GTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFR--AKISDFGA 79 (253)
Q Consensus 3 ~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~--~kl~Dfgl 79 (253)
+||+|-+.| -+|.+++..... .+.+......++.+++..+.-||..| +.|+|+.+.||+++.++. ++++||.-
T Consensus 101 ~LVTe~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 101 LLVTEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EEEEEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 689998853 588888765321 14677777889999999999999999 999999999999986666 89999976
Q ss_pred cc
Q 044510 80 SR 81 (253)
Q Consensus 80 ~~ 81 (253)
++
T Consensus 177 ~r 178 (216)
T PRK09902 177 SR 178 (216)
T ss_pred cc
Confidence 54
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=4.6e-06 Score=65.35 Aligned_cols=69 Identities=22% Similarity=0.237 Sum_probs=50.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+.+||||++|--|...- +..+....++..|+.-+..+-..| ++|+|+++-||+++.+|.+.++||-.+.
T Consensus 182 HaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 182 HAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred ceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEEEeCcccc
Confidence 46899999886665432 122333344555555555555778 9999999999999999999999997654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.14 E-value=7.2e-06 Score=63.54 Aligned_cols=76 Identities=20% Similarity=0.234 Sum_probs=57.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCC-------------------------------
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTT------------------------------- 50 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~------------------------------- 50 (253)
.++||||++|.++.+.+.. ..+++.....++.+++..|..||+..
T Consensus 75 ~~~v~e~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (223)
T cd05154 75 PFYVMERVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASR 150 (223)
T ss_pred ceEEEEEeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhc
Confidence 4899999999988776532 13666777777778888888887421
Q ss_pred ----------------------CCCeEecCCCCCceeecC--CCceEEcccCCcc
Q 044510 51 ----------------------SIPIYHRDIKSANILLDD--KFRAKISDFGASR 81 (253)
Q Consensus 51 ----------------------~~~i~H~dl~~~nili~~--~~~~kl~Dfgl~~ 81 (253)
...++|+|+.+.||+++. ++.+.|+||+.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 151 TDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred ccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 134799999999999998 5668899998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.09 E-value=0.00011 Score=62.70 Aligned_cols=110 Identities=25% Similarity=0.431 Sum_probs=81.0
Q ss_pred CEEEEeecCC-CChhHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPN-GTLYRYIHDQT------------EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~-~sL~~~l~~~~------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
.++|++|.++ ++|.++--... .....+++..|.++.|+..||.++|+.| +.-+-+.+.+|++++
T Consensus 352 lvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G 428 (655)
T KOG3741|consen 352 LVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTG 428 (655)
T ss_pred EEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeC
Confidence 3789999985 57766643321 1224788999999999999999999999 888999999999999
Q ss_pred CCceEEcccCCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCC
Q 044510 69 KFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQK 132 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~ 132 (253)
+.+++|...|..-....+. . |.+.+ ..+-|.-.||.++..|.||..
T Consensus 429 ~~RIriS~C~i~Dvl~~d~-------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 429 KMRIRISGCGIMDVLQEDP-------------T--EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred cceEEEecccceeeecCCC-------------C--cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 9999998887654332111 0 11111 123477789999999999854
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.93 E-value=3.4e-05 Score=59.92 Aligned_cols=74 Identities=20% Similarity=0.246 Sum_probs=53.9
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhh-CCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS-TTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|||||+.. . ..-.......++....+..+..++++.+.-|-. .+ +||+||+.-|||+. ++.+.++|++.+.
T Consensus 142 VLvMEfIg~-~--g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV 214 (268)
T COG1718 142 VLVMEFIGD-D--GLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAV 214 (268)
T ss_pred eEEEEeccC-C--CCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeEEEEECcccc
Confidence 689999943 3 111111122234444677777888888888887 77 99999999999999 7799999999876
Q ss_pred cc
Q 044510 82 YV 83 (253)
Q Consensus 82 ~~ 83 (253)
..
T Consensus 215 ~~ 216 (268)
T COG1718 215 TI 216 (268)
T ss_pred cc
Confidence 44
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00023 Score=53.80 Aligned_cols=80 Identities=23% Similarity=0.314 Sum_probs=61.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|.||...+++...-....+....+|..+.+++.++++.+.+++....-.+.-.|++++|+-++.++++|+.|.....
T Consensus 31 ~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 31 RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 36789999877665321111111247899999999999999999997433238899999999999999999999997543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00047 Score=64.16 Aligned_cols=166 Identities=16% Similarity=0.175 Sum_probs=108.2
Q ss_pred EEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCC---ceeecCCCceEEc--ccCC
Q 044510 5 VYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA---NILLDDKFRAKIS--DFGA 79 (253)
Q Consensus 5 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~---nili~~~~~~kl~--Dfgl 79 (253)
..|+|..-++.+.+.... .++......+..++..||.|+|... +.|.-+... +--++..+.+..+ ||+.
T Consensus 264 ~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~s 337 (1351)
T KOG1035|consen 264 LQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDS 337 (1351)
T ss_pred HHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHHHhc---cceeEEecccccccccCccceeecchhhhcc
Confidence 346777778888877654 4888899999999999999999886 666655555 4444555666666 8877
Q ss_pred cccccCCCcceeeeccccccccccchhccCCC--CCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQF--TKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
++......... .......+.++|....... +...|+|.+|.....+..|..+-.....
T Consensus 338 s~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~------------------ 397 (1351)
T KOG1035|consen 338 SKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV------------------ 397 (1351)
T ss_pred cccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc------------------
Confidence 66544322211 1223445667777765443 4457999999999998887654211110
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
. ....... ......+...+|+..++.+|+++.+++.+.-
T Consensus 398 ~-----~~~l~~~---~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 398 P-----VSLLDVL---STSELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred h-----hhhhccc---cchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 0 0000000 0013555889999999999999999997753
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0018 Score=56.41 Aligned_cols=74 Identities=23% Similarity=0.238 Sum_probs=52.3
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHH-HHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGA-LSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~-l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+|||++|-.+.+...-... ++..+.+ +..++.+ +..+-..| +.|+|..|.||++..++++.+.|||+..
T Consensus 242 VLtmE~i~Gi~i~d~~~l~~~--g~d~k~i---a~~~~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g 313 (517)
T COG0661 242 VLTMEWIDGIKISDIAALKSA--GIDRKEL---AELLVRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVG 313 (517)
T ss_pred EEEEEeeCCEecccHHHHHhc--CCCHHHH---HHHHHHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCccee
Confidence 689999999888887432211 2443333 2233332 34444567 9999999999999999999999999876
Q ss_pred ccc
Q 044510 82 YVT 84 (253)
Q Consensus 82 ~~~ 84 (253)
...
T Consensus 314 ~l~ 316 (517)
T COG0661 314 RLD 316 (517)
T ss_pred cCC
Confidence 544
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.0073 Score=52.73 Aligned_cols=74 Identities=20% Similarity=0.238 Sum_probs=51.6
Q ss_pred CEEEEeecCCCChhHHh--hccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC----CCceEEc
Q 044510 2 PLLVYEFIPNGTLYRYI--HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD----KFRAKIS 75 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l--~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~----~~~~kl~ 75 (253)
.+|+|||++|..+.|+- ... .++...+..-+.+.. +..|-..| ++|+|--|.||++.+ +..+.+.
T Consensus 277 RVLtME~~~G~~i~Dl~~i~~~----gi~~~~i~~~l~~~~--~~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivll 347 (538)
T KOG1235|consen 277 RVLTMEYVDGIKINDLDAIDKR----GISPHDILNKLVEAY--LEQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLL 347 (538)
T ss_pred eEEEEEecCCccCCCHHHHHHc----CCCHHHHHHHHHHHH--HHHHHhcC---CccCCCCCCcEEEecCCCCCccEEEE
Confidence 37999999998876653 333 366554444333332 23344567 999999999999984 6689999
Q ss_pred ccCCccccc
Q 044510 76 DFGASRYVT 84 (253)
Q Consensus 76 Dfgl~~~~~ 84 (253)
|||+.....
T Consensus 348 DhGl~~~is 356 (538)
T KOG1235|consen 348 DHGLYAVIS 356 (538)
T ss_pred ccccccccc
Confidence 999877554
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.0074 Score=47.36 Aligned_cols=29 Identities=28% Similarity=0.503 Sum_probs=24.6
Q ss_pred CeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 53 PIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 53 ~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|+|+.+.||+++++...-|.||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 38999999999999877656799999654
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.00024 Score=67.94 Aligned_cols=131 Identities=12% Similarity=0.027 Sum_probs=91.7
Q ss_pred EEEEeecCCCChhHHhhccCCCCC-CCHHHHHHHHHHHHHHHHhHhhCCC--CCeEecCCCCCceeecCCCceEEcccCC
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFT-ITWEISLRIAVEVSGALSYLHSTTS--IPIYHRDIKSANILLDDKFRAKISDFGA 79 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~-~~~~~~~~i~~~i~~~l~~lh~~~~--~~i~H~dl~~~nili~~~~~~kl~Dfgl 79 (253)
|..++|+.+|.+.+.+.....+++ +...-+.....+.+....-+|.... --.+|+++++-|.+|..+..++++++|+
T Consensus 1307 ~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gL 1386 (2724)
T KOG1826|consen 1307 YIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGL 1386 (2724)
T ss_pred HHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccccc
Confidence 456788999999999987554433 3333333333333555555553321 1257999999999999999999999999
Q ss_pred cccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCC
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPI 134 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf 134 (253)
.++... .........+++.|+.+++.+.-.++.++|+|..|+.+|....|-.+|
T Consensus 1387 dKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1387 DKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred ccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 883221 112223355778899999998888888899999999999887666554
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.012 Score=46.36 Aligned_cols=30 Identities=23% Similarity=0.269 Sum_probs=25.7
Q ss_pred CCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 52 IPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 52 ~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+.++|+|+.+.||+++++..+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 348999999999999987778899998653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.0014 Score=57.59 Aligned_cols=123 Identities=22% Similarity=0.157 Sum_probs=82.5
Q ss_pred CEEEEeecCCC-ChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNG-TLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
++++++++.++ +........ ...+..-+...+.+.-..+++++|+.. -+|+| ||+... +..+..+|+..
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~s--e~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~ 378 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVS--EIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVP 378 (829)
T ss_pred cchhhhhhcCCccccccCChh--hHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCC
Confidence 46777777665 222222111 112333344566677788899999865 57888 665554 58899999876
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCC
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRS 136 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~ 136 (253)
..... ........+++.+++||+.....+..+.|.|+++.-..++.-|.+|-..
T Consensus 379 ~~L~~--~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 379 PQLTR--TMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred cccCc--ccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 54432 1133446689999999999988899999999999877777777766543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.034 Score=43.43 Aligned_cols=28 Identities=21% Similarity=0.248 Sum_probs=24.5
Q ss_pred CeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 53 PIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 53 ~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|+|+.|.||++++++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 378999999999999887 9999998653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.0039 Score=50.77 Aligned_cols=70 Identities=19% Similarity=0.187 Sum_probs=50.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++|||++.|-.|..+..- .....+. ..+..-+--|..+| ++|+|++--||++.+++.++++||-...
T Consensus 183 H~Vvmelv~g~Pl~~v~~v------~d~~~ly---~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 183 HCVVMELVDGYPLRQVRHV------EDPPTLY---DDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred eeeHHHhhcccceeeeeec------CChHHHH---HHHHHHHHHHHHcC---ceecccchheeEEecCCCEEEeechHhh
Confidence 4789999988777665422 2233333 34444456677889 9999999999999999999999997544
Q ss_pred cc
Q 044510 82 YV 83 (253)
Q Consensus 82 ~~ 83 (253)
.+
T Consensus 251 S~ 252 (465)
T KOG2268|consen 251 ST 252 (465)
T ss_pred cc
Confidence 33
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.029 Score=46.56 Aligned_cols=70 Identities=23% Similarity=0.236 Sum_probs=52.5
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
|++|++- |+++... . ...++++..++++.+..+.-+...- +.-||++.-.||+|+ .|.+.|+||-+++.
T Consensus 302 yl~~kdh-gt~is~i-k------~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 302 YLHFKDH-GTPISII-K------ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred EEEEecC-Cceeeee-e------cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence 5566655 5444322 1 2567888889888888777776543 378999999999999 89999999999885
Q ss_pred c
Q 044510 83 V 83 (253)
Q Consensus 83 ~ 83 (253)
-
T Consensus 371 ~ 371 (488)
T COG5072 371 S 371 (488)
T ss_pred c
Confidence 4
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.05 Score=44.58 Aligned_cols=32 Identities=16% Similarity=0.265 Sum_probs=28.0
Q ss_pred CCeEecCCCCCceeecCCCceEEcccCCcccc
Q 044510 52 IPIYHRDIKSANILLDDKFRAKISDFGASRYV 83 (253)
Q Consensus 52 ~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~~ 83 (253)
..++|+|+.+.|+++++..-+-|.||+++..-
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 35899999999999998888999999987643
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.065 Score=50.12 Aligned_cols=31 Identities=26% Similarity=0.303 Sum_probs=24.2
Q ss_pred CeEecCCCCCceeecCC-Cc-eEEcccCCcccc
Q 044510 53 PIYHRDIKSANILLDDK-FR-AKISDFGASRYV 83 (253)
Q Consensus 53 ~i~H~dl~~~nili~~~-~~-~kl~Dfgl~~~~ 83 (253)
.++|+|+++.||+++.+ +. .-|.||.++..-
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 49999999999999853 33 578999876543
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.95 E-value=0.11 Score=40.66 Aligned_cols=29 Identities=28% Similarity=0.437 Sum_probs=25.1
Q ss_pred CeEecCCCCCceeecC-CCceEEcccCCcc
Q 044510 53 PIYHRDIKSANILLDD-KFRAKISDFGASR 81 (253)
Q Consensus 53 ~i~H~dl~~~nili~~-~~~~kl~Dfgl~~ 81 (253)
.++|+|+.+.||++++ ++.+.++||..+.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 3899999999999998 5789999997653
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=93.86 E-value=0.099 Score=42.79 Aligned_cols=29 Identities=24% Similarity=0.323 Sum_probs=25.3
Q ss_pred CeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 53 PIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 53 ~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|+|+.+.|+++++++.+.|.||+.+.
T Consensus 188 ~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 188 GVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred ccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 49999999999999988777899998653
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.60 E-value=0.19 Score=40.93 Aligned_cols=30 Identities=27% Similarity=0.427 Sum_probs=25.7
Q ss_pred CCeEecCCCCCceeecCC----CceEEcccCCcc
Q 044510 52 IPIYHRDIKSANILLDDK----FRAKISDFGASR 81 (253)
Q Consensus 52 ~~i~H~dl~~~nili~~~----~~~kl~Dfgl~~ 81 (253)
..++|+|+.+.||+++++ +.+.++||..+.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 347999999999999974 789999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.48 E-value=0.18 Score=41.17 Aligned_cols=27 Identities=33% Similarity=0.445 Sum_probs=23.6
Q ss_pred eEecCCCCCceeecCCCceEEcccCCcc
Q 044510 54 IYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 54 i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 189 liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 189 FCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred eEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 899999999999987 578899998543
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.45 E-value=0.17 Score=40.65 Aligned_cols=49 Identities=22% Similarity=0.232 Sum_probs=36.0
Q ss_pred HHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 32 SLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 32 ~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
..+.+..+-..+.-.+..- .-++|+|+.|+|++.++.+.++|+||.-+.
T Consensus 134 ~~~~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 134 LRKKLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 3345555555666555541 127999999999999999999999997654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=93.45 E-value=0.08 Score=40.96 Aligned_cols=29 Identities=34% Similarity=0.508 Sum_probs=19.7
Q ss_pred CeEecCCCCCceeec-CCCceEEcccCCcc
Q 044510 53 PIYHRDIKSANILLD-DKFRAKISDFGASR 81 (253)
Q Consensus 53 ~i~H~dl~~~nili~-~~~~~kl~Dfgl~~ 81 (253)
.++|+|+.+.||+++ .++.+.|+||+.+.
T Consensus 167 ~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 167 VLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred EEEEeccccccceeeeccceeEEEecccce
Confidence 389999999999999 55566799998653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=92.87 E-value=0.16 Score=41.21 Aligned_cols=28 Identities=25% Similarity=0.349 Sum_probs=24.9
Q ss_pred eEecCCCCCceeecCCCceEEcccCCcc
Q 044510 54 IYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 54 i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
++|+|+.|.|+++++++.+.|.||+.+.
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhc
Confidence 8999999999999988777899998654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.56 E-value=0.21 Score=41.08 Aligned_cols=42 Identities=21% Similarity=0.150 Sum_probs=26.9
Q ss_pred CHHHHHHHHHHHHHHHHhH-hhCCCCCeEecCCCCCceeecCC
Q 044510 28 TWEISLRIAVEVSGALSYL-HSTTSIPIYHRDIKSANILLDDK 69 (253)
Q Consensus 28 ~~~~~~~i~~~i~~~l~~l-h~~~~~~i~H~dl~~~nili~~~ 69 (253)
..+.+..+..|++.-.-.+ ...+.-..+|-||||+|||+-++
T Consensus 277 ~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 277 LVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred HHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 3445566677776654344 22323338999999999999544
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.54 E-value=0.1 Score=39.27 Aligned_cols=27 Identities=15% Similarity=0.263 Sum_probs=23.8
Q ss_pred eEecCCCCCceeecCCCceEEcccCCcc
Q 044510 54 IYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 54 i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.+|+|+.|.|+++++++ ++|+||+.+.
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCccc
Confidence 58999999999998876 8899998764
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.32 E-value=0.095 Score=43.09 Aligned_cols=29 Identities=21% Similarity=0.280 Sum_probs=24.7
Q ss_pred CeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 53 PIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 53 ~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++|+|+.+.||+++++...-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 39999999999999976556899998664
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=92.16 E-value=0.11 Score=41.30 Aligned_cols=28 Identities=18% Similarity=0.291 Sum_probs=24.1
Q ss_pred CeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 53 PIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 53 ~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|+|+.+.||++++++ +.|+||..+.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 379999999999999876 7899998654
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=91.98 E-value=0.43 Score=36.41 Aligned_cols=57 Identities=26% Similarity=0.328 Sum_probs=37.8
Q ss_pred CChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC--C--ceEEcc-cCC
Q 044510 12 GTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK--F--RAKISD-FGA 79 (253)
Q Consensus 12 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~--~--~~kl~D-fgl 79 (253)
-+|.+++.... ++. ...+.+.++.. +|-..+ |+.+|++|.||++... + .+.|+| ||-
T Consensus 108 ~TL~~~l~~~~----~~~-~~~~~L~~f~~---~l~~~~---Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 108 PTLEDYLKEGG----LTE-ELRQALDEFKR---YLLDHH---IVIRDLNPHNIVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred ccHHHHHHcCC----ccH-HHHHHHHHHHH---HHHHcC---CeecCCCcccEEEEecCCCceEEEEEeCCCC
Confidence 36788885432 555 55555555544 555666 9999999999999632 2 577777 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=91.72 E-value=0.42 Score=40.09 Aligned_cols=76 Identities=17% Similarity=0.217 Sum_probs=53.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
++|||+|+ |.+= +.........++...+..+-.+++.-+.-|...+. +||.||+--|+|+-+. .+.++|.+.+.
T Consensus 239 hVLVM~Fl-Grdg--w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~LyhdG-~lyiIDVSQSV 312 (520)
T KOG2270|consen 239 HVLVMEFL-GRDG--WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYHDG-KLYIIDVSQSV 312 (520)
T ss_pred ceEeeeec-cCCC--CcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEECC-EEEEEEccccc
Confidence 47999999 4321 22222222246666777777788888888775543 9999999999998764 88999988766
Q ss_pred cc
Q 044510 82 YV 83 (253)
Q Consensus 82 ~~ 83 (253)
..
T Consensus 313 E~ 314 (520)
T KOG2270|consen 313 EH 314 (520)
T ss_pred cC
Confidence 43
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=91.32 E-value=0.14 Score=39.36 Aligned_cols=28 Identities=29% Similarity=0.502 Sum_probs=19.9
Q ss_pred eEecCCCCCceee-cCCCceEEcccCCcc
Q 044510 54 IYHRDIKSANILL-DDKFRAKISDFGASR 81 (253)
Q Consensus 54 i~H~dl~~~nili-~~~~~~kl~Dfgl~~ 81 (253)
++|.|+.+.||++ +.++.++++||..+.
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHh
Confidence 7899999999999 788899999998664
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=91.06 E-value=0.2 Score=38.14 Aligned_cols=29 Identities=24% Similarity=0.328 Sum_probs=23.7
Q ss_pred CeEecCCCCCceeecCCC-----ceEEcccCCcc
Q 044510 53 PIYHRDIKSANILLDDKF-----RAKISDFGASR 81 (253)
Q Consensus 53 ~i~H~dl~~~nili~~~~-----~~kl~Dfgl~~ 81 (253)
.++|||+.+.|+++..++ .+.+.||..+.
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 389999999999997543 58899998654
|
subfamily of choline kinases |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=91.06 E-value=0.36 Score=39.93 Aligned_cols=54 Identities=24% Similarity=0.282 Sum_probs=31.6
Q ss_pred HHHHHHHHHHHHHHHhHhh-CCCCCeEecCCCCCceeecCC------------------CceEEcccCCcccc
Q 044510 30 EISLRIAVEVSGALSYLHS-TTSIPIYHRDIKSANILLDDK------------------FRAKISDFGASRYV 83 (253)
Q Consensus 30 ~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nili~~~------------------~~~kl~Dfgl~~~~ 83 (253)
+.+..+..|++.-.--+.. .+.-..+|-||||+|||+-++ -.++|-||.+++..
T Consensus 275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 3445556666543211322 122237999999999999433 24567777766543
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.62 E-value=0.72 Score=38.22 Aligned_cols=28 Identities=32% Similarity=0.567 Sum_probs=24.6
Q ss_pred eEecCCCCCceeecCCCc-eEEcccCCcc
Q 044510 54 IYHRDIKSANILLDDKFR-AKISDFGASR 81 (253)
Q Consensus 54 i~H~dl~~~nili~~~~~-~kl~Dfgl~~ 81 (253)
++|+|+.++||+++.+.. +.+.||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 899999999999998874 8899998653
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.61 E-value=0.12 Score=44.99 Aligned_cols=80 Identities=23% Similarity=0.203 Sum_probs=45.5
Q ss_pred CCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc-chhchhhhhhhcHHHHHHHHHHHHHhcccCC
Q 044510 112 TKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF-DMLDAQVLKEAKEEEIITVAMLAKRCLNLNG 190 (253)
Q Consensus 112 ~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP 190 (253)
.+++|||++|.++.++.-|..-+......+ +......-.... ....-........+....++++..+|+-..|
T Consensus 109 ~pKsdVwsl~~i~~el~L~~~l~~~~~~s~------~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~ 182 (725)
T KOG1093|consen 109 GPKSDVWSLGFIILELYLGISLEAELTESE------YLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEP 182 (725)
T ss_pred CcchhhhhHHHHHHHHHHhhHHHHHHHHHH------HHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCcccc
Confidence 469999999999999988765443322221 111111111110 0000011113344556778889999999999
Q ss_pred CCCCCHH
Q 044510 191 RKRPTMK 197 (253)
Q Consensus 191 ~~Rps~~ 197 (253)
..||...
T Consensus 183 ~ir~l~~ 189 (725)
T KOG1093|consen 183 IIRPLPM 189 (725)
T ss_pred ccccchh
Confidence 9887643
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=90.23 E-value=0.35 Score=37.63 Aligned_cols=39 Identities=26% Similarity=0.160 Sum_probs=31.1
Q ss_pred HHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCC
Q 044510 40 SGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGA 79 (253)
Q Consensus 40 ~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl 79 (253)
+.+|.-.|+.. ...+|+|.+|+||+-+..|-+|+.|-+.
T Consensus 151 i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 35566777433 1389999999999999999999999763
|
The function of this family is unknown. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=90.06 E-value=0.56 Score=39.14 Aligned_cols=29 Identities=24% Similarity=0.450 Sum_probs=24.7
Q ss_pred CeEecCCCCCceeecC-CCceEEcccCCcc
Q 044510 53 PIYHRDIKSANILLDD-KFRAKISDFGASR 81 (253)
Q Consensus 53 ~i~H~dl~~~nili~~-~~~~kl~Dfgl~~ 81 (253)
.++|+|+++.||++++ ++.+.++||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 3799999999999986 4679999998654
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=90.05 E-value=0.25 Score=39.84 Aligned_cols=30 Identities=23% Similarity=0.519 Sum_probs=24.5
Q ss_pred CeEecCCCCCceeecCCCc-eEEcccCCccc
Q 044510 53 PIYHRDIKSANILLDDKFR-AKISDFGASRY 82 (253)
Q Consensus 53 ~i~H~dl~~~nili~~~~~-~kl~Dfgl~~~ 82 (253)
.++|+|+.+.||++++++. .-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999997555 56999987643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=90.02 E-value=0.5 Score=38.73 Aligned_cols=28 Identities=14% Similarity=0.300 Sum_probs=25.7
Q ss_pred eEecCCCCCceeecCCCceEEcccCCcc
Q 044510 54 IYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 54 i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
++|+|+.++|+++++++.+.++||..+.
T Consensus 198 lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 198 LVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 8999999999999998899999998664
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=89.63 E-value=0.6 Score=34.92 Aligned_cols=66 Identities=17% Similarity=0.145 Sum_probs=44.0
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCC-CceeecCCCceEEcccCCcc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS-ANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~-~nili~~~~~~kl~Dfgl~~ 81 (253)
++.|||+.|-.|.++-... .-.+ +..++....-|...| |-|+.|+- ...++..++.+.|+||..+.
T Consensus 88 ~i~me~i~G~~L~~~~~~~------~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG------DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhhhcCcchhhhhhcc------cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence 4568999887887765421 1222 234566666777788 99999964 44444444499999998765
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=88.15 E-value=0.81 Score=43.97 Aligned_cols=28 Identities=36% Similarity=0.570 Sum_probs=23.7
Q ss_pred eEecCCCCCceeecCCC--ceE-EcccCCcc
Q 044510 54 IYHRDIKSANILLDDKF--RAK-ISDFGASR 81 (253)
Q Consensus 54 i~H~dl~~~nili~~~~--~~k-l~Dfgl~~ 81 (253)
++|+|++++||+++.++ ++. |+|||-+.
T Consensus 205 vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 205 VIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred eECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 99999999999999775 454 99999664
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=87.73 E-value=1 Score=38.37 Aligned_cols=29 Identities=17% Similarity=0.338 Sum_probs=24.4
Q ss_pred CCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 52 IPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 52 ~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
..++|||+.+.||++..+ .++++||.++.
T Consensus 223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a~ 251 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE-ETKVIDPEFAF 251 (401)
T ss_pred CceeeccCCcccEEeeCC-CcEEEeccccc
Confidence 348999999999999876 68999997654
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=84.58 E-value=1.3 Score=42.53 Aligned_cols=28 Identities=29% Similarity=0.383 Sum_probs=22.9
Q ss_pred eEecCCCCCceeecCCC--c---eEEcccCCcc
Q 044510 54 IYHRDIKSANILLDDKF--R---AKISDFGASR 81 (253)
Q Consensus 54 i~H~dl~~~nili~~~~--~---~kl~Dfgl~~ 81 (253)
++|+|++++||+++.+. . .-|+|||-+.
T Consensus 210 ~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 210 AVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred ccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 99999999999998652 2 4799999654
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=84.55 E-value=1.8 Score=35.79 Aligned_cols=26 Identities=27% Similarity=0.401 Sum_probs=22.2
Q ss_pred eEecCCCCCceeecCCCceEEcccCCcc
Q 044510 54 IYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 54 i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
++|+|+.+.||+++ + .+.|+||+-+.
T Consensus 198 liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 198 RLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 79999999999995 3 67899998654
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=84.53 E-value=1.6 Score=35.36 Aligned_cols=28 Identities=29% Similarity=0.381 Sum_probs=22.9
Q ss_pred eEecCCCCCceeecCC--C---ceEEcccCCcc
Q 044510 54 IYHRDIKSANILLDDK--F---RAKISDFGASR 81 (253)
Q Consensus 54 i~H~dl~~~nili~~~--~---~~kl~Dfgl~~ 81 (253)
++|||++.+||++..+ + .+++.||..++
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeecccccc
Confidence 7999999999999644 2 58899997654
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=84.40 E-value=0.9 Score=37.68 Aligned_cols=28 Identities=25% Similarity=0.418 Sum_probs=24.0
Q ss_pred eEecCCCCCceeecC-CCceEEcccCCcc
Q 044510 54 IYHRDIKSANILLDD-KFRAKISDFGASR 81 (253)
Q Consensus 54 i~H~dl~~~nili~~-~~~~kl~Dfgl~~ 81 (253)
++|.|+.+.||++++ ++.++++||..+.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 689999999999975 4689999998653
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=82.85 E-value=3.8 Score=35.10 Aligned_cols=59 Identities=17% Similarity=0.210 Sum_probs=42.9
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhh-CCCCCeEecCCCCCceeecC
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS-TTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nili~~ 68 (253)
.++=+|..|.++..++.... .+++...+++.-.+.|+.-|-- .+ .+|.|+.|.||++-.
T Consensus 321 vl~E~~~~Gl~v~~~v~~~~----~pe~l~kkva~lg~~AllkMl~vDN---FvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWKS----QPEALVKKVAKLGVNALLKMLIVDN---FVHADLHPGNVLIRF 380 (565)
T ss_pred eeeeeccccccHHhhhhccc----ChHHHHHHHHHHHHHHHHHHHHhhc---ceecccCCCcEEEEe
Confidence 35556888888888887654 5566677777767777655543 34 899999999999853
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=82.52 E-value=2.3 Score=35.68 Aligned_cols=28 Identities=21% Similarity=0.387 Sum_probs=23.4
Q ss_pred CeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 53 PIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 53 ~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|||+.+.||+++++ .++++|+..+.
T Consensus 193 ~llHGDl~~gNi~~~~~-~~~~iD~e~~~ 220 (370)
T TIGR01767 193 TLLHGDLHSGSIFVSEH-ETKVIDPEFAF 220 (370)
T ss_pred eeeeccCCcccEEEcCC-CCEEEcCcccc
Confidence 48999999999999876 47799987554
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 253 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-32 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-31 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-26 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-26 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-23 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-22 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-12 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-05 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-05 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-05 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 9e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-04 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-04 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 2e-71
Identities = 75/203 (36%), Positives = 117/203 (57%), Gaps = 5/203 (2%)
Query: 3 LLVYEFIPNGTLYRYIHD-QTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
+L+Y+++ NG L R+++ +++WE L I + + L YLH+ I HRD+KS
Sbjct: 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKS 167
Query: 62 ANILLDDKFRAKISDFGASRYVTI-DQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
NILLD+ F KI+DFG S+ T DQTHL+T V+GT GY+D EYF + T+K DVYSF
Sbjct: 168 INILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GVV +L + I + E +LA + + + L ++D + + + E +
Sbjct: 228 GVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGD 287
Query: 181 LAKRCLNLNGRKRPTMKEVAFEL 203
A +CL L+ RP+M +V ++L
Sbjct: 288 TAVKCLALSSEDRPSMGDVLWKL 310
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 1e-65
Identities = 66/200 (33%), Positives = 113/200 (56%), Gaps = 3/200 (1%)
Query: 3 LLVYEFIPNGTLYRYIHDQTE-EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
LLVY ++ NG++ + ++ E + + W RIA+ + L+YLH I HRD+K+
Sbjct: 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 162
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
ANILLD++F A + DFG ++ + TH+TT V+GT G++ EY + + ++K DV+ +G
Sbjct: 163 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 222
Query: 122 VVFVGLLTGQKPIRSTDT--EEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVA 179
V+ + L+TGQ+ ++D L + +KE L ++D + K+EE+ +
Sbjct: 223 VMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLI 282
Query: 180 MLAKRCLNLNGRKRPTMKEV 199
+A C + +RP M EV
Sbjct: 283 QVALLCTQSSPMERPKMSEV 302
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 5e-64
Identities = 70/209 (33%), Positives = 108/209 (51%), Gaps = 9/209 (4%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
LVY ++PNG+L + ++W + +IA + +++LH HRDIKSA
Sbjct: 106 CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSA 162
Query: 63 NILLDDKFRAKISDFGASR-YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
NILLD+ F AKISDFG +R QT +T+R+ GT Y+ E R + T K D+YSFG
Sbjct: 163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFG 221
Query: 122 VVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN-CLFDMLDAQVLKEAKEEEIITVAM 180
VV + ++TG + E + L E + D +D + + +A + +
Sbjct: 222 VVLLEIITGLPAVDE--HREPQLLLDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYS 278
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIRAS 209
+A +CL+ KRP +K+V L + AS
Sbjct: 279 VASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-48
Identities = 47/223 (21%), Positives = 82/223 (36%), Gaps = 29/223 (13%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSI-------PIY 55
L+ F G+L ++ ++W IA ++ L+YLH I
Sbjct: 98 WLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAIS 153
Query: 56 HRDIKSANILLDDKFRAKISDFGASRYVTIDQTHL-TTRVQGTFGYLDLEYFRSS----- 109
HRDIKS N+LL + A I+DFG + ++ T GT Y+ E +
Sbjct: 154 HRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQR 213
Query: 110 QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKE 169
+ D+Y+ G+V L + D D+ + + + L DM + V K+
Sbjct: 214 DAFLRIDMYAMGLVLWELASRCTAA---DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKK 270
Query: 170 A---------KEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203
K + + + C + + R + V +
Sbjct: 271 KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERI 313
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-44
Identities = 50/215 (23%), Positives = 92/215 (42%), Gaps = 25/215 (11%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV E+ G+LY +H T ++ ++ S ++YLHS + HRD+K N
Sbjct: 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN 135
Query: 64 ILLDDKFR-AKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
+LL KI DFG + + QTH+T G+ ++ E F S +++K DV+S+G+
Sbjct: 136 LLLVAGGTVLKICDFGTACDI---QTHMTNNK-GSAAWMAPEVFEGSNYSEKCDVFSWGI 191
Query: 123 VFVGLLTGQKPIRSTDTEEDKSLAGYF--LR-AMKENCLFDMLDAQVLKEAKEEEIITVA 179
+ ++T +KP + + R + +N +
Sbjct: 192 ILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI-----------------E 234
Query: 180 MLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQN 214
L RC + + +RP+M+E+ + + +
Sbjct: 235 SLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-42
Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 35/219 (15%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E++ G+LYR +H + L +A +V+ ++YLH+ PI HR++KS N
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPN 169
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
+L+D K+ K+ DFG SR + GT ++ E R +K DVYSFGV+
Sbjct: 170 LLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLRDEPSNEKSDVYSFGVI 228
Query: 124 FVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEE----EIIT-- 177
L T Q+P ++ AQV+ + EI
Sbjct: 229 LWELATLQQPWG------------------------NLNPAQVVAAVGFKCKRLEIPRNL 264
Query: 178 ---VAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQ 213
VA + + C KRP+ + L + S P
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-38
Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 37/214 (17%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
P +V EF+P G LY + D+ I W + LR+ ++++ + Y+ + PI HRD++S
Sbjct: 96 PRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRS 152
Query: 62 ANILLDDK-----FRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYF--RSSQFTKK 114
NI L AK++DFG S+ H + + G F ++ E +T+K
Sbjct: 153 PNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEK 208
Query: 115 GDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEE 174
D YSF ++ +LTG+ P Y +K + +E
Sbjct: 209 ADTYSFAMILYTILTGEGP-----------FDEYSYGKIK-------FINMIREEGLRPT 250
Query: 175 IIT-----VAMLAKRCLNLNGRKRPTMKEVAFEL 203
I + + + C + + +KRP + EL
Sbjct: 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-38
Identities = 59/220 (26%), Positives = 92/220 (41%), Gaps = 48/220 (21%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV EF G L R + + I +I + AV+++ ++YLH +PI HRD+KS+N
Sbjct: 83 LVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSN 138
Query: 64 ILLDDKFR--------AKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKG 115
IL+ K KI+DFG +R +T + G + ++ E R+S F+K
Sbjct: 139 ILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSAA-GAYAWMAPEVIRASMFSKGS 195
Query: 116 DVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEE-- 173
DV+S+GV+ LLTG+ P R + V
Sbjct: 196 DVWSYGVLLWELLTGEVPFR------------------------GIDGLAVAYGVAMNKL 231
Query: 174 --EIIT-----VAMLAKRCLNLNGRKRPTMKEVAFELGGI 206
I + A L + C N + RP+ + +L I
Sbjct: 232 ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-38
Identities = 46/237 (19%), Positives = 87/237 (36%), Gaps = 35/237 (14%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSI------PIYH 56
LLV E+ PNG+L +Y+ T W S R+A V+ L+YLH+ I H
Sbjct: 88 LLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISH 143
Query: 57 RDIKSANILLDDKFRAKISDFGASR-------YVTIDQTHLTTRVQGTFGYLDLEYFRSS 109
RD+ S N+L+ + ISDFG S ++ + GT Y+ E +
Sbjct: 144 RDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGA 203
Query: 110 -------QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDML 162
K+ D+Y+ G+++ + + ++ + +A + DM
Sbjct: 204 VNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA-FQTEVGNHPTFEDMQ 262
Query: 163 DAQVLK----------EAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209
+ + + ++ + C + + R T + + +
Sbjct: 263 VLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-35
Identities = 47/230 (20%), Positives = 79/230 (34%), Gaps = 31/230 (13%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSI-----PIYHR 57
L+ ++ NG+LY Y+ T + + L++A L +LH+ I HR
Sbjct: 111 YLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHR 166
Query: 58 DIKSANILLDDKFRAKISDFGASR---YVTIDQTHLTTRVQGTFGYL------DLEYFRS 108
D+KS NIL+ I+D G + T + GT Y+ +
Sbjct: 167 DLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNH 226
Query: 109 SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLK 168
Q D+YSFG++ + + + Y + DM + +K
Sbjct: 227 FQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ----LPYHDLVPSDPSYEDMREIVCIK 282
Query: 169 ---------EAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209
+ +E + + L C N R T V L + S
Sbjct: 283 KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-35
Identities = 37/212 (17%), Positives = 81/212 (38%), Gaps = 44/212 (20%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L+ ++P G+LY +H+ T F + +++ A++++ +++LH+ I + S +
Sbjct: 86 LITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSRS 143
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQ---FTKKGDVYSF 120
+++D+ A+IS + ++ E + + D++SF
Sbjct: 144 VMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSF 197
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEE----EII 176
V+ L+T + P D+ + ++ + E I
Sbjct: 198 AVLLWELVTREVPFA------------------------DLSNMEIGMKVALEGLRPTIP 233
Query: 177 T-----VAMLAKRCLNLNGRKRPTMKEVAFEL 203
V+ L K C+N + KRP + L
Sbjct: 234 PGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-34
Identities = 48/224 (21%), Positives = 78/224 (34%), Gaps = 33/224 (14%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSI-----PIYHRD 58
L+ + G+LY Y+ T + LRI + ++ L++LH I HRD
Sbjct: 83 LITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRD 138
Query: 59 IKSANILLDDKFRAKISDFGASRYV----TIDQTHLTTRVQGTFGY-----LDLE-YFRS 108
+KS NIL+ + I+D G + RV GT Y LD
Sbjct: 139 LKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDC 197
Query: 109 SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLK 168
K+ D+++FG+V + ED ++ + DM +
Sbjct: 198 FDSYKRVDIWAFGLVLWEVARRMVS---NGIVEDYKPP-FYDVVPNDPSFEDMRKVVCVD 253
Query: 169 ---------EAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203
+ + ++A L K C N R T + L
Sbjct: 254 QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-34
Identities = 41/213 (19%), Positives = 76/213 (35%), Gaps = 34/213 (15%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
++ TLY + D + +IA E+ + YLH+ I H+D+KS N
Sbjct: 106 IITSLCKGRTLYSVVRDAKIVLD--VNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKN 160
Query: 64 ILLDDKFRAKISDFGASRYVTI----DQTHLTTRVQGTFGYLDLEYFRSSQ--------- 110
+ D+ + I+DFG + + G +L E R
Sbjct: 161 VFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLP 219
Query: 111 FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEA 170
F+K DV++ G ++ L + P ++ E + M ++ + KE
Sbjct: 220 FSKHSDVFALGTIWYELHAREWPFKTQPAEA-------IIWQMGTGMKPNLSQIGMGKE- 271
Query: 171 KEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203
++ + C +RPT ++ L
Sbjct: 272 -------ISDILLFCWAFEQEERPTFTKLMDML 297
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-34
Identities = 47/231 (20%), Positives = 87/231 (37%), Gaps = 31/231 (13%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTS-----IPIYHRD 58
LV ++ +G+L+ Y++ T +T E +++A+ + L++LH I HRD
Sbjct: 117 LVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 172
Query: 59 IKSANILLDDKFRAKISDFGASR---YVTIDQTHLTTRVQGTFGY-----LDLEY-FRSS 109
+KS NIL+ I+D G + T GT Y LD +
Sbjct: 173 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 232
Query: 110 QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKE 169
+ K+ D+Y+ G+VF + + + Y+ + + +M ++
Sbjct: 233 ESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ----LPYYDLVPSDPSVEEMRKVVCEQK 288
Query: 170 ---------AKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIG 211
E + +A + + C NG R T + L + G
Sbjct: 289 LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-33
Identities = 48/204 (23%), Positives = 89/204 (43%), Gaps = 20/204 (9%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V ++ +LY ++H E + + IA + + + YLH+ I HRD+KS N
Sbjct: 96 IVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNN 150
Query: 64 ILLDDKFRAKISDFGASRYVT-IDQTHLTTRVQGTFGYLDLEYFR---SSQFTKKGDVYS 119
I L + KI DFG + + +H ++ G+ ++ E R S+ ++ + DVY+
Sbjct: 151 IFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYA 210
Query: 120 FGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVA 179
FG+V L+TGQ P + + + + L D ++ + +
Sbjct: 211 FGIVLYELMTGQLPY------SNINNRDQIIEMVGRGSL--SPDLSKVRSNCPKRM---K 259
Query: 180 MLAKRCLNLNGRKRPTMKEVAFEL 203
L CL +RP+ + E+
Sbjct: 260 RLMAECLKKKRDERPSFPRILAEI 283
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-32
Identities = 45/230 (19%), Positives = 83/230 (36%), Gaps = 38/230 (16%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+ E+I GTL I ++ W + A +++ ++YLHS + I HRD+ S N
Sbjct: 84 FITEYIKGGTLRGIIKSMDSQYP--WSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHN 138
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDL-------------EYFRSSQ 110
L+ + ++DFG +R + ++T E
Sbjct: 139 CLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS 198
Query: 111 FTKKGDVYSFGVVFVGLLTGQKP---IRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVL 167
+ +K DV+SFG+V ++ + ++ G+ R NC
Sbjct: 199 YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNC-----PPSFF 253
Query: 168 KEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNCEG 217
+ RC +L+ KRP+ ++ L +R + G
Sbjct: 254 P------------ITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-25
Identities = 52/199 (26%), Positives = 82/199 (41%), Gaps = 20/199 (10%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFT-ITWEISLRIAVEVSGALSYLHS--TTSIPIYHRDIK 60
+V E+ G L I T+E + E LR+ +++ AL H + HRD+K
Sbjct: 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
AN+ LD K K+ DFG +R + D + T V GT Y+ E + +K D++S
Sbjct: 144 PANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSL 202
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
G + L P + +E L F + + E E
Sbjct: 203 GCLLYELCALMPPFTAFSQKE--------LAGKIREGKFRRIPYRYSDELNE-------- 246
Query: 181 LAKRCLNLNGRKRPTMKEV 199
+ R LNL RP+++E+
Sbjct: 247 IITRMLNLKDYHRPSVEEI 265
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 7e-24
Identities = 44/200 (22%), Positives = 76/200 (38%), Gaps = 29/200 (14%)
Query: 4 LVYEFIPNGTLYRYIHDQT----EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDI 59
+V ++ G L++ I+ Q +E I L V++ AL ++H I HRDI
Sbjct: 100 IVMDYCEGGDLFKRINAQKGVLFQEDQI-----LDWFVQICLALKHVHDRK---ILHRDI 151
Query: 60 KSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYS 119
KS NI L ++ DFG +R + + GT YL E + + K D+++
Sbjct: 152 KSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNNKSDIWA 210
Query: 120 FGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVA 179
G V L T + + + L + F + + +
Sbjct: 211 LGCVLYELCTLKHAFEAGSMKN--------LVLKIISGSFPPVSLHYSYDLRS------- 255
Query: 180 MLAKRCLNLNGRKRPTMKEV 199
L + N R RP++ +
Sbjct: 256 -LVSQLFKRNPRDRPSVNSI 274
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-23
Identities = 38/133 (28%), Positives = 59/133 (44%), Gaps = 6/133 (4%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
LV E+I TL YI ++ + ++ ++ + + H I HRDIK
Sbjct: 85 CYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIK 138
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
NIL+D KI DFG ++ ++ T V GT Y E + + D+YS
Sbjct: 139 PQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSI 198
Query: 121 GVVFVGLLTGQKP 133
G+V +L G+ P
Sbjct: 199 GIVLYEMLVGEPP 211
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-23
Identities = 33/135 (24%), Positives = 50/135 (37%), Gaps = 10/135 (7%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
+ I L + + + ++ I ++ AL H+ HRD+K
Sbjct: 108 QLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVK 161
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTT--RVQGTFGYLDLEYFRSSQFTKKGDVY 118
NIL+ A + DFG + LT GT Y+ E F S T + D+Y
Sbjct: 162 PENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIY 219
Query: 119 SFGVVFVGLLTGQKP 133
+ V LTG P
Sbjct: 220 ALTCVLYECLTGSPP 234
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-23
Identities = 42/135 (31%), Positives = 65/135 (48%), Gaps = 8/135 (5%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
+P +V E++ TL +H E +T + ++ + + AL++ H I HRD+K
Sbjct: 90 LPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVK 143
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTT--RVQGTFGYLDLEYFRSSQFTKKGDVY 118
ANI++ K+ DFG +R + +T V GT YL E R + DVY
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVY 203
Query: 119 SFGVVFVGLLTGQKP 133
S G V +LTG+ P
Sbjct: 204 SLGCVLYEVLTGEPP 218
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 2e-23
Identities = 45/200 (22%), Positives = 80/200 (40%), Gaps = 32/200 (16%)
Query: 12 GTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK-- 69
TL Y+ + ++F + + + + L++LHS I HRD+K NIL+
Sbjct: 102 ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNA 156
Query: 70 ---FRAKISDFGASRYVTIDQTHLTTR--VQGTFGYLDLEYFRSSQF---TKKGDVYSFG 121
+A ISDFG + + + + + R V GT G++ E T D++S G
Sbjct: 157 HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG 216
Query: 122 VVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLD--AQVLKEAKEEEIITVA 179
VF +++ + + C D L A+E
Sbjct: 217 CVFYYVISEGSHPFGKSLQRQ-------ANILLGACSLDCLHPEKHEDVIARE------- 262
Query: 180 MLAKRCLNLNGRKRPTMKEV 199
L ++ + ++ +KRP+ K V
Sbjct: 263 -LIEKMIAMDPQKRPSAKHV 281
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-23
Identities = 46/201 (22%), Positives = 83/201 (41%), Gaps = 37/201 (18%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+ EF GTL ++I + E + ++L + +++ + Y+HS + +RD+K +N
Sbjct: 97 IQMEFCDKGTLEQWIEKRRGEK-LDKVLALELFEQITKGVDYIHSKK---LINRDLKPSN 152
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
I L D + KI DFG ++ TR +GT Y+ E S + K+ D+Y+ G++
Sbjct: 153 IFLVDTKQVKIGDFGLVT--SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLI 210
Query: 124 FVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVL-----KEAKEEEIITV 178
LL A + + F L ++ K+ K
Sbjct: 211 LAELLHVCDT------------------AFETSKFFTDLRDGIISDIFDKKEKT------ 246
Query: 179 AMLAKRCLNLNGRKRPTMKEV 199
L ++ L+ RP E+
Sbjct: 247 --LLQKLLSKKPEDRPNTSEI 265
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-23
Identities = 45/200 (22%), Positives = 79/200 (39%), Gaps = 30/200 (15%)
Query: 7 EFIPNGTLYRYIHDQTE------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
E G L R I + E T+ + V++ AL ++HS + HRDIK
Sbjct: 112 ELADAGDLSRMIKHFKKQKRLIPERTV-----WKYFVQLCSALEHMHSRR---VMHRDIK 163
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
AN+ + K+ D G R+ + T + V GT Y+ E + + K D++S
Sbjct: 164 PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSL 222
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVL-KEAKEEEIITVA 179
G + + Q P + +L + + + + L + +E ++
Sbjct: 223 GCLLYEMAALQSPFYG----DKMNLYSLCKKIEQCD--YPPLPSDHYSEELRQ------- 269
Query: 180 MLAKRCLNLNGRKRPTMKEV 199
L C+N + KRP + V
Sbjct: 270 -LVNMCINPDPEKRPDVTYV 288
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 5e-22
Identities = 41/204 (20%), Positives = 80/204 (39%), Gaps = 32/204 (15%)
Query: 7 EFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILL 66
+ L +++ + + L I ++++ A+ +LHS + HRD+K +NI
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFF 197
Query: 67 DDKFRAKISDFGASRYVTIDQTHLT-----------TRVQGTFGYLDLEYFRSSQFTKKG 115
K+ DFG + D+ T T GT Y+ E + ++ K
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 116 DVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEI 175
D++S G++ LL ST E + + +R N F +L Q + +
Sbjct: 258 DIFSLGLILFELLYSF----STQMERVRIITD--VR----NLKFPLLFTQKYPQEH--MM 305
Query: 176 ITVAMLAKRCLNLNGRKRPTMKEV 199
+ + L+ + +RP ++
Sbjct: 306 V------QDMLSPSPTERPEATDI 323
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 91.3 bits (226), Expect = 1e-21
Identities = 30/203 (14%), Positives = 50/203 (24%), Gaps = 22/203 (10%)
Query: 3 LLVYEFIPNGTLYRYIHD----QTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRD 58
LL+ + L + ++ + L S + H
Sbjct: 164 LLLMPA-ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGH 219
Query: 59 IKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSS--QFTKKGD 116
N+ + R + D A V Y E+ +S FT +
Sbjct: 220 FTPDNLFIMPDGRLMLGDVSALWKV----GTRGPASSVPVTYAPREFLNASTATFTHALN 275
Query: 117 VYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEII 176
+ G+ + P S LR + L + K
Sbjct: 276 AWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKT---- 331
Query: 177 TVAMLAKRCLNLNGRKRPTMKEV 199
L R LN + R+R E
Sbjct: 332 ----LIGRFLNFDRRRRLLPLEA 350
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-21
Identities = 39/206 (18%), Positives = 75/206 (36%), Gaps = 32/206 (15%)
Query: 5 VYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANI 64
+ L +++ + + L I ++++ A+ +LHS + HRD+K +NI
Sbjct: 93 QMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNI 149
Query: 65 LLDDKFRAKISDFGASRYVTIDQTHLTTRVQ-----------GTFGYLDLEYFRSSQFTK 113
K+ DFG + D+ T GT Y+ E + ++
Sbjct: 150 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSH 209
Query: 114 KGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEE 173
K D++S G++ LL P T+ ++ +R N F L Q
Sbjct: 210 KVDIFSLGLILFELLY---PF---STQMERVRTLTDVR----NLKFPPLFTQKYPCEYV- 258
Query: 174 EIITVAMLAKRCLNLNGRKRPTMKEV 199
+ + L+ + +RP +
Sbjct: 259 -------MVQDMLSPSPMERPEAINI 277
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-21
Identities = 48/215 (22%), Positives = 85/215 (39%), Gaps = 44/215 (20%)
Query: 4 LVYEFIPNGTLYRYIHDQ---TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
+ E+ NGTLY IH + + + R+ ++ ALSY+HS I HRD+K
Sbjct: 92 IQMEYCENGTLYDLIHSENLNQQR-----DEYWRLFRQILEALSYIHSQG---IIHRDLK 143
Query: 61 SANILLDDKFRAKISDFGASRYVT--------------IDQTHLTTRVQGTFGYLDLEYF 106
NI +D+ KI DFG ++ V +LT+ + GT Y+ E
Sbjct: 144 PMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVL 202
Query: 107 R-SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD-MLDA 164
+ + +K D+YS G++F ++ + + F D
Sbjct: 203 DGTGHYNEKIDMYSLGIIFFEMIYPFST--------GMERVNILKKLRSVSIEFPPDFDD 254
Query: 165 QVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
+K K+ + + ++ + KRP + +
Sbjct: 255 NKMKVEKK--------IIRLLIDHDPNKRPGARTL 281
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 9e-21
Identities = 43/225 (19%), Positives = 78/225 (34%), Gaps = 33/225 (14%)
Query: 3 LLVYEFIPNGTLYRYI---HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDI 59
L+ F GTL+ I D+ T +I L + + + L +H+ HRD+
Sbjct: 106 WLLLPFFKRGTLWNEIERLKDKGNFLT-EDQI-LWLLLGICRGLEAIHAK---GYAHRDL 160
Query: 60 KSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQ--------GTFGYLDLEYF---RS 108
K NILL D+ + + D G+ I + T Y E F
Sbjct: 161 KPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSH 220
Query: 109 SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLK 168
++ DV+S G V ++ G+ P + G + +N L +
Sbjct: 221 CVIDERTDVWSLGCVLYAMMFGEGPY------DMVFQKGDSVALAVQNQLSIPQSPRHSS 274
Query: 169 EAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQ 213
+ L + ++ +RP + + +L ++ Q
Sbjct: 275 ALWQ--------LLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-20
Identities = 49/217 (22%), Positives = 87/217 (40%), Gaps = 43/217 (19%)
Query: 11 NGTLYRYI---HDQTEEFTITWEISLRIAV-EVSGALSYLHSTTSIPIYHRDIKSANILL 66
N L + + E + E + + +++ +++LHS + I HRD+K NIL+
Sbjct: 92 NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILV 148
Query: 67 DDK-------------FRAKISDFGASRYVTIDQTHLTTRVQ---GTFGYLDLEYFRSSQ 110
R ISDFG + + Q+ T + GT G+ E S
Sbjct: 149 STSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESN 208
Query: 111 F-------TKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDML 162
T+ D++S G VF +L+ G+ P + E + G F + + +
Sbjct: 209 NLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF----SLDEMKCLH 264
Query: 163 DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
D ++ EA + L + ++ + KRPT +V
Sbjct: 265 DRSLIAEATD--------LISQMIDHDPLKRPTAMKV 293
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 2e-20
Identities = 34/133 (25%), Positives = 58/133 (43%), Gaps = 15/133 (11%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
V +V E++ +L R + + ++ +E+ ALSYLHS I + + D+K
Sbjct: 158 VGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLHS---IGLVYNDLK 209
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
NI+L ++ + K+ D GA I+ + GT G+ E R+ T D+Y+
Sbjct: 210 PENIMLTEE-QLKLIDLGAVS--RINSFGY---LYGTPGFQAPEIVRTGP-TVATDIYTV 262
Query: 121 GVVFVGLLTGQKP 133
G L
Sbjct: 263 GRTLAALTLDLPT 275
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 88.2 bits (218), Expect = 4e-20
Identities = 40/143 (27%), Positives = 60/143 (41%), Gaps = 8/143 (5%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
PLL E+ G L +Y++ + + ++S AL YLH I HRD+K
Sbjct: 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKP 149
Query: 62 ANILLDDKFRA---KISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVY 118
NI+L + KI D G ++ + T V GT YL E ++T D +
Sbjct: 150 ENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV-GTLQYLAPELLEQKKYTVTVDYW 207
Query: 119 SFGVVFVGLLTGQKPIRSTDTEE 141
SFG + +TG +P
Sbjct: 208 SFGTLAFECITGFRPFLPNWQPV 230
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 6e-20
Identities = 39/142 (27%), Positives = 63/142 (44%), Gaps = 17/142 (11%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L+ EF P G+LY + + + + + L + +V G +++L I HR+IK N
Sbjct: 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGN 142
Query: 64 ILL----DDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL--------DLEYFRSSQF 111
I+ D + K++DFGA+R + D + GT YL L ++
Sbjct: 143 IMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHPDMYERAVLRKDHQKKY 200
Query: 112 TKKGDVYSFGVVFVGLLTGQKP 133
D++S GV F TG P
Sbjct: 201 GATVDLWSIGVTFYHAATGSLP 222
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 7e-20
Identities = 55/199 (27%), Positives = 81/199 (40%), Gaps = 32/199 (16%)
Query: 4 LVYEFIPNGTLYRYIHDQ---TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
L+ E+ P GT+YR + E+ + E++ ALSY HS + HRDIK
Sbjct: 86 LILEYAPLGTVYRELQKLSKFDEQ------RTATYITELANALSYCHSKR---VIHRDIK 136
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
N+LL KI+DFG S + GT YL E +K D++S
Sbjct: 137 PENLLLGSAGELKIADFGWSVH-APSSRRTDL--CGTLDYLPPEMIEGRMHDEKVDLWSL 193
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GV+ L G+ P E + + R + F V + A++
Sbjct: 194 GVLCYEFLVGKPPF------EANTYQETYKRISRVEFTF---PDFVTEGARD-------- 236
Query: 181 LAKRCLNLNGRKRPTMKEV 199
L R L N +RP ++EV
Sbjct: 237 LISRLLKHNPSQRPMLREV 255
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-19
Identities = 39/142 (27%), Positives = 63/142 (44%), Gaps = 17/142 (11%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L+ EF P G+LY + + + + + L + +V G +++L I HR+IK N
Sbjct: 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGN 142
Query: 64 ILL----DDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL--------DLEYFRSSQF 111
I+ D + K++DFGA+R + D + GT YL L ++
Sbjct: 143 IMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHPDMYERAVLRKDHQKKY 200
Query: 112 TKKGDVYSFGVVFVGLLTGQKP 133
D++S GV F TG P
Sbjct: 201 GATVDLWSIGVTFYHAATGSLP 222
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-19
Identities = 44/216 (20%), Positives = 80/216 (37%), Gaps = 41/216 (18%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+V E + G ++ + + + L++ + + + YL S I HRD+ +
Sbjct: 188 YIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVGDAAAGMEYLESKCCI---HRDLAAR 242
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDL-----EYFRSSQFTKKGDV 117
N L+ +K KISDFG SR G + + E +++ + DV
Sbjct: 243 NCLVTEKNVLKISDFGMSREEADGV---YAASGGL-RQVPVKWTAPEALNYGRYSSESDV 298
Query: 118 YSFGVVFVGLLT-GQKPIRSTDTEE--DKSLAGYFLRAMKENC---LFDMLDAQVLKEAK 171
+SFG++ + G P + ++ + G L E C +F +
Sbjct: 299 WSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCP-ELCPDAVFRL---------- 347
Query: 172 EEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207
M +C +RP+ + EL IR
Sbjct: 348 --------ME--QCWAYEPGQRPSFSTIYQELQSIR 373
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-19
Identities = 45/193 (23%), Positives = 82/193 (42%), Gaps = 23/193 (11%)
Query: 7 EFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILL 66
E + +GTL Y+ + ++ ++ L +LH+ + PI HRD+K NI +
Sbjct: 109 ELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFI 164
Query: 67 DDKF-RAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFV 125
KI D G + T+ + V GT ++ E + ++ + DVY+FG+ +
Sbjct: 165 TGPTGSVKIGDLGLA---TLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCML 220
Query: 126 GLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRC 185
+ T + P E ++ A + R D + E K EII + C
Sbjct: 221 EMATSEYPY-----SECQNAAQIYRRVTSGVKP-ASFDKVAIPEVK--EII------EGC 266
Query: 186 LNLNGRKRPTMKE 198
+ N +R ++K+
Sbjct: 267 IRQNKDERYSIKD 279
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 8e-19
Identities = 48/197 (24%), Positives = 83/197 (42%), Gaps = 25/197 (12%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEI-SLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
LV E NG + RY+ ++ + F+ E + ++ + YLHS I HRD+ +
Sbjct: 88 LVLEMCHNGEMNRYLKNRVKPFS---ENEARHFMHQIITGMLYLHSHG---ILHRDLTLS 141
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N+LL KI+DFG + + + T + GT Y+ E S + DV+S G
Sbjct: 142 NLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLESDVWSLGC 200
Query: 123 VFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLA 182
+F LL G+ P + ++ + + + + + EAK+ L
Sbjct: 201 MFYTLLIGRPPF------DTDTVKNTLNKVVLADYEM---PSFLSIEAKD--------LI 243
Query: 183 KRCLNLNGRKRPTMKEV 199
+ L N R ++ V
Sbjct: 244 HQLLRRNPADRLSLSSV 260
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-18
Identities = 32/136 (23%), Positives = 65/136 (47%), Gaps = 11/136 (8%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
L+ + +P G L Y+ + + + ++ V+++ ++YL + HRD+ +
Sbjct: 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLN--WCVQIAKGMNYLEDRRLV---HRDLAA 145
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGT---FGYLDLEYFRSSQFTKKGDVY 118
N+L+ KI+DFG ++ + ++ +G ++ LE +T + DV+
Sbjct: 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVW 203
Query: 119 SFGVVFVGLLT-GQKP 133
S+GV L+T G KP
Sbjct: 204 SYGVTVWELMTFGSKP 219
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-18
Identities = 46/211 (21%), Positives = 84/211 (39%), Gaps = 25/211 (11%)
Query: 4 LVYEFIPNGTLYRYIH-----DQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRD 58
++YE++ N ++ ++ D+ I ++ I V + SY+H+ +I HRD
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNI--CHRD 177
Query: 59 IKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFT--KKGD 116
+K +NIL+D R K+SDFG S Y+ + GT+ ++ E+F + K D
Sbjct: 178 VKPSNILMDKNGRVKLSDFGESEYMV--DKKIKGSR-GTYEFMPPEFFSNESSYNGAKVD 234
Query: 117 VYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEII 176
++S G+ + P SL F +N + + L ++
Sbjct: 235 IWSLGICLYVMFYNVVPF-----SLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKST 289
Query: 177 TVAM--------LAKRCLNLNGRKRPTMKEV 199
K L N +R T ++
Sbjct: 290 CSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 1e-18
Identities = 45/207 (21%), Positives = 83/207 (40%), Gaps = 31/207 (14%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
++ EF+ G L Y+ + ++ + L +A ++S A+ YL I HR++ +
Sbjct: 292 YIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFI---HRNLAAR 347
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N L+ + K++DFG SR +T D + + E ++F+ K DV++FGV
Sbjct: 348 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 407
Query: 123 VFVGLLT-GQKPIRSTDTEE--DKSLAGYFLRAMKENC---LFDMLDAQVLKEAKEEEII 176
+ + T G P D + + Y + E C ++++
Sbjct: 408 LLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-EGCPEKVYEL--------------- 451
Query: 177 TVAMLAKRCLNLNGRKRPTMKEVAFEL 203
M C N RP+ E+
Sbjct: 452 ---MR--ACWQWNPSDRPSFAEIHQAF 473
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-18
Identities = 32/189 (16%), Positives = 65/189 (34%), Gaps = 28/189 (14%)
Query: 12 GTLYRYIHDQTEEFTITWEISLR-IAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF 70
+L ++ E + + AL++LHS + H D+K ANI L +
Sbjct: 141 PSLQQHCEAWGASLP---EAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRG 194
Query: 71 RAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTG 130
R K+ DFG + +G Y+ E + + DV+S G+ + +
Sbjct: 195 RCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACN 251
Query: 131 QKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNG 190
+ + + +++ L A + E + + L +
Sbjct: 252 MELPHGGEG----------WQQLRQGYLPPEFTAGLSSELRS--------VLVMMLEPDP 293
Query: 191 RKRPTMKEV 199
+ R T + +
Sbjct: 294 KLRATAEAL 302
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-18
Identities = 42/209 (20%), Positives = 77/209 (36%), Gaps = 36/209 (17%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E N L ++ + +I + A+ +H I H D+K AN
Sbjct: 105 MVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPAN 157
Query: 64 ILLDDKFRAKISDFGASRYVTIDQT--HLTTRVQGTFGY-----------LDLEYFRSSQ 110
L+ D K+ DFG + + D T ++V GT Y S+
Sbjct: 158 FLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSSSRENGKSKSK 215
Query: 111 FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEA 170
+ K DV+S G + + G+ P + + K + N + D K+
Sbjct: 216 ISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-----LHAIIDPNHEIEFPD-IPEKDL 269
Query: 171 KEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
++ + K CL + ++R ++ E+
Sbjct: 270 QD--------VLKCCLKRDPKQRISIPEL 290
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-18
Identities = 37/133 (27%), Positives = 58/133 (43%), Gaps = 8/133 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E P G+L + F + R AV+V+ + YL S I HRD+ + N
Sbjct: 97 MVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGMGYLESKRFI---HRDLAARN 151
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGY--LDLEYFRSSQFTKKGDVYSFG 121
+LL + KI DFG R + + H + + E ++ F+ D + FG
Sbjct: 152 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 211
Query: 122 VVFVGLLT-GQKP 133
V + T GQ+P
Sbjct: 212 VTLWEMFTYGQEP 224
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 4e-18
Identities = 16/106 (15%), Positives = 33/106 (31%), Gaps = 8/106 (7%)
Query: 33 LRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTT 92
L++ ++V L+ LH + H ++ +I+LD + ++ F
Sbjct: 214 LQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG 270
Query: 93 RVQGTFGYLDLEYFRSSQ-----FTKKGDVYSFGVVFVGLLTGQKP 133
R Q T D ++ G+ + P
Sbjct: 271 RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 4e-18
Identities = 23/207 (11%), Positives = 59/207 (28%), Gaps = 35/207 (16%)
Query: 3 LLVYEFIPNGTLYRYI----HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRD 58
+Y L + + ++ L++ ++V L+ LH + H
Sbjct: 176 FFLYP-RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTY 231
Query: 59 IKSANILLDDKFRAKISDFGASRYVTIDQTHLTTR------VQGTFGYLDLEYFRSSQFT 112
++ +I+LD + ++ F +R ++ + R + T
Sbjct: 232 LRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMT 291
Query: 113 KKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKE 172
D ++ G+V + P + + + R+ + + +
Sbjct: 292 FSFDAWALGLVIYWIWCADLP---ITKDAALGGSEWIFRS----------CKNIPQPVRA 338
Query: 173 EEIITVAMLAKRCLNLNGRKRPTMKEV 199
L + L R +
Sbjct: 339 --------LLEGFLRYPKEDRLLPLQA 357
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-18
Identities = 41/209 (19%), Positives = 76/209 (36%), Gaps = 36/209 (17%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E N L ++ + +I + A+ +H I H D+K AN
Sbjct: 86 MVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPAN 138
Query: 64 ILLDDKFRAKISDFGASRYVTIDQT--HLTTRVQGTFGY-----------LDLEYFRSSQ 110
L+ D K+ DFG + + D T ++V GT Y S+
Sbjct: 139 FLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSSSRENGKSKSK 196
Query: 111 FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEA 170
+ K DV+S G + + G+ P + + K + N + K+
Sbjct: 197 ISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-----LHAIIDPNHEIE-FPDIPEKDL 250
Query: 171 KEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
++ + K CL + ++R ++ E+
Sbjct: 251 QD--------VLKCCLKRDPKQRISIPEL 271
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 6e-18
Identities = 49/224 (21%), Positives = 94/224 (41%), Gaps = 31/224 (13%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+V E++ G+L ++ +T ++ + + +A +++ ++Y+ + HRD+++A
Sbjct: 337 YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRDLRAA 392
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
NIL+ + K++DFG +R + ++ + + E +FT K DV+SFG+
Sbjct: 393 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 452
Query: 123 VFVGLLT-GQKPIRSTDTEE--DKSLAGYFLRAMKENC---LFDMLDAQVLKEAKEEEII 176
+ L T G+ P E D+ GY + C L D+
Sbjct: 453 LLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP-PECPESLHDL--------------- 496
Query: 177 TVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNCEGIDF 220
M +C +RPT + + L S PQ G +
Sbjct: 497 ---MC--QCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 535
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 6e-18
Identities = 39/135 (28%), Positives = 66/135 (48%), Gaps = 8/135 (5%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
+LV E G L++++ + I + +VS + YL + HR++ +
Sbjct: 410 LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFV---HRNLAA 464
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGY--LDLEYFRSSQFTKKGDVYS 119
N+LL ++ AKISDFG S+ + D ++ T R G + E +F+ + DV+S
Sbjct: 465 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWS 524
Query: 120 FGVVFVGLLT-GQKP 133
+GV L+ GQKP
Sbjct: 525 YGVTMWEALSYGQKP 539
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 8e-18
Identities = 44/196 (22%), Positives = 73/196 (37%), Gaps = 24/196 (12%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E +L + +T + ++ YLH + HRD+K N
Sbjct: 118 VVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGN 171
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
+ L++ KI DFG + V D + GT Y+ E + + DV+S G +
Sbjct: 172 LFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFEVDVWSIGCI 230
Query: 124 FVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAK 183
LL G+ P E L +LR K + + + A L +
Sbjct: 231 MYTLLVGKPPF------ETSCLKETYLRIKK--NEYSI-PKHINPVAAS--------LIQ 273
Query: 184 RCLNLNGRKRPTMKEV 199
+ L + RPT+ E+
Sbjct: 274 KMLQTDPTARPTINEL 289
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 9e-18
Identities = 42/141 (29%), Positives = 58/141 (41%), Gaps = 15/141 (10%)
Query: 4 LVYEFIPNGTLYRYIHDQ---TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
L+ EF P G LY+ + E+ S E++ AL Y H + HRDIK
Sbjct: 91 LMLEFAPRGELYKELQKHGRFDEQ------RSATFMEELADALHYCHERK---VIHRDIK 141
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
N+L+ K KI+DFG S + + GT YL E +K D++
Sbjct: 142 PENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMIEGKTHDEKVDLWCA 198
Query: 121 GVVFVGLLTGQKPIRSTDTEE 141
GV+ L G P S E
Sbjct: 199 GVLCYEFLVGMPPFDSPSHTE 219
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 1e-17
Identities = 49/224 (21%), Positives = 94/224 (41%), Gaps = 31/224 (13%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+V E++ G+L ++ +T ++ + + +A +++ ++Y+ + HRD+++A
Sbjct: 254 YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRDLRAA 309
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
NIL+ + K++DFG +R + ++ + + E +FT K DV+SFG+
Sbjct: 310 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 369
Query: 123 VFVGLLT-GQKPIRSTDTEE--DKSLAGYFLRAMKENC---LFDMLDAQVLKEAKEEEII 176
+ L T G+ P E D+ GY + C L D+
Sbjct: 370 LLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP-PECPESLHDL--------------- 413
Query: 177 TVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNCEGIDF 220
M +C +RPT + + L S PQ G +
Sbjct: 414 ---MC--QCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 452
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-17
Identities = 40/134 (29%), Positives = 67/134 (50%), Gaps = 8/134 (5%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+LV E G L++++ + I + +VS + YL + HRD+ +
Sbjct: 85 MLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFV---HRDLAAR 139
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF--GYLDLEYFRSSQFTKKGDVYSF 120
N+LL ++ AKISDFG S+ + D ++ T R G + + E +F+ + DV+S+
Sbjct: 140 NVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY 199
Query: 121 GVVFVGLLT-GQKP 133
GV L+ GQKP
Sbjct: 200 GVTMWEALSYGQKP 213
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 2e-17
Identities = 41/209 (19%), Positives = 76/209 (36%), Gaps = 36/209 (17%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E N L ++ + +I + A+ +H I H D+K AN
Sbjct: 133 MVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPAN 185
Query: 64 ILLDDKFRAKISDFGASRYVTIDQT--HLTTRVQGTFGY-----------LDLEYFRSSQ 110
L+ D K+ DFG + + D T ++V G Y S+
Sbjct: 186 FLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPEAIKDMSSSRENGKSKSK 243
Query: 111 FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEA 170
+ K DV+S G + + G+ P + + K + N + D K+
Sbjct: 244 ISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-----LHAIIDPNHEIEFPD-IPEKDL 297
Query: 171 KEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
++ + K CL + ++R ++ E+
Sbjct: 298 QD--------VLKCCLKRDPKQRISIPEL 318
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-17
Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L+ E++P G+L Y+ E + ++ + YL + I HRD+ + N
Sbjct: 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQ--YTSQICKGMEYLGTKRYI---HRDLATRN 175
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF--GYLDLEYFRSSQFTKKGDVYSFG 121
IL++++ R KI DFG ++ + D+ + + G + E S+F+ DV+SFG
Sbjct: 176 ILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFG 235
Query: 122 VVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEI------ 175
VV L T E+ KS F+R + + M+ +++ K
Sbjct: 236 VVLYELFTY--------IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDG 287
Query: 176 --ITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210
+ M+ C N N +RP+ +++A + IR +
Sbjct: 288 CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-17
Identities = 44/196 (22%), Positives = 72/196 (36%), Gaps = 24/196 (12%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E +L + +T + ++ YLH + HRD+K N
Sbjct: 92 VVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGN 145
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
+ L++ KI DFG + V D GT Y+ E + + DV+S G +
Sbjct: 146 LFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHSFEVDVWSIGCI 204
Query: 124 FVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAK 183
LL G+ P E L +LR K + + + A L +
Sbjct: 205 MYTLLVGKPPF------ETSCLKETYLRIKK--NEYSI-PKHINPVAAS--------LIQ 247
Query: 184 RCLNLNGRKRPTMKEV 199
+ L + RPT+ E+
Sbjct: 248 KMLQTDPTARPTINEL 263
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-17
Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 23/218 (10%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L+ E++P G+L Y+ E + ++ + YL + I HRD+ + N
Sbjct: 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQ--YTSQICKGMEYLGTKRYI---HRDLATRN 144
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF--GYLDLEYFRSSQFTKKGDVYSFG 121
IL++++ R KI DFG ++ + D+ + G + E S+F+ DV+SFG
Sbjct: 145 ILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFG 204
Query: 122 VVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEI------ 175
VV L T E+ KS F+R + + M+ +++ K
Sbjct: 205 VVLYELFTY--------IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDG 256
Query: 176 --ITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIG 211
+ M+ C N N +RP+ +++A + IR ++
Sbjct: 257 CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-17
Identities = 32/136 (23%), Positives = 65/136 (47%), Gaps = 11/136 (8%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
L+ + +P G L Y+ + + + ++ V+++ ++YL + HRD+ +
Sbjct: 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLN--WCVQIAKGMNYLEDRRLV---HRDLAA 145
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGT---FGYLDLEYFRSSQFTKKGDVY 118
N+L+ KI+DFG ++ + ++ +G ++ LE +T + DV+
Sbjct: 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVW 203
Query: 119 SFGVVFVGLLT-GQKP 133
S+GV L+T G KP
Sbjct: 204 SYGVTVWELMTFGSKP 219
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 3e-17
Identities = 34/177 (19%), Positives = 57/177 (32%), Gaps = 22/177 (12%)
Query: 4 LVYEFIPNGTLYRYIHD--QTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
LV E GTL I+ T E + + + A+ + + +H I H DIK
Sbjct: 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKP 200
Query: 62 ANILLDDKFRA-----------KISDFGASRYVTI--DQTHLTTRVQGTFGYLDLEYFRS 108
N +L + F + D G S + + T T + T G+ +E +
Sbjct: 201 DNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC-ETSGFQCVEMLSN 259
Query: 109 SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE---DKSLAGYFLRAMKENCLFDML 162
+ + D + +L G + E + M ML
Sbjct: 260 KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVML 316
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-17
Identities = 43/212 (20%), Positives = 82/212 (38%), Gaps = 26/212 (12%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
L+ EF+P+G+L Y+ + + ++ AV++ + YL S + HRD+ +
Sbjct: 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLK--YAVQICKGMDYLGSRQYV---HRDLAAR 155
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF--GYLDLEYFRSSQFTKKGDVYSF 120
N+L++ + + KI DFG ++ + D+ + T + + E S+F DV+SF
Sbjct: 156 NVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSF 215
Query: 121 GVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEI---- 175
GV LLT + M +++ KE +
Sbjct: 216 GVTLHELLTYCDSDSSPMALFLKMIGPTH----------GQMTVTRLVNTLKEGKRLPCP 265
Query: 176 ----ITVAMLAKRCLNLNGRKRPTMKEVAFEL 203
V L ++C R + + +
Sbjct: 266 PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 5e-17
Identities = 53/203 (26%), Positives = 83/203 (40%), Gaps = 33/203 (16%)
Query: 4 LVYEFIPNGTLYRYIHDQ---TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
LV E G L+ I + E + I +V ++YLH I HRD+K
Sbjct: 113 LVMECYKGGELFDEIIHRMKFNEV------DAAVIIKQVLSGVTYLHKHN---IVHRDLK 163
Query: 61 SANILLDDK---FRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDV 117
N+LL+ K KI DFG S + + R+ GT Y+ E R + +K DV
Sbjct: 164 PENLLLESKEKDALIKIVDFGLSAVFENQKK-MKERL-GTAYYIAPEVLRKK-YDEKCDV 220
Query: 118 YSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLD-AQVLKEAKEEEII 176
+S GV+ LL G P ++ + K FD + V + AK+
Sbjct: 221 WSIGVILFILLAGYPPFG------GQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD---- 270
Query: 177 TVAMLAKRCLNLNGRKRPTMKEV 199
L K+ L + ++R + ++
Sbjct: 271 ----LIKQMLQFDSQRRISAQQA 289
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-17
Identities = 52/214 (24%), Positives = 82/214 (38%), Gaps = 12/214 (5%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
LV E++P G+L Y+ + I L A ++ ++YLH+ I HRD+ +
Sbjct: 111 QLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQHYI---HRDLAAR 163
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF--GYLDLEYFRSSQFTKKGDVYSF 120
N+LLD+ KI DFG ++ V + R G + E + +F DV+SF
Sbjct: 164 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSF 223
Query: 121 GVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVA 179
GV LLT + M L ++L+ ++ V
Sbjct: 224 GVTLYELLTHCDSSQSPPTKFLELIGIAQ--GQMTVLRLTELLERGERLPRPDKCPAEVY 281
Query: 180 MLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQ 213
L K C RPT + + L + Q
Sbjct: 282 HLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-17
Identities = 30/136 (22%), Positives = 62/136 (45%), Gaps = 11/136 (8%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
LV +++P G+L ++ ++ V+++ + YL + HR++ +
Sbjct: 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLN--WGVQIAKGMYYLEEHGMV---HRNLAA 143
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGT---FGYLDLEYFRSSQFTKKGDVY 118
N+LL + +++DFG + + D L ++ LE ++T + DV+
Sbjct: 144 RNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMALESIHFGKYTHQSDVW 201
Query: 119 SFGVVFVGLLT-GQKP 133
S+GV L+T G +P
Sbjct: 202 SYGVTVWELMTFGAEP 217
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 7e-17
Identities = 39/134 (29%), Positives = 66/134 (49%), Gaps = 9/134 (6%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+LV E G L +Y+ + + + + +VS + YL + + HRD+ +
Sbjct: 93 MLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESNFV---HRDLAAR 146
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF--GYLDLEYFRSSQFTKKGDVYSF 120
N+LL + AKISDFG S+ + D+ + + G + + E +F+ K DV+SF
Sbjct: 147 NVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF 206
Query: 121 GVVFVGLLT-GQKP 133
GV+ + GQKP
Sbjct: 207 GVLMWEAFSYGQKP 220
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 8e-17
Identities = 47/203 (23%), Positives = 89/203 (43%), Gaps = 10/203 (4%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV E++P+G L ++ + + + ++ + YL S + HRD+ + N
Sbjct: 103 LVMEYLPSGCLRDFLQRHRARLDASRLLL--YSSQICKGMEYLGSRRCV---HRDLAARN 157
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF--GYLDLEYFRSSQFTKKGDVYSFG 121
IL++ + KI+DFG ++ + +D+ + R G + E + F+++ DV+SFG
Sbjct: 158 ILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFG 217
Query: 122 VVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
VV L T K + + E + G + L ++L+ A V
Sbjct: 218 VVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHE 275
Query: 181 LAKRCLNLNGRKRPTMKEVAFEL 203
L K C + + RP+ + +L
Sbjct: 276 LMKLCWAPSPQDRPSFSALGPQL 298
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 2e-16
Identities = 32/114 (28%), Positives = 60/114 (52%), Gaps = 5/114 (4%)
Query: 34 RIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTR 93
++++ V L+YL I HRD+K +NIL++ + K+ DFG S + + +
Sbjct: 135 KVSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SF 190
Query: 94 VQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAG 147
V GT Y+ E + + ++ + D++S G+ V + G+ PI D +E + + G
Sbjct: 191 V-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 243
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-16
Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 33/203 (16%)
Query: 4 LVYEFIPNGTLYRYIHDQ---TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
LV E G L+ I + +E + RI +V ++Y+H I HRD+K
Sbjct: 103 LVGEVYTGGELFDEIISRKRFSEV------DAARIIRQVLSGITYMHKNK---IVHRDLK 153
Query: 61 SANILLDDK---FRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDV 117
N+LL+ K +I DFG S + + + ++ GT Y+ E + + +K DV
Sbjct: 154 PENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKI-GTAYYIAPEVLHGT-YDEKCDV 210
Query: 118 YSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLD-AQVLKEAKEEEII 176
+S GV+ LL+G P + + K F++ +V + AK+
Sbjct: 211 WSTGVILYILLSGCPPFN------GANEYDILKKVEKGKYTFELPQWKKVSESAKD---- 260
Query: 177 TVAMLAKRCLNLNGRKRPTMKEV 199
L ++ L R + ++
Sbjct: 261 ----LIRKMLTYVPSMRISARDA 279
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-16
Identities = 61/203 (30%), Positives = 84/203 (41%), Gaps = 33/203 (16%)
Query: 4 LVYEFIPNGTLYRYIHDQ---TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
LV EF G L+ I ++ E I ++ + YLH I HRDIK
Sbjct: 123 LVTEFYEGGELFEQIINRHKFDECDAA------NIMKQILSGICYLHKHN---IVHRDIK 173
Query: 61 SANILLDDK---FRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDV 117
NILL++K KI DFG S + + D L R+ GT Y+ E + + +K DV
Sbjct: 174 PENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRDRL-GTAYYIAPEVLKKK-YNEKCDV 230
Query: 118 YSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLD-AQVLKEAKEEEII 176
+S GV+ LL G P ++ + K FD D + EAKE
Sbjct: 231 WSCGVIMYILLCGYPPFG------GQNDQDIIKKVEKGKYYFDFNDWKNISDEAKE---- 280
Query: 177 TVAMLAKRCLNLNGRKRPTMKEV 199
L K L + KR T +E
Sbjct: 281 ----LIKLMLTYDYNKRCTAEEA 299
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 4e-16
Identities = 34/136 (25%), Positives = 59/136 (43%), Gaps = 12/136 (8%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
++ E P G L Y+ + + ++++ A++YL S + HRDI
Sbjct: 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVL--YSLQICKAMAYLESINCV---HRDIAV 141
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGT---FGYLDLEYFRSSQFTKKGDVY 118
NIL+ K+ DFG SRY+ + + T ++ E +FT DV+
Sbjct: 142 RNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLPIKWMSPESINFRRFTTASDVW 198
Query: 119 SFGVVFVGLLT-GQKP 133
F V +L+ G++P
Sbjct: 199 MFAVCMWEILSFGKQP 214
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-16
Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 30/199 (15%)
Query: 4 LVYEFIPNGTLYRYI--HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
L+ E+ G ++ Y+ H + +E + + ++ A+ Y H I HRD+K+
Sbjct: 91 LIMEYASGGEVFDYLVAHGRMKE-----KEARSKFRQIVSAVQYCHQKR---IVHRDLKA 142
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFT-KKGDVYSF 120
N+LLD KI+DFG S T+ L G Y E F+ ++ + DV+S
Sbjct: 143 ENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC-GAPPYAAPELFQGKKYDGPEVDVWSL 200
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
GV+ L++G P + +E LR + + + + +
Sbjct: 201 GVILYTLVSGSLPFDGQNLKE--------LRERVLRGKYRIPF-YMSTDCEN-------- 243
Query: 181 LAKRCLNLNGRKRPTMKEV 199
L KR L LN KR T++++
Sbjct: 244 LLKRFLVLNPIKRGTLEQI 262
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-16
Identities = 35/130 (26%), Positives = 54/130 (41%), Gaps = 7/130 (5%)
Query: 7 EFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILL 66
E +P G+L + + + ++ L YLH I HRDIK N+L+
Sbjct: 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLI 155
Query: 67 DDKF-RAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQ--FTKKGDVYSFGVV 123
+ KISDFG S+ + T GT Y+ E + K D++S G
Sbjct: 156 NTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCT 214
Query: 124 FVGLLTGQKP 133
+ + TG+ P
Sbjct: 215 IIEMATGKPP 224
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 9e-16
Identities = 28/133 (21%), Positives = 51/133 (38%), Gaps = 13/133 (9%)
Query: 7 EFIPNGTLYRYIHDQTEEFTITWEISLR-IAVEVSGALSYLHSTTSIPIYHRDIKSANIL 65
E + G+ + ++ E + L YLH+ + H D+K+ N+L
Sbjct: 130 ELLEGGS----LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRIL---HGDVKADNVL 182
Query: 66 LDDK-FRAKISDFGASRYVTIDQTHLTTR----VQGTFGYLDLEYFRSSQFTKKGDVYSF 120
L RA + DFG + + D + + GT ++ E K D++S
Sbjct: 183 LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSS 242
Query: 121 GVVFVGLLTGQKP 133
+ + +L G P
Sbjct: 243 CCMMLHMLNGCHP 255
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 9e-16
Identities = 39/134 (29%), Positives = 62/134 (46%), Gaps = 8/134 (5%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
++V E++ NG+L ++ +FTI + + V + YL + HRD+ +
Sbjct: 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVG--MLRGVGAGMRYLSDLGYV---HRDLAAR 180
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL--DLEYFRSSQFTKKGDVYSF 120
N+L+D K+SDFG SR + D T G E F+ DV+SF
Sbjct: 181 NVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSF 240
Query: 121 GVVFVGLLT-GQKP 133
GVV +L G++P
Sbjct: 241 GVVMWEVLAYGERP 254
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-15
Identities = 43/166 (25%), Positives = 71/166 (42%), Gaps = 17/166 (10%)
Query: 39 VSGALSYLHSTTSIPIYHRDIKSANILLDDKFRA---KISDFGASRYVTIDQTHLTTRVQ 95
+ A+S++H + HRD+K N+L D+ KI DFG +R D L T
Sbjct: 115 LVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC- 170
Query: 96 GTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRS-TDTEEDKSLAGYFLRAMK 154
T Y E + + + D++S GV+ +L+GQ P +S + S + K
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK 230
Query: 155 ENCLFDMLD-AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
+ F+ V +EAK+ L + L ++ KR M +
Sbjct: 231 GDFSFEGEAWKNVSQEAKD--------LIQGLLTVDPNKRLKMSGL 268
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 34/134 (25%), Positives = 66/134 (49%), Gaps = 8/134 (5%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+++ E++ NG L +++ + ++ + + + ++ + YL + + HRD+ +
Sbjct: 122 MIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLANMNYV---HRDLAAR 176
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGY--LDLEYFRSSQFTKKGDVYSF 120
NIL++ K+SDFG SR + D T G E +FT DV+SF
Sbjct: 177 NILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSF 236
Query: 121 GVVFVGLLT-GQKP 133
G+V ++T G++P
Sbjct: 237 GIVMWEVMTYGERP 250
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-15
Identities = 54/214 (25%), Positives = 89/214 (41%), Gaps = 39/214 (18%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
+P ++ ++ +G L ++I T+ IS ++V+ + YL + HRD+
Sbjct: 97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS--FGLQVARGMEYLAEQKFV---HRDLA 151
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL-----DLEYFRSSQFTKKG 115
+ N +LD+ F K++DFG +R I + Q L LE ++ +FT K
Sbjct: 152 ARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKS 209
Query: 116 DVYSFGVVFVGLLT-GQKPIRSTDTEE--DKSLAGYFLRAMKENC---LFDMLDAQVLKE 169
DV+SFGV+ LLT G P R D + G L E C L+ +
Sbjct: 210 DVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQP-EYCPDSLYQV-------- 260
Query: 170 AKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203
M +C + RPT + + E+
Sbjct: 261 ----------MQ--QCWEADPAVRPTFRVLVGEV 282
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-15
Identities = 38/139 (27%), Positives = 64/139 (46%), Gaps = 20/139 (14%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+V E+I NG L Y+ + + + + +V +++L S I HRD+ +
Sbjct: 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLE--MCYDVCEGMAFLESHQFI---HRDLAAR 133
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDL-------EYFRSSQFTKKG 115
N L+D K+SDFG +RYV DQ GT E F +++ K
Sbjct: 134 NCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGT----KFPVKWSAPEVFHYFKYSSKS 186
Query: 116 DVYSFGVVFVGLLT-GQKP 133
DV++FG++ + + G+ P
Sbjct: 187 DVWAFGILMWEVFSLGKMP 205
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 2e-15
Identities = 43/221 (19%), Positives = 87/221 (39%), Gaps = 34/221 (15%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
L+ + G L ++ ++ + L+I + A+ ++H PI HRD+K
Sbjct: 109 FLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVE 167
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLE-----YFRS-------SQ 110
N+LL ++ K+ DFG++ ++ + + + ++ +R+ S
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227
Query: 111 F--TKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLK 168
F +K D+++ G + L Q P ED + LR + N + +
Sbjct: 228 FPIGEKQDIWALGCILYLLCFRQHPF------EDGAK----LRIV--NGKYSIPPHDTQY 275
Query: 169 EAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209
L + L +N +R ++ EV +L I A+
Sbjct: 276 TV-------FHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-15
Identities = 39/139 (28%), Positives = 67/139 (48%), Gaps = 20/139 (14%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
++ E++ NG L Y+ + F + + +V A+ YL S + HRD+ +
Sbjct: 95 FIITEYMANGCLLNYLREMRHRFQTQQLLE--MCKDVCEAMEYLESKQFL---HRDLAAR 149
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDL-------EYFRSSQFTKKG 115
N L++D+ K+SDFG SRYV D+ T G+ E S+F+ K
Sbjct: 150 NCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGS----KFPVRWSPPEVLMYSKFSSKS 202
Query: 116 DVYSFGVVFVGLLT-GQKP 133
D+++FGV+ + + G+ P
Sbjct: 203 DIWAFGVLMWEIYSLGKMP 221
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-15
Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 8/134 (5%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
++V E++ NG+L ++ +FT+ + + ++ + YL + HRD+ +
Sbjct: 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVG--MLRGIASGMKYLSDMGYV---HRDLAAR 176
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL--DLEYFRSSQFTKKGDVYSF 120
NIL++ K+SDFG R + D T G E +FT DV+S+
Sbjct: 177 NILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSY 236
Query: 121 GVVFVGLLT-GQKP 133
G+V +++ G++P
Sbjct: 237 GIVLWEVMSYGERP 250
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-15
Identities = 41/134 (30%), Positives = 66/134 (49%), Gaps = 10/134 (7%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
LV EF+ +G L Y+ Q F + + ++V ++YL I HRD+ +
Sbjct: 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLG--MCLDVCEGMAYLEEACVI---HRDLAAR 133
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGY--LDLEYFRSSQFTKKGDVYSF 120
N L+ + K+SDFG +R+V DQ T+ F E F S+++ K DV+SF
Sbjct: 134 NCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 191
Query: 121 GVVFVGLLT-GQKP 133
GV+ + + G+ P
Sbjct: 192 GVLMWEVFSEGKIP 205
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-15
Identities = 33/134 (24%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
++ EF+ G+L ++ + + +++ ++++ I HRD+++A
Sbjct: 258 YIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIEQRNYI---HRDLRAA 313
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGY--LDLEYFRSSQFTKKGDVYSF 120
NIL+ KI+DFG +R + ++ T R F E FT K DV+SF
Sbjct: 314 NILVSASLVCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 371
Query: 121 GVVFVGLLT-GQKP 133
G++ + ++T G+ P
Sbjct: 372 GILLMEIVTYGRIP 385
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-15
Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 15/139 (10%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
PL+V ++ +G L +I ++T T+ + + ++V+ + YL S + HRD+ +
Sbjct: 102 PLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASKKFV---HRDLAA 156
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL------DLEYFRSSQFTKKG 115
N +LD+KF K++DFG +R + V G LE ++ +FT K
Sbjct: 157 RNCMLDEKFTVKVADFGLARDM---YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKS 213
Query: 116 DVYSFGVVFVGLLT-GQKP 133
DV+SFGV+ L+T G P
Sbjct: 214 DVWSFGVLLWELMTRGAPP 232
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 5e-15
Identities = 36/132 (27%), Positives = 60/132 (45%), Gaps = 6/132 (4%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
++ E G L ++ + + I A ++S AL+YL S + HRDI +
Sbjct: 466 WIIMELCTLGELRSFLQVRKFSLDLASLIL--YAYQLSTALAYLESKRFV---HRDIAAR 520
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N+L+ K+ DFG SRY+ + ++ + ++ E +FT DV+ FGV
Sbjct: 521 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 580
Query: 123 VFVGLLT-GQKP 133
+L G KP
Sbjct: 581 CMWEILMHGVKP 592
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 6e-15
Identities = 48/209 (22%), Positives = 84/209 (40%), Gaps = 35/209 (16%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
++ EF+ G L Y+ + + ++ + L +A ++S A+ YL I HRD+ +
Sbjct: 85 YIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKNFI---HRDLAAR 140
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGY--LDLEYFRSSQFTKKGDVYSF 120
N L+ + K++DFG SR +T D T F E ++F+ K DV++F
Sbjct: 141 NCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 198
Query: 121 GVVFVGLLT-GQKPIRSTDTEE--DKSLAGYFLRAMKENC---LFDMLDAQVLKEAKEEE 174
GV+ + T G P D + + Y + E C ++++
Sbjct: 199 GVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-EGCPEKVYEL------------- 244
Query: 175 IITVAMLAKRCLNLNGRKRPTMKEVAFEL 203
M C N RP+ E+
Sbjct: 245 -----MR--ACWQWNPSDRPSFAEIHQAF 266
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 7e-15
Identities = 41/138 (29%), Positives = 73/138 (52%), Gaps = 13/138 (9%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
PL+V ++ +G L +I ++T T+ ++ + ++V+ + +L S + HRD+ +
Sbjct: 166 PLVVLPYMKHGDLRNFIRNETHNPTVK-DL-IGFGLQVAKGMKFLASKKFV---HRDLAA 220
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL-----DLEYFRSSQFTKKGD 116
N +LD+KF K++DFG +R + + T L LE ++ +FT K D
Sbjct: 221 RNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMALESLQTQKFTTKSD 278
Query: 117 VYSFGVVFVGLLT-GQKP 133
V+SFGV+ L+T G P
Sbjct: 279 VWSFGVLLWELMTRGAPP 296
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-14
Identities = 40/165 (24%), Positives = 64/165 (38%), Gaps = 27/165 (16%)
Query: 41 GALSYLHSTTSIPIYHRDIKSANILLDDKFRA---KISDFGASRYVTIDQTHLTTRVQGT 97
AL Y H I HRD+K +LL K + K+ FG + + RV GT
Sbjct: 141 EALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GT 196
Query: 98 FGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157
++ E + + K DV+ GV+ LL+G P T + +
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL--------FEGIIK-G 247
Query: 158 LFDMLD---AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
+ M + + + AK+ L +R L L+ +R T+ E
Sbjct: 248 KYKMNPRQWSHISESAKD--------LVRRMLMLDPAERITVYEA 284
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 44/163 (26%), Positives = 68/163 (41%), Gaps = 24/163 (14%)
Query: 41 GALSYLHSTTSIPIYHRDIKSANILLDDK---FRAKISDFGASRYVTIDQTHLTTRVQGT 97
++Y+H I HRD+K NILL+ K KI DFG S + + R+ GT
Sbjct: 132 SGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GT 186
Query: 98 FGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157
Y+ E R + + +K DV+S GV+ LL+G P K+ R
Sbjct: 187 AYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFY------GKNEYDILKRVETGKY 239
Query: 158 LFDMLD-AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
FD+ + +AK+ L ++ L + R T +
Sbjct: 240 AFDLPQWRTISDDAKD--------LIRKMLTFHPSLRITATQC 274
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-14
Identities = 45/206 (21%), Positives = 81/206 (39%), Gaps = 33/206 (16%)
Query: 4 LVYEFIPNGTLYRYIHDQ---TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
+V E + G L I Q +E E S + ++ + YLH+ + HRD+K
Sbjct: 93 VVTELMKGGELLDKILRQKFFSER-----EAS-AVLFTITKTVEYLHAQG---VVHRDLK 143
Query: 61 SANILL----DDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGD 116
+NIL + +I DFG ++ + + L T T ++ E + D
Sbjct: 144 PSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVLERQGYDAACD 202
Query: 117 VYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLD---AQVLKEAKEE 173
++S GV+ +LTG P + + + + L + F + V AK+
Sbjct: 203 IWSLGVLLYTMLTGYTPFANGPDDTPEEI----LARIGS-GKFSLSGGYWNSVSDTAKD- 256
Query: 174 EIITVAMLAKRCLNLNGRKRPTMKEV 199
L + L+++ +R T V
Sbjct: 257 -------LVSKMLHVDPHQRLTAALV 275
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-14
Identities = 37/134 (27%), Positives = 68/134 (50%), Gaps = 9/134 (6%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
++ E++ NG+L ++ +T L +A +++ ++++ I HRD+++A
Sbjct: 83 YIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERNYI---HRDLRAA 138
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGY--LDLEYFRSSQFTKKGDVYSF 120
NIL+ D KI+DFG +R + ++ T R F E FT K DV+SF
Sbjct: 139 NILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 196
Query: 121 GVVFVGLLT-GQKP 133
G++ ++T G+ P
Sbjct: 197 GILLTEIVTHGRIP 210
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-14
Identities = 48/206 (23%), Positives = 85/206 (41%), Gaps = 34/206 (16%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E + G L+ + + ++ A+ YLH I HRD+K N
Sbjct: 216 IVLELMEGGELFDKV---VGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPEN 269
Query: 64 ILLDDK---FRAKISDFGASRYVTIDQTHLTTRVQGTFGYLD---LEYFRSSQFTKKGDV 117
+LL + KI+DFG S+ + + + + T GT YL L ++ + + D
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDC 327
Query: 118 YSFGVVFVGLLTGQKPIRSTDTEE---DKSLAGYFLRAMKENCLFDMLD-AQVLKEAKEE 173
+S GV+ L+G P T+ D+ +G + F A+V ++A +
Sbjct: 328 WSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY--------NFIPEVWAEVSEKALD- 378
Query: 174 EIITVAMLAKRCLNLNGRKRPTMKEV 199
L K+ L ++ + R T +E
Sbjct: 379 -------LVKKLLVVDPKARFTTEEA 397
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-14
Identities = 37/134 (27%), Positives = 58/134 (43%), Gaps = 10/134 (7%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
++ E G L ++ + + I A ++S AL+YL S + HRDI +
Sbjct: 91 WIIMELCTLGELRSFLQVRKYSLDLASLIL--YAYQLSTALAYLESKRFV---HRDIAAR 145
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF--GYLDLEYFRSSQFTKKGDVYSF 120
N+L+ K+ DFG SRY+ +G ++ E +FT DV+ F
Sbjct: 146 NVLVSSNDCVKLGDFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMF 203
Query: 121 GVVFVGLLT-GQKP 133
GV +L G KP
Sbjct: 204 GVCMWEILMHGVKP 217
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-14
Identities = 47/195 (24%), Positives = 76/195 (38%), Gaps = 37/195 (18%)
Query: 14 LYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAK 73
L + + E + ++ V + AL YL + I HRD+K +NILLD++ + K
Sbjct: 113 LKKRMQGPIPERILG-----KMTVAIVKALYYLKEKHGV-I-HRDVKPSNILLDERGQIK 165
Query: 74 ISDFGASRYVTIDQTHLTTRVQGTFGY-----LDLEYFRSSQFTKKGDVYSFGVVFVGLL 128
+ DFG S + D G Y +D + + DV+S G+ V L
Sbjct: 166 LCDFGISGRLV-DDKAKDRSA-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA 223
Query: 129 TGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEA---KEEEIITVAM--LAK 183
TGQ P ++ T+ F++L + +E + K
Sbjct: 224 TGQFPYKNCKTD------------------FEVLTKVLQEEPPLLPGHMGFSGDFQSFVK 265
Query: 184 RCLNLNGRKRPTMKE 198
CL + RKRP +
Sbjct: 266 DCLTKDHRKRPKYNK 280
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 45/165 (27%), Positives = 67/165 (40%), Gaps = 26/165 (15%)
Query: 41 GALSYLHSTTSIPIYHRDIKSANILLDDKFRA---KISDFGASRYVTIDQTHLTTRVQGT 97
A+ + H + HR++K N+LL K + K++DFG + V +Q GT
Sbjct: 121 EAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GT 176
Query: 98 FGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE--DKSLAGYFLRAMKE 155
GYL E R + K D+++ GV+ LL G P D + AG +
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAY------ 230
Query: 156 NCLFDMLD-AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
F + V EAK+ L + L +N KR T E
Sbjct: 231 --DFPSPEWDTVTPEAKD--------LINKMLTINPSKRITAAEA 265
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-14
Identities = 35/133 (26%), Positives = 67/133 (50%), Gaps = 13/133 (9%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E++ G+L Y+ + + + L+ +++V A+ YL + HRD+ + N
Sbjct: 264 IVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNNFV---HRDLAARN 319
Query: 64 ILLDDKFRAKISDFGASR--YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
+L+ + AK+SDFG ++ T D L + + E R +F+ K DV+SFG
Sbjct: 320 VLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFG 373
Query: 122 VVFVGLLT-GQKP 133
++ + + G+ P
Sbjct: 374 ILLWEIYSFGRVP 386
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-14
Identities = 34/150 (22%), Positives = 56/150 (37%), Gaps = 38/150 (25%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+LV EF+ G+L Y+ I W++ +A +++ A+ +L T I H ++ +
Sbjct: 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLE--VAKQLAAAMHFLEENTLI---HGNVCAK 142
Query: 63 NILLDDKFR--------AKISDFGASRYVTIDQTHLTTRVQGTFGYLD----------LE 104
NILL + K+SD G S V L +E
Sbjct: 143 NILLIREEDRKTGNPPFIKLSDPGISITVLPKD------------ILQERIPWVPPECIE 190
Query: 105 YFRSSQFTKKGDVYSFGVVFVGLLT-GQKP 133
+ D +SFG + + G KP
Sbjct: 191 NPK--NLNLATDKWSFGTTLWEICSGGDKP 218
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-14
Identities = 43/202 (21%), Positives = 79/202 (39%), Gaps = 32/202 (15%)
Query: 4 LVYEFIPNGTLYRYIHDQ--TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
+V+E + G + + +E+ + ++ + YLH I HRDIK
Sbjct: 115 MVFELVNQGPVMEVPTLKPLSED------QARFYFQDLIKGIEYLHYQK---IIHRDIKP 165
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFT---KKGDVY 118
+N+L+ + KI+DFG S L+ V GT ++ E ++ K DV+
Sbjct: 166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVW 224
Query: 119 SFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVL-KEAKEEEIIT 177
+ GV + GQ P D+ + + + + D + ++ K+
Sbjct: 225 AMGVTLYCFVFGQCPF------MDERIMCLHSKIKSQA--LEFPDQPDIAEDLKD----- 271
Query: 178 VAMLAKRCLNLNGRKRPTMKEV 199
L R L+ N R + E+
Sbjct: 272 ---LITRMLDKNPESRIVVPEI 290
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-14
Identities = 48/229 (20%), Positives = 92/229 (40%), Gaps = 42/229 (18%)
Query: 2 PLLVYEFIPNGTLYRYI---HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRD 58
P+++ F+ +G L+ ++ F + + +R V+++ + YL S I HRD
Sbjct: 106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFI---HRD 162
Query: 59 IKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL-----DLEYFRSSQFTK 113
+ + N +L + ++DFG SR + + QG L LE + +T
Sbjct: 163 LAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASKLPVKWLALESLADNLYTV 218
Query: 114 KGDVYSFGVVFVGLLT-GQKPIRSTDTEE--DKSLAGYFLRAMKENC---LFDMLDAQVL 167
DV++FGV ++T GQ P + E + + G L C ++D+
Sbjct: 219 HSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL-KQPPECMEEVYDL------ 271
Query: 168 KEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNCE 216
M +C + + ++RP+ + EL I + +
Sbjct: 272 ------------MY--QCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 4e-14
Identities = 33/141 (23%), Positives = 60/141 (42%), Gaps = 5/141 (3%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKSA 62
LV + G + +I++ E+ E ++ L +LH I +RD+K
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPE 318
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N+LLDD +ISD G + + QT GT G++ E ++ D ++ GV
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGV 377
Query: 123 VFVGLLTGQKPIRSTDTEEDK 143
++ + P R+ + +
Sbjct: 378 TLYEMIAARGPFRARGEKVEN 398
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-14
Identities = 43/173 (24%), Positives = 71/173 (41%), Gaps = 30/173 (17%)
Query: 34 RIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTR 93
+IAV + AL +LHS S+ I HRD+K +N+L++ + K+ DFG S Y+
Sbjct: 113 KIAVSIVKALEHLHSKLSV-I-HRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDI 168
Query: 94 VQGTFGYLDLE----YFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF 149
G Y+ E ++ K D++S G+ + L + P S T
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP--------- 219
Query: 150 LRAMKENCLFDMLDAQVLKEA--KEEEIITVAMLA--KRCLNLNGRKRPTMKE 198
F L V + + + + + +CL N ++RPT E
Sbjct: 220 ---------FQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-14
Identities = 49/223 (21%), Positives = 88/223 (39%), Gaps = 42/223 (18%)
Query: 2 PLLVYEFIPNGTLYRYI---HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRD 58
P+++ F+ G L+ Y+ +T I + L+ V+++ + YL + + HRD
Sbjct: 116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFL---HRD 172
Query: 59 IKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL-----DLEYFRSSQFTK 113
+ + N +L D ++DFG S+ + + QG + +E +T
Sbjct: 173 LAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMPVKWIAIESLADRVYTS 228
Query: 114 KGDVYSFGVVFVGLLT-GQKPIRSTDTEE--DKSLAGYFLRAMKENC---LFDMLDAQVL 167
K DV++FGV + T G P E D L G+ L E+C L+++
Sbjct: 229 KSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL-KQPEDCLDELYEI------ 281
Query: 168 KEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210
M C + RPT + +L + S+
Sbjct: 282 ------------MY--SCWRTDPLDRPTFSVLRLQLEKLLESL 310
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-14
Identities = 43/165 (26%), Positives = 70/165 (42%), Gaps = 26/165 (15%)
Query: 41 GALSYLHSTTSIPIYHRDIKSANILLDDKFRA---KISDFGASRYVTIDQTHLTTRVQGT 97
A++YLH I HRD+K N+L KI+DFG S+ V Q + T GT
Sbjct: 159 EAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTVC-GT 213
Query: 98 FGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157
GY E R + + D++S G++ LL G +P ++ + NC
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-------MFRRILNC 266
Query: 158 LFDMLD---AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
+ + +V AK+ L ++ + L+ +KR T +
Sbjct: 267 EYYFISPWWDEVSLNAKD--------LVRKLIVLDPKKRLTTFQA 303
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-14
Identities = 46/201 (22%), Positives = 81/201 (40%), Gaps = 39/201 (19%)
Query: 4 LVYEFI-PNGTLYRYI--HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
L+ E P L+ +I +E E++ +V A+ + H+ + HRDIK
Sbjct: 125 LILERPEPVQDLFDFITERGALQE-----ELARSFFWQVLEAVRHCHNCG---VLHRDIK 176
Query: 61 SANILLD-DKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFT-KKGDVY 118
NIL+D ++ K+ DFG+ + T T GT Y E+ R ++ + V+
Sbjct: 177 DENILIDLNRGELKLIDFGSGALLK--DTVYTDFD-GTRVYSPPEWIRYHRYHGRSAAVW 233
Query: 119 SFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITV 178
S G++ ++ G P +++ + G +V E +
Sbjct: 234 SLGILLYDMVCGDIPFE----HDEEIIRGQV-----------FFRQRVSSECQH------ 272
Query: 179 AMLAKRCLNLNGRKRPTMKEV 199
L + CL L RPT +E+
Sbjct: 273 --LIRWCLALRPSDRPTFEEI 291
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-13
Identities = 40/143 (27%), Positives = 66/143 (46%), Gaps = 15/143 (10%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKSA 62
+ + + G L+ ++ Q F+ E +R A E+ L ++H+ + +RD+K A
Sbjct: 269 FILDLMNGGDLHYHLS-QHGVFS---EADMRFYAAEIILGLEHMHNRF---VVYRDLKPA 321
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLE-YFRSSQFTKKGDVYSFG 121
NILLD+ +ISD G + + + H V GT GY+ E + + D +S G
Sbjct: 322 NILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLG 378
Query: 122 VVFVGLLTGQKPIR---STDTEE 141
+ LL G P R + D E
Sbjct: 379 CMLFKLLRGHSPFRQHKTKDKHE 401
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 1e-13
Identities = 41/175 (23%), Positives = 66/175 (37%), Gaps = 27/175 (15%)
Query: 34 RIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRA--KISDFGASRYVTI----DQ 87
I ++ AL YLH+ I HRDIK N L K+ DFG S+ +
Sbjct: 172 NIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228
Query: 88 THLTTRVQGTFGYLDLEYFRSSQ--FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSL 145
+TT+ GT ++ E ++ + K D +S GV+ LL G P +
Sbjct: 229 YGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF------PGVND 281
Query: 146 AGYFLRAMKENCLFDMLD-AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
A + + + F+ + + A++ L LN N +R
Sbjct: 282 ADTISQVLNKKLCFENPNYNVLSPLARD--------LLSNLLNRNVDERFDAMRA 328
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-13
Identities = 37/165 (22%), Positives = 63/165 (38%), Gaps = 28/165 (16%)
Query: 41 GALSYLHSTTSIPIYHRDIKSANILL---DDKFRAKISDFGASRYVTIDQTHLTTRVQGT 97
A+ YLH I HRD+K N+L ++ + I+DFG S+ ++T GT
Sbjct: 117 SAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTAC-GT 170
Query: 98 FGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157
GY+ E ++K D +S GV+ LL G P + +K
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-------LFEKIK-EG 222
Query: 158 LFDMLD---AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
++ + + AK+ L + +R T ++
Sbjct: 223 YYEFESPFWDDISESAKD--------FICHLLEKDPNERYTCEKA 259
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-13
Identities = 46/161 (28%), Positives = 68/161 (42%), Gaps = 23/161 (14%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDK---FRAKISDFGASRYVTIDQTHLTTRVQGTF 98
AL+Y HS + H+D+K NIL D KI DFG + D+ T GT
Sbjct: 136 ALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-STNAA-GTA 190
Query: 99 GYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158
Y+ E F+ T K D++S GVV LLTG P SL +A +
Sbjct: 191 LYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPF------TGTSLEEVQQKATYKEPN 243
Query: 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
+ + + +A + L K+ L + +RP+ +V
Sbjct: 244 YAVECRPLTPQAVD--------LLKQMLTKDPERRPSAAQV 276
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 2e-13
Identities = 42/142 (29%), Positives = 66/142 (46%), Gaps = 10/142 (7%)
Query: 4 LVYEFIPNGTLYRYIHDQTEE-FTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKS 61
LV + G L +I+ + F E A E+ L LH I +RD+K
Sbjct: 261 LVLTLMNGGDLKFHIYHMGQAGFP---EARAVFYAAEICCGLEDLHRER---IVYRDLKP 314
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
NILLDD +ISD G + +V QT + RV GT GY+ E ++ ++T D ++ G
Sbjct: 315 ENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYTFSPDWWALG 372
Query: 122 VVFVGLLTGQKPIRSTDTEEDK 143
+ ++ GQ P + + +
Sbjct: 373 CLLYEMIAGQSPFQQRKKKIKR 394
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-13
Identities = 38/160 (23%), Positives = 61/160 (38%), Gaps = 31/160 (19%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLD-DKFRAKISDFGASRYVTIDQTHLTTRVQGTFGY 100
A+ + HS + HRDIK NIL+D + AK+ DFG+ + T GT Y
Sbjct: 151 AIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDFD-GTRVY 204
Query: 101 LDLEYFRSSQFT-KKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159
E+ Q+ V+S G++ ++ G P + + L
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE----RDQEILEAEL---------- 250
Query: 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
A V + L +RCL RP+++E+
Sbjct: 251 -HFPAHVSPDCCA--------LIRRCLAPKPSSRPSLEEI 281
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-13
Identities = 34/138 (24%), Positives = 67/138 (48%), Gaps = 23/138 (16%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E++ G+L Y+ + + + L+ +++V A+ YL + HRD+ + N
Sbjct: 92 IVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNNFV---HRDLAARN 147
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDL-------EYFRSSQFTKKGD 116
+L+ + AK+SDFG ++ + +T+ G E R +F+ K D
Sbjct: 148 VLVSEDNVAKVSDFGLTKEAS------STQDTGKL-----PVKWTAPEALREKKFSTKSD 196
Query: 117 VYSFGVVFVGLLT-GQKP 133
V+SFG++ + + G+ P
Sbjct: 197 VWSFGILLWEIYSFGRVP 214
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-13
Identities = 47/176 (26%), Positives = 69/176 (39%), Gaps = 33/176 (18%)
Query: 34 RIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTR 93
+I + AL++L I HRDIK +NILLD K+ DFG S + + TR
Sbjct: 129 KITLATVKALNHLKENLKI--IHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTR 184
Query: 94 VQGTFGYLDLEYFRSSQ----FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF 149
G Y+ E S + + DV+S G+ L TG+ P ++
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS---------- 234
Query: 150 LRAMKENCLFDMLDAQVLKEA-----KEEEIITVAMLA--KRCLNLNGRKRPTMKE 198
+FD L V + EE + + + CL + KRP KE
Sbjct: 235 --------VFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 6e-13
Identities = 36/163 (22%), Positives = 62/163 (38%), Gaps = 24/163 (14%)
Query: 41 GALSYLHSTTSIPIYHRDIKSANILLDDK---FRAKISDFGASRYVTIDQTHLTTRVQGT 97
A++Y H + HRD+K N L K+ DFG + + + T+V GT
Sbjct: 117 SAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-GT 171
Query: 98 FGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157
Y+ + + + D +S GV+ LL G P + + L+ +
Sbjct: 172 PYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFS------APTDSEVMLKIREGTF 224
Query: 158 LFDMLD-AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
F D V +A+ L +R L + ++R T +
Sbjct: 225 TFPEKDWLNVSPQAES--------LIRRLLTKSPKQRITSLQA 259
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-13
Identities = 39/140 (27%), Positives = 57/140 (40%), Gaps = 9/140 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKSA 62
+ NG L +YI + F E R E+ AL YLH I HRD+K
Sbjct: 107 FGLSYAKNGELLKYIR-KIGSFD---ETCTRFYTAEIVSALEYLHGKG---IIHRDLKPE 159
Query: 63 NILLDDKFRAKISDFG-ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
NILL++ +I+DFG A + GT Y+ E K D+++ G
Sbjct: 160 NILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALG 219
Query: 122 VVFVGLLTGQKPIRSTDTEE 141
+ L+ G P R+ +
Sbjct: 220 CIIYQLVAGLPPFRAGNEYL 239
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 7e-13
Identities = 40/139 (28%), Positives = 64/139 (46%), Gaps = 8/139 (5%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKSA 62
V E+ G L+ ++ + F+ E R E+ AL YLHS ++ +Y RD+K
Sbjct: 225 FVMEYANGGELFFHLS-RERVFS---EDRARFYGAEIVSALDYLHSEKNV-VY-RDLKLE 278
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N++LD KI+DFG + I GT YL E + + + D + GV
Sbjct: 279 NLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 337
Query: 123 VFVGLLTGQKPIRSTDTEE 141
V ++ G+ P + D E+
Sbjct: 338 VMYEMMCGRLPFYNQDHEK 356
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-13
Identities = 42/163 (25%), Positives = 67/163 (41%), Gaps = 23/163 (14%)
Query: 41 GALSYLHSTTSIPIYHRDIKSANILLDDKFRA---KISDFGASRYVTIDQTHLTTRVQGT 97
+++Y HS I HR++K N+LL K + K++DFG + V D GT
Sbjct: 139 ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFA-GT 193
Query: 98 FGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157
GYL E + ++K D+++ GV+ LL G P D+ + +
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW------DEDQHRLYAQIKAGAY 247
Query: 158 LFDMLD-AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
+ + V EAK L L +N +KR T +
Sbjct: 248 DYPSPEWDTVTPEAKS--------LIDSMLTVNPKKRITADQA 282
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-12
Identities = 49/201 (24%), Positives = 86/201 (42%), Gaps = 21/201 (10%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
L++ E + G L+ I ++ ++ E + I ++ A+ +LHS I HRD+K
Sbjct: 102 LIIMECMEGGELFSRIQERGDQAFTEREAA-EIMRDIGTAIQFLHS---HNIAHRDVKPE 157
Query: 63 NILLDDKFRA---KISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYS 119
N+L K + K++DFG ++ Q L T T Y+ E ++ K D++S
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFAKE--TTQNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWS 214
Query: 120 FGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLD-AQVLKEAKEEEIITV 178
GV+ LL G P S G R F + ++V ++AK+
Sbjct: 215 LGVIMYILLCGFPPFYSNT--GQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQ------ 266
Query: 179 AMLAKRCLNLNGRKRPTMKEV 199
L + L + +R T+ +
Sbjct: 267 --LIRLLLKTDPTERLTITQF 285
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-12
Identities = 49/220 (22%), Positives = 87/220 (39%), Gaps = 46/220 (20%)
Query: 2 PLLVYEFIPNGTLYRY-------IHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPI 54
L++ E + G L Y + + + +++A E++ ++YL++ +
Sbjct: 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV-- 160
Query: 55 YHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL-----DLEYFRSS 109
HRD+ + N ++ + F KI DFG +R + R G G L E +
Sbjct: 161 -HRDLAARNCMVAEDFTVKIGDFGMTRDI---YETDYYRKGGK-GLLPVRWMSPESLKDG 215
Query: 110 QFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEE--DKSLAGYFLRAMKENC---LFDMLD 163
FT DV+SFGVV + T ++P + E+ + G L +NC LF++
Sbjct: 216 VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL-DKPDNCPDMLFEL-- 272
Query: 164 AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203
M C N + RP+ E+ +
Sbjct: 273 ----------------MR--MCWQYNPKMRPSFLEIISSI 294
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-12
Identities = 44/163 (26%), Positives = 68/163 (41%), Gaps = 24/163 (14%)
Query: 41 GALSYLHSTTSIPIYHRDIKSANILLDDK---FRAKISDFGASRYVTIDQTHLTTRVQGT 97
++Y+H I HRD+K NILL+ K KI DFG S + + R+ GT
Sbjct: 132 SGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GT 186
Query: 98 FGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157
Y+ E R + + +K DV+S GV+ LL+G P K+ R
Sbjct: 187 AYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFY------GKNEYDILKRVETGKY 239
Query: 158 LFDMLD-AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
FD+ + +AK+ L ++ L + R T +
Sbjct: 240 AFDLPQWRTISDDAKD--------LIRKMLTFHPSLRITATQC 274
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 13/153 (8%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKSA 62
+V + + G L RY Q F E ++++ E+ AL YL + I HRD+K
Sbjct: 92 MVVDLLLGGDL-RYHLQQNVHFK---EETVKLFICELVMALDYLQNQR---IIHRDMKPD 144
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQF---TKKGDVYS 119
NILLD+ I+DF + + + T + GT Y+ E F S + + D +S
Sbjct: 145 NILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSSRKGAGYSFAVDWWS 202
Query: 120 FGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRA 152
GV LL G++P + K + F
Sbjct: 203 LGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT 235
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-12
Identities = 44/168 (26%), Positives = 74/168 (44%), Gaps = 31/168 (18%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDK---FRAKISDFGASRYVTIDQTHLTTRVQGTF 98
A+ YLH I HRD+K N+LL + KI+DFG S+ + + + + T GT
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GTP 180
Query: 99 GYLD---LEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE---DKSLAGYFLRA 152
YL L ++ + + D +S GV+ L+G P T+ D+ +G +
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY--- 237
Query: 153 MKENCLFDMLD-AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
F A+V ++A + L K+ L ++ + R T +E
Sbjct: 238 -----NFIPEVWAEVSEKALD--------LVKKLLVVDPKARFTTEEA 272
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-12
Identities = 45/166 (27%), Positives = 61/166 (36%), Gaps = 26/166 (15%)
Query: 41 GALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGY 100
+ LH I HRD+K NILLDD K++DFG S + + L GT Y
Sbjct: 135 EVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVC-GTPSY 189
Query: 101 LDLEYFRSSQF------TKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK 154
L E S K+ D++S GV+ LL G P + M
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW------HRKQMLMLRMIMS 243
Query: 155 ENCLFDMLD-AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
N F + K+ L R L + +KR T +E
Sbjct: 244 GNYQFGSPEWDDYSDTVKD--------LVSRFLVVQPQKRYTAEEA 281
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-12
Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 4/99 (4%)
Query: 35 IAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRV 94
+ E AL +LHS I HRDIKS NILL K++DFG +T +Q+ +T V
Sbjct: 121 VCRECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
Query: 95 QGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKP 133
GT ++ E + K D++S G++ + ++ G+ P
Sbjct: 178 -GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-12
Identities = 51/193 (26%), Positives = 72/193 (37%), Gaps = 60/193 (31%)
Query: 35 IAV---EVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLT 91
IA EV L YLH I HRD+K+ NILL + +I+DFG S ++
Sbjct: 123 IATILREVLEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179
Query: 92 TRVQGTF----------------GYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIR 135
+V+ TF GY K D++SFG+ + L TG P
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGY-----------DFKADIWSFGITAIELATGAAP-- 226
Query: 136 STDTEEDKSLAGYF-LRAMKENCLFDML--DAQVLKEAKEEEIITVA-------MLAKRC 185
Y MK L L D L+ +++ + M++ C
Sbjct: 227 ------------YHKYPPMK--VLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISL-C 271
Query: 186 LNLNGRKRPTMKE 198
L + KRPT E
Sbjct: 272 LQKDPEKRPTAAE 284
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 4e-12
Identities = 47/170 (27%), Positives = 69/170 (40%), Gaps = 19/170 (11%)
Query: 34 RIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRA---KISDFGASRYVTIDQTHL 90
I + A+ YLHS I I HRD+K N+L K K++DFG ++ T + L
Sbjct: 165 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-L 220
Query: 91 TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFL 150
TT T Y+ E ++ K D++S GV+ LL G P S G
Sbjct: 221 TTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKT 277
Query: 151 RAMKENCLFDMLD-AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
R F + ++V +E K L + L +R T+ E
Sbjct: 278 RIRMGQYEFPNPEWSEVSEEVKM--------LIRNLLKTEPTQRMTITEF 319
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 4e-12
Identities = 42/163 (25%), Positives = 67/163 (41%), Gaps = 23/163 (14%)
Query: 41 GALSYLHSTTSIPIYHRDIKSANILLDDKFRA---KISDFGASRYVTIDQTHLTTRVQGT 97
+++Y HS I HR++K N+LL K + K++DFG + V D GT
Sbjct: 116 ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFA-GT 170
Query: 98 FGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157
GYL E + ++K D+++ GV+ LL G P D+ + +
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW------DEDQHRLYAQIKAGAY 224
Query: 158 LFDMLD-AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
+ + V EAK L L +N +KR T +
Sbjct: 225 DYPSPEWDTVTPEAKS--------LIDSMLTVNPKKRITADQA 259
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-12
Identities = 52/225 (23%), Positives = 88/225 (39%), Gaps = 48/225 (21%)
Query: 4 LVYEFIPNGTLYRYIHDQ---TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
LV+E + G++ +IH + E E S + +V+ AL +LH+ I HRD+K
Sbjct: 88 LVFEKMRGGSILSHIHKRRHFNEL-----EAS-VVVQDVASALDFLHN---KGIAHRDLK 138
Query: 61 SANILLDDKFRA---KISDFGASRYV-------TIDQTHLTTRVQGTFGY-----LDLEY 105
NIL + + KI DF + I L T G+ Y ++
Sbjct: 139 PENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAPEVVEAFS 197
Query: 106 FRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM---- 161
+S + K+ D++S GV+ LL+G P D +N LF+
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGYPPFVG-RCGSDCGWDRGEACPACQNMLFESIQEG 256
Query: 162 -LD------AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
+ A + AK+ L + L + ++R + +V
Sbjct: 257 KYEFPDKDWAHISCAAKD--------LISKLLVRDAKQRLSAAQV 293
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-12
Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 4/99 (4%)
Query: 35 IAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRV 94
+ V AL+YLH+ I HRDIKS +ILL R K+SDFG ++ D + V
Sbjct: 146 VCEAVLQALAYLHAQGVI---HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 202
Query: 95 QGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKP 133
GT ++ E S + + D++S G++ + ++ G+ P
Sbjct: 203 -GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-12
Identities = 45/238 (18%), Positives = 85/238 (35%), Gaps = 70/238 (29%)
Query: 2 PLLVYEFIPNGTL-------------YRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS 48
++ E+ G L Y Y ++ E +T++ + +++ + YL S
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221
Query: 49 TTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRS 108
I HRD+ + N+L+ + KI+DFG +R + Y ++
Sbjct: 222 QKCI---HRDLAARNVLVTENNVMKIADFGLARDI----------------NNIDYYKKT 262
Query: 109 SQ-----------------FTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEE--DKSLAGY 148
+ +T + DV+SFGV+ + T G P EE G+
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 322
Query: 149 FLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206
+ NC ++ + + C + +RPT K++ +L I
Sbjct: 323 RMDKP-ANCTNELYM-----------------MMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 5e-12
Identities = 42/166 (25%), Positives = 66/166 (39%), Gaps = 26/166 (15%)
Query: 41 GALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGY 100
A+S+LH+ I HRD+K NILLDD + ++SDFG S ++ + L GT GY
Sbjct: 211 EAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC-GTPGY 265
Query: 101 L------DLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK 154
L + K+ D+++ GV+ LL G P + M+
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW------HRRQILMLRMIME 319
Query: 155 ENCLFDMLD-AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
F + K+ L R L ++ R T ++
Sbjct: 320 GQYQFSSPEWDDRSSTVKD--------LISRLLQVDPEARLTAEQA 357
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 6e-12
Identities = 47/205 (22%), Positives = 79/205 (38%), Gaps = 36/205 (17%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVE----VSGALSYLHSTTSIPIYHRDI 59
L+ EF+ G L+ I + + + E + L ++H + I H DI
Sbjct: 125 LILEFLSGGELFDRIAAEDYKMS---E---AEVINYMRQACEGLKHMHEHS---IVHLDI 175
Query: 60 KSANILLDDKFRA--KISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDV 117
K NI+ + K + KI DFG + + D+ + T + E D+
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEI-VKVTT-ATAEFAAPEIVDREPVGFYTDM 233
Query: 118 YSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLD---AQVLKEAKEEE 174
++ GV+ LL+G P D E L+ +K C ++ + + V EAK+
Sbjct: 234 WAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVK-RCDWEFDEDAFSSVSPEAKD-- 283
Query: 175 IITVAMLAKRCLNLNGRKRPTMKEV 199
K L RKR T+ +
Sbjct: 284 ------FIKNLLQKEPRKRLTVHDA 302
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 7e-12
Identities = 36/144 (25%), Positives = 60/144 (41%), Gaps = 12/144 (8%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKSA 62
LV ++ G L + + E R E+ A+ +H + HRDIK
Sbjct: 151 LVMDYYVGGDLLTLLSKFEDRLP---EEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPD 204
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKG-----DV 117
NIL+D +++DFG+ + D T ++ GT Y+ E ++ + K D
Sbjct: 205 NILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDW 264
Query: 118 YSFGVVFVGLLTGQKPIRSTDTEE 141
+S GV +L G+ P + E
Sbjct: 265 WSLGVCMYEMLYGETPFYAESLVE 288
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 7e-12
Identities = 24/121 (19%), Positives = 38/121 (31%), Gaps = 36/121 (29%)
Query: 35 IAV---EVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLT 91
IA V AL Y+H + HR +K+++IL+ + +S ++ +
Sbjct: 130 IAYILQGVLKALDYIHHMGYV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQR 186
Query: 92 TRV-------------------QGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQK 132
Q GY K D+YS G+ L G
Sbjct: 187 VVHDFPKYSVKVLPWLSPEVLQQNLQGY-----------DAKSDIYSVGITACELANGHV 235
Query: 133 P 133
P
Sbjct: 236 P 236
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 7e-12
Identities = 44/200 (22%), Positives = 79/200 (39%), Gaps = 37/200 (18%)
Query: 4 LVYEFIPNGT-LYRYI--HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
LV E +G L+ +I H + +E ++ I ++ A+ YL I HRDIK
Sbjct: 106 LVMEKHGSGLDLFAFIDRHPRLDE-----PLASYIFRQLVSAVGYLRLKD---IIHRDIK 157
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFT-KKGDVYS 119
NI++ + F K+ DFG++ Y+ + T GT Y E + + + +++S
Sbjct: 158 DENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFC-GTIEYCAPEVLMGNPYRGPELEMWS 215
Query: 120 FGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVA 179
GV L+ + P E ++++ V KE
Sbjct: 216 LGVTLYTLVFEENPFC----ELEETVEAAI-----------HPPYLVSKELMS------- 253
Query: 180 MLAKRCLNLNGRKRPTMKEV 199
L L +R T++++
Sbjct: 254 -LVSGLLQPVPERRTTLEKL 272
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-12
Identities = 31/152 (20%), Positives = 57/152 (37%), Gaps = 49/152 (32%)
Query: 2 PLLVYEFIPNGTL-------------YRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS 48
++ E+ G L Y Y E ++ + + A +V+ + YL S
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209
Query: 49 TTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRS 108
I HRD+ + N+L+ + KI+DFG +R + + Y ++
Sbjct: 210 KKCI---HRDLAARNVLVTEDNVMKIADFGLARDI----------------HHIDYYKKT 250
Query: 109 SQ-----------------FTKKGDVYSFGVV 123
+ +T + DV+SFGV+
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 282
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 7e-12
Identities = 48/201 (23%), Positives = 76/201 (37%), Gaps = 28/201 (13%)
Query: 4 LVYEFIPNGTLYRYI--HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
L E+ G L+ I E + R ++ + YLH I HRDIK
Sbjct: 82 LFLEYCSGGELFDRIEPDIGMPE-----PDAQRFFHQLMAGVVYLHGIG---ITHRDIKP 133
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQT--HLTTRVQGTFGYLDLEYFRSSQFT-KKGDVY 118
N+LLD++ KISDFG + + L GT Y+ E + +F + DV+
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREFHAEPVDVW 192
Query: 119 SFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITV 178
S G+V +L G+ P + S + KE + ++
Sbjct: 193 SCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------ 240
Query: 179 AMLAKRCLNLNGRKRPTMKEV 199
L + L N R T+ ++
Sbjct: 241 --LLHKILVENPSARITIPDI 259
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 7e-12
Identities = 40/203 (19%), Positives = 76/203 (37%), Gaps = 32/203 (15%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVE----VSGALSYLHSTTSIPIYHRDI 59
++YEF+ G L+ + D+ + + E AVE V L ++H H D+
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMS---E---DEAVEYMRQVCKGLCHMHENN---YVHLDL 281
Query: 60 KSANILLDDKFRA--KISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDV 117
K NI+ K K+ DFG + ++ Q+ + GT + E D+
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHLDPKQS-VKVTT-GTAEFAAPEVAEGKPVGYYTDM 339
Query: 118 YSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLD-AQVLKEAKEEEII 176
+S GV+ LL+G P ++ + D + + ++ K+
Sbjct: 340 WSVGVLSYILLSGLSPFG------GENDDETLRNVKSCDWNMDDSAFSGISEDGKD---- 389
Query: 177 TVAMLAKRCLNLNGRKRPTMKEV 199
++ L + R T+ +
Sbjct: 390 ----FIRKLLLADPNTRMTIHQA 408
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-12
Identities = 30/152 (19%), Positives = 58/152 (38%), Gaps = 49/152 (32%)
Query: 2 PLLVYEFIPNGTL-------------YRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS 48
++ E+ G L Y Y ++ E +T++ + +++ + YL S
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175
Query: 49 TTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRS 108
I HRD+ + N+L+ + KI+DFG +R + Y ++
Sbjct: 176 QKCI---HRDLAARNVLVTENNVMKIADFGLARDI----------------NNIDYYKKT 216
Query: 109 SQ-----------------FTKKGDVYSFGVV 123
+ +T + DV+SFGV+
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 248
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 7e-12
Identities = 31/153 (20%), Positives = 53/153 (34%), Gaps = 51/153 (33%)
Query: 3 LLVYEFIPNGTLYRY---------------IHDQTEEFTITWEISLRIAVEVSGALSYLH 47
L++ E+ G L + + +E + E L + +V+ +++L
Sbjct: 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA 162
Query: 48 STTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFR 107
S I HRD+ + NILL KI DFG +R + D Y
Sbjct: 163 SKNCI---HRDLAARNILLTHGRITKICDFGLARDI----------------KNDSNYVV 203
Query: 108 SSQ-----------------FTKKGDVYSFGVV 123
+T + DV+S+G+
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-12
Identities = 36/152 (23%), Positives = 59/152 (38%), Gaps = 49/152 (32%)
Query: 2 PLLVYEFIPNGTL-------------YRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS 48
+++ EF G L Y+ + + +T E + + +V+ + +L S
Sbjct: 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 166
Query: 49 TTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRS 108
I HRD+ + NILL +K KI DFG +R + Y D +Y R
Sbjct: 167 RKCI---HRDLAARNILLSEKNVVKICDFGLARDI----------------YKDPDYVRK 207
Query: 109 SQ-----------------FTKKGDVYSFGVV 123
+T + DV+SFGV+
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 239
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 9e-12
Identities = 36/139 (25%), Positives = 60/139 (43%), Gaps = 25/139 (17%)
Query: 3 LLVYEFIPNGTLYRY-------------IHDQTEEFTITWEISLRIAVEVSGALSYLHST 49
++V+E++ +G L ++ + + + L IA +++ + YL S
Sbjct: 93 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ 152
Query: 50 TSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL-----DLE 104
+ HRD+ + N L+ KI DFG SR V + RV G L E
Sbjct: 153 HFV---HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY---RVGGH-TMLPIRWMPPE 205
Query: 105 YFRSSQFTKKGDVYSFGVV 123
+FT + DV+SFGV+
Sbjct: 206 SIMYRKFTTESDVWSFGVI 224
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-11
Identities = 38/216 (17%), Positives = 73/216 (33%), Gaps = 52/216 (24%)
Query: 7 EFIPNGTLYRYIHDQTEEFTITWEISLR-IAVEVSGALSYLHSTTSIPIYHRDIKSANIL 65
E+ G+L I + + E L+ + ++V L Y+HS + + H DIK +NI
Sbjct: 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIF 147
Query: 66 LD-------------------DKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYF 106
+ +K KI D G ++ Q +G +L E
Sbjct: 148 ISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVL 202
Query: 107 RSSQ-FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE--NCLFDMLD 163
+ + K D+++ + V + R+ D E +
Sbjct: 203 QENYTHLPKADIFALALTVVCAAGAEPLPRNGD-------------QWHEIRQGRLPRIP 249
Query: 164 AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
+ +E E L K ++ + +RP+ +
Sbjct: 250 QVLSQEFTE--------LLKVMIHPDPERRPSAMAL 277
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-11
Identities = 38/146 (26%), Positives = 55/146 (37%), Gaps = 14/146 (9%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKSA 62
LV E+ G L + E R E+ A+ +H + HRDIK
Sbjct: 138 LVMEYYVGGDLLTLLSKFGERIPAEM---ARFYLAEIVMAIDSVHR---LGYVHRDIKPD 191
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVY---- 118
NILLD +++DFG+ + D T + GT YL E ++ Y
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPEC 251
Query: 119 ---SFGVVFVGLLTGQKPIRSTDTEE 141
+ GV + GQ P + T E
Sbjct: 252 DWWALGVFAYEMFYGQTPFYADSTAE 277
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-11
Identities = 54/175 (30%), Positives = 75/175 (42%), Gaps = 39/175 (22%)
Query: 35 IAV---EVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLT 91
IA E+ L YLHS I HRDIK+AN+LL + K++DFG + +T Q
Sbjct: 121 IATILREILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 177
Query: 92 TRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF-L 150
T V GT ++ E + S + K D++S G+ + L G+ P + L
Sbjct: 178 TFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP--------------HSEL 222
Query: 151 RAMKENCLFDM-------LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKE 198
MK LF + L+ K KE + CLN RPT KE
Sbjct: 223 HPMK--VLFLIPKNNPPTLEGNYSKPLKE-------FVEA-CLNKEPSFRPTAKE 267
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-11
Identities = 49/206 (23%), Positives = 77/206 (37%), Gaps = 38/206 (18%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVE----VSGALSYLHSTTSIPIYHRDI 59
LV E++ G L+ I D++ T E + + + ++H I H D+
Sbjct: 163 LVMEYVDGGELFDRIIDESYNLT---E---LDTILFMKQICEGIRHMHQMY---ILHLDL 213
Query: 60 KSANILLDDKFRA--KISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDV 117
K NIL ++ KI DFG +R + L GT +L E + D+
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARRYKPREK-LKVNF-GTPEFLAPEVVNYDFVSFPTDM 271
Query: 118 YSFGVVFVGLLTGQKPIRS-TDTEEDKSLAGYFLRAMKENCLFDMLD---AQVLKEAKEE 173
+S GV+ LL+G P D E L + C +D+ D + +EAKE
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAET--------LNNIL-ACRWDLEDEEFQDISEEAKE- 321
Query: 174 EIITVAMLAKRCLNLNGRKRPTMKEV 199
+ L R + E
Sbjct: 322 -------FISKLLIKEKSWRISASEA 340
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 42/139 (30%), Positives = 62/139 (44%), Gaps = 9/139 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKSA 62
V E++ G L +I Q F E A E++ L +L S I +RD+K
Sbjct: 419 FVMEYVNGGDLMYHIQ-QVGRFK---EPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLD 471
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N++LD + KI+DFG + I T GT Y+ E + K D ++FGV
Sbjct: 472 NVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 530
Query: 123 VFVGLLTGQKPIRSTDTEE 141
+ +L GQ P D +E
Sbjct: 531 LLYEMLAGQAPFEGEDEDE 549
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 7/102 (6%)
Query: 35 IAV---EVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLT 91
IA L YLH I HRDIK+ NILL+ + AK++DFG + +T
Sbjct: 127 IATILQSTLKGLEYLHFMRKI---HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN 183
Query: 92 TRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKP 133
T + GT ++ E + + D++S G+ + + G+ P
Sbjct: 184 TVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 3e-11
Identities = 31/114 (27%), Positives = 51/114 (44%), Gaps = 12/114 (10%)
Query: 15 YRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKI 74
+ + +T E + + +V+ + +L S HRD+ + NILL +K KI
Sbjct: 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 234
Query: 75 SDFGASRYVTIDQTHLTTRVQGTFGYLDL-----EYFRSSQFTKKGDVYSFGVV 123
DFG +R + D + V+ L L E +T + DV+SFGV+
Sbjct: 235 CDFGLARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 284
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-11
Identities = 30/149 (20%), Positives = 54/149 (36%), Gaps = 47/149 (31%)
Query: 3 LLVYEFIPNGTLYRYIHD-----------QTEEFTITWEISLRIAVEVSGALSYLHSTTS 51
L++ E+ G L ++ T + L + +V+ +++L S
Sbjct: 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC 185
Query: 52 IPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQ- 110
I HRD+ + N+LL + AKI DFG +R + D Y
Sbjct: 186 I---HRDVAARNVLLTNGHVAKIGDFGLARDI----------------MNDSNYIVKGNA 226
Query: 111 ----------------FTKKGDVYSFGVV 123
+T + DV+S+G++
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGIL 255
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-11
Identities = 48/201 (23%), Positives = 76/201 (37%), Gaps = 28/201 (13%)
Query: 4 LVYEFIPNGTLYRYI--HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
L E+ G L+ I E + R ++ + YLH I HRDIK
Sbjct: 82 LFLEYCSGGELFDRIEPDIGMPE-----PDAQRFFHQLMAGVVYLHGIG---ITHRDIKP 133
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQT--HLTTRVQGTFGYLDLEYFRSSQFT-KKGDVY 118
N+LLD++ KISDFG + + L GT Y+ E + +F + DV+
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREFHAEPVDVW 192
Query: 119 SFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITV 178
S G+V +L G+ P + S + KE + ++
Sbjct: 193 SCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA------ 240
Query: 179 AMLAKRCLNLNGRKRPTMKEV 199
L + L N R T+ ++
Sbjct: 241 --LLHKILVENPSARITIPDI 259
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-11
Identities = 42/203 (20%), Positives = 82/203 (40%), Gaps = 31/203 (15%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L+ E + G L+ ++ ++ +++ E + ++ ++YLH+ I H D+K N
Sbjct: 92 LILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPEN 145
Query: 64 ILL----DDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYS 119
I+L K+ DFG + + D GT ++ E + D++S
Sbjct: 146 IMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWS 203
Query: 120 FGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLD---AQVLKEAKEEEII 176
GV+ LL+G P +E L + + +D + + + AK+
Sbjct: 204 IGVITYILLSGASPFLGDTKQE-------TLANIT-SVSYDFDEEFFSHTSELAKD---- 251
Query: 177 TVAMLAKRCLNLNGRKRPTMKEV 199
++ L RKR T++E
Sbjct: 252 ----FIRKLLVKETRKRLTIQEA 270
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-11
Identities = 37/143 (25%), Positives = 58/143 (40%), Gaps = 13/143 (9%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKSA 62
+V E++P G L + + E R EV AL +HS + HRD+K
Sbjct: 146 MVMEYMPGGDLVNLM--SNYDVP---EKWARFYTAEVVLALDAIHS---MGFIHRDVKPD 197
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRS----SQFTKKGDVY 118
N+LLD K++DFG + + GT Y+ E +S + ++ D +
Sbjct: 198 NMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 257
Query: 119 SFGVVFVGLLTGQKPIRSTDTEE 141
S GV +L G P +
Sbjct: 258 SVGVFLYEMLVGDTPFYADSLVG 280
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 6e-11
Identities = 38/160 (23%), Positives = 60/160 (37%), Gaps = 57/160 (35%)
Query: 2 PLLVYEFIPNGTLYRY---------------------IHDQTEEFTITWEISLRIAVEVS 40
LL+ E+ G+L + D +E +T + A ++S
Sbjct: 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQIS 160
Query: 41 GALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGY 100
+ YL + HRD+ + NIL+ + + KISDFG SR V Y
Sbjct: 161 QGMQYLAEMKLV---HRDLAARNILVAEGRKMKISDFGLSRDV----------------Y 201
Query: 101 LDLEYFRSSQ-----------------FTKKGDVYSFGVV 123
+ Y + SQ +T + DV+SFGV+
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 241
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-11
Identities = 37/139 (26%), Positives = 57/139 (41%), Gaps = 24/139 (17%)
Query: 2 PLLVYEFIPNGTLYRY------------IHDQTEEFTITWEISLRIAVEVSGALSYLHST 49
L+V+E++ +G L R+ + + L +A +V+ + YL
Sbjct: 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 177
Query: 50 TSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL-----DLE 104
+ HRD+ + N L+ KI DFG SR + RV G L E
Sbjct: 178 HFV---HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---YYRVGGR-TMLPIRWMPPE 230
Query: 105 YFRSSQFTKKGDVYSFGVV 123
+FT + DV+SFGVV
Sbjct: 231 SILYRKFTTESDVWSFGVV 249
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-11
Identities = 32/143 (22%), Positives = 58/143 (40%), Gaps = 29/143 (20%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFT--ITWEISLRIAVEVSGALSYLHSTTSIPIYHRDI 59
P LV+E + N + T+ +EI L+ AL Y HS I HRD+
Sbjct: 108 PALVFEHVNNTDFKQLYQTLTDYDIRFYMYEI-LK-------ALDYCHSMG---IMHRDV 156
Query: 60 KSANILLDDKFRA-KISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFR-------SSQF 111
K N+++D + R ++ D+G + + RV + YF+ +
Sbjct: 157 KPHNVMIDHEHRKLRLIDWGLAEF-YHPGQEYNVRV-AS------RYFKGPELLVDYQMY 208
Query: 112 TKKGDVYSFGVVFVGLLTGQKPI 134
D++S G + ++ ++P
Sbjct: 209 DYSLDMWSLGCMLASMIFRKEPF 231
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 1e-10
Identities = 45/139 (32%), Positives = 71/139 (51%), Gaps = 9/139 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKSA 62
L+ +F+ G L+ + + FT E ++ E++ AL +LHS I +RD+K
Sbjct: 103 LILDFLRGGDLFTRLS-KEVMFT---EEDVKFYLAELALALDHLHSLG---IIYRDLKPE 155
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
NILLD++ K++DFG S+ +ID GT Y+ E T+ D +SFGV
Sbjct: 156 NILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGV 214
Query: 123 VFVGLLTGQKPIRSTDTEE 141
+ +LTG P + D +E
Sbjct: 215 LMFEMLTGTLPFQGKDRKE 233
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-10
Identities = 29/95 (30%), Positives = 36/95 (37%), Gaps = 6/95 (6%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFG-ASRYVTIDQTHLTTRVQGTFGY 100
L YLHS I H+DIK N+LL KIS G A QG+ +
Sbjct: 121 GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 101 LDLEYFRSSQF--TKKGDVYSFGVVFVGLLTGQKP 133
E K D++S GV + TG P
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-10
Identities = 27/108 (25%), Positives = 51/108 (47%), Gaps = 14/108 (12%)
Query: 35 IAV---EVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLT 91
I V ++ AL++LHS I HRD+K+ N+L+ + +++DFG S
Sbjct: 119 IQVVCRQMLEALNFLHSKRII---HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD 175
Query: 92 TRVQGTFGY------LDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKP 133
+ + GT Y + E + + + K D++S G+ + + + P
Sbjct: 176 SFI-GT-PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 1e-10
Identities = 42/133 (31%), Positives = 64/133 (48%), Gaps = 13/133 (9%)
Query: 4 LVYEFIPNGTLYRYI--HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
+V E++ G L+ YI H + EE + R+ ++ A+ Y H + HRD+K
Sbjct: 88 MVMEYVSGGELFDYICKHGRVEE-----MEARRLFQQILSAVDYCHRHM---VVHRDLKP 139
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFT-KKGDVYSF 120
N+LLD AKI+DFG S ++ D L T G+ Y E + + D++S
Sbjct: 140 ENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSC-GSPNYAAPEVISGRLYAGPEVDIWSC 197
Query: 121 GVVFVGLLTGQKP 133
GV+ LL G P
Sbjct: 198 GVILYALLCGTLP 210
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-10
Identities = 37/139 (26%), Positives = 64/139 (46%), Gaps = 9/139 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKSA 62
L+ E++ G L+ + + F E + E+S AL +LH I +RD+K
Sbjct: 98 LILEYLSGGELFMQLE-REGIFM---EDTACFYLAEISMALGHLHQKG---IIYRDLKPE 150
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
NI+L+ + K++DFG + +I +T GT Y+ E S + D +S G
Sbjct: 151 NIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGA 209
Query: 123 VFVGLLTGQKPIRSTDTEE 141
+ +LTG P + ++
Sbjct: 210 LMYDMLTGAPPFTGENRKK 228
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-10
Identities = 46/207 (22%), Positives = 73/207 (35%), Gaps = 38/207 (18%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVE----VSGALSYLHSTTSIPIYHRDI 59
L+ E+ G ++ + E +S + + + YLH I H D+
Sbjct: 106 LILEYAAGGEIFSLCLPELAEM-----VSENDVIRLIKQILEGVYYLHQNN---IVHLDL 157
Query: 60 KSANILLDDKF---RAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGD 116
K NILL + KI DFG SR + L + GT YL E T D
Sbjct: 158 KPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIM-GTPEYLAPEILNYDPITTATD 215
Query: 117 VYSFGVVFVGLLTGQKP-IRSTDTEEDKSLAGYFLRAMKENCLFDMLD---AQVLKEAKE 172
+++ G++ LLT P + + E + D + + V + A +
Sbjct: 216 MWNIGIIAYMLLTHTSPFVGEDNQET--------YLNIS-QVNVDYSEETFSSVSQLATD 266
Query: 173 EEIITVAMLAKRCLNLNGRKRPTMKEV 199
+ L N KRPT +
Sbjct: 267 --------FIQSLLVKNPEKRPTAEIC 285
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-10
Identities = 35/134 (26%), Positives = 53/134 (39%), Gaps = 19/134 (14%)
Query: 2 PLLVYEFIPNGTLYRYI----HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHR 57
++ E + G L ++ ++ ++ L +A +++ YL I HR
Sbjct: 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFI---HR 164
Query: 58 DIKSANILLD---DKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL-----DLEYFRSS 109
DI + N LL AKI DFG +R + R G L E F
Sbjct: 165 DIAARNCLLTCPGPGRVAKIGDFGMARDI---YRASYYRKGGC-AMLPVKWMPPEAFMEG 220
Query: 110 QFTKKGDVYSFGVV 123
FT K D +SFGV+
Sbjct: 221 IFTSKTDTWSFGVL 234
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-10
Identities = 30/159 (18%), Positives = 56/159 (35%), Gaps = 56/159 (35%)
Query: 2 PLLVYEFIPNGTLYRY--------------------IHDQTEEFTITWEISLRIAVEVSG 41
L++E+ G L Y + ++ + +T+E L A +V+
Sbjct: 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
+ +L + + HRD+ + N+L+ KI DFG +R +
Sbjct: 184 GMEFLEFKSCV---HRDLAARNVLVTHGKVVKICDFGLARDI----------------MS 224
Query: 102 DLEYFRSSQ-----------------FTKKGDVYSFGVV 123
D Y +T K DV+S+G++
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 263
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-10
Identities = 32/150 (21%), Positives = 67/150 (44%), Gaps = 40/150 (26%)
Query: 4 LVYEFIPNGTLYRYI-HDQTEEFTITWEIS-------LRIAVEVSGALSYLHSTTSIPIY 55
+V E++P+ TL+R + + + +R ++ LH S+ +
Sbjct: 103 VVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIR-------SIGCLH-LPSVNVC 153
Query: 56 HRDIKSANILLD-DKFRAKISDFGASRYVTIDQTH---LTTRVQGTFGYLDLEYFR---- 107
HRDIK N+L++ K+ DFG+++ ++ + + + +R Y+R
Sbjct: 154 HRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR-----------YYRAPEL 202
Query: 108 ---SSQFTKKGDVYSFGVVFVGLLTGQKPI 134
+ +T D++S G +F ++ G+ PI
Sbjct: 203 IFGNQHYTTAVDIWSVGCIFAEMMLGE-PI 231
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 45/203 (22%), Positives = 84/203 (41%), Gaps = 31/203 (15%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L+ E + G L+ ++ ++ +++ E + ++ ++YLH+ I H D+K N
Sbjct: 92 LILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPEN 145
Query: 64 ILLDDK----FRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYS 119
I+L DK K+ DFG + + D GT ++ E + D++S
Sbjct: 146 IMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWS 203
Query: 120 FGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLD---AQVLKEAKEEEII 176
GV+ LL+G P +E L + +D + +Q + AK+
Sbjct: 204 IGVITYILLSGASPFLGDTKQE-------TLANIT-AVSYDFDEEFFSQTSELAKD---- 251
Query: 177 TVAMLAKRCLNLNGRKRPTMKEV 199
++ L RKR T++E
Sbjct: 252 ----FIRKLLVKETRKRLTIQEA 270
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-10
Identities = 29/139 (20%), Positives = 58/139 (41%), Gaps = 25/139 (17%)
Query: 3 LLVYEFIPNGTLYRY-------------IHDQTEEFTITWEISLRIAVEVSGALSYLHST 49
+++ + +G L+ + D+T + + + + +++ + YL S
Sbjct: 88 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH 147
Query: 50 TSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL-----DLE 104
+ H+D+ + N+L+ DK KISD G R V ++ G L E
Sbjct: 148 HVV---HKDLATRNVLVYDKLNVKISDLGLFREV---YAADYYKLLGN-SLLPIRWMAPE 200
Query: 105 YFRSSQFTKKGDVYSFGVV 123
+F+ D++S+GVV
Sbjct: 201 AIMYGKFSIDSDIWSYGVV 219
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-10
Identities = 20/49 (40%), Positives = 27/49 (55%), Gaps = 6/49 (12%)
Query: 35 IAV---EVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80
IA L+YLHS I HRD+K+ NILL + K+ DFG++
Sbjct: 156 IAAVTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-10
Identities = 41/139 (29%), Positives = 61/139 (43%), Gaps = 9/139 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKSA 62
V E+ G L+ ++ + FT E R E+ AL YLHS + +RDIK
Sbjct: 82 FVMEYANGGELFFHLS-RERVFT---EERARFYGAEIVSALEYLHSRD---VVYRDIKLE 134
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N++LD KI+DFG + I GT YL E + + + D + GV
Sbjct: 135 NLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 193
Query: 123 VFVGLLTGQKPIRSTDTEE 141
V ++ G+ P + D E
Sbjct: 194 VMYEMMCGRLPFYNQDHER 212
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-10
Identities = 21/49 (42%), Positives = 26/49 (53%), Gaps = 6/49 (12%)
Query: 35 IAV---EVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80
IA E+ LS+LH I HRDIK N+LL + K+ DFG S
Sbjct: 131 IAYICREILRGLSHLHQHKVI---HRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-10
Identities = 41/151 (27%), Positives = 66/151 (43%), Gaps = 44/151 (29%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFT---------ITWEISLRIAVEVSGALSYLHSTTSIPI 54
LV +++P T+YR + +++ R +L+Y+HS I
Sbjct: 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL-FR-------SLAYIHS---FGI 177
Query: 55 YHRDIKSANILLD-DKFRAKISDFGASRYVTIDQ--TH-LTTRVQGTFGYLDLEYFR--- 107
HRDIK N+LLD D K+ DFG+++ + + + +R Y+R
Sbjct: 178 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-----------YYRAPE 226
Query: 108 ----SSQFTKKGDVYSFGVVFVGLLTGQKPI 134
++ +T DV+S G V LL GQ PI
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-10
Identities = 30/148 (20%), Positives = 66/148 (44%), Gaps = 43/148 (29%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFT---------ITWEISLRIAVEVSGALSYLHSTTSIPI 54
++ E++P+ TL++ + +++ R A+ ++HS + I
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQL-FR-------AVGFIHS---LGI 162
Query: 55 YHRDIKSANILLD-DKFRAKISDFGASRYVTIDQTH---LTTRVQGTFGYLDLEYFR--- 107
HRDIK N+L++ K+ DFG+++ + + + +R ++R
Sbjct: 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR-----------FYRAPE 211
Query: 108 ----SSQFTKKGDVYSFGVVFVGLLTGQ 131
++++T D++S G VF L+ G+
Sbjct: 212 LMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-10
Identities = 43/139 (30%), Positives = 60/139 (43%), Gaps = 9/139 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKSA 62
V E++ G L +I +F A E+ L +LHS I +RD+K
Sbjct: 95 FVMEYLNGGDLMYHIQ-SCHKFD---LSRATFYAAEIILGLQFLHSKG---IVYRDLKLD 147
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
NILLD KI+DFG + + T GT Y+ E ++ D +SFGV
Sbjct: 148 NILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGV 206
Query: 123 VFVGLLTGQKPIRSTDTEE 141
+ +L GQ P D EE
Sbjct: 207 LLYEMLIGQSPFHGQDEEE 225
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-10
Identities = 15/146 (10%), Positives = 34/146 (23%), Gaps = 36/146 (24%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
L+V E+I G+L + ++R ++ A H +
Sbjct: 105 GGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDH 156
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
+ + + ++ + D+
Sbjct: 157 PSRVRVSIDGDVVLAYPATMPDANP---------------------QD-------DIRGI 188
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLA 146
G LL + P+ + A
Sbjct: 189 GASLYALLVNRWPLPEAGVRSGLAPA 214
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 4e-10
Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 9/139 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKSA 62
V ++I G L+ ++ + F E R A E++ AL YLHS I +RD+K
Sbjct: 116 FVLDYINGGELFYHLQ-RERCFL---EPRARFYAAEIASALGYLHSLN---IVYRDLKPE 168
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
NILLD + ++DFG + I+ T+ GT YL E + + D + G
Sbjct: 169 NILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGA 227
Query: 123 VFVGLLTGQKPIRSTDTEE 141
V +L G P S +T E
Sbjct: 228 VLYEMLYGLPPFYSRNTAE 246
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-10
Identities = 38/139 (27%), Positives = 61/139 (43%), Gaps = 26/139 (18%)
Query: 2 PLLVYEFIPNGTL-------------YRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS 48
L E+ P+G L + + T++ + L A +V+ + YL
Sbjct: 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 160
Query: 49 TTSIPIYHRDIKSANILLDDKFRAKISDFGASR----YVTIDQTHLTTRVQGTFGYLDLE 104
I HRD+ + NIL+ + + AKI+DFG SR YV L R ++ +E
Sbjct: 161 KQFI---HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR------WMAIE 211
Query: 105 YFRSSQFTKKGDVYSFGVV 123
S +T DV+S+GV+
Sbjct: 212 SLNYSVYTTNSDVWSYGVL 230
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 4e-10
Identities = 42/139 (30%), Positives = 62/139 (44%), Gaps = 9/139 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKSA 62
V E++ G L +I Q F E A E++ L +L S I +RD+K
Sbjct: 98 FVMEYVNGGDLMYHIQ-QVGRFK---EPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLD 150
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N++LD + KI+DFG + I T GT Y+ E + K D ++FGV
Sbjct: 151 NVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 209
Query: 123 VFVGLLTGQKPIRSTDTEE 141
+ +L GQ P D +E
Sbjct: 210 LLYEMLAGQAPFEGEDEDE 228
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 4e-10
Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 13/133 (9%)
Query: 4 LVYEFIPNGTLYRYI--HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
+V E++ G L+ YI + + +E + S R+ ++ + Y H + HRD+K
Sbjct: 93 MVMEYVSGGELFDYICKNGRLDE-----KESRRLFQQILSGVDYCHRHM---VVHRDLKP 144
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFT-KKGDVYSF 120
N+LLD AKI+DFG S ++ + L T G+ Y E + + D++S
Sbjct: 145 ENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSC-GSPNYAAPEVISGRLYAGPEVDIWSS 202
Query: 121 GVVFVGLLTGQKP 133
GV+ LL G P
Sbjct: 203 GVILYALLCGTLP 215
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-10
Identities = 42/164 (25%), Positives = 61/164 (37%), Gaps = 25/164 (15%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKF--RAKISDFGASRYVTIDQTHLTTRVQGTFG 99
+SY HS I HRD+K N LLD R KI DFG S+ + + V GT
Sbjct: 128 GVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV-GTPA 182
Query: 100 YLDLEYFRSSQFT-KKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF--LRAMKEN 156
Y+ E ++ K DV+S GV +L G P ED + +
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF------EDPEEPRDYRKTIQRILS 236
Query: 157 CLFDMLDAQVL-KEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
+ + D + E L R + R ++ E+
Sbjct: 237 VKYSIPDDIRISPECCH--------LISRIFVADPATRISIPEI 272
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-10
Identities = 25/99 (25%), Positives = 44/99 (44%), Gaps = 18/99 (18%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
+ +LHS I HRD+K +NI++ KI DFG +R T + + T Y+
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMT------PYV 187
Query: 102 DLEYFR------SSQFTKKGDVYSFGVVFVGLLTGQKPI 134
Y+R + + D++S G + ++ G +
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVL 225
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 5e-10
Identities = 43/205 (20%), Positives = 74/205 (36%), Gaps = 36/205 (17%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVE----VSGALSYLHSTTSIPIYHRDI 59
+++EFI ++ I+ E E R V V AL +LHS I H DI
Sbjct: 78 MIFEFISGLDIFERINTSAFELN---E---REIVSYVHQVCEALQFLHSHN---IGHFDI 128
Query: 60 KSANILLDDKFRA--KISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDV 117
+ NI+ + + KI +FG +R + Y E + + D+
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLF-TAPEYYAPEVHQHDVVSTATDM 186
Query: 118 YSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLD---AQVLKEAKEEE 174
+S G + LL+G P + +T + + + N + + ++ EA +
Sbjct: 187 WSLGTLVYVLLSGINPFLA-ETNQQ------IIENIM-NAEYTFDEEAFKEISIEAMD-- 236
Query: 175 IITVAMLAKRCLNLNGRKRPTMKEV 199
R L + R T E
Sbjct: 237 ------FVDRLLVKERKSRMTASEA 255
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 6e-10
Identities = 39/139 (28%), Positives = 63/139 (45%), Gaps = 9/139 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKSA 62
V EF+ G L +I ++ F E R A E+ AL +LH I +RD+K
Sbjct: 101 FVMEFVNGGDLMFHIQ-KSRRFD---EARARFYAAEIISALMFLHDKG---IIYRDLKLD 153
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N+LLD + K++DFG + I T GT Y+ E + + D ++ GV
Sbjct: 154 NVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGV 212
Query: 123 VFVGLLTGQKPIRSTDTEE 141
+ +L G P + + ++
Sbjct: 213 LLYEMLCGHAPFEAENEDD 231
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 7e-10
Identities = 35/134 (26%), Positives = 53/134 (39%), Gaps = 19/134 (14%)
Query: 2 PLLVYEFIPNGTLYRYI----HDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHR 57
++ E + G L ++ ++ ++ L +A +++ YL I HR
Sbjct: 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFI---HR 205
Query: 58 DIKSANILLD---DKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL-----DLEYFRSS 109
DI + N LL AKI DFG +R + R G L E F
Sbjct: 206 DIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY---YRKGGC-AMLPVKWMPPEAFMEG 261
Query: 110 QFTKKGDVYSFGVV 123
FT K D +SFGV+
Sbjct: 262 IFTSKTDTWSFGVL 275
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 8e-10
Identities = 39/166 (23%), Positives = 66/166 (39%), Gaps = 28/166 (16%)
Query: 41 GALSYLHSTTSIPIYHRDIKSANILLDDKFRA----KISDFGASRYVTIDQTHLTTRVQG 96
+ YLHS I H D+K NI+L D+ KI DFG + + G
Sbjct: 125 NGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF-G 179
Query: 97 TFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156
T ++ E + D++S GV+ LL+G P DT+++ L +
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQE------TLANVSA- 231
Query: 157 CLFDMLD---AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
++ D + AK+ +R L + +KR T+++
Sbjct: 232 VNYEFEDEYFSNTSALAKD--------FIRRLLVKDPKKRMTIQDS 269
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 9e-10
Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 44/159 (27%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFT---------ITWEISLRIAVEVSGALSYLHSTTSIPI 54
LV E++P T+YR + +++ LR +L+Y+HS I I
Sbjct: 115 LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQL-LR-------SLAYIHS---IGI 162
Query: 55 YHRDIKSANILLD-DKFRAKISDFGASRYVTIDQ--TH-LTTRVQGTFGYLDLEYFR--- 107
HRDIK N+LLD K+ DFG+++ + + + +R Y+R
Sbjct: 163 CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR-----------YYRAPE 211
Query: 108 ----SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142
++ +T D++S G V L+ GQ P+ ++ D
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGID 249
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-09
Identities = 32/143 (22%), Positives = 64/143 (44%), Gaps = 36/143 (25%)
Query: 4 LVYEFIPNGTLYRYIHDQ--TEEFT--ITWEISLRIAVEVSGALSYLHSTTSIPIYHRDI 59
LV F+ L + + + E+ + +++ L+ L Y+H+ I HRD+
Sbjct: 107 LVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQM-LK-------GLRYIHAAG---IIHRDL 154
Query: 60 KSANILLDDKFRAKISDFGASRYVTIDQT-HLTTRVQGTFGYLDLEYFR-------SSQF 111
K N+ +++ KI DFG +R + T ++ TR ++R ++
Sbjct: 155 KPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR-----------WYRAPEVILNWMRY 203
Query: 112 TKKGDVYSFGVVFVGLLTGQKPI 134
T+ D++S G + ++TG K +
Sbjct: 204 TQTVDIWSVGCIMAEMITG-KTL 225
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-09
Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 23/159 (14%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
A+ Y H I HRD+K N+LLDD KI+DFG S +T L T G+ Y
Sbjct: 120 AIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTSC-GSPNYA 174
Query: 102 DLEYFRSSQFT-KKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160
E + + DV+S G+V +L G+ P +D+ + F + C++
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF------DDEFIPNLFKKVNS--CVYV 226
Query: 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
M D + A+ L +R + + +R T++E+
Sbjct: 227 MPD-FLSPGAQS--------LIRRMIVADPMQRITIQEI 256
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 1e-09
Identities = 43/206 (20%), Positives = 80/206 (38%), Gaps = 37/206 (17%)
Query: 4 LVYEFIPNGTLYRYIHDQ---TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
L+ E + G L+ ++ ++ TE+ + ++ + YLHS I H D+K
Sbjct: 85 LILELVSGGELFDFLAEKESLTEDEAT------QFLKQILDGVHYLHSKR---IAHFDLK 135
Query: 61 SANILLDDKFRA----KISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGD 116
NI+L DK K+ DFG + + GT ++ E + D
Sbjct: 136 PENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFKNIF-GTPEFVAPEIVNYEPLGLEAD 193
Query: 117 VYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLD---AQVLKEAKEE 173
++S GV+ LL+G P +E L + +D + + + AK+
Sbjct: 194 MWSIGVITYILLSGASPFLGETKQE-------TLTNISA-VNYDFDEEYFSNTSELAKD- 244
Query: 174 EIITVAMLAKRCLNLNGRKRPTMKEV 199
+R L + ++R T+ +
Sbjct: 245 -------FIRRLLVKDPKRRMTIAQS 263
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-09
Identities = 26/101 (25%), Positives = 46/101 (45%), Gaps = 23/101 (22%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTH-LTTRVQGTFGY 100
L Y+HS + HRD+K N+ +++ KI DFG +R+ + T + TR
Sbjct: 138 GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR------- 187
Query: 101 LDLEYFR-------SSQFTKKGDVYSFGVVFVGLLTGQKPI 134
++R + + D++S G + +LTG K +
Sbjct: 188 ----WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTL 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-09
Identities = 36/188 (19%), Positives = 64/188 (34%), Gaps = 42/188 (22%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
+ +LHS I HRD+K +NI++ KI DFG +R T + + T Y+
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMT------PYV 224
Query: 102 DLEYFR------SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDT---------------E 140
Y+R + + D++S G + ++ + D
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284
Query: 141 ED----KSLAGYFLRAM--KENCLFDMLDAQVLKEAKEEEIITVAMLA----KRCLNLNG 190
E + ++ F L L A E A A + L ++
Sbjct: 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 344
Query: 191 RKRPTMKE 198
KR ++ +
Sbjct: 345 AKRISVDD 352
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-09
Identities = 35/143 (24%), Positives = 63/143 (44%), Gaps = 36/143 (25%)
Query: 4 LVYEFIPNGTLYRYIHDQ--TEEFT--ITWEISLRIAVEVSGALSYLHSTTSIPIYHRDI 59
LV + L + Q T++ + ++I LR L Y+HS I HRD+
Sbjct: 111 LVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQI-LR-------GLKYIHSAD---IIHRDL 158
Query: 60 KSANILLDDKFRAKISDFGASRYVTIDQT-HLTTRVQGTFGYLDLEYFR-------SSQF 111
K +N+ +++ KI DFG +R+ + T ++ TR ++R +
Sbjct: 159 KPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----------WYRAPEIMLNWMHY 207
Query: 112 TKKGDVYSFGVVFVGLLTGQKPI 134
+ D++S G + LLTG + +
Sbjct: 208 NQTVDIWSVGCIMAELLTG-RTL 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 4e-09
Identities = 38/144 (26%), Positives = 53/144 (36%), Gaps = 34/144 (23%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFT------ITWEISLRIAVEVSGALSYLHSTTSIPIYHR 57
LV E + L + IHDQ + + I L L LH + HR
Sbjct: 111 LVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHI-LL-------GLHVLHEAG---VVHR 158
Query: 58 DIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFR-------SSQ 110
D+ NILL D I DF +R T D + T Y+ ++R
Sbjct: 159 DLHPGNILLADNNDITICDFNLAREDTADA-NKT-------HYVTHRWYRAPELVMQFKG 210
Query: 111 FTKKGDVYSFGVVFVGLLTGQKPI 134
FTK D++S G V + K +
Sbjct: 211 FTKLVDMWSAGCVMAEMFNR-KAL 233
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 4e-09
Identities = 37/151 (24%), Positives = 61/151 (40%), Gaps = 31/151 (20%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFT------ITWEISLRIAVEVSGALSYLHSTTSIPIYHR 57
LV+E+ + T+ + ITW+ L+ A+++ H HR
Sbjct: 79 LVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQT-LQ-------AVNFCHKHN---CIHR 126
Query: 58 DIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEY------FRSSQF 111
D+K NIL+ K+ DFG +R +T + V T Y +Q+
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-T-----RWYRSPELLVGDTQY 180
Query: 112 TKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142
DV++ G VF LL+G P+ ++ D
Sbjct: 181 GPPVDVWAIGCVFAELLSG-VPLWPGKSDVD 210
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 54.8 bits (133), Expect = 5e-09
Identities = 32/151 (21%), Positives = 61/151 (40%), Gaps = 30/151 (19%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFT------ITWEISLRIAVEVSGALSYLHSTTSIPIYHR 57
LV+EF L +Y + +++ L+ L + HS + HR
Sbjct: 78 LVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQL-LK-------GLGFCHSRN---VLHR 125
Query: 58 DIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEY------FRSSQF 111
D+K N+L++ K+++FG +R I + V + L Y F + +
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV------VTLWYRPPDVLFGAKLY 179
Query: 112 TKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142
+ D++S G +F L +P+ + +D
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 5e-09
Identities = 35/131 (26%), Positives = 62/131 (47%), Gaps = 9/131 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKSA 62
V E++ G L ++ + + E R + E+S AL+YLH I +RD+K
Sbjct: 87 FVIEYVNGGDLMFHMQ-RQRKLP---EEHARFYSAEISLALNYLHERG---IIYRDLKLD 139
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N+LLD + K++D+G + + T+ GT Y+ E R + D ++ GV
Sbjct: 140 NVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 198
Query: 123 VFVGLLTGQKP 133
+ ++ G+ P
Sbjct: 199 LMFEMMAGRSP 209
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 5e-09
Identities = 33/151 (21%), Positives = 57/151 (37%), Gaps = 31/151 (20%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFT------ITWEISLRIAVEVSGALSYLHSTTSIPIYHR 57
LV+EF+ + T+ + ++I + + + HS I HR
Sbjct: 101 LVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQI-IN-------GIGFCHSHN---IIHR 148
Query: 58 DIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEY------FRSSQF 111
DIK NIL+ K+ DFG +R + V T Y ++
Sbjct: 149 DIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-T-----RWYRAPELLVGDVKY 202
Query: 112 TKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142
K DV++ G + + G +P+ D++ D
Sbjct: 203 GKAVDVWAIGCLVTEMFMG-EPLFPGDSDID 232
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-09
Identities = 33/139 (23%), Positives = 62/139 (44%), Gaps = 12/139 (8%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKSA 62
+V E++ G ++ ++ F+ E R A ++ YLHS + +RD+K
Sbjct: 118 MVMEYVAGGEMFSHLRRI-GRFS---EPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N+L+D + +++DFG ++ V T + GT L E S + K D ++ GV
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGV 226
Query: 123 VFVGLLTGQKPIRSTDTEE 141
+ + G P + +
Sbjct: 227 LIYEMAAGYPPFFADQPIQ 245
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-09
Identities = 45/144 (31%), Positives = 67/144 (46%), Gaps = 10/144 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKSA 62
L+ ++I G L+ ++ Q E FT E ++I E+ AL +LH I +RDIK
Sbjct: 136 LILDYINGGELFTHLS-QRERFT---EHEVQIYVGEIVLALEHLHKLG---IIYRDIKLE 188
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQ--FTKKGDVYSF 120
NILLD ++DFG S+ D+T GT Y+ + R K D +S
Sbjct: 189 NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 248
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKS 144
GV+ LLTG P + ++
Sbjct: 249 GVLMYELLTGASPFTVDGEKNSQA 272
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-09
Identities = 35/131 (26%), Positives = 62/131 (47%), Gaps = 9/131 (6%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRI-AVEVSGALSYLHSTTSIPIYHRDIKSA 62
V E++ G L ++ + + E R + E+S AL+YLH I +RD+K
Sbjct: 130 FVIEYVNGGDLMFHMQ-RQRKLP---EEHARFYSAEISLALNYLHERG---IIYRDLKLD 182
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N+LLD + K++D+G + + T+ GT Y+ E R + D ++ GV
Sbjct: 183 NVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 241
Query: 123 VFVGLLTGQKP 133
+ ++ G+ P
Sbjct: 242 LMFEMMAGRSP 252
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 7e-09
Identities = 40/146 (27%), Positives = 66/146 (45%), Gaps = 36/146 (24%)
Query: 4 LVYEFIPNGT-LYRYIHDQ--TEEFT--ITWEISLRIAVEVSGALSYLHSTTSIPIYHRD 58
+V + + T LY+ + Q + + ++I LR L Y+HS + HRD
Sbjct: 107 IVQDLM--ETDLYKLLKTQHLSNDHICYFLYQI-LR-------GLKYIHSAN---VLHRD 153
Query: 59 IKSANILLDDKFRAKISDFGASRYVTIDQTH---LTTRVQGTFGYLDLEYFR-------S 108
+K +N+LL+ KI DFG +R D H LT Y+ ++R S
Sbjct: 154 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-------EYVATRWYRAPEIMLNS 206
Query: 109 SQFTKKGDVYSFGVVFVGLLTGQKPI 134
+TK D++S G + +L+ +PI
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSN-RPI 231
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 30/148 (20%), Positives = 58/148 (39%), Gaps = 33/148 (22%)
Query: 2 PLLVYEFIPNGTLYRY---------------------IHDQTEEFTITWEISLRIAVEVS 40
L++E++ G L + ++ L IA +V+
Sbjct: 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 184
Query: 41 GALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGY 100
++YL + HRD+ + N L+ + KI+DFG SR + + + G
Sbjct: 185 AGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFGLSRNIYSADYY---KADGN-DA 237
Query: 101 L-----DLEYFRSSQFTKKGDVYSFGVV 123
+ E +++T + DV+++GVV
Sbjct: 238 IPIRWMPPESIFYNRYTTESDVWAYGVV 265
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-08
Identities = 23/103 (22%), Positives = 47/103 (45%), Gaps = 14/103 (13%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTF--- 98
A+ LH + + HRD+K +N+L++ K+ DFG +R + +
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 99 GYLDLEYFR-------SSQFTKKGDVYSFGVVFVGLLTGQKPI 134
++ ++R S+++++ DV+S G + L +PI
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPI 222
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-08
Identities = 29/112 (25%), Positives = 46/112 (41%), Gaps = 22/112 (19%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTI----DQTHLTTRVQGT 97
L Y+H I HRD+K+AN+L+ K++DFG +R ++ T RV T
Sbjct: 136 GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-T 191
Query: 98 FGYLDLEYFR-------SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142
Y R + D++ G + + T PI +TE+
Sbjct: 192 LWY------RPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQGNTEQH 236
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-08
Identities = 29/107 (27%), Positives = 51/107 (47%), Gaps = 16/107 (14%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
+++ H I HRD+K N+L++ K++DFG +R I T V +
Sbjct: 131 GVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV------V 181
Query: 102 DLEY------FRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142
L Y S +++ D++S G +F ++TG KP+ T++D
Sbjct: 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVTDDD 227
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 3e-08
Identities = 27/107 (25%), Positives = 51/107 (47%), Gaps = 16/107 (14%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
L+Y H + HRD+K N+L++++ K++DFG +R +I V +
Sbjct: 112 GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV------V 162
Query: 102 DLEY------FRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142
L Y S+ ++ + D++ G +F + TG +P+ T E+
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPLFPGSTVEE 208
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 3e-08
Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
L +LHS + HRD+K NIL+ + K++DFG +R + LT+ V T Y
Sbjct: 132 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVV-TLWYR 186
Query: 102 DLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142
E S + D++S G +F + KP+ ++ D
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRR-KPLFRGSSDVD 226
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 4e-08
Identities = 27/107 (25%), Positives = 50/107 (46%), Gaps = 16/107 (14%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
L++ H I HRD+K N+L++ + + K+ DFG +R I ++ V +
Sbjct: 120 GLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV------V 170
Query: 102 DLEY------FRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142
L Y S ++ D++S G + ++TG KP+ +E+
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPLFPGTNDEE 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 4e-08
Identities = 31/101 (30%), Positives = 47/101 (46%), Gaps = 6/101 (5%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
L +LH+ I HRD+K NIL+ K++DFG +R + LT V T Y
Sbjct: 132 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTPVVV-TLWYR 186
Query: 102 DLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142
E S + D++S G +F + KP+ ++E D
Sbjct: 187 APEVLLQSTYATPVDMWSVGCIFAEMFRR-KPLFCGNSEAD 226
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 6e-08
Identities = 29/104 (27%), Positives = 51/104 (49%), Gaps = 22/104 (21%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKF-RAKISDFGASRYVTIDQTH---LTTRVQGT 97
L Y+HS + HRD+K AN+ ++ + KI DFG +R + +H L+
Sbjct: 132 GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS------ 182
Query: 98 FGYLDLEYFR-------SSQFTKKGDVYSFGVVFVGLLTGQKPI 134
L +++R + +TK D+++ G +F +LTG K +
Sbjct: 183 -EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTL 224
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 8e-08
Identities = 32/151 (21%), Positives = 60/151 (39%), Gaps = 31/151 (20%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFT------ITWEISLRIAVEVSGALSYLHSTTSIPIYHR 57
LV+E + L + + ++ L ++Y H + HR
Sbjct: 77 LVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQL-LN-------GIAYCHDRR---VLHR 124
Query: 58 DIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEY------FRSSQF 111
D+K N+L++ + KI+DFG +R I T + + L Y S ++
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI------VTLWYRAPDVLMGSKKY 178
Query: 112 TKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142
+ D++S G +F ++ G P+ +E D
Sbjct: 179 STTIDIWSVGCIFAEMVNG-TPLFPGVSEAD 208
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 24/120 (20%), Positives = 42/120 (35%), Gaps = 25/120 (20%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
+++H + I HRD+K AN LL+ K+ DFG +R + ++
Sbjct: 141 GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 102 DL----------EY------------FRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDT 139
+ +TK D++S G +F LL + + T
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-07
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 32/165 (19%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVS------GALSYLHSTTSIPIYHR 57
L++++ + L+ I + L + S + YLH+ + HR
Sbjct: 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHR 152
Query: 58 DIKSANILL----DDKFRAKISDFGASRYVTI---DQTHLTTRVQGTFGYLDLEYFR--- 107
D+K ANIL+ ++ R KI+D G +R L V TF Y R
Sbjct: 153 DLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY------RAPE 205
Query: 108 ----SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGY 148
+ +TK D+++ G +F LLT +PI E+ K+ Y
Sbjct: 206 LLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKTSNPY 249
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-07
Identities = 30/114 (26%), Positives = 48/114 (42%), Gaps = 25/114 (21%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
+ YLHS + HRD+K +NILL+ + K++DFG SR +
Sbjct: 121 VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 102 DL---------EY------------FRSSQFTKKGDVYSFGVVFVGLLTGQKPI 134
+ +Y S+++TK D++S G + +L G KPI
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPI 230
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 4e-07
Identities = 40/110 (36%), Positives = 56/110 (50%), Gaps = 15/110 (13%)
Query: 36 AVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQ 95
A EV AL YLHS I +RD+K NILLD KI+DFG ++YV D T+
Sbjct: 112 AAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTY------ 161
Query: 96 GTF-G---YLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE 141
T G Y+ E + + K D +SFG++ +L G P ++T +
Sbjct: 162 -TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 4e-07
Identities = 37/151 (24%), Positives = 58/151 (38%), Gaps = 31/151 (20%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFT------ITWEISLRIAVEVSGALSYLHSTTSIPIYHR 57
LV++F+ L I D + T L+ L YLH I HR
Sbjct: 89 LVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMT-LQ-------GLEYLHQHW---ILHR 136
Query: 58 DIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEY------FRSSQF 111
D+K N+LLD+ K++DFG ++ T +V T Y F + +
Sbjct: 137 DLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-T-----RWYRAPELLFGARMY 190
Query: 112 TKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142
D+++ G + LL P D++ D
Sbjct: 191 GVGVDMWAVGCILAELLLR-VPFLPGDSDLD 220
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 6e-07
Identities = 27/112 (24%), Positives = 45/112 (40%), Gaps = 21/112 (18%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRA-----KISDFGASRYVTIDQTHLTTRVQG 96
+++ HS HRD+K N+LL + KI DFG +R I T +
Sbjct: 144 GVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEI-- 198
Query: 97 TFGYLDLEY------FRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142
+ L Y S ++ D++S ++ +L P+ D+E D
Sbjct: 199 ----ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPLFPGDSEID 245
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 18/74 (24%), Positives = 27/74 (36%), Gaps = 3/74 (4%)
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL 101
+ Y+HS I HRD+K AN L++ K+ DFG +R V + +
Sbjct: 168 GVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 102 DLEYFRSSQFTKKG 115
K
Sbjct: 225 MNLVTFPHTKNLKR 238
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 47.6 bits (112), Expect = 2e-06
Identities = 20/116 (17%), Positives = 40/116 (34%), Gaps = 17/116 (14%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V EF G + + + + I +++ +L+ S+ HRD+ N
Sbjct: 139 IVLEFEFGGIDLEQMRTKL----SSLATAKSILHQLTASLAVAE--ASLRFEHRDLHWGN 192
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYL-DLEYFRSSQFTKKGDVY 118
+LL K+ + TI + G + + S+ + G V
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTI----------PSCGLQVSIIDYTLSRLERDGIVV 238
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 34/117 (29%), Positives = 53/117 (45%), Gaps = 20/117 (17%)
Query: 34 RIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRA--KISDFGASRYVTIDQTHLT 91
+ A ++ AL +L + + I H D+K NILL + R+ KI DFG+S +
Sbjct: 161 KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIY 216
Query: 92 TRVQGTFGY------LDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142
+Q F Y L + Y D++S G + V + TG +P+ S E D
Sbjct: 217 QYIQSRF-YRSPEVLLGMPY------DLAIDMWSLGCILVEMHTG-EPLFSGANEVD 265
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 34/117 (29%), Positives = 49/117 (41%), Gaps = 22/117 (18%)
Query: 34 RIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRA--KISDFGASRYVTIDQTHLT 91
+ A + L LH I H D+K NILL + R+ K+ DFG+S + +
Sbjct: 204 KFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVY 257
Query: 92 TRVQGTFGY------LDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142
T +Q F Y L Y D++S G + LLTG P+ + E D
Sbjct: 258 TYIQSRF-YRAPEVILGARY------GMPIDMWSLGCILAELLTG-YPLLPGEDEGD 306
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 4e-06
Identities = 41/172 (23%), Positives = 58/172 (33%), Gaps = 44/172 (25%)
Query: 34 RIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRA---KISDFGASRYVTIDQTHL 90
I + A+ YLHS I I HRD+K N+L K K++DFG
Sbjct: 121 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG-----------F 166
Query: 91 TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFL 150
G Y K D++S GV+ LL G P S G
Sbjct: 167 AKETTGE-KY-----------DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKT 212
Query: 151 RAMKENCLFDMLDA---QVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
R ++ + +V +E K L + L +R T+ E
Sbjct: 213 RIRM--GQYEFPNPEWSEVSEEVKM--------LIRNLLKTEPTQRMTITEF 254
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 8e-06
Identities = 32/144 (22%), Positives = 58/144 (40%), Gaps = 15/144 (10%)
Query: 34 RIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD------KFRAKISDFGASRYVTIDQ 87
+I+ ++ L Y+H I I H DIK N+L++ + KI+D G + +
Sbjct: 135 QISKQLLLGLDYMHRRCGI-I-HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--- 189
Query: 88 THLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAG 147
H T +Q Y E + + D++S + L+TG + D +
Sbjct: 190 EHYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITG-DFLFEPDEGHSYTKDD 247
Query: 148 YFLRAMKENCLFDMLDAQVLKEAK 171
+ + E L L + +L+ K
Sbjct: 248 DHIAQIIE--LLGELPSYLLRNGK 269
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-05
Identities = 17/59 (28%), Positives = 30/59 (50%), Gaps = 5/59 (8%)
Query: 33 LRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKI--SDFGASRYVTIDQTH 89
L++ + + L Y+H + H DIK+AN+LL K ++ +D+G S + H
Sbjct: 154 LQLGIRMLDVLEYIHENEYV---HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 4e-05
Identities = 15/60 (25%), Positives = 31/60 (51%), Gaps = 7/60 (11%)
Query: 33 LRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKI--SDFG-ASRYVTIDQTH 89
L++A + AL +LH + H ++ + NI +D + ++++ + +G A RY H
Sbjct: 162 LQVACRLLDALEFLHENEYV---HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP-SGKH 217
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 8e-05
Identities = 18/60 (30%), Positives = 33/60 (55%), Gaps = 7/60 (11%)
Query: 33 LRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKI--SDFG-ASRYVTIDQTH 89
L++++ + L Y+H + H DIK++N+LL+ K ++ D+G A RY + H
Sbjct: 155 LQLSLRILDILEYIHEHEYV---HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP-EGVH 210
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 2e-04
Identities = 51/248 (20%), Positives = 71/248 (28%), Gaps = 90/248 (36%)
Query: 34 RIAVEVSGALSYLHSTTSIPIYHRDIKSANILL--------------------------- 66
+I +V L YLH+ I H DIK NILL
Sbjct: 150 KIIQQVLQGLDYLHTKCRII--HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 67 ----------------------DDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLE 104
+K + KI+D G + +V H T +Q T Y LE
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV---HKHFTEDIQ-TRQYRSLE 263
Query: 105 YFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED---------------------- 142
S + D++S + L TG EE
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323
Query: 143 ---KSLAGYF--------LRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGR 191
K +F + +K LF++L + E +EE L L
Sbjct: 324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY--EWSQEEAAGFTDFLLPMLELIPE 381
Query: 192 KRPTMKEV 199
KR T E
Sbjct: 382 KRATAAEC 389
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 39.2 bits (91), Expect = 7e-04
Identities = 32/142 (22%), Positives = 59/142 (41%), Gaps = 19/142 (13%)
Query: 33 LRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAK---ISDFGASR--YVTIDQ 87
L +A ++ + ++HS + + HRDIK N L+ RA I DFG ++ T
Sbjct: 106 LMLADQMINRVEFVHSKSFL---HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
Query: 88 THLTTR----VQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKP---IRSTDTE 140
H+ R + GT Y + + +++ D+ S G V + L G P +++ +
Sbjct: 163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 222
Query: 141 EDKSLAGYFLRAMKENCLFDML 162
+ + K + L
Sbjct: 223 QKYEK----ISEKKVATSIEAL 240
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 253 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.98 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.98 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.98 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.98 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.98 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.96 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.79 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.63 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.38 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.13 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.46 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.44 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.35 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.08 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.88 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.77 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.55 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.16 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.13 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 96.81 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.7 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.71 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 92.62 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 91.7 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 91.56 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 89.95 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 89.73 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 88.38 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 88.25 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 87.57 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 87.25 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 86.91 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 86.03 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.03 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.23 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 82.34 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 81.72 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=301.84 Aligned_cols=193 Identities=23% Similarity=0.386 Sum_probs=148.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|||||||+||+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~ 180 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLAT 180 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCB
T ss_pred EEEEEEcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCce
Confidence 4899999999999999976432 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCC-cceeeeccccccccccchhcc---CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 82 YVTIDQ-THLTTRVQGTFGYLDLEYFRS---SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 82 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
...... ........||+.|||||++.+ .+|+.++|||||||++|||+||..||........ .........
T Consensus 181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~------~~~~~~~~~ 254 (307)
T 3omv_A 181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ------IIFMVGRGY 254 (307)
T ss_dssp C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHTTC
T ss_pred ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCC
Confidence 654322 223345679999999999964 3589999999999999999999999976543221 111121111
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
.... ....+...+..+.+++.+||+.||.+|||+.+|+++|+.++..+
T Consensus 255 ~~p~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 255 ASPD-----LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp CCCC-----STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred CCCC-----cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 1100 11122334557889999999999999999999999999887664
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=299.67 Aligned_cols=190 Identities=21% Similarity=0.229 Sum_probs=151.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC-ceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF-RAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~-~~kl~Dfgl~ 80 (253)
.|||||||+||+|.+++.+.+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla 198 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHA 198 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTC
T ss_pred EEEEEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCC
Confidence 489999999999999998765 5999999999999999999999999 99999999999999887 6999999999
Q ss_pred ccccCCCcc----eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 81 RYVTIDQTH----LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 81 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
+........ .....+||+.|||||++.+..|+.++|||||||++|+|++|..||......+... ......
T Consensus 199 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~i~~~~ 272 (336)
T 4g3f_A 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL------KIASEP 272 (336)
T ss_dssp EEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH------HHHHSC
T ss_pred eEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH------HHHcCC
Confidence 876432211 1223569999999999999999999999999999999999999998765433211 111111
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcC
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIG 211 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 211 (253)
.. ....+...+..+.++|.+||+.||.+|||+.|++++|........
T Consensus 273 ~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 273 PP--------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp CG--------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred CC--------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 11 112233445678899999999999999999999999988776643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=298.54 Aligned_cols=189 Identities=23% Similarity=0.368 Sum_probs=153.5
Q ss_pred CEEEEeecCCCChhHHhhccC----------CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT----------EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFR 71 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~ 71 (253)
.|||||||+||+|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCc
Confidence 489999999999999997642 2235999999999999999999999999 999999999999999999
Q ss_pred eEEcccCCcccccCCCcce-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHH
Q 044510 72 AKISDFGASRYVTIDQTHL-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYF 149 (253)
Q Consensus 72 ~kl~Dfgl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~ 149 (253)
+||+|||+++......... .....||+.|||||++.+..|+.++|||||||++|||+| |..||......+.
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~------- 239 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV------- 239 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-------
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------
Confidence 9999999998654332222 223458999999999999999999999999999999998 8999987654331
Q ss_pred HHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 150 LRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
...+..+... ..+...+..+.+++.+||+.||.+|||+++|++.|+++...
T Consensus 240 ~~~i~~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 240 IECITQGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1112222111 12233445788999999999999999999999999988765
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=298.76 Aligned_cols=189 Identities=24% Similarity=0.394 Sum_probs=146.5
Q ss_pred CEEEEeecCCCChhHHhhccCC------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK 69 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~ 69 (253)
.|||||||++|+|.+++..... ..++++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQG 194 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETT
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCC
Confidence 4899999999999999976431 235999999999999999999999999 9999999999999999
Q ss_pred CceEEcccCCcccccCCCc-ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHH
Q 044510 70 FRAKISDFGASRYVTIDQT-HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAG 147 (253)
Q Consensus 70 ~~~kl~Dfgl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~ 147 (253)
+.+||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |..||......+.
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~----- 269 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA----- 269 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH-----
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH-----
Confidence 9999999999986543322 22334568999999999999999999999999999999999 8999987654331
Q ss_pred HHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 148 YFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
...+..+.. ...+...+..+.+++.+||+.||.+|||++||+++|+.+...
T Consensus 270 --~~~i~~g~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 270 --IDCITQGRE---------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp --HHHHHHTCC---------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --HHHHHcCCC---------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 111111111 112233445788999999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=296.47 Aligned_cols=186 Identities=19% Similarity=0.355 Sum_probs=151.1
Q ss_pred CEEEEeecCCCChhHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
.+||||||++|+|.++|..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECC
Confidence 4899999999999999965321 235899999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCc-ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhH
Q 044510 69 KFRAKISDFGASRYVTIDQT-HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLA 146 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~ 146 (253)
++.+||+|||+++....... .......||+.|+|||++.+..|+.++|||||||++|||+| |..||.+....+.
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~---- 256 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV---- 256 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH----
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH----
Confidence 99999999999986543222 22334568999999999999999999999999999999998 8999987654331
Q ss_pred HHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 147 GYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
...+..+... ..+...+..+.+++.+||+.||.+|||+++|+++|++.
T Consensus 257 ---~~~i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 ---VEMIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ---HHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---HHHHHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1222222111 12233455788999999999999999999999999865
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=301.74 Aligned_cols=180 Identities=23% Similarity=0.355 Sum_probs=146.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|||||||+||+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~ 173 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIAR 173 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEES
T ss_pred EEEEEeCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccce
Confidence 489999999999999997643 225899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+. +....... ..
T Consensus 174 ~~~~~-~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~i~~~~-~~-- 243 (350)
T 4b9d_A 174 VLNST-VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL------VLKIISGS-FP-- 243 (350)
T ss_dssp CCCHH-HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHTC-CC--
T ss_pred eecCC-cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHcCC-CC--
Confidence 65321 1223346799999999999999999999999999999999999999987654321 12222221 11
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+...+..+.+||.+||+.||.+|||+.|++++
T Consensus 244 -------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 -------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122334578899999999999999999999874
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=293.54 Aligned_cols=179 Identities=23% Similarity=0.324 Sum_probs=146.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|||||||+||+|.+++.+. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 146 ~~ivmEy~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA 218 (346)
T ss_dssp EEEEECCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCce
Confidence 48999999999999999763 4999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... ......+||+.|+|||++.+..|+.++||||+||++|+|++|..||.+....+.. ..+........
T Consensus 219 ~~~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-------~~i~~~~~~~~ 290 (346)
T 4fih_A 219 QVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-------KMIRDNLPPRL 290 (346)
T ss_dssp ECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------HHHHHSSCCCC
T ss_pred ecCCCC-CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-------HHHHcCCCCCC
Confidence 764322 2334567999999999999889999999999999999999999999876543321 11111111111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. .....+..+.+||.+||+.||.+|||+.|++++
T Consensus 291 ~-------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 291 K-------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp S-------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C-------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 112234578899999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=299.75 Aligned_cols=190 Identities=25% Similarity=0.403 Sum_probs=153.5
Q ss_pred CEEEEeecCCCChhHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
.|||||||++|+|.++|..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSE 220 (353)
T ss_dssp CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCC
Confidence 4899999999999999975321 234899999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhH
Q 044510 69 KFRAKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLA 146 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~ 146 (253)
++.+||+|||+++........ ......||+.|||||++.+..|+.++|||||||++|||+| |..||.+....+.
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~---- 296 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---- 296 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH----
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH----
Confidence 999999999999866443322 2334568999999999999999999999999999999998 8999987553221
Q ss_pred HHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 147 GYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
+...+..+... ..+...+..+.+++.+||+.||.+|||+.+|+++|+.+...
T Consensus 297 --~~~~i~~g~~~---------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 297 --FCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp --HHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHcCCCC---------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 11222222111 12223345788899999999999999999999999988754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=287.85 Aligned_cols=179 Identities=23% Similarity=0.395 Sum_probs=141.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC-CCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD-KFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~-~~~~kl~Dfgl~ 80 (253)
.|||||||+||+|.+++.+.. .+++..+..++.||+.||.|||+++ .+|+||||||+|||++. ++.+||+|||++
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla 179 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCC
Confidence 489999999999999998764 5999999999999999999999876 23999999999999984 789999999999
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
+... .......+||+.|||||++. ++|+.++|||||||++|+|+||..||....... .+...........
T Consensus 180 ~~~~---~~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~------~~~~~i~~~~~~~ 249 (290)
T 3fpq_A 180 TLKR---ASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPA 249 (290)
T ss_dssp GGCC---TTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCG
T ss_pred EeCC---CCccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH------HHHHHHHcCCCCC
Confidence 7543 22334567999999999987 469999999999999999999999997644321 1122222221111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. .+...++.+.++|.+||+.||.+|||++|++++
T Consensus 250 ~--------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 250 S--------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp G--------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred C--------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 111223468889999999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=291.91 Aligned_cols=177 Identities=25% Similarity=0.406 Sum_probs=146.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|||||||+||+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~ 180 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAK 180 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCce
Confidence 489999999999999998765 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCC-cceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQ-THLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
...... .......+||+.|+|||++.+..|+.++|+||+||++|+|++|..||.+.+..+. +....... .
T Consensus 181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~------~~~i~~~~-~-- 251 (311)
T 4aw0_A 181 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI------FAKIIKLE-Y-- 251 (311)
T ss_dssp ECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTC-C--
T ss_pred ecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHcCC-C--
Confidence 764332 2234456899999999999999999999999999999999999999987654321 11222211 1
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAF 201 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 201 (253)
..+...+..+.++|.+||+.||.+|||++|++.
T Consensus 252 --------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 252 --------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp --------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred --------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 012223456889999999999999999998653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=295.56 Aligned_cols=179 Identities=23% Similarity=0.324 Sum_probs=146.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|||||||+||+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 223 ~~iVmEy~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA 295 (423)
T ss_dssp EEEEEECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccce
Confidence 48999999999999999754 3999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... ......+||+.|||||++.+..|+.++|||||||++|+|++|..||.+....+.. ..+........
T Consensus 296 ~~~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-------~~i~~~~~~~~ 367 (423)
T 4fie_A 296 QVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-------KMIRDNLPPRL 367 (423)
T ss_dssp ECCSSC-CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------HHHHHSCCCCC
T ss_pred ECCCCC-ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-------HHHHcCCCCCC
Confidence 664322 2334567999999999999999999999999999999999999999876543321 11111111111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. .....+..+.+||.+||+.||.+|||+.|++++
T Consensus 368 ~-------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 K-------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp S-------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c-------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 112234568899999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=288.31 Aligned_cols=177 Identities=27% Similarity=0.357 Sum_probs=143.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|||||||+||+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~ 174 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK 174 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred EEEEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccce
Confidence 489999999999999998765 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......||+.|+|||++.+..|+.++|+||+||++|+|++|..||.+.+..+. +....... .
T Consensus 175 ~~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~i~~~~-~--- 243 (304)
T 3ubd_A 175 ESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET------MTMILKAK-L--- 243 (304)
T ss_dssp C------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCC-C---
T ss_pred eccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH------HHHHHcCC-C---
Confidence 653222 223446799999999999999999999999999999999999999987654332 11111111 1
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT-----MKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~~ 202 (253)
..+...+..+.++|.+||+.||.+||| ++|++++
T Consensus 244 -------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 244 -------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred -------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 112223457889999999999999998 4677653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=285.48 Aligned_cols=202 Identities=22% Similarity=0.286 Sum_probs=147.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCC-----CCCeEecCCCCCceeecCCCceEEcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTT-----SIPIYHRDIKSANILLDDKFRAKISD 76 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-----~~~i~H~dl~~~nili~~~~~~kl~D 76 (253)
.|||||||+||+|.+++.+. +++++.+++++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 38999999999999999764 3999999999999999999999861 11299999999999999999999999
Q ss_pred cCCcccccCCCcce---eeeccccccccccchhccC------CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhh----
Q 044510 77 FGASRYVTIDQTHL---TTRVQGTFGYLDLEYFRSS------QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDK---- 143 (253)
Q Consensus 77 fgl~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~---- 143 (253)
||+++......... .....||+.|+|||++.+. .++.++|||||||++|||+||..||.........
T Consensus 152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~ 231 (303)
T 3hmm_A 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc
Confidence 99998765433221 2335799999999999754 3577999999999999999998776443221110
Q ss_pred ----hhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 144 ----SLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 144 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
..................++.. ....+....+.+++.+||+.||.+|||+.+|++.|+++....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~rp~~p~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 232 VPSDPSVEEMRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGG---GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccccchHHHHHHHHhcccCCCCCCcc---ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 0111122222222221111111 112345567889999999999999999999999999987653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=279.70 Aligned_cols=175 Identities=25% Similarity=0.373 Sum_probs=134.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+ +|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 88 ~~ivmEy~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~ 160 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSN 160 (275)
T ss_dssp EEEEEECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-
T ss_pred EEEEEeCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCe
Confidence 48999999 779999998754 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCC-CCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQF-TKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..... .......||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+...... ...+.....
T Consensus 161 ~~~~~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~-------~~~i~~~~~-- 229 (275)
T 3hyh_A 161 IMTDG--NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL-------FKNISNGVY-- 229 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCC--
T ss_pred ecCCC--CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHcCCC--
Confidence 65422 22344679999999999998876 5799999999999999999999987543321 111111111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+|||++|++++
T Consensus 230 --------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 --------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred --------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0112234568889999999999999999999874
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=275.55 Aligned_cols=180 Identities=19% Similarity=0.299 Sum_probs=132.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+|||||+||+|.+++..........+..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 90 l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~ 166 (299)
T 4g31_A 90 LYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVT 166 (299)
T ss_dssp EEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC-
T ss_pred EEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccce
Confidence 3799999999999999987654334667788999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcc-----------eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHH
Q 044510 82 YVTIDQTH-----------LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFL 150 (253)
Q Consensus 82 ~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~ 150 (253)
........ .....+||+.|||||++.+..|+.++|||||||++|||++ ||.... + ....+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~---~~~~~~ 238 (299)
T 4g31_A 167 AMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--E---RVRTLT 238 (299)
T ss_dssp -------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--H---HHHHHH
T ss_pred ecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--H---HHHHHH
Confidence 76432211 1223569999999999999999999999999999999996 774321 1 111111
Q ss_pred HHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 151 RAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ...... + .......+.+.+++.+||+.||.+|||+.|++++
T Consensus 239 ~-~~~~~~-----p----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 239 D-VRNLKF-----P----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp H-HHTTCC-----C----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred H-HhcCCC-----C----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 111111 1 1122233456789999999999999999999863
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=276.42 Aligned_cols=194 Identities=20% Similarity=0.261 Sum_probs=143.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|||||||. |+|.+++.... ++++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 389999995 68999997654 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCC---cceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 82 YVTIDQ---THLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 82 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
...... .......+||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+................
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 654321 2223456799999999998875 468999999999999999999999988765443222211100000000
Q ss_pred ccch--------------hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 LFDM--------------LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~~~~--------------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.... ..+..........+..+.+||.+||+.||.+|||+.|++++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00000001111234578899999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=269.57 Aligned_cols=128 Identities=21% Similarity=0.387 Sum_probs=108.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC-CceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK-FRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~-~~~kl~Dfgl~ 80 (253)
.|+||||++||+|.+++. .+++..+..++.|++.||.|||++| |+||||||+|||++.+ +.+||+|||++
T Consensus 95 ~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 379999999999999984 3899999999999999999999999 9999999999999876 79999999999
Q ss_pred ccccCCCc---------------------------ceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCC
Q 044510 81 RYVTIDQT---------------------------HLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQK 132 (253)
Q Consensus 81 ~~~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~ 132 (253)
+....... ......+||+.|+|||++.+. .|+.++|+||+||++|+|++|..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 75432211 112335699999999999875 48999999999999999999999
Q ss_pred CCCCCC
Q 044510 133 PIRSTD 138 (253)
Q Consensus 133 pf~~~~ 138 (253)
||....
T Consensus 246 Pf~~~~ 251 (361)
T 4f9c_A 246 PFYKAS 251 (361)
T ss_dssp SSSCCS
T ss_pred CCCCCC
Confidence 996543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=285.91 Aligned_cols=178 Identities=22% Similarity=0.296 Sum_probs=143.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|||||||+||+|.+++.+.+ .+++..+..++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+++
T Consensus 267 lylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence 489999999999999998765 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..... .....+||+.|||||++.. ..|+.++|+||+||++|+|++|..||.+...... ... .........
T Consensus 341 ~~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i-~~~i~~~~~-- 411 (689)
T 3v5w_A 341 DFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEI-DRMTLTMAV-- 411 (689)
T ss_dssp ECSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHH-HHHHHHCCC--
T ss_pred ecCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHH-HHhhcCCCC--
Confidence 76432 2334679999999999964 5799999999999999999999999976433221 111 111111111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT-----MKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~~ 202 (253)
..+...+..+.++|.+||+.||.+|++ +.||.+|
T Consensus 412 --------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 412 --------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred --------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 112234457889999999999999998 6888765
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=256.97 Aligned_cols=205 Identities=35% Similarity=0.594 Sum_probs=168.4
Q ss_pred CEEEEeecCCCChhHHhhccCC-CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 4899999999999999976432 225899999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCCc-ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 81 RYVTIDQT-HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 81 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
+....... .......|++.|+|||++.+..++.++|+||||+++|+|++|..||......+......+...........
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 76432221 12233458999999999988889999999999999999999999998766655544444444444444455
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
...++..........+..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 55555555566777888999999999999999999999999999988754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=279.24 Aligned_cols=181 Identities=20% Similarity=0.284 Sum_probs=145.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC--CceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK--FRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~--~~~kl~Dfgl 79 (253)
.|||||||+||+|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||+
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred EEEEEeecCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccc
Confidence 4899999999999999975432 5999999999999999999999999 9999999999999854 7999999999
Q ss_pred cccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
++..... ......+||+.|+|||++.+..|+.++|+||+||++|+|++|..||.+....+. +..........
T Consensus 304 a~~~~~~--~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~------~~~i~~~~~~~ 375 (573)
T 3uto_A 304 TAHLDPK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKSCDWNM 375 (573)
T ss_dssp CEECCTT--SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHTTCCCC
T ss_pred eeEccCC--CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHhCCCCC
Confidence 9876432 334456799999999999999999999999999999999999999987655432 11111111110
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.. ......+..+.+||.+||+.||.+||++.|+++|
T Consensus 376 ---~~----~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 376 ---DD----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ---CS----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---Cc----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 1112234568899999999999999999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=248.58 Aligned_cols=205 Identities=16% Similarity=0.197 Sum_probs=159.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCc-----eEEcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFR-----AKISD 76 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~-----~kl~D 76 (253)
.++||||+ +++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++. +||+|
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~D 154 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVD 154 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred eEEEEEec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence 47999999 9999999987532 4999999999999999999999999 999999999999987665 99999
Q ss_pred cCCcccccCCCcc------eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHH
Q 044510 77 FGASRYVTIDQTH------LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFL 150 (253)
Q Consensus 77 fgl~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~ 150 (253)
||+++........ ......||+.|+|||++.+..++.++|+||||+++|+|++|..||................
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (298)
T 1csn_A 155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 234 (298)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence 9999866533221 1234568999999999998889999999999999999999999998765433222221111
Q ss_pred HHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCCCCCCCccc
Q 044510 151 RAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNCEGIDFV 221 (253)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~ 221 (253)
........ .......+..+.+++.+||+.||.+||++++|++.|+++...........++|.
T Consensus 235 ~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 296 (298)
T 1csn_A 235 EKKQSTPL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN 296 (298)
T ss_dssp HHHHHSCH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred hhccCccH---------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccC
Confidence 11111110 111112345788899999999999999999999999999998776666656553
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=255.48 Aligned_cols=202 Identities=34% Similarity=0.586 Sum_probs=163.3
Q ss_pred CEEEEeecCCCChhHHhhccCC-CCCCCHHHHHHHHHHHHHHHHhHhhC---CCCCeEecCCCCCceeecCCCceEEccc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-EFTITWEISLRIAVEVSGALSYLHST---TSIPIYHRDIKSANILLDDKFRAKISDF 77 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~~i~H~dl~~~nili~~~~~~kl~Df 77 (253)
.++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+. + ++||||||+||+++.++.+||+||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEEECCC
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEEeccC
Confidence 4899999999999999987542 23499999999999999999999999 8 999999999999999999999999
Q ss_pred CCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChh--hhhhhHHHHHHHHhh
Q 044510 78 GASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTE--EDKSLAGYFLRAMKE 155 (253)
Q Consensus 78 gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~--~~~~~~~~~~~~~~~ 155 (253)
|+++..............|++.|+|||++.+..++.++|+||||+++|+|++|..||...... .......+.......
T Consensus 179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 3uim_A 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258 (326)
T ss_dssp SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred ccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence 999876544444445556899999999998888999999999999999999999999632111 111222222223333
Q ss_pred ccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 156 NCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
.......+.......+...+..+.+++.+||+.||.+|||+.+++++|+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 344445555555666778888999999999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=247.49 Aligned_cols=205 Identities=17% Similarity=0.211 Sum_probs=159.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceee---cCCCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILL---DDKFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili---~~~~~~kl~Dfg 78 (253)
.++||||+ +++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||++ +.++.+||+|||
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred eEEEEEcc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 47999999 9999999985432 5999999999999999999999999 9999999999999 788899999999
Q ss_pred CcccccCCCcc------eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHH
Q 044510 79 ASRYVTIDQTH------LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRA 152 (253)
Q Consensus 79 l~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 152 (253)
+++........ ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||..................
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc
Confidence 99866543221 123456899999999999888999999999999999999999999876544332222222111
Q ss_pred HhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCCCCCCCccc
Q 044510 153 MKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNCEGIDFV 221 (253)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~ 221 (253)
...... .......+..+.+++.+||+.||.+||++.++++.|+++............+|.
T Consensus 234 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 4hgt_A 234 KMSTPI---------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp HHHSCH---------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGG
T ss_pred cccchh---------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchh
Confidence 111100 001112234688899999999999999999999999999998776655555543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=257.51 Aligned_cols=190 Identities=24% Similarity=0.367 Sum_probs=151.7
Q ss_pred CEEEEeecCCCChhHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
.|+||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTE 238 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECT
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECC
Confidence 5899999999999999987532 124889999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhH
Q 044510 69 KFRAKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLA 146 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~ 146 (253)
++.+||+|||+++........ ......+++.|+|||++.+..++.++|+|||||++|+|++ |..||......+..
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~--- 315 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--- 315 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---
Confidence 999999999999865432221 1223446789999999998889999999999999999999 99999876544311
Q ss_pred HHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 147 GYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
........ ...+...+..+.+++.+||+.||.+||++.++++.|+++....
T Consensus 316 ----~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 316 ----KLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp ----HHHHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----HHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111111 1112233456888999999999999999999999999987653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=247.74 Aligned_cols=206 Identities=17% Similarity=0.216 Sum_probs=160.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCc-----eEEcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFR-----AKISD 76 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~-----~kl~D 76 (253)
.++||||+ +++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++. +||+|
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~D 153 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLCDR--TFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIID 153 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECC
T ss_pred cEEEEEeC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEE
Confidence 48999999 9999999986422 5999999999999999999999999 999999999999998877 99999
Q ss_pred cCCcccccCCCcc------eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHH
Q 044510 77 FGASRYVTIDQTH------LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFL 150 (253)
Q Consensus 77 fgl~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~ 150 (253)
||+++........ ......||+.|+|||++.+..++.++|+|||||++|+|++|..||................
T Consensus 154 Fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~ 233 (330)
T 2izr_A 154 FALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233 (330)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH
T ss_pred cccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH
Confidence 9999865432221 1234568999999999999889999999999999999999999998765433222211111
Q ss_pred HHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCCCCCCCcccCC
Q 044510 151 RAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNCEGIDFVGG 223 (253)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~~ 223 (253)
....... . .......+ .+.+++..||+.||.+||++++|++.|+.+....+.......+|...
T Consensus 234 ~~~~~~~------~---~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 296 (330)
T 2izr_A 234 DTKRATP------I---EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGK 296 (330)
T ss_dssp HHHHHSC------H---HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTTS
T ss_pred hhhccCC------H---HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCCC
Confidence 1111000 0 00011122 68889999999999999999999999999998877766666666643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=245.16 Aligned_cols=205 Identities=17% Similarity=0.210 Sum_probs=158.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec---CCCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD---DKFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~---~~~~~kl~Dfg 78 (253)
.++||||+ +++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++ .++.+||+|||
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 153 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred eEEEEEec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence 47999999 9999999975432 5999999999999999999999999 99999999999994 78899999999
Q ss_pred CcccccCCCcc------eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHH
Q 044510 79 ASRYVTIDQTH------LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRA 152 (253)
Q Consensus 79 l~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 152 (253)
+++........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 3uzp_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc
Confidence 98866543221 123456899999999999888999999999999999999999999875543322222221111
Q ss_pred HhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCCCCCCCccc
Q 044510 153 MKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNCEGIDFV 221 (253)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~ 221 (253)
...... .......+..+.+++.+||+.||.+||++.++++.|+++............+|.
T Consensus 234 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 3uzp_A 234 KMSTPI---------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp HHHSCH---------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGG
T ss_pred ccCCch---------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 111100 011122335688899999999999999999999999999988766555555543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=249.83 Aligned_cols=190 Identities=22% Similarity=0.358 Sum_probs=149.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 156 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLAR 156 (310)
T ss_dssp EEEEEECCTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred eEEEEEecCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccce
Confidence 4799999999999999987433 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcce-------------eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHH
Q 044510 82 YVTIDQTHL-------------TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGY 148 (253)
Q Consensus 82 ~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~ 148 (253)
......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~- 235 (310)
T 3s95_A 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN- 235 (310)
T ss_dssp ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-
T ss_pred ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-
Confidence 654322111 113568999999999999889999999999999999999999987644322111000
Q ss_pred HHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 149 FLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
.........+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 236 -------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 236 -------------VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp -------------HHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------------hhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 0000001111222345788999999999999999999999999998764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=255.31 Aligned_cols=209 Identities=15% Similarity=0.239 Sum_probs=158.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec--CCCceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD--DKFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~--~~~~~kl~Dfgl 79 (253)
.|+||||+ |++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||+++ .++.+||+|||+
T Consensus 127 ~~lv~e~~-g~~L~~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~~~kl~DFG~ 200 (364)
T 3op5_A 127 RFMIMDRF-GSDLQKIYEANAK--RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGL 200 (364)
T ss_dssp EEEEEECE-EEEHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTTCEEECCCTT
T ss_pred EEEEEeCC-CCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCCeEEEEECCc
Confidence 58999999 9999999987532 5999999999999999999999999 99999999999998 889999999999
Q ss_pred cccccCCCcc------eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHH
Q 044510 80 SRYVTIDQTH------LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAM 153 (253)
Q Consensus 80 ~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 153 (253)
++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .........
T Consensus 201 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~--~~~~~~~~~ 278 (364)
T 3op5_A 201 AYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK--YVRDSKIRY 278 (364)
T ss_dssp CEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH--HHHHHHHHH
T ss_pred ceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH--HHHHHHHHh
Confidence 9765432211 11234589999999999988899999999999999999999999975332211 111111111
Q ss_pred hhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCCCCCCCcccC
Q 044510 154 KENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNCEGIDFVG 222 (253)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~ 222 (253)
........+.... ....+..+.+++..||+.||.+||++.+|++.|+.+............+|..
T Consensus 279 -~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 343 (364)
T 3op5_A 279 -RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSV 343 (364)
T ss_dssp -HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC--
T ss_pred -hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEe
Confidence 1111111111100 0122456888999999999999999999999999999988777766666653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=252.49 Aligned_cols=198 Identities=21% Similarity=0.293 Sum_probs=150.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhC----------CCCCeEecCCCCCceeecCCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHST----------TSIPIYHRDIKSANILLDDKFR 71 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~----------~~~~i~H~dl~~~nili~~~~~ 71 (253)
.++||||+++|+|.+++... .+++..++.++.|++.||.|||+. + ++||||||+||+++.++.
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCC
T ss_pred EEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCe
Confidence 38999999999999999764 399999999999999999999998 8 999999999999999999
Q ss_pred eEEcccCCcccccCCCcc-eeeeccccccccccchhccC-----CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhh
Q 044510 72 AKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSS-----QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSL 145 (253)
Q Consensus 72 ~kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~ 145 (253)
+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 999999999766433222 12235689999999999863 456788999999999999999999977543221111
Q ss_pred H---------HHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 146 A---------GYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 146 ~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
. ................... ......+..+.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCGG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhccCCchhhhhhhhhcccCCCCcccc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1 1111111111111111111 11224456789999999999999999999999999998765
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=245.95 Aligned_cols=187 Identities=25% Similarity=0.405 Sum_probs=149.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 152 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTR 152 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEE
T ss_pred eEEEEEccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccce
Confidence 4799999999999999987532 4999999999999999999999999 9999999999999999999999999988
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||......+.. .........
T Consensus 153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~~~~~~~-- 224 (268)
T 3sxs_A 153 YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV------LKVSQGHRL-- 224 (268)
T ss_dssp ECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HHHHTTCCC--
T ss_pred ecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH------HHHHcCCCC--
Confidence 665433333333445678999999998889999999999999999999 99999766543211 111111100
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
. .+...+..+.+++.+||+.||.+|||+++++++|+.+.+.
T Consensus 225 -~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 225 -Y-------RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -C-------CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -C-------CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 0 1111234688899999999999999999999999998765
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=251.28 Aligned_cols=193 Identities=28% Similarity=0.400 Sum_probs=143.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++|+|.+++........+++..++.++.|++.||.|||+.+ .+++||||||+||+++.++.+||+|||+++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 4899999999999999987543334899999999999999999999986 238999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... ........|++.|+|||++.+..++.++|+||||+++|+|++|..||......+... .........
T Consensus 188 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~------~~~~~~~~~-- 258 (309)
T 3p86_A 188 LKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA------AVGFKCKRL-- 258 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------HHHHSCCCC--
T ss_pred ccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhcCCCC--
Confidence 54322 112234568999999999998889999999999999999999999998765433111 111011010
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcC
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIG 211 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 211 (253)
..+...+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 259 -------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 259 -------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred -------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 1122234468889999999999999999999999999987643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=247.77 Aligned_cols=193 Identities=23% Similarity=0.319 Sum_probs=147.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHh--------hCCCCCeEecCCCCCceeecCCCceE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLH--------STTSIPIYHRDIKSANILLDDKFRAK 73 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--------~~~~~~i~H~dl~~~nili~~~~~~k 73 (253)
.|+||||+++|+|.+++... .+++..++.++.|++.||.||| +.+ ++||||||+||+++.++.+|
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred eEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence 47999999999999999643 4999999999999999999999 888 99999999999999999999
Q ss_pred EcccCCcccccCCCcce---eeeccccccccccchhccC------CCCCCCCeehhHHHHHHHHhC----------CCCC
Q 044510 74 ISDFGASRYVTIDQTHL---TTRVQGTFGYLDLEYFRSS------QFTKKGDVYSFGVVFVGLLTG----------QKPI 134 (253)
Q Consensus 74 l~Dfgl~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~lltg----------~~pf 134 (253)
|+|||+++......... .....||+.|+|||++.+. .++.++|+|||||++|+|++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999997654333221 2234689999999999876 345789999999999999999 7888
Q ss_pred CCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 135 RSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
.......... .................. .......+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 234 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPSF--EDMRKVVCVDQQRPNIPN---RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCCH--HHHHHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcch--hhhhHHHhccCCCCCCCh---hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 6543322111 111111111111111111 112345667899999999999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=251.72 Aligned_cols=188 Identities=24% Similarity=0.373 Sum_probs=148.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred cEEEeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccc
Confidence 5899999999999999976432 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcce--eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHL--TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+. .........
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------~~~~~~~~~ 272 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-------ISSVEEGYR 272 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-------HHHHHTTCC
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH-------HHHHHcCCC
Confidence 764332221 122345778999999998889999999999999999999 9999977654331 111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
...+...+..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 273 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 273 ---------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred ---------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 0112233456888999999999999999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=244.17 Aligned_cols=190 Identities=23% Similarity=0.379 Sum_probs=146.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||++|++|.+++.... ++++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 159 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAK 159 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSST
T ss_pred EEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcc
Confidence 489999999999999998764 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..............|++.|+|||++.+..++.++|+||+|+++|+|++|..||........ ....... ...
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~-~~~-- 230 (294)
T 4eqm_A 160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQD-SVP-- 230 (294)
T ss_dssp TC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSS-CCC--
T ss_pred ccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhc-cCC--
Confidence 6643333333445689999999999988899999999999999999999999987654321 1111111 111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhchhh
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-TMKEVAFELGGIRAS 209 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-s~~~l~~~l~~~~~~ 209 (253)
..........+..+.+++.+||+.||.+|| ++.++.+.|+.+...
T Consensus 231 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 231 ---NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp ---CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred ---CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 111112223345788899999999999998 899999999887654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=256.25 Aligned_cols=195 Identities=25% Similarity=0.378 Sum_probs=154.6
Q ss_pred CEEEEeecCCCChhHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
.++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~ 226 (382)
T 3tt0_A 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTE 226 (382)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECT
T ss_pred eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcC
Confidence 4899999999999999987531 135999999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCc-ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhH
Q 044510 69 KFRAKISDFGASRYVTIDQT-HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLA 146 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~ 146 (253)
++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+.
T Consensus 227 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~---- 302 (382)
T 3tt0_A 227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL---- 302 (382)
T ss_dssp TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH----
T ss_pred CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH----
Confidence 99999999999986543221 12223456789999999998889999999999999999999 9999977654321
Q ss_pred HHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCCCC
Q 044510 147 GYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNC 215 (253)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~ 215 (253)
.......... ..+...+..+.+++.+||+.||.+||++++++++|+++......+..
T Consensus 303 ---~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 359 (382)
T 3tt0_A 303 ---FKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM 359 (382)
T ss_dssp ---HHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred ---HHHHHcCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence 1122221111 11122344688899999999999999999999999999987654443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=247.17 Aligned_cols=187 Identities=26% Similarity=0.421 Sum_probs=149.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR 154 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred eEEEEEeCCCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccc
Confidence 4799999999999999976432 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||......+. .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~-------~~~~~~~~~-- 225 (269)
T 4hcu_A 155 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-------VEDISTGFR-- 225 (269)
T ss_dssp GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHTTCC--
T ss_pred cccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH-------HHHHhcCcc--
Confidence 654322222233446778999999998889999999999999999999 9999987654321 111111100
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
...+...+..+.+++.+||+.||.+||++++++++|+++.++
T Consensus 226 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 226 -------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 011112234688899999999999999999999999998765
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=247.94 Aligned_cols=187 Identities=23% Similarity=0.362 Sum_probs=140.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cEEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence 4899999999999999986432 5899999999999999999999999 9999999999999999999999999988
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+.. ..+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~-------~~i~~~~~~- 236 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-------GRIENGERL- 236 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTCCC-
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH-------HHHHcCCCC-
Confidence 664333223333456788999999998889999999999999999996 99999876543311 111111110
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
..+...+..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 237 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 237 --------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11122345688899999999999999999999999988765
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=243.78 Aligned_cols=179 Identities=24% Similarity=0.363 Sum_probs=144.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++|++|.+++... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCce
Confidence 47999999999999999764 3899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
....... ......|++.|+|||++.+..++.++|+|||||++|+|++|..||......... ....... ....
T Consensus 165 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~~~~~~-~~~~ 236 (297)
T 3fxz_A 165 QITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNG-TPEL 236 (297)
T ss_dssp ECCSTTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHHC-SCCC
T ss_pred ecCCccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhCC-CCCC
Confidence 6543322 233456899999999999889999999999999999999999999776543211 1111111 1111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. .+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 237 ~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 237 Q-------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp S-------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C-------CccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1 112234468889999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=252.70 Aligned_cols=195 Identities=25% Similarity=0.420 Sum_probs=146.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 4899999999999999987532 4999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcc--eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhh---------hhhHHHHH
Q 044510 82 YVTIDQTH--LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED---------KSLAGYFL 150 (253)
Q Consensus 82 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~---------~~~~~~~~ 150 (253)
........ ......++..|+|||.+.+..++.++||||||+++|+|++|..|+........ ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 66433221 12234467789999999988999999999999999999999999865322110 00000111
Q ss_pred HHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 151 RAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
....... ....+...+..+.+++.+||+.||.+|||+.++++.|+++.+.+
T Consensus 243 ~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 243 ELLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHhccC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 1111110 11112334457889999999999999999999999999998764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=245.82 Aligned_cols=197 Identities=24% Similarity=0.313 Sum_probs=148.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhC--------CCCCeEecCCCCCceeecCCCceE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHST--------TSIPIYHRDIKSANILLDDKFRAK 73 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--------~~~~i~H~dl~~~nili~~~~~~k 73 (253)
.++||||+++|+|.+++... .+++..++.++.|++.||.|||.. + ++||||||+||+++.++.+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEE
T ss_pred eEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEE
Confidence 47999999999999999764 399999999999999999999988 8 99999999999999999999
Q ss_pred EcccCCcccccCCCcce---eeeccccccccccchhccCCCCCC------CCeehhHHHHHHHHhC----------CCCC
Q 044510 74 ISDFGASRYVTIDQTHL---TTRVQGTFGYLDLEYFRSSQFTKK------GDVYSFGVVFVGLLTG----------QKPI 134 (253)
Q Consensus 74 l~Dfgl~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~------~Di~slG~~l~~lltg----------~~pf 134 (253)
|+|||+++......... .....||+.|+|||++.+..+... +|||||||++|+|++| ..||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999987654322221 123468999999999987766655 8999999999999999 6666
Q ss_pred CCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 135 RSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
......... ................... .......+..+.+++.+||+.||.+|||+.+++++|+.+.++.
T Consensus 263 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 263 HDLVPSDPS--YEDMREIVCIKKLRPSFPN---RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTSCSSCC--HHHHHHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hhhcCCCCc--hhhhHHHHhhhccCccccc---cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 554322211 1111111111111111111 1112356678999999999999999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=241.90 Aligned_cols=200 Identities=33% Similarity=0.513 Sum_probs=153.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++........+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 181 (307)
T 2nru_A 105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181 (307)
T ss_dssp CEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeeccccc
Confidence 4899999999999999986544446999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc-ccc
Q 044510 82 YVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN-CLF 159 (253)
Q Consensus 82 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~ 159 (253)
........ ......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||............ ........ ...
T Consensus 182 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~ 258 (307)
T 2nru_A 182 ASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI--KEEIEDEEKTIE 258 (307)
T ss_dssp ECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH--HHHHHTTSCCHH
T ss_pred ccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH--HHHhhhhhhhhh
Confidence 65432222 2233568999999999874 5889999999999999999999999875443221111 11111111 111
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchh
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRA 208 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 208 (253)
..++. .....+...+..+.+++.+||+.||.+||++++++++|+++.+
T Consensus 259 ~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 259 DYIDK-KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHSCS-SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hhccc-cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 11111 1123345667789999999999999999999999999998865
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=242.94 Aligned_cols=200 Identities=23% Similarity=0.335 Sum_probs=153.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceee----cCCCceEEccc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILL----DDKFRAKISDF 77 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili----~~~~~~kl~Df 77 (253)
.|+||||+++++|.+++........+++..++.++.|++.||.|||+.+ ++||||||+||++ +.++.+||+||
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Df 160 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccC
Confidence 4799999999999999988655445999999999999999999999999 9999999999999 77778999999
Q ss_pred CCcccccCCCcceeeeccccccccccchhc--------cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH
Q 044510 78 GASRYVTIDQTHLTTRVQGTFGYLDLEYFR--------SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF 149 (253)
Q Consensus 78 gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 149 (253)
|+++...... ......|++.|+|||++. +..++.++|+|||||++|+|++|..||......... ...+
T Consensus 161 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~ 236 (319)
T 4euu_A 161 GAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVM 236 (319)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHH
T ss_pred CCceecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHH
Confidence 9998654332 223356899999999986 467899999999999999999999999765432211 1111
Q ss_pred HHHHhhcccc---ch-------h----chhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchh
Q 044510 150 LRAMKENCLF---DM-------L----DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRA 208 (253)
Q Consensus 150 ~~~~~~~~~~---~~-------~----~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 208 (253)
.......... .. . ...............+.+++.+||+.||.+|||++|++++......
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 2222211100 00 0 0011123456777889999999999999999999999999886543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=262.30 Aligned_cols=191 Identities=20% Similarity=0.365 Sum_probs=151.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLAR 332 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred cEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence 4899999999999999986421 24889999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+.. ..+.....
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~-------~~i~~~~~-- 403 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-------RALERGYR-- 403 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-------HHHHHTCC--
T ss_pred EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCC--
Confidence 654221111222335678999999998889999999999999999999 99999876543311 11111111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCC
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGP 212 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 212 (253)
...+...+..+.+++.+||+.||.+|||+++|++.|+.+......
T Consensus 404 -------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 404 -------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred -------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 011223345688899999999999999999999999998765433
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=246.08 Aligned_cols=187 Identities=24% Similarity=0.381 Sum_probs=149.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 168 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSR 168 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred eEEEEeccCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccc
Confidence 4899999999999999987432 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............+++.|+|||++.+..++.++|+||+|+++|+|++ |..||......+.. ........
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~-------~~~~~~~~-- 239 (283)
T 3gen_A 169 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-------EHIAQGLR-- 239 (283)
T ss_dssp GBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-------HHHHTTCC--
T ss_pred cccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH-------HHHhcccC--
Confidence 654322222223446778999999998889999999999999999998 99999876543211 11111100
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
...+...+..+.+++.+||+.||.+|||+++++++|+++...
T Consensus 240 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 240 -------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 001111234688899999999999999999999999988764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=254.97 Aligned_cols=198 Identities=19% Similarity=0.242 Sum_probs=155.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceee---cCCCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILL---DDKFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili---~~~~~~kl~Dfg 78 (253)
.++||||+ +++|.+++..... .+++..++.++.||+.||.|||..+ |+||||||+|||+ +.++.+||+|||
T Consensus 78 ~~lvme~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFG 151 (483)
T 3sv0_A 78 NVLVMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (483)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred EEEEEECC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCC
Confidence 47999999 9999999986432 5999999999999999999999999 9999999999999 578899999999
Q ss_pred CcccccCCCcc------eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHH
Q 044510 79 ASRYVTIDQTH------LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRA 152 (253)
Q Consensus 79 l~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 152 (253)
+++........ ......|++.|+|||++.+..++.++|||||||++|+|++|..||..................
T Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (483)
T 3sv0_A 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (483)
T ss_dssp TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH
T ss_pred cceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc
Confidence 99876543221 122456899999999999989999999999999999999999999876554322222221111
Q ss_pred HhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCCC
Q 044510 153 MKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQN 214 (253)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~ 214 (253)
...... .......+..+.+++..||+.||.+||++.+|++.|+.+........
T Consensus 232 ~~~~~~---------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~ 284 (483)
T 3sv0_A 232 KVATSI---------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQF 284 (483)
T ss_dssp HHHSCH---------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred cccccH---------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCc
Confidence 111111 01111234568889999999999999999999999999987655443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=246.67 Aligned_cols=177 Identities=25% Similarity=0.323 Sum_probs=144.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 153 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 153 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchh
Confidence 489999999999999998754 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... ........||+.|+|||++.+..++.++|+|||||++|+|++|..||........ ...+.....
T Consensus 154 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------~~~i~~~~~--- 222 (337)
T 1o6l_A 154 EGISD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-------FELILMEEI--- 222 (337)
T ss_dssp CSCCT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC---
T ss_pred hcccC-CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCC---
Confidence 54322 2223445789999999999988899999999999999999999999977554321 111111111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
..+...+..+.++|.+||+.||.+|| ++++++++
T Consensus 223 -------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 -------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 01122345688899999999999999 89999876
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=243.69 Aligned_cols=187 Identities=21% Similarity=0.367 Sum_probs=146.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred CEEEEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCc
Confidence 4799999999999999987542 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+.. .........
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~-------~~~~~~~~~- 233 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI-------GVLEKGDRL- 233 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH-------HHHHHTCCC-
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH-------HHHhcCCCC-
Confidence 654333222333456788999999998889999999999999999998 99999765543311 111111110
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
..+...+..+.+++.+||+.||.+||++.+++++|+.+...
T Consensus 234 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 234 --------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 01112334688899999999999999999999999988654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=255.18 Aligned_cols=187 Identities=21% Similarity=0.342 Sum_probs=147.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred cEEEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 4899999999999999986432 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCccee-eeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTHLT-TRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
.......... ....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||......+. ..........
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~ 334 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-------REFVEKGGRL 334 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH-------HHHHHTTCCC
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCCC
Confidence 5432211111 11224678999999998889999999999999999998 9999987654321 1111111110
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
..+...+..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 335 ---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 335 ---------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 11222344688899999999999999999999999998764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=248.39 Aligned_cols=204 Identities=22% Similarity=0.338 Sum_probs=147.9
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhC---------CCCCeEecCCCCCceeecCCCceE
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHST---------TSIPIYHRDIKSANILLDDKFRAK 73 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---------~~~~i~H~dl~~~nili~~~~~~k 73 (253)
++||||+++|+|.+++.... .++..++.++.|++.||.|||+. + ++||||||+||+++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 79999999999999997654 68999999999999999999999 8 99999999999999999999
Q ss_pred EcccCCcccccCCCc-------ceeeeccccccccccchhcc-------CCCCCCCCeehhHHHHHHHHhCCCCCCCCCh
Q 044510 74 ISDFGASRYVTIDQT-------HLTTRVQGTFGYLDLEYFRS-------SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDT 139 (253)
Q Consensus 74 l~Dfgl~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~lltg~~pf~~~~~ 139 (253)
|+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999986543211 11223468999999999986 3456789999999999999999766543222
Q ss_pred h-hhhhh----------HHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchh
Q 044510 140 E-EDKSL----------AGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRA 208 (253)
Q Consensus 140 ~-~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 208 (253)
. +.... ................+.... ......+..+.+++.+||+.||.+|||++++++.|+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 1 10000 000111111111111111100 1122355679999999999999999999999999999998
Q ss_pred hcCCCCC
Q 044510 209 SIGPQNC 215 (253)
Q Consensus 209 ~~~~~~~ 215 (253)
.+..++.
T Consensus 319 ~~~~~~~ 325 (336)
T 3g2f_A 319 IWERNKS 325 (336)
T ss_dssp CCCC---
T ss_pred HHHhccc
Confidence 7655443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=248.64 Aligned_cols=176 Identities=26% Similarity=0.380 Sum_probs=143.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++|++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 162 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSN 162 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred EEEEEECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCce
Confidence 489999999999999998764 4999999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCcceeeeccccccccccchhccCCCC-CCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFT-KKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
...... ......||+.|+|||++.+..+. .++|+||+||++|+|++|..||.+....+. .........
T Consensus 163 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~~~-- 231 (328)
T 3fe3_A 163 EFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL-------RERVLRGKY-- 231 (328)
T ss_dssp GGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC--
T ss_pred ecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCC--
Confidence 654322 23345689999999999987764 789999999999999999999987654331 111111111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 232 --------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 --------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp --------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred --------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111234467889999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=249.62 Aligned_cols=187 Identities=23% Similarity=0.417 Sum_probs=147.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred cEEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccc
Confidence 379999999999999997642 25899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
........ ......+++.|+|||++.+..++.++|+||||+++|+|++ |..||......+.. .........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~ 236 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-------DLLEKGERL 236 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-------HHHHTTCBC
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH-------HHHHcCCCC
Confidence 76433322 2233457789999999998889999999999999999999 99999876543311 111111110
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
. .+...+..+.+++.+||+.||.+||++.+++++|+++...
T Consensus 237 ~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 237 A---------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp C---------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred C---------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 0111222466799999999999999999999999988654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=251.79 Aligned_cols=165 Identities=26% Similarity=0.408 Sum_probs=131.2
Q ss_pred CCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcccccCCCcc-eeeeccccccccccch
Q 044510 27 ITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEY 105 (253)
Q Consensus 27 ~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~ 105 (253)
+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++........ ......+|+.|+|||+
T Consensus 190 l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~ 266 (359)
T 3vhe_A 190 LTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266 (359)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhh
Confidence 899999999999999999999999 999999999999999999999999999765433222 2334567889999999
Q ss_pred hccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHH
Q 044510 106 FRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKR 184 (253)
Q Consensus 106 ~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 184 (253)
+.+..++.++||||||+++|+|++ |..||......+. ........... ..+...+..+.+++.+
T Consensus 267 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~l~~li~~ 331 (359)
T 3vhe_A 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRM---------RAPDYTTPEMYQTMLD 331 (359)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTCCC---------CCCTTCCHHHHHHHHH
T ss_pred hcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHcCCCC---------CCCCCCCHHHHHHHHH
Confidence 998889999999999999999998 9999977654321 11111111111 1112233468889999
Q ss_pred hcccCCCCCCCHHHHHHHHhhchhh
Q 044510 185 CLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 185 cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
||+.||.+|||+.+++++|+++...
T Consensus 332 ~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 332 CWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HccCChhhCCCHHHHHHHHHHHHHH
Confidence 9999999999999999999988764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=259.80 Aligned_cols=193 Identities=23% Similarity=0.363 Sum_probs=147.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR 328 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred eEEEehhhcCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccce
Confidence 4899999999999999975321 24899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+. ......+..
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-------~~~i~~~~~-- 399 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------LDQVERGYR-- 399 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTCC--
T ss_pred ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCC--
Confidence 654332222223446788999999998889999999999999999999 9999987654321 111111111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCCC
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQN 214 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~ 214 (253)
...+...+..+.+++.+||+.||.+|||++++++.|+.+.....++.
T Consensus 400 -------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~ 446 (452)
T 1fmk_A 400 -------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446 (452)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred -------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence 01122334568889999999999999999999999999887654443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=249.30 Aligned_cols=209 Identities=13% Similarity=0.205 Sum_probs=156.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC--ceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF--RAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~--~~kl~Dfgl 79 (253)
.|+||||+ +++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||+
T Consensus 133 ~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~ 207 (352)
T 2jii_A 133 RFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGF 207 (352)
T ss_dssp EEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGG
T ss_pred EEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcc
Confidence 48999999 999999998752 225999999999999999999999999 99999999999999988 899999999
Q ss_pred cccccCCCcc------eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHH
Q 044510 80 SRYVTIDQTH------LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAM 153 (253)
Q Consensus 80 ~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 153 (253)
++........ ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.......... .. .....
T Consensus 208 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~~-~~~~~ 285 (352)
T 2jii_A 208 AFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDI-MK-QKQKF 285 (352)
T ss_dssp CBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH-HH-HHHHH
T ss_pred eeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHH-HH-HHHhc
Confidence 9765432211 1123468999999999998889999999999999999999999997654221111 11 11111
Q ss_pred hhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCCCCCCCccc
Q 044510 154 KENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNCEGIDFV 221 (253)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~ 221 (253)
... ........ ......+..+.+++.+||+.||.+||++.++++.|+++............+|.
T Consensus 286 ~~~-~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~ 349 (352)
T 2jii_A 286 VDK-PGPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLP 349 (352)
T ss_dssp HHS-CCCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCC
T ss_pred cCC-hhhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCc
Confidence 111 11111000 00011234688899999999999999999999999999998766555555543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=245.75 Aligned_cols=189 Identities=24% Similarity=0.388 Sum_probs=150.9
Q ss_pred CEEEEeecCCCChhHHhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE---------------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~ 60 (253)
.++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+|||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 4899999999999999987532 124899999999999999999999999 9999999
Q ss_pred CCceeecCCCceEEcccCCcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCC
Q 044510 61 SANILLDDKFRAKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTD 138 (253)
Q Consensus 61 ~~nili~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~ 138 (253)
|+||+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999998765433222 1223446788999999998889999999999999999999 999998765
Q ss_pred hhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 139 TEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
..... ......... ..+...+..+.+++.+||+.||.+||++.+++++|+++...
T Consensus 258 ~~~~~-------~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PERLF-------NLLKTGHRM---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGGHH-------HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHH-------HHhhcCCcC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 54311 111111111 11223345688899999999999999999999999988764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=242.79 Aligned_cols=190 Identities=24% Similarity=0.368 Sum_probs=144.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhh---CCCCCeEecCCCCCceeecCCCc-eEEccc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS---TTSIPIYHRDIKSANILLDDKFR-AKISDF 77 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~~i~H~dl~~~nili~~~~~-~kl~Df 77 (253)
.++||||+++++|.+++........+++..++.++.|++.||.|||. .+ ++||||||+||+++.++. +||+||
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Df 150 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDF 150 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCC
T ss_pred cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccc
Confidence 47999999999999999876543357899999999999999999999 77 999999999999988776 799999
Q ss_pred CCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 78 GASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 78 gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
|++...... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||........ ....... ...
T Consensus 151 g~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~-~~~ 221 (307)
T 2eva_A 151 GTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWAVH-NGT 221 (307)
T ss_dssp CC----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHHHH-TTC
T ss_pred ccccccccc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHHHh-cCC
Confidence 998754321 2234589999999999988899999999999999999999999976443221 1111111 111
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCC
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGP 212 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 212 (253)
.. ......+..+.+++.+||+.||.+|||+.+++++|+.+......
T Consensus 222 ~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 222 RP---------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp CC---------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred CC---------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 11 11122334688899999999999999999999999999877644
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=250.83 Aligned_cols=192 Identities=25% Similarity=0.416 Sum_probs=143.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccc
Confidence 5899999999999999976433 4889999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCcc---eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 82 YVTIDQTH---LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 82 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
........ ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+... .......
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~------~~~~~~~ 314 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------YLLQGRR 314 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH------HHHTTCC
T ss_pred cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH------HHHcCCC
Confidence 65332211 1122346788999999998899999999999999999999 778887654432111 1111111
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCCC
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQN 214 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~ 214 (253)
. ..+...+..+.+++.+||+.||.+||++.++++.|+++........
T Consensus 315 ~----------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 315 L----------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred C----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 0 0112233468889999999999999999999999999998765443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=248.49 Aligned_cols=186 Identities=23% Similarity=0.442 Sum_probs=148.3
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
++|+||+.+|+|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 689999999999999987543 5999999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 83 VTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 83 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
....... ......+++.|+|||++.+..++.++|+|||||++|+|++ |..||......+.. .........
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-------~~~~~~~~~- 238 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGERL- 238 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTCCC-
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-------HHHHcCCCC-
Confidence 6433222 2223446789999999999999999999999999999999 99999876554311 111111110
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
..+...+..+.+++.+||+.||.+||++.+++++|+.+...
T Consensus 239 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 239 --------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred --------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 11122334688899999999999999999999999988754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=251.81 Aligned_cols=188 Identities=20% Similarity=0.364 Sum_probs=139.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 5899999999999999986532 5999999999999999999999999 9999999999999999999999999988
Q ss_pred cccCCCccee--eeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHLT--TRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
.......... ....+++.|+|||++.+..++.++|+||||+++|+|++ |..||......+. .........
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~-------~~~i~~~~~ 268 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-------IKAVDEGYR 268 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH-------HHHHHTTEE
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCC
Confidence 6643322111 12234678999999998899999999999999999998 9999976654321 111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
...+...+..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 269 ---------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 269 ---------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ---------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ---------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 0111223456888999999999999999999999999987653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=247.95 Aligned_cols=192 Identities=22% Similarity=0.406 Sum_probs=149.2
Q ss_pred CEEEEeecCCCChhHHhhccCCC--------------------CCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEE--------------------FTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~--------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~ 61 (253)
.++||||+++|+|.+++...... ..+++..++.++.|++.||.|||..+ ++||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence 58999999999999999875321 23789999999999999999999999 99999999
Q ss_pred CceeecCCCceEEcccCCcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCCh
Q 044510 62 ANILLDDKFRAKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDT 139 (253)
Q Consensus 62 ~nili~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~ 139 (253)
+||+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 9999999999999999998766433322 2223456789999999998889999999999999999998 9999977654
Q ss_pred hhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcC
Q 044510 140 EEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIG 211 (253)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 211 (253)
... ........... ..+...+..+.+++.+||+.||.+||++.+++++|+.+.+...
T Consensus 281 ~~~------~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 281 DAN------FYKLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp SHH------HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred HHH------HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 321 11111111110 1112234568889999999999999999999999999877643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=241.46 Aligned_cols=187 Identities=26% Similarity=0.416 Sum_probs=148.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~ 152 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR 152 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred eEEEEeCCCCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccc
Confidence 4899999999999999976532 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+. ..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~i~~~~~~- 224 (267)
T 3t9t_A 153 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-------VEDISTGFRL- 224 (267)
T ss_dssp GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHTTCCC-
T ss_pred ccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH-------HHHHhcCCcC-
Confidence 653222112223446778999999998889999999999999999999 8999977554321 1111111100
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
..+...+..+.+++.+||+.||.+||++.+++++|+++.++
T Consensus 225 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 225 --------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 01112234688899999999999999999999999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=250.79 Aligned_cols=177 Identities=22% Similarity=0.300 Sum_probs=140.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcccccee
Confidence 489999999999999998764 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... ........||+.|+|||++.+..++.++|+|||||++|+|++|..||......+. +.........
T Consensus 173 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~~~i~~~~~~--- 242 (353)
T 3txo_A 173 EGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL------FEAILNDEVV--- 242 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCC---
T ss_pred ecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH------HHHHHcCCCC---
Confidence 53322 2233445799999999999988899999999999999999999999987654331 1111111111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTM------KEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~------~~l~~~ 202 (253)
.+...+..+.+++.+||+.||.+||++ .+++++
T Consensus 243 --------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 243 --------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred --------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 111233467889999999999999998 777764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=260.50 Aligned_cols=187 Identities=24% Similarity=0.384 Sum_probs=149.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++..... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred EEEEEEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccce
Confidence 4899999999999999986432 25899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............+++.|+|||++.+..++.++|||||||++|+|++ |..||......+.. ..+....
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~~--- 436 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------ELLEKDY--- 436 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-------HHHHTTC---
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC---
Confidence 654332222222345678999999998889999999999999999999 99999876544311 1111111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRA 208 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 208 (253)
....+...+..+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 437 ------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 437 ------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 111122334568889999999999999999999999988754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=247.95 Aligned_cols=180 Identities=22% Similarity=0.342 Sum_probs=143.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC----ceEEccc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF----RAKISDF 77 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~----~~kl~Df 77 (253)
.|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 489999999999999997643 5999999999999999999999999 99999999999998776 7999999
Q ss_pred CCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 78 GASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 78 gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
|+++..... .......||+.|+|||++.+..++.++|+||+||++|+|++|..||.+....+. +.......
T Consensus 164 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~------~~~i~~~~- 234 (361)
T 2yab_A 164 GLAHEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANITAVS- 234 (361)
T ss_dssp SSCEECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHTTC-
T ss_pred CCceEcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcC-
Confidence 999865432 223345689999999999988899999999999999999999999987654321 11111111
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ..+... ....+..+.++|.+||..||.+|||+.+++++
T Consensus 235 ~--~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 235 Y--DFDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp C--CCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred C--CCCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 011111 11233468889999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=248.95 Aligned_cols=190 Identities=21% Similarity=0.359 Sum_probs=149.3
Q ss_pred CEEEEeecCCCChhHHhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE---------------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~ 60 (253)
.|+||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 4899999999999999987421 135999999999999999999999999 9999999
Q ss_pred CCceeecCCCceEEcccCCcccccCCCc-ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCC
Q 044510 61 SANILLDDKFRAKISDFGASRYVTIDQT-HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTD 138 (253)
Q Consensus 61 ~~nili~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~ 138 (253)
|+||+++.++.+||+|||+++....... .......+++.|+|||++.+..++.++|+||||+++|+|++ |..||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999876532221 12233457889999999998889999999999999999999 999997755
Q ss_pred hhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 139 TEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
..+. .......... ..+...+..+.+++.+||+.||.+||++.+++++|+++....
T Consensus 282 ~~~~-------~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 282 HEEV-------IYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp HHHH-------HHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred hHHH-------HHHHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 4321 1111111111 112223446888999999999999999999999999987654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=246.65 Aligned_cols=190 Identities=23% Similarity=0.420 Sum_probs=143.9
Q ss_pred CEEEEeecCCCChhHHhhccC---CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT---EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfg 78 (253)
+++||||+.+++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 106 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg 182 (323)
T 3qup_A 106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFG 182 (323)
T ss_dssp EEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCC
T ss_pred cEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeecc
Confidence 489999999999999996532 1224899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 79 ASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 79 l~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
+++........ ......+++.|+|||.+.+..++.++|+|||||++|+|++ |..||......+.. ......
T Consensus 183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-------~~~~~~ 255 (323)
T 3qup_A 183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY-------NYLIGG 255 (323)
T ss_dssp C-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTT
T ss_pred ccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH-------HHHhcC
Confidence 99765432221 1223346778999999998889999999999999999999 99999876554321 111111
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
... ..+...+..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus 256 ~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 256 NRL---------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp CCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CCC---------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 110 111223346888999999999999999999999999998864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=250.78 Aligned_cols=184 Identities=23% Similarity=0.366 Sum_probs=143.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.+.. .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceee
Confidence 489999999999999998754 5999999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhh--hhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED--KSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 159 (253)
..... ........||+.|+|||++.+..++.++|+|||||++|+|++|..||......+. ..........+.....
T Consensus 202 ~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~- 279 (396)
T 4dc2_A 202 EGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI- 279 (396)
T ss_dssp CCCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-
T ss_pred ecccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-
Confidence 53222 2233446799999999999999999999999999999999999999975432211 1111222222222211
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTM------KEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~------~~l~~~ 202 (253)
..+...+..+.++|.+||+.||.+||++ .+++++
T Consensus 280 ---------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 280 ---------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ---------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 1122234568889999999999999985 667664
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=242.64 Aligned_cols=188 Identities=24% Similarity=0.387 Sum_probs=152.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred EEEEEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccce
Confidence 4899999999999999987532 35999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......... ........
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~-------~~~~~~~~-- 230 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------ELLEKDYR-- 230 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-------HHHHTTCC--
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHhccCC--
Confidence 765443333334456788999999998889999999999999999999 99999876544311 11111100
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
...+...+..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 231 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 231 -------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 111222345688899999999999999999999999988765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=241.97 Aligned_cols=190 Identities=21% Similarity=0.387 Sum_probs=150.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLAR 157 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cEEEEecCCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccc
Confidence 4799999999999999976421 14899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+. .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------~~~~~~~~~-- 228 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-------IQNLERGYR-- 228 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTCC--
T ss_pred cccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH-------HHHHhcccC--
Confidence 664332222223446778999999998889999999999999999999 9999977554321 111111100
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcC
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIG 211 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 211 (253)
...+...+..+.+++.+||+.||.+|||++++++.|+.+.....
T Consensus 229 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 229 -------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred -------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 01112234568889999999999999999999999999887653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=247.26 Aligned_cols=193 Identities=20% Similarity=0.259 Sum_probs=146.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC--ceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF--RAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~--~~kl~Dfgl 79 (253)
.|+||||+ +++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||+
T Consensus 127 ~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kL~Dfg~ 199 (345)
T 2v62_A 127 RFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGL 199 (345)
T ss_dssp EEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSEEECCCTT
T ss_pred EEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcEEEEeCCC
Confidence 48999999 999999998754 5999999999999999999999999 99999999999998777 999999999
Q ss_pred cccccCCCc------ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHH
Q 044510 80 SRYVTIDQT------HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAM 153 (253)
Q Consensus 80 ~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 153 (253)
++....... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||......... ........
T Consensus 200 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~ 277 (345)
T 2v62_A 200 SYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA--VQTAKTNL 277 (345)
T ss_dssp CEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH--HHHHHHHH
T ss_pred ceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH--HHHHHHhh
Confidence 976542211 1113346899999999999888999999999999999999999999643221110 11111111
Q ss_pred hhccccchhchhhhhhh-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchh
Q 044510 154 KENCLFDMLDAQVLKEA-KEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRA 208 (253)
Q Consensus 154 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 208 (253)
... ......... ....+..+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 278 ~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 278 LDE-----LPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHT-----TTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred ccc-----ccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 110 111110000 01334578899999999999999999999999988654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=240.88 Aligned_cols=190 Identities=26% Similarity=0.416 Sum_probs=148.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred eEEEEeCCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccc
Confidence 5899999999999999976432 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcc---eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 82 YVTIDQTH---LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 82 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
........ ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |.+||......+... .......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~------~~~~~~~ 250 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------YLLQGRR 250 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH------HHHTTCC
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH------HHhcCCC
Confidence 65432211 1223446788999999998889999999999999999999 666766554332111 1111110
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCC
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGP 212 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 212 (253)
. ..+...+..+.+++.+||+.||.+||++.++++.|+++......
T Consensus 251 ~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 251 L----------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred C----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0 01112234688899999999999999999999999999887543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=251.51 Aligned_cols=190 Identities=21% Similarity=0.296 Sum_probs=149.0
Q ss_pred CEEEEeecCCCChhHHhhccCC----CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC---ceEE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE----EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF---RAKI 74 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~---~~kl 74 (253)
.|+||||++||+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 4899999999999999987431 235899999999999999999999999 99999999999998544 5999
Q ss_pred cccCCcccccCCC-cceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHH
Q 044510 75 SDFGASRYVTIDQ-THLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRA 152 (253)
Q Consensus 75 ~Dfgl~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~ 152 (253)
+|||+++...... ........+++.|+|||++.+..++.++|+|||||++|+|++ |..||......+. ...
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~-------~~~ 298 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-------LEF 298 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-------HHH
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHH
Confidence 9999987543211 122233557889999999998889999999999999999998 9999977654321 111
Q ss_pred HhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 153 MKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
....... ..+...+..+.+++.+||+.||.+||++.+|+++|+.+....
T Consensus 299 i~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 299 VTSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHcCCCC---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 1111111 111223346888999999999999999999999999887653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=242.39 Aligned_cols=191 Identities=25% Similarity=0.444 Sum_probs=139.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred cEEEEEecCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecc
Confidence 4799999999999999976432 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCC-cceeeeccccccccccchhc---cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 82 YVTIDQ-THLTTRVQGTFGYLDLEYFR---SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 82 ~~~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
...... ........|++.|+|||.+. +..++.++|+||||+++|+|++|..||......+. .........
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~ 242 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIEMVGRGS 242 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH------HHHHHHHTS
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH------HHHHhcccc
Confidence 554211 12223456899999999986 55678899999999999999999999977544321 111122111
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchh
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRA 208 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 208 (253)
.... ........+..+.+++.+||+.||.+||++.++++.|+++..
T Consensus 243 ~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 243 LSPD-----LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCCC-----TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCcc-----hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1110 011112334568889999999999999999999999998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=254.63 Aligned_cols=184 Identities=23% Similarity=0.418 Sum_probs=147.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~ 337 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 337 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred eEEEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence 4899999999999999987542 23799999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..... .....+++.|+|||++.+..++.++|+||||+++|+|++ |..||......+.. .....+..
T Consensus 338 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-------~~i~~~~~-- 404 (450)
T 1k9a_A 338 EASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PRVEKGYK-- 404 (450)
T ss_dssp ECC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH-------HHHHTTCC--
T ss_pred ccccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCC--
Confidence 54321 122346789999999998899999999999999999998 99999876543311 11111111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
...+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 405 -------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 405 -------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 111223445788899999999999999999999999988764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=246.23 Aligned_cols=177 Identities=25% Similarity=0.342 Sum_probs=143.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 489999999999999998754 4999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... ........||+.|+|||++.+..++.++|+|||||++|+|++|..||......+. +....... ..
T Consensus 170 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~~~i~~~~-~~-- 239 (353)
T 2i0e_A 170 ENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQSIMEHN-VA-- 239 (353)
T ss_dssp CCCCT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCC-CC--
T ss_pred ccccC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH------HHHHHhCC-CC--
Confidence 53322 2223445789999999999988899999999999999999999999987654321 11111111 10
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT-----MKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~~ 202 (253)
.+...+..+.+++.+||+.||.+||+ +++++++
T Consensus 240 --------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 240 --------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred --------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11223456888999999999999995 5777765
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=262.85 Aligned_cols=194 Identities=24% Similarity=0.335 Sum_probs=151.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSK 484 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred eEEEEEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence 479999999999999997643 25999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCccee--eeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHLT--TRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
.......... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||......+. ...+..+..
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-------~~~i~~~~~ 557 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------MAFIEQGKR 557 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH-------HHHHHTTCC
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHcCCC
Confidence 6543222111 12334678999999998899999999999999999998 9999987654331 111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCCCCC
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNCE 216 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~ 216 (253)
...+...+..+.+++.+||+.||.+||++.+|++.|+.+..........
T Consensus 558 ---------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~ 606 (613)
T 2ozo_A 558 ---------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 606 (613)
T ss_dssp ---------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCC
T ss_pred ---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCC
Confidence 1112234457888999999999999999999999999998876554443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=242.59 Aligned_cols=192 Identities=23% Similarity=0.382 Sum_probs=151.8
Q ss_pred CEEEEeecCCCChhHHhhccCC---------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceee
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE---------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILL 66 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili 66 (253)
.++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 4899999999999999987532 124899999999999999999999999 9999999999999
Q ss_pred cCCCceEEcccCCcccccCCCcce-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhh
Q 044510 67 DDKFRAKISDFGASRYVTIDQTHL-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKS 144 (253)
Q Consensus 67 ~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~ 144 (253)
+.++.+||+|||+++......... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence 999999999999987664433221 223446788999999998889999999999999999999 9999977654321
Q ss_pred hHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcC
Q 044510 145 LAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIG 211 (253)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 211 (253)
.......... . ..+...+..+.+++.+||+.||.+|||+.+++++|+++..+..
T Consensus 257 ----~~~~~~~~~~-~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 257 ----FYKMIKEGFR-M--------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp ----HHHHHHHTCC-C--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred ----HHHHhccCCC-C--------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 1111111110 0 1112234468889999999999999999999999999887643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=241.43 Aligned_cols=191 Identities=25% Similarity=0.363 Sum_probs=152.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSK 158 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred cEEEEEeCCCCCHHHHHHhCCc--cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECccccee
Confidence 4799999999999999975432 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcce--eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHL--TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
......... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+. .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~i~~~~~ 231 (287)
T 1u59_A 159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------MAFIEQGKR 231 (287)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-------HHHHHTTCC
T ss_pred eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH-------HHHHhcCCc
Confidence 664332221 122345789999999998889999999999999999998 9999977654321 111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCC
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQ 213 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~ 213 (253)
...+...+..+.+++.+||+.||.+||++.+++++|+++..+....
T Consensus 232 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 232 ---------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp ---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred ---------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 1112233457888999999999999999999999999998876443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=243.57 Aligned_cols=189 Identities=23% Similarity=0.376 Sum_probs=148.7
Q ss_pred CEEEEeecCCCChhHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-------------EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
.|+||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 177 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcC
Confidence 479999999999999997643 1235999999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHH
Q 044510 69 KFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAG 147 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~ 147 (253)
++.+||+|||+++.... ........+++.|+|||++.+..++.++|+||||+++|+|++ |..||......+.
T Consensus 178 ~~~~kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~----- 250 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----- 250 (327)
T ss_dssp GGCEEECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----
T ss_pred CCeEEEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH-----
Confidence 99999999999864321 111222346788999999998888999999999999999998 9999977654321
Q ss_pred HHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcC
Q 044510 148 YFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIG 211 (253)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 211 (253)
......... ...+...+..+.+++.+||+.||.+||++.+++++|+++.....
T Consensus 251 --~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 251 --YEKLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp --HHHGGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred --HHHhhcCCC---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111111110 01112234568889999999999999999999999999988753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=245.17 Aligned_cols=186 Identities=23% Similarity=0.450 Sum_probs=143.6
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
++|+||+.+|+|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred eEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 689999999999999987543 5999999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 83 VTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 83 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
....... ......+++.|+|||.+.+..++.++|+|||||++|+|++ |..||......+.. .........
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-------~~~~~~~~~- 238 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGERL- 238 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTCCC-
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-------HHHHcCCCC-
Confidence 5432221 1223346778999999998899999999999999999999 99999876654321 111111110
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
..+...+..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 239 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 239 --------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred --------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11122334688899999999999999999999999998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=238.19 Aligned_cols=183 Identities=32% Similarity=0.467 Sum_probs=139.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC--------CCceE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD--------KFRAK 73 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~--------~~~~k 73 (253)
.++||||+++++|.+++... .+++..++.++.|++.||.|||+.+..+++||||||+||+++. ++.++
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp CEEEEECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred eEEEEEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceE
Confidence 48999999999999998643 4999999999999999999999988555789999999999985 67899
Q ss_pred EcccCCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHH
Q 044510 74 ISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAM 153 (253)
Q Consensus 74 l~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 153 (253)
|+|||++....... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||......... .. .
T Consensus 157 l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~-~ 226 (271)
T 3dtc_A 157 ITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA------YG-V 226 (271)
T ss_dssp ECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH------HH-H
T ss_pred EccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------Hh-h
Confidence 99999987553221 22346899999999999888999999999999999999999999876543211 11 1
Q ss_pred hhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 154 KENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
....... ..+...+..+.+++.+||+.||.+|||+.+++++|+++
T Consensus 227 ~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 227 AMNKLAL--------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HTSCCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hcCCCCC--------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111111 11122334688899999999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=249.20 Aligned_cols=186 Identities=26% Similarity=0.309 Sum_probs=138.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC---CCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD---KFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~---~~~~kl~Dfg 78 (253)
.|+||||++||+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence 4799999999999999987532 25999999999999999999999999 999999999999987 7889999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||............ ...+.....
T Consensus 210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~i~~~~~ 284 (400)
T 1nxk_A 210 FAKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQY 284 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH---HHHHHHTCC
T ss_pred cccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH---HHHHHcCcc
Confidence 99865322 2223456899999999999888999999999999999999999999775433211101 011111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ...+ .....+..+.++|.+||+.||.+|||+.+++++
T Consensus 285 ~-~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 E-FPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp C-CCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c-CCCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0000 011234468889999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=243.95 Aligned_cols=181 Identities=22% Similarity=0.319 Sum_probs=144.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC--CCceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD--KFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~--~~~~kl~Dfgl 79 (253)
.++||||++|++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++. ++.+||+|||+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~ 150 (321)
T 1tki_A 76 LVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred EEEEEEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence 479999999999999997643 25999999999999999999999999 999999999999986 78999999999
Q ss_pred cccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
++..... .......+++.|+|||++.+..++.++|+||+||++|+|++|..||......+. ..........
T Consensus 151 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i~~~~~~- 221 (321)
T 1tki_A 151 ARQLKPG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIMNAEYT- 221 (321)
T ss_dssp CEECCTT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTCCC-
T ss_pred CeECCCC--CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHHHcCCCC-
Confidence 9866432 233445689999999999988889999999999999999999999987554321 1111111111
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.+.... ...+..+.+++.+||+.||.+|||+.+++++
T Consensus 222 --~~~~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 222 --FDEEAF----KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --CCHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --CChhhh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111 1234468899999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=244.01 Aligned_cols=192 Identities=23% Similarity=0.374 Sum_probs=151.4
Q ss_pred CEEEEeecCCCChhHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
.|+||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.
T Consensus 116 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTE 192 (334)
T ss_dssp CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECT
T ss_pred eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcC
Confidence 4899999999999999986532 124899999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhH
Q 044510 69 KFRAKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLA 146 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~ 146 (253)
++.+||+|||+++........ ......+++.|+|||++.+..++.++|+||||+++|+|++ |..||......+.
T Consensus 193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---- 268 (334)
T 2pvf_A 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL---- 268 (334)
T ss_dssp TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH----
T ss_pred CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH----
Confidence 999999999998865433221 1223346788999999988889999999999999999999 9999977654321
Q ss_pred HHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCC
Q 044510 147 GYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGP 212 (253)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 212 (253)
.......... ..+...+..+.+++.+||+.||.+||++.++++.|+++......
T Consensus 269 ---~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 269 ---FKLLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp ---HHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ---HHHHhcCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 1111111111 11122344688899999999999999999999999999876543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=243.20 Aligned_cols=180 Identities=23% Similarity=0.359 Sum_probs=143.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC----ceEEccc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF----RAKISDF 77 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~----~~kl~Df 77 (253)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++ .+||+||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 489999999999999997643 5999999999999999999999999 99999999999998877 7999999
Q ss_pred CCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 78 GASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 78 gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
|+++...... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||......+.. ........
T Consensus 163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~~~~~~~ 234 (326)
T 2y0a_A 163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ANVSAVNY 234 (326)
T ss_dssp TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------HHHHHTCC
T ss_pred CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHHhcCC
Confidence 9998654322 223456899999999999888999999999999999999999999775543211 11111110
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ..... ....+..+.+++.+||+.||.+|||+.+++++
T Consensus 235 ~---~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 E---FEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp C---CCHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C---cCccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 11111 11233468889999999999999999999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=243.44 Aligned_cols=181 Identities=25% Similarity=0.388 Sum_probs=142.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 153 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT 153 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccc
Confidence 479999999999999997654 5999999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCc-ceeeeccccccccccchhccCCC-CCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQT-HLTTRVQGTFGYLDLEYFRSSQF-TKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
....... .......|++.|+|||++.+..+ +.++|+|||||++|+|++|..||.......... .........
T Consensus 154 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~~~~~~~~~ 227 (323)
T 3tki_A 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTY 227 (323)
T ss_dssp ECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH------HHHHTTCTT
T ss_pred eeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH------HHHhccccc
Confidence 6542221 12234568999999999987765 778999999999999999999997655432110 011111000
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. . .....+..+.+++.+||+.||.+|||+.|++++
T Consensus 228 ~--~------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 L--N------PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp S--T------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C--C------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 0 011233467789999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=240.68 Aligned_cols=187 Identities=25% Similarity=0.372 Sum_probs=150.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred cEEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 479999999999999998754 4999999999999999999999999 9999999999999999999999999988
Q ss_pred cccCCCccee--eeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHLT--TRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
.......... ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+. .........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~ 238 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-------TAMLEKGER 238 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTCC
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCC
Confidence 6643332221 22335688999999998888999999999999999999 9999987654321 111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
. ..+...+..+.+++.+||+.||.+||++.++++.|+++....
T Consensus 239 ~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 239 M---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 1 112233456888999999999999999999999999988764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=247.75 Aligned_cols=177 Identities=27% Similarity=0.326 Sum_probs=142.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 489999999999999998754 4999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... ........||+.|+|||++.+..++.++|+|||||++|+|++|..||......+. +........
T Consensus 167 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~i~~~~~---- 235 (345)
T 1xjd_A 167 ENMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL------FHSIRMDNP---- 235 (345)
T ss_dssp CCCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCC----
T ss_pred hcccC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH------HHHHHhCCC----
Confidence 54321 2223446789999999999988899999999999999999999999987654321 111111111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMK-EVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~-~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+||++. +++++
T Consensus 236 -------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 236 -------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 01122345688899999999999999997 66543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=240.64 Aligned_cols=194 Identities=21% Similarity=0.225 Sum_probs=144.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+. ++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 94 ~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 168 (308)
T 3g33_A 94 VTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168 (308)
T ss_dssp EEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCTT
T ss_pred EEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCcccc
Confidence 479999996 599999987543 24999999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... .......+|+.|+|||++.+..++.++|+|||||++|+|++|..||......+....................
T Consensus 169 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (308)
T 3g33_A 169 IYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 246 (308)
T ss_dssp TSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSS
T ss_pred ccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccch
Confidence 65422 2223456899999999999889999999999999999999999999876554322111100000000000000
Q ss_pred ----------hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 ----------LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ----------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+..........+..+.+++.+||+.||.+|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 247 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00000111112344578899999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=241.50 Aligned_cols=190 Identities=21% Similarity=0.372 Sum_probs=145.0
Q ss_pred CEEEEeecCCCChhHHhhcc---CCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQ---TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfg 78 (253)
+++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCS
T ss_pred cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecC
Confidence 48999999999999998542 12235999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 79 ASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 79 l~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
+++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......... ......
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------~~~~~~ 265 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY-------DYLLHG 265 (313)
T ss_dssp CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-------HHHHTT
T ss_pred cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH-------HHHHcC
Confidence 98765432211 1223446789999999998889999999999999999999 88999776543311 111111
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
... ..+...+..+.+++.+||+.||.+||++.+++++|+++....
T Consensus 266 ~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 266 HRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp CCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 110 111223346888999999999999999999999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=237.77 Aligned_cols=179 Identities=23% Similarity=0.352 Sum_probs=143.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 117 ~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~ 189 (321)
T 2c30_A 117 LWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCA 189 (321)
T ss_dssp EEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeee
Confidence 47999999999999998653 4999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
....... ......||+.|+|||++.+..++.++|+||||+++|+|++|..||........ ............
T Consensus 190 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~-------~~~~~~~~~~~~ 261 (321)
T 2c30_A 190 QISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-------MKRLRDSPPPKL 261 (321)
T ss_dssp ECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHSSCCCC
T ss_pred ecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhcCCCCCc
Confidence 6543221 22345689999999999988899999999999999999999999976554321 111111111110
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. .....+..+.+++.+||+.||.+|||+.+++++
T Consensus 262 ~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 262 K-------NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp T-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred C-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 011233468889999999999999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=238.07 Aligned_cols=192 Identities=23% Similarity=0.380 Sum_probs=149.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLAR 172 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred cEEEEecccCCCHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence 5899999999999999977432 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCc---ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCC-CCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 82 YVTIDQT---HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQK-PIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 82 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
....... .......+++.|+|||.+.+..++.++|+||||+++|+|++|.. ||......+. ........
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~-------~~~~~~~~ 245 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL-------THFLAQGR 245 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH-------HHHHHTTC
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH-------HHHhhcCC
Confidence 5532211 12223457889999999998889999999999999999999554 4544433221 11111111
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCCC
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQN 214 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~ 214 (253)
.. ..+...+..+.+++.+||+.||.+|||++++++.|+++........
T Consensus 246 ~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 246 RL---------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred CC---------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 10 1112233468889999999999999999999999999988865443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=246.59 Aligned_cols=203 Identities=25% Similarity=0.333 Sum_probs=150.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++.... +++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence 379999999999999997653 899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcc--eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTH--LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
........ ......+++.|+|||++.+..++.++|+||||+++|+|++|..||.......... ..............
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-IGIAQGQMTVLRLT 261 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-HCSCCHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhh-hcccccchhHHHHH
Confidence 76543221 1223457788999999998889999999999999999999999986532211000 00000000000000
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCC
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGP 212 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 212 (253)
...........+...+..+.+++.+||+.||.+|||+.++++.|+.+.+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 00111111112233445788999999999999999999999999999887643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=248.50 Aligned_cols=181 Identities=23% Similarity=0.335 Sum_probs=144.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeE
Confidence 48999999999999999764 3899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCC----CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQ----FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
..............||+.|+|||++.+.. ++.++|+|||||++|+|++|..||......+. +........
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~~~ 290 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMNHKN 290 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTHHH
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH------HHHHHhccc
Confidence 76543333334567999999999998655 78999999999999999999999987654332 111111110
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRK--RPTMKEVAFE 202 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~l~~~ 202 (253)
...... ....+..+.++|.+||..+|.+ ||++++|+++
T Consensus 291 ~~~~p~-------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 291 SLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HCCCCT-------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cccCCC-------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 000000 0123346888999999999988 9999999987
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=244.02 Aligned_cols=174 Identities=20% Similarity=0.260 Sum_probs=143.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~ 189 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 189 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccce
Confidence 489999999999999998764 4999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... .....||+.|+|||++.+..++.++|+|||||++|+|++|..||......+. ...+......
T Consensus 190 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------~~~i~~~~~~-- 256 (350)
T 1rdq_E 190 RVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-------YEKIVSGKVR-- 256 (350)
T ss_dssp ECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCC--
T ss_pred eccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH-------HHHHHcCCCC--
Confidence 65422 2335689999999999988899999999999999999999999987554321 1111111110
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT-----MKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~~ 202 (253)
.+...+..+.++|.+||+.||.+||+ +++++++
T Consensus 257 --------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 257 --------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 11223456888999999999999998 8888865
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=243.20 Aligned_cols=188 Identities=21% Similarity=0.395 Sum_probs=143.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cEEEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcch
Confidence 4899999999999999976432 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcce--eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHL--TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
......... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+. .........
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-------~~~~~~~~~ 268 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-------MKAINDGFR 268 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHTTCC
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH-------HHHHHCCCc
Confidence 654322111 122335778999999998889999999999999999999 9999976554321 111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
. ..+...+..+.+++.+||+.||.+||++.+++++|+++....
T Consensus 269 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 269 L---------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp C---------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred C---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0 011223446888999999999999999999999999887653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=239.66 Aligned_cols=174 Identities=28% Similarity=0.405 Sum_probs=143.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~ 154 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK 154 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcce
Confidence 479999999999999998754 5999999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
.... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||........ +....... ..
T Consensus 155 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~i~~~~-~~-- 221 (318)
T 1fot_A 155 YVPD----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKILNAE-LR-- 221 (318)
T ss_dssp ECSS----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHCC-CC--
T ss_pred ecCC----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC-CC--
Confidence 6532 22345689999999999988899999999999999999999999977554321 11111111 10
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
.+...+..+.+++.+||+.||.+|| ++++++++
T Consensus 222 --------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 222 --------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1112334688899999999999999 88998865
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=245.23 Aligned_cols=188 Identities=24% Similarity=0.366 Sum_probs=125.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC---ceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF---RAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~---~~kl~Dfg 78 (253)
.|+||||++||+|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCT
T ss_pred EEEEEEccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccc
Confidence 479999999999999998754 5999999999999999999999999 99999999999997665 89999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
+++...... .......+|+.|+|||++.+..++.++|+|||||++|+|++|..||..................+.....
T Consensus 155 ~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~ 233 (325)
T 3kn6_A 155 FARLKPPDN-QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF 233 (325)
T ss_dssp TCEECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC
T ss_pred cceecCCCC-CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC
Confidence 997654322 2233456799999999999888999999999999999999999999875543222222222222222211
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ... ......+..+.+++.+||+.||.+|||+.+++++
T Consensus 234 ~--~~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 234 S--FEG----EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp C--CCS----HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred C--CCc----ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1 010 1112234578899999999999999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=247.05 Aligned_cols=181 Identities=23% Similarity=0.313 Sum_probs=143.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec---CCCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD---DKFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~---~~~~~kl~Dfg 78 (253)
.|+||||++||+|.+.+.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++ .++.+||+|||
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred EEEEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 489999999999999998754 4999999999999999999999999 99999999999998 46789999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
++....... .......||+.|+|||++.+..++.++||||+||++|+|++|..||......+. ...+.....
T Consensus 159 ~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~-------~~~i~~~~~ 230 (444)
T 3soa_A 159 LAIEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL-------YQQIKAGAY 230 (444)
T ss_dssp SCBCCCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHTCC
T ss_pred eeEEecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH-------HHHHHhCCC
Confidence 997654322 222345689999999999988899999999999999999999999977554321 111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ...+ .....+..+.+++.+||+.||.+|||+.+++++
T Consensus 231 ~-~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 231 D-FPSP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp C-CCTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred C-CCcc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 0000 011233468889999999999999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=241.36 Aligned_cols=180 Identities=18% Similarity=0.297 Sum_probs=139.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++.........++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 136 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 212 (332)
T 3qd2_B 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVT 212 (332)
T ss_dssp EEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCccc
Confidence 5899999999999999988665555777889999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCc-----------ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHH
Q 044510 82 YVTIDQT-----------HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFL 150 (253)
Q Consensus 82 ~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~ 150 (253)
....... .......||+.|+|||++.+..++.++|+||||+++|+|++|..|+.. . .. ..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~---~~-~~ 283 (332)
T 3qd2_B 213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----R---VR-II 283 (332)
T ss_dssp ECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----H---HH-HH
T ss_pred ccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----H---HH-HH
Confidence 7654321 112234689999999999988899999999999999999998765311 0 00 01
Q ss_pred HHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 151 RAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
........ +.........+.+++.+||+.||.+||++.+++++
T Consensus 284 ~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 284 TDVRNLKF---------PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHTTCC---------CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHhhccCC---------CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 11111111 11122334567889999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=242.50 Aligned_cols=184 Identities=23% Similarity=0.362 Sum_probs=142.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~ 158 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 158 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCB
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccc
Confidence 489999999999999998754 4999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhh--hhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDK--SLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~ 159 (253)
..... ........||+.|+|||++.+..++.++|+|||||++|+|++|..||......... .........+.....
T Consensus 159 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~- 236 (345)
T 3a8x_A 159 EGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI- 236 (345)
T ss_dssp CSCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-
T ss_pred cccCC-CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-
Confidence 53322 22234457899999999999888999999999999999999999999754322110 111111222221111
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTM------KEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~------~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+||++ .+++++
T Consensus 237 ---------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 237 ---------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ---------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1122234568889999999999999995 677654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=249.26 Aligned_cols=184 Identities=21% Similarity=0.311 Sum_probs=144.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 4899999999999999987422 5999999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCcceeeeccccccccccchhc-----cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR-----SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
..............||+.|+|||++. ...++.++|+|||||++|+|++|..||......+... ......
T Consensus 224 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~------~i~~~~ 297 (437)
T 4aw2_A 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHK 297 (437)
T ss_dssp ECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHTHH
T ss_pred hcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH------hhhhcc
Confidence 66544433344467999999999997 4568999999999999999999999998765433211 111110
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRK--RPTMKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~l~~~ 202 (253)
..... + ......+..+.++|.+||..+|.+ ||++++++++
T Consensus 298 ~~~~~--p----~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 298 ERFQF--P----TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHCCC--C----SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ccccC--C----cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 00000 0 001123446888999999888888 9999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=241.04 Aligned_cols=189 Identities=25% Similarity=0.382 Sum_probs=139.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||++|++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 489999999999999998754 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcc--eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTH--LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
........ ......|++.|+|||++.+..++.++|+||||+++|+|++|..||........ ...........
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCCCC
Confidence 65432221 22335689999999999988899999999999999999999999987654321 11111111111
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHH-HHHHHhhchhh
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKE-VAFELGGIRAS 209 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~-l~~~l~~~~~~ 209 (253)
+ .......+..+.+++.+||+.||.+||+..+ +...+.+....
T Consensus 239 ----~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 239 ----P---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp ----H---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred ----c---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 0 0111223456888999999999999996555 44556555443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=247.42 Aligned_cols=183 Identities=23% Similarity=0.265 Sum_probs=142.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.+... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhhe
Confidence 4899999999999999987532 4999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhc-------cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHh
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR-------SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK 154 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 154 (253)
..............||+.|+|||++. ...++.++|+|||||++|+|++|..||......+.. .....
T Consensus 211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~i~~ 284 (412)
T 2vd5_A 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY------GKIVH 284 (412)
T ss_dssp ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHT
T ss_pred eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH------HHHHh
Confidence 76543333333457999999999997 346899999999999999999999999876543321 11111
Q ss_pred hccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 044510 155 ENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKR---PTMKEVAFE 202 (253)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R---ps~~~l~~~ 202 (253)
...... . +......+..+.++|.+||. +|.+| |++++++++
T Consensus 285 ~~~~~~--~----p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 285 YKEHLS--L----PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHCC--C----C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred cccCcC--C----CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 100000 0 00112234578889999999 99998 589999876
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=242.25 Aligned_cols=191 Identities=25% Similarity=0.395 Sum_probs=151.1
Q ss_pred CEEEEeecCCCChhHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
.++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSE 183 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECG
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECC
Confidence 5899999999999999987542 112889999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhH
Q 044510 69 KFRAKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLA 146 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~ 146 (253)
++.+||+|||+++........ ......+++.|+|||++.+..++.++|+||||+++|+|++ |..||........
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---- 259 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---- 259 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH----
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH----
Confidence 999999999998765433222 2233457889999999998889999999999999999998 9999977553321
Q ss_pred HHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 147 GYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
............ .+...+..+.+++.+||+.||.+|||+.+++++|+.+....
T Consensus 260 --~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 260 --FCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp --HHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --HHHHhccCccCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 111111111111 11123346888999999999999999999999999988654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=261.45 Aligned_cols=192 Identities=23% Similarity=0.367 Sum_probs=151.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR 411 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred ceEeeehhcCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccce
Confidence 4899999999999999975321 24899999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............++..|+|||++.+..++.++|||||||++|+|++ |..||......+. ...+.....
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~-------~~~i~~~~~-- 482 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------LDQVERGYR-- 482 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH-------HHHHHTTCC--
T ss_pred ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCC--
Confidence 654221111222345678999999998889999999999999999999 9999977654321 111111111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCC
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQ 213 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~ 213 (253)
...+...+..+.+++.+||+.||.+||++.+|++.|+.+.....++
T Consensus 483 -------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~ 528 (535)
T 2h8h_A 483 -------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528 (535)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCS
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcc
Confidence 0112233456888999999999999999999999999987765444
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=247.50 Aligned_cols=195 Identities=24% Similarity=0.348 Sum_probs=148.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 4799999999999999987432 4999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcce--eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhh--------hhHHHHHH
Q 044510 82 YVTIDQTHL--TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDK--------SLAGYFLR 151 (253)
Q Consensus 82 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~--------~~~~~~~~ 151 (253)
......... .....+++.|+|||++.+..++.++|+||||+++|+|++|..||......... ........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 664333221 22345778899999999888999999999999999999999998653321100 00001111
Q ss_pred HHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 152 AMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
..... .....+...+..+.+++.+||+.||.+|||+.+++++|+.+....
T Consensus 256 ~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 256 LLEEG---------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred Hhhcc---------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11111 111122334457889999999999999999999999999987654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=242.17 Aligned_cols=189 Identities=23% Similarity=0.383 Sum_probs=148.4
Q ss_pred CEEEEeecCCCChhHHhhccCC-------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKI 74 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl 74 (253)
.++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEE
Confidence 4899999999999999976321 124789999999999999999999999 999999999999999999999
Q ss_pred cccCCcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHH
Q 044510 75 SDFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRA 152 (253)
Q Consensus 75 ~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~ 152 (253)
+|||+++........ ......+++.|+|||++.+..++.++|+||||+++|+|++ |..||........ ...
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------~~~ 252 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------LRF 252 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH-------HHH
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH-------HHH
Confidence 999998765432211 1122346788999999998889999999999999999999 8999977654321 111
Q ss_pred HhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 153 MKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
....... ..+...+..+.+++.+||+.||.+||++.+++++|+++...
T Consensus 253 ~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 253 VMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 1111111 11122344688899999999999999999999999887553
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=250.60 Aligned_cols=177 Identities=23% Similarity=0.302 Sum_probs=142.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhh-CCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS-TTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+ .+ |+||||||+||+++.++.+||+|||++
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a 296 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLC 296 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred EEEEEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCc
Confidence 479999999999999998754 59999999999999999999998 89 999999999999999999999999998
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
+..... ........||+.|+|||++.+..++.++|+|||||++|+|++|..||......... ..+......
T Consensus 297 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-------~~i~~~~~~- 367 (446)
T 4ejn_A 297 KEGIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELILMEEIR- 367 (446)
T ss_dssp CTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCCC-
T ss_pred eeccCC-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH-------HHHHhCCCC-
Confidence 754322 22233467899999999999889999999999999999999999999776543211 111111110
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
.+...+..+.+++.+||+.||.+|| ++++++++
T Consensus 368 ---------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 368 ---------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 1122334688899999999999999 99999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=248.10 Aligned_cols=192 Identities=22% Similarity=0.296 Sum_probs=140.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+. ++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 489999996 5899999764 4899999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCC--------------------cceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChh
Q 044510 82 YVTIDQ--------------------THLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTE 140 (253)
Q Consensus 82 ~~~~~~--------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~ 140 (253)
...... ........||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 653210 111233568999999999986 56899999999999999999999999887654
Q ss_pred hhhhhHHHHHH--------------------HHhhc------cccchhchhhhh-----hhcHHHHHHHHHHHHHhcccC
Q 044510 141 EDKSLAGYFLR--------------------AMKEN------CLFDMLDAQVLK-----EAKEEEIITVAMLAKRCLNLN 189 (253)
Q Consensus 141 ~~~~~~~~~~~--------------------~~~~~------~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~d 189 (253)
+.......... ..... ...... +.... ......+..+.+++.+||+.|
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIF-TKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCH-HHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhC-cchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 33221110000 00000 000000 00000 000022456889999999999
Q ss_pred CCCCCCHHHHHHH
Q 044510 190 GRKRPTMKEVAFE 202 (253)
Q Consensus 190 P~~Rps~~~l~~~ 202 (253)
|.+|||+++++++
T Consensus 317 P~~R~t~~e~l~H 329 (388)
T 3oz6_A 317 PNKRISANDALKH 329 (388)
T ss_dssp GGGSCCHHHHTTS
T ss_pred cccCCCHHHHhCC
Confidence 9999999999977
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=243.93 Aligned_cols=178 Identities=25% Similarity=0.361 Sum_probs=141.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+.||+|.+++.... .+++..++.++.|++.||.|||+.| |+||||||+||+++.++.+||+|||+++
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 163 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAA 163 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceee
Confidence 489999999999999998754 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhcc---CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS---SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
..... .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||............ ........
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~----~~~~~~~~ 237 (384)
T 4fr4_A 164 MLPRE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV----HTFETTVV 237 (384)
T ss_dssp ECCTT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH----HHHHHCCC
T ss_pred eccCC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH----HHHhhccc
Confidence 65422 23344679999999999974 35899999999999999999999999765433221111 11111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT-MKEVAF 201 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-~~~l~~ 201 (253)
..+...+..+.+++.+||+.||.+||+ +.++.+
T Consensus 238 ----------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 ----------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111223456888999999999999998 777765
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=239.19 Aligned_cols=197 Identities=24% Similarity=0.325 Sum_probs=150.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHh--------hCCCCCeEecCCCCCceeecCCCceE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLH--------STTSIPIYHRDIKSANILLDDKFRAK 73 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--------~~~~~~i~H~dl~~~nili~~~~~~k 73 (253)
.++||||+++|+|.+++... .+++..++.++.|++.||.||| ..+ ++||||||+||+++.++.+|
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEE
T ss_pred eEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEE
Confidence 48999999999999999764 4899999999999999999999 788 99999999999999999999
Q ss_pred EcccCCcccccCCCcc---eeeeccccccccccchhccCC------CCCCCCeehhHHHHHHHHhC----------CCCC
Q 044510 74 ISDFGASRYVTIDQTH---LTTRVQGTFGYLDLEYFRSSQ------FTKKGDVYSFGVVFVGLLTG----------QKPI 134 (253)
Q Consensus 74 l~Dfgl~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~lltg----------~~pf 134 (253)
|+|||+++........ ......|++.|+|||++.+.. ++.++|+||||+++|+|++| ..||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 9999999766543322 123346899999999998652 33689999999999999999 7788
Q ss_pred CCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 135 RSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
......... ................+... .........+.+++.+||+.||.+||++.+++++|+++..+.
T Consensus 268 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 268 YDLVPSDPS--VEEMRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TTTSCSSCC--HHHHHHHHTTSCCCCCCCGG---GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cccCcCccc--HHHHHHHHHHHHhCCCCccc---ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 664332111 11112222222111111111 112355667899999999999999999999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=234.76 Aligned_cols=185 Identities=28% Similarity=0.527 Sum_probs=143.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCc-----eEEcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFR-----AKISD 76 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~-----~kl~D 76 (253)
.++||||+++++|.+.+..... .+++..++.++.|++.||.|||+.+ .+++|+||||+||+++.++. +||+|
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 96 PRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TEEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CeEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 3799999999999998876433 5999999999999999999999986 23899999999999987776 99999
Q ss_pred cCCcccccCCCcceeeeccccccccccchhc--cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHh
Q 044510 77 FGASRYVTIDQTHLTTRVQGTFGYLDLEYFR--SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK 154 (253)
Q Consensus 77 fgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 154 (253)
||+++.... ......+++.|+|||++. ...++.++|+||+|+++|+|++|..||.......... .....
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-----~~~~~ 243 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-----INMIR 243 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-----HHHHH
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-----HHHHh
Confidence 999874332 233456899999999984 3457889999999999999999999997655432111 11111
Q ss_pred hccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 155 ENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
...... ..+...+..+.+++.+||+.||.+||+++++++.|+++
T Consensus 244 ~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EEGLRP--------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSCCCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccCCCC--------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111111 11223345688899999999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=261.92 Aligned_cols=187 Identities=25% Similarity=0.370 Sum_probs=147.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~ 517 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK 517 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEEEccCCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCcc
Confidence 379999999999999997654 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcc--eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTH--LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
........ ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+. ...+.....
T Consensus 518 ~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-------~~~i~~~~~ 590 (635)
T 4fl3_A 518 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-------TAMLEKGER 590 (635)
T ss_dssp HTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTCC
T ss_pred ccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCC
Confidence 66433221 1222346788999999998899999999999999999998 9999987665431 111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
. ..+...+..+.+++.+||+.||.+||++.+|++.|+.+....
T Consensus 591 ~---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 591 M---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1 112233457888999999999999999999999999887653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=244.85 Aligned_cols=172 Identities=27% Similarity=0.351 Sum_probs=139.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.+.. .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~ 187 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK 187 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred EEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccc
Confidence 489999999999999998754 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... ........||+.|+|||++.+..++.++|+|||||++|+|++|..||......+. +..... ....
T Consensus 188 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~~~i~~-~~~~-- 257 (373)
T 2r5t_A 188 ENIEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------YDNILN-KPLQ-- 257 (373)
T ss_dssp GGBCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH------HHHHHH-SCCC--
T ss_pred ccccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHh-cccC--
Confidence 54322 2233446789999999999988899999999999999999999999977554321 111111 1110
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMK 197 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~ 197 (253)
.+...+..+.+++.+||+.||.+||++.
T Consensus 258 --------~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 258 --------LKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp --------CCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred --------CCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 1112334688899999999999999974
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=237.20 Aligned_cols=194 Identities=18% Similarity=0.243 Sum_probs=141.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++ +|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 167 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCC-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCce
Confidence 4899999975 88888876432 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc--
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL-- 158 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 158 (253)
...... .......+++.|+|||++.+ ..++.++|+||+||++|+|++|..||......+.................
T Consensus 168 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 168 AFGIPV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp ETTSCC-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG
T ss_pred ecCCCc-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh
Confidence 654222 22333567999999999976 45899999999999999999999999876554322111110000000000
Q ss_pred -----------cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 -----------FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 -----------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
................+..+.+++.+||+.||.+|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000001111122234578899999999999999999999964
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=242.84 Aligned_cols=192 Identities=22% Similarity=0.274 Sum_probs=141.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC-------------
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD------------- 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~------------- 68 (253)
.++||||+ +++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred eEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcc
Confidence 47999999 9999999987542 24999999999999999999999999 999999999999975
Q ss_pred ------------CCceEEcccCCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCC
Q 044510 69 ------------KFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRS 136 (253)
Q Consensus 69 ------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~ 136 (253)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 788999999999764322 2235689999999999988999999999999999999999999987
Q ss_pred CChhhhhhhHHHHH--------HHHhhccccchhchh---------------------hhhhhcHHHHHHHHHHHHHhcc
Q 044510 137 TDTEEDKSLAGYFL--------RAMKENCLFDMLDAQ---------------------VLKEAKEEEIITVAMLAKRCLN 187 (253)
Q Consensus 137 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~li~~cl~ 187 (253)
....+......... ............... ............+.+++.+||+
T Consensus 262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 65443222111100 000000000000000 0000011112567899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 044510 188 LNGRKRPTMKEVAFE 202 (253)
Q Consensus 188 ~dP~~Rps~~~l~~~ 202 (253)
.||.+|||++|++++
T Consensus 342 ~dP~~Rpta~elL~h 356 (360)
T 3llt_A 342 IDPTLRPSPAELLKH 356 (360)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred CChhhCCCHHHHhcC
Confidence 999999999999854
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=244.03 Aligned_cols=190 Identities=21% Similarity=0.363 Sum_probs=148.6
Q ss_pred CEEEEeecCCCChhHHhhccCC-----------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-----------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF 70 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~ 70 (253)
.++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCC
Confidence 4899999999999999976321 224799999999999999999999999 99999999999999999
Q ss_pred ceEEcccCCcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHH
Q 044510 71 RAKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGY 148 (253)
Q Consensus 71 ~~kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~ 148 (253)
.++|+|||+++........ ......+++.|+|||++.+..++.++|+||||+++|+|++ |..||........
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------ 275 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK------ 275 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH------
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH------
Confidence 9999999998765433222 1223446788999999998889999999999999999998 9999976543321
Q ss_pred HHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 149 FLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
........... ..+...+..+.+++.+||+.||.+|||+.+++++|+++...
T Consensus 276 ~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 276 FYKLVKDGYQM---------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 11111111110 01111234678899999999999999999999999987764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=237.68 Aligned_cols=191 Identities=20% Similarity=0.236 Sum_probs=139.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~ 182 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIAS 182 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC--
T ss_pred EEEEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCc
Confidence 479999999999999998754 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ........ ...
T Consensus 183 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~-~~~- 253 (309)
T 2h34_A 183 ATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-------MGAHINQA-IPR- 253 (309)
T ss_dssp --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-------HHHHHHSC-CCC-
T ss_pred cccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-------HHHHhccC-CCC-
Confidence 654333233334568999999999998889999999999999999999999997643321 11111111 100
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhchhhcCC
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-TMKEVAFELGGIRASIGP 212 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-s~~~l~~~l~~~~~~~~~ 212 (253)
....+...+..+.+++.+||+.||.+|| +++++++.|++.......
T Consensus 254 -----~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 254 -----PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp -----GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred -----ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 0011222334688899999999999999 999999999988766543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=238.62 Aligned_cols=183 Identities=23% Similarity=0.323 Sum_probs=141.5
Q ss_pred CEEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCc---eEEccc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFR---AKISDF 77 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~---~kl~Df 77 (253)
.|+||||++|++|.+.+.... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecC
Confidence 489999999999988876532 2234899999999999999999999999 999999999999986554 999999
Q ss_pred CCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 78 GASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 78 gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
|+++...... .......||+.|+|||++.+..++.++|+|||||++|+|++|..||...... .........
T Consensus 178 g~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~i~~~~- 248 (351)
T 3c0i_A 178 GVAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-------LFEGIIKGK- 248 (351)
T ss_dssp TTCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-------HHHHHHHTC-
T ss_pred cceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-------HHHHHHcCC-
Confidence 9998664322 1223456899999999999888999999999999999999999999764211 111111111
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.. ..+... ...+..+.+++.+||+.||.+||++.+++++
T Consensus 249 ~~--~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 249 YK--MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CC--CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CC--CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 10 111111 1234468889999999999999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=240.39 Aligned_cols=180 Identities=24% Similarity=0.346 Sum_probs=142.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC---CceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK---FRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~---~~~kl~Dfg 78 (253)
.|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG 176 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFG 176 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecC
Confidence 489999999999999987653 5899999999999999999999999 9999999999999864 459999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
++....... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||......+. ...+.....
T Consensus 177 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------~~~i~~~~~ 247 (362)
T 2bdw_A 177 LAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-------YAQIKAGAY 247 (362)
T ss_dssp TCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCC
T ss_pred cceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhCCC
Confidence 997654322 22345689999999999988899999999999999999999999977554321 111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. . ... .....+..+.+++.+||+.||.+||++.+++++
T Consensus 248 ~-~-~~~----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 248 D-Y-PSP----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp C-C-CTT----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred C-C-Ccc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0 000 011233468889999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=237.21 Aligned_cols=184 Identities=22% Similarity=0.418 Sum_probs=143.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 165 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 165 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred eEEEEecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccc
Confidence 5899999999999999976431 13789999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+. .........
T Consensus 166 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-------~~~~~~~~~-- 232 (278)
T 1byg_A 166 EASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKGYK-- 232 (278)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-------HHHHTTTCC--
T ss_pred ccccc----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHhcCCC--
Confidence 54322 122346789999999998889999999999999999998 9999977654321 111111100
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
...+...+..+.+++.+||+.||.+||++.++++.|+++...
T Consensus 233 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 233 -------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 111223345688899999999999999999999999998765
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=259.68 Aligned_cols=177 Identities=25% Similarity=0.348 Sum_probs=144.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceee
Confidence 489999999999999998764 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... ........||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+..+. +....... .
T Consensus 491 ~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~-~--- 559 (674)
T 3pfq_A 491 ENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQSIMEHN-V--- 559 (674)
T ss_dssp ECCCT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHSSC-C---
T ss_pred ccccC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH------HHHHHhCC-C---
Confidence 54322 2233456799999999999989999999999999999999999999987654331 11111111 1
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTM-----KEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~-----~~l~~~ 202 (253)
..+...+..+.++|.+||+.||.+||++ ++|+++
T Consensus 560 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 560 -------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred -------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1122344578889999999999999997 777754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=241.35 Aligned_cols=183 Identities=28% Similarity=0.341 Sum_probs=142.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 479999999999999998754 4999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccC--CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS--QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
..............||+.|+|||++.+. .++.++|+|||||++|+|++|..||......... ...........
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~--- 282 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSE--- 282 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHCC---
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhccC---
Confidence 6543333333445789999999999853 4688999999999999999999999765432211 11111111111
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFEL 203 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~l 203 (253)
...+...+..+.+++.+||+.||.+|| ++++++++.
T Consensus 283 --------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 --------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 011222344678899999999999999 999998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=242.36 Aligned_cols=192 Identities=23% Similarity=0.361 Sum_probs=147.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 3799999999999999966433 4999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcc--eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhh--------hhhhHHHHHH
Q 044510 82 YVTIDQTH--LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE--------DKSLAGYFLR 151 (253)
Q Consensus 82 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~--------~~~~~~~~~~ 151 (253)
........ ......++..|+|||.+.+..++.++|+||+|+++|+|++|..|+....... ..........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 76543321 2233457788999999998889999999999999999999998864321100 0000111111
Q ss_pred HHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhch
Q 044510 152 AMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207 (253)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 207 (253)
...... ....+...+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 255 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111111 11112233457889999999999999999999999998874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=246.02 Aligned_cols=201 Identities=22% Similarity=0.321 Sum_probs=153.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceee----cCCCceEEccc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILL----DDKFRAKISDF 77 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili----~~~~~~kl~Df 77 (253)
.++||||+++|+|.+++........+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DF 160 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecC
Confidence 4899999999999999987654445999999999999999999999999 9999999999999 77778999999
Q ss_pred CCcccccCCCcceeeeccccccccccchhcc--------CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH
Q 044510 78 GASRYVTIDQTHLTTRVQGTFGYLDLEYFRS--------SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF 149 (253)
Q Consensus 78 gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 149 (253)
|+++...... ......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||......... ...+
T Consensus 161 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~ 236 (396)
T 4eut_A 161 GAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVM 236 (396)
T ss_dssp GGCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHH
T ss_pred CCceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHH
Confidence 9997654322 2233568999999999875 45778999999999999999999999764432211 1112
Q ss_pred HHHHhhccccch--------------hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 150 LRAMKENCLFDM--------------LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 150 ~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
............ ................+.+++.+||+.||.+||+++++++.++.+...
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 222222110000 000111233466778899999999999999999999999999887765
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=245.11 Aligned_cols=195 Identities=25% Similarity=0.412 Sum_probs=149.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 4899999999999999987532 5899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcce--eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhh---------hhhHHHHH
Q 044510 82 YVTIDQTHL--TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED---------KSLAGYFL 150 (253)
Q Consensus 82 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~---------~~~~~~~~ 150 (253)
......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ......+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 764332211 1223467789999999988889999999999999999999998754311100 00000111
Q ss_pred HHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 151 RAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
........ ...+...+..+.+++.+||+.||.+||++.++++.|+++++.+
T Consensus 274 ~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 274 ELLKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhhcCCC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111110 1112234457888999999999999999999999999998764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=244.20 Aligned_cols=182 Identities=24% Similarity=0.332 Sum_probs=131.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCc--eEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFR--AKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~--~kl~Dfgl 79 (253)
.++||||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++. +||+|||+
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~ 164 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGY 164 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCc
Confidence 479999999999999997754 4999999999999999999999999 999999999999987665 99999999
Q ss_pred cccccCCCcceeeeccccccccccchhccCCCCCC-CCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKK-GDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
++..... .......||+.|+|||++.+..+..+ +|+||+||++|+|++|..||........ ..............
T Consensus 165 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~~~~ 240 (361)
T 3uc3_A 165 SKSSVLH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSVKYS 240 (361)
T ss_dssp C-----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTTCCC
T ss_pred ccccccc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcCCCC
Confidence 8743221 22234568999999999988777655 8999999999999999999976543221 11111111111100
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. . .....+..+.+++.+||+.||.+|||+.+++++
T Consensus 241 ~---~------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 241 I---P------DDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp C---C------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred C---C------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0 0 001123467889999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=238.36 Aligned_cols=174 Identities=18% Similarity=0.201 Sum_probs=135.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+ +++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~ 205 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLV 205 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred EEEEEecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeee
Confidence 48999999 7799999877543 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... .......||+.|+|||++.+ .++.++|||||||++|+|++|..|+..... ...+.....
T Consensus 206 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~--- 269 (311)
T 3p1a_A 206 ELGTA--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYL--- 269 (311)
T ss_dssp ECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCC---
T ss_pred ecccC--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCC---
Confidence 65422 22334558999999999885 789999999999999999999766543211 111111111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.+. .+...+..+.+++.+||+.||.+|||+++++++
T Consensus 270 -~~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 270 -PPE----FTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -Ccc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111 112234578899999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=244.47 Aligned_cols=181 Identities=22% Similarity=0.301 Sum_probs=143.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC--CCceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD--KFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~--~~~~kl~Dfgl 79 (253)
.++||||+.||+|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++. .+.+||+|||+
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEeccc
Confidence 479999999999999997643 25999999999999999999999999 999999999999974 56799999999
Q ss_pred cccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
++...... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||......+. +....... ..
T Consensus 198 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~------~~~i~~~~-~~ 268 (387)
T 1kob_A 198 ATKLNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKRCD-WE 268 (387)
T ss_dssp CEECCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHHCC-CC
T ss_pred ceecCCCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC-CC
Confidence 98664322 23345689999999999988899999999999999999999999987554321 11111111 00
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.+. ......+..+.+++.+||+.||.+|||+.+++++
T Consensus 269 --~~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 269 --FDE----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --CCS----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --CCc----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 011 1111234468889999999999999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=238.49 Aligned_cols=177 Identities=25% Similarity=0.345 Sum_probs=139.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++|++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 489999999999999998754 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......|++.|+|||++.+..++.++|+||||+++|+|++|..||......+. ........ .
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~~~~-~--- 238 (327)
T 3a62_A 170 ESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT------IDKILKCK-L--- 238 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHTC-C---
T ss_pred ccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhCC-C---
Confidence 543221 222345689999999999988899999999999999999999999987654321 11111111 1
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 239 -------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 -------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 01112344688899999999999999 78888875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=241.54 Aligned_cols=184 Identities=21% Similarity=0.299 Sum_probs=141.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC----CceEEccc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK----FRAKISDF 77 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~----~~~kl~Df 77 (253)
.|+||||++||+|.+++.... .+++..+..++.||+.||.|||+.| |+||||||+||++... +.+||+||
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Df 164 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDF 164 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence 489999999999999998654 5999999999999999999999999 9999999999998543 35999999
Q ss_pred CCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 78 GASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 78 gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
|+++...... .......+|+.|+|||++.+..++.++|+|||||++|+|++|..||........ .. +...+....
T Consensus 165 g~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~-~~~~i~~~~ 239 (342)
T 2qr7_A 165 GFAKQLRAEN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP---EE-ILARIGSGK 239 (342)
T ss_dssp TTCEECBCTT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH---HH-HHHHHHHCC
T ss_pred CCcccCcCCC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH---HH-HHHHHccCC
Confidence 9998654322 223345689999999999887789999999999999999999999976432211 11 111111111
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.. . . .......+..+.+++.+||+.||.+||++.+++++
T Consensus 240 ~~-~-~----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 240 FS-L-S----GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp CC-C-C----STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cc-c-C----ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 0 0 00112234468889999999999999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=240.27 Aligned_cols=182 Identities=25% Similarity=0.323 Sum_probs=140.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC---CCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD---KFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~---~~~~kl~Dfg 78 (253)
.++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++. ++.+||+|||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred EEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 479999999999999986542 235999999999999999999999999 999999999999987 7899999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
+++...... ......|++.|+|||++.+..++.++|+||||+++|+|++|..||......+.. .........
T Consensus 180 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~i~~~~~~ 251 (327)
T 3lm5_A 180 MSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY------LNISQVNVD 251 (327)
T ss_dssp GCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHTCCC
T ss_pred cccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH------HHHHhcccc
Confidence 998654222 223356899999999999888999999999999999999999999776543211 111111100
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. . .......+..+.+++.+||+.||.+|||+++++++
T Consensus 252 ~---~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 252 Y---S----EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp C---C----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred c---C----chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 0 01112234468889999999999999999999865
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=259.15 Aligned_cols=187 Identities=24% Similarity=0.388 Sum_probs=147.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 489999999999999998643 25899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+....+. ...+......
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-------~~~i~~~~~~- 611 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------IGRIENGERL- 611 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHHTCCC-
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHcCCCC-
Confidence 664333323333456789999999998889999999999999999997 9999987654331 1111111111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
..+...+..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 612 --------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 612 --------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 11122345688899999999999999999999999988654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=232.99 Aligned_cols=178 Identities=23% Similarity=0.305 Sum_probs=139.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 113 ~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 185 (298)
T 2zv2_A 113 LYMVFELVNQGPVMEVPTLK----PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSN 185 (298)
T ss_dssp EEEEEECCTTCBSCCSSCSS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCCEEEecCCCcc
Confidence 48999999999998876432 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCC---CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQ---FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
...... .......|++.|+|||++.+.. ++.++|+|||||++|+|++|..||........ .........
T Consensus 186 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-------~~~~~~~~~ 257 (298)
T 2zv2_A 186 EFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL-------HSKIKSQAL 257 (298)
T ss_dssp ECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC
T ss_pred cccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH-------HHHHhcccC
Confidence 654322 2233456899999999998654 36789999999999999999999976543221 111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... . ....+..+.+++.+||+.||.+||++.+++++
T Consensus 258 ~~~-~-------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 258 EFP-D-------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp CCC-S-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCC-C-------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 100 0 11223468889999999999999999999754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=242.66 Aligned_cols=202 Identities=17% Similarity=0.208 Sum_probs=143.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccce
Confidence 4799999999999999987532 25999999999999999999999999 9999999999999999999999999876
Q ss_pred cccCCCc------ceeeeccccccccccchhcc--CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhH--HHHHH
Q 044510 82 YVTIDQT------HLTTRVQGTFGYLDLEYFRS--SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLA--GYFLR 151 (253)
Q Consensus 82 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~--~~~~~ 151 (253)
....... .......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||............ .....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 256 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence 5432111 11122468889999999987 56899999999999999999999999775543221100 00000
Q ss_pred HHhhc------------------cccch---------hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--
Q 044510 152 AMKEN------------------CLFDM---------LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE-- 202 (253)
Q Consensus 152 ~~~~~------------------~~~~~---------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~-- 202 (253)
..... ..... .........+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 00000 00000 00000011223345678999999999999999999999976
Q ss_pred Hhhch
Q 044510 203 LGGIR 207 (253)
Q Consensus 203 l~~~~ 207 (253)
++.+.
T Consensus 337 f~~~~ 341 (389)
T 3gni_B 337 FKQIK 341 (389)
T ss_dssp GGGC-
T ss_pred HHHHh
Confidence 55443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=231.13 Aligned_cols=184 Identities=20% Similarity=0.323 Sum_probs=144.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+. +++|+||||+||+++.++.++|.||++..
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSSS-CCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred eEeeecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCCC-ceecCCCccceEEEcCCcceeEEecccee
Confidence 489999999999999998753 2258999999999999999999998762 38999999999999999999999888765
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCC---CCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTK---KGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
.... ....+++.|+|||.+.+..++. ++|+||||+++|+|++|..||........ ..........
T Consensus 162 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~ 229 (271)
T 3kmu_A 162 SFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GMKVALEGLR 229 (271)
T ss_dssp TTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HHHHHHSCCC
T ss_pred eecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HHHHHhcCCC
Confidence 4221 1235789999999998765544 79999999999999999999976554321 1111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchh
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRA 208 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 208 (253)
. ..+...+..+.+++.+||+.||.+|||++++++.|+++.+
T Consensus 230 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 230 P---------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1 1122234468889999999999999999999999998764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=234.53 Aligned_cols=182 Identities=25% Similarity=0.384 Sum_probs=145.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 170 (284)
T 2a19_B 95 LFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT 170 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhhe
Confidence 479999999999999997642 225999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..|+... .............
T Consensus 171 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~~~~~~~~~~-- 237 (284)
T 2a19_B 171 SLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFFTDLRDGIIS-- 237 (284)
T ss_dssp ESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHHHHHHTTCCC--
T ss_pred eccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHHHHhhccccc--
Confidence 654322 223345899999999999888999999999999999999998876311 0011111111111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
...+..+.+++.+||+.||.+||++.+++++|..+....
T Consensus 238 ----------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 238 ----------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp ----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred ----------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 112345778999999999999999999999999887654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=248.72 Aligned_cols=183 Identities=15% Similarity=0.067 Sum_probs=136.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHH------HHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEIS------LRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKIS 75 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~------~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~ 75 (253)
.|+||||++ ++|.+++..... .+++..+ +.++.|++.||.|||+++ |+||||||+||+++.++.+||+
T Consensus 163 ~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~ 236 (371)
T 3q60_A 163 YLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLG 236 (371)
T ss_dssp EEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEE
Confidence 389999997 799999987432 2455555 677899999999999999 9999999999999999999999
Q ss_pred ccCCcccccCCCcceeeeccccccccccchhcc--CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHH
Q 044510 76 DFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRS--SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAM 153 (253)
Q Consensus 76 Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 153 (253)
|||+++.... ......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||............
T Consensus 237 DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~------- 305 (371)
T 3q60_A 237 DVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK------- 305 (371)
T ss_dssp CGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCC-------
T ss_pred ecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchh-------
Confidence 9999975531 2223456799999999987 67899999999999999999999999876433211000
Q ss_pred hhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 154 KENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
....................+..+.+++.+||+.||.+|||+.+++++
T Consensus 306 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 306 -RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp -BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred -hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000001111334578889999999999999999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=238.90 Aligned_cols=185 Identities=17% Similarity=0.178 Sum_probs=146.6
Q ss_pred CEEEEeecCCCChhHHhhccC--CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC-----------
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT--EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD----------- 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~----------- 68 (253)
.|+||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccc
Confidence 489999999999999997521 2235999999999999999999999999 999999999999988
Q ss_pred CCceEEcccCCcccccCC-CcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHH
Q 044510 69 KFRAKISDFGASRYVTID-QTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAG 147 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~ 147 (253)
++.+||+|||+++..... .........||+.|+|||++.+..++.++|+|||||++|+|++|..||........
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----- 293 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----- 293 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-----
Confidence 899999999999765322 22334456799999999999988899999999999999999999999854322110
Q ss_pred HHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHhhchhhc
Q 044510 148 YFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKR-PTMKEVAFELGGIRASI 210 (253)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R-ps~~~l~~~l~~~~~~~ 210 (253)
........ . .....+.+++..||+.+|.+| |++.++.+.|+......
T Consensus 294 ---------~~~~~~~~-----~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 294 ---------KPEGLFRR-----L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ---------EECSCCTT-----C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ---------eechhccc-----c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 00000000 0 113356679999999999999 78999999988877663
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=231.78 Aligned_cols=175 Identities=29% Similarity=0.411 Sum_probs=139.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~ 157 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV 157 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred EEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccc
Confidence 479999999999999998754 4999999999999999999999999 9999999999999999999999999875
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+.. ........
T Consensus 158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~--- 224 (279)
T 3fdn_A 158 HAPSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-------KRISRVEF--- 224 (279)
T ss_dssp CC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHHTCC---
T ss_pred cCCcc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH-------HHHHhCCC---
Confidence 43321 223356899999999999888999999999999999999999999865543211 11111100
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+||++++++++
T Consensus 225 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 -------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0111233467889999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=237.60 Aligned_cols=181 Identities=25% Similarity=0.368 Sum_probs=134.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC---CCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD---KFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~---~~~~kl~Dfg 78 (253)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++. ++.+||+|||
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg 196 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFG 196 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCc
Confidence 479999999999999997654 4899999999999999999999999 999999999999975 7899999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
+++..... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||........ ..........
T Consensus 197 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~i~~~~~ 268 (349)
T 2w4o_A 197 LSKIVEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF------MFRRILNCEY 268 (349)
T ss_dssp ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH------HHHHHHTTCC
T ss_pred cccccCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH------HHHHHHhCCC
Confidence 98765322 222345689999999999988899999999999999999999999976543221 1111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ... ......+..+.+++.+||+.||.+|||+.+++++
T Consensus 269 ~-~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 269 Y-FIS-----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp C-CCT-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c-cCC-----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000 0112234468889999999999999999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=236.60 Aligned_cols=182 Identities=23% Similarity=0.373 Sum_probs=139.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCc--------eE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFR--------AK 73 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~--------~k 73 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++. ++
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 4899999999999999987532 4899999999999999999999999 999999999999988776 99
Q ss_pred EcccCCcccccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhC-CCCCCCCChhhhhhhHHHHHH
Q 044510 74 ISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTG-QKPIRSTDTEEDKSLAGYFLR 151 (253)
Q Consensus 74 l~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg-~~pf~~~~~~~~~~~~~~~~~ 151 (253)
|+|||++..... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++| ..||........ ..
T Consensus 162 l~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-------~~ 229 (289)
T 4fvq_A 162 LSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-------LQ 229 (289)
T ss_dssp ECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-------HH
T ss_pred eccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-------HH
Confidence 999999864421 122457889999999987 6689999999999999999995 455544332211 11
Q ss_pred HHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcC
Q 044510 152 AMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIG 211 (253)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 211 (253)
....... .+...+..+.+++.+||+.||.+|||+.+++++|+++.....
T Consensus 230 ~~~~~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 230 FYEDRHQ-----------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp HHHTTCC-----------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred HhhccCC-----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 1111100 001112347779999999999999999999999999987643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=241.58 Aligned_cols=175 Identities=25% Similarity=0.373 Sum_probs=140.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+ +|+|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~ 156 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSN 156 (336)
T ss_dssp EEEEECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred EEEEEECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccce
Confidence 37999999 789999987754 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCC-CCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQF-TKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
...... ......|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...........
T Consensus 157 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~--------------- 219 (336)
T 3h4j_B 157 IMTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK--------------- 219 (336)
T ss_dssp TTTTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC---------------
T ss_pred eccCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH---------------
Confidence 654322 2234568999999999987776 6899999999999999999999976543321100
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
+... ....+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 220 -i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 220 -VNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -CCSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -HHcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0000 001122234568889999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=247.52 Aligned_cols=176 Identities=25% Similarity=0.425 Sum_probs=142.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~ 164 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSN 164 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchh
Confidence 489999999999999997654 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCC-CCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQF-TKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..... .......|++.|+|||++.+..+ +.++|+||+||++|+|++|..||........ ...+......
T Consensus 165 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-------~~~i~~~~~~- 234 (476)
T 2y94_A 165 MMSDG--EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL-------FKKICDGIFY- 234 (476)
T ss_dssp ECCTT--CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH-------HHHHHTTCCC-
T ss_pred hcccc--ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH-------HHHHhcCCcC-
Confidence 65432 22334568999999999987765 6899999999999999999999986544321 1111111110
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.+...+..+.+++.+||+.||.+|||+++++++
T Consensus 235 ---------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 235 ---------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 111223468889999999999999999999974
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=236.56 Aligned_cols=180 Identities=22% Similarity=0.347 Sum_probs=143.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC----ceEEccc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF----RAKISDF 77 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~----~~kl~Df 77 (253)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 489999999999999997643 5899999999999999999999999 99999999999999887 7999999
Q ss_pred CCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 78 GASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 78 gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
|++....... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......+. ... .....
T Consensus 164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~-i~~~~ 234 (321)
T 2a2a_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LAN-ITSVS 234 (321)
T ss_dssp TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHH-HHTTC
T ss_pred ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH------HHH-HHhcc
Confidence 9987654322 22345689999999999988899999999999999999999999977554321 111 11110
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ..++.. ....+..+.+++.+||+.||.+|||+.+++++
T Consensus 235 ~--~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 Y--DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp C--CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred c--ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 011111 11233468889999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=240.65 Aligned_cols=194 Identities=21% Similarity=0.274 Sum_probs=132.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+. |+|.+++........+++..++.++.|++.||.|||..+ .+++|+||||+||+++.++.+||+|||+++
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 186 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccce
Confidence 479999995 699999876433346999999999999999999999875 239999999999999999999999999998
Q ss_pred cccCCCcce-----------eeeccccccccccchh---ccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHH
Q 044510 82 YVTIDQTHL-----------TTRVQGTFGYLDLEYF---RSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAG 147 (253)
Q Consensus 82 ~~~~~~~~~-----------~~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~ 147 (253)
......... .....+++.|+|||++ .+..++.++|+||||+++|+|++|..||........
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~----- 261 (337)
T 3ll6_A 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI----- 261 (337)
T ss_dssp CCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred eccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-----
Confidence 664322111 1134588999999998 456688999999999999999999999965432210
Q ss_pred HHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCCCCC
Q 044510 148 YFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNCE 216 (253)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~ 216 (253)
.... .... .....+..+.+++.+||+.||.+||++.+++++|+.+..........
T Consensus 262 -----~~~~-~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~ 316 (337)
T 3ll6_A 262 -----VNGK-YSIP--------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316 (337)
T ss_dssp ----------CCCC--------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred -----hcCc-ccCC--------cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCc
Confidence 0000 0000 00111123677999999999999999999999999998875544333
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=246.28 Aligned_cols=171 Identities=14% Similarity=0.141 Sum_probs=133.0
Q ss_pred CEEEEeecCCCChhHHhhccCC----CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEccc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE----EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDF 77 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Df 77 (253)
.|+||||+ +|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 175 ~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DF 250 (377)
T 3byv_A 175 RFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGF 250 (377)
T ss_dssp EEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCG
T ss_pred EEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEec
Confidence 57999999 6799999986421 112345888899999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCcceeeeccccccccccchhccC-----------CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhH
Q 044510 78 GASRYVTIDQTHLTTRVQGTFGYLDLEYFRSS-----------QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLA 146 (253)
Q Consensus 78 gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~ 146 (253)
|+++... .......| +.|+|||++.+. .++.++|+|||||++|+|++|..||...........
T Consensus 251 G~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~- 324 (377)
T 3byv_A 251 EHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW- 324 (377)
T ss_dssp GGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGG-
T ss_pred hhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhh-
Confidence 9987532 23334557 999999999877 789999999999999999999999976443221110
Q ss_pred HHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 147 GYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... .....+..+.+++.+||+.||.+||++.+++++
T Consensus 325 --------------~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 325 --------------IFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp --------------GGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred --------------hhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 000 001223468889999999999999999999973
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=242.12 Aligned_cols=181 Identities=22% Similarity=0.264 Sum_probs=142.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceee--cCCCceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILL--DDKFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili--~~~~~~kl~Dfgl 79 (253)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||+
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~ 235 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGL 235 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSS
T ss_pred EEEEEeCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCC
Confidence 489999999999999887643 25899999999999999999999999 9999999999999 5677899999999
Q ss_pred cccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
++...... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||......+. +.........
T Consensus 236 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~i~~~~~~- 306 (373)
T 2x4f_A 236 ARRYKPRE--KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET------LNNILACRWD- 306 (373)
T ss_dssp CEECCTTC--BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTCCC-
T ss_pred ceecCCcc--ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhccCC-
Confidence 98664322 22334689999999999988899999999999999999999999987654321 1111111110
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ... .....+..+.+++.+||+.||.+||++.+++++
T Consensus 307 -~-~~~----~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 307 -L-EDE----EFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp -S-CSG----GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -C-Chh----hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 001 111234568889999999999999999999984
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=238.52 Aligned_cols=189 Identities=22% Similarity=0.293 Sum_probs=137.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCc---eEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFR---AKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~---~kl~Dfg 78 (253)
.|+||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++. +||+|||
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred EEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 489999999999999998754 5899999999999999999999999 999999999999987765 9999999
Q ss_pred CcccccCCCc------ceeeeccccccccccchhcc-----CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhh--
Q 044510 79 ASRYVTIDQT------HLTTRVQGTFGYLDLEYFRS-----SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSL-- 145 (253)
Q Consensus 79 l~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~-- 145 (253)
++........ .......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||......+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 239 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence 9875532211 11123458999999999975 4578999999999999999999999987643321110
Q ss_pred ------HHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 146 ------AGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 146 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.............. ..... ....+..+.+++.+||+.||.+|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~i~~~~~~--~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 240 EACPACQNMLFESIQEGKYE--FPDKD----WAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp -CCHHHHHHHHHHHHHCCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccchhHHHHHHHHHhccCcc--cCchh----cccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01111111111110 00000 01234568899999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=234.47 Aligned_cols=192 Identities=19% Similarity=0.318 Sum_probs=144.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC-------------
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD------------- 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~------------- 68 (253)
.++||||+ +++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 47999999 8899999987542 25899999999999999999999999 999999999999987
Q ss_pred ------CCceEEcccCCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhh
Q 044510 69 ------KFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142 (253)
Q Consensus 69 ------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~ 142 (253)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|+|||||++|+|++|..||......+.
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999998764322 2235689999999999988899999999999999999999999987665432
Q ss_pred hhhHHHHHHH-----Hhhccccchh----------------------chhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC
Q 044510 143 KSLAGYFLRA-----MKENCLFDML----------------------DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT 195 (253)
Q Consensus 143 ~~~~~~~~~~-----~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps 195 (253)
.......... .......... ............+..+.+++.+||+.||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 2211111000 0000000000 000001112345678899999999999999999
Q ss_pred HHHHHHH
Q 044510 196 MKEVAFE 202 (253)
Q Consensus 196 ~~~l~~~ 202 (253)
+.|++++
T Consensus 323 ~~ell~h 329 (339)
T 1z57_A 323 LREALKH 329 (339)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999865
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=245.06 Aligned_cols=189 Identities=19% Similarity=0.199 Sum_probs=137.3
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 143 ~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 143 YLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred EEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 899999966 57777643 3889999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH-------------
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF------------- 149 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~------------- 149 (253)
.... .......||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.+..+........
T Consensus 214 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 214 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ---C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred cCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 5422 2234467899999999999989999999999999999999999999887654332211110
Q ss_pred ---HHHHhhccc------cchhchhh---hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 150 ---LRAMKENCL------FDMLDAQV---LKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 150 ---~~~~~~~~~------~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
......... ........ ........+..+.+++.+||+.||.+|||++|++++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 00000000 001112336678999999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=238.60 Aligned_cols=188 Identities=20% Similarity=0.279 Sum_probs=142.1
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
|+||||+ +++|.+++... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 106 ~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp EEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 8999999 88999999763 4899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
.... .....+|+.|+|||++.+ ..++.++|+||+||++++|++|..||.+....+....................
T Consensus 178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 5322 233568999999999987 57899999999999999999999999876654322111100000000000000
Q ss_pred --------------hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 --------------LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 --------------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.............+..+.+++.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00000111112334578899999999999999999999985
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=234.38 Aligned_cols=196 Identities=22% Similarity=0.300 Sum_probs=142.3
Q ss_pred CEEEEeecCCCChhHHhhccC---CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT---EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfg 78 (253)
.++||||++ ++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 78 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 153 (317)
T 2pmi_A 78 LTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFG 153 (317)
T ss_dssp EEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCS
T ss_pred EEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCc
Confidence 489999997 59999887632 1224899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
+++...... .......+|+.|+|||++.+. .++.++|+|||||++|+|++|..||......+................
T Consensus 154 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 154 LARAFGIPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp SCEETTSCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred cceecCCCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence 987654222 122334689999999999764 589999999999999999999999987665432211111000000000
Q ss_pred ccc-----------------hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 LFD-----------------MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~~~-----------------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... .+............+..+.+++.+||+.||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000 000000111111234578999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=236.99 Aligned_cols=194 Identities=21% Similarity=0.318 Sum_probs=138.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+. ++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 148 (324)
T 3mtl_A 75 LTLVFEYLD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR 148 (324)
T ss_dssp EEEEEECCS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEE
T ss_pred EEEEecccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccc
Confidence 489999996 589999887543 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
...... .......+++.|+|||++.+ ..++.++|+||+||++|+|++|..||.+....+...................
T Consensus 149 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (324)
T 3mtl_A 149 AKSIPT-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 227 (324)
T ss_dssp CC-------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccCCc-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchh
Confidence 543222 12233467999999999976 4689999999999999999999999988665442222111100000000000
Q ss_pred hhch-------------hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDA-------------QVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~-------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.... ..........+..+.+++.+||+.||.+|||++|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 00001112234568899999999999999999999974
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=233.49 Aligned_cols=191 Identities=19% Similarity=0.259 Sum_probs=138.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+.+ +|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 148 (288)
T 1ob3_A 75 LVLVFEHLDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148 (288)
T ss_dssp EEEEEECCSE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred EEEEEEecCC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECcccc
Confidence 4899999975 99999876432 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc---
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC--- 157 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 157 (253)
...... .......+|+.|+|||++.+. .++.++|+||+||++|+|++|..||......+.... .........
T Consensus 149 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~ 224 (288)
T 1ob3_A 149 AFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR---IFRILGTPNSKN 224 (288)
T ss_dssp HHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCTTT
T ss_pred ccCccc-cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHHCCCChhh
Confidence 654221 122334679999999999764 589999999999999999999999987654332111 111110000
Q ss_pred ccc-----hhc-------hhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 LFD-----MLD-------AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~~~-----~~~-------~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... ..+ +..........+..+.+++.+||+.||.+|||+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 000 000011112344578899999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=235.39 Aligned_cols=194 Identities=23% Similarity=0.290 Sum_probs=139.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 150 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFAR 150 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCch
Confidence 479999999999999887643 4999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHH--------HH
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFL--------RA 152 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~--------~~ 152 (253)
...... .......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||......+......... ..
T Consensus 151 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 151 LLTGPS-DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp ECC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hccCcc-cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence 654222 12234568999999999976 567999999999999999999999998776544322111100 00
Q ss_pred Hhhcccc---chhch---hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 153 MKENCLF---DMLDA---QVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 153 ~~~~~~~---~~~~~---~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
....... ...++ ..........+..+.+++.+||+.||.+|||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000 00000 00000111234568899999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=233.80 Aligned_cols=188 Identities=23% Similarity=0.346 Sum_probs=146.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceeeEecccCCCHHHHHHhccC--CcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 3799999999999999987432 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcce--eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHL--TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
......... .....+++.|+|||++.+..++.++|+||||+++|+|++ |..||......+. ..........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~~~~~ 243 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEGER 243 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTSCCC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH------HHHHHccCCC
Confidence 664332221 123446778999999998888999999999999999999 9999977654321 1111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
. ..+...+..+.+++.+||+.||.+||++.++++.|+++...
T Consensus 244 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 244 L---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred C---------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 0 01122345688899999999999999999999999887654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=248.57 Aligned_cols=182 Identities=26% Similarity=0.299 Sum_probs=145.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~ 334 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAV 334 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccce
Confidence 4899999999999999987542 24999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||.......... .+.........
T Consensus 335 ~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~---~i~~~i~~~~~--- 406 (576)
T 2acx_A 335 HVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLVKEVPE--- 406 (576)
T ss_dssp ECCTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH---HHHHHHHHCCC---
T ss_pred ecccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH---HHHHHhhcccc---
Confidence 654322 2334579999999999998889999999999999999999999998754322111 11111111111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
..+...+..+.++|.+||+.||.+|| ++++++++
T Consensus 407 -------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 407 -------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11222345788899999999999999 78998876
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=237.76 Aligned_cols=189 Identities=21% Similarity=0.306 Sum_probs=146.9
Q ss_pred CEEEEeecCCCChhHHhhccCC----CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC---CCceEE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE----EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD---KFRAKI 74 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~---~~~~kl 74 (253)
.|+||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++. +..++|
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 4899999999999999987532 134899999999999999999999999 999999999999984 456999
Q ss_pred cccCCcccccCCCc-ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHH
Q 044510 75 SDFGASRYVTIDQT-HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRA 152 (253)
Q Consensus 75 ~Dfgl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~ 152 (253)
+|||+++....... .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+. ...
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~ 257 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-------LEF 257 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-------HHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH-------HHH
Confidence 99999875432221 12233457889999999998889999999999999999998 9999976554321 111
Q ss_pred HhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 153 MKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
....... ..+...+..+.+++.+||+.||.+||++.+++++|+.+...
T Consensus 258 ~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 258 VTSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhcCCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 1111111 11122334688899999999999999999999999988765
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=240.46 Aligned_cols=179 Identities=22% Similarity=0.276 Sum_probs=133.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+|||+ .+++|.+++.... .+++..++.++.|++.||.|||..+ |+||||||+||+++ ++.+||+|||+++
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIAN 155 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred EEEEEeC-CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccc
Confidence 4899995 5889999998754 5999999999999999999999999 99999999999997 5689999999998
Q ss_pred cccCCCcc-eeeeccccccccccchhcc-----------CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH
Q 044510 82 YVTIDQTH-LTTRVQGTFGYLDLEYFRS-----------SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF 149 (253)
Q Consensus 82 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 149 (253)
........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ...
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~ 230 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKL 230 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHH
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----HHH
Confidence 65433221 2234568999999999865 567889999999999999999999997543221 111
Q ss_pred HHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 150 LRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
......... ...+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 231 ~~~~~~~~~---------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 231 HAIIDPNHE---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHHCTTSC---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhcCCcc---------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111111111 11111123457889999999999999999999876
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=233.03 Aligned_cols=191 Identities=21% Similarity=0.289 Sum_probs=137.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+.+ +|.+.+..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 76 ~~lv~e~~~~-~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~ 149 (292)
T 3o0g_A 76 LTLVFEFCDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp EEEEEECCSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccce
Confidence 4799999976 66666655322 5999999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCcceeeeccccccccccchhccCC-CCCCCCeehhHHHHHHHHhCCCCCCCC-ChhhhhhhHHHHHHHHhhcc--
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQ-FTKKGDVYSFGVVFVGLLTGQKPIRST-DTEEDKSLAGYFLRAMKENC-- 157 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~-- 157 (253)
...... .......+|+.|+|||++.+.. ++.++|+||+||++|+|++|..||... ...+. ............
T Consensus 150 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~---~~~i~~~~~~~~~~ 225 (292)
T 3o0g_A 150 AFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ---LKRIFRLLGTPTEE 225 (292)
T ss_dssp ECCSCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH---HHHHHHHHCCCCTT
T ss_pred ecCCcc-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHHhCCCChh
Confidence 654222 2223456799999999998765 799999999999999999988875433 22211 111111110000
Q ss_pred -ccchh------------chhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 -LFDML------------DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 -~~~~~------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..... ............+..+.+++.+||+.||.+|||++|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000 0000011112344578899999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-35 Score=243.59 Aligned_cols=179 Identities=21% Similarity=0.277 Sum_probs=134.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||| +.+++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++ ++.+||+|||+++
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIAN 202 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred EEEEEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccc
Confidence 489999 55889999998754 5899999999999999999999999 99999999999995 5789999999998
Q ss_pred cccCCCcc-eeeeccccccccccchhcc-----------CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH
Q 044510 82 YVTIDQTH-LTTRVQGTFGYLDLEYFRS-----------SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF 149 (253)
Q Consensus 82 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 149 (253)
........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ..+
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~~ 277 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKL 277 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHH
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HHH
Confidence 65432221 2234568999999999875 357889999999999999999999997643221 111
Q ss_pred HHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 150 LRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.......... ..+...+..+.+++.+||+.||.+||++.+++++
T Consensus 278 ~~~~~~~~~~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 278 HAIIDPNHEI---------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHCTTSCC---------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhCccccC---------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111111110 0111113467889999999999999999999876
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=238.65 Aligned_cols=192 Identities=24% Similarity=0.258 Sum_probs=143.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhC-CCCCeEecCCCCCceeecCCC----------
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHST-TSIPIYHRDIKSANILLDDKF---------- 70 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dl~~~nili~~~~---------- 70 (253)
.|+||||+ +++|.+.+.... ...+++..++.++.||+.||.|||++ + |+||||||+||+++.++
T Consensus 120 ~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 120 ICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp EEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred EEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhh
Confidence 47999999 667777776542 22599999999999999999999998 9 99999999999998765
Q ss_pred ---------------------------------------ceEEcccCCcccccCCCcceeeeccccccccccchhccCCC
Q 044510 71 ---------------------------------------RAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQF 111 (253)
Q Consensus 71 ---------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 111 (253)
.+||+|||+++..... .....||+.|+|||++.+..+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~ 270 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGY 270 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSCC
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCCCC
Confidence 7999999998765322 233468999999999998889
Q ss_pred CCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHh--hccccchh----------c----------------
Q 044510 112 TKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK--ENCLFDML----------D---------------- 163 (253)
Q Consensus 112 ~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~----------~---------------- 163 (253)
+.++|||||||++|+|++|..||.................... ........ .
T Consensus 271 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (397)
T 1wak_A 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL 350 (397)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence 9999999999999999999999987654332221211111111 00000000 0
Q ss_pred -h--hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 164 -A--QVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 164 -~--~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ......+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0 00012345677789999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=228.98 Aligned_cols=179 Identities=22% Similarity=0.293 Sum_probs=141.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceee---cCCCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILL---DDKFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili---~~~~~~kl~Dfg 78 (253)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg 154 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFG 154 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence 489999999999999998754 4899999999999999999999999 9999999999999 778899999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
++....... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||......+. .........
T Consensus 155 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~ 224 (277)
T 3f3z_A 155 LAARFKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-------MLKIREGTF 224 (277)
T ss_dssp TCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC
T ss_pred cceeccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhCCC
Confidence 987654322 2234568999999999875 489999999999999999999999987654321 111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ...... ...+..+.+++.+||+.||.+||++.+++++
T Consensus 225 ~--~~~~~~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 225 T--FPEKDW----LNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp C--CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred C--CCchhh----hcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000000 1234568889999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=234.54 Aligned_cols=180 Identities=28% Similarity=0.457 Sum_probs=141.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++|++|.+++.... .+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++.
T Consensus 175 ~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp EEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCccc
Confidence 489999999999999998654 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccC------CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS------QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE 155 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 155 (253)
...... ......||+.|+|||++.+. .++.++|+|||||++|+|++|..||........ ......
T Consensus 249 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-------~~~i~~ 319 (365)
T 2y7j_A 249 HLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM-------LRMIME 319 (365)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHH
T ss_pred ccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHh
Confidence 654322 23345689999999998643 578899999999999999999999976543221 111111
Q ss_pred ccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 156 NCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.... . ..... ...+..+.+++.+||+.||.+||++.+++++
T Consensus 320 ~~~~-~-~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 320 GQYQ-F-SSPEW----DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp TCCC-C-CHHHH----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCC-C-CCccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1110 0 00000 1223468889999999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=243.86 Aligned_cols=131 Identities=25% Similarity=0.353 Sum_probs=113.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCc--eEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFR--AKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~--~kl~Dfgl 79 (253)
.++||||+. ++|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 479999995 699999987542 24999999999999999999999999 999999999999998877 99999999
Q ss_pred cccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhh
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE 141 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~ 141 (253)
++.... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||......+
T Consensus 249 a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 306 (429)
T 3kvw_A 249 SCYEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306 (429)
T ss_dssp CEETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ceecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 875432 2223568999999999998899999999999999999999999998876543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=229.88 Aligned_cols=175 Identities=27% Similarity=0.350 Sum_probs=142.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 162 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSV 162 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccc
Confidence 479999999999999998764 4899999999999999999999999 9999999999999999999999999986
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+.. ....... .
T Consensus 163 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~~-~--- 229 (284)
T 2vgo_A 163 HAPSL---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH------RRIVNVD-L--- 229 (284)
T ss_dssp ECSSS---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHTTC-C---
T ss_pred cCccc---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH------HHHhccc-c---
Confidence 54322 223356899999999999888999999999999999999999999775543211 1111111 0
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+||++++++++
T Consensus 230 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 230 -------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred -------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 0112233467889999999999999999999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=233.65 Aligned_cols=178 Identities=25% Similarity=0.336 Sum_probs=143.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 95 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 95 LWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAG 167 (303)
T ss_dssp EEEEEECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccce
Confidence 47999999999999998653 4999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......... .........
T Consensus 168 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~-- 237 (303)
T 3a7i_A 168 QLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL-------FLIPKNNPP-- 237 (303)
T ss_dssp ECBTTB-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------HHHHHSCCC--
T ss_pred ecCccc-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH-------HHhhcCCCC--
Confidence 654322 1223356899999999999888999999999999999999999999765543211 111111110
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFEL 203 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 203 (253)
..+...+..+.+++.+||+.||.+||++.+++++.
T Consensus 238 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 238 -------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp -------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred -------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 11112234688899999999999999999999764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=234.26 Aligned_cols=193 Identities=21% Similarity=0.307 Sum_probs=144.5
Q ss_pred CEEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.|+||||+.+++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 479999999999999997631 1235999999999999999999999999 999999999999999999999999987
Q ss_pred ccccCCCcc--------eeeeccccccccccchhccCC---CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH
Q 044510 81 RYVTIDQTH--------LTTRVQGTFGYLDLEYFRSSQ---FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF 149 (253)
Q Consensus 81 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 149 (253)
......... ......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||........ ..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~---- 256 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SV---- 256 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CH----
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hh----
Confidence 654211100 011234689999999997553 68899999999999999999999853211110 00
Q ss_pred HHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcC
Q 044510 150 LRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIG 211 (253)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 211 (253)
....... .. .......+..+.+++.+||+.||.+||++.+++++|+.+.....
T Consensus 257 ~~~~~~~-~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 257 ALAVQNQ-LS--------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp HHHHHCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred hHHhhcc-CC--------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 0001110 00 00011233468889999999999999999999999998876543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=231.61 Aligned_cols=190 Identities=21% Similarity=0.308 Sum_probs=140.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++ ++.++|+|||++.
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred eEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 489999999999999997643 25899999999999999999999999 99999999999998 6799999999876
Q ss_pred cccCCC----cceeeeccccccccccchhcc---------CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHH
Q 044510 82 YVTIDQ----THLTTRVQGTFGYLDLEYFRS---------SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGY 148 (253)
Q Consensus 82 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~ 148 (253)
...... ........|++.|+|||++.+ ..++.++|+||||+++|+|++|..||........
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------ 251 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI------ 251 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH------
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------
Confidence 543211 111223458899999999974 3468899999999999999999999987654321
Q ss_pred HHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCC
Q 044510 149 FLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGP 212 (253)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 212 (253)
.............. ...+..+.+++.+||+.||.+||++.++++.|+.+......
T Consensus 252 -~~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 252 -IWQMGTGMKPNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp -HHHHHTTCCCCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred -HHHhccCCCCCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 11111111111111 01223577899999999999999999999999999877544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=236.63 Aligned_cols=195 Identities=18% Similarity=0.229 Sum_probs=141.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+.+ +|.+.+..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 99 ~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 99 IYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp EEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 3799999965 78888776433 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCC---cceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 82 YVTIDQ---THLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 82 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
...... ........+|+.|+|||++.+. .++.++|+|||||++|+|++|..||.......................
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 654222 1122345679999999999764 579999999999999999999999987665433222211111000000
Q ss_pred ccchhchh--------------hhhh-hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 LFDMLDAQ--------------VLKE-AKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~~~~~~~~--------------~~~~-~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
........ .... .....+..+.+++.+||+.||.+|||++|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000000 0000 000113568899999999999999999999965
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=233.06 Aligned_cols=185 Identities=24% Similarity=0.281 Sum_probs=138.0
Q ss_pred CEEEEeecCCCChhHHhhccCC-------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-------------------------------------EFTITWEISLRIAVEVSGALS 44 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-------------------------------------~~~~~~~~~~~i~~~i~~~l~ 44 (253)
.++||||++||+|.+++..... ...+++..++.++.|++.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 4899999999999999863110 112467788999999999999
Q ss_pred hHhhCCCCCeEecCCCCCceeecCCC--ceEEcccCCcccccCCCc---ceeeeccccccccccchhcc--CCCCCCCCe
Q 044510 45 YLHSTTSIPIYHRDIKSANILLDDKF--RAKISDFGASRYVTIDQT---HLTTRVQGTFGYLDLEYFRS--SQFTKKGDV 117 (253)
Q Consensus 45 ~lh~~~~~~i~H~dl~~~nili~~~~--~~kl~Dfgl~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di 117 (253)
|||+.+ ++||||||+||+++.++ .+||+|||+++....... .......|++.|+|||.+.+ ..++.++|+
T Consensus 183 ~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 183 YLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 999999 99999999999998766 899999999986543221 12334568999999999975 568899999
Q ss_pred ehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 044510 118 YSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMK 197 (253)
Q Consensus 118 ~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~ 197 (253)
||||+++|+|++|..||......+. ............ .+ .....+..+.+++.+||+.||.+||++.
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~~~--~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~ 326 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADT------ISQVLNKKLCFE--NP-----NYNVLSPLARDLLSNLLNRNVDERFDAM 326 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCCTT--SG-----GGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcccccC--Cc-----ccccCCHHHHHHHHHHcCCChhHCCCHH
Confidence 9999999999999999987654321 111111111110 01 0112334688899999999999999999
Q ss_pred HHHHH
Q 044510 198 EVAFE 202 (253)
Q Consensus 198 ~l~~~ 202 (253)
+++++
T Consensus 327 ~~l~h 331 (345)
T 3hko_A 327 RALQH 331 (345)
T ss_dssp HHHHS
T ss_pred HHhcC
Confidence 99975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=233.46 Aligned_cols=131 Identities=24% Similarity=0.346 Sum_probs=112.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHh--hCCCCCeEecCCCCCceeec--CCCceEEccc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLH--STTSIPIYHRDIKSANILLD--DKFRAKISDF 77 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~~~~i~H~dl~~~nili~--~~~~~kl~Df 77 (253)
.|+||||+. ++|.+++..... ..+++..+..++.|++.||.||| ..+ |+||||||+||+++ .++.+||+||
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCC
T ss_pred eEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEec
Confidence 479999995 599999987532 25899999999999999999999 467 99999999999995 4778999999
Q ss_pred CCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhh
Q 044510 78 GASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE 141 (253)
Q Consensus 78 gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~ 141 (253)
|+++..... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||......+
T Consensus 206 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 265 (382)
T 2vx3_A 206 GSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265 (382)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999765322 233568999999999998889999999999999999999999998766543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=241.11 Aligned_cols=201 Identities=22% Similarity=0.267 Sum_probs=143.1
Q ss_pred CEEEEeecCCCChhHHhhc-cCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec-CCCceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHD-QTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD-DKFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~-~~~~~kl~Dfgl 79 (253)
.++||||+.++ +.+.+.. ......+++..++.++.|++.||.|||+.+ |+||||||+||+++ .++.+||+|||+
T Consensus 113 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 113 LNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 47999999774 4444332 212235999999999999999999999999 99999999999999 789999999999
Q ss_pred cccccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH--------H
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF--------L 150 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~ 150 (253)
++...... ......+++.|+|||++.+. .++.++|+||+||++|+|++|..||.+....+........ .
T Consensus 189 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 189 AKILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CEECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98654322 22345679999999999765 5899999999999999999999999886654322111110 0
Q ss_pred HHHhhcc----ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhchh
Q 044510 151 RAMKENC----LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE--LGGIRA 208 (253)
Q Consensus 151 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~--l~~~~~ 208 (253)
....... .................+..+.+++.+||+.||.+|||+.+++++ ++++..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 0000000 000000011111222345678999999999999999999999986 555443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=235.02 Aligned_cols=170 Identities=22% Similarity=0.357 Sum_probs=139.3
Q ss_pred CEEEEeecCCC-ChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNG-TLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.++||||+.+| +|.+++.... .+++..++.++.|++.||.|||..+ ++||||||+||+++.++.+||+|||++
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccc
Confidence 47999999776 9999998754 4999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCcceeeeccccccccccchhccCCC-CCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQF-TKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
+...... ......||+.|+|||++.+..+ +.++|+|||||++|+|++|..||........ ...
T Consensus 178 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------------~~~- 241 (335)
T 3dls_A 178 AYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE-------------AAI- 241 (335)
T ss_dssp EECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT-------------TCC-
T ss_pred eECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh-------------hcc-
Confidence 8654322 2234568999999999988776 7889999999999999999999965322110 000
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 242 ---------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 242 ---------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011123468889999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=238.78 Aligned_cols=180 Identities=25% Similarity=0.329 Sum_probs=133.9
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC---ceEEcccCC
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF---RAKISDFGA 79 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~---~~kl~Dfgl 79 (253)
|+||||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||+
T Consensus 215 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 215 YIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp EEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred EEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeeccc
Confidence 79999999999999987654 5999999999999999999999999 99999999999997544 599999999
Q ss_pred cccccCCCcceeeeccccccccccchhcc---CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRS---SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
++..... .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||........ . .......
T Consensus 289 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~----~~~i~~~ 360 (419)
T 3i6u_A 289 SKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--L----KDQITSG 360 (419)
T ss_dssp TTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--H----HHHHHTT
T ss_pred ceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--H----HHHHhcC
Confidence 9865422 22334568999999999863 4678899999999999999999999976543211 1 1111111
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... ..+. .....+..+.+++.+||+.||.+||++.+++++
T Consensus 361 ~~~--~~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 361 KYN--FIPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CCC--CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCC--CCch----hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 110 0111 111234568889999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=228.77 Aligned_cols=181 Identities=26% Similarity=0.406 Sum_probs=141.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 153 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT 153 (276)
T ss_dssp EEEEEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCcc
Confidence 479999999999999997543 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCc-ceeeeccccccccccchhccCCC-CCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQT-HLTTRVQGTFGYLDLEYFRSSQF-TKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
....... .......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||......... ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~ 227 (276)
T 2yex_A 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTY 227 (276)
T ss_dssp ECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH------HHHHHTTCTT
T ss_pred ccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHhhhcccc
Confidence 6542221 12234568999999999987665 77899999999999999999999775543211 0111111100
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.. .....+..+.+++.+||+.||.+|||+.+++++
T Consensus 228 --~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 228 --LN------PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp --ST------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --cC------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 00 011233467889999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=230.11 Aligned_cols=178 Identities=26% Similarity=0.376 Sum_probs=121.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~ 160 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVK--PFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLAT 160 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeeccee
Confidence 4899999999999999986432 5899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+... . ......
T Consensus 161 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~---~~~~~~ 229 (278)
T 3cok_A 161 QLKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-------K---VVLADY 229 (278)
T ss_dssp ECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CCSSCC
T ss_pred eccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-------H---Hhhccc
Confidence 6542221 2223568899999999998889999999999999999999999997654322100 0 000000
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+||++++++++
T Consensus 230 -------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 230 -------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0112234467889999999999999999999863
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=244.53 Aligned_cols=184 Identities=20% Similarity=0.267 Sum_probs=143.6
Q ss_pred CEEEEeecCCCChhHHhhccCC-CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.|+||||++||+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla 336 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA 336 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeeccee
Confidence 4899999999999999976432 335999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
+...... .......||+.|+|||++.+..++.++|+|||||++|+|++|..||........ .... .........
T Consensus 337 ~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~-~~~i~~~~~-- 410 (543)
T 3c4z_A 337 VELKAGQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKEL-KQRVLEQAV-- 410 (543)
T ss_dssp EECCTTC-CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHH-HHHHHHCCC--
T ss_pred eeccCCC-cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHH-HHHHhhccc--
Confidence 8654322 122335799999999999988899999999999999999999999987543211 1111 111111111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTM-----KEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~-----~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+||++ .+++++
T Consensus 411 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 411 --------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred --------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 1122334568889999999999999964 667654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=228.99 Aligned_cols=179 Identities=23% Similarity=0.397 Sum_probs=139.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec-CCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD-DKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~-~~~~~kl~Dfgl~ 80 (253)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ .+++|+||||+||+++ .++.++|+|||++
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 479999999999999998754 4899999999999999999999875 2389999999999998 7889999999998
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
...... ......+++.|+|||.+. ..++.++|+||+|+++|+|++|..||........ ............
T Consensus 180 ~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~ 249 (290)
T 1t4h_A 180 TLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPA 249 (290)
T ss_dssp GGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCG
T ss_pred cccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH------HHHHHhccCCcc
Confidence 654322 223456899999999887 5589999999999999999999999976543221 111111111111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. .+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 250 ~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 S--------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp G--------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred c--------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1 111122458889999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=235.09 Aligned_cols=192 Identities=23% Similarity=0.405 Sum_probs=141.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhC-CCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHST-TSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.++||||+++++|.+++.... .+++..+..++.+++.||.|||.. + ++|+||||+||+++.++.++|+|||++
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred EEEEEECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCC
Confidence 479999999999999998764 499999999999999999999985 8 999999999999999999999999998
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh-----
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE----- 155 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~----- 155 (253)
..... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||......+..............
T Consensus 180 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3eqc_A 180 GQLID---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256 (360)
T ss_dssp HHHHH---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred ccccc---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence 65432 1223356899999999999888999999999999999999999999876554321111000000000
Q ss_pred ------------------ccccchhchh----hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 156 ------------------NCLFDMLDAQ----VLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 156 ------------------~~~~~~~~~~----~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.......+.. .........+..+.+++.+||+.||.+|||+++++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000000000 0000011134568899999999999999999999976
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=225.53 Aligned_cols=180 Identities=24% Similarity=0.342 Sum_probs=141.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCc---eEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFR---AKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~---~kl~Dfg 78 (253)
.++||||+++++|.+.+.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++. ++|+|||
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg 153 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFG 153 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeece
Confidence 479999999999999887754 4999999999999999999999999 999999999999976554 9999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
++....... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||........ .........
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-------~~~~~~~~~ 224 (284)
T 3kk8_A 154 LAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-------YAQIKAGAY 224 (284)
T ss_dssp TCEECCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCC
T ss_pred eeEEcccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH-------HHHHHhccc
Confidence 987654322 22335689999999999988899999999999999999999999977554321 111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.. .. ......+..+.+++.+||+.||.+|||+.+++++
T Consensus 225 ~~-~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 225 DY-PS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CC-CT-----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cC-Cc-----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00 00 0011223468889999999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=242.65 Aligned_cols=194 Identities=22% Similarity=0.233 Sum_probs=134.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+ +++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 48999998 679999997653 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCc--------------------------ceeeeccccccccccchh-ccCCCCCCCCeehhHHHHHHHHh-----
Q 044510 82 YVTIDQT--------------------------HLTTRVQGTFGYLDLEYF-RSSQFTKKGDVYSFGVVFVGLLT----- 129 (253)
Q Consensus 82 ~~~~~~~--------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~llt----- 129 (253)
....... ......+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 6542211 112335689999999986 45568999999999999999998
Q ss_pred ------CCCCCCCCChhhh--------------hhhHHHHHHHHh--hccccchh------------------chhhhhh
Q 044510 130 ------GQKPIRSTDTEED--------------KSLAGYFLRAMK--ENCLFDML------------------DAQVLKE 169 (253)
Q Consensus 130 ------g~~pf~~~~~~~~--------------~~~~~~~~~~~~--~~~~~~~~------------------~~~~~~~ 169 (253)
|.++|.+...... ......+..... +......+ .......
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 6666655431100 000011111000 00000000 0000001
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 170 AKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 170 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.....+..+.+|+.+||..||.+|||++|++++
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111235578899999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=229.15 Aligned_cols=194 Identities=21% Similarity=0.302 Sum_probs=140.5
Q ss_pred CEEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 183 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC---
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccce
Confidence 479999999999999997521 1235899999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
....... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....... .. ............
T Consensus 184 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~-~~~~~~~~~~~~ 257 (310)
T 2wqm_A 184 RFFSSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YS-LCKKIEQCDYPP 257 (310)
T ss_dssp ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HH-HHHHHHTTCSCC
T ss_pred eeecCCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HH-HHHHhhcccCCC
Confidence 7654322 12223458899999999998889999999999999999999999997543221 11 111111111111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCC
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGP 212 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 212 (253)
.. ....+..+.+++.+||+.||.+||++.++++.|+++.+....
T Consensus 258 ~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 258 LP--------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp CC--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred Cc--------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 10 112334688899999999999999999999999999887544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=232.81 Aligned_cols=177 Identities=24% Similarity=0.373 Sum_probs=143.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+.+++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 116 ~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 189 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLAT 189 (335)
T ss_dssp EEEEECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCce
Confidence 489999999999999988754 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......+++.|+|||++.+..++.++|+||||+++|+|++|..||......+. ........ .
T Consensus 190 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~-~--- 258 (335)
T 2owb_A 190 KVEYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIKKNE-Y--- 258 (335)
T ss_dssp ECCSTT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTC-C---
T ss_pred ecccCc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHhcCC-C---
Confidence 654222 222335689999999999988899999999999999999999999976553321 11111111 0
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+||++.+++++
T Consensus 259 -------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 -------SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111223457889999999999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=228.44 Aligned_cols=186 Identities=23% Similarity=0.363 Sum_probs=142.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC----ceEEccc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF----RAKISDF 77 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~----~~kl~Df 77 (253)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence 479999999999999997654 4999999999999999999999999 99999999999998776 8999999
Q ss_pred CCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 78 GASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 78 gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
|++....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+. ........
T Consensus 157 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~- 227 (283)
T 3bhy_A 157 GIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET------LTNISAVN- 227 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTTC-
T ss_pred ccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH------HHHhHhcc-
Confidence 9987654322 22334689999999999988899999999999999999999999987554321 11111111
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhchh
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE--LGGIRA 208 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~--l~~~~~ 208 (253)
. ...... ....+..+.+++.+||+.||.+||++.+++++ ++.+..
T Consensus 228 ~--~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 228 Y--DFDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp C--CCCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred c--CCcchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 0 011111 11223468889999999999999999999984 444443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=236.90 Aligned_cols=185 Identities=23% Similarity=0.301 Sum_probs=121.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC---CCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD---KFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~---~~~~kl~Dfg 78 (253)
.++||||++||+|.+++..... ..+++..++.++.|++.||.|||..+ ++||||||+||+++. ++.+||+|||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence 4799999999999999987532 35999999999999999999999999 999999999999976 4559999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
+++..... ......+++.|+|||++.+..++.++|+||||+++|+|++|..||............ .........
T Consensus 177 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~ 250 (336)
T 3fhr_A 177 FAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRLGQY 250 (336)
T ss_dssp TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred cceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhcccc
Confidence 98755322 223356799999999998888899999999999999999999999765432210000 000000000
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.. ........+..+.+++.+||+.||.+|||+.+++++
T Consensus 251 -~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 251 -GF-----PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -CC-----CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -cc-----CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 000112234568889999999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=236.32 Aligned_cols=194 Identities=22% Similarity=0.309 Sum_probs=139.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 172 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 172 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred EEEEEecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCce
Confidence 489999999998888876543 4999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH--------HHH
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF--------LRA 152 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~~~ 152 (253)
...... .......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||......+........ ...
T Consensus 173 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 173 TLAAPG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred eecCCc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 654322 222335689999999999865 6889999999999999999999999876654322111100 000
Q ss_pred Hhhcc------ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 153 MKENC------LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 153 ~~~~~------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..... .................+..+.+++.+||+.||.+|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 000000001111112345678999999999999999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=231.92 Aligned_cols=192 Identities=18% Similarity=0.293 Sum_probs=141.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceee---------------
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILL--------------- 66 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili--------------- 66 (253)
.++||||+ +++|.+.+..... ..+++..++.++.|++.||.|||+.+ |+||||||+||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 47999999 6678777766432 25999999999999999999999999 9999999999999
Q ss_pred ----cCCCceEEcccCCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhh
Q 044510 67 ----DDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED 142 (253)
Q Consensus 67 ----~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~ 142 (253)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|+|||||++|+|++|..||......+.
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56789999999998754322 2335689999999999988899999999999999999999999987655432
Q ss_pred hhhHHHHHHH-----Hhhccccch----------h--ch----------hhhhhhcHHHHHHHHHHHHHhcccCCCCCCC
Q 044510 143 KSLAGYFLRA-----MKENCLFDM----------L--DA----------QVLKEAKEEEIITVAMLAKRCLNLNGRKRPT 195 (253)
Q Consensus 143 ~~~~~~~~~~-----~~~~~~~~~----------~--~~----------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps 195 (253)
.......... ......... . +. ..........+..+.+++.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 2111111000 000000000 0 00 0000112234567899999999999999999
Q ss_pred HHHHHHH
Q 044510 196 MKEVAFE 202 (253)
Q Consensus 196 ~~~l~~~ 202 (253)
+.+++++
T Consensus 328 ~~e~l~h 334 (355)
T 2eu9_A 328 LAEALLH 334 (355)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999854
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=235.17 Aligned_cols=193 Identities=18% Similarity=0.205 Sum_probs=135.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec-----CCCceEEcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD-----DKFRAKISD 76 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~-----~~~~~kl~D 76 (253)
.++||||+.+ +|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++ ..+.+||+|
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred EEEEEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECc
Confidence 4799999965 9999998764 4999999999999999999999999 99999999999994 455699999
Q ss_pred cCCcccccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh
Q 044510 77 FGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE 155 (253)
Q Consensus 77 fgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 155 (253)
||+++...... .......+++.|+|||++.+. .++.++|||||||++|+|++|..||......+..............
T Consensus 181 fg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 181 FGLARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259 (329)
T ss_dssp TTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred CCCccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCch
Confidence 99987654222 222334679999999999874 4799999999999999999999999876543321111100000000
Q ss_pred ccc-------------cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 156 NCL-------------FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 156 ~~~-------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... ................+..+.+++.+||+.||.+|||+++++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 000 00000011111112234578899999999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=233.44 Aligned_cols=192 Identities=19% Similarity=0.252 Sum_probs=140.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhC-CCCCeEecCCCCCceeec------CCCceEE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHST-TSIPIYHRDIKSANILLD------DKFRAKI 74 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dl~~~nili~------~~~~~kl 74 (253)
.++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+. + |+||||||+||+++ ..+.+||
T Consensus 105 ~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~~kl 179 (373)
T 1q8y_A 105 VVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKI 179 (373)
T ss_dssp EEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred EEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcceEEE
Confidence 47999999 8899999987532 2499999999999999999999998 9 99999999999994 3447999
Q ss_pred cccCCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHh
Q 044510 75 SDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK 154 (253)
Q Consensus 75 ~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 154 (253)
+|||+++..... .....+|+.|+|||++.+..++.++|+|||||++|+|++|..||....................
T Consensus 180 ~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (373)
T 1q8y_A 180 ADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255 (373)
T ss_dssp CCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred cccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHH
Confidence 999998765422 2234689999999999988899999999999999999999999986543221111111111110
Q ss_pred h-ccccch----------------------------hc--hhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 155 E-NCLFDM----------------------------LD--AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 155 ~-~~~~~~----------------------------~~--~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. +..... .. .......+...+..+.++|.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred hcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 0 000000 00 000112345677889999999999999999999999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=234.80 Aligned_cols=193 Identities=21% Similarity=0.291 Sum_probs=141.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+. ++|.+++... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 489999996 5999999764 3999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcce--eeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHL--TTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
......... .....||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+....+.................
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 654322111 2335689999999987644 4899999999999999999999999877654432211110000000000
Q ss_pred cchh--------------chhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDML--------------DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~--------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.... ............+..+.+++.+||+.||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000011112234568899999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=237.11 Aligned_cols=189 Identities=22% Similarity=0.256 Sum_probs=128.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+|||++ +++|.+++... .+++..++.++.|++.||.|||+.| ++||||||+||+++.++.+||+|||+++
T Consensus 109 ~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred EEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 48999999 78999998753 4999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
.... ......+|+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+....+...................
T Consensus 181 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 181 HTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred cccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 6432 1233568999999999986 5789999999999999999999999988665432221111000000000000
Q ss_pred hh--------------chhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 ML--------------DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~--------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.. ............+..+.+++.+||+.||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00 0000001111234568899999999999999999999976
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=239.75 Aligned_cols=126 Identities=26% Similarity=0.336 Sum_probs=104.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 489999995 59999997653 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCc---------------------ceeeeccccccccccchh-ccCCCCCCCCeehhHHHHHHHHhCCCCC
Q 044510 82 YVTIDQT---------------------HLTTRVQGTFGYLDLEYF-RSSQFTKKGDVYSFGVVFVGLLTGQKPI 134 (253)
Q Consensus 82 ~~~~~~~---------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~lltg~~pf 134 (253)
....... ......+||+.|+|||++ .+..++.++|+||+||++|+|++|..||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 6643221 112446789999999986 4556899999999999999999855444
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-33 Score=238.66 Aligned_cols=179 Identities=26% Similarity=0.353 Sum_probs=140.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec---CCCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD---DKFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~---~~~~~kl~Dfg 78 (253)
.|+||||+.+++|.+.+.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++ .++.+||+|||
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 169 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFG 169 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECC
Confidence 479999999999999987754 5999999999999999999999999 99999999999995 45679999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
+++..... .......||+.|+|||++.+ .++.++|+||+||++|+|++|..||.+....+. +.........
T Consensus 170 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i~~~~~~ 240 (486)
T 3mwu_A 170 LSTCFQQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI------LKRVETGKYA 240 (486)
T ss_dssp CTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTCCC
T ss_pred cCeECCCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCC
Confidence 99765432 22334568999999999985 589999999999999999999999987654321 1111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... + .....+..+.+++.+||+.||.+|||+.+++++
T Consensus 241 ~~~--~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 241 FDL--P-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SCS--G-----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCC--c-----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 110 0 011233468889999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=228.62 Aligned_cols=177 Identities=24% Similarity=0.373 Sum_probs=143.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 90 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 163 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLAT 163 (294)
T ss_dssp EEEEEECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCce
Confidence 479999999999999987754 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+. ........ .
T Consensus 164 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~-~--- 232 (294)
T 2rku_A 164 KVEYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIKKNE-Y--- 232 (294)
T ss_dssp ECCSTT-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTTC-C---
T ss_pred ecccCc-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhhcc-C---
Confidence 654222 122335689999999999988899999999999999999999999977554321 11111111 0
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+||++.+++++
T Consensus 233 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 -------SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0111223467889999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=230.59 Aligned_cols=183 Identities=22% Similarity=0.344 Sum_probs=140.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC-CCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD-KFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~-~~~~kl~Dfgl~ 80 (253)
.++||||+++++|.+++........+++..++.++.|++.||.|||+.+ ++|+||||+||+++. ++.++|+|||++
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~ 170 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTS 170 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccc
Confidence 4799999999999999987644445789999999999999999999999 999999999999987 889999999998
Q ss_pred ccccCCCcceeeeccccccccccchhccCC--CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQ--FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
....... .......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......... ........ .
T Consensus 171 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~~~-~ 243 (295)
T 2clq_A 171 KRLAGIN-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-----MFKVGMFK-V 243 (295)
T ss_dssp EESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-----HHHHHHHC-C
T ss_pred cccCCCC-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-----HHhhcccc-c
Confidence 7654221 1223356899999999997653 788999999999999999999999654322110 00100000 0
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
....+...+..+.+++.+||+.||.+||++.+++++
T Consensus 244 --------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 244 --------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp --------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred --------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011122334568889999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=229.22 Aligned_cols=191 Identities=24% Similarity=0.338 Sum_probs=139.1
Q ss_pred CEEEEeecCCCChhHHhhcc-----CCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQ-----TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISD 76 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~-----~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~D 76 (253)
.++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEe
Confidence 47999999999999998751 11235899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCc----ceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHH
Q 044510 77 FGASRYVTIDQT----HLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLR 151 (253)
Q Consensus 77 fgl~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~ 151 (253)
||++........ .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......... ..
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~ 238 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------ML 238 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HH
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH------HH
Confidence 998875532211 11233468999999999975 46899999999999999999999999876543311 11
Q ss_pred HHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 152 AMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..... .................+..+.+++.+||+.||.+||++.+++++
T Consensus 239 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 239 TLQND-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HHTSS-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhccC-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11111 111000000011112233468889999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-33 Score=225.28 Aligned_cols=181 Identities=23% Similarity=0.289 Sum_probs=142.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++..... .+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++.
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 173 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRNK--TLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAG 173 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccch
Confidence 4899999999999999974322 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......... .. .........
T Consensus 174 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~-~~~~~~~~~ 245 (314)
T 3com_A 174 QLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI------FM-IPTNPPPTF 245 (314)
T ss_dssp ECBTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HH-HHHSCCCCC
T ss_pred hhhhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH------HH-HhcCCCccc
Confidence 6543221 223346889999999999888999999999999999999999999765543211 11 111111111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.. +...+..+.+++.+||+.||.+||++.+++++
T Consensus 246 ~~-------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 246 RK-------PELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp SS-------GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CC-------cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01 11123468889999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=230.09 Aligned_cols=189 Identities=19% Similarity=0.241 Sum_probs=138.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC-ceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF-RAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~-~~kl~Dfgl~ 80 (253)
+++||||+.+++|.+++.. +++..++.++.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||++
T Consensus 108 ~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLA 178 (330)
T ss_dssp EEEEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence 4899999999999998842 889999999999999999999999 99999999999999766 8999999999
Q ss_pred ccccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH--------HH
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF--------LR 151 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~~ 151 (253)
+...... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||......... ..... ..
T Consensus 179 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 179 EFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYD 255 (330)
T ss_dssp EECCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHH
T ss_pred eEcCCCC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhh
Confidence 7654322 2233468899999999987 56899999999999999999999999654332111 11000 00
Q ss_pred HHhhcccc--------------chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 152 AMKENCLF--------------DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 152 ~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
........ ...............+..+.+++.+||+.||.+|||+++++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000 0000000001111235678999999999999999999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=231.55 Aligned_cols=187 Identities=25% Similarity=0.348 Sum_probs=142.3
Q ss_pred CEEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHhhCC--CCCeEecCCCCCceeecCCCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLHSTT--SIPIYHRDIKSANILLDDKFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~~i~H~dl~~~nili~~~~~~kl~Dfg 78 (253)
.|+||||+++++|.+++.... ....+++..++.++.|++.||.|||..+ ..+++|+||||+||+++.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 489999999999999997632 1224899999999999999999999865 1238999999999999999999999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
+++...... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+. ...+.....
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~i~~~~~ 233 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-------AGKIREGKF 233 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCC
T ss_pred hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH-------HHHHhhccc
Confidence 987653221 112234688999999999988899999999999999999999999987653221 111212211
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGG 205 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 205 (253)
. ..+...+..+.+++.+||+.||.+||++.++++++..
T Consensus 234 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 R---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred c---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1 1112234568889999999999999999999987643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-33 Score=239.34 Aligned_cols=179 Identities=27% Similarity=0.367 Sum_probs=141.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC---CceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK---FRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~---~~~kl~Dfg 78 (253)
.|+||||+++|+|.+.+.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.. +.+||+|||
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG 184 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFG 184 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECC
Confidence 479999999999999987754 4999999999999999999999999 9999999999999764 459999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
+++...... ......||+.|+|||++. ..++.++|+||+||++|+|++|..||......+. ...+.....
T Consensus 185 ~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~i~~~~~ 254 (494)
T 3lij_A 185 LSAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI-------LRKVEKGKY 254 (494)
T ss_dssp TCEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCC
T ss_pred CCeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCC
Confidence 998664322 233456899999999987 5689999999999999999999999987654331 111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. . .... ....+..+.+++.+||+.||.+|||+.+++++
T Consensus 255 ~-~-~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 255 T-F-DSPE----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp C-C-CSGG----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred C-C-Cchh----cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1 0 0000 11233468889999999999999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=229.08 Aligned_cols=181 Identities=28% Similarity=0.364 Sum_probs=135.2
Q ss_pred CEEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceee---cCCCceEEccc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILL---DDKFRAKISDF 77 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili---~~~~~~kl~Df 77 (253)
.++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||++ +.++.+||+||
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Df 171 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDF 171 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEee
Confidence 379999999999999986531 1225999999999999999999999999 9999999999999 45678999999
Q ss_pred CCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 78 GASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 78 gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
|++...... .......+++.|+|||++. ..++.++|+||||+++|+|++|..||......+... .......
T Consensus 172 g~a~~~~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~------~~~~~~~ 242 (285)
T 3is5_A 172 GLAELFKSD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ------KATYKEP 242 (285)
T ss_dssp CCCCC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCCC
T ss_pred ecceecCCc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh------hhccCCc
Confidence 998765432 2223456899999999986 568899999999999999999999998765432111 1111111
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.... . ....+..+.+++.+||+.||.+|||+.+++++
T Consensus 243 ~~~~-~-------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 243 NYAV-E-------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCCC----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cccc-c-------cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0 00123467789999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=231.34 Aligned_cols=189 Identities=20% Similarity=0.239 Sum_probs=133.4
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
|+||||+.+ +|.+++.. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 106 ~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 106 YIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred EEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 899999965 78888853 3889999999999999999999999 99999999999999999999999999876
Q ss_pred ccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHH--------------
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGY-------------- 148 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~-------------- 148 (253)
.... .......+++.|+|||++.+..++.++|+|||||++|+|++|..||.+....+.......
T Consensus 177 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 177 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred cccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 5322 122345689999999999988899999999999999999999999987654332111000
Q ss_pred --HHHHHhhcccc------chhchhh---hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 149 --FLRAMKENCLF------DMLDAQV---LKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 149 --~~~~~~~~~~~------~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
........... ....... ........+..+.+++.+||+.||.+|||+++++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000000 0000000 011123346779999999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=234.95 Aligned_cols=175 Identities=21% Similarity=0.302 Sum_probs=138.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+. |+|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 129 ~~lv~e~~~-g~l~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 202 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS 202 (348)
T ss_dssp EEEEEECCS-EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred EEEEEecCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCce
Confidence 479999996 588888865432 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhc---cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR---SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
.... .....|++.|+|||++. ...++.++|+|||||++|+|++|..||........ ........ .
T Consensus 203 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~~-~ 270 (348)
T 1u5q_A 203 IMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNE-S 270 (348)
T ss_dssp SSSS-----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSC-C
T ss_pred ecCC-----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcC-C
Confidence 5432 22346899999999985 45689999999999999999999999976554321 11111111 1
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.... ....+..+.+++.+||+.||.+|||+.+++++
T Consensus 271 ~~~~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 271 PALQ--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCC--------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1111 11223457889999999999999999999865
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=232.60 Aligned_cols=181 Identities=23% Similarity=0.319 Sum_probs=135.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++.... ...+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++.
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred EEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 489999999999999998643 225899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhc-----cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR-----SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
...... .......+++.|+|||++. +..++.++|+|||||++|+|++|..||......... .. ....
T Consensus 178 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~-~~~~ 249 (326)
T 2x7f_A 178 QLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FL-IPRN 249 (326)
T ss_dssp --------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HH-HHHS
T ss_pred ecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH------HH-hhcC
Confidence 653221 1223346899999999997 456889999999999999999999999765543211 11 1111
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...... ....+..+.+++.+||..||.+||++.+++++
T Consensus 250 ~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 250 PAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CCCCCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111111 11123468889999999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=229.17 Aligned_cols=191 Identities=23% Similarity=0.284 Sum_probs=143.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+. |+|.+++..... ..+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||+++
T Consensus 94 ~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 94 LTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred EEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 479999996 599999987542 24899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh---ccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE---NCL 158 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~ 158 (253)
..... .......+++.|+|||++.+..++.++|+||||+++|+|++|..||........... ....... ...
T Consensus 169 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~ 243 (326)
T 1blx_A 169 IYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK---ILDVIGLPGEEDW 243 (326)
T ss_dssp CCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCGGGS
T ss_pred cccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HHHHcCCCCcccC
Confidence 65322 122335689999999999988899999999999999999999999987654332111 1111000 000
Q ss_pred cch----------hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDM----------LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~----------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... .............+..+.+++.+||+.||.+||++.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 00000111122344578899999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=225.67 Aligned_cols=176 Identities=26% Similarity=0.431 Sum_probs=134.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 159 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSN 159 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred EEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccccc
Confidence 479999999999999998764 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCC-CCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQF-TKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
...... ......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||........ ..........
T Consensus 160 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~- 229 (276)
T 2h6d_A 160 MMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL-------FKKIRGGVFY- 229 (276)
T ss_dssp CCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCC-
T ss_pred ccCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-------HHHhhcCccc-
Confidence 654321 2233468899999999987665 6899999999999999999999976543221 1111111110
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.+...+..+.+++.+||+.||.+||++.+++++
T Consensus 230 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 ---------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111223467889999999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=229.22 Aligned_cols=179 Identities=23% Similarity=0.336 Sum_probs=141.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceee---cCCCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILL---DDKFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili---~~~~~~kl~Dfg 78 (253)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg 154 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFG 154 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred EEEEEEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCC
Confidence 479999999999999997654 4899999999999999999999999 9999999999999 678899999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
++..... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||........ ...+.....
T Consensus 155 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~i~~~~~ 224 (304)
T 2jam_A 155 LSKMEQN---GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL-------FEKIKEGYY 224 (304)
T ss_dssp TTCCCCC---BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHCCC
T ss_pred cceecCC---CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHcCCC
Confidence 9865432 122234589999999999988899999999999999999999999977554321 111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ... ......+..+.+++.+||+.||.+||++.+++++
T Consensus 225 ~--~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 225 E--FES----PFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp C--CCT----TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred C--CCc----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 000 1112234468889999999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=240.67 Aligned_cols=179 Identities=23% Similarity=0.300 Sum_probs=142.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceee---cCCCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILL---DDKFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili---~~~~~~kl~Dfg 78 (253)
.|+||||+.+++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 174 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFG 174 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred EEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence 489999999999999997654 5999999999999999999999999 9999999999999 567899999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
+++...... ......||+.|+|||++.+ .++.++|+||+||++|+|++|..||......+. ...+.....
T Consensus 175 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~i~~~~~ 244 (484)
T 3nyv_A 175 LSTHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI-------LKKVEKGKY 244 (484)
T ss_dssp HHHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC
T ss_pred eeEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHcCCC
Confidence 987654322 2234568999999999975 689999999999999999999999987654331 111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... .+ .....+..+.+++.+||+.||.+|||+.+++++
T Consensus 245 ~~~-~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 245 TFE-LP-----QWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CCC-SG-----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCC-Cc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 100 00 111234468889999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=238.50 Aligned_cols=179 Identities=28% Similarity=0.392 Sum_probs=142.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC---ceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF---RAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~---~~kl~Dfg 78 (253)
.|+||||++||+|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 121 ~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 194 (504)
T 3q5i_A 121 FYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFG 194 (504)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred EEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEECC
Confidence 489999999999999997754 4999999999999999999999999 99999999999998765 69999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
++...... .......||+.|+|||++. ..++.++|+||+||++|+|++|..||......+. ...+.....
T Consensus 195 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~i~~~~~ 264 (504)
T 3q5i_A 195 LSSFFSKD--YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI-------IKKVEKGKY 264 (504)
T ss_dssp TCEECCTT--SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC
T ss_pred CCEEcCCC--CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCCC
Confidence 99866432 2233456899999999987 5689999999999999999999999987654331 111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. .+.... ...+..+.+++.+||+.||.+|||+.+++++
T Consensus 265 ~--~~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 265 Y--FDFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp C--CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C--CCcccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1 011111 1233468899999999999999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=237.22 Aligned_cols=197 Identities=21% Similarity=0.300 Sum_probs=132.0
Q ss_pred CEEEEeecCCCChhHHhhccC------CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceee----cCCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT------EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILL----DDKFR 71 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili----~~~~~ 71 (253)
.|+||||+. ++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||++ +.++.
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCc
Confidence 479999995 58888876421 1224899999999999999999999999 9999999999999 67789
Q ss_pred eEEcccCCcccccCCCc--ceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhh---hhh
Q 044510 72 AKISDFGASRYVTIDQT--HLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED---KSL 145 (253)
Q Consensus 72 ~kl~Dfgl~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~---~~~ 145 (253)
+||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||........ ...
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 99999999986643211 222345689999999999874 489999999999999999999999976544210 000
Q ss_pred HHHHHHHHhhccc------cch---h---------chh---------hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 044510 146 AGYFLRAMKENCL------FDM---L---------DAQ---------VLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKE 198 (253)
Q Consensus 146 ~~~~~~~~~~~~~------~~~---~---------~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~ 198 (253)
...+......... ... . ... .........+..+.+|+.+||+.||.+|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 1111111110000 000 0 000 000000011346789999999999999999999
Q ss_pred HHHH
Q 044510 199 VAFE 202 (253)
Q Consensus 199 l~~~ 202 (253)
++++
T Consensus 331 ~L~h 334 (405)
T 3rgf_A 331 AMQD 334 (405)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=233.30 Aligned_cols=195 Identities=19% Similarity=0.264 Sum_probs=140.4
Q ss_pred CEEEEeecCCCChhHHhhc-cCCCCCCCHHHHHHHHHHHHHHHHhHh--hCCCCCeEecCCCCCceeecC-CCceEEccc
Q 044510 2 PLLVYEFIPNGTLYRYIHD-QTEEFTITWEISLRIAVEVSGALSYLH--STTSIPIYHRDIKSANILLDD-KFRAKISDF 77 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~~~~i~H~dl~~~nili~~-~~~~kl~Df 77 (253)
.++||||+.+ +|.+.+.. ......+++..++.++.|++.||.||| ..+ |+||||||+||+++. ++.+||+||
T Consensus 101 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 101 LNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp EEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCC
T ss_pred EEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeC
Confidence 4799999976 55554433 222335899999999999999999999 888 999999999999996 889999999
Q ss_pred CCcccccCCCcceeeeccccccccccchhccCC-CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH-------
Q 044510 78 GASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQ-FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF------- 149 (253)
Q Consensus 78 gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~------- 149 (253)
|+++...... ......+++.|+|||++.+.. ++.++|+|||||++|+|++|..||...............
T Consensus 177 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3e3p_A 177 GSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254 (360)
T ss_dssp TTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence 9998654322 223456899999999997654 899999999999999999999999876544322111100
Q ss_pred -HHHHhhc-cccch------hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 150 -LRAMKEN-CLFDM------LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 150 -~~~~~~~-~~~~~------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
....... ..... .............+..+.+++.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000 00000 00111111222345679999999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=239.40 Aligned_cols=195 Identities=24% Similarity=0.264 Sum_probs=139.7
Q ss_pred CEEEEeecCCCChhHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC-CceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQ-TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK-FRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~-~~~kl~Dfgl 79 (253)
.++||||+.+ +|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||+
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchh
Confidence 3689999965 677766541 12235999999999999999999999999 9999999999999955 5689999999
Q ss_pred cccccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH--------H
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF--------L 150 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~ 150 (253)
++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+........ .
T Consensus 204 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 204 AKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp CEECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98654322 22335689999999999764 6899999999999999999999999876543321111100 0
Q ss_pred HHHhhc----cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 151 RAMKEN----CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 151 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...... .........+........+..+.+++.+||+.||.+||++.|++++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000000 0000000001111122334678999999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=235.86 Aligned_cols=201 Identities=19% Similarity=0.226 Sum_probs=145.5
Q ss_pred CEEEEeecCCCChhHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec-CCCceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQ-TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD-DKFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~-~~~~~kl~Dfgl 79 (253)
.++||||++ ++|.+.+... .....+++..++.++.|++.||.|||+.| |+||||||+||+++ .++.+||+|||+
T Consensus 113 ~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~ 188 (383)
T 3eb0_A 113 LNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGS 188 (383)
T ss_dssp EEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCC
Confidence 479999997 4888777641 12235999999999999999999999999 99999999999997 688999999999
Q ss_pred cccccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHH--------
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFL-------- 150 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-------- 150 (253)
++...... ......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+....+.........
T Consensus 189 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 266 (383)
T 3eb0_A 189 AKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQM 266 (383)
T ss_dssp CEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 98654322 22334678999999998865 48999999999999999999999998766543222111000
Q ss_pred HHHhhc----cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhchh
Q 044510 151 RAMKEN----CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE--LGGIRA 208 (253)
Q Consensus 151 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~--l~~~~~ 208 (253)
...... ..............+...+..+.+++.+||+.||.+|||+.|++++ ++.+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 267 IRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred HHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 000000 0000011111222233345678999999999999999999999975 444443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=232.94 Aligned_cols=191 Identities=20% Similarity=0.204 Sum_probs=141.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+.+ +|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 4899999976 89988876432 5888999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh---cc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE---NC 157 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~ 157 (253)
...... .......+|+.|+|||++.+. .++.++|+|||||++|+|++|..||......+... . ....... ..
T Consensus 161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~--~-i~~~~~~~~~~~ 236 (346)
T 1ua2_A 161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT--R-IFETLGTPTEEQ 236 (346)
T ss_dssp TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--H-HHHHHCCCCTTT
T ss_pred eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH--H-HHHHcCCCChhh
Confidence 654322 222345689999999999754 47899999999999999999999998765432211 1 1111000 00
Q ss_pred ccch------hc-----hhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 LFDM------LD-----AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~~~~------~~-----~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.... .. ...........+..+.+++.+||+.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 00 000001112334678999999999999999999999976
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=227.15 Aligned_cols=174 Identities=20% Similarity=0.275 Sum_probs=135.0
Q ss_pred CEEEEeecCCCChhHHhhccCC-CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC------------
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD------------ 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~------------ 68 (253)
.++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~ 162 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGD 162 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccc
Confidence 4799999999999999986421 125899999999999999999999999 999999999999984
Q ss_pred -------CCceEEcccCCcccccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChh
Q 044510 69 -------KFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTE 140 (253)
Q Consensus 69 -------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~ 140 (253)
...++|+|||++....... ...+++.|+|||++.+. .++.++|+||||+++|+|++|..++.....
T Consensus 163 ~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~- 236 (289)
T 1x8b_A 163 EDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ- 236 (289)
T ss_dssp -------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-
T ss_pred cccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-
Confidence 4479999999987654321 23489999999999865 456899999999999999999877643211
Q ss_pred hhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 141 EDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.......... ..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 237 ---------~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 ---------WHEIRQGRLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ---------HHHHHTTCCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---------HHHHHcCCCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1111111111 1112234468889999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=233.35 Aligned_cols=190 Identities=22% Similarity=0.225 Sum_probs=135.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+. |+|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++
T Consensus 109 ~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 182 (362)
T 3pg1_A 109 LYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR 182 (362)
T ss_dssp EEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCTTC--
T ss_pred EEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEecCccc
Confidence 389999996 58988887643 25999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc--
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL-- 158 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 158 (253)
..... .......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||......+...... ........
T Consensus 183 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~ 257 (362)
T 3pg1_A 183 EDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV---EVVGTPKIED 257 (362)
T ss_dssp ---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCCCCHHH
T ss_pred ccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHcCCCChHH
Confidence 54322 22233568899999999986 568999999999999999999999998765443221111 00000000
Q ss_pred ----------------cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 ----------------FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ----------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
................+..+.+++.+||+.||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 00000001111122334568899999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=230.03 Aligned_cols=181 Identities=25% Similarity=0.367 Sum_probs=129.1
Q ss_pred CEEEEeecCCCChhHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHhHhhC-CCCCeEecCCCCCceeecCCCceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQ-TEEFTITWEISLRIAVEVSGALSYLHST-TSIPIYHRDIKSANILLDDKFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dl~~~nili~~~~~~kl~Dfgl 79 (253)
.++||||+++ +|.+++... .....+++..++.++.|++.||.|||+. + ++||||||+||+++.++.+||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T 3fme_A 81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGI 156 (290)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCC
Confidence 4899999964 888877652 1223599999999999999999999998 9 99999999999999999999999999
Q ss_pred cccccCCCcceeeeccccccccccchh----ccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYF----RSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE 155 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 155 (253)
+....... ......+++.|+|||++ .+..++.++|+||+|+++|+|++|..||....... .........
T Consensus 157 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~ 229 (290)
T 3fme_A 157 SGYLVDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-----QQLKQVVEE 229 (290)
T ss_dssp ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-----HHHHHHHHS
T ss_pred cccccccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-----HHHHHHhcc
Confidence 87654322 22234689999999996 45568899999999999999999999997643321 111111111
Q ss_pred ccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 156 NCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ..... ....+..+.+++.+||+.||.+|||+.+++++
T Consensus 230 ~-~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 230 P-SPQLP--------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp C-CCCCC--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred C-CCCcc--------cccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 1 11110 11233468889999999999999999999873
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-33 Score=226.55 Aligned_cols=181 Identities=25% Similarity=0.334 Sum_probs=139.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCc---eEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFR---AKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~---~kl~Dfg 78 (253)
.|+||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++. +||+|||
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 379999999999999987654 5999999999999999999999999 999999999999987654 9999999
Q ss_pred CcccccCCCcceeeeccccccccccchhc---cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFR---SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE 155 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 155 (253)
+++..... .......|++.|+|||++. ...++.++|+|||||++|+|++|..||........ .. .....
T Consensus 163 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~----~~~~~ 234 (322)
T 2ycf_A 163 HSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LK----DQITS 234 (322)
T ss_dssp TCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HH----HHHHH
T ss_pred cceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HH----HHHHh
Confidence 98765422 1223356899999999974 35678999999999999999999999976543211 11 11111
Q ss_pred ccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 156 NCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.... ..+.. ....+..+.+++.+||+.||.+||++.+++++
T Consensus 235 ~~~~--~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 235 GKYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp TCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred Cccc--cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 1110 01111 11234568889999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=225.50 Aligned_cols=180 Identities=28% Similarity=0.390 Sum_probs=141.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 99 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 99 FFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchh
Confidence 489999999999999998754 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhc------cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR------SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE 155 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 155 (253)
...... ......+++.|+|||++. ...++.++|+||||+++|+|++|..||........ .......
T Consensus 173 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~ 244 (298)
T 1phk_A 173 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM------LRMIMSG 244 (298)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHT
T ss_pred hcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH------HHHHhcC
Confidence 654322 223356899999999985 34578899999999999999999999976543321 1111111
Q ss_pred ccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 156 NCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. .. ... ......+..+.+++.+||+.||.+||++.+++++
T Consensus 245 ~-~~-~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 245 N-YQ-FGS-----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp C-CC-CCT-----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred C-cc-cCc-----ccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 1 11 000 0111234468889999999999999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.8e-33 Score=230.17 Aligned_cols=193 Identities=21% Similarity=0.239 Sum_probs=139.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+. ++|.+++... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 489999996 5899998763 4999999999999999999999999 9999999999999999999999999988
Q ss_pred cccCCCcc---------eeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHH
Q 044510 82 YVTIDQTH---------LTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLR 151 (253)
Q Consensus 82 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~ 151 (253)
........ ......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+...............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 65432111 1122467999999998764 5689999999999999999999999987664332111110000
Q ss_pred HHh-hccccch--------------hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 152 AMK-ENCLFDM--------------LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 152 ~~~-~~~~~~~--------------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... ....... .............+..+.+++.+||+.||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 0000000 00000011112345678899999999999999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.4e-33 Score=223.96 Aligned_cols=181 Identities=20% Similarity=0.302 Sum_probs=137.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++.
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred EEEEEEeCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 4899999999999999876432 4999999999999999999999999 9999999999999999999999999875
Q ss_pred cccCCCcceeeeccccccccccchhc-----cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR-----SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
..... ........+++.|+|||.+. +..++.++|+||||+++|+|++|..||........ ........
T Consensus 166 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~ 238 (302)
T 2j7t_A 166 KNLKT-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSD 238 (302)
T ss_dssp HHHHH-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSC
T ss_pred ccccc-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHhccC
Confidence 33211 11122346889999999983 56688999999999999999999999987654321 11111111
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...... +...+..+.+++.+||+.||.+|||+.+++++
T Consensus 239 -~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 239 -PPTLLT-------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp -CCCCSS-------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred -CcccCC-------ccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 111111 11223467889999999999999999999863
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=221.88 Aligned_cols=179 Identities=21% Similarity=0.233 Sum_probs=139.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+.++ |.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 48999999876 877776643 235999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCC-cceeeeccccccccccchhccCC--CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQ-THLTTRVQGTFGYLDLEYFRSSQ--FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
...... ........+++.|+|||++.+.. ++.++|+||||+++|+|++|..||......+. ...+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~i~~~~~ 230 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL-------FENIGKGSY 230 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHCCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH-------HHHHhcCCC
Confidence 654322 22233456899999999998644 37789999999999999999999987543321 111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+||++.+++++
T Consensus 231 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111233467889999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=228.60 Aligned_cols=187 Identities=21% Similarity=0.247 Sum_probs=135.7
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
|+||||+. ++|.+++.. .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 123 ~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp EEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred EEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 89999996 588888742 3899999999999999999999999 99999999999999999999999999875
Q ss_pred ccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||......+....................
T Consensus 194 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 194 ADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred ccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence 432 2233568999999999987 57899999999999999999999999876543321111000000000000000
Q ss_pred h--------------chhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 L--------------DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~--------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ............+..+.+++.+||+.||.+|||+.+++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 0000011112235678999999999999999999999976
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-33 Score=229.12 Aligned_cols=188 Identities=22% Similarity=0.357 Sum_probs=141.2
Q ss_pred CEEEEeecCCCChhHH------hhccCCCCCCCHHHHHHHHHHHHHHHHhHhh-CCCCCeEecCCCCCceeecCCCceEE
Q 044510 2 PLLVYEFIPNGTLYRY------IHDQTEEFTITWEISLRIAVEVSGALSYLHS-TTSIPIYHRDIKSANILLDDKFRAKI 74 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~------l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nili~~~~~~kl 74 (253)
.++||||+++++|.++ +.... ...+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|
T Consensus 118 ~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~~~~kl 193 (348)
T 2pml_X 118 VYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKL 193 (348)
T ss_dssp EEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTTSCEEE
T ss_pred EEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCCCcEEE
Confidence 4799999999999998 54421 2369999999999999999999999 99 999999999999999999999
Q ss_pred cccCCcccccCCCcceeeeccccccccccchhccC-CCCC-CCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHH
Q 044510 75 SDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTK-KGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRA 152 (253)
Q Consensus 75 ~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 152 (253)
+|||++...... ......+++.|+|||++.+. .++. ++|+||||+++|+|++|..||....... . ....
T Consensus 194 ~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~-~~~~ 264 (348)
T 2pml_X 194 SDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-----E-LFNN 264 (348)
T ss_dssp CCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-----H-HHHH
T ss_pred eccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-----H-HHHH
Confidence 999998765332 33445689999999999876 5655 9999999999999999999998755421 0 1111
Q ss_pred Hhhccccchh---------chhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 153 MKENCLFDML---------DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 153 ~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
+......... ............+..+.+++.+||+.||.+||++.+++++
T Consensus 265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111110000 0000000112344578899999999999999999999974
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=233.45 Aligned_cols=185 Identities=23% Similarity=0.310 Sum_probs=130.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCC----CCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC--------
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFT----ITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK-------- 69 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~----~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~-------- 69 (253)
.|+||||+. |+|.+++........ ..+..++.++.||+.||.|||+.+ |+||||||+||+++.+
T Consensus 84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~ 159 (434)
T 2rio_A 84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQ 159 (434)
T ss_dssp EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCT
T ss_pred EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccc
Confidence 489999995 699999987532110 123345789999999999999999 9999999999999754
Q ss_pred -----CceEEcccCCcccccCCCcc---eeeeccccccccccchhcc-------CCCCCCCCeehhHHHHHHHHh-CCCC
Q 044510 70 -----FRAKISDFGASRYVTIDQTH---LTTRVQGTFGYLDLEYFRS-------SQFTKKGDVYSFGVVFVGLLT-GQKP 133 (253)
Q Consensus 70 -----~~~kl~Dfgl~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~llt-g~~p 133 (253)
+.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P 239 (434)
T 2rio_A 160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239 (434)
T ss_dssp TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence 48999999999876432211 1223568999999999975 568899999999999999999 9999
Q ss_pred CCCCChhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 134 IRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 134 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
|....... ............ .........+..+.+++.+||+.||.+||++.+++++
T Consensus 240 f~~~~~~~--------~~i~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 240 FGDKYSRE--------SNIIRGIFSLDE----MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp TCSTTTHH--------HHHHHTCCCCCC----CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCchhhH--------HHHhcCCCCccc----ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 97644322 111111111000 0111234456788999999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=222.79 Aligned_cols=181 Identities=25% Similarity=0.446 Sum_probs=131.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 164 (303)
T 1zy4_A 90 LFIQMEYCENGTLYDLIHSENL--NQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164 (303)
T ss_dssp EEEEEECCCSCBHHHHHHHSCG--GGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCS
T ss_pred eEEEEecCCCCCHHHhhhcccc--ccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchh
Confidence 4799999999999999986432 5888999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCC-------------cceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHH
Q 044510 82 YVTIDQ-------------THLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAG 147 (253)
Q Consensus 82 ~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~ 147 (253)
...... ........+++.|+|||.+.+. .++.++|+|||||++|+|++ ||.... .. ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~~---~~ 236 (303)
T 1zy4_A 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--ER---VN 236 (303)
T ss_dssp CTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--HH---HH
T ss_pred hcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--hH---HH
Confidence 653211 1112335588999999999864 68999999999999999998 443211 10 11
Q ss_pred HHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 148 YFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.......... .. ....+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 237 -~~~~~~~~~~--~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 237 -ILKKLRSVSI--EF----PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -HHHHHHSTTC--CC----CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -HHHhcccccc--cc----CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1111111100 00 111222334467889999999999999999999974
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-33 Score=225.54 Aligned_cols=179 Identities=22% Similarity=0.289 Sum_probs=132.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||| +.+++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||++++ +.+||+|||++.
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccc
Confidence 479999 45889999998754 5899999999999999999999999 999999999999965 799999999987
Q ss_pred cccCCCcc-eeeeccccccccccchhcc-----------CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH
Q 044510 82 YVTIDQTH-LTTRVQGTFGYLDLEYFRS-----------SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF 149 (253)
Q Consensus 82 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~ 149 (253)
........ ......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||....... ...
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~ 249 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKL 249 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHH
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----HHH
Confidence 65432221 1223468999999999875 357889999999999999999999997643321 111
Q ss_pred HHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 150 LRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.......... ..+...+..+.+++.+||+.||.+||++.+++++
T Consensus 250 ~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 250 HAIIDPNHEI---------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHCTTSCC---------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhccccc---------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1111111110 1111123467889999999999999999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-33 Score=233.85 Aligned_cols=170 Identities=14% Similarity=0.150 Sum_probs=131.7
Q ss_pred EEEEeecCCCChhHHhhcc----CCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccC
Q 044510 3 LLVYEFIPNGTLYRYIHDQ----TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFG 78 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfg 78 (253)
+++|+++ +++|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 181 ~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG 256 (413)
T 3dzo_A 181 FFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 256 (413)
T ss_dssp EEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGG
T ss_pred EEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEecc
Confidence 5667766 77999998521 12235888899999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCcceeeeccccccccccchh----------ccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHH
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYF----------RSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGY 148 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~ 148 (253)
+++.... ......| +.|+|||++ .+..++.++|||||||++|+|++|..||......+....
T Consensus 257 ~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~--- 328 (413)
T 3dzo_A 257 HLVRDGA----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW--- 328 (413)
T ss_dssp GCEETTE----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGG---
T ss_pred ceeecCC----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHH---
Confidence 9875432 2334557 999999999 444578899999999999999999999976543321110
Q ss_pred HHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 149 FLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... .....+..+.+++.+||+.||.+||++.+++++
T Consensus 329 ------------~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 329 ------------IFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp ------------GGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ------------HHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000 000123468889999999999999998777654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-33 Score=226.87 Aligned_cols=169 Identities=24% Similarity=0.423 Sum_probs=136.7
Q ss_pred CEEEEeecCC-CChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec-CCCceEEcccCC
Q 044510 2 PLLVYEFIPN-GTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD-DKFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~-~~~~~kl~Dfgl 79 (253)
.++|||++.+ ++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++ .++.+||+|||+
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 3799999976 89999998754 5899999999999999999999999 99999999999999 778999999999
Q ss_pred cccccCCCcceeeeccccccccccchhccCCC-CCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQF-TKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
++..... ......|++.|+|||++.+..+ +.++|+||||+++|+|++|..||..... .......
T Consensus 197 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------~~~~~~~ 261 (320)
T 3a99_A 197 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVF 261 (320)
T ss_dssp CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHHCCCC
T ss_pred ccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------hhccccc
Confidence 8765422 2233468999999999987665 6789999999999999999999964211 0111100
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.+...+..+.+++.+||+.||.+||++.+++++
T Consensus 262 -----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 262 -----------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -----------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011223467889999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-33 Score=226.06 Aligned_cols=191 Identities=20% Similarity=0.252 Sum_probs=137.2
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec-CCCceEEcccCCcc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD-DKFRAKISDFGASR 81 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~-~~~~~kl~Dfgl~~ 81 (253)
|+||||+. |+|.+++... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++ .++.+||+|||+++
T Consensus 98 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~ 169 (320)
T 2i6l_A 98 YIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR 169 (320)
T ss_dssp EEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCB
T ss_pred eEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCcccc
Confidence 79999997 5999998653 4899999999999999999999999 99999999999997 56799999999987
Q ss_pred cccCCCc--ceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH--------H
Q 044510 82 YVTIDQT--HLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF--------L 150 (253)
Q Consensus 82 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~ 150 (253)
....... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......+........ .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (320)
T 2i6l_A 170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDR 249 (320)
T ss_dssp CC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHH
T ss_pred ccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhh
Confidence 6532211 11223456889999999875 56889999999999999999999999876643321111000 0
Q ss_pred HHHhhccccchhch------hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 151 RAMKENCLFDMLDA------QVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 151 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...... ....... ..........+..+.+++.+||+.||.+||++.+++++
T Consensus 250 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 250 QELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHTT-SCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhhhc-CcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 000000 0000000 00011112245678999999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=225.12 Aligned_cols=184 Identities=22% Similarity=0.264 Sum_probs=136.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+. ++|.+++.. .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 389999996 588887743 3899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc-
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF- 159 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 159 (253)
.... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+....+..... .... .....
T Consensus 175 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i---~~~~-~~~~~~ 246 (353)
T 3coi_A 175 HADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI---LKVT-GVPGTE 246 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHH---HHHH-CBCCHH
T ss_pred CCCC----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHh-CCCCHH
Confidence 5432 1233467999999999986 56899999999999999999999999876543321111 0000 00000
Q ss_pred ---chhc--------------hhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 ---DMLD--------------AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ---~~~~--------------~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...+ ...........+..+.+++.+||+.||.+|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 000011112345678999999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=230.27 Aligned_cols=181 Identities=25% Similarity=0.409 Sum_probs=130.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC-----CCceEEcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD-----KFRAKISD 76 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~-----~~~~kl~D 76 (253)
.|+||||+. |+|.+++..... ...+..++.++.|++.||.|||+.+ |+||||||+||+++. ...++|+|
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~D 166 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISD 166 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred EEEEEECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEec
Confidence 489999995 599999987542 3455567789999999999999999 999999999999953 23578999
Q ss_pred cCCcccccCCCc--ceeeeccccccccccchhcc---CCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHH
Q 044510 77 FGASRYVTIDQT--HLTTRVQGTFGYLDLEYFRS---SQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFL 150 (253)
Q Consensus 77 fgl~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~ 150 (253)
||+++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||....... .
T Consensus 167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--------~ 238 (432)
T 3p23_A 167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--------A 238 (432)
T ss_dssp TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--------H
T ss_pred ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--------H
Confidence 999876543221 12234568999999999973 456789999999999999999 999996543322 1
Q ss_pred HHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 151 RAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
............. ........+.+++.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 239 NILLGACSLDCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp HHHTTCCCCTTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhccCCccccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 1111111111111 112344567889999999999999999999954
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=215.27 Aligned_cols=179 Identities=26% Similarity=0.330 Sum_probs=139.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCC---CceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDK---FRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~---~~~kl~Dfg 78 (253)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||..+ ++|+||||+||+++.+ +.+||+|||
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred EEEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccC
Confidence 479999999999999987654 4999999999999999999999999 9999999999999754 469999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
++....... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||......+. .........
T Consensus 170 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~ 239 (287)
T 2wei_A 170 LSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-------LKRVETGKY 239 (287)
T ss_dssp GGGTBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC
T ss_pred cceeecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCCC
Confidence 987654322 2223457899999999875 589999999999999999999999987654321 111111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.... . .....+..+.+++.+||+.||.+|||+.+++++
T Consensus 240 ~~~~--~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 240 AFDL--P----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CCCS--G----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCCc--h----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 1000 0 011223468889999999999999999999974
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=221.04 Aligned_cols=169 Identities=27% Similarity=0.430 Sum_probs=137.4
Q ss_pred CEEEEee-cCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec-CCCceEEcccCC
Q 044510 2 PLLVYEF-IPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD-DKFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~-~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~-~~~~~kl~Dfgl 79 (253)
.++|||| +.+++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++ .++.++|+|||+
T Consensus 113 ~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 113 FMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcch
Confidence 4789999 78999999998754 4999999999999999999999999 99999999999999 788999999999
Q ss_pred cccccCCCcceeeeccccccccccchhccCCC-CCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQF-TKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
++..... ......+++.|+|||++.+..+ +.++|+||||+++|+|++|..||..... ..... .
T Consensus 187 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~~~~-~ 250 (312)
T 2iwi_A 187 GALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------------ILEAE-L 250 (312)
T ss_dssp CEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHHTC-C
T ss_pred hhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------------Hhhhc-c
Confidence 8765432 2233458999999999987665 4589999999999999999999964211 00000 0
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+||++.+++++
T Consensus 251 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 251 ----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0112233467889999999999999999999974
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=224.24 Aligned_cols=184 Identities=26% Similarity=0.333 Sum_probs=119.6
Q ss_pred CEEEEeecCCCChhHHhhcc--CCCCCCCHHHHHHHHHHHHHHHHhHhhC-CCCCeEecCCCCCceeecCCCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQ--TEEFTITWEISLRIAVEVSGALSYLHST-TSIPIYHRDIKSANILLDDKFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dl~~~nili~~~~~~kl~Dfg 78 (253)
.++||||+.+ +|.+++... .....+++..+..++.|++.||.|||.. + ++|+||||+||+++.++.+||+|||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCS
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCC
Confidence 4799999975 888887641 1123589999999999999999999998 9 9999999999999999999999999
Q ss_pred CcccccCCCcceeeeccccccccccchh----ccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHh
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYF----RSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK 154 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 154 (253)
+++...... ......|++.|+|||++ .+..++.++|+||||+++|+|++|..||........ ...
T Consensus 172 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------~~~ 240 (327)
T 3aln_A 172 ISGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------QLT 240 (327)
T ss_dssp SSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------C
T ss_pred Cceeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------HHH
Confidence 987654221 22234689999999998 455688999999999999999999999976432110 000
Q ss_pred hccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 155 ENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ......+..........+..+.+++.+||+.||.+||++.+++++
T Consensus 241 ~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 241 Q--VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp C--CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred H--HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0 000000000001111234468889999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=215.82 Aligned_cols=180 Identities=26% Similarity=0.385 Sum_probs=128.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhC-CCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHST-TSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.++||||+ ++.+..+...... .+++..++.++.|++.||.|||.. + ++|+||||+||+++.++.+||+|||++
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~ 172 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQG--PIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGIS 172 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecc-CCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCc
Confidence 48999999 6667666654322 589999999999999999999985 8 999999999999999999999999998
Q ss_pred ccccCCCcceeeeccccccccccchhc-----cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFR-----SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE 155 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 155 (253)
....... ......+++.|+|||.+. ...++.++|+||||+++|+|++|..||....... .........
T Consensus 173 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~ 245 (318)
T 2dyl_A 173 GRLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----EVLTKVLQE 245 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHHHS
T ss_pred hhccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----HHHHHHhcc
Confidence 7553221 223346899999999994 4567889999999999999999999997643221 111111111
Q ss_pred ccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 156 NCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... .... ....+..+.+++.+||+.||.+||++.+++++
T Consensus 246 ~~~-~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 246 EPP-LLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCC-CCCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCC-CCCc-------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111 0000 01123467889999999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-32 Score=236.02 Aligned_cols=193 Identities=23% Similarity=0.272 Sum_probs=138.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCc---eEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFR---AKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~---~kl~Dfg 78 (253)
+|+||||++||+|.+++........+++..++.++.|++.||.|||+.+ ++||||||+||+++.++. ++|+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 4799999999999999987654446899999999999999999999999 999999999999986654 8999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhH---HHHHHHHhh
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLA---GYFLRAMKE 155 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~---~~~~~~~~~ 155 (253)
++....... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||............ .........
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 998654322 223456899999999999889999999999999999999999999764322110000 000000000
Q ss_pred ccccchh----chhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 044510 156 NCLFDML----DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199 (253)
Q Consensus 156 ~~~~~~~----~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l 199 (253)
....... ............+..+.+++.+||..||.+|||+.++
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0000000 0000111233456678999999999999999999773
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=211.46 Aligned_cols=165 Identities=28% Similarity=0.375 Sum_probs=123.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC---CCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD---KFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~---~~~~kl~Dfg 78 (253)
.++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++. ++.++|+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 4799999999999999987532 25999999999999999999999999 999999999999997 7889999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
++.... +..++.++|+|||||++|+|++|..||........... ......
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-------~~~~~~ 215 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-------MKTRIR 215 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-------SCCSSC
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-------HHHHHh
Confidence 875321 24467889999999999999999999976543210000 000000
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.. ............+..+.+++.+||+.||.+|||+.+++++
T Consensus 216 ~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 216 MG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp TT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00 0000000111234578899999999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=231.22 Aligned_cols=169 Identities=24% Similarity=0.328 Sum_probs=132.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++|++|.+++.. .+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 4899999999999987754 4899999999999999999999999 9999999999999985 89999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||....... ...
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------~~~- 286 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------LPE- 286 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------CCT-
T ss_pred hcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc----------------ccc-
Confidence 65422 335689999999999865 4889999999999999999988876422111 000
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhchh
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-TMKEVAFELGGIRA 208 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-s~~~l~~~l~~~~~ 208 (253)
.......+..+.+++.+||+.||.+|| +++++...|..+..
T Consensus 287 ------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 287 ------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 001112334678899999999999999 56777777766543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=206.93 Aligned_cols=172 Identities=16% Similarity=0.150 Sum_probs=129.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHh-hCCCCCeEecCCCCCceeecCCC----------
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLH-STTSIPIYHRDIKSANILLDDKF---------- 70 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~~i~H~dl~~~nili~~~~---------- 70 (253)
.|+||||+++|++.+.+.+. .+++..++.++.||+.||.||| +.+ |+||||||+|||++.++
T Consensus 137 ~~lv~E~~~~g~ll~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~ 209 (336)
T 2vuw_A 137 LFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNG 209 (336)
T ss_dssp EEEEEEEECCCEETGGGTTT----CCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETT
T ss_pred EEEEEEecCCCccHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccC
Confidence 48999999999777766442 4899999999999999999999 899 99999999999999876
Q ss_pred ----------ceEEcccCCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHH-HHHHHhCCCCCCCCCh
Q 044510 71 ----------RAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV-FVGLLTGQKPIRSTDT 139 (253)
Q Consensus 71 ----------~~kl~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~-l~~lltg~~pf~~~~~ 139 (253)
.+||+|||+++..... ...||+.|+|||++.+.. +.++||||++++ .+++++|..||...
T Consensus 210 ~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-- 280 (336)
T 2vuw_A 210 KSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-- 280 (336)
T ss_dssp EEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--
T ss_pred ccccccCCCceEEEeeccccEecCCC------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch--
Confidence 8999999999865421 346899999999998665 889999998777 66788898887321
Q ss_pred hhhhhhHHHHHHHHh-hccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHH-HH
Q 044510 140 EEDKSLAGYFLRAMK-ENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVA-FE 202 (253)
Q Consensus 140 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~-~~ 202 (253)
........... ...... ..........+..+.+++.+||+.| |++|++ ++
T Consensus 281 ----~~~~~~~~~~~~~~~~~~----~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 281 ----LWLHYLTDKMLKQMTFKT----KCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp ----HHHHHHHHHHHHTCCCSS----CCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred ----hhhhHHHHhhhhhhccCc----ccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 00011111111 111111 1112234456778999999999976 889888 54
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-29 Score=201.41 Aligned_cols=161 Identities=13% Similarity=0.106 Sum_probs=121.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||++|++|.+++... .....+.+++.|++.||.|||+.| |+||||||+||+++.++.+||++++
T Consensus 106 ~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~--- 174 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA--- 174 (286)
T ss_dssp EEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC---
T ss_pred EEEEEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc---
Confidence 48999999999999999542 355678899999999999999999 9999999999999999999998543
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
|++ .++.++|+|||||++|+|++|..||............ .......
T Consensus 175 ------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------~~~~~~~ 221 (286)
T 3uqc_A 175 ------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------ERDTAGQ 221 (286)
T ss_dssp ------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--------CBCTTSC
T ss_pred ------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--------HHHhccC
Confidence 222 3688899999999999999999999876543210000 0000000
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
...........+..+.+++.+||+.||.+| |+.++++.|+++...
T Consensus 222 --~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 222 --PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp --BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred --CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 000011122334568899999999999999 999999999988765
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.4e-27 Score=203.24 Aligned_cols=120 Identities=23% Similarity=0.232 Sum_probs=85.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+||||||++|++|.++|.+.+ +++.. +|+.||+.||.|+|++| |+||||||+|||++.++.+||+|||+++
T Consensus 317 ~yLVMEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr 387 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIV 387 (569)
T ss_dssp EEEEEECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEE
T ss_pred EEEEEecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCe
Confidence 599999999999999998764 46654 47889999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCC
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQK 132 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~ 132 (253)
...... ......+||+.|++||++.+ .+...+|+|++|++++++.++..
T Consensus 388 ~~~~~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 388 TTPQDC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp SCC----CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred eCCCCC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 654322 23344679999999999985 46778999999998877655443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.8e-20 Score=162.81 Aligned_cols=117 Identities=18% Similarity=0.266 Sum_probs=97.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++|++|.+++.. +..++.|++.||.|||+++ |+||||||+||+++. .+||+|||+++
T Consensus 414 ~~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~ 477 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGK 477 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCE
T ss_pred cEEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCE
Confidence 4899999999999999865 4578999999999999999 999999999999999 99999999998
Q ss_pred cccCCCcce------eeeccccccccccchhcc--CCCCCCCCeehhHHHHHHHHhCCCCC
Q 044510 82 YVTIDQTHL------TTRVQGTFGYLDLEYFRS--SQFTKKGDVYSFGVVFVGLLTGQKPI 134 (253)
Q Consensus 82 ~~~~~~~~~------~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~lltg~~pf 134 (253)
......... .....||+.|+|||++.. ..|+..+|+|+..+-..+.+.++.+|
T Consensus 478 ~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 478 ISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp ECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 764322111 134578999999999986 56788889999888777776665554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=8.9e-17 Score=128.57 Aligned_cols=78 Identities=21% Similarity=0.143 Sum_probs=65.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||++|++|.+ +.. .....++.|++.||.|||+.| ++||||||+||+++ ++.++|+|||+++
T Consensus 175 ~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 175 NAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSV 240 (282)
T ss_dssp TEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred eEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence 589999999999998 421 123468999999999999999 99999999999999 9999999999986
Q ss_pred cccCCCcceeeeccccccccccchhc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR 107 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 107 (253)
. +..+.|||.+.
T Consensus 241 ~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 241 E--------------VGEEGWREILE 252 (282)
T ss_dssp E--------------TTSTTHHHHHH
T ss_pred E--------------CCCCCHHHHHH
Confidence 3 23467888875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=4.4e-13 Score=105.74 Aligned_cols=71 Identities=23% Similarity=0.252 Sum_probs=58.3
Q ss_pred CEEEEeecCC-C----ChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHh-hCCCCCeEecCCCCCceeecCCCceEEc
Q 044510 2 PLLVYEFIPN-G----TLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLH-STTSIPIYHRDIKSANILLDDKFRAKIS 75 (253)
Q Consensus 2 ~~lv~e~~~~-~----sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~~i~H~dl~~~nili~~~~~~kl~ 75 (253)
.++||||+.+ | +|.++... .++..+..++.|++.+|.||| ..| ++||||||.||+++. .++|+
T Consensus 143 ~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~NILl~~--~~~li 211 (258)
T 1zth_A 143 NVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHADLSEYNIMYID--KVYFI 211 (258)
T ss_dssp TEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCSTTSEEESS--SEEEC
T ss_pred CEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEEcC--cEEEE
Confidence 4799999932 3 66665432 224466788999999999999 999 999999999999998 99999
Q ss_pred ccCCcccc
Q 044510 76 DFGASRYV 83 (253)
Q Consensus 76 Dfgl~~~~ 83 (253)
|||++...
T Consensus 212 DFG~a~~~ 219 (258)
T 1zth_A 212 DMGQAVTL 219 (258)
T ss_dssp CCTTCEET
T ss_pred ECcccccC
Confidence 99998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.13 E-value=2.5e-11 Score=100.24 Aligned_cols=70 Identities=13% Similarity=0.130 Sum_probs=56.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC----------c
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF----------R 71 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~----------~ 71 (253)
++|||||+.|++|.++... ..+..++.|++.+|.+||..| |+||||||.|||++.++ .
T Consensus 186 ~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~~~~~~ 253 (397)
T 4gyi_A 186 HTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPSSITLT 253 (397)
T ss_dssp TEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTTSEEEE
T ss_pred ceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcccccccccc
Confidence 3699999999888765321 123467889999999999999 99999999999998765 3
Q ss_pred eEEcccCCcccc
Q 044510 72 AKISDFGASRYV 83 (253)
Q Consensus 72 ~kl~Dfgl~~~~ 83 (253)
+.|+||+.+...
T Consensus 254 ~~iID~~Q~V~~ 265 (397)
T 4gyi_A 254 PIIIXFPQMVSM 265 (397)
T ss_dssp EEECCCTTCEET
T ss_pred eEEEEeCCcccC
Confidence 899999977644
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.46 E-value=2.6e-08 Score=80.14 Aligned_cols=126 Identities=20% Similarity=0.228 Sum_probs=78.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCC-------------------------------
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTT------------------------------- 50 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~------------------------------- 50 (253)
+|+|||+++|.+|.+.... .++.+....++.+++..|..||...
T Consensus 91 ~~~vm~~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (304)
T 3sg8_A 91 SFAGFTKIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL 165 (304)
T ss_dssp SCEEEECCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred ceEEEcccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence 5899999999888754321 2667777777888888888887511
Q ss_pred ------------------------CCCeEecCCCCCceeecC--CCceEEcccCCcccccCCCccee-eec---------
Q 044510 51 ------------------------SIPIYHRDIKSANILLDD--KFRAKISDFGASRYVTIDQTHLT-TRV--------- 94 (253)
Q Consensus 51 ------------------------~~~i~H~dl~~~nili~~--~~~~kl~Dfgl~~~~~~~~~~~~-~~~--------- 94 (253)
...++|+|+++.||++++ ...+.|+||+.+........... ...
T Consensus 166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFV 245 (304)
T ss_dssp CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHH
T ss_pred CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHH
Confidence 123799999999999997 55678999997754321100000 000
Q ss_pred ---cccccccc-cchhccCCCCCCCCeehhHHHHHHHHhCCCCC
Q 044510 95 ---QGTFGYLD-LEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPI 134 (253)
Q Consensus 95 ---~~~~~y~a-PE~~~~~~~~~~~Di~slG~~l~~lltg~~pf 134 (253)
........ |+.... .....+.|+++.++|.+.+|..+|
T Consensus 246 ~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00001111 221111 012246799999999999998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=1.4e-07 Score=74.06 Aligned_cols=72 Identities=18% Similarity=0.166 Sum_probs=53.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCC-------------------------------
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTT------------------------------- 50 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~------------------------------- 50 (253)
+|+||||++|.+|.+.+.. ......++.+++.+|..||...
T Consensus 85 ~~lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred eEEEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 4899999999999876421 1122357778999999999810
Q ss_pred -------------------------CCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 51 -------------------------SIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 51 -------------------------~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
...++|+|+++.||+++++..+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0238999999999999876556799998653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.35 E-value=7e-07 Score=73.46 Aligned_cols=76 Identities=16% Similarity=0.223 Sum_probs=59.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCC-------------------------------
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTT------------------------------- 50 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~------------------------------- 50 (253)
+|+||||++|..+.+... ..++......++.+++..|..||...
T Consensus 116 ~~~vme~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE 190 (359)
T ss_dssp CEEEEECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred eEEEEEecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence 689999999987754211 13678888889999999999999731
Q ss_pred ------------------------CCCeEecCCCCCceeecCCCc--eEEcccCCccc
Q 044510 51 ------------------------SIPIYHRDIKSANILLDDKFR--AKISDFGASRY 82 (253)
Q Consensus 51 ------------------------~~~i~H~dl~~~nili~~~~~--~kl~Dfgl~~~ 82 (253)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134899999999999987653 68999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.08 E-value=1.9e-06 Score=67.25 Aligned_cols=28 Identities=21% Similarity=0.255 Sum_probs=24.4
Q ss_pred eEecCCCCCceeecCCCceEEcccCCcc
Q 044510 54 IYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 54 i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
++|+|++|.||+++++..+.|+||+.+.
T Consensus 186 l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 186 VTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 8999999999999877666799999764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.77 E-value=8.3e-05 Score=55.96 Aligned_cols=101 Identities=16% Similarity=0.075 Sum_probs=64.8
Q ss_pred ChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcccccCCCcceee
Q 044510 13 TLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTT 92 (253)
Q Consensus 13 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~~~~~~~~~~~ 92 (253)
+|.++|...++ +++++++|.++.|.+.+|.-+-.... -..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 34 SL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc-----------
Confidence 68899988655 69999999999999999877632110 11233456888898888888764 1110
Q ss_pred eccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCC
Q 044510 93 RVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQK 132 (253)
Q Consensus 93 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~ 132 (253)
.....+.|||... ...+.+.-|||+|+++|.-+--..
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 0122355777764 334567789999999998876443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00016 Score=58.02 Aligned_cols=28 Identities=25% Similarity=0.436 Sum_probs=23.4
Q ss_pred eEecCCCCCceeecC---CCc-eEEcccCCcc
Q 044510 54 IYHRDIKSANILLDD---KFR-AKISDFGASR 81 (253)
Q Consensus 54 i~H~dl~~~nili~~---~~~-~kl~Dfgl~~ 81 (253)
++|+|+++.||+++. ++. +.|+||+.+.
T Consensus 192 ~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 192 LIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp EECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred eEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 699999999999987 355 4899998664
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00065 Score=55.47 Aligned_cols=29 Identities=17% Similarity=0.228 Sum_probs=24.4
Q ss_pred CeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 53 PIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 53 ~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|+|+.+.||+++++..+.|+||+.+.
T Consensus 223 ~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 223 VLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp EEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred eEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 38999999999999964457899998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00049 Score=53.83 Aligned_cols=28 Identities=21% Similarity=0.309 Sum_probs=24.5
Q ss_pred eEecCCCCCceeecCCCceEEcccCCcc
Q 044510 54 IYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 54 i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
++|+|+.+.||++++++.+-|+||+.+.
T Consensus 195 l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 195 VTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 7899999999999987767799998764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.70 E-value=0.016 Score=46.64 Aligned_cols=28 Identities=21% Similarity=0.362 Sum_probs=25.3
Q ss_pred eEecCCCCCceeecCCCceEEcccCCcc
Q 044510 54 IYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 54 i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
++|+|+++.||+++.++.+.|+||+.+.
T Consensus 224 l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 224 LCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp EECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred eecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 9999999999999877889999998653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.71 E-value=0.034 Score=46.41 Aligned_cols=28 Identities=18% Similarity=0.387 Sum_probs=25.1
Q ss_pred eEecCCCCCceeecCCCceEEcccCCccc
Q 044510 54 IYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 54 i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
++|+|+++.||+++.++ +.|+||+.+..
T Consensus 234 liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 234 LIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp EECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred EEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 99999999999998776 99999987754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=92.62 E-value=0.17 Score=40.49 Aligned_cols=30 Identities=27% Similarity=0.438 Sum_probs=25.7
Q ss_pred CeEecCCCCCceeecCC----CceEEcccCCccc
Q 044510 53 PIYHRDIKSANILLDDK----FRAKISDFGASRY 82 (253)
Q Consensus 53 ~i~H~dl~~~nili~~~----~~~kl~Dfgl~~~ 82 (253)
.++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 38999999999999874 6789999987653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.70 E-value=0.19 Score=40.11 Aligned_cols=26 Identities=27% Similarity=0.385 Sum_probs=23.1
Q ss_pred eEecCCCCCceeecCCCceEEcccCCcc
Q 044510 54 IYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 54 i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
++|+|+++.||+++ + .+.|+||+.+.
T Consensus 197 l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 197 RLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp ECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 78999999999999 4 89999998654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.56 E-value=0.07 Score=42.55 Aligned_cols=28 Identities=18% Similarity=0.223 Sum_probs=24.2
Q ss_pred eEecCCCCCceeecCCCceEEcccCCcc
Q 044510 54 IYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 54 i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
++|+|+.+.||+++++..+.|+||+.+.
T Consensus 189 liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 189 VIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCCCCCccCEEEeCCceEEEecchhcc
Confidence 8999999999999987556899998654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=89.95 E-value=0.28 Score=39.60 Aligned_cols=29 Identities=24% Similarity=0.412 Sum_probs=25.6
Q ss_pred CeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 53 PIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 53 ~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 38999999999999987889999997654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=89.73 E-value=0.58 Score=36.85 Aligned_cols=28 Identities=32% Similarity=0.257 Sum_probs=23.7
Q ss_pred CeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 53 PIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 53 ~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|+|+.+.||+ ..++.+.++||..+.
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 3799999999999 556678999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=88.38 E-value=0.24 Score=40.39 Aligned_cols=27 Identities=30% Similarity=0.481 Sum_probs=22.7
Q ss_pred eEecCCCCCceeecCCCceEEcccCCcc
Q 044510 54 IYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 54 i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
++|+|+.+.||+++++ .+.|+||..+.
T Consensus 214 l~HgDl~~~Nil~~~~-~~~lID~e~a~ 240 (369)
T 3c5i_A 214 FCHNDLQENNIINTNK-CLRLIDFEYSG 240 (369)
T ss_dssp EECSCCCGGGEEECC--CEEECCCTTCE
T ss_pred EEeCCCCcccEEecCC-cEEEEEecCCC
Confidence 8999999999999865 48999998654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=88.25 E-value=0.6 Score=39.42 Aligned_cols=15 Identities=33% Similarity=0.459 Sum_probs=13.8
Q ss_pred CeEecCCCCCceeec
Q 044510 53 PIYHRDIKSANILLD 67 (253)
Q Consensus 53 ~i~H~dl~~~nili~ 67 (253)
.++|+|+.+.||+++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 379999999999998
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=87.57 E-value=0.28 Score=40.35 Aligned_cols=28 Identities=21% Similarity=0.426 Sum_probs=24.1
Q ss_pred eEecCCCCCceeecCCCceEEcccCCccc
Q 044510 54 IYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 54 i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
++|+|+.+.||+++.+ .++++||..+..
T Consensus 229 L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 229 LIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp EECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 8999999999999876 589999987653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=86.91 E-value=0.26 Score=41.24 Aligned_cols=17 Identities=35% Similarity=0.624 Sum_probs=14.6
Q ss_pred CeEecCCCCCceeecCC
Q 044510 53 PIYHRDIKSANILLDDK 69 (253)
Q Consensus 53 ~i~H~dl~~~nili~~~ 69 (253)
.++|+|+.+.||+++.+
T Consensus 250 v~~H~Dl~~gNiL~~~~ 266 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKA 266 (429)
T ss_dssp EEECSCCCGGGEEEEC-
T ss_pred EEEeCCCCCCeEEeeCC
Confidence 37999999999999875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=86.03 E-value=0.38 Score=39.52 Aligned_cols=29 Identities=34% Similarity=0.399 Sum_probs=25.1
Q ss_pred CeEecCCCCCceeecCC----CceEEcccCCcc
Q 044510 53 PIYHRDIKSANILLDDK----FRAKISDFGASR 81 (253)
Q Consensus 53 ~i~H~dl~~~nili~~~----~~~kl~Dfgl~~ 81 (253)
.++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 37999999999999876 689999998764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.23 E-value=1.3 Score=33.20 Aligned_cols=48 Identities=10% Similarity=0.099 Sum_probs=40.2
Q ss_pred CCHHHHHHHHHHHHHHHH-hHhhCCCCCeEecCCCCCceeecCCCceEEcccCC
Q 044510 27 ITWEISLRIAVEVSGALS-YLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGA 79 (253)
Q Consensus 27 ~~~~~~~~i~~~i~~~l~-~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl 79 (253)
++....++++.+|+.... +++. -+|--+.|+|++++.++.+++.-.|+
T Consensus 82 ~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~f~~~~~p~i~hRGi 130 (219)
T 4ano_A 82 TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLMFNRALEPFFLHVGV 130 (219)
T ss_dssp SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEEECTTCCEEESCCEE
T ss_pred cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEEEeCCCcEEEEEcCC
Confidence 778888999999988766 5554 45889999999999999999987775
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=82.34 E-value=0.73 Score=38.08 Aligned_cols=28 Identities=36% Similarity=0.525 Sum_probs=23.5
Q ss_pred eEecCCCCCceee------cCCCceEEcccCCcc
Q 044510 54 IYHRDIKSANILL------DDKFRAKISDFGASR 81 (253)
Q Consensus 54 i~H~dl~~~nili------~~~~~~kl~Dfgl~~ 81 (253)
++|+|+.+.||++ +.+..+.++||..+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 345679999998764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=81.72 E-value=1.5 Score=32.75 Aligned_cols=81 Identities=7% Similarity=0.065 Sum_probs=56.2
Q ss_pred CCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcccccCCCcceeeeccccccccccch
Q 044510 26 TITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEY 105 (253)
Q Consensus 26 ~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~ 105 (253)
..+....++++.+|+....+++. -+|--+.|+|++++.++.+++.-.|+... ++|..
T Consensus 77 ~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f~~~~~p~i~~RGik~~------------------l~P~~ 133 (215)
T 4ann_A 77 SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFFTRDGLPIAKTRGLQNV------------------VDPLP 133 (215)
T ss_dssp GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEECTTSCEEESCCEETTT------------------BSCCC
T ss_pred hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEEcCCCCEEEEEccCccC------------------CCCCC
Confidence 37788899999999887766654 34889999999999999999987765321 22221
Q ss_pred hccCCCCCCCCeehhHHHHHHHHhCCCCC
Q 044510 106 FRSSQFTKKGDVYSFGVVFVGLLTGQKPI 134 (253)
Q Consensus 106 ~~~~~~~~~~Di~slG~~l~~lltg~~pf 134 (253)
+ +...-.-.+=|++..+++++..|
T Consensus 134 ~-----~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 134 V-----SEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp C-----CHHHHHHHHHHHHHHHHCTTCCH
T ss_pred C-----CHHHHHHHHHHHHHHHHcCCCCH
Confidence 1 11111224567888888888876
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 253 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-46 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-40 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-40 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-39 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-39 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-38 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-38 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-38 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-38 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-37 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-36 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-36 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-36 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-36 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-36 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-35 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-35 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-35 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-35 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-35 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-34 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-34 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-33 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-33 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-33 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-31 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-31 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-30 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-29 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-29 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-27 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-26 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-25 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-25 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-24 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-23 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-23 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-23 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-23 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-23 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-23 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-22 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-22 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-21 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-21 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-20 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-20 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-18 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-17 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-16 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-15 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-13 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-46
Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 21/216 (9%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
+V ++ +LY ++H +F + IA + + + YLH+ I HRD+KS
Sbjct: 78 LAIVTQWCEGSSLYHHLHIIETKFE--MIKLIDIARQTAQGMDYLHAK---SIIHRDLKS 132
Query: 62 ANILLDDKFRAKISDFGASRYVT-IDQTHLTTRVQGTFGYLDLEYFRSSQ---FTKKGDV 117
NI L + KI DFG + + +H ++ G+ ++ E R ++ + DV
Sbjct: 133 NNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDV 192
Query: 118 YSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIIT 177
Y+FG+V L+TGQ P + + + + + L L K
Sbjct: 193 YAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLSPDLSKVRSNCPKA----- 241
Query: 178 VAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQ 213
+ L CL +RP ++ + + S+ P+
Sbjct: 242 MKRLMAECLKKKRDERPLFPQILASIELLARSL-PK 276
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 7e-42
Identities = 51/199 (25%), Positives = 81/199 (40%), Gaps = 20/199 (10%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEF-TITWEISLRIAVEVSGALSYLH--STTSIPIYHRDIK 60
+V E+ G L I T+E + E LR+ +++ AL H S + HRD+K
Sbjct: 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 141
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
AN+ LD K K+ DFG +R + D + GT Y+ E + +K D++S
Sbjct: 142 PANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQMNRMSYNEKSDIWSL 200
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
G + L P + +E L F + + E E
Sbjct: 201 GCLLYELCALMPPFTAFSQKE--------LAGKIREGKFRRIPYRYSDELNE-------- 244
Query: 181 LAKRCLNLNGRKRPTMKEV 199
+ R LNL RP+++E+
Sbjct: 245 IITRMLNLKDYHRPSVEEI 263
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-40
Identities = 41/212 (19%), Positives = 87/212 (41%), Gaps = 19/212 (8%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
+V E++ G+L ++ +T ++ + +A +++ ++Y+ + HRD+++
Sbjct: 86 IYIVTEYMSKGSLLDFLKGETGKYLR-LPQLVDMAAQIASGMAYVER---MNYVHRDLRA 141
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
ANIL+ + K++DFG +R + ++ + + E +FT K DV+SFG
Sbjct: 142 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 201
Query: 122 VVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAML 181
++ L T + + + D ++ E ++ L
Sbjct: 202 ILLTELTTKGRVPYPGMVNRE---------------VLDQVERGYRMPCPPECPESLHDL 246
Query: 182 AKRCLNLNGRKRPTMKEVAFELGGIRASIGPQ 213
+C +RPT + + L S PQ
Sbjct: 247 MCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 8e-40
Identities = 46/225 (20%), Positives = 94/225 (41%), Gaps = 35/225 (15%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
+ E + G+L + + I +I ++++ V L+YL I HRD+K
Sbjct: 79 ISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKP 133
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
+NIL++ + K+ DFG S + + GT Y+ E + + ++ + D++S G
Sbjct: 134 SNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMG 190
Query: 122 VVFVGLLTGQKPIRSTDTEED-----------------------KSLAGYFLRAMKENCL 158
+ V + G+ PI D +E + L+ Y + + +
Sbjct: 191 LSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAI 250
Query: 159 FDMLDAQVLKEAKEEEIITVAMLAK----RCLNLNGRKRPTMKEV 199
F++LD V + + ++ + +CL N +R +K++
Sbjct: 251 FELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 2e-39
Identities = 47/227 (20%), Positives = 89/227 (39%), Gaps = 23/227 (10%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS-----TTSIPIYHRD 58
LV ++ +G+L+ Y++ +T+T E +++A+ + L++LH I HRD
Sbjct: 78 LVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133
Query: 59 IKSANILLDDKFRAKISDFGASRYVTIDQTHL---TTRVQGTFGYLDLEYFRSS------ 109
+KS NIL+ I+D G + + GT Y+ E S
Sbjct: 134 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 193
Query: 110 QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEE----DKSLAGYFLRAMKENCLFDMLDAQ 165
+ K+ D+Y+ G+VF + + + D + + M++ L
Sbjct: 194 ESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPN 253
Query: 166 VLKEAKEEEII-TVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIG 211
+ + E + +A + + C NG R T + L + G
Sbjct: 254 IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 4e-39
Identities = 40/202 (19%), Positives = 80/202 (39%), Gaps = 19/202 (9%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
++ E++ NG+L ++ +T L +A +++ ++++ HRD+++
Sbjct: 82 IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRA 137
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
ANIL+ D KI+DFG +R + ++ + + E FT K DV+SFG
Sbjct: 138 ANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 197
Query: 122 VVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAML 181
++ ++T + T + + E + +E + L
Sbjct: 198 ILLTEIVTHGRIPYPGMTNPE-------VIQNLERGYRMVRPDNCPEELYQ--------L 242
Query: 182 AKRCLNLNGRKRPTMKEVAFEL 203
+ C RPT + L
Sbjct: 243 MRLCWKERPEDRPTFDYLRSVL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-38
Identities = 42/199 (21%), Positives = 80/199 (40%), Gaps = 23/199 (11%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
+LV E + +GTL Y+ + ++ ++ L +LH+ + PI HRD+K
Sbjct: 87 IVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKC 142
Query: 62 ANILLDDK-FRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
NI + KI D G + + + V GT ++ E + ++ + DVY+F
Sbjct: 143 DNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAF 198
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
G+ + + T + P R + D + E KE
Sbjct: 199 GMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPASFDKVAIPEVKE-------- 244
Query: 181 LAKRCLNLNGRKRPTMKEV 199
+ + C+ N +R ++K++
Sbjct: 245 IIEGCIRQNKDERYSIKDL 263
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-38
Identities = 46/208 (22%), Positives = 81/208 (38%), Gaps = 20/208 (9%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
LV+EF+ +G L Y+ Q E L + ++V ++YL + HRD+ +
Sbjct: 75 ICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAA 129
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
N L+ + K+SDFG +R+V DQ +T + + E F S+++ K DV+SFG
Sbjct: 130 RNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFG 189
Query: 122 VVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAML 181
V+ + + K + + + + + V +
Sbjct: 190 VLMWEVFSEGKIPYENRSNSE---------------VVEDISTGFRLYKPRLASTHVYQI 234
Query: 182 AKRCLNLNGRKRPTMKEVAFELGGIRAS 209
C RP + +L I S
Sbjct: 235 MNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 2e-38
Identities = 42/204 (20%), Positives = 87/204 (42%), Gaps = 23/204 (11%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E++ G+L Y+ + + + L+ +++V A+ YL HRD+ + N
Sbjct: 78 IVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARN 133
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
+L+ + AK+SDFG ++ + Q + + E R +F+ K DV+SFG++
Sbjct: 134 VLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFSTKSDVWSFGIL 189
Query: 124 FVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAK 183
+ + + +D + +++ D D E + K
Sbjct: 190 LWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPD-GCPPAVYE--------VMK 234
Query: 184 RCLNLNGRKRPTMKEVAFELGGIR 207
C +L+ RP+ ++ +L I+
Sbjct: 235 NCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 132 bits (333), Expect = 7e-38
Identities = 37/227 (16%), Positives = 79/227 (34%), Gaps = 40/227 (17%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFT---------------------ITWEISLRIAVEVS 40
L++E++ G L ++ + ++ L IA +V+
Sbjct: 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 150
Query: 41 GALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYV-TIDQTHLTTRVQGTFG 99
++YL HRD+ + N L+ + KI+DFG SR + + D
Sbjct: 151 AGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR 207
Query: 100 YLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159
++ E +++T + DV+++GVV + + E+ +
Sbjct: 208 WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE---------------VI 252
Query: 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206
+ + E + + L + C + RP+ + L +
Sbjct: 253 YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 4e-37
Identities = 47/205 (22%), Positives = 81/205 (39%), Gaps = 24/205 (11%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
+LV E G L++++ + EE + +VS + YL HRD+ +
Sbjct: 83 LMLVMEMAGGGPLHKFLVGKREEIP--VSNVAELLHQVSMGMKYLEEK---NFVHRDLAA 137
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTR--VQGTFGYLDLEYFRSSQFTKKGDVYS 119
N+LL ++ AKISDFG S+ + D ++ T R + + E +F+ + DV+S
Sbjct: 138 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWS 197
Query: 120 FGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITV 178
+GV L+ GQKP + E + +++ + + E
Sbjct: 198 YGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRME-CPPECPPELYA------ 243
Query: 179 AMLAKRCLNLNGRKRPTMKEVAFEL 203
L C RP V +
Sbjct: 244 --LMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 128 bits (323), Expect = 2e-36
Identities = 43/203 (21%), Positives = 82/203 (40%), Gaps = 19/203 (9%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
++ EF+ G L Y+ + ++ + L +A ++S A+ YL HRD+ + N
Sbjct: 90 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARN 145
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
L+ + K++DFG SR +T D + + E ++F+ K DV++FGV+
Sbjct: 146 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 205
Query: 124 FVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAK 183
+ T + + ++++L+ E E V L +
Sbjct: 206 LWEIATYGMS---------------PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 250
Query: 184 RCLNLNGRKRPTMKEVAFELGGI 206
C N RP+ E+ +
Sbjct: 251 ACWQWNPSDRPSFAEIHQAFETM 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 2e-36
Identities = 54/196 (27%), Positives = 82/196 (41%), Gaps = 26/196 (13%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L+ E+ P GT+YR + + + + E++ ALSY HS + HRDIK N
Sbjct: 83 LILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHS---KRVIHRDIKPEN 136
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
+LL KI+DFG S + + + GT YL E +K D++S GV+
Sbjct: 137 LLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVL 193
Query: 124 FVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAK 183
L G+ P + +E F D V + A++ L
Sbjct: 194 CYEFLVGKPPFEANTYQE--------TYKRISRVEFTFPD-FVTEGARD--------LIS 236
Query: 184 RCLNLNGRKRPTMKEV 199
R L N +RP ++EV
Sbjct: 237 RLLKHNPSQRPMLREV 252
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-36
Identities = 41/224 (18%), Positives = 81/224 (36%), Gaps = 38/224 (16%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFT--------------------ITWEISLRIAVEVSG 41
L++E+ G L Y+ + E+F+ +T+E L A +V+
Sbjct: 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 175
Query: 42 ALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLT-TRVQGTFGY 100
+ +L HRD+ + N+L+ KI DFG +R + D ++ + +
Sbjct: 176 GMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKW 232
Query: 101 LDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160
+ E +T K DV+S+G++ + + + + +N
Sbjct: 233 MAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN------FYKLIQNGFKM 286
Query: 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204
+E + + C + RKRP+ + LG
Sbjct: 287 DQPFYATEEIYI--------IMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 3e-36
Identities = 51/205 (24%), Positives = 81/205 (39%), Gaps = 25/205 (12%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
+LV E G L +Y+ + + + + +VS + YL + HRD+ +
Sbjct: 82 WMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAA 135
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTR--VQGTFGYLDLEYFRSSQFTKKGDVYS 119
N+LL + AKISDFG S+ + D+ + + + + E +F+ K DV+S
Sbjct: 136 RNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWS 195
Query: 120 FGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITV 178
FGV+ + GQKP R E + AM E A +E +
Sbjct: 196 FGVLMWEAFSYGQKPYRGMKGSE--------VTAMLEKGERMGCPAGCPREMYD------ 241
Query: 179 AMLAKRCLNLNGRKRPTMKEVAFEL 203
L C + RP V L
Sbjct: 242 --LMNLCWTYDVENRPGFAAVELRL 264
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 4e-36
Identities = 48/218 (22%), Positives = 85/218 (38%), Gaps = 31/218 (14%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFT-------------ITWEISLRIAVEVSGALSYLHST 49
+++ EF G L Y+ + EF +T E + + +V+ + +L S
Sbjct: 94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS- 152
Query: 50 TSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHL-TTRVQGTFGYLDLEYFRS 108
HRD+ + NILL +K KI DFG +R + D ++ + ++ E
Sbjct: 153 --RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 210
Query: 109 SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLK 168
+T + DV+SFGV+ + + +++ F R +KE D
Sbjct: 211 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRRLKEGTRMRAPD-YTTP 264
Query: 169 EAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206
E + C + +RPT E+ LG +
Sbjct: 265 EMYQ--------TMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 4e-36
Identities = 46/198 (23%), Positives = 79/198 (39%), Gaps = 22/198 (11%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L E+ G L+ I + + R ++ + YLH I I HRDIK N
Sbjct: 80 LFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPEN 133
Query: 64 ILLDDKFRAKISDFGASRYVTID-QTHLTTRVQGTFGYLDLEYFRSSQF-TKKGDVYSFG 121
+LLD++ KISDFG + + + L ++ GT Y+ E + +F + DV+S G
Sbjct: 134 LLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 193
Query: 122 VVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAML 181
+V +L G + ++ + KE + ++ L
Sbjct: 194 IVLTAMLAG-ELPWDQPSDSCQ-----EYSDWKEKKTYLNPWKKIDSAPLA--------L 239
Query: 182 AKRCLNLNGRKRPTMKEV 199
+ L N R T+ ++
Sbjct: 240 LHKILVENPSARITIPDI 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 8e-36
Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 23/211 (10%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
PL+V ++ +G L +I ++T T+ I ++V+ + +L S HRD+ +
Sbjct: 104 PLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKFLAS---KKFVHRDLAA 158
Query: 62 ANILLDDKFRAKISDFGASRYVT---IDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVY 118
N +LD+KF K++DFG +R + D H T + ++ LE ++ +FT K DV+
Sbjct: 159 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 218
Query: 119 SFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITV 178
SFGV+ L+T P D + + ++ L E
Sbjct: 219 SFGVLLWELMTRGAPP-----YPDVNTFDITVYLLQGRRLLQ--PEYCPDPLYE------ 265
Query: 179 AMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209
+ +C + RP+ E+ + I ++
Sbjct: 266 --VMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 125 bits (315), Expect = 3e-35
Identities = 39/209 (18%), Positives = 83/209 (39%), Gaps = 24/209 (11%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
+++ EF+ NG+L ++ +FT + + ++ + YL + HRD+ +
Sbjct: 102 VMIITEFMENGSLDSFLRQNDGQFT--VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAA 156
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTR----VQGTFGYLDLEYFRSSQFTKKGDV 117
NIL++ K+SDFG SR++ D + T + + E + +FT DV
Sbjct: 157 RNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDV 216
Query: 118 YSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIIT 177
+S+G+V +++ + T +D + + ++ +
Sbjct: 217 WSYGIVMWEVMSYGERPYWDMTNQD---------------VINAIEQDYRLPPPMDCPSA 261
Query: 178 VAMLAKRCLNLNGRKRPTMKEVAFELGGI 206
+ L C + RP ++ L +
Sbjct: 262 LHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 4e-35
Identities = 38/202 (18%), Positives = 81/202 (40%), Gaps = 21/202 (10%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
L+ + +P G L Y+ + + + L V+++ ++YL + HRD+ +
Sbjct: 86 QLITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQIAKGMNYLED---RRLVHRDLAAR 140
Query: 63 NILLDDKFRAKISDFGASRYV-TIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
N+L+ KI+DFG ++ + ++ + + ++ LE +T + DV+S+G
Sbjct: 141 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 200
Query: 122 VVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAML 181
V L+T + + + +L+ I V M+
Sbjct: 201 VTVWELMTFGSK---------------PYDGIPASEISSILEKGERLPQPPICTIDVYMI 245
Query: 182 AKRCLNLNGRKRPTMKEVAFEL 203
+C ++ RP +E+ E
Sbjct: 246 MVKCWMIDADSRPKFRELIIEF 267
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 5e-35
Identities = 39/209 (18%), Positives = 86/209 (41%), Gaps = 22/209 (10%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+++ E++ NG L +++ ++ EF+ + + ++ + YL + + HRD+ +
Sbjct: 85 MIITEYMENGALDKFLREKDGEFS--VLQLVGMLRGIAAGMKYLAN---MNYVHRDLAAR 139
Query: 63 NILLDDKFRAKISDFGASRYVTIDQ--THLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSF 120
NIL++ K+SDFG SR + D T+ T+ + + E +FT DV+SF
Sbjct: 140 NILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSF 199
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
G+V ++T + + + + ++ + +
Sbjct: 200 GIVMWEVMTYGERPYWELSNHE---------------VMKAINDGFRLPTPMDCPSAIYQ 244
Query: 181 LAKRCLNLNGRKRPTMKEVAFELGGIRAS 209
L +C +RP ++ L + +
Sbjct: 245 LMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 5e-35
Identities = 42/204 (20%), Positives = 75/204 (36%), Gaps = 20/204 (9%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
++ E G L ++ + +++ + A ++S AL+YL S HRDI +
Sbjct: 83 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAAR 137
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N+L+ K+ DFG SRY+ + ++ + ++ E +FT DV+ FGV
Sbjct: 138 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 197
Query: 123 VFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLA 182
+L D + EN + L
Sbjct: 198 CMWEILMHGVKPFQGVKNND-------VIGRIENGERLPMPPNCPPTLYS--------LM 242
Query: 183 KRCLNLNGRKRPTMKEVAFELGGI 206
+C + +RP E+ +L I
Sbjct: 243 TKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 7e-35
Identities = 44/197 (22%), Positives = 79/197 (40%), Gaps = 20/197 (10%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
++ E++ NG L Y+ + F + L + +V A+ YL S HRD+ +
Sbjct: 75 FIITEYMANGCLLNYLREMRHRFQ--TQQLLEMCKDVCEAMEYLESK---QFLHRDLAAR 129
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N L++D+ K+SDFG SRYV D+ + + + E S+F+ K D+++FGV
Sbjct: 130 NCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGV 189
Query: 123 VFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLA 182
+ + + K T + L ++ +
Sbjct: 190 LMWEIYSLGKMPYERFTNSE-------TAEHIAQGLRLYRPHLASEKVYT--------IM 234
Query: 183 KRCLNLNGRKRPTMKEV 199
C + +RPT K +
Sbjct: 235 YSCWHEKADERPTFKIL 251
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-34
Identities = 41/221 (18%), Positives = 82/221 (37%), Gaps = 33/221 (14%)
Query: 2 PLLVYEFIPNGTLYRYIHDQ---------------TEEFTITWEISLRIAVEVSGALSYL 46
L++ E+ G L ++ + +E + E L + +V+ +++L
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161
Query: 47 HSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEY 105
S HRD+ + NILL KI DFG +R + D + + + ++ E
Sbjct: 162 AS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPES 218
Query: 106 FRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQ 165
+ +T + DV+S+G+ L + + K + M+
Sbjct: 219 IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--------------FYKMIKEG 264
Query: 166 VLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206
+ E + + K C + + KRPT K++ +
Sbjct: 265 FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-34
Identities = 42/201 (20%), Positives = 73/201 (36%), Gaps = 25/201 (12%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
++ EF G + + + E +T + + AL+YLH I HRD+K+ N
Sbjct: 86 ILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGN 140
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQ-----FTKKGDVY 118
IL K++DFG S T + + GT ++ E + K DV+
Sbjct: 141 ILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYDYKADVW 199
Query: 119 SFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITV 178
S G+ + + + P + L+ K ++ K+
Sbjct: 200 SLGITLIEMAEIEPPHHELNPMR------VLLKIAKSEPPTLAQPSRWSSNFKD------ 247
Query: 179 AMLAKRCLNLNGRKRPTMKEV 199
K+CL N R T ++
Sbjct: 248 --FLKKCLEKNVDARWTTSQL 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 4e-34
Identities = 47/197 (23%), Positives = 88/197 (44%), Gaps = 24/197 (12%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E++ G+L + + + + E AL +LHS + HRDIKS N
Sbjct: 94 VVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDN 146
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
ILL K++DFG +T +Q+ +T V GT ++ E + K D++S G++
Sbjct: 147 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIM 205
Query: 124 FVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVL-KEAKEEEIITVAMLA 182
+ ++ G+ P + + L + N ++ + + L ++
Sbjct: 206 AIEMIEGEPPYLNENPLRA-------LYLIATNGTPELQNPEKLSAIFRD--------FL 250
Query: 183 KRCLNLNGRKRPTMKEV 199
RCL+++ KR + KE+
Sbjct: 251 NRCLDMDVEKRGSAKEL 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 5e-34
Identities = 44/217 (20%), Positives = 82/217 (37%), Gaps = 33/217 (15%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFT-------------ITWEISLRIAVEVSGALSYLHSTT 50
L E+ P+G L ++ T ++ + L A +V+ + YL
Sbjct: 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK- 146
Query: 51 SIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQ 110
HRD+ + NIL+ + + AKI+DFG SR + T + ++ +E S
Sbjct: 147 --QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSV 202
Query: 111 FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEA 170
+T DV+S+GV+ +++ T + L++ L E
Sbjct: 203 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------------LYEKLPQGYRLEK 247
Query: 171 KEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207
V L ++C +RP+ ++ L +
Sbjct: 248 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 3e-33
Identities = 44/221 (19%), Positives = 83/221 (37%), Gaps = 32/221 (14%)
Query: 2 PLLVYEFIPNGTLYRYIHDQ-------------TEEFTITWEISLRIAVEVSGALSYLHS 48
++ E+ G L Y+ + E ++ + + A +V+ + YL S
Sbjct: 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 153
Query: 49 TTSIPIYHRDIKSANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQ-GTFGYLDLEYFR 107
HRD+ + N+L+ + KI+DFG +R + + T ++ E
Sbjct: 154 K---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 210
Query: 108 SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVL 167
+T + DV+SFGV+ + T E+ LF +L
Sbjct: 211 DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------------LFKLLKEGHR 255
Query: 168 KEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRA 208
+ + M+ + C + +RPT K++ +L I A
Sbjct: 256 MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (300), Expect = 5e-33
Identities = 38/201 (18%), Positives = 70/201 (34%), Gaps = 29/201 (14%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
LV E+ + + + L+YLHS + HRD+K+
Sbjct: 90 AWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKA 143
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSS---QFTKKGDVY 118
NILL + K+ DFG++ + GT ++ E + Q+ K DV+
Sbjct: 144 GNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVW 198
Query: 119 SFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITV 178
S G+ + L + P+ + + L + +N + + +
Sbjct: 199 SLGITCIELAERKPPLFNMNAMSA-------LYHIAQNESPALQSGHWSEYFRN------ 245
Query: 179 AMLAKRCLNLNGRKRPTMKEV 199
CL + RPT + +
Sbjct: 246 --FVDSCLQKIPQDRPTSEVL 264
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 118 bits (297), Expect = 9e-33
Identities = 53/205 (25%), Positives = 81/205 (39%), Gaps = 29/205 (14%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
LV++ + G L+ Y+ ++ T++ + + +I + + LH I HRD+K
Sbjct: 85 FFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKP 138
Query: 62 ANILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQ------FTKKG 115
NILLDD K++DFG S +D V GT YL E S + K+
Sbjct: 139 ENILLDDDMNIKLTDFGFSCQ--LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEV 196
Query: 116 DVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLD-AQVLKEAKEEE 174
D++S GV+ LL G P M N F + K+
Sbjct: 197 DMWSTGVIMYTLLAGSPPFWHRKQML------MLRMIMSGNYQFGSPEWDDYSDTVKD-- 248
Query: 175 IITVAMLAKRCLNLNGRKRPTMKEV 199
L R L + +KR T +E
Sbjct: 249 ------LVSRFLVVQPQKRYTAEEA 267
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 4e-32
Identities = 45/197 (22%), Positives = 80/197 (40%), Gaps = 24/197 (12%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+ NG L +YI + + E+ AL YLH I HRD+K N
Sbjct: 85 FGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPEN 138
Query: 64 ILLDDKFRAKISDFGASRYVTID-QTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
ILL++ +I+DFG ++ ++ + + GT Y+ E K D+++ G
Sbjct: 139 ILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 198
Query: 123 VFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLA 182
+ L+ G P R+ + F + +K F + +A++ L
Sbjct: 199 IIYQLVAGLPPFRAGNEYL------IFQKIIKLEYDF---PEKFFPKARD--------LV 241
Query: 183 KRCLNLNGRKRPTMKEV 199
++ L L+ KR +E+
Sbjct: 242 EKLLVLDATKRLGCEEM 258
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 1e-31
Identities = 40/199 (20%), Positives = 71/199 (35%), Gaps = 23/199 (11%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V E P G+L + F R AV+V+ + YL S HRD+ + N
Sbjct: 87 MVTELAPLGSLLDRLRKHQGHFL--LGTLSRYAVQVAEGMGYLESK---RFIHRDLAARN 141
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTH--LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
+LL + KI DFG R + + H + + F + E ++ F+ D + FG
Sbjct: 142 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 201
Query: 122 VVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIIT-VAM 180
V + T + + +D + + + E+ +
Sbjct: 202 VTLWEMFTYGQEPWIGLNGSQ---------------ILHKIDKEGERLPRPEDCPQDIYN 246
Query: 181 LAKRCLNLNGRKRPTMKEV 199
+ +C RPT +
Sbjct: 247 VMVQCWAHKPEDRPTFVAL 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 5e-31
Identities = 46/213 (21%), Positives = 82/213 (38%), Gaps = 26/213 (12%)
Query: 2 PLLVYEFIPNGTLYRYIH-------DQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPI 54
L++ E + G L Y+ + + +++A E++ ++YL++
Sbjct: 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KF 154
Query: 55 YHRDIKSANILLDDKFRAKISDFGASRYVT-IDQTHLTTRVQGTFGYLDLEYFRSSQFTK 113
HRD+ + N ++ + F KI DFG +R + D + ++ E + FT
Sbjct: 155 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT 214
Query: 114 KGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEE 173
DV+SFGVV + T + + E LR + E L D D E
Sbjct: 215 YSDVWSFGVVLWEIATLAEQPYQGLSNEQ------VLRFVMEGGLLDKPD-NCPDMLFE- 266
Query: 174 EIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206
L + C N + RP+ E+ +
Sbjct: 267 -------LMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 115 bits (288), Expect = 6e-31
Identities = 43/203 (21%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
+++YEF+ G L+ + D+ + + + ++ +V L ++H H D+K
Sbjct: 98 MVMIYEFMSGGELFEKVADEHNKMS--EDEAVEYMRQVCKGLCHMHENN---YVHLDLKP 152
Query: 62 ANILLDDKF--RAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYS 119
NI+ K K+ DFG + ++ Q+ T GT + E D++S
Sbjct: 153 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTDMWS 210
Query: 120 FGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLD---AQVLKEAKEEEII 176
GV+ LL+G P + +E LR +K +C ++M D + + ++ K+
Sbjct: 211 VGVLSYILLSGLSPFGGENDDE-------TLRNVK-SCDWNMDDSAFSGISEDGKD---- 258
Query: 177 TVAMLAKRCLNLNGRKRPTMKEV 199
++ L + R T+ +
Sbjct: 259 ----FIRKLLLADPNTRMTIHQA 277
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 4e-30
Identities = 41/199 (20%), Positives = 70/199 (35%), Gaps = 24/199 (12%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+++EFI ++ I+ F + + +V AL +LHS I H DI+ N
Sbjct: 78 MIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPEN 132
Query: 64 ILLDDK--FRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
I+ + KI +FG +R + Y E + + D++S G
Sbjct: 133 IIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVSTATDMWSLG 190
Query: 122 VVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM-LDAQVLKEAKEEEIITVAM 180
+ LL+G P + ++ M FD ++ EA +
Sbjct: 191 TLVYVLLSGINPFLAETNQQ------IIENIMNAEYTFDEEAFKEISIEAMD-------- 236
Query: 181 LAKRCLNLNGRKRPTMKEV 199
R L + R T E
Sbjct: 237 FVDRLLVKERKSRMTASEA 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 109 bits (273), Expect = 2e-29
Identities = 49/211 (23%), Positives = 85/211 (40%), Gaps = 24/211 (11%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
+P +V E++ TL +H + +T + ++ + + AL++ H I HRD+K
Sbjct: 85 LPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVK 138
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHL--TTRVQGTFGYLDLEYFRSSQFTKKGDVY 118
ANI++ K+ DFG +R + + T V GT YL E R + DVY
Sbjct: 139 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVY 198
Query: 119 SFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD-MLDAQVLKEAKEEEIIT 177
S G V +LTG+ P S + ++E+ + + +
Sbjct: 199 SLGCVLYEVLTGEPPF------TGDSPVSVAYQHVREDPIPPSARHEGLSADLDA----- 247
Query: 178 VAMLAKRCLNLNGRKRP-TMKEVAFELGGIR 207
+ + L N R T E+ +L +
Sbjct: 248 ---VVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 110 bits (276), Expect = 4e-29
Identities = 44/199 (22%), Positives = 74/199 (37%), Gaps = 24/199 (12%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L+ EF+ G L+ I + ++ ++ + + L ++H I H DIK N
Sbjct: 103 LILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPEN 157
Query: 64 ILLDDKF--RAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFG 121
I+ + K KI DFG + ++ + T + E D+++ G
Sbjct: 158 IMCETKKASSVKIIDFGLATK--LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIG 215
Query: 122 VVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM-LDAQVLKEAKEEEIITVAM 180
V+ LL+G P D E + + FD + V EAK+
Sbjct: 216 VLGYVLLSGLSPFAGEDDLET------LQNVKRCDWEFDEDAFSSVSPEAKD-------- 261
Query: 181 LAKRCLNLNGRKRPTMKEV 199
K L RKR T+ +
Sbjct: 262 FIKNLLQKEPRKRLTVHDA 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 7e-29
Identities = 52/200 (26%), Positives = 83/200 (41%), Gaps = 18/200 (9%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
L+V E + G L+ I D+ ++ T + I + A+ YLHS I I HRD+K
Sbjct: 85 LIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 140
Query: 63 NILLDDKF---RAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYS 119
N+L K K++DFG ++ T + T T Y+ E ++ K D++S
Sbjct: 141 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGPEKYDKSCDMWS 198
Query: 120 FGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVA 179
GV+ LL G P S +R M + + ++V +E K
Sbjct: 199 LGVIMYILLCGYPPFYSNHGLAISPGMKTRIR-MGQYEFPNPEWSEVSEEVKM------- 250
Query: 180 MLAKRCLNLNGRKRPTMKEV 199
L + L +R T+ E
Sbjct: 251 -LIRNLLKTEPTQRMTITEF 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 106 bits (265), Expect = 6e-28
Identities = 43/197 (21%), Positives = 76/197 (38%), Gaps = 20/197 (10%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L+ + + G L+ I ++ T + R+ +V A+ YLH + +
Sbjct: 84 LIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLY 140
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
LD+ + ISDFG S+ D + + GT GY+ E ++K D +S GV+
Sbjct: 141 YSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 198
Query: 124 FVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM-LDAQVLKEAKEEEIITVAMLA 182
LL G P + + F + +K FD + AK+
Sbjct: 199 AYILLCGYPPFYDENDAK------LFEQILKAEYEFDSPYWDDISDSAKD--------FI 244
Query: 183 KRCLNLNGRKRPTMKEV 199
+ + + KR T ++
Sbjct: 245 RHLMEKDPEKRFTCEQA 261
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 4e-27
Identities = 45/206 (21%), Positives = 80/206 (38%), Gaps = 17/206 (8%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV+E + D+ E + E + ++ L +LHS + HRD+K N
Sbjct: 92 LVFEHVDQDLTT--YLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQN 146
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
IL+ + K++DFG +R + T V T Y E S + D++S G +
Sbjct: 147 ILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 204
Query: 124 FVGLLTGQKPIR-STDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM-- 180
F + + R S+D ++ + +E+ D+ + +K + I +
Sbjct: 205 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD 264
Query: 181 -------LAKRCLNLNGRKRPTMKEV 199
L +CL N KR +
Sbjct: 265 IDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 102 bits (256), Expect = 3e-26
Identities = 41/200 (20%), Positives = 72/200 (36%), Gaps = 24/200 (12%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+ + + G L+ ++ A E+ L ++H+ + +RD+K AN
Sbjct: 84 FILDLMNGGDLHYHLSQHGVFS---EADMRFYAAEIILGLEHMHN---RFVVYRDLKPAN 137
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQ-FTKKGDVYSFGV 122
ILLD+ +ISD G + + + H GT GY+ E + + D +S G
Sbjct: 138 ILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 194
Query: 123 VFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLA 182
+ LL G P R T++ + L E L E + L
Sbjct: 195 MLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------LPDSFSPELRS--------LL 240
Query: 183 KRCLNLNGRKRPTMKEVAFE 202
+ L + +R +
Sbjct: 241 EGLLQRDVNRRLGCLGRGAQ 260
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 1e-25
Identities = 50/195 (25%), Positives = 77/195 (39%), Gaps = 24/195 (12%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
V E++ G L +I + + A E+ L +LHS I +RD+K N
Sbjct: 80 FVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDN 133
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
ILLD KI+DFG + + T GT Y+ E ++ D +SFGV+
Sbjct: 134 ILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQKYNHSVDWWSFGVL 192
Query: 124 FVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAK 183
+L GQ P D EE +++ + F + KEAK+ L
Sbjct: 193 LYEMLIGQSPFHGQDEEE-------LFHSIRMDNPF--YPRWLEKEAKD--------LLV 235
Query: 184 RCLNLNGRKRPTMKE 198
+ KR ++
Sbjct: 236 KLFVREPEKRLGVRG 250
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 4e-25
Identities = 44/217 (20%), Positives = 77/217 (35%), Gaps = 33/217 (15%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV +++P H + T+ ++ +L+Y+H S I HRDIK N
Sbjct: 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQN 152
Query: 64 ILLD-DKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
+LLD D K+ DFG+++ + + + + + + F ++ +T DV+S G
Sbjct: 153 LLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRAPELIFGATDYTSSIDVWSAGC 211
Query: 123 VFVGLLTGQKPIRSTDTEE--------------------DKSLAGYFLRAMKENCLFDML 162
V LL GQ + + + + +K + +
Sbjct: 212 VLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVF 271
Query: 163 DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
+ EA L R L R T E
Sbjct: 272 RPRTPPEAIA--------LCSRLLEYTPTARLTPLEA 300
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 96.5 bits (239), Expect = 2e-24
Identities = 34/209 (16%), Positives = 74/209 (35%), Gaps = 18/209 (8%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+LV+E + E + + +++ ++Y H + HRD+K
Sbjct: 76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQ 129
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N+L++ + KI+DFG +R I T + + S +++ D++S G
Sbjct: 130 NLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC 189
Query: 123 VFVGLLTGQKPIRSTDTEE------------DKSLAGYFLRAMKENCLFDMLDAQVLKEA 170
+F ++ G + + K + F + + +
Sbjct: 190 IFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESF 249
Query: 171 KEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
+ + L + L L+ +R T K+
Sbjct: 250 LKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.5 bits (239), Expect = 3e-24
Identities = 35/215 (16%), Positives = 64/215 (29%), Gaps = 33/215 (15%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV++F+ + +T + L YLH I HRD+K N
Sbjct: 77 LVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNN 130
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
+LLD+ K++DFG ++ T +V + F + + D+++ G +
Sbjct: 131 LLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCI 190
Query: 124 FVGLLTGQKPIRSTDTEE-------------------DKSLAGYFLRAMKENCLFDMLDA 164
LL + + SL Y + +
Sbjct: 191 LAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFS 250
Query: 165 QVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
+ + L + N R T +
Sbjct: 251 AAGDDLLD--------LIQGLFLFNPCARITATQA 277
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.3 bits (233), Expect = 2e-23
Identities = 36/209 (17%), Positives = 73/209 (34%), Gaps = 19/209 (9%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV+EF + + EI ++ L + HS + HRD+K N
Sbjct: 78 LVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQN 131
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
+L++ K+++FG +R I + V + F + ++ D++S G +
Sbjct: 132 LLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 191
Query: 124 FVGLLTGQKPIRSTDTEED------------KSLAGYFLRAMKENCLFDMLDAQVLKEAK 171
F L +P+ + +D + + + + M A
Sbjct: 192 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV 251
Query: 172 EEEIITVAM-LAKRCLNLNGRKRPTMKEV 199
++ L + L N +R + +E
Sbjct: 252 VPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.8 bits (232), Expect = 3e-23
Identities = 35/215 (16%), Positives = 79/215 (36%), Gaps = 25/215 (11%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV++F + + + T R+ + L+ L+ I HRD+K+AN
Sbjct: 94 LVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML---LNGLYYIHRNKILHRDMKAAN 147
Query: 64 ILLDDKFRAKISDFGASRYVTIDQT---HLTTRVQGTFGYLDLEYFRSSQ-FTKKGDVYS 119
+L+ K++DFG +R ++ + + T T Y E + + D++
Sbjct: 148 VLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG 207
Query: 120 FGVVFVGLLTGQKPIRSTDTEE--------DKSLAGYFLRAMKENCLFDMLDAQVLKEAK 171
G + + T ++ + S+ + L++ L+ ++ K
Sbjct: 208 AGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRK 267
Query: 172 EEEIITVAM-------LAKRCLNLNGRKRPTMKEV 199
++ + + L + L L+ +R +
Sbjct: 268 VKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.8 bits (230), Expect = 3e-23
Identities = 44/199 (22%), Positives = 77/199 (38%), Gaps = 33/199 (16%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+L+ E TE + E++ +V A+ + H+ + HRDIK
Sbjct: 85 VLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDE 139
Query: 63 NILLD-DKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQF-TKKGDVYSF 120
NIL+D ++ K+ DFG+ + T T GT Y E+ R ++ + V+S
Sbjct: 140 NILIDLNRGELKLIDFGSGAL--LKDTVYTDFD-GTRVYSPPEWIRYHRYHGRSAAVWSL 196
Query: 121 GVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAM 180
G++ ++ G P + ++ F +V E +
Sbjct: 197 GILLYDMVCGDIPFEHDE------------EIIRGQVFF---RQRVSSECQH-------- 233
Query: 181 LAKRCLNLNGRKRPTMKEV 199
L + CL L RPT +E+
Sbjct: 234 LIRWCLALRPSDRPTFEEI 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 93.0 bits (230), Expect = 5e-23
Identities = 34/206 (16%), Positives = 65/206 (31%), Gaps = 24/206 (11%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
++V E + + + + + L +A ++ + Y+HS HRD+K
Sbjct: 79 VMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPD 132
Query: 63 NIL---LDDKFRAKISDFGASRYVTIDQTH------LTTRVQGTFGYLDLEYFRSSQFTK 113
N L I DFG ++ +TH + GT Y + + ++
Sbjct: 133 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSR 192
Query: 114 KGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEE 173
+ D+ S G V + G K + K + ++L E
Sbjct: 193 RDDLESLGYVLMYFNLG-SLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFAT- 250
Query: 174 EIITVAMLAKRCLNLNGRKRPTMKEV 199
C +L +P +
Sbjct: 251 -------YLNFCRSLRFDDKPDYSYL 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 93.2 bits (231), Expect = 5e-23
Identities = 48/198 (24%), Positives = 82/198 (41%), Gaps = 27/198 (13%)
Query: 5 VYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANI 64
+ ++I G L+ + ++ A EV AL YLHS I +RD+K NI
Sbjct: 82 IMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENI 135
Query: 65 LLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVF 124
LLD KI+DFG ++YV +T + GT Y+ E + + K D +SFG++
Sbjct: 136 LLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILI 191
Query: 125 VGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKR 184
+L G P ++T + + + + F ++ K+ L R
Sbjct: 192 YEMLAGYTPFYDSNTMK------TYEKILNAELRF---PPFFNEDVKD--------LLSR 234
Query: 185 CLNLNGRKRPTMKEVAFE 202
+ + +R + E
Sbjct: 235 LITRDLSQRLGNLQNGTE 252
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.9 bits (230), Expect = 5e-23
Identities = 45/200 (22%), Positives = 83/200 (41%), Gaps = 25/200 (12%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L+ E + G L+ ++ ++ ++T E + ++ L+ ++ S+ I H D+K N
Sbjct: 90 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQI---LNGVYYLHSLQIAHFDLKPEN 143
Query: 64 ILLDD----KFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYS 119
I+L D K R KI DFG + ID + + GT ++ E + D++S
Sbjct: 144 IMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 201
Query: 120 FGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVA 179
GV+ LL+G P +E + D + AK+
Sbjct: 202 IGVITYILLSGASPFLGDTKQET-----LANVSAVNYEFEDEYFSNTSALAKD------- 249
Query: 180 MLAKRCLNLNGRKRPTMKEV 199
+R L + +KR T+++
Sbjct: 250 -FIRRLLVKDPKKRMTIQDS 268
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.9 bits (227), Expect = 1e-22
Identities = 35/208 (16%), Positives = 68/208 (32%), Gaps = 17/208 (8%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV+EF+ + ++ L++ HS + HRD+K N
Sbjct: 78 LVFEFLHQDLKKFMDASALTGIP--LPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQN 132
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
+L++ + K++DFG +R + T V + ++ D++S G +
Sbjct: 133 LLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 192
Query: 124 FVGLLTGQKP------------IRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAK 171
F ++T + I T D+ + F Q +
Sbjct: 193 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 252
Query: 172 EEEIITVAMLAKRCLNLNGRKRPTMKEV 199
L + L+ + KR + K
Sbjct: 253 PPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (227), Expect = 2e-22
Identities = 40/216 (18%), Positives = 74/216 (34%), Gaps = 24/216 (11%)
Query: 1 VPLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60
+ + + LY+ + Q ++ + ++ L Y+HS + HRD+K
Sbjct: 84 KDVYLVTHLMGADLYKLLKTQH----LSNDHICYFLYQILRGLKYIHS---ANVLHRDLK 136
Query: 61 SANILLDDKFRAKISDFGASRYVTIDQTHLT--TRVQGTFGYLDLEYFRSSQ-FTKKGDV 117
+N+LL+ KI DFG +R D H T T Y E +S+ +TK D+
Sbjct: 137 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 196
Query: 118 YSFGVVFVGLLTGQKPIRSTDTEE--------------DKSLAGYFLRAMKENCLFDMLD 163
+S G + +L+ + + + L+A +
Sbjct: 197 WSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKN 256
Query: 164 AQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEV 199
L + L N KR +++
Sbjct: 257 KVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.8 bits (222), Expect = 1e-21
Identities = 50/199 (25%), Positives = 77/199 (38%), Gaps = 24/199 (12%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
V E+ G L+ ++ E T E + E+ AL YLHS + +RDIK N
Sbjct: 82 FVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLEN 135
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
++LD KI+DFG + D + T GT YL E + + + D + GVV
Sbjct: 136 LMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVV 194
Query: 124 FVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAK 183
++ G+ P + D E F + E F + EAK L
Sbjct: 195 MYEMMCGRLPFYNQDHER------LFELILMEEIRF---PRTLSPEAKS--------LLA 237
Query: 184 RCLNLNGRKRPTMKEVAFE 202
L + ++R +
Sbjct: 238 GLLKKDPKQRLGGGPSDAK 256
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 86.8 bits (214), Expect = 8e-21
Identities = 32/230 (13%), Positives = 66/230 (28%), Gaps = 26/230 (11%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
+LV + + + + A ++ + +H + +RDIK
Sbjct: 76 NVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKP 129
Query: 62 ANILLDDKFR-----AKISDFGASRYVTIDQT------HLTTRVQGTFGYLDLEYFRSSQ 110
N L+ + DFG ++ T + GT Y+ + +
Sbjct: 130 DNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE 189
Query: 111 FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEA 170
+++ D+ + G VF+ L G + K++ L A +E
Sbjct: 190 QSRRDDLEALGHVFMYFLRG-SLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEF 248
Query: 171 KEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNCEGIDF 220
+ NL P + + + E D+
Sbjct: 249 YK--------YMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 290
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 86.4 bits (213), Expect = 2e-20
Identities = 39/223 (17%), Positives = 78/223 (34%), Gaps = 38/223 (17%)
Query: 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61
P LV+E + N + T+T E+ AL Y HS + I HRD+K
Sbjct: 107 PALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKP 157
Query: 62 ANILLDDKFR-AKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQ-FTKKGDVYS 119
N+++D + R ++ D+G + + Q + + + E Q + D++S
Sbjct: 158 HNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDYSLDMWS 215
Query: 120 FGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVA 179
G + ++ ++P D+ + + + L+D +D ++ I
Sbjct: 216 LGCMLASMIFRKEPFFHGHDNYDQLVR--IAKVLGTEDLYDYIDKYNIELDPRFNDILGR 273
Query: 180 M-----------------------LAKRCLNLNGRKRPTMKEV 199
+ L + + R T +E
Sbjct: 274 HSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.9 bits (209), Expect = 8e-20
Identities = 39/210 (18%), Positives = 82/210 (39%), Gaps = 25/210 (11%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV F+ GT + + + + ++ L Y+H+ I HRD+K N
Sbjct: 100 LVMPFM--GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGN 151
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
+ +++ KI DFG +R + +T V + ++T+ D++S G +
Sbjct: 152 LAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCI 208
Query: 124 FVGLLTGQKPIRSTDTEE--------DKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEI 175
++TG+ + +D + + F++ ++ + + + E K+
Sbjct: 209 MAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS 268
Query: 176 ITVAM------LAKRCLNLNGRKRPTMKEV 199
I L ++ L L+ +R T E
Sbjct: 269 ILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 4e-18
Identities = 52/201 (25%), Positives = 80/201 (39%), Gaps = 21/201 (10%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
L+ ++I G L+ ++ + T E+ AL +LH + I +RDIK N
Sbjct: 106 LILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLEN 159
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQ--FTKKGDVYSFG 121
ILLD ++DFG S+ D+T GT Y+ + R K D +S G
Sbjct: 160 ILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG 219
Query: 122 VVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAML 181
V+ LLTG P E S A R +K + ++ AK+ L
Sbjct: 220 VLMYELLTGASPFTVDG--EKNSQAEISRRILKSEPPY---PQEMSALAKD--------L 266
Query: 182 AKRCLNLNGRKRPTMKEVAFE 202
+R L + +KR +
Sbjct: 267 IQRLLMKDPKKRLGCGPRDAD 287
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 78.7 bits (193), Expect = 1e-17
Identities = 34/190 (17%), Positives = 71/190 (37%), Gaps = 27/190 (14%)
Query: 5 VYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANI 64
V E++ G ++ ++ + + A ++ YLHS + + +RD+K N+
Sbjct: 119 VMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENL 172
Query: 65 LLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVF 124
L+D + +++DFG ++ T + GT L E S + K D ++ GV+
Sbjct: 173 LIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228
Query: 125 VGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKR 184
+ G P + + + + + K+ L +
Sbjct: 229 YEMAAGYPPFFADQPIQ--------IYEKIVSGKVRFPS-HFSSDLKD--------LLRN 271
Query: 185 CLNLNGRKRP 194
L ++ KR
Sbjct: 272 LLQVDLTKRF 281
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.2 bits (181), Expect = 4e-16
Identities = 43/221 (19%), Positives = 73/221 (33%), Gaps = 36/221 (16%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
LV E + + E + ++ + +LHS I HRD+K +N
Sbjct: 99 LVMELMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAGII---HRDLKPSN 149
Query: 64 ILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVV 123
I++ KI DFG +R T + + T T Y E + + D++S G +
Sbjct: 150 IVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 207
Query: 124 FVGLLTGQKP---------------IRSTDTEEDKSLAGYFLRAMKEN------CLFDML 162
++ + T E +R EN F L
Sbjct: 208 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267
Query: 163 DAQVLKEAKEEEIITVAMLAK----RCLNLNGRKRPTMKEV 199
L A E A A+ + L ++ KR ++ +
Sbjct: 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.5 bits (174), Expect = 5e-15
Identities = 37/211 (17%), Positives = 76/211 (36%), Gaps = 24/211 (11%)
Query: 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSA 62
+ + + L + Q +T + + ++ L Y+HS I HRD+K +
Sbjct: 98 VYLVTHLMGADLNNIVKCQK----LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPS 150
Query: 63 NILLDDKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122
N+ +++ KI DFG +R+ +T V + + + D++S G
Sbjct: 151 NLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 207
Query: 123 VFVGLLTGQKPIRSTDTEE--------DKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEE 174
+ LLTG+ TD + + L+ + + + +
Sbjct: 208 IMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA 267
Query: 175 IITVAM------LAKRCLNLNGRKRPTMKEV 199
+ + L ++ L L+ KR T +
Sbjct: 268 NVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 67.4 bits (163), Expect = 1e-13
Identities = 39/233 (16%), Positives = 74/233 (31%), Gaps = 43/233 (18%)
Query: 4 LVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSAN 63
+V F G + + E I +I+ ++ L Y+H I H DIK N
Sbjct: 99 VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGII--HTDIKPEN 156
Query: 64 ILLD------DKFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDV 117
+L++ + + KI+D G + + T+ T Y E + + D+
Sbjct: 157 VLMEIVDSPENLIQIKIADLGNACWYDEHYTN----SIQTREYRSPEVLLGAPWGCGADI 212
Query: 118 YSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK-------------------ENCL 158
+S + L+TG + + + ++ N
Sbjct: 213 WSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSR 272
Query: 159 FDMLDAQVLKEAKEEEIITVAM------------LAKRCLNLNGRKRPTMKEV 199
+ + LK E+++T L L+ RKR +
Sbjct: 273 GLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 44.0 bits (103), Expect = 4e-06
Identities = 12/71 (16%), Positives = 25/71 (35%), Gaps = 4/71 (5%)
Query: 11 NGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF 70
+ + D E + + E + + ++ + I H D+ N+L+ +
Sbjct: 84 GNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSE-E 139
Query: 71 RAKISDFGASR 81
I DF S
Sbjct: 140 GIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 253 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.53 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.92 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 94.58 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.35 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 91.82 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 87.66 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=287.40 Aligned_cols=193 Identities=24% Similarity=0.411 Sum_probs=148.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|||||+||+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT 152 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred EEEEEecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEcccccee
Confidence 4899999999999999976433 5999999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCc-ceeeeccccccccccchhccC---CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 82 YVTIDQT-HLTTRVQGTFGYLDLEYFRSS---QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 82 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
....... .......||+.|+|||++.+. .++.++|||||||++|||+||..||.+...... .........
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~~~ 226 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGY 226 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHHTS
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCC
Confidence 6643222 223445789999999999643 478899999999999999999999987554321 111111111
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
.... ....+...+..+.+++.+||+.||.+|||+++|+++|+.+.++.
T Consensus 227 ~~p~-----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 227 LSPD-----LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CCCC-----GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCc-----chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 1100 11122334457889999999999999999999999999988764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-44 Score=282.58 Aligned_cols=187 Identities=26% Similarity=0.422 Sum_probs=139.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~ 149 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR 149 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred eEEEEEecCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchhe
Confidence 4899999999999999876432 5899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............||+.|+|||++.+..++.++|||||||++|||+| |.+||......+. ......+..
T Consensus 150 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~-------~~~i~~~~~-- 220 (263)
T d1sm2a_ 150 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-------VEDISTGFR-- 220 (263)
T ss_dssp ---------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH-------HHHHHHTCC--
T ss_pred eccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHhcCC--
Confidence 765443333344568999999999999999999999999999999999 4566654433221 111111111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
...+...+..+.+++.+||+.||.+|||+++|+++|+++.++
T Consensus 221 -------~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 221 -------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 111222345688899999999999999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=279.32 Aligned_cols=175 Identities=29% Similarity=0.416 Sum_probs=144.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+|||||++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~ 154 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV 154 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred EEEEEeecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceee
Confidence 489999999999999998754 5999999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+. ...+.....
T Consensus 155 ~~~~~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------~~~i~~~~~--- 221 (263)
T d2j4za1 155 HAPSS---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-------YKRISRVEF--- 221 (263)
T ss_dssp CCCCC---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTTCC---
T ss_pred ecCCC---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCC---
Confidence 65322 23446799999999999998899999999999999999999999977654321 111111111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+|||++|++++
T Consensus 222 -------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 222 -------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 1112234568889999999999999999999863
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-43 Score=283.03 Aligned_cols=187 Identities=20% Similarity=0.391 Sum_probs=141.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+|||||++|+|.+++..... .+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccce
Confidence 4899999999999998876432 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcce----eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 82 YVTIDQTHL----TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 82 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
......... .....+|+.|+|||.+.+..++.++|||||||++|||+| |..||.+....+. ...+..+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~-------~~~i~~~ 249 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV-------INAIEQD 249 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHTT
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcC
Confidence 664332211 112347889999999998899999999999999999998 8999987654331 1111111
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
.. ...+...+..+.+++.+||+.||.+|||+++|++.|+++...
T Consensus 250 ~~---------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 250 YR---------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CC---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CC---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 11 111223445788899999999999999999999999987654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=279.88 Aligned_cols=181 Identities=25% Similarity=0.385 Sum_probs=143.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+|||||+||+|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT 151 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEeccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhhe
Confidence 489999999999999997644 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCc-ceeeeccccccccccchhccCCC-CCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQT-HLTTRVQGTFGYLDLEYFRSSQF-TKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
....... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.......... .........
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~------~~~~~~~~~ 225 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTY 225 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH------HHHHTTCTT
T ss_pred eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH------HHHhcCCCC
Confidence 7643322 22344679999999999988776 578999999999999999999997654322111 111111111
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ......+..+.+++.+||+.||.+|||++|++++
T Consensus 226 ~--------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 226 L--------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp S--------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C--------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 0111233467889999999999999999999753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-43 Score=279.41 Aligned_cols=179 Identities=24% Similarity=0.380 Sum_probs=145.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+|||||+||+|.+++... .+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||+++
T Consensus 92 ~~ivmEy~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp EEEEEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhhe
Confidence 48999999999999988754 4999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......||+.|+|||++.+..++.++||||+||++|+|++|..||.+...... +......... ..
T Consensus 165 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~~~~~-~~ 236 (293)
T d1yhwa1 165 QITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTP-EL 236 (293)
T ss_dssp ECCSTT-CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSC-CC
T ss_pred eecccc-ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH------HHHHHhCCCC-CC
Confidence 764322 233445799999999999998999999999999999999999999976554321 1122222111 11
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+...+..+.+++.+||+.||.+|||++|++++
T Consensus 237 -------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 237 -------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp -------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred -------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112234568899999999999999999999854
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=280.57 Aligned_cols=188 Identities=25% Similarity=0.370 Sum_probs=151.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||+++|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~ 157 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSK 157 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhh
Confidence 4899999999999999865432 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcce--eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHL--TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
......... .....||+.|+|||++.+..++.++|||||||++|||+| |..||......+. ...+..+..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~-------~~~i~~~~~ 230 (285)
T d1u59a_ 158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------MAFIEQGKR 230 (285)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-------HHHHHTTCC
T ss_pred cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCC
Confidence 765433222 223457899999999998899999999999999999998 8999987654321 111222111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
. ..+...+..+.+++.+||+.||.+|||+.+|++.|+....+.
T Consensus 231 ~---------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 231 M---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp C---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C---------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1 122234457889999999999999999999999998876654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=279.25 Aligned_cols=184 Identities=26% Similarity=0.370 Sum_probs=148.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 82 ~~lvmE~~~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~ 155 (277)
T d1xbba_ 82 WMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK 155 (277)
T ss_dssp EEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEcCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhh
Confidence 479999999999999998754 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcce--eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHL--TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
......... .....||+.|+|||.+.+..++.++|||||||++|||++ |..||.+....+. ...+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~-------~~~i~~~~~ 228 (277)
T d1xbba_ 156 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-------TAMLEKGER 228 (277)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTCC
T ss_pred hccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH-------HHHHHcCCC
Confidence 765433222 223568899999999998899999999999999999998 8999987654331 111221111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhch
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 207 (253)
...+...+..+.+++.+||+.||.+|||+++|++.|+...
T Consensus 229 ---------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 229 ---------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 1112233457889999999999999999999999887654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-43 Score=284.03 Aligned_cols=185 Identities=22% Similarity=0.417 Sum_probs=148.0
Q ss_pred CEEEEeecCCCChhHHhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE--------------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKS 61 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~ 61 (253)
.|+|||||+||+|.+++..... ...+++..++.++.|++.||.|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 5899999999999999976432 124899999999999999999999999 99999999
Q ss_pred CceeecCCCceEEcccCCcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCCh
Q 044510 62 ANILLDDKFRAKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDT 139 (253)
Q Consensus 62 ~nili~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~ 139 (253)
+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |..||.+...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876543332 2234557999999999999999999999999999999998 8999987554
Q ss_pred hhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 044510 140 EEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELG 204 (253)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 204 (253)
... +......... ...+...+..+.+++.+||+.||.+|||++||+++|.
T Consensus 273 ~~~------~~~~~~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DAN------FYKLIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHH------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH------HHHHHhcCCC---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 321 1122222211 1112233457889999999999999999999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-43 Score=278.16 Aligned_cols=187 Identities=20% Similarity=0.371 Sum_probs=147.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++..... ..+++..+++++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLAR 157 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceE
Confidence 4899999999999998765432 24899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCC-CCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKP-IRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............|++.|+|||++.+..++.++|||||||++|||+||..| |......+ ....+.....
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-------~~~~i~~~~~-- 228 (272)
T d1qpca_ 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------VIQNLERGYR-- 228 (272)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC--
T ss_pred EccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHhcCC--
Confidence 7654433333445688999999999988899999999999999999996554 44433222 1111111111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRA 208 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 208 (253)
...+...+..+.+++.+||+.||.+|||+++|++.|+.+..
T Consensus 229 -------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 229 -------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 11122334468889999999999999999999999987654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-42 Score=278.13 Aligned_cols=187 Identities=23% Similarity=0.358 Sum_probs=149.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred eEEEeecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcccccee
Confidence 4899999999999999976432 35999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCC-CCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIR-STDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............|++.|+|||++.+..++.++|||||||++|||++|..||. ...... .......+.
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-------~~~~i~~~~--- 233 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDY--- 233 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHTTC---
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-------HHHHHhcCC---
Confidence 765444333444557889999999999999999999999999999999766653 333221 111222211
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRA 208 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 208 (253)
....+...+..+.+++.+||+.||.+|||++++++.|+.+..
T Consensus 234 ------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 234 ------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111223344578899999999999999999999999987654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=279.16 Aligned_cols=184 Identities=26% Similarity=0.372 Sum_probs=135.9
Q ss_pred CEEEEeecCCCChhHHhhccC-CCCCCCHHHHHHHHHHHHHHHHhHhhCCC--CCeEecCCCCCceeecCCCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT-EEFTITWEISLRIAVEVSGALSYLHSTTS--IPIYHRDIKSANILLDDKFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--~~i~H~dl~~~nili~~~~~~kl~Dfg 78 (253)
.|+|||||+||+|.+++.... ....+++..++.++.|++.||.|||+++. .+|+||||||+||+++.++.+||+|||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 379999999999999987532 22359999999999999999999998541 239999999999999999999999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......+. ...+.....
T Consensus 160 ~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~-------~~~i~~~~~ 231 (269)
T d2java1 160 LARILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-------AGKIREGKF 231 (269)
T ss_dssp HHHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHTCC
T ss_pred ceeecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH-------HHHHHcCCC
Confidence 998764322 223446789999999999988999999999999999999999999987654321 111222211
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.. .+...+..+.+++.+||+.||.+|||+.|++++
T Consensus 232 ~~---------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 232 RR---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11 122334578899999999999999999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=279.83 Aligned_cols=190 Identities=25% Similarity=0.384 Sum_probs=144.3
Q ss_pred CEEEEeecCCCChhHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
.++|||||++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECC
Confidence 4899999999999999975321 224899999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhC-CCCCCCCChhhhhhhH
Q 044510 69 KFRAKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTG-QKPIRSTDTEEDKSLA 146 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg-~~pf~~~~~~~~~~~~ 146 (253)
++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++| ..||......+.
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~---- 245 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---- 245 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH----
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH----
Confidence 999999999999865433222 22345689999999999999999999999999999999986 567866543221
Q ss_pred HHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 147 GYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
+......+... ..+...+..+.+++.+||+.||.+|||+++++++|+.+..+
T Consensus 246 --~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 246 --FCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp --HHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHhcCCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11122222111 11223345688899999999999999999999999987643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-42 Score=272.61 Aligned_cols=179 Identities=23% Similarity=0.396 Sum_probs=141.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec-CCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD-DKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~-~~~~~kl~Dfgl~ 80 (253)
.|+||||+++|+|.+++.+.. .+++..+..++.||+.||.|||+++ .+|+||||||+|||++ .++.+||+|||++
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEEeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 379999999999999998764 5999999999999999999999876 3389999999999997 5789999999999
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
+.... .......||+.|+|||++.+ +++.++|||||||++|+|++|..||........ .......+....
T Consensus 163 ~~~~~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~------~~~~i~~~~~~~ 232 (270)
T d1t4ha_ 163 TLKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPA 232 (270)
T ss_dssp GGCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCG
T ss_pred eeccC---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH------HHHHHHcCCCCc
Confidence 75432 23345679999999999874 699999999999999999999999976443221 112222211111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. .+...++.+.+++.+||+.||.+|||+.|++++
T Consensus 233 ~--------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 233 S--------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp G--------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred c--------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1 111223458889999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-42 Score=279.05 Aligned_cols=192 Identities=24% Similarity=0.413 Sum_probs=142.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhh-CCCCCeEecCCCCCceeecCCCceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS-TTSIPIYHRDIKSANILLDDKFRAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~ 80 (253)
.|+||||++||+|.+++.+.. .+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||++
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla 152 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 152 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred EEEEEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCc
Confidence 489999999999999998764 59999999999999999999997 48 999999999999999999999999999
Q ss_pred ccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHH-HHHHHhh----
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGY-FLRAMKE---- 155 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~-~~~~~~~---- 155 (253)
+.... ......+||+.|+|||++.+..|+.++||||+||++|+|++|+.||......+....... .......
T Consensus 153 ~~~~~---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 153 GQLID---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229 (322)
T ss_dssp HHHHH---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred cccCC---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcc
Confidence 86532 122346799999999999999999999999999999999999999987654322111000 0000000
Q ss_pred ---------------cc---ccchhchhhh----hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 156 ---------------NC---LFDMLDAQVL----KEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 156 ---------------~~---~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.. .......... .......+..+.+++.+||+.||.+|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00 0000000000 00001124578899999999999999999999985
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=274.02 Aligned_cols=187 Identities=23% Similarity=0.362 Sum_probs=141.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEEEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhe
Confidence 4899999999999998776432 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............+|+.|+|||.+.+..++.++|||||||++|||++ |..||......+.. .....+...
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~-------~~i~~~~~~- 228 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-------GRIENGERL- 228 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTCCC-
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH-------HHHHcCCCC-
Confidence 765444434445668999999999999999999999999999999998 89999876654321 111111111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
..+...+..+.+++.+||+.||.+|||+.+|+++|+.+...
T Consensus 229 --------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 229 --------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11223345788999999999999999999999999987654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=271.37 Aligned_cols=181 Identities=22% Similarity=0.282 Sum_probs=142.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+|||||+||+|.+++.+... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhh
Confidence 4799999999999999876432 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhc-----cCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFR-----SSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKEN 156 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 156 (253)
..... ........||+.|+|||++. +..|+.++||||+||++|+|++|..||......+. +.......
T Consensus 159 ~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~~~i~~~~ 231 (288)
T d2jfla1 159 KNTRT-IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKIAKSE 231 (288)
T ss_dssp ECHHH-HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHHSC
T ss_pred ccCCC-cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------HHHHHcCC
Confidence 54321 11223456899999999984 44578999999999999999999999987655432 11112211
Q ss_pred cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 157 CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ... ..+...+..+.+++.+||+.||.+|||++|++++
T Consensus 232 ~-~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 232 P-PTL-------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp C-CCC-------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred C-CCC-------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 111 1112234578899999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-42 Score=268.78 Aligned_cols=184 Identities=24% Similarity=0.389 Sum_probs=149.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++|+|.+++..... .+++..+++++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~ 148 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSR 148 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred eEEEEEccCCCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhhe
Confidence 3799999999999999776433 5899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............+|+.|+|||.+.+..++.++|||||||++|||+| |..||......+. ...+.....
T Consensus 149 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~-------~~~i~~~~~-- 219 (258)
T d1k2pa_ 149 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-------AEHIAQGLR-- 219 (258)
T ss_dssp BCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-------HHHHHTTCC--
T ss_pred eccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH-------HHHHHhCCC--
Confidence 665444434444568999999999999999999999999999999998 8999987665432 111222111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
...+...+..+.+++.+||+.||.+|||+++|+++|..+
T Consensus 220 -------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 220 -------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -------CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 111222335788999999999999999999999998653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-41 Score=274.45 Aligned_cols=180 Identities=25% Similarity=0.361 Sum_probs=134.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec---CCCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD---DKFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~---~~~~~kl~Dfg 78 (253)
.|+|||||+||+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||++. .++.+||+|||
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG 155 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFG 155 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-
T ss_pred EEEEEeccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccc
Confidence 489999999999999998654 5999999999999999999999999 99999999999995 47889999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
+++..... .......||+.|+|||++.+..++.++||||+||++|+|++|..||.+....+. ..........
T Consensus 156 ~a~~~~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i~~~~~~ 227 (307)
T d1a06a_ 156 LSKMEDPG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL------FEQILKAEYE 227 (307)
T ss_dssp -------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHTTCCC
T ss_pred eeEEccCC--CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH------HHHHhccCCC
Confidence 99865432 223346799999999999998999999999999999999999999987554321 1111211111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. .. ......+..+.+++.+||+.||.+|||++|++++
T Consensus 228 ~---~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 F---DS----PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp C---CT----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C---CC----ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1 00 1112234568899999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-42 Score=275.22 Aligned_cols=178 Identities=25% Similarity=0.394 Sum_probs=142.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+|||||+||+|.+++...+ .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~ 156 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAK 156 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccce
Confidence 489999999999999988765 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCC-cceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQ-THLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
...... ........||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+. +....... .
T Consensus 157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i~~~~-~-- 227 (288)
T d1uu3a_ 157 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI------FQKIIKLE-Y-- 227 (288)
T ss_dssp ECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHTTC-C--
T ss_pred ecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH------HHHHHcCC-C--
Confidence 764332 2223345799999999999999999999999999999999999999987654321 11111111 1
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..+...+..+.++|.+||+.||.+|||++|++++
T Consensus 228 --------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 --------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp --------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred --------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1122334568899999999999999999987654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=268.76 Aligned_cols=187 Identities=20% Similarity=0.349 Sum_probs=141.2
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+.++++.+++..... .+++..+++++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhh
Confidence 4799999999999998876433 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcc--eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCC-CChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTH--LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRS-TDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
........ ......||+.|+|||++.+..++.++|||||||++|||+++..|+.. ....+ ....+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-------~~~~i~~~~- 230 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDGF- 230 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTC-
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-------HHHHHhccC-
Confidence 76433221 12234578999999999999999999999999999999996555433 32221 112222211
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
....+...+..+.+++.+||+.||.+|||+.+|++.|+++...
T Consensus 231 --------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 231 --------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp --------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1112223445688999999999999999999999999987654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=270.04 Aligned_cols=191 Identities=21% Similarity=0.340 Sum_probs=143.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|..++..... ..+++..++.++.||+.||.|||..+ ++||||||+||+++.++.+||+|||+++
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~ 161 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR 161 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred eEEEEEecCCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhh
Confidence 3799999999999998876422 24999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCC-CCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPI-RSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..............+++.|+|||++.+..++.++|||||||++|||++|..|+ ......+. ...+......
T Consensus 162 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~-------~~~i~~~~~~- 233 (285)
T d1fmka3 162 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------LDQVERGYRM- 233 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTCCC-
T ss_pred hccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHH-------HHHHHhcCCC-
Confidence 76544433444466899999999999999999999999999999999965554 43332221 1111111111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCC
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGP 212 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 212 (253)
..+...+..+.+++.+||+.||.+||++++|+++|+....+..+
T Consensus 234 --------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 234 --------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred --------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 11223345688999999999999999999999999987766443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=270.32 Aligned_cols=177 Identities=25% Similarity=0.321 Sum_probs=146.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~ 153 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 153 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred cccceeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccc
Confidence 489999999999999998765 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... .......+||+.|+|||++.+..|+.++|+||+||++|+|++|..||.+.+..+. .........
T Consensus 154 ~~~~~-~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-------~~~i~~~~~--- 222 (337)
T d1o6la_ 154 EGISD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-------FELILMEEI--- 222 (337)
T ss_dssp CSCCT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC---
T ss_pred ccccC-CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH-------HHHHhcCCC---
Confidence 65432 2233446799999999999999999999999999999999999999987665331 111111111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT-----MKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~~ 202 (253)
..+...+..+.++|.+||+.||.+|++ +.+++++
T Consensus 223 -------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 -------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 112234456889999999999999995 8888875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.9e-41 Score=273.72 Aligned_cols=181 Identities=19% Similarity=0.277 Sum_probs=144.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec--CCCceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD--DKFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~--~~~~~kl~Dfgl 79 (253)
.|+|||||+||+|.+++..... .+++..+..++.||+.||.|||+.| |+||||||+||+++ .++.+||+|||+
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEEcCCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecch
Confidence 4899999999999999965432 5999999999999999999999999 99999999999996 457899999999
Q ss_pred cccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
++..... .......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+. +..........
T Consensus 173 a~~~~~~--~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~~~~~ 244 (350)
T d1koaa2 173 TAHLDPK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKSCDWNM 244 (350)
T ss_dssp CEECCTT--SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTCCCS
T ss_pred heecccc--cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCCC
Confidence 9876432 233446789999999999998999999999999999999999999987654321 11111111110
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... .....+..+.++|.+||+.||.+|||++|++++
T Consensus 245 ---~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 ---DDS----AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---CCG----GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---Ccc----cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 111233468889999999999999999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-41 Score=272.58 Aligned_cols=186 Identities=27% Similarity=0.327 Sum_probs=144.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC---CCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD---KFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~---~~~~kl~Dfg 78 (253)
.|+|||||+||+|.+++...+. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++. .+.+||+|||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 4899999999999999986432 25999999999999999999999999 999999999999985 4579999999
Q ss_pred CcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 79 ASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 79 l~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
+++...... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+......... +.....
T Consensus 160 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-------~~~~i~ 230 (335)
T d2ozaa1 160 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-------MKTRIR 230 (335)
T ss_dssp TCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCC
T ss_pred eeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-------HHHHHh
Confidence 998664322 23445799999999999988999999999999999999999999976543221100 000000
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..... .........+..+.+++.+||+.||.+|||+.|++++
T Consensus 231 ~~~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 231 MGQYE--FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SCSSS--CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCCC--CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00000 0011122345678999999999999999999999885
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=267.62 Aligned_cols=189 Identities=25% Similarity=0.393 Sum_probs=152.3
Q ss_pred CEEEEeecCCCChhHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTE-------------EFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
.|+||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTE 170 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECT
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecC
Confidence 4899999999999999975431 235899999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhH
Q 044510 69 KFRAKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLA 146 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~ 146 (253)
++.+||+|||+++........ ......+++.|+|||.+.++.|+.++|||||||++|+|++ |..||.......
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~----- 245 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 245 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-----
Confidence 999999999999866543322 2233568899999999999999999999999999999998 788887655432
Q ss_pred HHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 147 GYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
....+..+... ..+...+..+.+++.+||+.||.+|||+.||++.|+++.+.
T Consensus 246 --~~~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 246 --LFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp --HHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 12222222111 11222345688999999999999999999999999988653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-40 Score=272.76 Aligned_cols=181 Identities=23% Similarity=0.298 Sum_probs=145.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec--CCCceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD--DKFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~--~~~~~kl~Dfgl 79 (253)
.|+|||||+||+|.+++..... ++++..++.++.||+.||.|||+.| |+||||||+|||++ .++.+||+|||+
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGl 175 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGL 175 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEEEEcCCCChHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeeccc
Confidence 4899999999999998876432 5999999999999999999999999 99999999999997 578999999999
Q ss_pred cccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
++..... .......||+.|+|||++.+..++.++||||+||++|+|++|..||.+....+. +..........
T Consensus 176 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~~~~ 247 (352)
T d1koba_ 176 ATKLNPD--EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKRCDWEF 247 (352)
T ss_dssp CEECCTT--SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHHCCCCC
T ss_pred ceecCCC--CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCCC
Confidence 9876532 233446789999999999999999999999999999999999999987654331 11111111110
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. .......+..+.++|.+||+.||.+|||+.|++++
T Consensus 248 ---~----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 ---D----EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ---C----SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---C----cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 01112234468889999999999999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-41 Score=270.67 Aligned_cols=175 Identities=21% Similarity=0.273 Sum_probs=140.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+|||||.+|+|..++.... ++++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~ 163 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS 163 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred EEEEEEecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeeccccc
Confidence 489999999999987766543 5999999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCcceeeeccccccccccchhcc---CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS---SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
.... .....||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+....+. +....... .
T Consensus 164 ~~~~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~------~~~i~~~~-~ 231 (309)
T d1u5ra_ 164 IMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNE-S 231 (309)
T ss_dssp SSSS-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSC-C
T ss_pred ccCC-----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhCC-C
Confidence 5432 234569999999999864 3588999999999999999999999976544321 11112111 1
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.... +...+..+.+++.+||+.||.+|||+++++++
T Consensus 232 ~~~~--------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 232 PALQ--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CCCS--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCC--------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1111 11223468889999999999999999999863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-41 Score=264.14 Aligned_cols=184 Identities=22% Similarity=0.418 Sum_probs=143.3
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+++|+|.+++..... ..+++..+++++.||+.||.|||+.+ ++||||||+||+++.++.+|++|||+++
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 151 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred EEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccce
Confidence 4899999999999999976421 14899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..... .....+++.|+|||.+.+..++.++|||||||++|||+| |..||......+. ...+..+..
T Consensus 152 ~~~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~-------~~~i~~~~~-- 218 (262)
T d1byga_ 152 EASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKGYK-- 218 (262)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-------HHHHTTTCC--
T ss_pred ecCCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHcCCC--
Confidence 64322 223457889999999998899999999999999999998 7888876544331 111111111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
...+...+..+.+++.+||+.||.+|||+.+++++|++++..
T Consensus 219 -------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 219 -------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 122233345788999999999999999999999999988754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.8e-40 Score=270.51 Aligned_cols=178 Identities=22% Similarity=0.297 Sum_probs=143.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+|||||+||+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceee
Confidence 489999999999999998765 5899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
..... ......||+.|+|||++.. ..++.++|||||||++|+|++|..||.......... .........
T Consensus 156 ~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----~~~~~~~~~--- 225 (364)
T d1omwa3 156 DFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTMA--- 225 (364)
T ss_dssp ECSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH----HHHHSSSCC---
T ss_pred ecCCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcccCC---
Confidence 66432 2334569999999999974 468999999999999999999999998755433111 111111100
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPT-----MKEVAFE 202 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~~ 202 (253)
...+...+..+.++|.+||+.||.+||| +++++++
T Consensus 226 -------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 226 -------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 0111223456889999999999999999 7888875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=264.81 Aligned_cols=180 Identities=24% Similarity=0.369 Sum_probs=144.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC----ceEEccc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF----RAKISDF 77 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~----~~kl~Df 77 (253)
.|+|||||+||+|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++ .+|++||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence 389999999999999998764 5999999999999999999999999 99999999999998766 5999999
Q ss_pred CCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 78 GASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 78 gl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
|+++..... .......+++.|+|||++.+..++.++||||+||++|+|++|..||.+....+. +........
T Consensus 162 G~a~~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i~~~~~ 233 (293)
T d1jksa_ 162 GLAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANVSAVNY 233 (293)
T ss_dssp TTCEECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHTTCC
T ss_pred hhhhhcCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH------HHHHHhcCC
Confidence 999866432 223345689999999999988899999999999999999999999987654331 111111111
Q ss_pred ccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 LFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ... ..+...+..+.++|.+||+.||.+|||++|++++
T Consensus 234 ~---~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 E---FED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp C---CCH----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C---CCc----hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 011 1112234568899999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.4e-40 Score=260.27 Aligned_cols=187 Identities=26% Similarity=0.397 Sum_probs=143.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+||||++|++|.+++...+ .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++..+++|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 589999999999999988765 5999999999999999999999999 9999999999999999999999999876
Q ss_pred cccCCC--cceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQ--THLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
...... ........||+.|+|||++.+..++.++||||+||++|+|++|..||......+ ............
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcCCCC
Confidence 543222 122344578999999999998889999999999999999999999998765432 122222222111
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhch
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-TMKEVAFELGGIR 207 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-s~~~l~~~l~~~~ 207 (253)
. .......+..+.++|.+||+.||.+|| |++++++.|.+++
T Consensus 234 ~-------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 P-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp G-------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred C-------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1 111122345688899999999999998 8999999888764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-40 Score=268.27 Aligned_cols=186 Identities=23% Similarity=0.438 Sum_probs=147.9
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
++++||+.+|+|.+.+..... .+++..+++++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred eEEEEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeecccccee
Confidence 688999999999998877533 5999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCcce-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccccc
Q 044510 83 VTIDQTHL-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCLFD 160 (253)
Q Consensus 83 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (253)
........ .....||+.|+|||++.++.++.++|||||||++|||+| |..||......+.. .....+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-------~~i~~~~~-- 231 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGER-- 231 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-------HHHHHTCC--
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-------HHHHcCCC--
Confidence 65433222 233468999999999999999999999999999999998 88999776544321 11111111
Q ss_pred hhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 161 MLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
...+...+..+.+++.+||+.||.+|||+.+|+++|..+...
T Consensus 232 -------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 232 -------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp -------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 111223345688899999999999999999999999887643
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=262.43 Aligned_cols=185 Identities=24% Similarity=0.346 Sum_probs=146.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+++|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred hheeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhh
Confidence 3799999999999998876432 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcce--eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTHL--TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
......... .....++..|+|||.+.+..++.++||||||+++|||+| |..||.+....+. ..........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~------~~~i~~~~~~ 233 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEGER 233 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTSCCC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH------HHHHHhCCCC
Confidence 765433222 223457889999999999889999999999999999998 8999987655432 1111112111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGI 206 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 206 (253)
. ..+...+..+.+++.+||+.||.+|||+.+|++.|.+.
T Consensus 234 ~---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 L---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 11222334688999999999999999999999998764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-40 Score=265.85 Aligned_cols=187 Identities=20% Similarity=0.340 Sum_probs=147.2
Q ss_pred CEEEEeecCCCChhHHhhccC---------------------CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT---------------------EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIK 60 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~---------------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~ 60 (253)
.++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 479999999999999996422 1224889999999999999999999999 9999999
Q ss_pred CCceeecCCCceEEcccCCcccccCCCc-ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCC-CCCCCCC
Q 044510 61 SANILLDDKFRAKISDFGASRYVTIDQT-HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQ-KPIRSTD 138 (253)
Q Consensus 61 ~~nili~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~-~pf~~~~ 138 (253)
|+||+++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++|. +||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 9999999999999999999986543222 2223456789999999999999999999999999999999985 6777665
Q ss_pred hhhhhhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhch
Q 044510 139 TEEDKSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIR 207 (253)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 207 (253)
..+.. .....+... ..+...+..+.+++.+||+.||.+|||+.||+++|+++.
T Consensus 248 ~~e~~-------~~v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HEEVI-------YYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHH-------HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHH-------HHHHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 54321 112222111 122233456888999999999999999999999999874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-39 Score=263.10 Aligned_cols=174 Identities=27% Similarity=0.387 Sum_probs=143.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~ 152 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK 152 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred eeeEeeecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccce
Confidence 489999999999999998765 4889999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... .....||+.|+|||++.+..|+.++||||+||++|+|++|..||.+.+..+. ..........
T Consensus 153 ~~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~~~~~~--- 219 (316)
T d1fota_ 153 YVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKILNAELR--- 219 (316)
T ss_dssp ECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHCCCC---
T ss_pred Eeccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH------HHHHHcCCCC---
Confidence 75432 2346799999999999988999999999999999999999999987654331 1111111110
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
.+...+..+.+++.+||+.||.+|+ ++++++++
T Consensus 220 --------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 --------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1112334688899999999999996 89999876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-40 Score=265.10 Aligned_cols=188 Identities=23% Similarity=0.363 Sum_probs=148.5
Q ss_pred CEEEEeecCCCChhHHhhcc-------------CCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQ-------------TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD 68 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~ 68 (253)
.|+||||++||+|.+++... .....+++..++.++.||+.||.|||+.+ ++||||||+|||++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 162 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECG
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcC
Confidence 48999999999999999754 12336999999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCC-CCCCCCChhhhhhhHH
Q 044510 69 KFRAKISDFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQ-KPIRSTDTEEDKSLAG 147 (253)
Q Consensus 69 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~-~pf~~~~~~~~~~~~~ 147 (253)
++.+||+|||+++...... ......+|..|+|||.+.+..++.++|||||||++|||++|. .||...+..+.
T Consensus 163 ~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~----- 235 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----- 235 (309)
T ss_dssp GGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----
T ss_pred CCceEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH-----
Confidence 9999999999987543221 222345889999999999999999999999999999999965 56766554331
Q ss_pred HHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhc
Q 044510 148 YFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASI 210 (253)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 210 (253)
...+..+.. ...+...+..+.+++.+||+.||++|||+++|+++|+++....
T Consensus 236 --~~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 236 --YEKLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp --HHHGGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred --HHHHHhcCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 111211111 1122234457889999999999999999999999999987653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-40 Score=266.32 Aligned_cols=176 Identities=26% Similarity=0.330 Sum_probs=144.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||++||+|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||+++
T Consensus 78 ~yivmEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~ 151 (320)
T d1xjda_ 78 LFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 151 (320)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred eeEEEeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhh
Confidence 389999999999999998765 4899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
...... .......||+.|+|||++.+..++.++||||+||++|+|++|..||.+...... ...+.....
T Consensus 152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~-------~~~i~~~~~--- 220 (320)
T d1xjda_ 152 ENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-------FHSIRMDNP--- 220 (320)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC---
T ss_pred hccccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCCC---
Confidence 654322 233345799999999999999999999999999999999999999987654431 111111111
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMK-EVAF 201 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~-~l~~ 201 (253)
..+...+..+.++|.+||+.||.+||++. ++++
T Consensus 221 -------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 -------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11122345688999999999999999985 6765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=262.13 Aligned_cols=192 Identities=23% Similarity=0.389 Sum_probs=149.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|||||++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~lv~E~~~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~ 178 (311)
T d1r0pa_ 104 PLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR 178 (311)
T ss_dssp EEEEEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGC
T ss_pred eEEEEEEeecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchh
Confidence 4799999999999999876543 4788899999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcc---eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 82 YVTIDQTH---LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 82 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
........ ......||+.|+|||.+....++.++||||||+++|||++|..||....... ... .. ...+..
T Consensus 179 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~---~~-i~~g~~ 252 (311)
T d1r0pa_ 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DIT---VY-LLQGRR 252 (311)
T ss_dssp CTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CH---HH-HHTTCC
T ss_pred hccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHH---HH-HHcCCC
Confidence 66433221 1223457899999999998999999999999999999999888876533211 111 11 111111
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCC
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQ 213 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~ 213 (253)
. ..+...+..+.+++.+||+.||++||++.||+++|+++.......
T Consensus 253 ~---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 253 L---------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred C---------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 1 111223346888999999999999999999999999998765443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-39 Score=259.09 Aligned_cols=201 Identities=23% Similarity=0.291 Sum_probs=149.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhh--------CCCCCeEecCCCCCceeecCCCceE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS--------TTSIPIYHRDIKSANILLDDKFRAK 73 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~--------~~~~~i~H~dl~~~nili~~~~~~k 73 (253)
.|+||||+++|+|.+++.+. ++++..++.++.|++.||.|+|. .+ |+||||||+||+++.++.+|
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~---IvHrDlKp~NILl~~~~~~K 148 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCC 148 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred EEEEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---eeccccCccceEEcCCCCeE
Confidence 47999999999999999865 39999999999999999999996 36 99999999999999999999
Q ss_pred EcccCCcccccCCCcc---eeeeccccccccccchhccCC------CCCCCCeehhHHHHHHHHhCCCCCCCCChhhh--
Q 044510 74 ISDFGASRYVTIDQTH---LTTRVQGTFGYLDLEYFRSSQ------FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEED-- 142 (253)
Q Consensus 74 l~Dfgl~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~-- 142 (253)
|+|||+++........ ......||+.|+|||++.+.. ++.++|||||||++|||+||..||........
T Consensus 149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~ 228 (303)
T d1vjya_ 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence 9999999876543322 223467899999999987542 46789999999999999999888754322111
Q ss_pred ------hhhHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCC
Q 044510 143 ------KSLAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGP 212 (253)
Q Consensus 143 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 212 (253)
...................+.. ..........+.+++.+||+.||.+|||+.||+++|+++....+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~ 301 (303)
T d1vjya_ 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCG---GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred hhcccccchHHHHHHHHhccccCCCCCc---ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence 0111111222222111111111 111233456688899999999999999999999999999876543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-39 Score=258.27 Aligned_cols=180 Identities=29% Similarity=0.409 Sum_probs=144.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.||||||++||+|.+++..+. .+++..++.++.||+.||.|||..+ |+||||||+||+++.++.+||+|||+++
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhee
Confidence 489999999999999998755 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhcc------CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS------SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE 155 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 155 (253)
...... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|..||.+...... .......
T Consensus 159 ~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~------~~~i~~~ 230 (277)
T d1phka_ 159 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM------LRMIMSG 230 (277)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHT
T ss_pred EccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH------HHHHHhC
Confidence 765322 2344678999999999863 2467899999999999999999999987654331 1122222
Q ss_pred ccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 156 NCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
..... .......++.+.+++.+||+.||.+|||++|++++
T Consensus 231 ~~~~~-------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 231 NYQFG-------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CCCCC-------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCCC-------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11110 01112234578899999999999999999999865
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-39 Score=265.12 Aligned_cols=174 Identities=20% Similarity=0.274 Sum_probs=143.7
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+.||+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~ 189 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 189 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cccccccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeee
Confidence 379999999999999998765 5999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccccch
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLFDM 161 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (253)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+...... +....... ..
T Consensus 190 ~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~~~~-~~-- 256 (350)
T d1rdqe_ 190 RVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI------YEKIVSGK-VR-- 256 (350)
T ss_dssp ECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCC-CC--
T ss_pred ecccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH------HHHHhcCC-CC--
Confidence 76432 2345699999999999999999999999999999999999999987554321 11111111 10
Q ss_pred hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 162 LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
.+...+..+.++|.+||+.||.+|+ ++++++++
T Consensus 257 --------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 257 --------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 1122345688899999999999994 89999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-39 Score=261.32 Aligned_cols=190 Identities=23% Similarity=0.394 Sum_probs=149.9
Q ss_pred CEEEEeecCCCChhHHhhccC---------------CCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceee
Q 044510 2 PLLVYEFIPNGTLYRYIHDQT---------------EEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILL 66 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili 66 (253)
.++|||||++|+|.+++.... ....+++..+..++.||+.||.|||+++ ++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 589999999999999997642 1225899999999999999999999999 9999999999999
Q ss_pred cCCCceEEcccCCcccccCCCcc-eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHh-CCCCCCCCChhhhhh
Q 044510 67 DDKFRAKISDFGASRYVTIDQTH-LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLT-GQKPIRSTDTEEDKS 144 (253)
Q Consensus 67 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~llt-g~~pf~~~~~~~~~~ 144 (253)
+.++.++++|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+| |.+||......+.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~-- 256 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 99999999999999876543332 2234568999999999998999999999999999999998 5666655443221
Q ss_pred hHHHHHHHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 145 LAGYFLRAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
+......+. ....+...+..+.+++.+||+.||.+|||+.+|+++|++....
T Consensus 257 ----~~~~i~~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 257 ----FYKMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp ----HHHHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHhcCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 111122211 1111222345688999999999999999999999999887654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-39 Score=260.27 Aligned_cols=194 Identities=19% Similarity=0.132 Sum_probs=141.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+.++++..+..... .+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 75 ~~ivmE~~~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~ 148 (299)
T d1ua2a_ 75 ISLVFDFMETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 148 (299)
T ss_dssp CEEEEECCSEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eeehhhhhcchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCcccc
Confidence 489999998887776665433 5899999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc-
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF- 159 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 159 (253)
....... .....+||+.|+|||++.+. .++.++||||+||++|+|++|..||.+....+..................
T Consensus 149 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 149 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227 (299)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred ccCCCcc-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 6543322 22345689999999998754 57999999999999999999999998765543221111000000000000
Q ss_pred ----------chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 ----------DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ----------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...............+..+.+++.+||+.||.+|||++|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000000011112234578999999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-38 Score=255.31 Aligned_cols=181 Identities=22% Similarity=0.299 Sum_probs=144.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC--CCceEEcccCC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD--KFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~--~~~~kl~Dfgl 79 (253)
.|+|||||+||+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+||+++. ...+||+|||+
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred EEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccch
Confidence 4899999999999999976432 5999999999999999999999999 999999999999984 45899999999
Q ss_pred cccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
++..... .......+++.|+|||...+..++.++||||+||++|+|++|..||......+. +.........
T Consensus 151 ~~~~~~~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~------~~~i~~~~~~- 221 (321)
T d1tkia_ 151 ARQLKPG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIMNAEYT- 221 (321)
T ss_dssp CEECCTT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTCCC-
T ss_pred hhccccC--CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCC-
Confidence 9865432 233445689999999999988899999999999999999999999987654321 1122221111
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.+.... ...+..+.+++.+||..||.+|||++|++++
T Consensus 222 --~~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 222 --FDEEAF----KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --CCHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --CChhhc----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111 1224468899999999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-38 Score=252.06 Aligned_cols=205 Identities=17% Similarity=0.210 Sum_probs=151.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeec---CCCceEEcccC
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLD---DKFRAKISDFG 78 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~---~~~~~kl~Dfg 78 (253)
.++||||+ +++|.+.+..... .+++..+..++.|++.||.|||+++ |+||||||+||+++ .+..++++|||
T Consensus 78 ~~ivme~~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 78 NVMVMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG 151 (299)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred EEEEEEEc-CCchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccC
Confidence 47899999 6677777665432 5999999999999999999999999 99999999999975 35579999999
Q ss_pred CcccccCCCcc------eeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHH
Q 044510 79 ASRYVTIDQTH------LTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRA 152 (253)
Q Consensus 79 l~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~ 152 (253)
+++........ ......||+.|+|||.+.+..++.++|||||||++|+|++|..||..................
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ckia_ 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231 (299)
T ss_dssp SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred cceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc
Confidence 99876543221 223457999999999999888999999999999999999999999876554332222111111
Q ss_pred HhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCCCCCCCccc
Q 044510 153 MKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNCEGIDFV 221 (253)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~ 221 (253)
..... ........+..+.+++.+||+.||.+||++.++.+.|+.+............+|.
T Consensus 232 ~~~~~---------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~ 291 (299)
T d1ckia_ 232 KMSTP---------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 291 (299)
T ss_dssp HHHSC---------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHH
T ss_pred cCCCC---------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCch
Confidence 11110 0111122345688899999999999999999999999988766544444444443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=257.20 Aligned_cols=194 Identities=21% Similarity=0.225 Sum_probs=142.9
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.+++|||+.++.+....... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 90 LTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred EEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhh
Confidence 37999999887665444432 225999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc--
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF-- 159 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 159 (253)
.... ........||+.|+|||++.+.+|+.++||||+||++|+|++|..||.+.+..+..................
T Consensus 165 ~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 165 IYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 5432 223344679999999999999999999999999999999999999998766543211111000000000000
Q ss_pred --------chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 --------DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 --------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...............+..+.+|+.+||+.||.+|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000111222334578899999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-38 Score=255.58 Aligned_cols=189 Identities=22% Similarity=0.362 Sum_probs=148.9
Q ss_pred CEEEEeecCCCChhHHhhcc-------CCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEE
Q 044510 2 PLLVYEFIPNGTLYRYIHDQ-------TEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKI 74 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~-------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl 74 (253)
.++||||+++|+|.+++... .....+++..+.+++.|++.||.|||+++ |+||||||+|||++.++.+||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEE
Confidence 48999999999999998652 11224789999999999999999999999 999999999999999999999
Q ss_pred cccCCcccccCCCcce-eeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhC-CCCCCCCChhhhhhhHHHHHHH
Q 044510 75 SDFGASRYVTIDQTHL-TTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTG-QKPIRSTDTEEDKSLAGYFLRA 152 (253)
Q Consensus 75 ~Dfgl~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg-~~pf~~~~~~~~~~~~~~~~~~ 152 (253)
+|||+++......... .....+++.|+|||.+.+..++.++|+||||+++|||+|| ..||......+. +...
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~------~~~i 248 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------LRFV 248 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH------HHHH
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH------HHHH
Confidence 9999998664332222 2234578999999999999999999999999999999997 577766554331 1111
Q ss_pred HhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhh
Q 044510 153 MKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRAS 209 (253)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 209 (253)
. ..... ..+...+..+.+++.+||+.||.+|||+.+|+++|++..+.
T Consensus 249 ~-~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 249 M-EGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp H-TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred H-hCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 1 11111 11223345789999999999999999999999999887553
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.8e-37 Score=246.00 Aligned_cols=204 Identities=16% Similarity=0.194 Sum_probs=155.5
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC-----CCceEEcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD-----KFRAKISD 76 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~-----~~~~kl~D 76 (253)
.++||||+ +++|.+++..... .++...+..++.|++.||.|||+.| |+||||||+||+++. ++.++|+|
T Consensus 76 ~~~vme~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~D 149 (293)
T d1csna_ 76 NVLVIDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVD 149 (293)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred cEEEEEec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcc
Confidence 48999999 7899999876543 5999999999999999999999999 999999999999964 56899999
Q ss_pred cCCcccccCCCc------ceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHH
Q 044510 77 FGASRYVTIDQT------HLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFL 150 (253)
Q Consensus 77 fgl~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~ 150 (253)
||+++....... .......||+.|+|||++.+..++.++|+|||||++|+|++|..||................
T Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~ 229 (293)
T d1csna_ 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229 (293)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred cceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH
Confidence 999987643221 12234569999999999999889999999999999999999999998765443222221111
Q ss_pred HHHhhccccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhchhhcCCCCCCCCcc
Q 044510 151 RAMKENCLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFELGGIRASIGPQNCEGIDF 220 (253)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~ 220 (253)
........ . ......+.++.+++..|+..+|.+||+++.+.+.|+++...........++|
T Consensus 230 ~~~~~~~~-----~----~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw 290 (293)
T d1csna_ 230 EKKQSTPL-----R----ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 290 (293)
T ss_dssp HHHHHSCH-----H----HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred hccCCCCh-----H----HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 11111110 1 1111233468889999999999999999999999998877765544444444
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=252.66 Aligned_cols=169 Identities=24% Similarity=0.411 Sum_probs=136.2
Q ss_pred CEEEEeecCC-CChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecC-CCceEEcccCC
Q 044510 2 PLLVYEFIPN-GTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDD-KFRAKISDFGA 79 (253)
Q Consensus 2 ~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~-~~~~kl~Dfgl 79 (253)
.|+||||+.+ +++.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 3899999976 67888887654 5999999999999999999999999 999999999999985 47899999999
Q ss_pred cccccCCCcceeeeccccccccccchhccCCC-CCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhccc
Q 044510 80 SRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQF-TKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCL 158 (253)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 158 (253)
++..... ......||+.|+|||++.+..+ +.++||||+||++|+|++|..||..... .......
T Consensus 158 a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------i~~~~~~ 222 (273)
T d1xwsa_ 158 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVF 222 (273)
T ss_dssp CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHHCCCC
T ss_pred ceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------------HhhcccC
Confidence 9765322 2334679999999999987765 5779999999999999999999965211 1111100
Q ss_pred cchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 FDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.+...+..+.+++.+||+.||.+|||++|++++
T Consensus 223 -----------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 223 -----------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -----------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 111234568899999999999999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-37 Score=248.51 Aligned_cols=197 Identities=19% Similarity=0.254 Sum_probs=141.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+.+ ++.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 76 ~~iv~e~~~~-~~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~ 150 (298)
T d1gz8a_ 76 LYLVFEFLHQ-DLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150 (298)
T ss_dssp EEEEEECCSE-EHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred eeEEEeecCC-chhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcce
Confidence 3899999965 5555554432 225999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccCC-CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHh--hccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQ-FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK--ENCL 158 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~ 158 (253)
...... .......||+.|+|||.+.... ++.++|+||+||++|+|++|..||.+.+..+.... ....... ....
T Consensus 151 ~~~~~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~--i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 151 AFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVW 227 (298)
T ss_dssp HHCCCS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--HHHHHCCCCTTTS
T ss_pred eccCCc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHH--HHHhcCCCchhhc
Confidence 664322 2233456899999999987665 47899999999999999999999987654322111 1110000 0000
Q ss_pred cch------------hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhc
Q 044510 159 FDM------------LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE--LGGI 206 (253)
Q Consensus 159 ~~~------------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~--l~~~ 206 (253)
... .............+..+.+++.+||+.||.+|||++|++++ ++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 000 00000011112234578899999999999999999999986 5444
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-37 Score=253.13 Aligned_cols=201 Identities=23% Similarity=0.242 Sum_probs=142.1
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC-ceEEcccCCcc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF-RAKISDFGASR 81 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~-~~kl~Dfgl~~ 81 (253)
|+|||||.++.+..+.........+++..+..++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+++
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchh
Confidence 799999976544443332223336999999999999999999999999 99999999999999765 89999999988
Q ss_pred cccCCCcceeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHH--------HHH
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYF--------LRA 152 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------~~~ 152 (253)
...... ......|++.|+|||.+.+ ..++.++||||+||++|+|++|..||......+........ ...
T Consensus 172 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 172 QLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp ECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 654322 2334568999999998875 46899999999999999999999999876544322111100 000
Q ss_pred Hhhc----cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhchh
Q 044510 153 MKEN----CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE--LGGIRA 208 (253)
Q Consensus 153 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~--l~~~~~ 208 (253)
.... ..................+..+.+|+.+||+.||.+|||+.|++++ ++++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 0000 0000000001111122344578899999999999999999999975 555543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-36 Score=248.56 Aligned_cols=193 Identities=20% Similarity=0.285 Sum_probs=140.7
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
+++++|+.+|+|.+++... ++++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||+++.
T Consensus 86 ~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 4566677799999999764 4999999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCCcc--eeeeccccccccccchhcc-CCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 83 VTIDQTH--LTTRVQGTFGYLDLEYFRS-SQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 83 ~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
....... ......|++.|+|||++.. ..++.++|+||+||++|+|++|..||......+..................
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 5432221 2234568999999999854 457899999999999999999999998766543222211110000000000
Q ss_pred chh--------------chhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 160 DML--------------DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 160 ~~~--------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
... ............+..+.+++.+||+.||.+|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0000001111223468899999999999999999999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-36 Score=245.76 Aligned_cols=195 Identities=18% Similarity=0.218 Sum_probs=139.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+.++.+........ .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 92 ~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 92 IYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp EEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceee
Confidence 379999998766555443332 5899999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCc---ceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc
Q 044510 82 YVTIDQT---HLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC 157 (253)
Q Consensus 82 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 157 (253)
....... .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.....................
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 6543221 122335689999999998765 589999999999999999999999987654432222111110000000
Q ss_pred ccch--------h------chhhhhh-hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 LFDM--------L------DAQVLKE-AKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~~~~--------~------~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.... . ....... ........+.+++.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000 0 0000000 011123467889999999999999999999966
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-35 Score=242.95 Aligned_cols=193 Identities=20% Similarity=0.275 Sum_probs=143.6
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.|+||||+ +.+|..++... .+++..++.++.||+.||.|||+.| |+||||||+||+++.++.+|++|||+++
T Consensus 98 ~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccccee
Confidence 38999999 77888877653 4999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHH-----Hhh
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRA-----MKE 155 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~-----~~~ 155 (253)
..... .....+|+.|+|||.+.+. .++.++||||+||++|+|++|..||...+.............. ...
T Consensus 170 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 170 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 65422 2345689999999998764 4689999999999999999999999876544322111110000 000
Q ss_pred c----------cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhch
Q 044510 156 N----------CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE--LGGIR 207 (253)
Q Consensus 156 ~----------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~--l~~~~ 207 (253)
. .... .............+..+.+|+.+||+.||.+|||++|++++ ++.+.
T Consensus 246 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPE-LEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CSCHHHHHHHHHSCC-CCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hcchhhhhhhccCCc-ccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0 0000 00000111122334568899999999999999999999987 65554
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-36 Score=243.15 Aligned_cols=191 Identities=18% Similarity=0.223 Sum_probs=137.4
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.+++|||+.++.+..+..... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+|++|||.+.
T Consensus 75 ~~i~~e~~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~ 148 (286)
T d1ob3a_ 75 LVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148 (286)
T ss_dssp EEEEEECCSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred eeEEEEeehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccce
Confidence 378999998766666655443 5999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc---
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC--- 157 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 157 (253)
...... .......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+....+..... ........
T Consensus 149 ~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i---~~~~~~~~~~~ 224 (286)
T d1ob3a_ 149 AFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI---FRILGTPNSKN 224 (286)
T ss_dssp HHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCTTT
T ss_pred ecccCc-cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHH---HHhhCCCChhh
Confidence 654322 223344688999999999765 4689999999999999999999999876543321111 11100000
Q ss_pred cc------------chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 158 LF------------DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 158 ~~------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
.. ...............+..+.+++.+||+.||.+|||++|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000000111122334578899999999999999999999854
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-36 Score=245.09 Aligned_cols=182 Identities=26% Similarity=0.325 Sum_probs=144.0
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++||||+.+|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 479999999999999998765 4889999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcceeeeccccccccccchhccC--CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcccc
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSS--QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENCLF 159 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (253)
..............|++.|++||.+.+. .++.++||||+||++|+|++|..||........... .........
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~---i~~~~~~~~-- 252 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE---ISRRILKSE-- 252 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH---HHHHHHHCC--
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcccCC--
Confidence 7654444444456789999999999754 367899999999999999999999987654432211 111111110
Q ss_pred chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 044510 160 DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRP-----TMKEVAFE 202 (253)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~ 202 (253)
...+...+..+.+++.+||+.||.+|| +++|++++
T Consensus 253 --------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 253 --------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 111223455788899999999999999 48888864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.3e-35 Score=239.04 Aligned_cols=190 Identities=19% Similarity=0.242 Sum_probs=138.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCC-ceEEcccCCc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKF-RAKISDFGAS 80 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~-~~kl~Dfgl~ 80 (253)
.++||||+.+++|..+.. .+++..+..++.||+.||.|||++| |+||||||+|||++.++ .+||+|||++
T Consensus 107 ~~~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a 177 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLA 177 (328)
T ss_dssp EEEEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred eeEEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccc
Confidence 478999999999877642 4899999999999999999999999 99999999999998654 6899999999
Q ss_pred ccccCCCcceeeeccccccccccchhccC-CCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhh-hHHHHH------HH
Q 044510 81 RYVTIDQTHLTTRVQGTFGYLDLEYFRSS-QFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKS-LAGYFL------RA 152 (253)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~-~~~~~~------~~ 152 (253)
+...... ......+|+.|+|||.+.+. .++.++|+||+||++++|++|..||.......... ...... ..
T Consensus 178 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 178 EFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp EECCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred eeccCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence 8654322 23345689999999998765 47999999999999999999999997765432211 110000 00
Q ss_pred Hhhccc---cc---h--------hchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 153 MKENCL---FD---M--------LDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 153 ~~~~~~---~~---~--------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
...... .. . .............+..+.+|+.+||+.||.+|||++|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 00 0 00000111112234578899999999999999999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-35 Score=238.58 Aligned_cols=190 Identities=18% Similarity=0.211 Sum_probs=134.1
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+|+|||||.++ +.+.+.. .+++..++.++.||+.||.|||..| |+||||||+||+++.++.++++|||+++
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchH-HHHhhhc-----CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 48999999665 5554432 3899999999999999999999999 9999999999999999999999999887
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHH-------------
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGY------------- 148 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~------------- 148 (253)
..... .......+|+.|+|||++.+..++.++|+||+||++++|++|..||.+.+..........
T Consensus 168 ~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 168 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred ccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 65432 233345689999999999988999999999999999999999999987654332211100
Q ss_pred ---HHHHHhhcccc------chhch---hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 149 ---FLRAMKENCLF------DMLDA---QVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 149 ---~~~~~~~~~~~------~~~~~---~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
........... ..... ..........+..+.+|+.+||+.||.+|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00001110000 00000 00111233456789999999999999999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-35 Score=239.68 Aligned_cols=188 Identities=22% Similarity=0.257 Sum_probs=136.2
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
++|++|+.||+|.+++... ++++..+..++.||+.||.|||++| |+||||||+||+++.++.+|++|||++..
T Consensus 98 ~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred EEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcc
Confidence 5677888899999999653 4999999999999999999999999 99999999999999999999999999865
Q ss_pred ccCCCcceeeeccccccccccchhccCC-CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhh----c-
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRSSQ-FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKE----N- 156 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~----~- 156 (253)
.. .......|++.|+|||...+.. ++.++|+||+||++|+|++|..||.+.+................. .
T Consensus 171 ~~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 171 TD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp CT----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cC----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 43 2223356889999999977654 588999999999999999999999876654322211110000000 0
Q ss_pred ----------cccchhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 157 ----------CLFDMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 157 ----------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
....... ..........+..+.+||.+||+.||.+|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPK-MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCHHHHHHHTTSCCCCC-CCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhhhcccCCC-cchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000000 00001111234568899999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-34 Score=229.66 Aligned_cols=191 Identities=19% Similarity=0.236 Sum_probs=140.0
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCccc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
++|+|++.+++|..++.... .+++..+..++.|++.||.|||.++ |+||||||+||+++.++.+|++|||.++.
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~ 150 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA 150 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEeeecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhc
Confidence 78999999999888877654 5899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCcceeeeccccccccccchhccCC-CCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHhhcc---c
Q 044510 83 VTIDQTHLTTRVQGTFGYLDLEYFRSSQ-FTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMKENC---L 158 (253)
Q Consensus 83 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~ 158 (253)
...... ......+++.|+|||.+.+.. ++.++||||+||++|+|++|..||......... ...+........ .
T Consensus 151 ~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 151 FGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQW 227 (292)
T ss_dssp CCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTC
T ss_pred ccCCCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--HHHHHhhcCCCChhhh
Confidence 643222 223345678899999987665 689999999999999999999987543322111 111111111000 0
Q ss_pred c------------chhchhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 159 F------------DMLDAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 159 ~------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
. ...............+..+.+++.+||+.||.+|||++|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000001111222334578899999999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=3.5e-31 Score=217.95 Aligned_cols=193 Identities=19% Similarity=0.192 Sum_probs=133.0
Q ss_pred EEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhh-CCCCCeEecCCCCCceeecCCC------ceEEc
Q 044510 3 LLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHS-TTSIPIYHRDIKSANILLDDKF------RAKIS 75 (253)
Q Consensus 3 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dl~~~nili~~~~------~~kl~ 75 (253)
+++|+++..+..............+++..+..++.|++.||.|||+ .| |+||||||+||+++.++ .++++
T Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~kl~ 174 (362)
T d1q8ya_ 98 HVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIA 174 (362)
T ss_dssp EEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEEC
T ss_pred eeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceeeEe
Confidence 3555655554443333333344469999999999999999999997 88 99999999999997554 38999
Q ss_pred ccCCcccccCCCcceeeeccccccccccchhccCCCCCCCCeehhHHHHHHHHhCCCCCCCCChhhhhhhHHHHHHHHh-
Q 044510 76 DFGASRYVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGVVFVGLLTGQKPIRSTDTEEDKSLAGYFLRAMK- 154 (253)
Q Consensus 76 Dfgl~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~- 154 (253)
|||.+..... ......|++.|+|||++.+..++.++|+||+||++++|++|..||....................
T Consensus 175 dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~ 250 (362)
T d1q8ya_ 175 DLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250 (362)
T ss_dssp CCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred eccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHH
Confidence 9999875432 22345689999999999988999999999999999999999999976543211111111111000
Q ss_pred -hc---------c----------ccch--------h--chhhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 044510 155 -EN---------C----------LFDM--------L--DAQVLKEAKEEEIITVAMLAKRCLNLNGRKRPTMKEVAFE 202 (253)
Q Consensus 155 -~~---------~----------~~~~--------~--~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 202 (253)
+. . .... . ............+..+.+|+.+||..||.+|||++|++++
T Consensus 251 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred hCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0 0000 0 0011122345677889999999999999999999999875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.53 E-value=7.1e-16 Score=114.51 Aligned_cols=103 Identities=20% Similarity=0.216 Sum_probs=70.8
Q ss_pred CEEEEeecCCCChhHHhhccCCCCCCCHHHHHHHHHHHHHHHHhHhhCCCCCeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 2 PLLVYEFIPNGTLYRYIHDQTEEFTITWEISLRIAVEVSGALSYLHSTTSIPIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 2 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.+++|||+.+..+.+ ++...+..++.|++.+|.|||.+| ++||||||+||+++++ .++|+|||+++
T Consensus 85 ~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG~a~ 150 (191)
T d1zara2 85 NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSV 150 (191)
T ss_dssp TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCTTCE
T ss_pred CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECCCcc
Confidence 368999998765432 334445678999999999999999 9999999999999965 58999999987
Q ss_pred cccCCCcceeeeccccccccccchhccCCCCCCCCeehhHH
Q 044510 82 YVTIDQTHLTTRVQGTFGYLDLEYFRSSQFTKKGDVYSFGV 122 (253)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 122 (253)
........... ...... -.+.+ ...|+.++|+||+.-
T Consensus 151 ~~~~~~~~~~l--~rd~~~-~~~~f-~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 151 EVGEEGWREIL--ERDVRN-IITYF-SRTYRTEKDINSAID 187 (191)
T ss_dssp ETTSTTHHHHH--HHHHHH-HHHHH-HHHHCCCCCHHHHHH
T ss_pred cCCCCCcHHHH--HHHHHH-HHHHH-cCCCCCcccHHHHHH
Confidence 65422211100 000000 01222 356788999999653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.92 E-value=0.00048 Score=51.72 Aligned_cols=28 Identities=29% Similarity=0.425 Sum_probs=24.1
Q ss_pred eEecCCCCCceeecCCCceEEcccCCcc
Q 044510 54 IYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 54 i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
++|+|+.+.||++++++.+-|.||+.+.
T Consensus 185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEEeeccCcceeecCCceEEEeechhcc
Confidence 7899999999999987666799998654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=94.58 E-value=0.026 Score=44.71 Aligned_cols=28 Identities=21% Similarity=0.426 Sum_probs=24.3
Q ss_pred eEecCCCCCceeecCCCceEEcccCCccc
Q 044510 54 IYHRDIKSANILLDDKFRAKISDFGASRY 82 (253)
Q Consensus 54 i~H~dl~~~nili~~~~~~kl~Dfgl~~~ 82 (253)
++|+|+.+.||+++++ .++|+||..+..
T Consensus 225 LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 225 LIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp EECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred eeccCCcCCceeEcCC-ceEEechhhccc
Confidence 8999999999999876 589999987653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.35 E-value=0.012 Score=45.05 Aligned_cols=29 Identities=17% Similarity=0.197 Sum_probs=25.6
Q ss_pred CeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 53 PIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 53 ~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
+++|+|+.++||+++++...-|.||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 38999999999999988777899999764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=91.82 E-value=0.031 Score=41.08 Aligned_cols=28 Identities=21% Similarity=0.255 Sum_probs=24.3
Q ss_pred eEecCCCCCceeecCCCceEEcccCCcc
Q 044510 54 IYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 54 i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
++|+|+.+.||+++++..+-|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 7999999999999987667899998653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=87.66 E-value=0.68 Score=35.05 Aligned_cols=27 Identities=30% Similarity=0.393 Sum_probs=22.0
Q ss_pred CeEecCCCCCceeecCCCceEEcccCCcc
Q 044510 53 PIYHRDIKSANILLDDKFRAKISDFGASR 81 (253)
Q Consensus 53 ~i~H~dl~~~nili~~~~~~kl~Dfgl~~ 81 (253)
.++|+|+.+.||+++++ ..++||+-+.
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eeecCCCCcccEEEeCC--ceEEechhcc
Confidence 47999999999999743 4588998664
|